data_2kl6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kl6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 110.226 -0.287 . . . . 72.31 110.226 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.62 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 59.2 Cg_endo -75.41 175.18 11.6 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.577 2.184 . . . . 65.33 113.399 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -153.58 81.59 1.17 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.847 -0.615 . . . . 75.52 110.194 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.496 HD12 HG13 ' A' ' 470' ' ' VAL . 96.6 mt -81.34 145.09 31.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.22 0.534 . . . . 72.52 111.833 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.555 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 12.0 t -148.55 156.37 42.34 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.103 0.478 . . . . 64.4 111.672 176.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.514 HG13 HG11 ' A' ' 462' ' ' VAL . 27.9 m -125.76 147.95 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.941 -0.572 . . . . 75.04 110.871 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 40.2 mt-10 -134.57 117.98 16.75 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.854 0.359 . . . . 63.32 111.623 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 59.5 mt -94.21 131.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.406 -0.361 . . . . 72.52 110.727 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -142.44 138.85 31.34 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.632 0.253 . . . . 75.02 111.486 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.62 -162.39 32.44 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.017 -0.611 . . . . 73.33 113.51 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.46 124.52 10.42 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.886 2.391 . . . . 55.54 113.189 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -85.72 -15.81 41.01 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.123 0.416 . . . . 72.42 112.123 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 538' ' ' SER . 87.2 t -133.01 126.61 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 120.711 0.291 . . . . 72.52 110.574 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.61 163.4 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.02 0.438 . . . . 73.41 111.648 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.17 157.52 26.03 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.165 -0.541 . . . . 63.53 113.012 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.549 HG22 ' ND2' ' A' ' 453' ' ' ASN . 8.1 p -72.34 140.49 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.006 0.432 . . . . 65.24 111.393 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . 0.549 ' ND2' HG22 ' A' ' 452' ' ' VAL . 41.9 m-80 60.23 23.81 13.19 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.658 0.383 . . . . 73.41 111.936 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -112.3 155.62 23.78 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.545 -0.298 . . . . 74.35 111.075 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 502' ' ' SER . 33.5 tp -90.55 139.81 30.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.878 0.37 . . . . 74.15 111.568 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -131.89 143.59 50.26 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.847 0.356 . . . . 62.32 111.608 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -111.32 126.09 54.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.103 0.478 . . . . 62.22 111.643 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -121.96 150.27 42.27 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.152 -0.476 . . . . 73.22 110.729 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.521 ' HG2' HG21 ' A' ' 500' ' ' THR . 37.8 mt-10 -121.8 128.08 51.29 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.129 -0.487 . . . . 73.55 111.384 -176.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 42.6 t -107.65 114.74 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.183 -0.462 . . . . 74.02 111.229 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 42.0 m-70 -90.49 111.55 22.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.722 0.296 . . . . 74.22 110.377 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.665 HG12 HG22 ' A' ' 475' ' ' VAL . 31.6 m -107.82 122.81 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.005 0.431 . . . . 74.5 110.36 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 496' ' ' GLU . 3.6 ptpp? -141.69 152.86 44.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.586 0.707 . . . . 73.21 112.765 -173.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.663 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 49.1 t-20 -100.8 138.68 37.53 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.159 -0.928 . . . . 71.23 109.758 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 94.4 mt -120.94 -5.58 9.58 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.409 0.522 . . . . 73.3 112.409 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -77.83 -25.19 62.96 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.211 -0.518 . . . . 74.34 114.047 -176.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.62 15.98 59.15 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.243 -0.503 . . . . 75.24 113.776 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.2 tt -134.66 142.69 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.113 0.565 . . . . 71.43 110.736 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.82 140.78 35.22 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.322 0.489 . . . . 64.44 114.322 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.496 HG13 HD12 ' A' ' 440' ' ' LEU . 47.0 t -131.85 114.3 15.28 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 122.454 0.301 . . . . 74.01 111.671 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -88.84 -10.57 4.19 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 123.196 2.597 . . . . 71.4 113.281 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 84.9 p -85.0 13.27 6.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.636 0.775 . . . . 72.11 112.876 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 63.3 m -87.4 93.35 9.38 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.909 0.861 . . . . 71.12 112.32 -165.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -97.44 127.28 43.27 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.144 -0.934 . . . . 73.33 110.441 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.665 HG22 HG12 ' A' ' 462' ' ' VAL . 47.7 t -114.06 125.1 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.673 0.273 . . . . 71.22 111.079 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . 0.476 ' HD2' ' OE1' ' A' ' 519' ' ' GLU . 62.8 mtt85 -125.52 149.79 47.99 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.99 0.424 . . . . 75.11 111.812 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.87 127.09 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.125 0.488 . . . . 73.3 111.436 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -120.37 136.8 54.59 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.932 -0.577 . . . . 74.21 111.384 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 60.1 mt -109.0 107.87 23.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.22 -0.446 . . . . 75.43 109.982 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 57.43 34.9 25.3 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.123 0.487 . . . . 74.22 111.214 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.57 -5.86 84.22 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 116.122 -0.49 . . . . 74.01 113.848 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 42.3 m -93.34 125.63 38.04 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.051 0.426 . . . . 53.24 111.33 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.1 tp -65.72 117.56 8.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.115 0.413 . . . . 75.33 112.115 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -88.74 -45.21 9.97 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.535 -0.302 . . . . 75.44 111.449 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -169.99 161.98 8.98 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.671 0.272 . . . . 73.44 111.4 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -131.93 152.04 51.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.038 0.447 . . . . 65.5 111.595 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -134.54 147.27 50.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.029 -0.532 . . . . 74.11 110.864 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.0 m -121.36 119.21 31.48 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.116 -0.328 . . . . 64.45 110.116 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.5 172.81 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.154 0.502 . . . . 75.3 111.476 -176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 91.5 p -126.0 132.44 52.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.252 -0.431 . . . . 55.45 110.649 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.492 HD12 HD22 ' A' ' 440' ' ' LEU . 95.9 mt -118.23 119.74 35.59 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.842 0.353 . . . . 73.34 111.373 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -78.45 -165.49 27.77 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.056 -0.593 . . . . 70.43 112.975 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.24 95.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.084 1.856 . . . . 71.25 112.413 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.0 mttt 65.78 44.05 2.97 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.646 -0.706 . . . . 63.31 112.61 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -98.43 152.57 19.36 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.089 -0.505 . . . . 74.42 111.347 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 463' ' ' LYS . 35.6 tt0 -130.72 138.8 50.16 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.934 0.397 . . . . 72.33 111.694 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -119.55 138.76 52.98 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.948 -0.39 . . . . 73.35 109.948 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.01 113.24 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.021 0.439 . . . . 75.0 111.801 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 82.3 mt -103.88 146.46 28.62 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.288 -0.414 . . . . 71.33 111.267 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' THR . . . . . 0.521 HG21 ' HG2' ' A' ' 459' ' ' GLU . 43.4 p -127.06 156.76 41.16 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.189 0.518 . . . . 73.24 111.803 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -155.56 148.23 24.12 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.97 -0.559 . . . . 75.03 111.031 171.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.511 ' HB3' HD11 ' A' ' 455' ' ' LEU . 43.3 m -110.98 115.23 29.13 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.297 -0.411 . . . . 73.34 110.849 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -108.54 135.03 50.48 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.818 0.342 . . . . 73.5 111.763 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.3 m -116.14 100.68 53.7 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 116.39 -0.368 . . . . 71.13 111.262 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 74.5 Cg_endo -76.17 97.36 1.11 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.388 2.059 . . . . 72.53 112.881 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 67.0 p -76.71 -22.61 53.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.104 0.409 . . . . 70.12 112.104 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -107.33 138.58 43.26 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.843 0.354 . . . . 73.31 110.803 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.74 140.41 30.52 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.285 0.565 . . . . 65.04 112.189 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 148.49 -179.13 25.58 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.89 -0.595 . . . . 70.51 112.153 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 67.6 mtp -94.02 126.35 39.19 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.8 -0.824 . . . . 73.55 111.664 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.93 131.61 53.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.122 -0.49 . . . . 71.22 111.126 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -97.24 122.01 39.78 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.914 0.388 . . . . 73.41 111.263 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 63.1 mt -100.58 119.59 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.03 0.443 . . . . 72.45 110.951 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -115.82 151.87 34.41 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.04 0.448 . . . . 75.03 111.712 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -128.12 132.8 48.94 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.063 -0.517 . . . . 63.13 110.547 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 44.0 p -128.89 143.14 50.81 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.317 -0.401 . . . . 75.04 111.292 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.9 141.13 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.019 0.437 . . . . 74.31 111.697 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 21.8 t70 50.23 49.75 19.94 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.632 0.773 . . . . 74.51 112.632 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . 0.476 ' OE1' ' HD2' ' A' ' 476' ' ' ARG . 54.6 mt-10 -53.0 -29.45 29.29 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.247 0.546 . . . . 74.42 111.171 172.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.466 ' HB2' HG22 ' A' ' 522' ' ' THR . 0.0 OUTLIER -65.24 -17.3 64.38 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.655 -0.702 . . . . 72.24 110.933 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.91 56.57 5.27 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.243 0.544 . . . . 73.14 110.394 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' THR . . . . . 0.466 HG22 ' HB2' ' A' ' 520' ' ' GLU . 64.5 p -83.9 -36.66 23.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.207 -0.451 . . . . 71.53 111.413 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.22 141.68 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.459 0.54 . . . . 74.4 112.459 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 57.8 t -85.09 119.43 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.197 -0.456 . . . . 72.52 110.461 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.62 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 25.5 mt-10 -115.14 174.8 5.8 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.992 0.738 . . . . 74.32 112.992 -174.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.06 -39.65 55.0 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.511 -0.768 . . . . 73.54 112.286 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -120.07 118.66 31.19 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.207 0.527 . . . . 63.4 111.346 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.78 -20.84 32.6 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.345 0.593 . . . . 74.32 111.495 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -93.39 -4.38 51.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.227 0.537 . . . . 74.25 111.339 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.555 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 62.5 t30 -86.73 -10.79 52.88 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 120.982 0.42 . . . . 72.03 111.72 -174.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -85.02 1.45 47.57 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.117 0.784 . . . . 74.3 113.117 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.2 t -127.46 136.93 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 112.38 0.511 . . . . 70.53 112.38 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -125.44 141.19 52.19 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.269 -0.423 . . . . 74.33 110.883 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 84.4 m -127.59 119.7 26.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.168 0.433 . . . . 75.3 112.168 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -126.22 123.38 38.05 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.822 0.344 . . . . 74.33 110.847 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -94.38 120.56 34.8 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.877 0.37 . . . . 75.55 111.848 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.9 t -112.68 141.26 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.191 0.519 . . . . 74.54 111.94 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' SER . . . . . 0.455 ' HB3' HG22 ' A' ' 449' ' ' VAL . 40.2 t -113.79 115.88 28.48 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.296 -0.411 . . . . 74.53 111.031 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 43.6 t -99.8 120.83 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.859 0.362 . . . . 73.23 111.05 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.6 164.5 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.498 0.555 . . . . 72.33 112.498 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.4 mt -77.73 -30.86 51.85 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.356 0.502 . . . . 74.04 112.356 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--O 1.251 1.167 0 N-CA-C 112.383 0.512 . . . . 75.25 112.383 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 CA--C 1.533 0.291 0 CA-C-O 120.547 0.213 . . . . 74.34 110.461 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.571 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 61.3 Cg_endo -71.73 175.73 9.2 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.711 2.274 . . . . 75.53 112.789 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -151.6 83.66 1.29 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.123 -0.49 . . . . 70.03 109.872 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.506 HD23 HD12 ' A' ' 491' ' ' LEU . 80.0 mt -83.23 99.15 9.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.014 -0.539 . . . . 74.14 111.132 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.475 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 6.5 t -116.64 149.62 39.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.451 . . . . 74.21 111.149 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.517 ' O ' ' HB2' ' A' ' 533' ' ' ALA . 31.4 m -121.37 148.56 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.263 -0.426 . . . . 65.22 111.227 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.3 mt-10 -130.01 117.74 20.51 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.628 0.251 . . . . 71.25 111.388 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 55.4 mt -92.47 131.05 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 110.456 -0.202 . . . . 74.55 110.456 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -142.45 144.51 33.08 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.541 0.21 . . . . 74.32 111.23 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.32 -159.3 29.04 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.989 -0.624 . . . . 74.43 113.38 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.69 134.22 21.71 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.906 2.404 . . . . 75.12 113.22 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -92.3 -20.25 21.3 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.433 0.531 . . . . 73.52 112.433 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.1 t -127.97 125.75 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.959 -0.463 . . . . 75.31 111.241 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 33.6 m -135.65 161.27 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.982 0.42 . . . . 75.44 111.32 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -95.51 166.49 25.39 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.061 -0.59 . . . . 65.14 113.012 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.518 HG23 ' ND2' ' A' ' 453' ' ' ASN . 12.4 p -69.93 139.27 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 O-C-N 122.277 -0.543 . . . . 73.43 111.409 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . 0.518 ' ND2' HG23 ' A' ' 452' ' ' VAL . 48.4 m-80 63.6 17.95 10.75 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.913 0.485 . . . . 75.2 112.166 -177.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . 0.513 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.8 mmmt -95.15 150.85 19.75 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.857 0.361 . . . . 74.34 110.812 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 502' ' ' SER . 37.6 tp -96.69 118.97 34.28 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.7 0.286 . . . . 70.0 111.004 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.06 134.74 54.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.886 0.374 . . . . 73.22 111.715 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -108.55 130.05 55.3 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.0 0.428 . . . . 73.34 111.45 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -122.33 166.44 14.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.088 0.47 . . . . 74.45 111.488 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -121.19 127.5 51.56 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.975 -0.557 . . . . 70.15 111.24 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 29.8 t -104.83 113.04 40.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 75.21 110.024 173.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 29.9 m-70 -98.34 106.22 18.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.648 0.261 . . . . 75.52 110.512 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.519 HG12 HG22 ' A' ' 475' ' ' VAL . 19.4 m -105.8 123.48 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.2 0.524 . . . . 70.34 110.104 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.53 ' HD3' HD22 ' A' ' 465' ' ' LEU . 15.2 ptpt -139.89 144.18 37.05 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.517 0.562 . . . . 74.32 112.517 -170.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.4 t-20 -102.76 126.7 49.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.191 -0.67 . . . . 73.54 109.191 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.53 HD22 ' HD3' ' A' ' 463' ' ' LYS . 67.9 mt -112.69 0.15 15.25 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.011 -0.43 . . . . 75.22 112.034 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -83.87 -21.47 57.5 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.073 -0.584 . . . . 73.02 113.797 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.61 21.4 47.8 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.07 -0.586 . . . . 64.41 113.861 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.409 HG22 ' HB3' ' A' ' 438' ' ' PRO . 3.7 tt -138.1 133.77 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 122.662 -0.316 . . . . 73.54 111.076 175.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.1 141.41 34.28 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 114.684 0.634 . . . . 74.35 114.684 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.67 116.27 16.02 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.834 0.454 . . . . 61.13 111.344 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.71 -12.17 11.19 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.056 2.504 . . . . 74.53 113.086 175.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 50.7 m -81.59 13.51 3.06 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.587 0.755 . . . . 71.05 112.79 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' THR . . . . . 0.421 HG22 HG23 ' A' ' 517' ' ' VAL . 62.9 m -86.56 91.15 8.47 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 122.119 0.962 . . . . 62.44 111.465 -165.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -95.08 121.7 36.99 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.698 -1.137 . . . . 75.34 110.364 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.519 HG22 HG12 ' A' ' 462' ' ' VAL . 41.4 t -104.31 118.24 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.001 0.429 . . . . 64.43 111.291 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -116.58 144.37 44.46 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.642 0.258 . . . . 73.43 111.555 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 95.6 t -120.17 120.25 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.801 0.334 . . . . 70.21 110.881 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -116.08 137.39 52.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.25 -0.432 . . . . 74.11 111.387 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.478 HG12 HG12 ' A' ' 513' ' ' ILE . 63.3 mt -111.85 107.94 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.799 -0.445 . . . . 74.44 109.799 174.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 56.27 34.44 24.04 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.093 0.473 . . . . 75.24 111.183 -173.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.9 -20.65 47.88 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 116.252 -0.431 . . . . 54.42 113.732 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 45.5 m -81.93 121.71 26.84 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.357 -0.496 . . . . 75.41 111.81 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -63.91 120.32 11.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.077 0.465 . . . . 74.51 111.555 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -102.91 -43.89 5.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.201 -0.454 . . . . 74.12 111.982 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -146.91 152.53 38.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.583 0.23 . . . . 75.13 111.107 -174.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -145.3 139.15 26.87 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.103 0.478 . . . . 73.41 111.496 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -129.7 148.86 51.63 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.121 -0.49 . . . . 75.31 110.709 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 78.5 m -117.62 118.48 32.24 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.69 0.281 . . . . 72.21 110.244 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.1 m -141.8 173.43 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.283 0.563 . . . . 71.34 111.765 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 64.9 m -121.35 135.48 55.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.121 -0.49 . . . . 72.31 110.914 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.506 HD12 HD23 ' A' ' 440' ' ' LEU . 85.1 mt -118.11 119.85 35.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.806 0.336 . . . . 70.32 111.072 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -82.72 -169.03 43.6 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.326 -0.464 . . . . 61.02 113.449 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.51 107.88 0.64 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.417 2.078 . . . . 74.35 112.7 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.0 mmtp 68.45 29.21 5.79 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.126 -0.488 . . . . 75.24 111.596 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -92.2 147.4 22.96 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.369 -0.378 . . . . 71.31 111.728 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -135.12 129.35 33.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.605 0.362 . . . . 71.43 111.479 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -116.79 136.63 52.8 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.677 0.275 . . . . 74.14 110.704 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 63.1 t -101.77 113.54 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 121.199 0.523 . . . . 61.34 111.488 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 68.7 mt -110.7 131.15 55.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.97 -0.559 . . . . 65.41 110.489 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 26.6 p -113.9 154.7 27.08 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.267 0.556 . . . . 72.43 112.32 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -144.4 148.8 35.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.645 -0.707 . . . . 64.14 110.816 174.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.5 ' HB2' HD11 ' A' ' 455' ' ' LEU . 76.0 p -115.04 114.36 25.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.065 0.46 . . . . 72.23 110.805 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -113.56 137.18 51.94 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.24 -0.436 . . . . 64.12 112.002 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.4 m -116.24 102.03 53.72 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.093 -0.503 . . . . 75.44 111.222 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 60.7 Cg_endo -71.92 99.38 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.534 2.156 . . . . 74.21 112.955 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 33.1 p -74.04 -21.88 59.77 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.944 0.402 . . . . 75.34 111.907 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -112.36 141.19 46.39 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.413 -0.358 . . . . 71.44 111.107 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.68 151.18 23.64 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.257 0.551 . . . . 75.23 111.926 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 148.02 -170.97 28.6 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.06 -0.591 . . . . 70.15 112.77 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' MET . . . . . 0.411 ' HE2' ' HB2' ' A' ' 536' ' ' ASP . 13.7 tpt -98.76 120.83 39.87 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.503 -0.41 . . . . 74.32 110.729 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -120.23 116.22 25.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.899 0.38 . . . . 74.42 111.701 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -92.47 112.94 25.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.901 0.381 . . . . 74.34 110.482 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.478 HG12 HG12 ' A' ' 479' ' ' ILE . 58.1 mt -93.8 117.34 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.254 0.55 . . . . 75.31 110.907 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -117.05 134.66 54.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 74.53 111.1 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.35 133.16 53.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.733 0.301 . . . . 65.5 110.646 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 532' ' ' VAL . 66.5 p -125.41 140.32 52.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.99 0.424 . . . . 73.33 111.61 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . 0.421 HG23 HG22 ' A' ' 473' ' ' THR . 7.4 p -120.29 140.83 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.814 0.34 . . . . 72.14 111.022 174.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.6 t0 43.43 58.74 3.3 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.393 0.677 . . . . 71.31 112.778 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -57.75 -29.99 65.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.608 0.718 . . . . 74.33 110.475 171.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.62 -17.3 64.56 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.259 -0.882 . . . . 73.44 111.791 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 19.7 m120 51.4 55.4 9.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.671 0.748 . . . . 75.34 111.306 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 51.1 p -67.21 -19.72 65.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.377 -0.829 . . . . 74.22 111.363 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.22 141.13 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.749 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 74.0 t -83.58 119.78 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 110.069 -0.345 . . . . 75.11 110.069 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.571 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 18.9 mt-10 -110.24 -175.03 2.63 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.699 0.629 . . . . 73.04 112.699 -171.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 99.2 mt -69.48 -39.26 77.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.275 -0.42 . . . . 71.41 111.209 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -126.73 124.85 40.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.343 -0.39 . . . . 63.01 110.864 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -83.2 -23.98 32.61 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.848 0.314 . . . . 74.5 111.848 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -103.49 4.2 35.71 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.631 0.604 . . . . 71.33 112.631 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.475 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.7 t30 -86.62 -1.75 57.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.087 0.47 . . . . 74.22 111.373 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -80.85 -1.06 41.69 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.677 0.621 . . . . 74.14 112.677 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.508 HG22 HG23 ' A' ' 516' ' ' THR . 56.6 t -124.53 129.61 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.112 0.412 . . . . 64.02 112.112 -176.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -114.3 142.86 45.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.342 -0.39 . . . . 52.11 111.162 177.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 63.2 m -116.22 130.14 56.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.36 -0.382 . . . . 74.31 111.963 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -142.88 117.64 9.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.443 -0.344 . . . . 71.44 110.28 174.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . 0.411 ' HB2' ' HE2' ' A' ' 510' ' ' MET . 6.5 p-10 -96.34 134.31 39.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.185 0.516 . . . . 61.34 112.277 -176.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.03 138.12 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.086 -0.506 . . . . 74.3 111.52 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.3 t -104.26 127.28 51.87 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.597 -0.274 . . . . 75.04 111.422 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 47.1 t -111.35 126.61 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.803 0.335 . . . . 73.01 111.258 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 28.8 m -121.04 164.3 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.596 0.591 . . . . 72.52 112.596 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 79.6 mt -88.26 11.06 17.55 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.508 0.558 . . . . 74.03 112.508 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--O 1.251 1.179 0 N-CA-C 112.369 0.507 . . . . 53.1 112.369 -176.688 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 120.597 0.236 . . . . 71.11 110.759 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.505 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 74.4 Cg_endo -81.77 175.96 8.86 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.944 2.429 . . . . 75.23 113.433 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -155.73 86.79 1.06 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.051 -0.522 . . . . 73.53 109.997 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.507 HD22 HD11 ' A' ' 491' ' ' LEU . 75.7 mt -89.0 105.37 17.74 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.975 0.417 . . . . 70.11 111.981 -176.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.705 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 8.0 t -113.14 152.12 30.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.2 0.524 . . . . 74.14 111.804 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.523 HG13 HG11 ' A' ' 462' ' ' VAL . 33.5 m -124.35 147.88 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.788 -0.642 . . . . 63.55 111.123 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 41.7 mt-10 -133.47 142.31 48.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.691 -0.231 . . . . 73.05 111.263 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 58.2 mt -111.59 129.77 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.723 0.297 . . . . 75.43 111.077 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -133.02 133.9 43.7 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.25 -0.281 . . . . 75.04 111.202 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.38 -170.94 39.75 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.89 -0.672 . . . . 73.04 113.5 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.14 126.87 13.54 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.702 2.268 . . . . 64.03 113.079 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -77.9 -19.99 53.72 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.058 0.392 . . . . 73.11 112.058 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.67 127.94 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.438 0.295 . . . . 74.13 110.38 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.84 163.93 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.28 0.562 . . . . 75.4 111.885 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.14 153.74 20.34 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.229 -0.51 . . . . 72.32 113.253 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.45 HG11 HD21 ' A' ' 541' ' ' LEU . 14.4 p -68.47 141.76 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.626 0.25 . . . . 72.21 111.236 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 59.97 21.44 10.51 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.058 0.456 . . . . 73.15 111.808 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -107.26 165.08 11.64 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.011 0.434 . . . . 75.42 111.483 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 502' ' ' SER . 29.4 tp -103.77 117.37 34.2 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.415 -0.357 . . . . 74.33 111.341 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.94 133.27 56.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.687 0.28 . . . . 71.2 111.509 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -110.7 133.76 53.05 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.081 0.467 . . . . 73.03 111.836 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -123.49 163.25 21.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.94 -0.573 . . . . 72.34 111.144 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -119.86 127.31 52.62 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.854 0.359 . . . . 75.34 110.569 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.47 112.96 36.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.69 -0.485 . . . . 71.4 109.69 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 30.7 m-70 -96.21 107.83 20.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.425 -0.352 . . . . 73.22 110.661 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.552 HG12 HG22 ' A' ' 475' ' ' VAL . 14.4 m -108.97 122.0 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.139 0.495 . . . . 65.12 110.451 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 496' ' ' GLU . 4.6 ptpp? -138.63 144.2 39.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.382 0.611 . . . . 74.43 112.253 -173.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 51.6 t-20 -99.96 127.3 46.17 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.599 -0.728 . . . . 71.4 109.808 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.419 HD21 ' HD3' ' A' ' 463' ' ' LYS . 82.7 mt -111.92 -1.9 15.33 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.958 0.355 . . . . 64.3 111.958 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -81.71 -15.72 74.88 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.388 -0.434 . . . . 74.42 113.831 -178.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.88 20.4 65.57 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 120.938 -0.649 . . . . 73.03 113.854 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.426 HG21 ' HB3' ' A' ' 438' ' ' PRO . 5.8 tt -138.47 135.03 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 122.731 -0.276 . . . . 74.55 111.412 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -66.88 134.88 32.27 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 114.123 0.409 . . . . 52.41 114.123 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.494 HG13 HD12 ' A' ' 440' ' ' LEU . 86.9 t -129.6 116.75 18.41 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 122.651 0.38 . . . . 75.51 111.842 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.2 -10.44 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.085 2.523 . . . . 74.51 113.143 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.8 t -80.62 12.52 3.06 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.149 0.58 . . . . 74.02 112.469 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' THR . . . . . 0.414 HG23 HG23 ' A' ' 517' ' ' VAL . 67.7 m -87.61 91.09 8.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.958 0.885 . . . . 74.3 111.803 -166.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 517' ' ' VAL . 91.4 mttt -94.5 124.15 38.35 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.956 -1.02 . . . . 73.31 110.29 173.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.552 HG22 HG12 ' A' ' 462' ' ' VAL . 41.3 t -110.19 119.61 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.721 0.296 . . . . 75.32 111.005 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . 0.408 ' NH1' ' HB2' ' A' ' 519' ' ' GLU . 71.8 mtt180 -122.5 146.81 47.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 111.79 0.293 . . . . 73.21 111.79 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.8 t -120.65 124.18 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.044 0.45 . . . . 75.13 111.186 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -111.78 137.15 50.1 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.976 -0.557 . . . . 65.03 110.704 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.536 HG12 HG12 ' A' ' 513' ' ' ILE . 59.8 mt -117.37 108.67 25.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.854 0.359 . . . . 74.33 111.34 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 66.2 t30 60.06 34.1 21.31 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.266 0.555 . . . . 72.45 111.462 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 97.65 -12.79 64.47 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.274 -0.489 . . . . 44.33 114.031 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 89.8 m -105.21 127.07 52.75 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.332 0.566 . . . . 74.22 111.75 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.7 tp -61.98 128.0 34.06 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.943 0.401 . . . . 73.53 110.855 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -105.38 -43.6 4.94 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.644 0.609 . . . . 71.11 112.644 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -162.75 159.33 24.05 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.272 -0.267 . . . . 74.4 111.02 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -145.53 157.2 44.03 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.894 0.378 . . . . 62.1 111.753 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 -137.2 148.75 46.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.191 -0.459 . . . . 75.3 110.754 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 51.8 m -117.96 118.04 30.89 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.881 0.372 . . . . 70.32 110.168 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.12 174.55 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.21 0.528 . . . . 72.22 111.752 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 89.9 p -129.39 140.08 51.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.148 -0.478 . . . . 71.51 110.608 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.507 HD11 HD22 ' A' ' 440' ' ' LEU . 79.4 mt -117.44 121.49 41.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.852 0.358 . . . . 75.43 111.752 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -78.41 -172.18 40.1 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.357 -0.449 . . . . 71.12 113.08 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.16 110.54 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.45 2.1 . . . . 73.34 112.906 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 39.5 mmtm 67.0 26.63 9.01 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.986 -0.552 . . . . 75.44 111.929 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -99.2 146.89 25.69 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.109 -0.496 . . . . 73.31 112.064 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 41.6 tt0 -129.07 145.77 51.19 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.103 0.478 . . . . 63.23 111.937 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -121.6 137.18 54.85 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.784 -0.45 . . . . 74.41 109.784 172.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 52.9 t -101.04 112.12 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.139 0.495 . . . . 72.12 110.814 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 57.8 mt -103.15 146.57 28.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.989 -0.551 . . . . 71.34 110.714 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 20.0 p -130.21 155.31 46.47 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.549 0.69 . . . . 75.43 112.591 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.26 148.65 26.1 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.32 -0.855 . . . . 73.22 110.21 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 455' ' ' LEU . 51.8 p -116.88 114.79 24.38 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.911 0.386 . . . . 74.4 110.984 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -104.15 136.72 43.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.262 -0.426 . . . . 73.51 111.896 -174.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.6 m -117.43 100.7 52.86 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 116.39 -0.368 . . . . 74.12 111.096 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.16 100.14 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.751 2.3 . . . . 73.14 113.072 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.9 p -78.57 -29.64 46.35 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.268 0.47 . . . . 74.32 112.268 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -100.43 131.67 46.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.832 0.349 . . . . 64.03 110.73 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.36 150.37 23.88 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.11 0.481 . . . . 73.22 112.068 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.79 -170.38 29.91 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.365 -0.445 . . . . 74.43 112.924 -178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 14.9 tpt -91.6 124.54 35.84 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 122.437 -0.449 . . . . 74.31 111.565 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -128.4 151.96 48.76 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.985 0.421 . . . . 74.33 111.258 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -124.18 119.72 30.22 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.104 -0.372 . . . . 63.01 111.615 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.536 HG12 HG12 ' A' ' 479' ' ' ILE . 52.6 mt -95.95 126.77 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.019 0.438 . . . . 72.14 111.306 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -123.01 145.21 48.7 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.989 0.423 . . . . 75.32 111.575 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.68 134.26 53.76 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.185 -0.461 . . . . 74.43 110.309 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 50.5 p -136.93 151.37 48.96 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.955 0.407 . . . . 73.05 111.945 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 474' ' ' LYS . 7.8 p -128.92 149.8 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 116.26 -0.427 . . . . 72.43 111.722 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 17.2 t70 47.9 43.53 17.57 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.71 0.767 . . . . 65.42 111.741 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . 0.408 ' HB2' ' NH1' ' A' ' 476' ' ' ARG . 6.9 mm-40 -51.4 -30.94 20.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.68 -0.691 . . . . 65.25 111.627 174.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -23.65 66.33 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.807 -0.633 . . . . 75.1 110.678 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 62.59 82.11 0.19 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.249 0.619 . . . . 75.33 110.303 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 53.8 p -109.45 -26.95 9.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 72.41 111.637 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.04 141.59 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 112.978 0.733 . . . . 70.33 112.978 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 99.0 t -84.6 114.5 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.141 -0.481 . . . . 74.44 110.296 172.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.485 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 27.3 mt-10 -101.78 176.8 5.1 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.636 0.606 . . . . 75.43 112.636 -174.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.15 -39.61 86.99 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.904 -0.589 . . . . 71.15 110.944 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . 0.561 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 32.2 t30 -141.55 93.19 2.54 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.371 0.605 . . . . 73.23 110.302 173.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.55 14.95 3.37 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.064 -0.516 . . . . 64.4 112.212 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -104.62 -3.44 23.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.718 0.771 . . . . 72.11 109.67 167.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.705 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.1 t30 -86.55 -0.65 56.56 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.418 -0.81 . . . . 74.4 111.355 -174.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -83.76 -6.86 59.53 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.882 0.697 . . . . 73.44 112.882 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.49 138.45 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.215 0.45 . . . . 75.41 112.215 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.08 142.84 50.57 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.215 -0.448 . . . . 71.22 111.183 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.4 m -126.77 133.91 50.73 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.665 0.269 . . . . 73.34 111.626 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -143.15 129.73 20.19 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.818 0.342 . . . . 74.34 111.08 177.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -93.6 134.7 35.61 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.877 0.37 . . . . 74.11 111.883 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 63.0 t -128.83 128.36 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.044 0.449 . . . . 74.44 111.43 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 46.6 t -103.82 120.88 41.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.77 0.319 . . . . 72.53 111.078 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.23 120.08 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.896 0.379 . . . . 75.11 111.321 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.0 m -119.49 167.74 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.183 0.516 . . . . 74.44 112.116 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . 0.45 HD21 HG11 ' A' ' 452' ' ' VAL . 98.0 mt -80.4 25.94 0.39 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.215 0.45 . . . . 74.3 112.215 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.545 -0.741 . . . . 64.43 111.914 -177.62 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 120.756 0.313 . . . . 74.22 110.425 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.86 174.19 11.93 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.707 2.271 . . . . 65.43 114.046 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.0 93.97 2.99 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.424 -0.807 . . . . 74.13 109.471 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 98.4 mt -98.07 108.21 20.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.872 0.368 . . . . 75.23 111.348 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 8.7 t -123.34 152.68 41.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.136 0.493 . . . . 75.12 111.669 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.485 HG13 HG11 ' A' ' 462' ' ' VAL . 34.8 m -120.87 147.85 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.972 -0.558 . . . . 71.43 110.846 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.605 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 43.1 mt-10 -130.28 137.18 49.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.666 -0.243 . . . . 55.04 110.747 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.05 138.02 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.146 0.498 . . . . 75.01 111.689 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -137.1 146.1 44.7 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.049 -0.523 . . . . 74.45 110.97 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.64 -171.2 33.63 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.674 -0.774 . . . . 61.25 114.025 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.04 123.45 8.38 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.819 2.346 . . . . 73.01 112.712 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.48 -13.32 52.34 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.397 0.517 . . . . 75.41 112.397 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 80.2 t -131.38 122.96 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.653 0.263 . . . . 73.44 110.75 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 31.2 m -135.81 163.19 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.172 0.511 . . . . 73.23 111.802 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -100.78 163.91 18.59 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 116.188 -0.46 . . . . 41.5 112.979 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.464 HG23 ' ND2' ' A' ' 453' ' ' ASN . 8.6 p -68.91 144.01 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 122.496 -0.414 . . . . 74.22 111.339 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . 0.464 ' ND2' HG23 ' A' ' 452' ' ' VAL . 40.2 m-80 60.17 17.61 7.06 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.221 0.452 . . . . 73.25 112.221 -177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . 0.422 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.1 mmmt -103.82 138.84 39.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.923 0.392 . . . . 73.15 111.299 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.507 HD11 ' HB3' ' A' ' 502' ' ' SER . 36.2 tp -85.39 125.35 32.91 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.194 -0.457 . . . . 74.14 111.251 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -124.79 136.66 54.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.917 0.389 . . . . 70.54 111.81 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.33 133.94 46.43 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.049 0.452 . . . . 73.1 111.746 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 86.1 m-85 -122.31 150.93 41.68 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.205 -0.452 . . . . 72.41 111.03 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -120.88 127.23 51.68 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.951 -0.568 . . . . 64.25 110.875 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.6 t -113.68 127.47 71.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 122.785 0.434 . . . . 71.23 111.212 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 77.7 m-70 -107.75 110.67 22.55 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.812 0.339 . . . . 74.11 110.594 176.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.608 HG12 HG22 ' A' ' 475' ' ' VAL . 33.6 m -107.47 124.27 63.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 120.896 0.379 . . . . 64.34 110.304 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.518 ' HD3' HD22 ' A' ' 465' ' ' LEU . 13.4 ptpt -143.73 153.75 42.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.159 0.8 . . . . 64.54 113.159 -170.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 48.9 t-20 -112.0 126.45 55.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.355 -0.839 . . . . 74.35 109.47 173.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.518 HD22 ' HD3' ' A' ' 463' ' ' LYS . 47.1 mt -114.28 5.16 15.69 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.867 0.365 . . . . 73.11 111.658 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -82.36 -20.14 62.96 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.308 -0.472 . . . . 54.41 113.682 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.84 14.91 62.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.021 -0.609 . . . . 73.31 113.603 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.9 tt -135.94 133.46 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 122.52 0.328 . . . . 75.14 111.119 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.36 139.86 28.6 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 114.172 0.429 . . . . 72.24 114.172 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 52.8 t -130.36 114.35 17.12 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 111.95 0.352 . . . . 74.4 111.95 -177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.28 -11.33 13.32 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.982 2.455 . . . . 73.33 112.755 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' SER . . . . . 0.484 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 20.1 m -80.55 11.38 3.77 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.658 0.783 . . . . 65.22 112.773 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 39.9 m -89.53 91.92 8.89 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.652 0.739 . . . . 65.23 112.316 -165.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -101.9 126.75 48.87 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.403 -0.817 . . . . 74.4 110.357 171.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.608 HG22 HG12 ' A' ' 462' ' ' VAL . 55.6 t -112.62 128.97 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.813 0.339 . . . . 61.55 111.286 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . 0.552 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 82.6 mtt180 -115.63 151.22 35.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.78 0.324 . . . . 75.24 111.312 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.3 t -121.31 120.21 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.835 0.35 . . . . 73.42 111.08 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -114.29 144.67 42.87 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.277 -0.419 . . . . 74.43 111.553 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.526 HG12 HG12 ' A' ' 513' ' ' ILE . 55.2 mt -123.6 107.93 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.115 -0.493 . . . . 64.43 109.73 173.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 53.42 39.14 29.48 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 120.88 0.371 . . . . 73.24 111.84 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 85.63 -0.96 88.31 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.097 -0.573 . . . . 73.34 114.066 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 94.4 m -98.51 120.45 38.95 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.25 0.525 . . . . 73.4 111.401 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 59.7 tp -69.7 115.04 8.48 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.189 0.518 . . . . 74.32 111.376 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -90.03 -43.28 10.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.121 -0.491 . . . . 75.31 111.754 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -167.32 162.25 14.72 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.664 0.268 . . . . 73.21 111.516 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -147.49 152.6 38.33 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.688 0.28 . . . . 75.41 111.139 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 24.7 m-90 -130.0 134.77 47.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.818 0.342 . . . . 74.43 110.764 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 57.1 m -104.38 118.12 35.84 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.731 0.3 . . . . 72.33 110.257 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 22.3 m -140.83 172.85 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.343 0.592 . . . . 71.44 111.489 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 79.6 p -118.51 135.05 54.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.94 -0.573 . . . . 73.15 110.281 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.1 mt -116.96 119.68 36.08 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.886 0.374 . . . . 64.44 110.882 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -80.3 -177.35 50.9 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.079 -0.582 . . . . 51.42 113.116 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.56 108.75 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.476 2.117 . . . . 74.22 112.457 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.2 mmtp 67.91 32.98 4.9 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.14 -0.482 . . . . 73.34 111.816 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -101.33 148.61 24.95 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 111.92 0.341 . . . . 74.23 111.92 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . 0.419 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 14.4 tt0 -131.8 143.68 50.38 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.428 -0.351 . . . . 74.54 111.206 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.637 ' HZ2' ' HB3' ' A' ' 497' ' ' LYS . 2.3 mmmp? -124.67 134.85 52.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.72 0.295 . . . . 75.52 110.575 175.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.06 117.57 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.244 0.545 . . . . 71.41 111.295 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 52.4 mt -114.07 146.7 39.87 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.038 -0.528 . . . . 73.23 110.861 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 33.3 p -129.41 154.47 46.91 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.27 0.557 . . . . 72.53 112.026 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.1 p90 -148.01 149.49 32.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.779 -0.646 . . . . 73.02 110.651 173.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.507 ' HB3' HD11 ' A' ' 455' ' ' LEU . 43.0 m -110.11 115.29 29.49 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.013 0.435 . . . . 71.21 110.333 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -118.05 136.58 53.47 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.969 0.414 . . . . 75.22 112.043 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.7 m -119.11 112.27 36.34 Favored Pre-proline 0 N--CA 1.472 0.653 0 CA-C-N 116.17 -0.468 . . . . 74.32 111.121 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 67.4 Cg_endo -75.06 118.85 5.4 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.418 2.079 . . . . 70.41 112.684 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 42.1 p -92.22 0.75 57.47 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.788 0.662 . . . . 65.52 112.788 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -143.75 145.93 32.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.701 0.286 . . . . 75.54 110.835 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -79.32 150.28 31.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.125 0.488 . . . . 71.1 111.148 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.76 -170.31 30.58 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.256 -0.497 . . . . 75.3 112.542 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' MET . . . . . 0.459 ' SD ' ' C ' ' A' ' 510' ' ' MET . 0.0 OUTLIER -96.43 111.14 23.35 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.93 0.395 . . . . 73.0 110.481 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -115.21 111.5 21.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.068 0.461 . . . . 73.34 111.644 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -96.31 124.85 40.46 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.901 0.381 . . . . 70.12 111.135 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.526 HG12 HG12 ' A' ' 479' ' ' ILE . 57.9 mt -98.55 124.1 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.214 -0.448 . . . . 71.44 111.127 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 21.3 m120 -122.61 138.47 54.58 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.026 0.441 . . . . 75.42 111.415 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.08 132.89 54.57 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.596 -0.275 . . . . 75.24 110.443 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' THR . . . . . 0.508 HG23 HG23 ' A' ' 532' ' ' VAL . 54.1 p -123.47 140.34 53.1 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.875 0.369 . . . . 75.43 111.768 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.42 147.73 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.77 0.319 . . . . 74.03 111.319 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 37.9 t70 57.38 42.23 25.14 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.611 0.72 . . . . 74.25 111.81 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . 0.552 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.2 mm-40 -56.22 -32.55 64.54 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.966 -0.459 . . . . 75.33 111.481 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -67.71 -19.39 65.15 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.259 -0.428 . . . . 71.31 111.64 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 65.52 78.94 0.26 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.093 0.473 . . . . 74.5 111.306 -175.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 44.7 p -132.81 -13.54 2.86 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.061 0.763 . . . . 73.12 113.061 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.9 p -134.64 143.63 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.167 0.508 . . . . 62.22 112.272 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 68.0 t -100.73 117.96 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.343 -0.389 . . . . 74.12 111.096 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -92.64 175.31 6.86 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.242 0.544 . . . . 74.22 111.4 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.57 -29.97 59.5 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.114 -0.494 . . . . 73.54 110.828 172.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -135.35 145.42 47.37 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.697 -0.683 . . . . 60.33 110.239 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.23 2.33 10.85 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.303 0.483 . . . . 72.51 112.303 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -87.25 -4.12 59.07 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.791 0.329 . . . . 62.14 111.708 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -111.83 -2.85 15.1 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.442 0.534 . . . . 71.53 112.442 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -69.67 -17.6 63.5 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.213 0.449 . . . . 74.33 112.213 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.508 HG23 HG23 ' A' ' 516' ' ' THR . 41.1 t -124.13 131.99 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.672 0.272 . . . . 73.13 111.121 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -113.63 138.49 50.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.659 0.266 . . . . 64.44 111.083 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 50.0 m -112.18 127.65 56.01 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.123 0.416 . . . . 72.45 112.123 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -134.86 126.85 29.6 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.37 -0.377 . . . . 62.02 110.303 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.98 124.92 39.31 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.081 0.4 . . . . 75.42 112.081 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.18 128.45 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.139 0.495 . . . . 71.4 111.301 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.6 t -105.37 120.12 40.78 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.256 -0.277 . . . . 75.31 110.726 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 53.7 t -104.7 128.58 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.911 0.386 . . . . 75.34 111.871 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.83 160.08 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 116.337 -0.392 . . . . 73.02 111.546 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.57 -17.03 61.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.141 0.423 . . . . 74.13 112.141 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--O 1.252 1.233 0 N-CA-C 112.104 0.409 . . . . 72.44 112.104 -178.845 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 109.855 -0.424 . . . . 73.53 109.855 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.519 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 60.4 Cg_endo -73.45 173.91 13.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.25 1.966 . . . . 75.21 113.96 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -152.95 109.13 3.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.156 -0.929 . . . . 73.31 109.462 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.512 HD21 HD13 ' A' ' 491' ' ' LEU . 83.1 mt -105.36 156.85 17.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 72.45 111.171 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.624 HG23 ' HG3' ' A' ' 463' ' ' LYS . 2.0 t -161.28 149.89 15.97 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.037 0.446 . . . . 71.11 112.026 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.537 HG13 HG11 ' A' ' 462' ' ' VAL . 35.8 m -121.11 147.67 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.03 -0.532 . . . . 73.31 111.621 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -139.56 135.39 33.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.112 -0.494 . . . . 72.32 111.153 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 59.2 mt -109.18 131.36 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.534 0.206 . . . . 75.54 110.958 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -133.78 145.17 49.53 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.479 0.181 . . . . 64.24 110.952 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.39 -171.2 34.06 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 120.797 -0.716 . . . . 53.33 113.999 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.54 123.1 9.84 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.956 2.437 . . . . 73.11 112.991 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -83.58 -8.76 59.25 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.286 0.476 . . . . 75.02 112.286 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 73.3 t -131.67 120.87 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 122.342 -0.224 . . . . 71.53 110.783 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 32.9 m -135.4 164.15 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.054 0.454 . . . . 75.31 111.853 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -94.89 162.33 24.03 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.3 -0.476 . . . . 41.23 113.439 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.55 HG21 ' ND2' ' A' ' 453' ' ' ASN . 8.4 p -74.26 140.71 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 O-C-N 122.436 -0.45 . . . . 71.01 111.484 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . 0.55 ' ND2' HG21 ' A' ' 452' ' ' VAL . 46.5 m-80 59.4 16.57 5.22 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.227 0.611 . . . . 70.14 112.056 -177.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -98.75 157.9 15.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.995 0.426 . . . . 75.42 111.394 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 502' ' ' SER . 26.8 tp -96.07 130.94 42.96 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.343 -0.389 . . . . 74.43 111.2 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -134.91 134.39 40.61 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.519 0.2 . . . . 64.24 111.339 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -100.31 133.05 45.3 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.351 0.596 . . . . 62.33 111.921 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -122.66 164.0 19.04 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.735 -0.666 . . . . 71.31 110.633 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -121.32 127.7 51.56 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.108 0.48 . . . . 75.51 111.965 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 52.7 t -100.03 113.78 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.068 -0.514 . . . . 74.12 110.062 172.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -99.35 110.45 22.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 74.13 110.699 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.75 HG12 HG22 ' A' ' 475' ' ' VAL . 30.5 m -110.72 122.95 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.079 0.466 . . . . 71.23 110.517 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.624 ' HG3' HG23 ' A' ' 441' ' ' THR . 3.0 ptpp? -135.44 151.39 50.37 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.785 0.661 . . . . 73.31 112.785 -173.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 51.2 t-20 -106.19 128.37 53.88 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.296 -0.865 . . . . 72.11 109.761 175.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.413 HD21 ' HD3' ' A' ' 463' ' ' LYS . 73.6 mt -107.61 -23.32 12.18 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.91 0.337 . . . . 71.11 111.91 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -60.22 -25.97 63.16 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 114.604 0.602 . . . . 44.44 114.604 -173.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.53 17.49 58.47 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.831 -0.7 . . . . 74.45 113.271 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.6 tt -137.73 140.92 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 122.785 0.434 . . . . 72.35 110.85 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . 0.431 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -67.43 136.29 31.89 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.204 0.442 . . . . 65.15 114.204 -176.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.4 113.7 21.27 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-O 120.799 0.333 . . . . 74.13 111.339 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -88.36 -9.73 4.95 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.267 2.645 . . . . 74.2 113.095 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' SER . . . . . 0.463 ' HB2' ' OG1' ' A' ' 522' ' ' THR . 93.2 p -87.79 11.95 14.16 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.5 0.926 . . . . 64.51 113.5 -173.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 60.3 m -87.85 108.58 19.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.605 0.717 . . . . 72.11 112.825 -164.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -112.12 131.03 55.69 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.437 -0.801 . . . . 64.44 111.181 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.75 HG22 HG12 ' A' ' 462' ' ' VAL . 41.5 t -111.23 137.24 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 122.458 0.303 . . . . 74.5 111.564 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -131.52 143.08 50.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.468 0.307 . . . . 74.43 111.495 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 96.5 t -120.96 122.89 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.863 0.363 . . . . 73.22 111.278 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -113.37 139.29 49.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.867 0.467 . . . . 75.53 110.831 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 513' ' ' ILE . 56.7 mt -119.65 111.15 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.68 0.276 . . . . 75.21 110.28 176.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 55.05 34.02 21.61 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.297 -0.41 . . . . 63.23 111.807 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 101.06 -29.14 13.16 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 116.327 -0.397 . . . . 63.42 113.581 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 91.0 m -81.92 125.82 31.19 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 122.411 -0.464 . . . . 74.4 111.899 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.79 114.54 5.12 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.267 0.556 . . . . 73.23 110.815 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -88.43 -43.97 11.08 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.319 0.489 . . . . 73.5 112.319 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -167.02 160.51 14.17 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.589 0.218 . . . . 71.11 111.589 -175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -141.65 152.94 44.39 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.914 0.388 . . . . 74.51 111.741 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -131.84 148.94 52.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.76 0.424 . . . . 74.21 111.346 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 81.4 m -115.46 119.19 35.38 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.487 -0.324 . . . . 74.4 110.147 173.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.34 173.86 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.442 0.639 . . . . 64.12 112.261 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 88.1 p -129.28 133.6 47.55 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.866 -0.606 . . . . 74.15 110.378 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.512 HD13 HD21 ' A' ' 440' ' ' LEU . 96.1 mt -117.26 120.45 38.28 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.985 0.422 . . . . 74.24 111.45 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . 0.431 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -84.09 -177.62 51.47 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.066 -0.588 . . . . 73.24 112.882 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.53 107.68 0.22 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.876 2.384 . . . . 71.54 113.04 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 74.3 mmtt 67.01 34.43 5.16 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.045 -0.525 . . . . 73.53 112.04 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -102.41 151.85 21.79 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.372 0.508 . . . . 72.21 112.372 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 34.9 tt0 -133.87 141.44 47.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.089 0.471 . . . . 73.43 111.345 173.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -116.85 131.65 56.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.149 -0.478 . . . . 75.24 109.835 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 57.2 t -100.03 113.26 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.234 0.54 . . . . 73.25 111.312 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 47.6 mt -105.87 146.15 30.31 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.834 -0.621 . . . . 74.34 111.106 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 32.0 p -125.23 154.84 41.01 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.274 0.559 . . . . 74.32 111.947 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -154.76 150.54 27.67 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.829 -0.623 . . . . 73.03 110.588 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.525 ' HB2' HD11 ' A' ' 455' ' ' LEU . 79.6 p -109.93 114.3 27.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.018 0.437 . . . . 71.33 110.641 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 33.0 t90 -108.59 138.19 45.3 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.884 -0.598 . . . . 74.42 111.947 -174.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 94.7 m -124.31 109.0 29.25 Favored Pre-proline 0 N--CA 1.473 0.69 0 CA-C-N 116.109 -0.496 . . . . 73.23 111.56 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.37 119.32 3.77 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.787 2.324 . . . . 75.54 112.918 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 66.5 p -89.31 13.77 12.69 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.255 0.465 . . . . 73.31 112.255 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . 0.614 ' HB3' ' OH ' ' A' ' 511' ' ' TYR . 25.9 tt0 -143.14 142.02 31.36 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.746 0.418 . . . . 74.11 110.474 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -88.47 135.87 33.27 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.105 0.479 . . . . 74.41 110.883 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.85 -166.99 29.9 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.087 -0.577 . . . . 70.32 112.872 -175.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 96.2 mmm -83.97 120.62 26.33 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.167 0.508 . . . . 73.53 112.319 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . 0.614 ' OH ' ' HB3' ' A' ' 507' ' ' GLN . 48.9 m-85 -118.62 113.62 21.51 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.155 -0.475 . . . . 71.41 111.446 175.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 512' ' ' ARG . 15.7 ttm180 -96.48 111.38 23.51 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.914 0.388 . . . . 75.34 110.687 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 479' ' ' ILE . 57.6 mt -96.52 113.81 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.023 0.44 . . . . 75.02 111.409 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 21.5 m120 -107.59 151.84 25.08 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.929 0.395 . . . . 53.42 111.725 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -134.79 136.87 42.89 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.767 0.317 . . . . 63.22 111.074 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 58.1 p -129.17 152.37 48.83 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.215 -0.448 . . . . 72.13 111.034 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.14 141.82 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.212 0.529 . . . . 73.2 111.898 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 2.8 t0 48.78 44.33 21.66 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.832 0.853 . . . . 71.42 112.471 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -51.75 -30.06 21.12 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.232 0.539 . . . . 64.02 111.181 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.451 ' HB2' HG21 ' A' ' 522' ' ' THR . 0.9 OUTLIER -66.92 -16.99 64.69 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.66 -0.7 . . . . 71.12 111.431 -176.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 27.4 m120 59.75 44.82 13.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.379 0.609 . . . . 64.13 111.213 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 472' ' ' SER . 57.0 p -67.03 -39.47 87.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.83 -0.623 . . . . 75.51 111.581 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 12.5 p -115.28 143.57 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 116.146 -0.479 . . . . 73.43 111.844 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . 0.519 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 52.2 t -83.27 117.05 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 122.164 -0.335 . . . . 74.45 111.007 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -103.35 177.63 4.79 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.789 0.662 . . . . 74.45 112.789 -175.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.16 -39.06 18.29 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.662 -0.699 . . . . 74.45 112.339 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -114.97 164.2 14.49 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.216 0.531 . . . . 72.54 112.284 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -125.01 -7.43 7.19 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.088 0.47 . . . . 72.31 111.695 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -107.46 16.88 23.4 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.63 0.604 . . . . 74.43 112.63 -173.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.553 ' HB2' ' HB ' ' A' ' 441' ' ' THR . 6.8 p-10 -114.78 -17.77 11.51 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.258 1.207 . . . . 62.45 114.258 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -89.37 17.81 5.82 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.62 0.97 . . . . 74.34 113.62 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.41 134.27 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.062 0.458 . . . . 73.04 111.511 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -128.37 141.89 51.28 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.501 -0.318 . . . . 54.23 111.176 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.0 m -129.32 121.6 27.83 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.889 0.329 . . . . 73.53 111.889 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -121.78 126.11 48.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.804 0.335 . . . . 75.44 110.873 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.75 119.21 32.43 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.888 0.375 . . . . 74.43 111.742 -177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.66 134.99 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.269 0.557 . . . . 75.1 111.924 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 31.0 t -108.83 114.32 28.0 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.965 -0.561 . . . . 55.13 110.543 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 40.4 t -102.19 125.79 56.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.994 0.426 . . . . 74.35 111.775 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.17 168.34 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 115.89 -0.595 . . . . 73.15 111.434 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 70.9 mt -71.38 1.34 6.41 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.132 0.79 . . . . 74.53 113.132 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 112.318 0.488 . . . . 74.05 112.318 -176.848 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 CA--C 1.542 0.637 0 CA-C-O 120.703 0.287 . . . . 75.41 110.793 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.703 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 58.9 Cg_endo -73.05 175.63 10.22 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.158 2.572 . . . . 55.41 114.236 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -153.7 86.84 1.21 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.578 -0.737 . . . . 72.02 109.706 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.51 HD23 HD11 ' A' ' 491' ' ' LEU . 88.7 mt -90.09 109.68 20.72 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.119 0.485 . . . . 64.22 112.193 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.419 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.6 t -113.2 152.84 29.23 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.127 -0.358 . . . . 72.54 111.722 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.515 HG13 HG11 ' A' ' 462' ' ' VAL . 28.3 m -128.42 148.86 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.18 0.514 . . . . 64.45 112.154 -176.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 44.2 mt-10 -129.35 146.66 51.18 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.177 -0.465 . . . . 72.41 111.47 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 62.1 mt -110.01 135.16 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.026 0.441 . . . . 75.34 110.722 173.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 63.6 tttp -135.12 145.03 47.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.357 -0.383 . . . . 73.13 110.521 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 154.64 -167.08 32.51 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.282 -0.961 . . . . 63.14 114.341 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.48 ' HD2' ' CZ ' ' A' ' 458' ' ' TYR . 16.5 Cg_exo -65.66 141.02 64.6 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.312 2.675 . . . . 72.11 113.776 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.28 -52.2 5.34 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.84 0.456 . . . . 74.24 111.236 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 538' ' ' SER . 59.4 t -116.31 127.15 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.691 -0.231 . . . . 63.24 110.717 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.15 163.21 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.007 0.432 . . . . 74.22 111.972 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.69 155.81 25.1 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.2 -0.455 . . . . 74.22 112.921 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.507 HG23 ' ND2' ' A' ' 453' ' ' ASN . 13.2 p -67.96 143.61 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.119 0.485 . . . . 75.11 111.839 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . 0.507 ' ND2' HG23 ' A' ' 452' ' ' VAL . 55.7 m-80 61.81 21.26 12.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.018 -0.537 . . . . 75.23 112.268 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . 0.532 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.7 mmmt -103.18 150.75 23.37 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.017 0.437 . . . . 75.31 111.732 177.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 502' ' ' SER . 48.7 tp -93.86 119.38 32.72 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.338 -0.392 . . . . 73.21 111.344 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.59 133.03 54.99 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.706 0.288 . . . . 63.35 111.584 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.95 137.73 38.93 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.115 0.483 . . . . 65.32 111.688 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . 0.48 ' CZ ' ' HD2' ' A' ' 447' ' ' PRO . 10.3 m-85 -122.27 162.23 21.85 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.67 -0.696 . . . . 74.05 110.76 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 445' ' ' LYS . 51.9 mt-10 -120.38 127.3 52.17 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.998 0.427 . . . . 72.21 111.661 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 28.9 t -101.95 114.02 40.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.212 -0.449 . . . . 73.1 109.9 171.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 12.2 m-70 -101.3 110.6 22.63 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.702 0.287 . . . . 75.41 110.736 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.515 HG11 HG13 ' A' ' 442' ' ' VAL . 14.5 m -119.59 137.54 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.069 0.461 . . . . 74.11 110.917 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.22 152.87 37.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.1 0.476 . . . . 75.32 111.764 -176.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.5 t-20 -99.87 127.44 46.04 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.052 -0.522 . . . . 75.3 110.12 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 82.0 mt -110.29 -7.93 14.78 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.971 0.36 . . . . 73.43 111.971 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -76.59 -23.12 70.98 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.182 -0.533 . . . . 72.4 113.447 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.48 22.7 53.27 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.021 -0.609 . . . . 72.12 113.546 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.2 tt -139.71 136.96 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.594 0.358 . . . . 74.22 111.362 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . 0.537 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -69.57 135.54 27.06 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 114.94 0.736 . . . . 74.12 114.94 -175.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.41 115.37 16.08 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 122.816 0.446 . . . . 74.33 111.632 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.38 -11.46 10.7 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.052 2.502 . . . . 71.33 113.251 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 45.6 m -81.14 11.35 4.26 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.256 0.622 . . . . 72.41 112.592 -175.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' THR . . . . . 0.438 HG21 HD13 ' A' ' 440' ' ' LEU . 56.5 m -86.88 98.98 11.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.828 0.823 . . . . 63.41 111.973 -162.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -108.24 123.04 48.16 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.119 -0.946 . . . . 74.41 111.195 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.481 HG22 HG12 ' A' ' 462' ' ' VAL . 46.2 t -104.24 123.7 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.379 -0.373 . . . . 73.03 110.72 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 515' ' ' ALA . 83.2 mtt180 -114.9 145.99 41.61 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.713 0.292 . . . . 74.23 111.75 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.63 119.73 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.995 0.426 . . . . 63.54 111.085 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -112.2 145.11 40.47 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.37 -0.377 . . . . 73.55 111.149 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.77 107.54 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.952 -0.388 . . . . 74.22 109.952 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 56.63 33.87 23.51 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.054 0.454 . . . . 75.45 111.365 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 100.08 -30.97 9.02 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.432 -0.414 . . . . 43.22 113.679 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 85.4 m -82.02 119.2 23.69 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.393 -0.475 . . . . 74.02 111.787 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.4 tp -62.57 115.03 3.91 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.063 0.458 . . . . 75.12 111.342 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -87.29 -43.4 12.19 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.373 -0.376 . . . . 72.5 111.854 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -166.11 161.1 16.93 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.357 -0.214 . . . . 72.4 111.324 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . 0.402 HD21 ' N ' ' A' ' 486' ' ' ASN . 0.1 OUTLIER -155.24 159.63 40.21 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.798 0.332 . . . . 75.32 111.613 177.229 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -133.41 149.36 51.82 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.33 -0.395 . . . . 71.53 111.12 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 38.5 m -115.32 118.63 33.8 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.89 0.376 . . . . 74.15 110.589 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.6 173.42 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.197 0.522 . . . . 74.43 111.424 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 92.6 p -120.59 132.59 55.22 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.356 -0.384 . . . . 71.5 110.139 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.51 HD11 HD23 ' A' ' 440' ' ' LEU . 96.5 mt -118.22 119.05 33.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.818 0.342 . . . . 72.34 110.948 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . 0.537 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -80.52 -167.07 35.95 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.992 -0.549 . . . . 70.14 113.082 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.95 105.72 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.596 2.197 . . . . 73.2 112.426 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 33.9 mmtp 67.67 29.93 6.73 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.342 0.591 . . . . 75.32 111.461 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -83.47 152.71 24.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.502 -0.772 . . . . 62.24 111.13 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -135.0 150.7 50.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.839 0.352 . . . . 73.1 111.68 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 462' ' ' VAL . 23.8 mmtm -145.25 127.16 15.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.078 0.466 . . . . 73.51 111.32 176.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.48 112.93 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.127 0.489 . . . . 72.24 110.805 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 27.5 mt -107.93 137.14 46.45 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.051 -0.522 . . . . 75.25 111.209 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 22.4 p -112.89 149.49 33.09 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.653 0.612 . . . . 74.31 112.653 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -144.33 148.56 34.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.764 -0.653 . . . . 65.33 110.909 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.514 ' HB2' HD11 ' A' ' 455' ' ' LEU . 83.0 p -115.82 115.27 25.99 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.891 0.377 . . . . 75.24 111.214 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -116.51 137.98 51.75 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.456 -0.338 . . . . 73.31 111.808 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 85.9 m -111.98 101.04 50.83 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-N 116.538 -0.301 . . . . 74.1 111.681 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 59.5 Cg_endo -71.61 88.67 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.155 1.904 . . . . 74.53 112.417 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 19.2 p -76.2 -0.99 24.2 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.102 0.408 . . . . 61.33 112.102 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -129.54 135.88 49.14 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.519 -0.309 . . . . 74.32 110.44 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -83.27 151.18 25.73 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.766 0.654 . . . . 64.03 112.766 -174.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 141.9 -179.82 19.56 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.999 -0.546 . . . . 64.05 112.518 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' MET . . . . . 0.409 ' HE3' ' HB3' ' A' ' 510' ' ' MET . 56.1 mtp -93.11 115.88 28.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.486 0.643 . . . . 74.43 111.655 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -110.49 129.84 55.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.19 -0.459 . . . . 74.25 111.321 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -99.45 116.41 31.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.056 0.455 . . . . 74.5 111.598 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.73 127.65 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.847 -0.615 . . . . 73.21 110.948 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -122.42 131.42 53.87 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.494 -0.321 . . . . 74.15 111.472 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 476' ' ' ARG . . . -111.82 133.08 54.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.711 0.291 . . . . 75.23 110.37 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' THR . . . . . 0.47 HG23 HG22 ' A' ' 532' ' ' VAL . 71.5 p -133.74 155.9 48.93 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.778 0.323 . . . . 65.21 111.517 -176.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.1 p -130.38 140.53 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.831 0.348 . . . . 73.25 111.62 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 1.6 t70 41.13 50.39 3.29 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.884 0.874 . . . . 62.21 112.754 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -53.97 -32.93 55.54 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.048 0.451 . . . . 75.13 112.178 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.561 ' HG3' HG22 ' A' ' 522' ' ' THR . 7.4 pt-20 -81.49 2.65 27.92 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.809 -0.632 . . . . 74.3 112.603 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 55.74 36.22 26.83 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.404 0.89 . . . . 71.32 113.404 171.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' THR . . . . . 0.561 HG22 ' HG3' ' A' ' 520' ' ' GLU . 75.0 p -63.06 -25.92 68.6 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.059 0.457 . . . . 73.54 111.141 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 10.8 p -107.49 140.76 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 116.201 -0.454 . . . . 71.43 111.271 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 74.6 t -90.77 115.32 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 122.148 -0.345 . . . . 73.34 110.444 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.703 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 15.2 mt-10 -113.02 -174.02 2.37 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.92 0.711 . . . . 65.25 112.92 -174.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 88.0 mt -82.6 -38.81 23.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.587 -0.733 . . . . 63.13 111.271 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -138.77 158.6 43.93 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.982 0.42 . . . . 75.15 110.942 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -129.51 -8.07 4.65 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.981 0.419 . . . . 73.43 111.553 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -77.21 -20.72 54.92 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.339 0.496 . . . . 74.31 112.339 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.419 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 17.4 p-10 -101.75 5.55 41.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.179 0.437 . . . . 64.02 112.179 -177.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -82.2 1.2 37.56 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.181 0.437 . . . . 70.3 112.181 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.47 HG22 HG23 ' A' ' 516' ' ' THR . 58.3 t -131.14 129.37 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.013 0.435 . . . . 53.12 111.644 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -115.26 136.09 53.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.382 -0.372 . . . . 54.43 110.744 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 61.8 m -117.82 129.7 55.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.659 0.266 . . . . 74.33 111.552 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -139.87 129.28 24.1 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.792 0.33 . . . . 74.23 111.244 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -95.42 137.62 34.23 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.692 0.282 . . . . 72.21 111.707 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 53.6 t -123.74 141.13 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.876 0.37 . . . . 72.31 110.991 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' SER . . . . . 0.509 ' HB3' HG22 ' A' ' 449' ' ' VAL . 48.3 t -112.54 114.83 27.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.917 0.389 . . . . 74.31 111.296 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.76 124.1 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.947 0.403 . . . . 74.41 111.357 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.29 163.17 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.299 0.571 . . . . 75.22 112.182 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 97.5 mt -90.4 14.81 11.94 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.133 -0.485 . . . . 75.5 111.83 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 C--O 1.249 1.055 0 N-CA-C 112.609 0.596 . . . . 75.43 112.609 -172.121 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 120.581 0.229 . . . . 71.54 110.642 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.435 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 55.5 Cg_endo -72.91 175.37 10.49 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.516 2.144 . . . . 75.31 113.23 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -153.94 81.42 1.14 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.086 0.469 . . . . 74.12 110.113 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.48 HD22 HD11 ' A' ' 491' ' ' LEU . 93.9 mt -87.44 143.76 27.07 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.329 0.585 . . . . 73.23 111.769 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.452 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.9 t -153.4 164.93 37.3 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.076 -0.511 . . . . 73.02 111.403 176.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.507 HG13 HG11 ' A' ' 462' ' ' VAL . 30.9 m -133.71 148.19 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.142 -0.481 . . . . 71.41 111.108 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 53.1 mt-10 -127.05 132.31 50.72 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.509 -0.314 . . . . 61.51 111.113 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 63.2 mt -100.33 125.28 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.02 0.438 . . . . 64.21 110.648 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 26.9 tptp -128.05 131.6 49.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.43 -0.35 . . . . 73.44 110.893 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.75 -172.51 35.01 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 120.667 -0.777 . . . . 37.85 113.956 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.5 135.51 22.25 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.971 2.447 . . . . 71.44 113.244 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.24 -15.71 42.6 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.213 0.449 . . . . 71.41 112.213 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 86.6 t -131.28 131.56 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.59 0.233 . . . . 71.03 110.672 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.34 157.55 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.058 0.456 . . . . 74.24 111.779 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.56 158.87 26.65 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.116 -0.564 . . . . 71.11 113.124 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.543 HG23 ' ND2' ' A' ' 453' ' ' ASN . 9.1 p -66.84 134.49 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.095 0.474 . . . . 73.55 111.575 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . 0.543 ' ND2' HG23 ' A' ' 452' ' ' VAL . 44.1 m-80 64.9 9.16 5.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.542 0.737 . . . . 75.24 112.347 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -87.93 162.24 17.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.042 0.449 . . . . 74.3 111.496 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 502' ' ' SER . 27.1 tp -100.45 121.08 40.96 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.869 0.366 . . . . 74.23 111.188 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -120.34 132.72 55.41 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.569 0.223 . . . . 74.43 111.499 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.89 128.75 49.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.218 0.532 . . . . 73.41 111.919 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -122.45 154.09 38.24 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.79 -0.641 . . . . 62.45 110.803 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.503 ' HG2' HG21 ' A' ' 500' ' ' THR . 41.3 mt-10 -121.29 127.56 51.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 72.13 111.071 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.44 113.45 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.827 0.346 . . . . 62.32 110.507 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.603 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 35.5 m-70 -92.17 110.5 21.88 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.313 -0.254 . . . . 75.04 110.313 176.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.527 HG12 HG22 ' A' ' 475' ' ' VAL . 24.7 m -105.45 123.07 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.098 0.475 . . . . 75.4 109.871 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.531 ' HD3' HD22 ' A' ' 465' ' ' LEU . 15.5 ptpt -141.0 145.69 36.27 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.842 0.682 . . . . 73.03 112.842 -170.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.548 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -102.66 128.4 49.38 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.345 -0.843 . . . . 70.24 109.449 173.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.531 HD22 ' HD3' ' A' ' 463' ' ' LYS . 61.1 mt -117.64 -2.03 11.52 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.097 -0.377 . . . . 74.54 111.845 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -79.69 -21.57 66.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.07 -0.586 . . . . 72.13 113.691 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.5 19.19 55.39 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.199 -0.524 . . . . 64.51 113.57 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 3.1 tt -136.86 133.63 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 122.417 -0.461 . . . . 72.42 111.185 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . 0.476 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -62.94 130.3 42.14 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 114.202 0.441 . . . . 72.23 114.202 -176.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.467 HG13 HD11 ' A' ' 440' ' ' LEU . 61.5 t -126.81 113.6 22.36 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 112.125 0.417 . . . . 74.53 112.125 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.13 -10.28 10.26 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.208 2.605 . . . . 74.33 112.701 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 49.9 m -80.4 12.01 3.27 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.424 0.69 . . . . 72.5 112.678 -175.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 32.6 m -88.51 93.53 9.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.848 0.832 . . . . 75.33 112.257 -167.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -110.39 123.88 50.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.224 -0.898 . . . . 72.21 110.504 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.527 HG22 HG12 ' A' ' 462' ' ' VAL . 63.2 t -115.0 129.49 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.832 0.348 . . . . 75.05 111.742 -174.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -120.08 151.8 38.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.862 0.363 . . . . 75.41 111.326 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 96.6 t -121.15 122.16 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.41 -0.359 . . . . 75.53 111.189 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -116.16 136.84 52.65 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.925 0.393 . . . . 74.14 111.533 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.544 HG12 HG12 ' A' ' 513' ' ' ILE . 51.1 mt -111.86 108.47 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 122.676 0.39 . . . . 71.34 110.043 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 55.03 34.71 23.07 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.996 0.427 . . . . 63.44 111.382 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.27 0.62 84.79 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.3 -0.476 . . . . 37.85 113.652 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 36.9 m -103.31 119.61 39.2 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.373 -0.486 . . . . 70.43 111.113 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.0 tp -63.07 120.43 11.42 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.389 0.515 . . . . 74.51 112.389 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -88.64 -45.38 9.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.332 -0.395 . . . . 75.42 111.305 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . 0.543 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 31.0 ttpt -171.89 162.26 6.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.546 0.213 . . . . 73.52 111.098 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -139.95 150.98 45.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.962 0.411 . . . . 62.44 111.725 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . 0.543 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 18.7 m-90 -130.82 149.23 52.56 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.86 0.464 . . . . 74.4 111.438 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 60.8 m -120.24 118.91 31.69 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.613 0.244 . . . . 74.04 110.436 173.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.2 m -139.87 172.98 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.073 0.463 . . . . 62.41 111.713 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 96.0 p -122.88 133.23 54.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.251 -0.431 . . . . 73.34 110.329 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.48 HD11 HD22 ' A' ' 440' ' ' LEU . 96.0 mt -118.64 119.67 35.16 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.721 0.296 . . . . 73.13 111.246 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . 0.476 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -79.39 -171.52 41.46 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.186 -0.53 . . . . 73.05 113.133 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.44 106.43 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.6 2.2 . . . . 72.35 112.581 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.9 mmtp 69.89 23.38 5.56 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.118 -0.492 . . . . 63.33 111.881 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -89.04 149.97 22.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.039 0.385 . . . . 65.34 112.039 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . 0.431 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 24.1 tt0 -135.09 143.87 46.87 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.785 0.326 . . . . 75.34 111.478 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -126.89 133.59 50.65 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.819 -0.437 . . . . 75.33 109.819 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 37.9 t -101.17 112.76 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.074 0.464 . . . . 73.54 111.591 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 61.9 mt -100.38 147.65 25.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 75.13 110.933 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' THR . . . . . 0.503 HG21 ' HG2' ' A' ' 459' ' ' GLU . 12.0 p -125.66 149.78 48.16 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.952 0.406 . . . . 74.11 111.956 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.72 147.82 27.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.071 0.462 . . . . 71.03 111.149 172.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.485 ' HB2' HD11 ' A' ' 455' ' ' LEU . 83.2 p -111.36 119.12 37.79 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.098 -0.501 . . . . 72.12 111.067 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -107.7 136.64 47.11 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.01 0.433 . . . . 73.12 111.645 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.9 m -122.06 100.88 42.34 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.125 -0.489 . . . . 72.53 110.695 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -81.6 101.46 1.2 Allowed 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.813 2.342 . . . . 72.42 113.228 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.2 p -82.67 6.64 17.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.213 0.449 . . . . 74.25 112.213 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -140.47 127.21 20.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.565 -0.289 . . . . 74.11 110.599 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -73.19 151.62 41.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.21 0.528 . . . . 75.42 112.381 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.94 -168.89 31.88 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.151 -0.547 . . . . 75.25 113.125 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 15.8 tpt -99.2 118.1 35.15 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 122.45 -0.441 . . . . 75.0 110.993 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -123.94 113.09 18.0 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.862 0.363 . . . . 73.32 111.902 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -94.67 115.17 27.21 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.922 0.392 . . . . 72.25 110.785 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.544 HG12 HG12 ' A' ' 479' ' ' ILE . 55.9 mt -95.47 124.03 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.016 0.436 . . . . 71.41 111.045 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -123.15 145.99 48.14 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.966 0.412 . . . . 71.44 111.53 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -122.45 136.87 54.99 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.332 -0.395 . . . . 62.32 110.556 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 475' ' ' VAL . 21.4 p -132.24 141.02 48.88 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.92 0.391 . . . . 73.52 112.032 -177.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.31 142.0 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.78 0.324 . . . . 74.31 111.375 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.53 49.77 15.97 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.788 0.804 . . . . 74.41 111.42 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -51.7 -28.51 15.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.663 -0.699 . . . . 73.41 111.603 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -65.68 -22.21 66.61 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.052 -0.522 . . . . 74.23 111.308 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 55.97 72.14 0.51 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.358 0.599 . . . . 75.33 111.432 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 66.0 p -117.88 -14.19 10.07 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.516 0.561 . . . . 64.12 112.516 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 10.0 p -126.89 141.27 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.797 0.666 . . . . 73.23 112.797 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 87.2 t -94.29 110.76 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.959 -0.564 . . . . 71.2 110.136 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.435 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 24.9 mt-10 -102.94 179.97 4.12 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.744 0.646 . . . . 73.43 112.744 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.95 -39.89 79.26 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.032 -0.531 . . . . 74.15 112.05 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . 0.541 ' HB3' ' HB2' ' A' ' 530' ' ' ASN . 52.3 t-20 -120.26 112.86 19.58 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.924 0.392 . . . . 63.14 110.317 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -83.74 -7.94 59.36 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 120.955 0.407 . . . . 72.43 111.941 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -101.03 8.64 42.86 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.344 0.592 . . . . 73.24 110.821 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 527' ' ' ASN . 57.6 t30 -88.85 -22.59 23.12 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.815 -0.629 . . . . 75.42 112.297 -171.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -78.51 -4.31 47.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.014 1.116 . . . . 72.23 114.014 -168.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 61.5 t -123.16 130.88 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 112.489 0.551 . . . . 74.25 112.489 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -123.82 142.03 51.49 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.298 -0.41 . . . . 73.32 111.104 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 53.1 m -128.86 135.72 49.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.355 0.502 . . . . 74.54 112.355 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -140.69 133.09 28.4 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 120.894 0.378 . . . . 73.21 111.353 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.38 130.5 43.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.928 0.344 . . . . 71.42 111.928 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 60.7 t -124.14 131.88 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.142 0.496 . . . . 74.02 111.582 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.9 t -105.9 121.99 45.21 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.423 -0.353 . . . . 74.35 111.0 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.65 120.72 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.775 0.322 . . . . 74.22 111.402 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.48 165.36 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 121.132 0.492 . . . . 61.23 111.974 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 86.0 mt -85.72 10.28 13.97 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.303 0.483 . . . . 71.24 112.303 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 112.299 0.481 . . . . 73.15 112.299 -175.613 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 110.297 -0.261 . . . . 73.44 110.297 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.529 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 55.6 Cg_endo -70.99 173.78 11.57 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.597 2.198 . . . . 74.42 113.495 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -153.84 87.59 1.22 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.731 -0.668 . . . . 55.0 109.267 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.502 HD21 HD13 ' A' ' 491' ' ' LEU . 51.5 mt -91.91 111.85 23.54 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.043 -0.526 . . . . 74.35 111.549 -175.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.638 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 13.5 t -120.81 155.99 32.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.159 0.504 . . . . 71.21 111.865 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.524 HG13 HG11 ' A' ' 462' ' ' VAL . 32.2 m -126.63 148.52 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.88 -0.6 . . . . 71.32 111.116 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 41.1 mt-10 -122.97 146.88 47.23 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.715 0.265 . . . . 54.23 111.715 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 515' ' ' ALA . 49.1 mt -124.48 114.62 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.872 0.368 . . . . 73.43 110.547 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -129.62 139.29 51.48 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.863 0.363 . . . . 72.12 111.483 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.32 -171.37 39.83 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.36 -0.448 . . . . 74.34 112.914 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.17 135.16 28.79 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.579 2.186 . . . . 74.3 113.573 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -79.11 -50.6 10.77 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.105 0.409 . . . . 70.41 112.105 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 538' ' ' SER . 87.8 t -110.03 128.53 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.98 0.419 . . . . 70.23 111.198 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.76 160.95 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.057 0.456 . . . . 72.34 111.692 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -87.71 154.99 26.36 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.267 -0.492 . . . . 52.41 113.095 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.439 HG22 ' ND2' ' A' ' 453' ' ' ASN . 12.4 p -69.15 139.27 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 122.383 -0.481 . . . . 72.32 111.103 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . 0.439 ' ND2' HG22 ' A' ' 452' ' ' VAL . 30.9 m-80 66.5 20.18 10.87 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.202 0.601 . . . . 73.1 111.908 -176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . 0.519 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -103.33 159.78 15.26 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.978 0.418 . . . . 73.51 111.516 176.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 502' ' ' SER . 39.2 tp -95.59 122.95 38.89 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.327 -0.397 . . . . 75.34 111.249 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.04 132.73 54.66 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.803 0.335 . . . . 74.33 111.555 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -107.6 136.18 47.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.298 0.57 . . . . 73.55 112.1 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -126.9 159.02 35.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.865 -0.607 . . . . 73.12 110.559 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.463 ' HG2' HG21 ' A' ' 500' ' ' THR . 52.2 mt-10 -119.26 127.5 53.3 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.791 0.329 . . . . 74.34 111.175 177.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 43.9 t -100.8 112.52 33.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.734 -0.469 . . . . 54.35 109.734 170.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.566 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 46.1 m-70 -100.6 109.35 21.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.692 0.282 . . . . 65.32 110.255 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.587 HG12 HG22 ' A' ' 475' ' ' VAL . 10.8 m -110.82 126.37 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.18 0.514 . . . . 62.34 110.556 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.508 ' HB3' ' HZ3' ' A' ' 463' ' ' LYS . 0.0 OUTLIER -144.53 150.2 37.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.223 0.535 . . . . 73.33 112.375 -174.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.9 t-20 -102.61 127.14 49.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.582 -0.735 . . . . 75.12 109.592 174.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.439 HD21 ' HD3' ' A' ' 463' ' ' LYS . 97.8 mt -108.72 -10.29 15.18 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.009 0.374 . . . . 75.45 112.009 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -73.1 -19.16 79.52 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.076 -0.583 . . . . 60.03 114.052 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.71 15.53 63.31 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.032 -0.604 . . . . 60.22 113.954 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.9 tt -137.52 140.08 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 122.69 0.396 . . . . 74.44 110.863 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -75.38 142.55 29.34 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 114.827 0.691 . . . . 74.32 114.827 -172.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 471' ' ' PRO . 59.2 t -131.74 120.12 17.44 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 122.977 0.511 . . . . 73.31 111.282 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 470' ' ' VAL . 4.7 Cg_endo -86.42 -12.05 5.77 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.119 2.546 . . . . 73.1 113.098 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 23.0 t -84.33 13.39 5.4 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.959 0.726 . . . . 73.13 112.959 -175.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' THR . . . . . 0.431 HG21 ' CG2' ' A' ' 517' ' ' VAL . 90.5 m -86.47 91.81 8.66 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.016 0.912 . . . . 72.4 112.126 -165.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -97.69 131.01 44.62 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.123 -0.944 . . . . 75.33 110.681 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.587 HG22 HG12 ' A' ' 462' ' ' VAL . 45.2 t -113.07 127.26 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.596 0.358 . . . . 72.25 110.898 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -130.17 148.02 51.96 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.898 0.38 . . . . 72.21 111.917 -175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 72.0 t -120.25 122.21 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.862 0.363 . . . . 74.14 111.134 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -113.25 136.82 52.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.357 -0.383 . . . . 70.43 111.308 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 513' ' ' ILE . 62.0 mt -110.68 112.02 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 110.068 -0.345 . . . . 72.42 110.068 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 54.77 34.93 22.91 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.901 0.381 . . . . 72.22 111.461 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 100.37 -36.33 4.21 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.189 -0.529 . . . . 63.5 113.96 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 52.2 m -82.45 131.59 35.22 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 117.163 0.481 . . . . 74.13 111.795 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.22 132.94 54.38 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.216 0.532 . . . . 71.21 111.852 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -105.19 -43.89 4.9 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.161 -0.472 . . . . 73.24 111.852 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -161.3 151.06 16.93 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.647 -0.251 . . . . 73.53 110.497 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -140.12 152.01 45.78 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.32 0.581 . . . . 71.11 112.522 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -136.62 149.42 47.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.528 -0.76 . . . . 75.15 111.063 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 63.1 m -122.97 119.13 29.48 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.14 -0.318 . . . . 74.51 110.14 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.93 173.42 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.304 0.573 . . . . 72.2 111.569 -177.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.4 p -120.45 135.02 55.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.976 -0.556 . . . . 75.14 110.479 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.502 HD13 HD21 ' A' ' 440' ' ' LEU . 74.7 mt -117.33 120.15 37.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.84 0.353 . . . . 64.42 111.315 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -83.06 -170.31 45.91 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.948 -0.644 . . . . 61.2 113.091 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.02 109.34 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.423 2.082 . . . . 75.34 112.491 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.3 mmtm 70.19 19.23 6.72 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.954 0.501 . . . . 75.14 112.176 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -80.08 150.96 30.12 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.175 0.435 . . . . 75.43 112.175 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -135.5 134.12 39.18 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.341 -0.391 . . . . 64.22 111.358 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -116.9 129.83 56.31 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.801 -0.444 . . . . 75.41 109.801 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.16 115.81 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.176 0.512 . . . . 74.34 111.303 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 76.7 mt -105.38 143.53 33.42 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.979 -0.555 . . . . 74.21 110.986 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' THR . . . . . 0.463 HG21 ' HG2' ' A' ' 459' ' ' GLU . 6.9 p -129.29 147.12 51.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.069 0.461 . . . . 72.53 111.409 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -149.48 148.44 29.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 75.43 110.463 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.478 ' HB2' HD11 ' A' ' 455' ' ' LEU . 79.4 p -115.6 114.18 24.58 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.222 0.534 . . . . 65.11 110.995 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -102.14 134.07 45.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 73.4 111.323 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 37.0 m -113.29 100.76 52.39 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-N 116.366 -0.379 . . . . 74.31 110.701 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . 0.519 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.4 Cg_endo -76.06 95.4 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.485 2.123 . . . . 62.34 113.088 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 65.6 p -80.43 5.98 13.55 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.994 0.426 . . . . 75.31 111.66 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -133.56 142.53 48.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.841 0.457 . . . . 75.51 109.94 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.9 150.92 20.26 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.099 0.476 . . . . 74.24 112.168 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.96 -169.73 30.04 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.222 -0.514 . . . . 64.5 112.952 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 14.0 tpt -98.65 112.87 24.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.987 0.422 . . . . 73.35 110.447 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.26 112.37 21.49 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.907 0.384 . . . . 71.23 111.682 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -92.37 115.05 27.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.18 0.514 . . . . 71.55 110.943 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 479' ' ' ILE . 60.6 mt -98.1 125.55 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.99 -0.55 . . . . 73.13 111.453 -178.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -120.84 143.79 48.7 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.988 0.423 . . . . 73.32 111.683 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . 0.484 ' N ' HD12 ' A' ' 444' ' ' ILE . . . -120.47 138.75 53.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.322 -0.399 . . . . 61.24 110.365 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' THR . . . . . 0.411 HG23 HG23 ' A' ' 532' ' ' VAL . 48.8 p -133.1 158.0 43.88 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.019 0.438 . . . . 54.42 111.593 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . 0.431 ' CG2' HG21 ' A' ' 473' ' ' THR . 7.6 p -132.53 140.49 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.163 -0.471 . . . . 73.11 111.423 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 28.1 t70 42.73 54.76 4.51 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.474 0.654 . . . . 75.31 111.952 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -55.17 -32.85 62.49 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.199 0.524 . . . . 71.4 111.522 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -67.89 -5.76 18.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.282 -0.872 . . . . 74.1 112.457 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.2 t30 53.07 55.09 9.37 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.501 0.667 . . . . 73.34 111.221 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 34.9 p -88.44 -35.44 17.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 72.31 111.449 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 12.5 p -103.72 144.14 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 116.091 -0.504 . . . . 73.43 111.829 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . 0.513 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 75.4 t -83.41 114.87 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.758 0.314 . . . . 74.04 110.953 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.28 176.08 6.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.498 0.666 . . . . 75.13 112.617 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 87.4 mt -82.26 -25.65 33.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.793 -0.64 . . . . 72.32 109.947 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 26.2 t30 -155.39 110.64 3.02 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.565 -0.743 . . . . 73.15 110.447 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 38.0 mp0 -82.81 -1.61 52.28 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.985 0.421 . . . . 55.13 111.719 -173.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -93.08 -8.84 41.61 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.273 0.559 . . . . 75.33 110.973 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.638 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 65.3 t30 -86.53 -6.78 58.8 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.051 0.453 . . . . 73.31 111.743 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -79.06 8.22 6.09 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.844 0.683 . . . . 75.54 112.844 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.411 HG23 HG23 ' A' ' 516' ' ' THR . 48.5 t -132.46 145.84 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.321 0.489 . . . . 75.14 112.321 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -133.9 142.31 47.71 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.288 -0.415 . . . . 72.03 110.757 172.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 90.6 m -121.89 125.38 46.29 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.354 0.501 . . . . 71.34 112.354 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -133.12 141.06 47.96 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.886 0.374 . . . . 73.11 110.495 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -116.72 126.62 53.42 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.045 0.45 . . . . 75.13 112.161 -176.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.5 t -117.21 143.72 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 116.033 -0.53 . . . . 74.31 111.783 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' SER . . . . . 0.402 ' HB3' HG22 ' A' ' 449' ' ' VAL . 46.6 t -118.02 120.73 38.69 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.332 -0.394 . . . . 71.04 110.996 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 44.5 t -103.42 123.38 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.692 0.282 . . . . 70.4 111.23 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.7 m -109.28 160.25 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 112.612 0.597 . . . . 73.4 112.612 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.71 -5.98 57.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.296 -0.411 . . . . 71.23 112.101 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.253 1.238 0 N-CA-C 112.594 0.59 . . . . 74.31 112.594 -177.059 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 120.573 0.225 . . . . 75.15 111.153 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.486 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 24.5 Cg_exo -64.86 173.03 6.23 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.026 2.484 . . . . 74.24 114.417 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -161.25 86.81 0.69 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.897 -1.047 . . . . 74.45 108.462 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 74.8 mt -97.41 132.39 43.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.233 0.54 . . . . 74.32 112.006 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.509 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.0 t -132.85 151.74 51.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.03 0.443 . . . . 65.54 111.906 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.565 HG11 HG13 ' A' ' 462' ' ' VAL . 32.2 m -123.23 148.66 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.95 -0.568 . . . . 62.12 111.439 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 44.4 mt-10 -130.99 129.68 42.41 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.551 -0.295 . . . . 65.53 111.68 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.6 mt -101.99 126.94 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 120.659 0.266 . . . . 74.14 110.798 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -131.68 134.58 46.09 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.411 -0.181 . . . . 74.24 111.135 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.37 -169.88 35.57 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.603 -0.808 . . . . 54.2 113.762 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.3 127.41 14.12 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.809 2.339 . . . . 73.45 113.058 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -85.86 -20.78 28.58 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.135 0.42 . . . . 52.21 112.135 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.23 121.32 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 120.625 0.25 . . . . 74.35 110.801 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 30.1 m -130.72 162.74 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.207 0.527 . . . . 73.31 111.852 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.62 163.27 28.42 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.1 -0.571 . . . . 62.21 113.246 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.541 HG23 ' ND2' ' A' ' 453' ' ' ASN . 10.8 p -70.31 140.22 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.037 0.446 . . . . 72.42 111.578 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . 0.541 ' ND2' HG23 ' A' ' 452' ' ' VAL . 42.3 m-80 63.63 18.22 10.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.084 0.554 . . . . 74.22 112.136 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -102.35 164.72 11.52 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.193 0.521 . . . . 74.12 111.937 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 502' ' ' SER . 53.2 tp -95.29 136.8 35.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.13 -0.486 . . . . 75.04 111.493 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -135.49 132.22 37.08 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.906 0.384 . . . . 71.55 110.96 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -113.49 131.96 55.85 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.045 0.45 . . . . 73.25 111.364 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 74.8 m-85 -122.28 159.49 27.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 75.12 110.957 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -120.11 127.18 52.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.994 -0.548 . . . . 74.34 110.942 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 42.1 t -102.69 112.65 36.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.829 -0.434 . . . . 73.22 109.829 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 40.2 m-70 -100.04 112.72 25.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.748 0.309 . . . . 71.51 110.315 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.565 HG13 HG11 ' A' ' 442' ' ' VAL . 24.5 m -113.12 124.45 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.212 0.529 . . . . 73.42 110.828 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.432 ' HD3' HD21 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -136.4 151.67 49.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.258 0.552 . . . . 74.42 112.284 -176.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.573 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.2 t-20 -99.9 128.5 45.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.639 -0.71 . . . . 63.24 110.225 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.432 HD21 ' HD3' ' A' ' 463' ' ' LYS . 89.5 mt -113.71 -6.4 13.32 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.023 -0.423 . . . . 73.3 112.034 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -75.37 -18.89 79.82 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.971 -0.633 . . . . 74.2 113.556 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.39 19.35 69.17 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.126 -0.559 . . . . 61.42 113.383 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 10.1 tt -135.35 138.67 48.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 122.554 0.341 . . . . 74.2 110.803 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . 0.513 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -66.73 122.86 21.04 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.402 -0.428 . . . . 65.23 113.784 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 438' ' ' PRO . 48.0 t -119.68 113.72 34.59 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 122.615 -0.344 . . . . 71.12 111.841 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.08 -11.12 10.01 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.94 2.426 . . . . 74.51 112.394 172.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' SER . . . . . 0.599 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 47.8 m -81.23 12.04 3.82 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.857 0.863 . . . . 73.4 113.033 -173.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 88.1 m -88.91 99.71 12.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.773 0.797 . . . . 62.41 112.332 -167.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -105.13 130.65 53.26 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.675 -0.693 . . . . 64.12 110.895 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.404 ' CG2' HG11 ' A' ' 462' ' ' VAL . 25.9 t -105.31 118.72 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.439 0.296 . . . . 74.52 111.03 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . 0.506 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 86.3 mtt180 -116.54 138.15 51.62 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.107 -0.371 . . . . 74.32 111.121 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 89.6 t -120.88 130.47 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.975 0.417 . . . . 71.05 111.466 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -121.68 139.29 53.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.19 -0.459 . . . . 75.43 111.257 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.496 HG12 HG12 ' A' ' 513' ' ' ILE . 55.6 mt -118.83 115.95 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 110.139 -0.319 . . . . 75.2 110.139 172.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 52.67 38.87 27.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.122 0.487 . . . . 74.22 111.573 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.91 -17.51 50.26 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.227 -0.511 . . . . 55.32 113.829 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 73.2 m -88.94 130.82 35.37 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 117.168 0.484 . . . . 74.11 111.623 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.4 tp -64.33 115.06 4.7 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.946 0.403 . . . . 72.55 111.233 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -89.99 -43.86 10.26 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.171 -0.468 . . . . 75.34 112.141 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -168.5 160.03 10.72 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.518 -0.31 . . . . 74.33 110.456 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -150.83 149.87 30.24 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.057 0.456 . . . . 70.3 112.072 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . 0.401 ' CD2' HD11 ' A' ' 499' ' ' LEU . 24.5 m-90 -129.79 144.01 51.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.848 0.459 . . . . 72.03 110.716 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 38.5 m -111.02 117.79 34.29 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.859 -0.423 . . . . 73.01 109.859 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.49 174.34 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.277 0.56 . . . . 72.43 112.02 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 83.0 p -122.55 134.99 54.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.986 -0.552 . . . . 73.44 111.046 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 94.5 mt -120.18 119.45 33.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.648 0.261 . . . . 75.53 111.084 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . 0.513 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -79.63 -171.52 41.96 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.086 -0.578 . . . . 75.13 113.205 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.63 103.5 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.668 2.245 . . . . 65.23 112.524 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.1 mttt 63.63 36.97 10.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.266 0.555 . . . . 75.21 112.117 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -95.96 155.48 16.73 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.966 -0.561 . . . . 73.4 110.845 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -134.82 143.29 46.96 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.842 0.353 . . . . 71.23 111.76 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -126.35 132.33 51.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.194 -0.457 . . . . 75.23 110.867 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 50.3 t -101.39 117.62 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.007 0.432 . . . . 73.2 111.435 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . 0.401 HD11 ' CD2' ' A' ' 487' ' ' TRP . 49.7 mt -111.85 146.12 38.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.201 -0.454 . . . . 74.42 110.815 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 16.7 p -135.46 152.3 51.23 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.366 0.603 . . . . 74.33 112.354 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 47.9 p90 -145.36 154.39 42.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.768 -0.651 . . . . 75.32 111.073 175.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.498 ' HB2' HD11 ' A' ' 455' ' ' LEU . 32.3 p -112.58 114.7 27.47 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.049 0.452 . . . . 75.51 111.229 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . 0.424 ' CZ2' ' HB3' ' A' ' 505' ' ' PRO . 31.1 t90 -114.38 137.47 51.78 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.08 0.552 . . . . 74.4 111.341 -175.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 96.7 m -126.14 103.47 26.53 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 120.751 0.31 . . . . 74.14 111.749 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . 0.424 ' HB3' ' CZ2' ' A' ' 503' ' ' TRP . 98.7 Cg_endo -80.9 97.92 1.03 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.495 2.13 . . . . 71.13 112.905 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 68.4 p -77.33 -6.78 54.52 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.071 0.462 . . . . 75.12 111.121 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . 0.449 ' HB3' ' OH ' ' A' ' 511' ' ' TYR . 51.1 tt0 -114.48 141.29 47.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.122 -0.49 . . . . 74.4 110.238 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.13 149.88 21.62 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.861 0.362 . . . . 65.4 111.194 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 140.39 -171.62 23.89 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.328 -0.463 . . . . 62.31 112.883 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 94.6 mmm -83.9 127.58 33.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.076 0.465 . . . . 72.22 111.975 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . 0.449 ' OH ' ' HB3' ' A' ' 507' ' ' GLN . 76.9 m-85 -126.32 111.94 15.11 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.992 -0.549 . . . . 63.42 110.923 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -93.79 115.44 27.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.01 0.434 . . . . 75.01 111.307 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.496 HG12 HG12 ' A' ' 479' ' ' ILE . 60.3 mt -96.2 128.43 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.864 -0.607 . . . . 75.4 110.962 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -124.81 132.31 53.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.5 -0.318 . . . . 74.31 111.294 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.33 134.4 53.89 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.469 -0.332 . . . . 64.2 110.283 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' THR . . . . . 0.442 HG23 HG23 ' A' ' 532' ' ' VAL . 80.2 p -133.62 141.01 47.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.918 0.39 . . . . 74.02 111.257 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.22 139.26 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.928 0.394 . . . . 73.24 110.96 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 34.5 t0 38.74 64.89 0.71 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.798 0.839 . . . . 73.24 112.685 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . 0.506 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.1 mm-40 -52.54 -33.7 46.76 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.498 0.666 . . . . 71.52 111.048 172.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.61 -24.28 61.05 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.18 -0.918 . . . . 74.22 111.633 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 14.7 m120 54.15 55.52 8.14 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.886 0.85 . . . . 75.04 110.521 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' THR . . . . . 0.599 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 60.5 p -73.34 -6.06 43.67 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.888 -1.051 . . . . 75.24 111.628 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 14.5 p -134.34 143.25 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.255 -0.43 . . . . 72.41 110.9 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . 0.486 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 48.1 t -81.52 109.57 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.027 0.441 . . . . 74.45 110.998 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.472 ' HG2' ' HB2' ' A' ' 438' ' ' PRO . 37.1 mt-10 -98.58 177.02 5.45 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.274 0.559 . . . . 75.13 112.141 -175.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.03 -38.75 17.55 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.208 -0.451 . . . . 73.33 112.204 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . 0.498 HD22 ' HB2' ' A' ' 529' ' ' ASN . 7.2 t30 -142.07 120.0 12.0 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.868 0.322 . . . . 75.34 111.868 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . 0.538 ' HA ' ' OD1' ' A' ' 531' ' ' ASN . 11.4 pt-20 -93.5 14.2 19.46 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.337 0.495 . . . . 73.34 112.337 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . 0.498 ' HB2' HD22 ' A' ' 527' ' ' ASN . 73.1 m-20 -90.66 -26.38 19.62 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.335 0.494 . . . . 64.14 112.335 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.509 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 17.1 p-10 -97.89 -5.05 35.29 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 111.974 0.361 . . . . 75.22 111.974 -175.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . 0.538 ' OD1' ' HA ' ' A' ' 528' ' ' GLU . 12.3 m120 -62.96 -24.73 68.02 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.125 0.417 . . . . 74.44 112.125 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.442 HG23 HG23 ' A' ' 516' ' ' THR . 47.3 t -115.51 137.36 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.876 0.369 . . . . 74.2 111.706 -176.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.51 127.31 43.77 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.455 -0.339 . . . . 73.41 110.872 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 57.2 m -105.39 132.89 51.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.856 0.36 . . . . 70.35 111.628 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -139.7 117.28 11.47 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.765 0.317 . . . . 70.32 110.803 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.94 127.33 39.65 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.99 0.424 . . . . 64.22 111.924 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.96 137.63 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.109 -0.496 . . . . 72.0 111.235 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.8 t -107.44 122.42 46.59 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.826 0.346 . . . . 72.32 111.009 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.1 t -108.19 129.99 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.102 0.477 . . . . 74.54 111.305 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 21.5 m -125.33 162.74 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.157 0.503 . . . . 73.31 112.257 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.93 -12.23 60.11 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.945 0.402 . . . . 75.15 111.995 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 119.24 -0.409 . . . . 74.45 111.724 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 110.469 -0.197 . . . . 74.22 110.469 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.467 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 58.5 Cg_endo -72.67 173.34 13.51 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.216 1.944 . . . . 74.31 113.152 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -153.29 87.99 1.28 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.892 -0.595 . . . . 63.04 109.59 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.1 mt -89.15 112.0 22.89 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.278 -0.419 . . . . 75.24 111.548 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.552 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.0 t -120.84 158.97 26.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.067 0.46 . . . . 72.41 111.688 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.527 HG11 HG11 ' A' ' 462' ' ' VAL . 35.2 m -134.31 148.59 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.062 -0.517 . . . . 71.24 111.537 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.3 mt-10 -125.45 136.3 53.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.479 -0.328 . . . . 72.52 111.258 177.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . 0.416 HD13 ' N ' ' A' ' 515' ' ' ALA . 56.2 mt -105.41 124.61 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.733 0.301 . . . . 75.22 110.536 174.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 29.1 tptp -132.88 131.99 41.57 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.616 -0.266 . . . . 75.25 110.931 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 166.32 -175.06 41.85 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.743 -0.742 . . . . 50.14 113.801 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.03 134.16 31.05 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.983 2.455 . . . . 74.03 113.537 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.6 -38.53 65.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.192 -0.458 . . . . 71.12 111.911 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.18 131.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.642 0.258 . . . . 73.42 111.31 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.61 163.53 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 121.176 0.512 . . . . 75.24 111.672 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.43 158.44 21.01 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.183 -0.532 . . . . 71.11 113.341 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.421 HG13 HD21 ' A' ' 541' ' ' LEU . 14.0 p -64.9 137.94 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 O-C-N 122.54 -0.388 . . . . 73.33 111.598 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . 0.411 ' OD1' ' HA ' ' A' ' 506' ' ' THR . 92.9 m-20 62.6 14.62 7.27 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.511 0.56 . . . . 71.23 112.511 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . 0.466 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.5 mmmt -94.33 150.02 20.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.818 0.342 . . . . 75.34 111.155 175.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 502' ' ' SER . 32.2 tp -92.77 117.07 29.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.872 0.368 . . . . 72.14 110.936 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -120.67 132.69 55.23 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.901 0.382 . . . . 74.12 111.679 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -102.16 139.15 38.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.154 0.502 . . . . 71.11 111.84 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -123.66 165.14 17.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.862 -0.608 . . . . 62.31 111.26 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 445' ' ' LYS . 51.5 mt-10 -119.95 127.49 52.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.911 -0.586 . . . . 74.53 110.907 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.5 t -108.27 112.78 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.668 -0.493 . . . . 74.34 109.668 170.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.602 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 48.3 m-70 -97.92 107.65 20.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.737 0.303 . . . . 75.41 110.641 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.743 HG12 HG22 ' A' ' 475' ' ' VAL . 14.0 m -108.34 125.98 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.01 0.433 . . . . 74.02 110.55 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.572 ' HD3' HD23 ' A' ' 465' ' ' LEU . 16.0 ptpt -145.76 147.02 31.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.549 0.574 . . . . 75.54 112.549 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.9 t-20 -100.31 126.99 46.71 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.756 -0.657 . . . . 75.02 109.557 174.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.572 HD23 ' HD3' ' A' ' 463' ' ' LYS . 85.6 mt -116.26 8.65 14.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.037 0.384 . . . . 73.52 112.037 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -86.59 -20.89 53.15 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.099 -0.572 . . . . 73.12 113.02 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.74 14.34 63.33 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.116 -0.564 . . . . 44.45 113.591 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 7.4 tt -136.42 133.78 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 122.608 -0.348 . . . . 75.04 110.934 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.43 143.84 37.92 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 114.824 0.69 . . . . 44.43 114.824 -172.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.27 113.53 15.82 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 122.702 0.401 . . . . 74.2 111.41 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.79 -10.57 10.55 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.093 2.529 . . . . 74.34 113.324 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 65.6 m -87.87 13.22 11.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.602 0.761 . . . . 51.54 112.839 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 96.9 m -87.86 106.87 18.38 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.678 0.752 . . . . 71.52 112.649 -165.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -107.42 131.26 54.47 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.551 -0.749 . . . . 70.12 111.243 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.743 HG22 HG12 ' A' ' 462' ' ' VAL . 45.6 t -114.79 127.86 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 122.609 0.364 . . . . 74.54 110.823 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . 0.445 ' NH2' ' HB2' ' A' ' 519' ' ' GLU . 20.9 mtm180 -130.53 152.94 49.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.068 0.461 . . . . 72.34 112.16 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.21 122.73 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.111 -0.495 . . . . 75.13 111.319 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -113.93 137.53 51.56 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.2 -0.454 . . . . 72.53 111.388 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 513' ' ' ILE . 58.9 mt -114.38 111.07 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 109.909 -0.404 . . . . 75.0 109.909 174.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 58.01 33.53 23.29 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.265 0.555 . . . . 75.12 110.8 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 91.79 -19.51 47.98 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.073 -0.512 . . . . 74.52 113.783 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 34.3 m -82.23 124.46 29.94 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.331 -0.511 . . . . 75.14 111.41 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.9 tp -64.91 115.16 5.08 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.083 0.468 . . . . 74.11 111.186 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -91.23 -44.03 9.47 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.15 -0.477 . . . . 75.33 111.979 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -162.98 155.49 18.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.648 0.261 . . . . 75.13 111.159 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.23 143.35 31.71 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.744 0.646 . . . . 74.32 112.744 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -129.52 146.61 51.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.751 -0.659 . . . . 73.43 110.786 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 66.4 m -115.87 118.09 32.0 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.012 -0.366 . . . . 73.5 110.012 170.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.35 173.22 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.343 0.592 . . . . 75.24 112.022 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 72.0 p -124.76 132.93 53.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.06 -0.518 . . . . 73.33 110.569 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.26 121.52 38.88 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.894 0.378 . . . . 73.13 111.203 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -79.7 -170.51 40.41 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.318 -0.467 . . . . 37.34 113.429 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.03 110.6 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.573 2.182 . . . . 72.31 112.626 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.9 mmtp 62.82 37.76 12.08 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.086 0.469 . . . . 74.04 111.428 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -105.03 147.34 27.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.187 -0.46 . . . . 74.22 111.554 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -132.51 143.44 49.75 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.161 0.505 . . . . 61.54 112.332 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -126.37 144.05 50.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.938 -0.573 . . . . 74.13 110.775 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.64 112.01 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 121.033 0.444 . . . . 75.21 110.696 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.4 mt -106.41 125.61 51.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.351 -0.386 . . . . 75.33 110.315 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 35.2 p -113.39 153.33 28.75 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.238 0.542 . . . . 74.2 112.165 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -144.51 150.9 38.33 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.824 -0.625 . . . . 72.45 110.382 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.517 ' HB2' HD11 ' A' ' 455' ' ' LEU . 87.3 p -110.19 114.32 27.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.797 0.332 . . . . 74.45 110.585 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -106.26 130.24 54.15 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.017 0.437 . . . . 75.2 111.936 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 85.5 m -113.97 100.96 53.47 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 115.97 -0.559 . . . . 73.12 110.86 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 72.0 Cg_endo -74.26 91.05 0.96 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.426 2.084 . . . . 72.21 113.018 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' THR . . . . . 0.411 ' HA ' ' OD1' ' A' ' 453' ' ' ASN . 58.0 p -67.97 -16.92 64.27 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.193 0.442 . . . . 74.24 112.193 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -119.34 132.86 55.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.441 -0.345 . . . . 74.41 110.499 174.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.32 150.87 22.39 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.533 0.682 . . . . 65.13 112.469 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.45 -168.43 30.94 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.691 -0.686 . . . . 51.42 112.249 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 13.8 tpt -94.68 124.46 38.73 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 122.332 -0.51 . . . . 73.4 111.076 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -127.92 152.95 47.23 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.042 0.448 . . . . 74.34 112.007 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -123.78 122.31 37.7 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.206 -0.452 . . . . 74.45 110.87 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 479' ' ' ILE . 59.8 mt -103.1 123.93 56.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.968 0.414 . . . . 73.33 111.125 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -119.73 138.9 53.03 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.398 -0.364 . . . . 75.03 111.419 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . 0.416 ' N ' HD13 ' A' ' 444' ' ' ILE . . . -112.44 134.02 54.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.925 0.393 . . . . 73.52 110.481 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 82.4 p -123.34 144.43 49.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.169 -0.469 . . . . 74.53 111.254 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.83 139.61 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.594 0.235 . . . . 64.3 111.133 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 35.8 t0 36.28 60.97 0.83 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.876 0.87 . . . . 74.31 112.855 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . 0.445 ' HB2' ' NH2' ' A' ' 476' ' ' ARG . 39.9 mt-10 -58.63 -32.66 69.24 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.044 0.45 . . . . 75.21 110.985 173.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -66.23 -24.21 66.56 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.357 -0.608 . . . . 70.24 109.357 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' ' 521' ' ' ASN . 1.2 t-20 51.04 74.15 0.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.965 -1.016 . . . . 72.43 110.809 177.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 30.3 p -84.83 -10.64 56.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.879 -1.055 . . . . 64.13 111.408 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.4 HG21 ' HG3' ' A' ' 438' ' ' PRO . 11.3 p -135.24 143.61 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.914 -0.585 . . . . 64.4 112.255 -172.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.2 t -82.47 115.48 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.074 0.464 . . . . 75.31 110.709 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -107.2 -179.84 4.05 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.821 0.674 . . . . 63.32 112.821 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.98 -39.06 51.86 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.983 -0.553 . . . . 74.35 112.237 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -142.54 124.19 14.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.225 0.536 . . . . 75.2 111.432 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -84.08 -20.2 33.03 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.965 -0.562 . . . . 70.51 111.956 -175.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -85.48 3.42 40.37 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.11 0.481 . . . . 72.11 111.092 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.552 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 66.7 t30 -92.16 -13.24 30.95 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.21 0.528 . . . . 72.15 111.376 -176.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -78.81 0.22 27.89 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.368 0.877 . . . . 73.33 113.368 -174.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.6 t -130.68 135.38 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.588 0.588 . . . . 75.2 112.588 -175.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -122.11 142.85 49.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.148 -0.478 . . . . 73.44 110.859 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 92.7 m -124.01 126.13 45.76 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.617 0.599 . . . . 73.41 112.617 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -139.67 123.44 17.48 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.517 -0.31 . . . . 74.11 110.964 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -93.64 137.3 33.04 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.984 0.421 . . . . 71.11 111.96 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.38 132.29 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.227 -0.442 . . . . 74.42 111.444 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.0 t -100.44 117.76 35.27 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.319 -0.4 . . . . 70.14 110.993 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' A' ' 505' ' ' PRO . 38.2 t -106.21 130.65 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.96 0.41 . . . . 71.35 111.466 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 16.2 m -133.27 168.23 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 120.978 0.418 . . . . 72.31 111.993 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . 0.421 HD21 HG13 ' A' ' 452' ' ' VAL . 83.7 mt -74.58 -36.98 63.03 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.495 0.554 . . . . 73.12 112.495 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--O 1.253 1.259 0 N-CA-C 112.83 0.678 . . . . 65.12 112.83 -176.666 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 110.014 -0.365 . . . . 72.12 110.014 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.517 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 55.3 Cg_endo -80.13 174.86 10.96 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.552 2.168 . . . . 74.11 113.746 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -147.81 93.39 2.19 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.29 -0.868 . . . . 62.14 109.651 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.404 HD12 HG13 ' A' ' 470' ' ' VAL . 79.3 mt -91.81 111.87 23.57 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.098 0.475 . . . . 74.35 111.357 -177.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.406 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.0 t -114.47 148.36 37.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.165 0.507 . . . . 72.45 111.35 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.511 HG11 HG11 ' A' ' 462' ' ' VAL . 33.8 m -121.99 148.13 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.079 -0.51 . . . . 72.41 111.069 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 36.6 mt-10 -131.81 139.76 48.97 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.415 -0.357 . . . . 63.25 110.563 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 56.1 mt -114.16 132.69 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.899 0.381 . . . . 71.52 111.381 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -135.27 147.07 49.12 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.403 -0.362 . . . . 75.42 111.308 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.0 -173.35 35.86 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.001 -0.619 . . . . 63.01 113.103 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.18 129.61 18.52 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.63 2.22 . . . . 74.13 113.306 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.33 -41.9 65.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.044 0.449 . . . . 70.44 111.475 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.31 129.48 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.339 -0.391 . . . . 72.4 111.111 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.22 163.15 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.91 0.385 . . . . 74.45 111.509 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -92.92 153.36 21.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.306 -0.473 . . . . 74.55 112.99 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.556 HG23 ' ND2' ' A' ' 453' ' ' ASN . 12.1 p -67.43 136.66 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.001 0.429 . . . . 74.01 111.745 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . 0.556 ' ND2' HG23 ' A' ' 452' ' ' VAL . 46.6 m-80 65.07 17.57 11.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.239 0.616 . . . . 75.5 112.298 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -104.38 167.17 9.92 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.13 0.49 . . . . 74.54 111.75 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 502' ' ' SER . 31.6 tp -100.34 131.3 46.34 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.268 -0.424 . . . . 72.43 111.423 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.45 132.39 45.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.844 0.354 . . . . 74.12 111.796 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -103.68 135.55 45.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.866 0.365 . . . . 74.44 111.278 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -125.54 161.6 26.79 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.449 -0.342 . . . . 74.25 110.909 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -119.67 127.93 53.34 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.782 0.325 . . . . 74.41 111.234 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 50.4 t -102.44 113.11 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.95 0.405 . . . . 75.33 110.012 170.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 41.1 m-70 -96.57 105.71 17.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.454 -0.339 . . . . 62.25 110.857 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 475' ' ' VAL . 17.5 m -106.52 123.69 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.15 0.5 . . . . 74.34 110.476 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.445 ' HD3' HD21 ' A' ' 465' ' ' LEU . 3.7 ptpp? -142.52 148.21 37.26 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.878 0.695 . . . . 75.2 112.878 -173.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.1 t-20 -99.42 128.55 45.55 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.347 -0.842 . . . . 71.13 109.814 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.445 HD21 ' HD3' ' A' ' 463' ' ' LYS . 81.8 mt -111.71 -14.73 13.56 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.092 0.405 . . . . 75.42 112.092 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -66.27 -22.7 71.2 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 121.479 -0.391 . . . . 64.23 113.947 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.45 18.79 56.41 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.178 -0.534 . . . . 38.12 113.912 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.429 HG21 ' HB3' ' A' ' 438' ' ' PRO . 5.5 tt -137.44 138.1 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 122.795 0.438 . . . . 75.11 111.001 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -65.19 135.08 36.82 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.485 -0.388 . . . . 73.11 113.87 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.404 HG13 HD12 ' A' ' 440' ' ' LEU . 60.3 t -129.0 114.71 18.81 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 112.16 0.43 . . . . 63.21 112.16 -176.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.58 -10.94 14.4 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.037 2.491 . . . . 73.41 112.504 173.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' SER . . . . . 0.455 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 50.3 m -81.15 11.84 3.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.617 0.767 . . . . 72.44 112.976 -175.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 48.6 m -88.95 94.05 9.81 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.798 0.809 . . . . 75.21 112.183 -169.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -111.67 123.38 50.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.293 -0.867 . . . . 73.13 110.507 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.651 HG22 HG12 ' A' ' 462' ' ' VAL . 29.6 t -105.49 132.49 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 111.873 0.323 . . . . 73.22 111.873 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -128.25 144.53 51.13 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.901 0.381 . . . . 75.21 111.366 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -121.19 126.7 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.895 0.379 . . . . 75.12 111.266 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 482' ' ' THR . 82.6 m-85 -121.93 137.03 54.95 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.309 -0.405 . . . . 75.45 111.426 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 513' ' ' ILE . 59.0 mt -108.73 107.5 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 110.091 -0.337 . . . . 73.23 110.091 173.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 57.66 34.1 24.07 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.896 0.379 . . . . 75.03 111.289 -174.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.23 -10.36 74.47 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.207 -0.52 . . . . 64.51 113.537 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 478' ' ' TYR . 40.9 m -85.14 127.32 34.21 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.603 -0.351 . . . . 73.23 111.17 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.8 tp -69.15 118.41 12.01 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.853 0.359 . . . . 73.14 111.331 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -94.79 -45.1 7.47 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.818 0.342 . . . . 74.3 111.743 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -170.52 160.08 7.16 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.564 0.221 . . . . 74.42 111.073 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -132.1 157.2 44.81 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.088 0.47 . . . . 75.44 111.52 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 30.9 m-90 -135.99 143.78 44.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.095 0.558 . . . . 74.05 110.785 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 98.8 m -122.09 116.97 25.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.711 0.291 . . . . 70.34 110.422 173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.7 173.93 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.363 0.601 . . . . 64.23 111.872 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 55.1 p -125.68 133.68 52.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.958 -0.565 . . . . 75.13 110.693 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.404 HD23 ' HG2' ' A' ' 497' ' ' LYS . 75.3 mt -116.94 120.46 38.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.796 0.331 . . . . 74.44 111.502 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -75.35 -170.51 27.77 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.052 -0.594 . . . . 65.34 112.746 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.89 118.08 4.95 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.175 1.917 . . . . 73.13 112.364 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 74.4 mmtt 65.32 21.8 12.01 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.111 -0.495 . . . . 72.43 112.109 175.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -89.98 154.74 19.6 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.454 0.539 . . . . 71.42 112.454 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -135.0 145.09 47.75 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.855 0.359 . . . . 70.21 111.927 177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.404 ' HG2' HD23 ' A' ' 491' ' ' LEU . 31.6 mmmt -122.31 129.83 52.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.2 -0.454 . . . . 74.01 109.887 170.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.2 t -100.28 117.31 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.183 0.516 . . . . 73.32 111.213 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 50.9 mt -106.61 146.46 30.67 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.027 -0.533 . . . . 63.11 111.05 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 21.3 p -127.06 147.02 50.16 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.005 0.431 . . . . 71.1 111.657 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -147.87 148.67 31.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.113 -0.494 . . . . 75.24 110.648 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.498 ' HB2' HD11 ' A' ' 455' ' ' LEU . 68.3 p -113.0 114.07 26.38 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.269 0.557 . . . . 75.43 111.419 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -106.2 137.2 44.56 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.643 -0.708 . . . . 75.25 111.341 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.7 m -119.35 100.8 49.7 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.606 -0.27 . . . . 71.55 111.125 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.47 108.43 1.72 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.624 2.216 . . . . 73.41 113.353 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 58.7 p -85.16 -13.43 50.11 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.108 0.41 . . . . 73.14 112.108 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -113.55 134.87 54.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.66 0.266 . . . . 75.41 111.183 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.74 151.55 37.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.6 0.714 . . . . 72.5 112.387 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 135.97 175.76 14.0 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.815 -0.629 . . . . 61.44 112.538 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 65.0 mtp -88.35 128.13 35.5 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.176 0.512 . . . . 65.02 111.542 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -120.05 119.48 33.49 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.15 -0.477 . . . . 60.42 110.762 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -92.75 114.37 26.91 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.059 0.457 . . . . 74.4 110.857 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 479' ' ' ILE . 59.0 mt -98.77 123.64 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.039 -0.528 . . . . 70.21 111.277 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -120.72 136.82 54.76 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.87 0.367 . . . . 73.4 111.806 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.27 143.99 42.43 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.327 -0.397 . . . . 72.23 110.917 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' THR . . . . . 0.403 HG23 HG22 ' A' ' 532' ' ' VAL . 60.8 p -131.14 157.0 44.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.253 -0.43 . . . . 73.41 111.427 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.74 140.18 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 121.005 0.431 . . . . 73.42 111.403 171.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 25.2 t0 41.51 62.48 1.52 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.138 0.975 . . . . 70.33 113.159 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.7 -30.86 71.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.015 0.436 . . . . 65.44 111.317 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.12 -9.38 39.1 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.254 -0.43 . . . . 72.22 112.121 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 57.61 49.69 12.15 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.141 0.496 . . . . 62.22 111.383 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 60.1 p -88.03 -12.31 44.71 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.294 -0.412 . . . . 64.33 111.773 -178.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.28 142.34 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.877 0.37 . . . . 71.12 111.242 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . 0.437 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 74.8 t -82.75 110.25 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.023 0.44 . . . . 72.02 111.218 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.69 162.12 13.91 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.845 -0.616 . . . . 74.43 112.117 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.72 -38.79 73.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.83 -0.623 . . . . 74.4 111.564 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -137.82 126.4 23.59 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.802 -0.181 . . . . 62.14 111.16 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -83.47 -24.88 31.6 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 73.22 111.109 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -81.34 -0.66 42.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.181 -0.463 . . . . 61.13 112.088 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.406 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 57.8 t30 -96.47 -23.0 16.78 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.897 0.379 . . . . 74.13 111.765 -177.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.78 16.37 1.16 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.058 0.762 . . . . 62.12 113.058 -174.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.403 HG22 HG23 ' A' ' 516' ' ' THR . 77.0 t -135.08 142.5 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 120.896 0.379 . . . . 73.23 111.62 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . 0.453 ' HB3' HG23 ' A' ' 442' ' ' VAL . . . -127.25 144.03 51.12 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.545 0.338 . . . . 73.01 111.103 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.9 m -123.42 124.99 44.14 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.559 0.578 . . . . 75.24 112.559 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -134.13 124.22 25.73 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.682 0.277 . . . . 74.43 110.545 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.17 130.19 45.46 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.361 0.6 . . . . 72.14 112.132 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.38 145.02 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.729 -0.669 . . . . 75.33 111.413 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 48.3 t -117.68 113.99 22.71 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.853 0.358 . . . . 61.42 111.236 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.91 120.16 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.503 -0.317 . . . . 73.21 111.223 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.8 m -114.84 165.38 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.099 0.476 . . . . 74.33 112.231 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.8 mt -82.24 -1.26 48.72 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.204 0.446 . . . . 75.14 112.204 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--O 1.253 1.27 0 N-CA-C 112.126 0.417 . . . . 72.32 112.126 -179.138 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 120.715 0.293 . . . . 71.43 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 60.5 Cg_endo -72.13 174.92 10.62 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.794 2.329 . . . . 71.32 113.02 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 25.4 t70 -150.0 81.22 1.38 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.866 -0.606 . . . . 62.3 109.901 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.498 HD22 HD11 ' A' ' 491' ' ' LEU . 43.7 mt -84.45 105.72 15.48 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.858 -0.61 . . . . 75.24 111.487 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.457 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 8.1 t -113.08 148.08 35.97 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.079 0.466 . . . . 74.33 111.334 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.55 HG13 HG11 ' A' ' 462' ' ' VAL . 27.3 m -121.08 146.91 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.226 -0.443 . . . . 75.14 111.108 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 46.3 mt-10 -137.0 136.35 38.4 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.252 -0.431 . . . . 73.11 111.305 -175.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.2 mt -110.14 132.51 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.914 0.388 . . . . 75.52 111.62 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -136.61 136.39 39.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.45 -0.341 . . . . 74.04 111.093 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.51 -170.76 39.79 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.209 -0.52 . . . . 73.22 112.97 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.77 121.21 7.7 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.574 2.183 . . . . 72.42 112.921 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.4 -16.75 44.68 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.041 0.385 . . . . 73.52 112.041 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 63.6 t -129.33 123.97 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.682 0.277 . . . . 72.4 110.676 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.41 160.99 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.281 0.562 . . . . 75.35 112.27 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.43 158.19 26.28 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.049 -0.523 . . . . 72.43 112.8 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.4 HG12 HD22 ' A' ' 541' ' ' LEU . 13.8 p -69.21 140.54 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 120.95 0.405 . . . . 74.33 111.948 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 68.1 12.35 8.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.178 0.591 . . . . 73.52 112.405 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -93.58 174.63 7.09 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.0 0.429 . . . . 73.22 111.476 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 502' ' ' SER . 40.3 tp -108.15 119.39 39.34 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.894 0.378 . . . . 74.24 111.338 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.05 131.55 56.33 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.026 0.441 . . . . 75.13 111.54 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -116.65 130.44 56.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.281 0.562 . . . . 73.11 111.658 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -122.56 162.37 21.94 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.786 -0.643 . . . . 75.23 111.089 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -120.34 127.55 52.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.828 0.347 . . . . 72.54 111.151 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.3 t -100.49 113.25 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.077 0.465 . . . . 75.31 110.151 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 52.2 m-70 -94.27 105.85 17.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.29 -0.413 . . . . 74.22 110.341 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.57 HG12 HG22 ' A' ' 475' ' ' VAL . 8.7 m -106.19 123.12 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.119 0.485 . . . . 74.24 110.246 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.417 ' HG3' HG23 ' A' ' 441' ' ' THR . 3.5 ptpp? -139.39 147.05 40.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.158 0.504 . . . . 74.3 112.276 -173.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 53.5 t-20 -104.69 126.91 52.23 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.801 -0.636 . . . . 71.43 109.877 175.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 89.3 mt -103.97 -20.61 13.82 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.051 -0.406 . . . . 72.33 111.972 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -60.94 -26.01 64.89 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.309 -0.472 . . . . 74.14 114.016 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.81 18.35 56.49 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.986 -0.626 . . . . 65.43 113.471 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.6 tt -137.07 133.8 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 122.613 0.365 . . . . 73.4 110.705 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.9 145.31 41.39 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 114.718 0.647 . . . . 62.41 114.718 -174.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.8 117.9 16.42 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 122.817 0.447 . . . . 74.13 111.44 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.67 -12.19 11.23 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.752 2.302 . . . . 72.33 112.594 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 17.3 m -81.02 11.63 3.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.812 0.845 . . . . 74.02 112.804 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 74.1 m -88.57 93.83 9.68 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.952 0.882 . . . . 75.33 112.591 -166.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -99.02 126.37 44.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.203 -0.908 . . . . 73.35 110.176 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.57 HG22 HG12 ' A' ' 462' ' ' VAL . 47.3 t -112.17 118.81 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.754 0.312 . . . . 70.44 110.97 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -125.25 152.64 44.33 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.123 0.487 . . . . 72.21 111.785 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 99.3 t -121.21 130.07 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.108 -0.496 . . . . 72.33 111.33 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -123.39 136.46 54.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.077 -0.51 . . . . 74.21 111.592 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 65.6 mt -109.33 112.33 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 110.076 -0.342 . . . . 71.31 110.076 174.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 53.87 33.75 17.85 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.974 0.416 . . . . 64.22 111.45 -175.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 99.54 -23.67 35.26 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.252 -0.499 . . . . 64.03 113.91 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 85.3 m -82.86 133.52 35.12 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.338 0.569 . . . . 75.22 111.763 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.5 tp -68.01 116.84 9.1 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.008 0.432 . . . . 74.44 111.495 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -96.5 -43.57 7.56 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.957 0.354 . . . . 71.35 111.957 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . 0.485 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 8.9 tppt? -150.23 155.26 39.39 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.593 -0.276 . . . . 71.13 110.822 -174.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . 0.432 ' N ' ' HG3' ' A' ' 485' ' ' LYS . 8.1 p30 -143.97 141.99 30.49 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.995 0.426 . . . . 74.35 111.525 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . 0.485 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 8.6 m-90 -133.19 148.7 52.06 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.145 -0.479 . . . . 73.33 111.126 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 65.1 m -120.34 119.04 31.96 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.234 -0.284 . . . . 74.53 110.234 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.5 174.79 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.132 0.492 . . . . 73.11 111.491 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 92.5 p -121.64 139.4 53.59 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.527 -0.306 . . . . 72.14 110.332 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.498 HD11 HD22 ' A' ' 440' ' ' LEU . 68.1 mt -117.78 120.6 38.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.884 0.374 . . . . 71.42 111.105 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -84.37 -169.37 45.47 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.239 -0.505 . . . . 42.24 112.939 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.27 111.95 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.399 2.066 . . . . 74.24 112.519 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 45.5 mmtm 66.46 18.41 10.82 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.267 -0.424 . . . . 74.41 112.01 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -86.39 149.14 25.22 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.064 0.394 . . . . 71.52 112.064 -176.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -133.84 135.7 43.92 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.235 -0.439 . . . . 75.33 111.618 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.508 ' HZ2' ' HB3' ' A' ' 497' ' ' LYS . 2.3 mmmp? -122.39 134.09 54.63 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.44 -0.345 . . . . 72.11 110.582 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.73 115.67 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.979 0.418 . . . . 74.14 111.247 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 72.0 mt -107.92 128.93 55.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.247 -0.433 . . . . 63.13 110.801 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 36.5 p -113.08 150.01 32.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.546 0.688 . . . . 75.51 112.617 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -145.65 148.34 32.98 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.586 -0.734 . . . . 74.11 110.982 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.496 ' HB2' HD11 ' A' ' 455' ' ' LEU . 78.5 p -111.69 113.57 26.02 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.182 0.515 . . . . 51.12 111.216 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -108.63 134.27 51.6 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.391 -0.368 . . . . 71.4 110.993 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.3 m -111.08 100.72 47.94 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-N 116.37 -0.377 . . . . 72.54 110.946 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . 0.456 ' HB2' HG11 ' A' ' 539' ' ' VAL . 71.6 Cg_endo -74.06 88.77 1.07 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.258 1.972 . . . . 73.31 112.693 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 22.4 p -73.97 -14.24 61.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.211 0.448 . . . . 74.34 112.211 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -115.75 146.21 42.11 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.706 0.288 . . . . 74.15 110.711 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.12 149.55 21.49 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.83 0.348 . . . . 53.33 111.87 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.3 -167.62 27.92 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.998 -0.62 . . . . 63.35 113.416 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' MET . . . . . 0.545 ' HE2' ' HA ' ' A' ' 510' ' ' MET . 2.4 tpt -90.91 107.63 19.32 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.795 0.331 . . . . 74.3 111.503 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -114.17 146.84 39.8 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.051 -0.406 . . . . 72.52 111.526 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 35.5 ttp180 -124.42 116.78 23.09 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.554 -0.293 . . . . 73.03 111.268 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 63.2 mt -96.4 130.16 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.843 0.354 . . . . 72.42 111.249 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -125.41 147.79 49.05 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.869 0.366 . . . . 71.34 111.567 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -121.63 133.68 54.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.317 -0.401 . . . . 60.32 110.604 174.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.0 p -127.57 142.65 51.31 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.813 0.339 . . . . 52.34 111.726 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.43 139.66 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 120.733 0.302 . . . . 74.34 111.3 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 46.6 t0 38.96 66.59 0.52 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.682 0.793 . . . . 74.42 112.595 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.95 -31.81 72.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.097 -0.501 . . . . 71.34 111.655 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.88 -19.63 62.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.352 -0.386 . . . . 74.14 111.044 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.1 m120 59.74 51.88 5.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.46 0.648 . . . . 72.14 110.917 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 68.5 p -67.02 -29.09 68.81 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.76 -0.654 . . . . 73.15 111.205 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 9.8 p -114.88 143.41 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.03 -0.532 . . . . 74.21 111.032 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . 0.491 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 51.4 t -82.62 118.18 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.071 0.462 . . . . 74.1 111.227 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -92.38 162.01 14.43 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.775 -0.648 . . . . 71.14 112.593 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 87.5 mt -70.05 -38.12 75.71 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.134 -0.485 . . . . 74.1 110.814 172.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -130.53 118.17 20.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.089 -0.505 . . . . 74.34 111.079 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.39 3.16 32.99 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.007 0.432 . . . . 73.2 112.106 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -107.19 16.78 23.71 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.542 0.687 . . . . 71.22 110.03 173.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.457 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.4 t30 -100.18 -22.44 15.16 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.514 -0.766 . . . . 74.21 112.41 -170.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -81.58 11.54 4.57 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.913 1.079 . . . . 72.35 113.913 -167.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.73 144.22 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.501 0.556 . . . . 73.52 112.501 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . 0.503 ' HB2' HG23 ' A' ' 442' ' ' VAL . . . -129.28 142.75 50.75 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.997 -0.547 . . . . 62.04 110.957 173.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.0 m -128.49 123.3 33.25 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.975 0.417 . . . . 73.13 111.872 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -142.74 117.72 10.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.881 0.372 . . . . 74.21 110.652 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 0.5 OUTLIER -97.24 137.21 36.6 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.485 0.66 . . . . 72.1 112.561 -177.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.58 132.38 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.653 -0.703 . . . . 74.53 111.558 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.3 t -99.27 122.04 41.88 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.893 0.377 . . . . 63.1 111.07 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.456 HG11 ' HB2' ' A' ' 505' ' ' PRO . 26.1 t -103.85 132.42 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.441 -0.345 . . . . 71.43 110.688 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.83 164.37 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.092 0.472 . . . . 71.3 112.241 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . 0.4 HD22 HG12 ' A' ' 452' ' ' VAL . 95.4 mt -78.42 -1.9 35.77 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.265 0.468 . . . . 73.33 112.265 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.254 1.332 0 N-CA-C 112.434 0.531 . . . . 75.33 112.434 -175.707 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 120.655 0.264 . . . . 73.12 110.495 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 72.0 Cg_endo -77.0 173.85 13.8 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.506 2.137 . . . . 73.22 114.241 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -145.17 94.93 2.59 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.161 -0.927 . . . . 75.43 108.679 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.516 HD23 HD12 ' A' ' 491' ' ' LEU . 66.5 mt -100.25 120.66 40.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.076 0.465 . . . . 75.03 111.579 -172.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.625 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.5 t -129.36 159.55 35.85 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.319 0.58 . . . . 75.33 112.375 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.556 HG11 HG11 ' A' ' 462' ' ' VAL . 28.7 m -122.42 148.37 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.772 -0.649 . . . . 74.54 111.473 -178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 37.6 mt-10 -132.27 136.87 47.24 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.406 -0.361 . . . . 74.3 110.241 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 56.6 mt -112.88 126.95 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 120.934 0.397 . . . . 63.33 111.8 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -131.0 144.05 51.18 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.198 -0.455 . . . . 62.45 110.334 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.9 -176.35 36.63 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.653 -0.784 . . . . 63.4 113.317 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.52 114.86 3.43 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.842 2.362 . . . . 74.22 113.122 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -74.93 -14.49 60.65 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.611 0.597 . . . . 72.31 112.611 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.65 126.48 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 122.171 -0.331 . . . . 64.12 110.76 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.93 162.09 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.261 0.553 . . . . 75.41 111.796 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.96 153.91 20.14 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.213 -0.518 . . . . 62.21 112.957 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.543 HG13 HD22 ' A' ' 541' ' ' LEU . 14.5 p -64.0 142.22 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 O-C-N 122.619 -0.342 . . . . 72.44 111.414 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 65.82 13.45 9.0 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.628 0.603 . . . . 75.21 112.628 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -105.29 162.75 13.15 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.059 0.457 . . . . 74.41 111.943 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 502' ' ' SER . 49.2 tp -92.94 133.54 36.01 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.468 -0.333 . . . . 73.21 111.634 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -131.4 132.58 44.49 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.797 0.332 . . . . 73.42 111.46 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -112.92 131.88 55.56 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.804 0.335 . . . . 74.12 111.183 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -121.59 157.61 30.39 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.235 -0.438 . . . . 75.11 111.013 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.479 ' HG2' HG21 ' A' ' 500' ' ' THR . 41.9 mt-10 -120.26 127.02 52.01 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.997 -0.547 . . . . 63.14 111.344 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.62 113.68 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.165 173.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 44.8 m-70 -95.09 111.63 23.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.869 0.366 . . . . 75.32 110.267 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.556 HG11 HG11 ' A' ' 442' ' ' VAL . 33.1 m -106.57 122.71 60.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.99 0.424 . . . . 75.22 110.652 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.493 ' HD3' HD22 ' A' ' 465' ' ' LEU . 1.4 ptpp? -130.42 148.55 52.25 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.295 0.569 . . . . 74.41 112.282 -174.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.7 t-20 -99.64 128.07 45.75 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.668 -0.696 . . . . 73.32 110.014 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.493 HD22 ' HD3' ' A' ' 463' ' ' LYS . 79.9 mt -109.45 -10.7 14.88 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.752 0.311 . . . . 73.24 111.747 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -76.26 -28.48 60.0 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.294 -0.479 . . . . 40.55 113.566 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.13 22.39 45.27 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.955 -0.64 . . . . 72.04 113.389 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.6 tt -137.73 135.82 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 122.738 0.415 . . . . 75.43 111.102 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . 0.404 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -70.02 133.08 24.32 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 114.608 0.603 . . . . 62.4 114.608 -174.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.39 118.48 17.09 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.21 0.604 . . . . 63.22 111.306 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -88.85 -9.86 4.47 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.074 2.516 . . . . 73.12 113.851 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.3 p -81.65 11.95 4.29 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.83 0.678 . . . . 74.32 112.83 -177.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' THR . . . . . 0.492 ' HA ' ' OD1' ' A' ' 518' ' ' ASP . 98.7 m -87.24 109.96 19.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.072 0.939 . . . . 75.33 112.094 -164.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -119.99 128.14 53.28 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.009 -0.996 . . . . 75.03 110.892 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.545 HG22 HG12 ' A' ' 462' ' ' VAL . 25.1 t -104.59 135.83 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.404 -0.362 . . . . 62.04 111.902 -175.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . 0.553 ' NH1' ' HB2' ' A' ' 519' ' ' GLU . 59.2 mtt85 -123.64 143.39 50.27 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.369 -0.378 . . . . 75.31 111.273 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.52 123.18 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 120.996 0.427 . . . . 73.03 111.123 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -111.55 137.82 48.9 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.042 -0.526 . . . . 74.32 110.7 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 62.5 mt -115.99 109.66 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 110.025 -0.361 . . . . 75.43 110.025 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 55.16 34.62 23.04 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.089 0.471 . . . . 73.41 111.292 -174.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 97.39 -24.09 33.0 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.049 -0.523 . . . . 72.0 113.699 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 66.0 m -82.67 120.4 25.52 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.394 -0.474 . . . . 73.45 111.76 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -62.8 115.05 4.0 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.054 0.454 . . . . 75.15 110.971 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -89.74 -43.54 10.62 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.382 0.512 . . . . 72.51 112.382 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -164.45 161.23 21.31 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.19 -0.319 . . . . 73.02 111.454 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.58 154.98 42.75 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.936 0.398 . . . . 74.51 111.941 177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -135.02 148.87 50.05 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.848 0.459 . . . . 74.43 111.431 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 79.6 m -105.64 119.24 38.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 110.156 -0.313 . . . . 75.44 110.156 171.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.07 173.34 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.394 0.616 . . . . 72.42 111.876 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 75.1 p -126.58 134.71 50.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.081 -0.508 . . . . 65.21 110.686 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.516 HD12 HD23 ' A' ' 440' ' ' LEU . 92.1 mt -117.38 118.89 33.48 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.875 0.369 . . . . 74.44 111.275 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . 0.404 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -81.47 -166.56 36.95 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.193 -0.527 . . . . 71.23 112.652 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.03 107.12 0.73 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.15 1.9 . . . . 74.43 112.172 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 41.6 mmtm 68.66 22.9 7.32 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.204 -0.453 . . . . 75.0 111.772 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -81.81 149.88 28.14 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.892 0.33 . . . . 74.21 111.892 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 462' ' ' VAL . 41.5 tt0 -135.38 134.59 39.91 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.744 0.307 . . . . 63.12 111.286 176.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -118.91 149.79 40.98 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.639 -0.255 . . . . 73.5 110.621 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.92 113.22 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.001 0.429 . . . . 71.42 111.48 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 50.6 mt -105.71 146.23 30.05 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.242 -0.436 . . . . 75.13 111.047 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' THR . . . . . 0.479 HG21 ' HG2' ' A' ' 459' ' ' GLU . 20.9 p -129.47 149.8 51.09 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.367 0.603 . . . . 72.44 112.611 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -144.33 148.46 34.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.793 -0.639 . . . . 72.23 111.156 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 455' ' ' LEU . 24.8 p -110.96 115.06 28.85 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.207 0.527 . . . . 75.41 111.577 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -120.88 137.44 54.58 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.008 -0.542 . . . . 75.31 111.601 -174.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 92.9 m -120.61 102.05 45.32 Favored Pre-proline 0 N--CA 1.473 0.688 0 CA-C-N 116.458 -0.337 . . . . 65.11 111.282 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.97 104.43 1.91 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.578 2.185 . . . . 74.52 113.068 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 77.0 p -86.82 -15.76 38.23 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.021 0.438 . . . . 73.22 111.995 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.22 137.13 42.59 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.731 0.301 . . . . 71.1 110.837 171.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.17 150.21 25.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.009 0.433 . . . . 74.25 112.151 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 143.98 -167.73 26.7 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.177 -0.535 . . . . 75.02 113.181 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 89.6 mmm -89.57 121.1 31.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.064 0.459 . . . . 74.5 111.395 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -121.58 111.7 17.55 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.427 0.632 . . . . 74.52 111.207 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -104.02 120.34 40.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.805 -0.634 . . . . 72.32 111.308 -177.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 62.2 mt -95.73 128.44 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.841 -0.618 . . . . 75.11 111.473 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -122.95 135.3 54.43 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.196 -0.457 . . . . 74.24 111.041 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.56 139.53 48.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.784 0.325 . . . . 62.41 111.416 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' THR . . . . . 0.5 HG23 HG23 ' A' ' 532' ' ' VAL . 71.2 p -129.26 151.85 49.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.921 0.391 . . . . 73.02 111.035 177.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.5 p -130.0 141.8 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.525 -0.307 . . . . 52.23 111.524 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . 0.492 ' OD1' ' HA ' ' A' ' 473' ' ' THR . 1.3 m-20 50.17 47.91 22.9 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.456 0.539 . . . . 72.53 112.456 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . 0.553 ' HB2' ' NH1' ' A' ' 476' ' ' ARG . 6.0 mm-40 -53.62 -32.78 52.67 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.283 0.475 . . . . 74.13 112.283 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.42 -17.05 64.12 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.171 0.434 . . . . 72.21 112.171 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 49.84 37.17 12.81 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.742 0.645 . . . . 64.3 112.742 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 38.5 p -72.38 -16.66 61.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.858 0.361 . . . . 72.22 111.78 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 8.3 p -108.01 136.53 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.417 -0.356 . . . . 75.23 111.07 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . 0.424 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 90.7 t -84.23 113.3 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.873 0.368 . . . . 75.33 110.879 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -100.61 174.23 6.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.259 0.552 . . . . 71.52 112.269 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.7 mt -82.85 -24.39 33.29 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.68 -0.691 . . . . 72.21 111.675 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . 0.555 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 25.0 t-20 -118.6 158.24 25.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.145 0.498 . . . . 75.01 111.579 -174.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -118.35 -23.8 7.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.165 -0.471 . . . . 74.43 111.981 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -105.89 -7.39 18.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.3 0.481 . . . . 72.42 112.3 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.625 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 58.2 t30 -86.77 -7.7 58.02 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.713 0.634 . . . . 72.43 112.713 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -75.42 -0.27 19.44 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.159 0.799 . . . . 73.33 113.159 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.5 HG23 HG23 ' A' ' 516' ' ' THR . 48.4 t -126.86 146.05 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.439 0.533 . . . . 62.43 112.439 -175.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . 0.401 ' CB ' HG21 ' A' ' 442' ' ' VAL . . . -136.14 142.69 44.25 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.245 -0.434 . . . . 72.22 111.276 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.8 m -117.3 134.83 54.34 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.404 0.52 . . . . 75.31 112.404 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -138.54 126.64 22.71 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.369 -0.378 . . . . 63.25 110.363 174.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -102.6 123.44 46.34 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.825 0.345 . . . . 74.32 111.85 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.47 144.45 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.996 0.427 . . . . 73.23 111.667 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.0 t -112.95 127.03 56.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.776 0.322 . . . . 75.14 111.413 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.1 120.51 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.85 0.357 . . . . 74.41 111.066 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.74 158.91 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.442 0.534 . . . . 63.21 112.442 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . 0.543 HD22 HG13 ' A' ' 452' ' ' VAL . 89.9 mt -81.3 -28.43 34.62 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.251 -0.431 . . . . 74.14 111.632 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.254 1.339 0 N-CA-C 112.725 0.639 . . . . 75.31 112.725 -176.893 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 120.689 0.28 . . . . 75.34 110.474 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.408 ' HG2' HG21 ' A' ' 523' ' ' VAL . 2.6 Cg_exo -75.03 173.91 13.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.922 2.415 . . . . 75.21 114.223 -176.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -152.87 78.2 1.18 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.784 -1.098 . . . . 73.41 108.972 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.417 HD22 HD13 ' A' ' 491' ' ' LEU . 70.4 mt -84.12 110.48 18.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.669 -0.696 . . . . 73.4 111.416 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.466 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 13.7 t -115.57 149.32 38.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.146 0.498 . . . . 70.31 111.459 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.522 HG11 HG11 ' A' ' 462' ' ' VAL . 27.1 m -121.02 148.41 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.966 -0.561 . . . . 73.13 111.144 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 43.7 mt-10 -139.69 131.58 27.65 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.496 -0.32 . . . . 73.32 110.872 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 53.8 mt -105.55 138.69 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 122.129 -0.357 . . . . 75.2 111.463 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -141.59 134.97 29.56 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 120.563 0.221 . . . . 74.35 111.287 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.68 -164.87 37.63 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.947 -0.644 . . . . 64.54 113.678 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.2 136.84 32.81 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.743 2.296 . . . . 74.31 113.44 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -82.95 -44.94 14.73 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.898 0.38 . . . . 70.44 111.751 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.16 133.72 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 120.989 0.423 . . . . 75.23 111.278 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.5 m -135.7 162.99 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.068 0.461 . . . . 75.1 111.539 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -98.34 165.65 21.66 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.178 -0.534 . . . . 71.44 113.056 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.511 HG22 ' ND2' ' A' ' 453' ' ' ASN . 11.9 p -69.44 136.76 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 120.853 0.359 . . . . 63.14 111.591 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . 0.511 ' ND2' HG22 ' A' ' 452' ' ' VAL . 53.3 m-80 64.67 15.65 9.87 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.151 0.58 . . . . 71.32 112.547 -176.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -95.82 143.93 26.62 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.13 0.49 . . . . 70.44 111.656 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 502' ' ' SER . 43.1 tp -81.75 123.14 28.51 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.277 -0.42 . . . . 73.14 111.159 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -118.36 132.31 56.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.84 0.352 . . . . 75.12 111.288 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -120.7 132.03 54.86 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.201 0.524 . . . . 71.21 111.747 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -123.76 159.42 29.51 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.739 -0.664 . . . . 75.45 110.96 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.451 ' HG3' HG21 ' A' ' 500' ' ' THR . 1.9 mp0 -120.22 127.46 52.45 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.069 0.462 . . . . 74.44 110.745 175.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.7 t -100.52 121.46 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.274 -0.421 . . . . 63.03 111.48 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 11.6 m-70 -96.22 110.58 22.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.081 -0.509 . . . . 74.11 110.522 176.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.522 HG11 HG11 ' A' ' 442' ' ' VAL . 19.8 m -114.4 123.42 70.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.962 0.411 . . . . 75.33 110.342 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.543 ' HD3' HD21 ' A' ' 465' ' ' LEU . 4.5 ptpp? -139.17 148.37 43.1 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.467 0.651 . . . . 75.32 112.705 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 49.4 t-20 -100.23 127.58 46.48 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.495 -0.775 . . . . 71.22 109.873 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.543 HD21 ' HD3' ' A' ' 463' ' ' LYS . 77.9 mt -115.02 -2.66 12.76 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.364 0.505 . . . . 71.12 112.364 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -72.88 -22.85 78.8 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.979 -0.629 . . . . 53.14 113.174 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.75 16.42 59.92 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.255 -0.498 . . . . 73.24 113.307 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 10.2 tt -135.69 139.73 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 122.729 -0.277 . . . . 74.42 110.942 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.4 137.08 25.65 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.171 -0.538 . . . . 55.15 114.079 -176.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 57.7 t -131.68 112.9 15.16 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 120.802 0.334 . . . . 75.33 111.796 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -88.01 -10.9 4.78 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.3 2.667 . . . . 71.1 113.057 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 79.9 p -81.95 13.3 3.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.534 0.734 . . . . 72.21 112.674 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 91.0 m -87.42 108.82 19.18 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.755 0.788 . . . . 71.51 112.436 -164.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -110.57 130.59 55.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.352 -0.84 . . . . 75.23 111.42 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.506 HG22 HG12 ' A' ' 462' ' ' VAL . 47.3 t -111.53 130.74 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 122.314 0.246 . . . . 63.1 110.981 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . 0.594 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 96.0 mtt180 -124.2 150.11 45.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.945 0.402 . . . . 74.41 111.418 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.98 120.71 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.218 -0.446 . . . . 71.33 111.085 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -113.75 137.1 52.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.473 -0.33 . . . . 75.11 110.99 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.529 HG12 HG12 ' A' ' 513' ' ' ILE . 63.2 mt -113.34 111.89 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 110.166 -0.309 . . . . 61.02 110.166 174.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 54.46 34.38 20.84 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.108 0.48 . . . . 64.34 111.77 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.18 -19.06 55.35 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.382 -0.437 . . . . 75.12 113.482 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 89.7 m -87.11 124.38 33.18 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.543 -0.386 . . . . 62.13 111.693 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.6 tp -62.7 120.4 11.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.1 0.476 . . . . 72.44 111.774 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . 0.446 ' CE2' ' HE2' ' A' ' 485' ' ' LYS . 19.3 t80 -94.81 -43.07 8.39 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.19 -0.459 . . . . 74.33 112.124 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . 0.446 ' HE2' ' CE2' ' A' ' 484' ' ' TYR . 4.5 ttpt -167.67 159.78 12.21 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 122.235 -0.291 . . . . 74.54 111.464 -177.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -143.17 144.12 32.06 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.939 0.4 . . . . 75.05 112.037 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -132.78 149.6 52.25 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.991 0.516 . . . . 75.42 111.208 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.0 m -118.06 119.95 36.31 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 110.202 -0.295 . . . . 74.33 110.202 170.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.48 172.98 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.32 0.581 . . . . 73.11 111.966 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 79.1 p -111.9 137.4 49.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.04 -0.527 . . . . 74.43 110.752 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.417 HD13 HD22 ' A' ' 440' ' ' LEU . 69.0 mt -127.55 118.99 25.01 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.828 0.347 . . . . 73.34 110.721 174.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -84.43 -174.79 50.53 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.951 -0.642 . . . . 74.32 112.702 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.97 105.84 0.23 Allowed 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.365 2.043 . . . . 70.23 112.052 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.7 mmtp 71.59 29.19 2.67 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.154 0.427 . . . . 75.23 112.154 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.95 155.31 17.14 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.814 0.34 . . . . 70.41 111.869 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -130.34 143.21 50.63 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.215 -0.448 . . . . 64.44 111.393 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 462' ' ' VAL . 43.6 mmtm -117.21 146.85 42.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.052 0.541 . . . . 65.32 110.039 172.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.57 113.14 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.047 0.451 . . . . 74.43 110.938 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 56.7 mt -110.84 141.24 44.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.405 -0.362 . . . . 73.52 111.166 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' THR . . . . . 0.451 HG21 ' HG3' ' A' ' 459' ' ' GLU . 21.5 p -113.81 151.7 31.69 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.493 0.553 . . . . 74.14 112.493 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -150.84 148.51 28.56 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.019 -0.537 . . . . 75.13 111.311 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.524 ' HB2' HD11 ' A' ' 455' ' ' LEU . 89.9 p -118.42 125.89 50.91 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.271 -0.422 . . . . 75.53 111.111 -178.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -125.97 136.8 53.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.914 0.388 . . . . 74.04 111.136 -177.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.4 m -121.31 100.77 44.71 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.694 0.283 . . . . 64.33 111.016 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -77.64 106.3 2.17 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.623 2.215 . . . . 62.03 113.108 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.8 p -87.54 12.17 13.09 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.042 0.386 . . . . 72.25 112.042 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -142.74 132.72 24.31 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.711 0.404 . . . . 61.44 110.967 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -73.68 150.73 41.07 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.475 0.546 . . . . 73.22 112.475 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 145.76 -173.35 26.15 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.879 -0.676 . . . . 54.22 113.397 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 95.9 mmm -99.31 112.61 24.74 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.049 0.452 . . . . 72.12 111.032 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -115.05 119.21 35.68 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.2 0.524 . . . . 75.33 111.431 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -97.72 117.91 33.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.104 -0.498 . . . . 74.34 111.153 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.529 HG12 HG12 ' A' ' 479' ' ' ILE . 65.0 mt -95.29 120.01 44.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.0 -0.545 . . . . 74.32 111.119 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.48 137.35 52.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.934 0.397 . . . . 72.52 111.341 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.1 132.96 54.54 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.299 -0.409 . . . . 72.52 110.738 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' THR . . . . . 0.481 HG23 HG23 ' A' ' 532' ' ' VAL . 43.9 p -126.03 141.14 52.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.887 0.375 . . . . 73.52 111.244 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.36 141.89 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.95 0.405 . . . . 74.52 111.43 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.3 t0 49.89 58.66 5.21 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.643 0.735 . . . . 64.31 111.919 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . 0.594 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.9 mm-40 -59.12 -32.69 70.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.284 0.564 . . . . 75.51 111.322 174.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.55 -18.05 64.27 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.763 -0.653 . . . . 71.41 111.68 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 52.02 70.22 0.58 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.719 0.771 . . . . 65.24 110.8 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 67.4 p -96.76 -10.87 25.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.472 -0.785 . . . . 73.33 111.689 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.408 HG21 ' HG2' ' A' ' 438' ' ' PRO . 11.7 p -141.66 144.15 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.057 0.456 . . . . 74.42 111.736 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.5 t -82.79 116.27 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.968 0.413 . . . . 74.31 111.528 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.88 156.25 17.62 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.888 -0.597 . . . . 73.22 112.423 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.84 -38.85 70.05 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.765 -0.652 . . . . 72.45 111.329 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -119.81 122.07 40.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.842 0.353 . . . . 74.12 110.703 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -83.05 -17.55 42.84 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.006 0.431 . . . . 70.12 111.934 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -102.08 14.98 30.46 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.102 -0.374 . . . . 74.34 111.669 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.466 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 66.3 t30 -104.93 -11.39 16.72 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.289 0.477 . . . . 73.35 112.289 -172.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -86.56 6.11 32.33 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.923 0.712 . . . . 72.23 112.923 -172.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.481 HG23 HG23 ' A' ' 516' ' ' THR . 51.4 t -130.42 143.15 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.018 0.437 . . . . 54.05 112.107 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -129.73 143.2 50.7 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.386 -0.37 . . . . 72.41 111.023 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 56.9 m -117.78 135.48 54.03 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.856 0.36 . . . . 63.33 111.909 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -141.98 116.91 9.9 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.51 -0.552 . . . . 74.23 109.51 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -101.62 124.34 47.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.201 0.524 . . . . 60.34 111.813 -175.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.7 t -112.32 144.44 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.961 -0.563 . . . . 73.44 111.64 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 30.1 t -112.38 128.53 56.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.525 -0.307 . . . . 62.02 111.131 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.6 t -111.12 125.59 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 120.827 0.346 . . . . 73.24 111.691 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.75 161.12 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.165 0.507 . . . . 73.13 111.893 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.0 -14.37 58.0 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.754 0.65 . . . . 73.45 112.754 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 112.856 0.687 . . . . 62.21 112.856 -176.298 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 120.582 0.229 . . . . 74.35 110.788 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.541 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 20.6 Cg_endo -79.99 174.37 11.63 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.334 2.022 . . . . 52.31 113.53 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 11.7 t70 -149.38 82.96 1.42 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.686 -0.688 . . . . 73.2 109.794 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.493 HD12 HG13 ' A' ' 470' ' ' VAL . 92.1 mt -84.73 114.76 22.28 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.105 -0.498 . . . . 72.2 111.771 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.478 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.2 t -126.37 158.6 35.47 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.009 0.433 . . . . 65.14 111.382 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.51 HG13 HG11 ' A' ' 462' ' ' VAL . 33.8 m -132.1 148.13 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 116.112 -0.495 . . . . 65.32 111.319 -177.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.5 mt-10 -125.08 137.15 54.2 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.421 0.288 . . . . 71.01 110.994 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.8 mt -108.76 127.68 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.919 0.39 . . . . 72.22 111.471 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -128.37 132.04 48.55 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.673 -0.239 . . . . 75.33 111.15 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 172.15 -173.77 45.27 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.654 -0.784 . . . . 75.13 113.678 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.75 136.48 23.26 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.774 2.316 . . . . 73.3 113.395 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.57 -47.89 58.04 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.966 -0.561 . . . . 65.45 111.898 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.1 t -117.83 125.83 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.765 0.317 . . . . 74.23 111.078 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.3 160.77 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.179 0.514 . . . . 74.53 111.867 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.53 148.56 19.34 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.074 -0.584 . . . . 63.14 113.323 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.511 HG23 ' ND2' ' A' ' 453' ' ' ASN . 11.0 p -64.39 138.42 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 120.857 0.361 . . . . 73.52 111.284 177.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . 0.511 ' ND2' HG23 ' A' ' 452' ' ' VAL . 45.0 m-80 63.56 18.68 11.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.959 0.504 . . . . 74.42 111.951 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -108.9 161.38 15.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.194 0.521 . . . . 71.21 111.623 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 502' ' ' SER . 37.8 tp -99.0 126.24 44.65 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.004 -0.544 . . . . 75.22 111.745 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.51 132.69 45.75 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.814 0.34 . . . . 54.21 111.582 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -104.98 138.58 40.97 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.42 0.629 . . . . 74.23 112.098 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 59.1 m-85 -122.84 151.34 41.79 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.554 -0.748 . . . . 71.55 110.302 177.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -120.02 127.2 52.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.094 0.474 . . . . 75.22 111.029 -175.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 21.6 t -105.07 114.78 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.101 -0.5 . . . . 75.21 111.124 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 46.8 m-70 -92.16 107.56 19.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.851 0.358 . . . . 74.43 110.299 174.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.602 HG12 HG22 ' A' ' 475' ' ' VAL . 20.2 m -105.55 133.21 50.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.927 0.394 . . . . 71.43 110.193 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.555 ' HB3' ' HZ2' ' A' ' 463' ' ' LYS . 0.1 OUTLIER -148.2 152.3 36.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.585 0.587 . . . . 70.23 112.585 -172.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.551 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.8 t-20 -107.72 127.46 53.7 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.634 -0.712 . . . . 73.52 109.524 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.535 HD21 ' HD3' ' A' ' 463' ' ' LYS . 79.9 mt -111.86 0.05 16.02 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.172 0.434 . . . . 72.35 112.172 -176.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -82.91 -25.38 49.61 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.92 -0.657 . . . . 63.34 113.632 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.88 22.73 41.22 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.101 -0.571 . . . . 73.2 113.577 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 9.5 tt -138.18 144.18 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 122.51 -0.406 . . . . 74.51 110.763 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . 0.463 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -71.82 138.72 27.51 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.154 -0.546 . . . . 62.14 114.059 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.493 HG13 HD12 ' A' ' 440' ' ' LEU . 40.7 t -129.71 117.36 18.44 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 112.34 0.496 . . . . 72.51 112.34 -177.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.2 -11.0 8.77 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.105 2.537 . . . . 74.4 112.759 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 57.7 m -80.98 11.44 4.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.457 0.703 . . . . 55.32 112.685 -176.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 39.3 m -88.97 91.1 8.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.661 0.743 . . . . 63.23 112.422 -166.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 517' ' ' VAL . 95.9 mttt -96.81 131.33 43.65 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.514 -0.766 . . . . 71.32 110.152 171.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.602 HG22 HG12 ' A' ' 462' ' ' VAL . 49.4 t -117.89 118.36 58.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 122.12 -0.363 . . . . 75.41 110.709 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -126.43 153.47 44.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.276 0.56 . . . . 63.23 112.076 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 84.8 t -120.41 135.79 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.006 -0.543 . . . . 75.14 111.141 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . 0.4 ' HE1' ' OG1' ' A' ' 516' ' ' THR . 25.1 m-85 -124.51 142.09 51.59 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.188 -0.46 . . . . 74.41 111.196 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.453 HG12 HG12 ' A' ' 513' ' ' ILE . 64.5 mt -114.82 111.55 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.295 -0.412 . . . . 74.13 109.998 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 54.34 34.03 19.74 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.195 0.521 . . . . 72.21 111.278 -173.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 98.07 -25.69 26.58 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.177 -0.465 . . . . 72.34 113.765 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 28.0 m -82.04 129.75 34.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.327 0.563 . . . . 74.15 111.851 -174.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.3 tp -62.48 124.23 20.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.096 0.474 . . . . 71.42 111.689 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . 0.457 ' HH ' ' HA ' ' A' ' 503' ' ' TRP . 82.2 t80 -105.58 -43.72 4.87 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.518 0.562 . . . . 74.02 112.518 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -155.45 152.55 29.12 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 110.324 -0.25 . . . . 74.31 110.324 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -141.09 147.89 39.27 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.434 0.531 . . . . 75.04 112.434 -176.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.5 m-90 -132.69 148.81 52.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.949 -0.569 . . . . 74.54 110.94 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.9 m -124.88 117.12 23.39 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.557 -0.534 . . . . 75.02 109.557 167.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.42 172.87 11.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.139 0.495 . . . . 75.41 111.587 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 30.3 m -116.93 133.89 55.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.186 -0.461 . . . . 70.35 110.335 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 72.8 mt -120.53 120.48 35.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.941 0.401 . . . . 74.41 110.978 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . 0.463 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -80.85 -168.83 40.14 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.176 -0.535 . . . . 52.51 113.141 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -63.08 109.95 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.463 2.109 . . . . 72.22 112.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.5 mttt 63.45 37.48 10.62 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.618 0.723 . . . . 75.45 111.239 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -85.98 149.35 25.24 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.208 -0.905 . . . . 75.13 111.419 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -136.09 145.42 45.91 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.839 0.352 . . . . 71.12 111.473 172.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -141.6 147.33 37.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.002 0.521 . . . . 74.32 111.018 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 42.3 t -111.15 112.99 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.209 0.528 . . . . 72.12 111.54 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.7 127.85 55.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.178 -0.465 . . . . 74.23 110.268 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 76.0 p -112.96 163.05 15.14 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.136 0.791 . . . . 73.22 113.136 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 47.8 p90 -152.23 148.29 27.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.305 -0.861 . . . . 74.34 110.906 172.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 455' ' ' LEU . 78.6 p -114.9 114.72 25.86 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.072 0.463 . . . . 64.04 111.08 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . 0.46 ' CZ2' ' HB3' ' A' ' 505' ' ' PRO . 25.1 t90 -107.73 137.33 45.94 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.069 0.547 . . . . 75.14 111.776 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 93.4 m -125.9 101.47 29.39 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 116.407 -0.36 . . . . 73.3 111.02 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . 0.46 ' HB3' ' CZ2' ' A' ' 503' ' ' TRP . 85.5 Cg_endo -82.22 102.18 1.18 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.528 2.152 . . . . 74.21 113.321 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 63.4 p -76.38 -21.77 55.63 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.856 0.36 . . . . 74.44 111.185 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -107.91 125.76 51.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.932 0.396 . . . . 65.43 111.373 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.06 150.86 46.15 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.4 0.519 . . . . 74.31 112.4 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.83 -173.12 33.23 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.083 -0.579 . . . . 75.53 113.061 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 8.8 tpt -99.71 126.94 45.83 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.577 -0.366 . . . . 74.55 110.727 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -132.86 112.0 11.54 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.337 0.495 . . . . 75.33 112.337 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -93.03 118.23 30.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.869 0.366 . . . . 74.23 110.776 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.453 HG12 HG12 ' A' ' 479' ' ' ILE . 64.2 mt -95.47 127.93 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.093 0.473 . . . . 75.01 111.507 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -121.43 152.57 38.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.926 0.393 . . . . 73.4 111.194 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -128.9 135.35 48.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.769 0.318 . . . . 63.34 111.135 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' THR . . . . . 0.518 HG22 HG23 ' A' ' 532' ' ' VAL . 38.5 p -123.73 149.44 45.55 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.326 -0.397 . . . . 71.24 111.431 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 474' ' ' LYS . 7.3 p -119.4 139.56 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 116.422 -0.354 . . . . 75.51 111.459 170.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.9 t70 43.8 70.41 0.32 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.609 0.764 . . . . 73.03 111.687 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -61.97 -33.06 73.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.792 -0.64 . . . . 71.24 111.437 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.34 -13.66 62.5 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.651 0.612 . . . . 72.43 112.651 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.1 t30 56.34 55.9 6.22 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.535 0.683 . . . . 73.21 110.428 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 68.5 p -85.25 -31.73 22.96 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.923 -0.58 . . . . 72.41 111.133 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.56 141.75 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.01 -0.541 . . . . 70.25 111.034 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.8 112.13 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.844 0.354 . . . . 74.34 111.557 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.48 ' OE2' ' HG2' ' A' ' 438' ' ' PRO . 13.5 mm-40 -91.22 163.7 14.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.258 0.551 . . . . 73.24 112.124 -176.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.6 mt -71.98 -39.14 69.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.279 0.561 . . . . 72.34 110.854 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -129.46 110.48 11.91 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.945 -0.57 . . . . 73.42 110.271 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -83.09 -21.8 33.6 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.989 0.423 . . . . 73.24 111.4 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -75.39 -12.31 60.23 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.147 0.499 . . . . 72.33 110.821 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.478 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 41.7 t30 -86.72 -14.62 41.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.999 -0.546 . . . . 74.14 111.145 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -69.0 -13.97 62.77 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.08 0.77 . . . . 72.14 113.08 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.518 HG23 HG22 ' A' ' 516' ' ' THR . 57.7 t -116.57 134.0 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.528 0.566 . . . . 73.22 112.528 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -114.42 143.07 45.52 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.218 -0.446 . . . . 63.15 110.54 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 70.0 m -125.76 125.86 43.64 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.022 0.439 . . . . 70.42 111.888 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -137.65 122.98 19.44 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.042 0.449 . . . . 74.11 110.781 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -93.36 129.12 39.6 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.411 -0.359 . . . . 64.22 111.386 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.87 142.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.332 0.587 . . . . 75.41 111.93 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 22.8 t -118.38 127.2 53.45 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.343 -0.389 . . . . 75.41 111.189 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.0 t -104.85 123.62 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.825 0.345 . . . . 71.43 111.31 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 31.0 m -116.1 161.75 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.795 0.665 . . . . 64.15 112.795 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.02 -17.38 43.54 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.037 -0.529 . . . . 74.31 111.737 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.253 1.267 0 CA-C-N 116.031 -0.531 . . . . 73.2 112.176 178.499 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 110.392 -0.225 . . . . 71.12 110.392 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.553 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 72.9 Cg_endo -74.27 169.53 22.27 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.344 2.029 . . . . 64.4 113.567 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . 0.434 ' HB2' HD13 ' A' ' 526' ' ' LEU . 37.3 t70 -128.74 96.05 4.27 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.727 -0.669 . . . . 74.03 109.833 176.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.494 HD22 HD11 ' A' ' 491' ' ' LEU . 88.7 mt -94.36 112.81 24.61 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.873 0.368 . . . . 73.44 111.077 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.507 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 6.8 t -122.46 153.42 39.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.994 0.426 . . . . 73.41 111.92 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.53 HG13 HG11 ' A' ' 462' ' ' VAL . 32.2 m -129.79 150.16 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.131 -0.486 . . . . 74.05 111.814 -177.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 49.6 mt-10 -130.23 144.81 51.58 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.21 -0.45 . . . . 73.04 110.918 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 53.4 mt -116.27 129.66 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.931 0.395 . . . . 74.14 111.199 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -134.19 137.43 44.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.414 -0.357 . . . . 74.11 110.981 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.29 -176.87 40.86 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.265 -0.969 . . . . 64.11 114.074 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.62 117.18 5.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.831 2.354 . . . . 73.52 113.071 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -71.85 -30.37 65.37 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.783 0.66 . . . . 70.05 112.783 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 94.6 t -120.73 122.98 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.885 -0.51 . . . . 75.54 111.503 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.97 163.28 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.084 0.469 . . . . 72.32 112.059 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.75 156.91 24.13 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.346 -0.454 . . . . 50.05 113.296 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.569 HG22 ' ND2' ' A' ' 453' ' ' ASN . 10.7 p -69.95 140.41 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.015 0.436 . . . . 71.05 111.807 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . 0.569 ' ND2' HG22 ' A' ' 452' ' ' VAL . 56.4 m-80 60.7 24.4 14.22 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.52 0.563 . . . . 62.33 112.52 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -105.94 176.13 5.27 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.125 0.488 . . . . 75.11 111.733 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 41.9 tp -105.09 120.2 40.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.338 -0.392 . . . . 75.1 111.431 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -129.25 132.78 47.27 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.739 0.304 . . . . 74.42 111.647 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -112.28 139.85 47.49 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.294 0.569 . . . . 72.5 111.548 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 53.7 m-85 -121.97 157.51 31.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.752 -0.658 . . . . 65.22 110.726 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -121.0 129.01 53.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.922 0.489 . . . . 75.24 111.079 -174.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 41.0 t -115.26 119.25 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.758 0.313 . . . . 74.32 111.353 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 49.3 m-70 -96.26 104.6 16.57 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.6 -0.273 . . . . 75.43 110.98 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.568 HG12 HG22 ' A' ' 475' ' ' VAL . 18.7 m -106.77 124.76 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.856 0.36 . . . . 72.13 110.988 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.441 ' HG3' HG23 ' A' ' 441' ' ' THR . 6.6 pttm -140.92 158.73 43.53 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.31 0.856 . . . . 75.13 113.31 -175.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.5 t-20 -107.94 128.7 54.86 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.677 -1.147 . . . . 63.34 109.468 175.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 86.4 mt -119.17 16.75 13.21 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.785 0.326 . . . . 75.21 111.86 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -100.81 -12.48 37.25 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.114 -0.565 . . . . 74.31 113.331 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.83 21.15 69.16 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.149 -0.548 . . . . 71.45 113.735 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.491 HG21 ' HB3' ' A' ' 438' ' ' PRO . 3.7 tt -134.67 132.99 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 122.602 -0.352 . . . . 73.42 111.048 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -66.43 134.61 33.37 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.367 -0.444 . . . . 74.51 113.679 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.94 116.06 16.82 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 122.562 0.345 . . . . 61.31 111.74 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.99 -11.21 12.42 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.117 2.544 . . . . 64.01 112.593 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' SER . . . . . 0.422 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 50.8 m -80.65 11.78 3.58 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.043 0.757 . . . . 73.21 113.043 -174.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.1 m -88.61 95.12 10.12 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.951 0.882 . . . . 62.13 111.937 -169.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -106.5 126.54 52.39 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.24 -0.891 . . . . 74.23 110.558 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.568 HG22 HG12 ' A' ' 462' ' ' VAL . 44.6 t -106.8 122.98 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 122.3 -0.25 . . . . 73.41 111.614 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . 0.62 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 46.9 mtt180 -115.75 146.9 41.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.746 0.308 . . . . 62.34 111.339 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 77.9 t -121.6 121.86 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.917 0.389 . . . . 73.14 111.308 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -112.1 141.12 46.17 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.305 -0.407 . . . . 72.31 111.826 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.543 HG12 HG12 ' A' ' 513' ' ' ILE . 53.8 mt -124.24 111.77 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.552 -0.295 . . . . 74.52 110.811 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 52.77 34.83 17.15 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.532 0.567 . . . . 74.41 112.532 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 90.41 3.05 72.55 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 120.858 -0.686 . . . . 72.31 113.887 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.7 m -110.73 121.61 45.76 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.423 -0.457 . . . . 75.35 111.432 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.6 tp -64.17 114.8 4.44 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.923 0.392 . . . . 74.42 110.643 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -84.33 -45.09 13.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.492 -0.322 . . . . 64.23 111.673 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -171.27 159.25 5.71 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.786 0.327 . . . . 72.03 111.449 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.87 153.81 42.72 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.324 0.49 . . . . 73.43 112.324 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -129.56 149.53 51.28 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.083 -0.508 . . . . 70.33 110.864 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 91.2 m -114.46 119.46 36.96 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.768 0.318 . . . . 55.52 110.766 174.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.77 173.59 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.366 0.603 . . . . 72.4 111.747 -177.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.0 p -123.43 138.09 54.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.055 -0.52 . . . . 75.5 110.456 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.494 HD11 HD22 ' A' ' 440' ' ' LEU . 90.7 mt -117.54 119.06 33.87 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.736 0.303 . . . . 72.05 111.141 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -77.25 -171.6 35.85 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.208 -0.52 . . . . 73.24 112.994 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.09 100.63 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.378 2.052 . . . . 74.52 112.329 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.6 mttt 66.64 40.39 3.36 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.494 -0.775 . . . . 72.05 112.068 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -99.69 151.4 21.26 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.941 -0.572 . . . . 72.14 111.136 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . 0.423 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 32.8 tt0 -132.47 137.39 47.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.899 0.381 . . . . 64.13 111.419 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -120.03 146.54 45.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.506 -0.316 . . . . 73.24 110.262 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 49.1 t -113.79 115.04 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.929 0.395 . . . . 64.25 111.311 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 69.4 mt -107.39 130.81 54.76 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.415 -0.357 . . . . 72.52 111.438 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 51.5 p -113.86 150.75 33.13 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.221 0.534 . . . . 73.2 112.001 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 49.5 p90 -144.36 148.56 34.87 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.127 -0.488 . . . . 73.34 111.395 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 78.5 p -110.48 115.28 29.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.26 0.553 . . . . 60.21 110.957 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -112.36 136.88 51.28 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.288 -0.415 . . . . 74.31 111.363 -176.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.0 m -118.18 103.9 49.01 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.345 -0.389 . . . . 74.22 111.047 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.13 99.37 1.17 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.708 2.272 . . . . 71.23 112.711 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.6 p -78.23 -12.83 60.03 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.589 0.589 . . . . 75.32 112.589 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -122.17 141.63 51.25 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.762 0.315 . . . . 75.14 110.884 174.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.87 151.86 31.56 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.179 0.514 . . . . 64.14 112.083 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 145.43 -173.51 25.8 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.043 -0.598 . . . . 70.1 113.175 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 511' ' ' TYR . 0.0 OUTLIER -90.63 133.8 34.86 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.014 0.435 . . . . 75.32 110.839 179.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . 0.462 ' N ' ' SD ' ' A' ' 510' ' ' MET . 96.0 m-85 -132.25 120.46 22.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.133 0.492 . . . . 73.24 111.791 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 479' ' ' ILE . 47.9 ttp85 -94.15 118.37 31.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.224 -0.444 . . . . 74.41 111.072 177.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.543 HG12 HG12 ' A' ' 479' ' ' ILE . 55.6 mt -103.9 126.03 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.985 0.421 . . . . 74.14 111.48 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -125.8 142.55 51.46 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.979 0.418 . . . . 64.13 111.681 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -119.09 133.56 55.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.261 -0.427 . . . . 64.5 110.758 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' THR . . . . . 0.509 HG23 HG23 ' A' ' 532' ' ' VAL . 33.9 p -130.82 140.71 50.29 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.323 -0.398 . . . . 73.15 111.689 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.02 140.67 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.933 0.397 . . . . 72.21 111.226 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 39.7 t0 42.53 66.61 0.72 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.62 -0.718 . . . . 63.44 111.685 -174.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . 0.62 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.8 mm-40 -57.5 -31.94 66.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.0 -0.546 . . . . 74.03 111.293 173.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.4 ' HB2' HG22 ' A' ' 522' ' ' THR . 6.7 mm-40 -68.5 -25.78 65.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.85 -0.614 . . . . 75.24 110.761 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 56.59 63.85 1.84 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.808 0.813 . . . . 74.5 110.663 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 67.0 p -94.86 -15.66 23.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.503 -0.771 . . . . 71.53 111.892 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.5 p -118.68 142.53 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.665 0.269 . . . . 53.33 111.056 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . 0.404 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 50.4 t -82.68 121.04 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.847 0.356 . . . . 74.12 111.2 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.96 159.31 15.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.068 -0.514 . . . . 62.02 112.285 -171.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 439' ' ' ASP . 94.4 mt -68.57 -33.5 74.18 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.961 0.41 . . . . 74.23 111.521 174.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -145.56 129.31 17.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.377 -0.374 . . . . 73.15 110.795 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -83.15 -24.93 32.33 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.177 0.513 . . . . 74.34 111.542 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -86.91 13.98 8.1 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.901 0.381 . . . . 71.32 111.453 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.507 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 62.7 t30 -106.82 -15.02 14.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.103 0.477 . . . . 74.22 111.001 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -73.19 -16.86 61.41 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.724 0.638 . . . . 70.21 112.724 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.509 HG23 HG23 ' A' ' 516' ' ' THR . 45.2 t -111.69 133.33 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.754 0.65 . . . . 72.34 112.754 -171.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -123.52 139.0 54.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.166 -0.47 . . . . 52.31 110.719 173.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 87.5 m -119.86 134.71 55.14 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.033 0.383 . . . . 71.33 112.033 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -139.8 136.54 34.17 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.868 0.366 . . . . 65.3 110.527 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.63 133.32 50.57 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.09 0.472 . . . . 75.31 112.17 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 64.0 t -124.74 141.21 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.286 -0.415 . . . . 74.14 111.65 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.9 t -118.19 117.54 29.43 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.472 -0.331 . . . . 74.14 110.679 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 66.5 t -101.31 123.02 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.026 0.441 . . . . 74.31 111.801 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.42 167.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 116.023 -0.535 . . . . 75.25 112.248 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.03 10.33 16.83 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.914 0.387 . . . . 73.44 111.684 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.254 1.322 0 CA-C-N 116.304 -0.407 . . . . 71.54 112.086 -176.567 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 120.722 0.296 . . . . 75.3 110.756 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.509 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 64.3 Cg_endo -72.41 173.65 12.82 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.493 2.129 . . . . 72.32 113.208 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -140.61 87.36 2.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.548 -0.538 . . . . 70.44 109.548 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.452 ' HB3' HG21 ' A' ' 517' ' ' VAL . 79.4 mt -90.58 137.9 31.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.092 -0.504 . . . . 75.44 111.364 -175.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.446 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.6 t -148.81 165.32 31.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.079 0.466 . . . . 73.15 112.014 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.552 HG13 HG12 ' A' ' 462' ' ' VAL . 27.5 m -133.72 149.19 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.83 -0.623 . . . . 75.33 111.569 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 6.5 mm-40 -130.99 129.76 42.51 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.229 -0.441 . . . . 72.11 111.519 176.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 50.1 mt -107.99 117.77 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.181 -0.463 . . . . 61.42 110.591 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -136.01 139.29 43.02 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.925 0.393 . . . . 75.22 111.73 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.66 -163.31 36.18 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.091 -0.504 . . . . 53.41 112.885 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.04 118.77 5.7 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.779 2.319 . . . . 71.41 113.027 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -86.74 -14.26 42.92 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.299 0.481 . . . . 64.51 112.299 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.0 t -128.87 117.85 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 122.146 -0.346 . . . . 73.53 110.704 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.94 164.21 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.241 0.543 . . . . 63.44 112.178 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -96.46 163.48 22.85 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 116.195 -0.457 . . . . 54.52 112.998 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.7 p -71.53 140.05 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 120.861 0.362 . . . . 75.44 111.214 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 65.87 17.33 10.8 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.656 0.613 . . . . 71.45 112.656 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . 0.411 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -98.33 176.3 5.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.863 0.363 . . . . 73.53 111.457 176.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 502' ' ' SER . 40.4 tp -115.28 130.14 56.82 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.747 0.308 . . . . 75.14 111.33 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.07 134.22 47.23 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.881 0.326 . . . . 73.22 111.881 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.3 128.31 53.89 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.108 0.48 . . . . 72.31 111.934 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -122.01 154.88 36.66 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.961 -0.563 . . . . 75.31 110.274 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.528 ' HG2' HG21 ' A' ' 500' ' ' THR . 54.8 mt-10 -120.34 127.74 52.62 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.899 0.38 . . . . 74.33 111.631 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 24.2 t -96.8 112.56 29.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.008 -0.542 . . . . 64.2 109.651 169.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 35.2 m-70 -94.13 108.95 20.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.832 0.348 . . . . 72.12 110.39 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.774 HG13 HG22 ' A' ' 475' ' ' VAL . 14.4 m -106.1 126.88 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 71.31 110.079 -176.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.526 ' HD3' HD22 ' A' ' 465' ' ' LEU . 15.7 ptpt -144.03 148.92 35.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.791 0.663 . . . . 74.51 112.791 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.517 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -105.91 127.42 53.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.273 -0.876 . . . . 72.24 109.314 174.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.526 HD22 ' HD3' ' A' ' 463' ' ' LYS . 73.5 mt -118.05 8.7 12.52 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.825 0.306 . . . . 74.11 111.825 -177.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -87.87 -16.16 60.13 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.247 -0.501 . . . . 75.01 113.769 -177.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 83.0 17.17 67.99 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 120.911 -0.661 . . . . 51.15 113.468 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.4 tt -134.66 135.58 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 122.909 0.484 . . . . 71.24 111.035 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . 0.48 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -70.95 132.62 21.91 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.474 -0.393 . . . . 71.4 113.701 -176.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 62.6 t -128.23 114.0 19.97 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 111.984 0.364 . . . . 73.31 111.984 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.87 -9.84 11.85 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.091 2.527 . . . . 73.1 112.739 174.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' SER . . . . . 0.461 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 39.0 m -80.87 10.6 4.81 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.688 0.996 . . . . 70.2 113.688 -171.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' THR . . . . . 0.419 HG23 HG22 ' A' ' 517' ' ' VAL . 94.3 m -88.14 100.59 13.07 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.86 0.838 . . . . 72.32 112.629 -166.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -114.4 117.54 31.31 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.291 -0.868 . . . . 75.32 110.746 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.774 HG22 HG13 ' A' ' 462' ' ' VAL . 45.3 t -104.17 132.72 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.063 0.394 . . . . 74.45 112.063 -173.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . 0.677 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 93.7 mtt180 -114.47 152.42 31.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.965 0.412 . . . . 74.33 111.832 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 82.5 t -122.43 126.27 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.056 -0.52 . . . . 75.44 111.008 173.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 513' ' ' ILE . 95.3 m-85 -115.47 138.83 50.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.851 0.357 . . . . 75.13 111.775 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 64.2 mt -115.0 107.93 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.954 -0.387 . . . . 72.51 109.954 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 55.94 34.76 24.23 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.088 0.47 . . . . 73.32 111.708 -173.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.13 -6.64 83.26 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 121.344 -0.455 . . . . 55.3 113.693 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.0 m -92.38 124.8 36.7 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 122.388 -0.478 . . . . 74.2 111.31 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.42 122.6 16.64 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.177 0.513 . . . . 75.13 111.579 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -101.97 -45.37 5.21 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.098 -0.501 . . . . 74.02 112.187 -178.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . 0.469 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 33.6 ttpt -171.01 160.09 6.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.242 0.217 . . . . 72.42 110.869 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.31 154.16 38.58 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.832 0.349 . . . . 64.11 111.863 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . 0.469 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 19.3 m-90 -129.83 147.22 51.58 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.313 -0.403 . . . . 74.24 111.362 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 34.6 m -110.28 118.57 36.69 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 110.326 -0.25 . . . . 72.02 110.326 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.56 172.17 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.49 0.662 . . . . 70.3 111.858 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 77.6 p -120.0 133.42 55.55 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.887 -0.597 . . . . 61.21 110.955 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.9 mt -118.48 118.93 33.06 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.861 0.362 . . . . 75.23 111.31 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . 0.48 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -82.21 -166.39 37.95 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.164 -0.541 . . . . 63.53 113.62 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.98 105.87 0.49 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.622 2.215 . . . . 73.04 112.518 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.5 mmtp 67.46 30.97 6.57 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.114 0.483 . . . . 72.12 111.573 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -94.33 149.45 21.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.325 -0.398 . . . . 52.12 111.97 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . 0.508 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 32.7 tt0 -134.58 139.1 45.12 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.004 0.431 . . . . 74.42 111.554 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -125.67 140.65 52.53 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.325 -0.398 . . . . 75.54 110.273 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.32 117.37 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.894 0.378 . . . . 74.12 111.428 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.53 138.96 41.75 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.35 -0.386 . . . . 73.11 110.698 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' THR . . . . . 0.528 HG21 ' HG2' ' A' ' 459' ' ' GLU . 42.6 p -120.55 155.46 33.62 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.349 0.595 . . . . 65.45 112.125 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -152.29 148.28 27.35 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.688 -0.687 . . . . 75.35 110.831 170.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.512 ' HB2' HD12 ' A' ' 455' ' ' LEU . 20.4 p -117.19 114.96 24.41 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.156 0.503 . . . . 71.12 110.949 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -109.06 136.7 48.14 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.217 -0.447 . . . . 73.02 111.9 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 87.9 m -113.24 101.32 53.34 Favored Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.974 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 61.1 Cg_endo -72.38 88.48 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.472 2.115 . . . . 75.52 112.925 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.2 p -75.67 6.73 4.48 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.786 0.662 . . . . 64.33 112.786 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -143.5 135.75 26.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 110.483 -0.192 . . . . 63.11 110.483 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.76 151.32 37.61 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.092 0.472 . . . . 74.2 112.238 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.95 -169.08 28.09 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.16 -0.543 . . . . 71.33 113.064 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 12.5 tpt -99.46 124.53 44.7 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.733 0.301 . . . . 64.13 110.859 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -128.32 111.95 13.92 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.179 0.514 . . . . 75.42 111.688 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 32.8 ttm180 -94.66 120.82 35.48 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.119 -0.492 . . . . 75.12 111.141 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 478' ' ' TYR . 67.6 mt -95.41 126.05 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.087 0.47 . . . . 75.22 111.523 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -124.95 129.15 49.78 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.289 -0.414 . . . . 74.45 111.324 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.3 146.3 38.48 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.846 0.355 . . . . 55.52 111.326 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' THR . . . . . 0.51 HG23 HG23 ' A' ' 532' ' ' VAL . 76.4 p -130.19 140.92 50.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.18 -0.464 . . . . 75.02 111.011 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . 0.503 ' HB ' HG12 ' A' ' 442' ' ' VAL . 7.4 p -100.51 138.42 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 110.207 -0.294 . . . . 75.23 110.207 174.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.5 t0 35.46 71.58 0.12 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.604 0.716 . . . . 73.43 110.961 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . 0.677 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.4 tm-20 -51.29 -45.52 62.16 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.098 -0.955 . . . . 62.13 111.71 -176.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -69.72 -17.29 63.45 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.411 -0.359 . . . . 74.01 111.49 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 51.51 79.36 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.798 0.809 . . . . 54.31 111.394 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 81.9 p -97.34 2.59 50.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.156 -0.929 . . . . 73.42 110.861 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.57 142.03 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.832 -0.622 . . . . 73.2 110.51 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.58 116.02 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.782 0.325 . . . . 72.31 111.847 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -92.59 170.33 9.82 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.349 0.595 . . . . 71.12 111.903 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.48 -29.25 67.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.853 -0.612 . . . . 75.13 111.978 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -141.38 128.33 20.64 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.773 0.32 . . . . 74.24 111.42 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.75 -24.17 31.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.131 0.491 . . . . 75.12 111.643 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -79.76 4.32 16.72 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.659 0.742 . . . . 73.35 110.767 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.446 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 56.0 t30 -92.16 -20.16 21.52 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.878 -0.601 . . . . 73.1 111.553 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . 0.455 ' HA ' HG13 ' A' ' 517' ' ' VAL . 12.9 m120 -72.8 -25.48 61.17 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.922 1.082 . . . . 72.44 113.922 -172.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.51 HG23 HG23 ' A' ' 516' ' ' THR . 42.9 t -109.32 143.37 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.922 0.712 . . . . 75.42 112.922 -172.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . 0.41 ' HB2' HG22 ' A' ' 442' ' ' VAL . . . -129.95 142.81 50.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.172 -0.467 . . . . 62.32 111.043 174.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 72.4 m -118.9 129.24 55.08 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.134 0.42 . . . . 74.13 112.134 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -143.17 117.67 9.73 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.648 0.261 . . . . 74.34 110.849 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 10.3 p-10 -93.42 137.78 32.38 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.246 0.461 . . . . 63.42 112.246 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 56.1 t -125.95 134.56 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.392 -0.367 . . . . 74.45 111.672 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 45.5 t -104.08 126.26 51.05 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.56 -0.291 . . . . 73.31 111.297 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.12 121.93 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.975 0.416 . . . . 65.33 111.465 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.9 m -111.83 161.74 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.367 0.506 . . . . 75.24 112.367 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 86.7 mt -82.66 16.92 1.97 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.264 0.468 . . . . 73.2 112.264 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 119.324 -0.37 . . . . 75.35 111.83 -179.705 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 120.405 0.145 . . . . 75.51 110.935 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.91 173.39 14.55 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.434 2.09 . . . . 73.22 113.474 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -157.2 94.08 1.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.369 -0.832 . . . . 61.23 109.447 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.524 HD22 HD11 ' A' ' 491' ' ' LEU . 53.4 mt -98.26 114.54 26.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.045 0.45 . . . . 74.13 111.382 -175.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.527 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.9 t -122.67 150.6 42.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.179 0.514 . . . . 72.2 112.116 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.512 HG13 HG11 ' A' ' 462' ' ' VAL . 28.8 m -121.31 148.88 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.064 -0.516 . . . . 74.44 111.286 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.9 mt-10 -136.83 143.18 42.97 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.655 -0.248 . . . . 71.42 110.911 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 57.7 mt -120.39 135.5 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 120.974 0.416 . . . . 73.12 111.599 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -137.23 147.05 45.53 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.29 -0.414 . . . . 73.3 110.652 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 160.51 -166.46 35.37 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.676 -0.774 . . . . 72.53 113.489 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.9 132.55 24.99 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.985 2.456 . . . . 74.54 113.491 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -78.66 -43.51 25.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.14 -0.482 . . . . 73.41 112.173 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 538' ' ' SER . 44.1 t -123.7 129.78 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.767 0.318 . . . . 54.44 111.082 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.47 163.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.147 0.498 . . . . 71.34 111.74 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -95.25 162.89 23.9 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.279 -0.486 . . . . 62.31 113.196 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.529 HG22 ' ND2' ' A' ' 453' ' ' ASN . 12.9 p -67.65 136.18 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 121.228 0.537 . . . . 75.35 111.625 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . 0.529 ' ND2' HG22 ' A' ' 452' ' ' VAL . 51.7 m-80 65.2 14.75 9.61 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.858 -0.61 . . . . 73.33 112.479 -177.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . 0.492 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.2 mmmt -97.07 153.84 17.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.068 0.461 . . . . 74.11 111.645 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 502' ' ' SER . 46.3 tp -90.19 138.79 31.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.019 0.438 . . . . 75.55 111.569 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -135.86 133.02 37.33 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.824 0.345 . . . . 73.32 111.656 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -109.45 134.58 51.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.849 0.357 . . . . 72.31 111.657 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -125.53 154.62 41.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.28 -0.418 . . . . 64.44 111.176 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -119.59 127.75 53.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.159 0.504 . . . . 75.31 110.719 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 39.8 t -105.54 115.34 47.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.997 -0.547 . . . . 73.13 110.949 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 27.1 m-70 -92.6 105.34 17.52 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.654 0.264 . . . . 71.04 110.643 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.512 HG11 HG13 ' A' ' 442' ' ' VAL . 33.8 m -106.24 122.74 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.075 0.464 . . . . 71.31 110.178 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -139.09 153.09 47.98 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.84 0.682 . . . . 74.04 112.84 -173.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.569 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 53.4 t-20 -106.1 128.64 54.02 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.256 -0.883 . . . . 75.44 110.025 176.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 90.7 mt -113.83 -2.42 13.65 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.023 0.379 . . . . 71.45 112.023 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -81.17 -16.44 74.38 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.247 -0.501 . . . . 54.14 113.884 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.42 21.89 68.74 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.077 -0.582 . . . . 73.02 113.737 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 3.2 tt -137.68 133.3 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.577 0.351 . . . . 73.42 111.405 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.36 134.54 22.9 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 114.214 0.445 . . . . 74.0 114.214 -176.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 50.7 t -131.14 114.54 16.21 Favored Pre-proline 0 CA--C 1.547 0.833 0 O-C-N 122.585 -0.362 . . . . 62.21 111.663 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -83.93 -10.24 9.41 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.151 2.567 . . . . 75.44 113.004 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 20.3 t -81.95 11.83 4.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.548 0.739 . . . . 64.1 112.328 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.2 m -88.82 97.39 11.13 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.719 0.771 . . . . 73.24 112.27 -167.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -101.87 130.63 48.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.357 -0.838 . . . . 73.11 110.66 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.486 HG22 HG12 ' A' ' 462' ' ' VAL . 60.4 t -115.37 133.41 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 122.793 0.437 . . . . 75.54 111.058 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . 0.503 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 90.6 mtt180 -126.66 149.04 49.75 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.828 0.347 . . . . 74.12 111.557 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.28 120.54 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.466 -0.334 . . . . 73.21 111.182 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -112.46 139.02 48.38 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.987 0.422 . . . . 74.21 111.699 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.512 HG12 HG12 ' A' ' 513' ' ' ILE . 54.0 mt -114.13 107.58 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 109.855 -0.424 . . . . 73.23 109.855 172.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 54.57 34.47 21.36 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.262 -0.426 . . . . 73.25 112.04 -175.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 103.29 -30.06 11.12 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.125 -0.56 . . . . 75.22 113.75 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.9 m -82.35 125.47 31.05 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.42 -0.459 . . . . 75.23 112.004 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.0 tp -65.57 115.73 6.08 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.01 0.433 . . . . 65.35 111.319 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -82.67 -44.14 16.07 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.355 -0.384 . . . . 72.31 111.38 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . 0.416 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 32.6 ttpt -170.38 157.83 6.28 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.672 -0.24 . . . . 75.31 110.876 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -137.38 156.69 47.91 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.095 0.474 . . . . 73.52 111.945 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . 0.416 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 18.2 m-90 -137.3 149.12 46.85 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.118 -0.492 . . . . 75.52 110.79 177.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 89.6 m -121.54 119.24 31.4 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 110.057 -0.349 . . . . 61.13 110.057 174.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.0 m -139.83 172.74 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.369 0.604 . . . . 75.25 112.115 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.7 p -115.1 133.88 55.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.925 -0.579 . . . . 72.02 110.474 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.524 HD11 HD22 ' A' ' 440' ' ' LEU . 73.5 mt -116.75 120.43 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.858 0.361 . . . . 63.23 111.098 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.47 -173.88 48.54 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.163 -0.541 . . . . 72.55 113.264 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.9 99.53 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.532 2.155 . . . . 74.12 112.484 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 98.0 mttt 67.57 50.45 0.91 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.918 -0.583 . . . . 64.51 111.796 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -110.39 148.36 32.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.516 -0.765 . . . . 73.13 111.27 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -130.04 136.87 49.87 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.058 0.456 . . . . 75.11 111.444 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -118.87 135.63 54.46 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.544 -0.539 . . . . 74.2 109.544 173.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 89.9 t -100.96 113.12 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.266 0.555 . . . . 73.33 111.116 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 63.6 mt -105.82 126.68 52.45 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.844 -0.616 . . . . 75.43 110.711 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 22.1 p -112.3 154.36 25.78 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.317 0.579 . . . . 71.02 111.909 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -145.64 148.9 33.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.608 -0.724 . . . . 72.43 110.701 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.555 ' HB2' HD11 ' A' ' 455' ' ' LEU . 24.0 p -110.24 113.75 26.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.308 0.575 . . . . 64.13 110.642 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -110.48 137.12 48.6 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.865 -0.607 . . . . 73.23 111.192 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 36.5 m -122.65 100.3 41.17 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 116.475 -0.329 . . . . 73.55 111.073 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.3 Cg_endo -76.52 106.8 2.32 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.318 2.012 . . . . 71.14 112.638 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 64.4 p -89.08 -5.88 57.5 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.817 0.342 . . . . 73.54 111.913 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -125.68 136.04 52.79 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.605 -0.27 . . . . 74.52 110.9 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -73.34 151.08 41.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.936 0.398 . . . . 74.25 111.93 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.8 178.33 24.65 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.223 -0.513 . . . . 54.24 112.913 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' MET . . . . . 0.484 ' HE2' ' HB2' ' A' ' 536' ' ' ASP . 14.4 tpt -92.74 114.58 27.17 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.877 0.37 . . . . 73.13 111.061 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -111.22 144.9 39.64 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.678 0.275 . . . . 75.14 111.447 -178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . 0.453 ' HG2' ' OD1' ' A' ' 514' ' ' ASN . 16.2 ttm180 -123.19 115.45 21.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.735 0.302 . . . . 75.22 111.075 176.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.512 HG12 HG12 ' A' ' 479' ' ' ILE . 59.9 mt -96.05 113.7 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.135 -0.484 . . . . 75.4 111.21 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.453 ' OD1' ' HG2' ' A' ' 512' ' ' ARG . 4.0 m-20 -118.91 145.79 45.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.405 -0.361 . . . . 73.13 111.469 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 532' ' ' VAL . . . -115.48 145.15 42.87 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.779 0.324 . . . . 71.03 111.274 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' THR . . . . . 0.5 HG23 HG23 ' A' ' 532' ' ' VAL . 58.9 p -132.82 148.76 52.31 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.183 -0.462 . . . . 65.34 111.643 -178.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.23 152.69 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 120.756 0.312 . . . . 72.01 111.243 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 35.8 t70 54.72 39.99 31.65 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.702 0.763 . . . . 75.13 111.369 -176.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . 0.503 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 8.5 mm-40 -52.6 -31.6 37.16 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.802 -0.636 . . . . 75.24 111.315 172.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.422 ' HB2' HG21 ' A' ' 522' ' ' THR . 4.2 mm-40 -67.67 -25.39 65.68 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.732 -0.667 . . . . 74.34 111.153 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.6 m120 59.31 71.92 0.56 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.419 0.628 . . . . 74.1 110.614 -176.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' THR . . . . . 0.422 HG21 ' HB2' ' A' ' 520' ' ' GLU . 82.6 p -107.41 -32.89 7.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.581 -0.736 . . . . 75.11 112.355 -174.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 14.4 p -124.37 143.31 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.589 0.588 . . . . 72.41 112.589 -172.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.3 111.69 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.45 -0.341 . . . . 73.42 110.716 176.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -99.73 -179.49 4.2 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.427 0.528 . . . . 74.45 112.427 -175.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.58 -41.08 24.66 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.251 -0.431 . . . . 74.42 111.552 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -130.31 98.49 4.73 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.124 0.488 . . . . 53.44 111.006 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -84.3 10.19 11.14 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.274 0.559 . . . . 71.14 111.502 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -108.16 0.62 21.66 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.467 0.651 . . . . 73.42 110.131 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.527 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.4 t30 -95.54 -0.84 51.64 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.85 -0.614 . . . . 74.13 111.551 -174.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -81.95 -19.25 41.06 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.424 0.898 . . . . 74.42 113.424 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.5 HG23 HG23 ' A' ' 516' ' ' THR . 39.9 t -112.42 141.19 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 112.365 0.506 . . . . 74.54 112.365 -174.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -132.49 135.52 46.07 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.597 -0.274 . . . . 71.12 111.439 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 30.6 m -106.53 134.91 48.95 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.472 0.545 . . . . 72.32 112.472 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -142.99 117.5 9.72 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.174 -0.467 . . . . 73.42 110.28 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . 0.484 ' HB2' ' HE2' ' A' ' 510' ' ' MET . 6.6 p-10 -94.34 137.45 33.47 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.253 0.549 . . . . 70.33 112.155 -177.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.21 130.64 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.95 -0.568 . . . . 73.34 111.518 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' SER . . . . . 0.412 ' HB3' HG22 ' A' ' 449' ' ' VAL . 41.3 t -96.97 117.97 32.34 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.527 -0.306 . . . . 70.33 111.351 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.95 120.47 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.935 0.398 . . . . 73.42 111.077 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.58 166.54 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 112.498 0.555 . . . . 72.54 112.498 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.87 -12.3 55.72 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.177 0.436 . . . . 73.35 112.177 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.252 1.206 0 N-CA-C 112.513 0.56 . . . . 55.12 112.513 178.748 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 110.146 -0.316 . . . . 71.41 110.146 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.61 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 56.9 Cg_endo -72.16 174.41 11.44 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.269 1.979 . . . . 73.24 112.92 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -154.06 80.29 1.13 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.365 0.602 . . . . 73.13 110.041 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.452 HD22 HD13 ' A' ' 491' ' ' LEU . 61.1 mt -80.05 116.54 20.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.953 -0.567 . . . . 71.31 111.596 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 8.1 t -126.38 153.53 44.82 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.859 0.361 . . . . 72.44 111.096 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.501 HG13 HG11 ' A' ' 462' ' ' VAL . 21.0 m -131.84 149.58 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.193 0.52 . . . . 74.05 112.358 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 49.4 mt-10 -128.47 144.03 51.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.883 -0.599 . . . . 72.11 110.843 175.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 65.8 mt -114.75 132.73 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.635 0.255 . . . . 73.05 110.766 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -132.81 145.87 51.35 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.579 0.228 . . . . 74.4 110.929 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.77 -173.66 36.51 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.672 -0.775 . . . . 74.21 113.752 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.62 126.43 12.09 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.991 2.461 . . . . 71.3 112.993 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -76.37 -21.47 56.04 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.153 -0.476 . . . . 64.14 112.218 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.6 t -131.0 128.82 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.754 0.312 . . . . 74.42 111.09 176.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.78 156.41 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 120.997 0.427 . . . . 75.51 111.682 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.34 154.57 24.37 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.319 -0.467 . . . . 71.14 113.25 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 11.7 p -65.62 141.46 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.889 0.376 . . . . 75.32 111.781 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 65.53 8.54 5.15 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.257 0.623 . . . . 70.32 112.272 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . 0.54 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 31.3 mmmt -96.13 167.15 11.38 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.943 0.402 . . . . 74.31 111.473 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 502' ' ' SER . 33.4 tp -103.81 134.06 47.75 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.68 0.276 . . . . 73.35 111.35 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -133.57 140.13 46.98 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.799 0.333 . . . . 75.32 111.774 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -100.53 138.15 37.98 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.907 0.384 . . . . 75.53 111.595 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -129.66 155.15 46.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.943 0.401 . . . . 71.5 111.084 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -119.73 127.55 52.94 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.096 -0.502 . . . . 55.32 111.379 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 29.9 t -104.54 113.01 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.271 -0.422 . . . . 74.42 110.046 171.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 41.9 m-70 -94.81 105.13 17.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.519 -0.31 . . . . 73.04 110.31 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.586 HG12 HG22 ' A' ' 475' ' ' VAL . 26.4 m -106.14 126.02 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.087 0.47 . . . . 72.31 110.346 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.42 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.8 ptpt -146.69 157.32 43.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.297 0.57 . . . . 71.04 112.315 -175.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -114.32 127.17 55.73 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.552 -0.749 . . . . 64.44 109.662 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.42 HD21 ' HD3' ' A' ' 463' ' ' LYS . 85.2 mt -113.28 0.91 14.99 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.843 0.354 . . . . 73.41 111.844 -177.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -76.99 -19.44 77.46 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.039 -0.6 . . . . 54.44 113.32 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.16 13.31 64.21 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.319 -0.467 . . . . 73.31 113.87 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.7 tt -137.35 133.26 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 122.575 0.35 . . . . 72.42 110.651 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.38 137.77 20.17 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.775 0.67 . . . . 71.21 114.775 -173.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 46.8 t -123.76 113.19 28.74 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 122.76 0.424 . . . . 62.41 111.184 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.78 -10.79 9.34 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.93 2.42 . . . . 75.12 112.807 175.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 29.0 t -83.28 11.21 6.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.229 0.612 . . . . 74.12 112.467 -176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 97.6 m -90.17 113.55 25.34 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.093 0.775 . . . . 74.44 113.093 -166.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -103.89 131.24 51.3 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.964 -0.562 . . . . 73.22 111.617 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.586 HG22 HG12 ' A' ' 462' ' ' VAL . 53.7 t -110.36 130.58 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 122.885 0.474 . . . . 72.3 111.264 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . 0.701 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 68.2 mtt180 -125.97 152.54 45.55 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.133 0.492 . . . . 75.12 111.755 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 75.9 t -120.89 128.75 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.117 -0.492 . . . . 71.34 110.818 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -118.68 136.52 53.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.835 0.35 . . . . 63.12 111.569 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 66.2 mt -108.1 108.05 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.965 -0.383 . . . . 74.25 109.965 173.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 56.68 33.64 23.19 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.099 0.476 . . . . 73.44 111.413 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 99.71 -26.56 23.95 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.409 -0.424 . . . . 51.31 113.76 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 86.1 m -81.88 129.72 34.84 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 117.078 0.439 . . . . 71.25 111.727 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 54.8 tp -65.65 121.36 14.8 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.199 0.523 . . . . 75.33 111.831 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -92.75 -43.79 8.86 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.791 -0.641 . . . . 72.15 111.686 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -161.77 154.5 20.27 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.69 -0.232 . . . . 74.22 110.826 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.62 147.87 47.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.362 0.504 . . . . 61.23 112.362 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -133.23 146.79 51.77 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.04 -0.527 . . . . 74.41 110.844 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.2 m -115.0 118.74 34.27 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.9 -0.408 . . . . 74.34 109.9 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.37 172.5 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.576 0.703 . . . . 74.4 112.471 -172.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 87.2 p -116.06 134.01 55.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.649 -0.705 . . . . 71.3 110.594 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.452 HD13 HD22 ' A' ' 440' ' ' LEU . 92.6 mt -124.41 119.18 28.47 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.814 0.34 . . . . 72.04 111.066 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.07 -174.08 48.43 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.126 -0.488 . . . . 75.43 113.622 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.68 106.07 0.58 Allowed 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.619 2.213 . . . . 45.14 112.416 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.9 mttt 66.25 36.23 5.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.364 0.602 . . . . 75.4 111.653 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -95.85 142.77 27.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.757 -0.656 . . . . 64.33 111.165 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -128.15 133.56 48.96 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.915 0.388 . . . . 75.41 111.416 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -126.74 134.2 50.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.281 -0.418 . . . . 72.32 111.208 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 51.3 t -102.61 113.08 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.047 0.451 . . . . 52.34 111.414 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 57.5 mt -104.05 126.57 51.27 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.231 -0.441 . . . . 63.2 110.323 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 32.9 p -113.46 151.09 31.88 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.356 0.598 . . . . 75.41 112.361 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -146.58 148.99 32.69 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.635 -0.711 . . . . 72.13 110.875 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.483 ' HB2' HD11 ' A' ' 455' ' ' LEU . 86.1 p -110.19 115.55 29.92 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.324 0.583 . . . . 74.12 110.669 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -107.82 137.23 46.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.983 -0.553 . . . . 74.1 111.757 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 86.0 m -109.05 101.37 44.5 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.298 -0.41 . . . . 74.13 111.307 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.9 Cg_endo -75.56 92.19 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.324 2.016 . . . . 63.52 112.722 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 40.0 p -82.38 12.32 4.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.275 0.472 . . . . 72.54 112.275 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -143.56 130.99 21.0 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.406 -0.361 . . . . 74.11 110.644 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.1 150.87 33.63 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.498 0.555 . . . . 72.1 112.498 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 143.13 -170.2 25.46 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.817 -0.706 . . . . 74.32 113.94 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' MET . . . . . 0.512 ' HE2' ' HA ' ' A' ' 510' ' ' MET . 0.1 OUTLIER -89.85 117.13 28.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.776 0.43 . . . . 72.51 111.033 178.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -119.02 143.28 47.16 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.059 0.457 . . . . 73.42 111.347 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 57.5 ttp180 -123.52 120.16 32.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.562 -0.29 . . . . 71.52 110.748 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 62.6 mt -95.07 120.45 44.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 73.2 110.755 178.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 18.2 m120 -118.92 132.98 56.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.311 -0.404 . . . . 65.44 111.093 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.8 137.39 49.8 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.8 0.333 . . . . 75.34 110.774 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' THR . . . . . 0.535 HG23 HG23 ' A' ' 532' ' ' VAL . 39.7 p -122.81 140.37 52.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.017 -0.538 . . . . 75.21 110.936 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 440' ' ' LEU . 14.9 p -115.53 141.69 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.538 -0.301 . . . . 72.35 111.353 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.1 t70 48.1 58.58 4.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.946 0.879 . . . . 72.14 110.199 -170.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . 0.701 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 2.6 mm-40 -55.33 -32.89 62.86 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.925 -1.034 . . . . 73.23 113.172 -176.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -77.22 -12.55 59.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.541 0.21 . . . . 74.34 111.493 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 54.63 69.75 0.69 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.687 0.756 . . . . 64.11 110.847 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 80.4 p -100.3 -7.0 25.05 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.234 -0.894 . . . . 72.13 112.01 -174.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.3 p -140.12 142.01 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.954 0.407 . . . . 74.32 111.926 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 80.3 t -83.89 118.87 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.477 -0.329 . . . . 64.14 110.523 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.61 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 19.7 mt-10 -110.71 174.62 5.78 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.044 0.757 . . . . 73.33 113.044 -173.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.32 -39.36 93.74 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.771 -0.65 . . . . 73.3 112.304 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -145.15 108.62 4.64 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.895 0.379 . . . . 74.14 111.325 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . 0.448 ' HA ' ' OD1' ' A' ' 531' ' ' ASN . 12.6 pt-20 -83.68 21.84 1.19 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.979 0.419 . . . . 73.24 111.796 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -107.49 -19.19 13.64 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.453 0.538 . . . . 75.11 112.453 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -99.71 12.73 35.86 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.571 0.582 . . . . 71.41 112.571 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 528' ' ' GLU . 15.0 m120 -77.79 -5.02 49.38 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.325 0.491 . . . . 72.03 112.325 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . 0.535 HG23 HG23 ' A' ' 516' ' ' THR . 41.2 t -127.94 133.25 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 120.901 0.382 . . . . 72.12 111.639 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -114.33 141.81 47.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.546 -0.297 . . . . 65.31 111.057 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 52.4 m -122.67 122.33 38.54 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.205 0.446 . . . . 70.33 112.205 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -137.74 117.16 12.82 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.286 -0.415 . . . . 74.42 110.041 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 1.1 p30 -97.88 136.32 38.35 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.511 0.672 . . . . 75.32 112.302 -177.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.59 142.1 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.317 -0.856 . . . . 71.31 111.515 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.5 t -104.05 123.31 46.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.161 -0.472 . . . . 73.53 110.977 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 50.6 t -103.15 120.72 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.767 0.317 . . . . 73.14 111.373 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.7 m -114.36 159.55 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.269 0.557 . . . . 72.52 112.194 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 90.2 mt -82.36 0.21 42.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.123 -0.489 . . . . 74.43 112.192 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 C--O 1.251 1.147 0 N-CA-C 112.471 0.545 . . . . 73.44 112.471 -174.472 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 120.678 0.275 . . . . 75.14 110.891 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.482 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 2.8 Cg_exo -74.99 174.41 12.83 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.014 2.476 . . . . 64.05 113.69 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -154.85 81.64 1.09 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.296 -0.866 . . . . 75.15 109.003 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.497 HD12 HG13 ' A' ' 470' ' ' VAL . 69.5 mt -86.72 127.94 34.99 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.857 -0.611 . . . . 74.51 111.811 -173.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' THR . . . . . 0.596 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.5 t -130.48 156.28 45.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.046 0.45 . . . . 74.35 111.762 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.545 HG13 HG11 ' A' ' 462' ' ' VAL . 31.6 m -132.8 147.78 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.972 -0.558 . . . . 74.43 111.586 -177.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 54.9 mt-10 -133.04 139.64 47.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.453 -0.34 . . . . 74.52 111.151 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 58.4 mt -109.21 129.22 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.972 0.415 . . . . 74.0 111.472 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -131.28 131.0 43.54 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.508 -0.315 . . . . 75.22 111.335 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 167.11 -168.49 40.42 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.486 -0.864 . . . . 74.34 113.871 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.52 122.8 7.67 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.802 2.335 . . . . 64.41 113.179 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -70.72 -33.19 70.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.234 -0.439 . . . . 75.22 111.501 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.3 t -120.83 132.01 71.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.775 0.321 . . . . 64.44 111.267 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.2 m -132.56 163.29 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.112 0.482 . . . . 65.33 111.712 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -94.71 149.49 19.38 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.234 -0.508 . . . . 71.54 112.849 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.494 HG22 ' ND2' ' A' ' 453' ' ' ASN . 11.2 p -63.28 137.46 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-O 120.906 0.384 . . . . 73.21 111.829 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . 0.494 ' ND2' HG22 ' A' ' 452' ' ' VAL . 55.4 m-80 62.07 25.23 15.11 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.996 0.519 . . . . 64.44 112.392 -178.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -111.73 162.46 15.2 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.964 0.411 . . . . 72.15 111.577 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 502' ' ' SER . 50.6 tp -90.5 128.04 36.42 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.843 0.354 . . . . 73.34 111.583 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.33 143.05 49.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.793 0.33 . . . . 74.12 111.38 177.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -122.74 144.51 49.11 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.945 0.402 . . . . 70.12 111.491 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -132.05 157.55 43.86 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.007 0.432 . . . . 72.24 111.296 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -120.52 127.74 52.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.858 -0.61 . . . . 75.12 110.738 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.95 116.13 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.37 -0.377 . . . . 64.21 111.319 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.553 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 30.2 m-70 -93.22 113.98 26.33 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.399 -0.364 . . . . 74.42 110.652 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 475' ' ' VAL . 17.8 m -116.08 122.42 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.781 0.324 . . . . 62.35 110.751 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 496' ' ' GLU . 0.7 OUTLIER -139.93 154.47 47.23 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.064 0.765 . . . . 74.01 113.064 -176.768 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.545 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.4 t-20 -103.03 128.6 49.82 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.119 -0.946 . . . . 74.5 110.386 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 88.6 mt -115.32 4.87 14.52 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.078 0.399 . . . . 73.0 112.078 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -85.75 -23.86 44.52 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.248 -0.501 . . . . 74.44 113.43 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.44 17.8 58.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.959 -0.639 . . . . 75.31 113.68 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 12.2 tt -137.37 141.73 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 122.57 0.348 . . . . 72.5 110.617 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . 0.46 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -65.68 136.31 36.1 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.139 -0.553 . . . . 74.31 113.612 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.497 HG13 HD12 ' A' ' 440' ' ' LEU . 38.5 t -129.88 112.97 17.48 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 112.515 0.561 . . . . 63.21 112.515 -176.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.77 -11.41 12.64 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.236 2.624 . . . . 63.43 112.22 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 70.1 m -80.18 11.61 3.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.5 0.72 . . . . 73.34 112.161 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 33.5 m -88.28 90.83 8.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.849 0.833 . . . . 75.14 111.073 -169.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -106.02 123.16 47.56 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.194 -0.912 . . . . 61.11 110.272 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 462' ' ' VAL . 39.2 t -103.71 121.02 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.826 0.346 . . . . 70.34 110.904 -177.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 476' ' ' ARG . 33.3 ttm180 -129.13 144.96 51.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.694 0.283 . . . . 75.31 111.656 -174.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 66.3 t -120.5 130.27 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.071 0.463 . . . . 71.2 111.722 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -119.52 137.04 54.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.96 -0.564 . . . . 74.4 111.177 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.492 HG12 HG12 ' A' ' 513' ' ' ILE . 59.2 mt -111.94 107.76 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.712 0.292 . . . . 72.34 110.32 174.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 57.29 34.87 25.38 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.929 0.395 . . . . 52.14 111.31 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.95 -2.18 85.47 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.336 -0.459 . . . . 37.34 113.398 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 63.1 m -90.25 123.42 34.03 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.606 -0.349 . . . . 71.45 111.389 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 44.4 tp -63.88 115.06 4.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.98 0.419 . . . . 74.14 111.0 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -105.05 -44.05 4.89 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.102 0.779 . . . . 72.0 113.102 -175.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -165.88 161.02 17.45 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 122.168 -0.332 . . . . 72.4 111.17 -172.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . 0.537 ' N ' HD21 ' A' ' 486' ' ' ASN . 0.0 OUTLIER -161.1 154.32 21.46 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.826 0.676 . . . . 74.02 112.826 177.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -136.0 149.79 48.97 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.687 0.795 . . . . 72.4 110.44 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.2 m -115.08 119.41 36.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.9 0.381 . . . . 74.45 111.21 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.9 m -137.57 173.56 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.158 0.504 . . . . 73.22 111.695 -176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 95.3 p -125.57 135.11 51.88 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.871 0.367 . . . . 75.25 110.882 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.477 HD11 HD23 ' A' ' 440' ' ' LEU . 94.9 mt -117.63 120.1 37.01 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.455 -0.339 . . . . 75.31 111.24 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . 0.46 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -77.78 -170.09 34.62 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.223 -0.513 . . . . 42.41 113.279 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.56 97.03 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.341 2.027 . . . . 74.45 112.445 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.6 mttt 66.29 59.61 0.65 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.853 0.835 . . . . 74.55 111.791 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -120.85 152.94 37.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.046 -0.979 . . . . 74.31 110.651 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 39.5 tt0 -134.63 137.25 43.5 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.936 0.398 . . . . 71.04 111.931 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.425 ' HG2' ' CD2' ' A' ' 491' ' ' LEU . 28.5 mmmt -116.94 150.3 38.74 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.203 -0.453 . . . . 75.45 110.241 174.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.4 113.56 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.925 0.393 . . . . 72.14 111.555 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 77.9 mt -110.51 136.07 50.21 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.24 -0.436 . . . . 74.51 111.314 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 41.0 p -117.91 150.62 38.91 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.094 0.473 . . . . 70.24 111.943 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -145.63 151.61 38.35 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.248 -0.433 . . . . 74.42 111.02 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.522 ' HB2' HD11 ' A' ' 455' ' ' LEU . 72.9 p -111.67 141.47 45.22 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.28 -0.418 . . . . 75.33 111.297 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.5 t90 -139.34 137.49 35.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.281 -0.418 . . . . 74.35 111.094 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.1 m -118.2 100.43 51.75 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-O 120.758 0.313 . . . . 74.14 111.277 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.99 102.99 1.63 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.519 2.146 . . . . 75.14 112.841 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 81.1 p -81.58 -1.21 45.57 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.167 0.432 . . . . 74.55 112.167 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -137.24 145.74 43.94 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.711 0.291 . . . . 74.3 111.316 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.459 ' HA ' ' HB ' ' A' ' 539' ' ' VAL . 0.3 OUTLIER -83.19 152.03 25.41 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.516 0.561 . . . . 74.53 112.516 -177.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.63 -176.32 30.07 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.038 -0.601 . . . . 63.12 113.694 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' MET . . . . . 0.523 ' HE2' ' HA ' ' A' ' 510' ' ' MET . 1.2 tpt -92.56 106.28 18.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.536 0.335 . . . . 72.43 110.669 178.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -107.66 121.9 45.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.179 0.514 . . . . 74.3 111.795 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . 0.489 ' HD2' HG21 ' A' ' 534' ' ' THR . 19.6 tpp85 -94.21 112.74 24.56 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.188 -0.46 . . . . 74.14 111.52 177.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.492 HG12 HG12 ' A' ' 479' ' ' ILE . 40.6 mt -98.75 127.24 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.068 0.461 . . . . 74.3 110.858 175.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -124.09 138.15 54.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.335 -0.393 . . . . 73.54 111.553 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.94 132.48 54.73 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.832 -0.433 . . . . 75.15 109.832 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 38.9 p -132.93 141.1 48.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.352 -0.385 . . . . 75.51 111.497 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.55 140.05 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.762 0.315 . . . . 72.24 110.949 175.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.2 t0 43.98 67.9 0.6 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.517 0.675 . . . . 75.21 111.594 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -55.8 -31.67 62.85 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.821 -0.627 . . . . 72.54 112.246 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' GLU . . . . . 0.435 ' HB2' HG23 ' A' ' 522' ' ' THR . 8.4 mm-40 -78.17 -19.29 54.25 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.276 -0.42 . . . . 73.44 111.518 -178.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 62.16 46.62 6.14 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.742 0.782 . . . . 73.15 110.011 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' THR . . . . . 0.435 HG23 ' HB2' ' A' ' 520' ' ' GLU . 52.1 p -67.59 -37.76 83.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.486 -0.779 . . . . 73.35 111.588 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.426 HG21 ' HG2' ' A' ' 438' ' ' PRO . 10.7 p -102.33 143.91 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 116.096 -0.502 . . . . 74.45 110.993 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' VAL . . . . . 0.438 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 59.1 t -81.87 115.62 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.992 0.425 . . . . 74.13 111.119 -177.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -91.75 155.96 17.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.888 -0.596 . . . . 73.22 112.32 -173.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.19 -39.53 78.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.145 0.498 . . . . 73.53 110.472 173.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -133.92 113.35 12.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.832 -0.622 . . . . 73.3 110.495 174.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -83.17 -3.43 57.36 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.318 0.58 . . . . 74.12 111.379 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -92.54 -1.64 56.79 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.982 0.42 . . . . 75.43 111.306 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' ASN . . . . . 0.596 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 65.5 t30 -95.82 -6.65 39.0 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 116.345 -0.388 . . . . 70.34 112.0 -174.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -83.66 3.92 30.83 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.54 0.941 . . . . 71.21 113.54 -173.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 52.4 t -126.86 142.21 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 112.798 0.666 . . . . 74.22 112.798 -173.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . 0.464 ' HB2' HG23 ' A' ' 442' ' ' VAL . . . -128.58 143.96 51.06 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.119 -0.491 . . . . 71.41 111.232 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 534' ' ' THR . . . . . 0.489 HG21 ' HD2' ' A' ' 512' ' ' ARG . 59.6 m -120.66 134.12 55.31 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 111.94 0.348 . . . . 72.01 111.94 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -142.5 136.88 29.8 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 120.713 0.292 . . . . 74.31 111.067 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -104.87 125.01 50.45 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.662 0.268 . . . . 70.32 111.692 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.6 t -114.3 128.77 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.8 0.333 . . . . 73.4 111.28 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 30.1 t -112.88 121.59 45.12 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.655 0.264 . . . . 71.31 111.02 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 508' ' ' GLU . 41.9 t -98.93 131.43 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.691 0.281 . . . . 73.15 111.353 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.42 ' HB ' ' HG2' ' A' ' 542' ' ' GLU . 28.8 m -113.16 156.32 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.226 0.454 . . . . 74.21 112.226 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 94.9 mt -95.57 -13.36 24.48 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.323 -0.399 . . . . 74.3 111.652 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 542' ' ' GLU . . . . . 0.42 ' HG2' ' HB ' ' A' ' 540' ' ' VAL . 8.3 pt-20 . . . . . 0 C--O 1.249 1.055 0 N-CA-C 112.449 0.537 . . . . 61.21 112.449 -176.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.84 0.352 . . . . 71.22 110.105 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -97.59 117.57 32.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.228 0.537 . . . . 75.11 111.752 -174.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -121.37 128.61 25.6 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.746 -0.661 . . . . 72.31 110.226 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.62 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 59.2 Cg_endo -75.41 175.18 11.6 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.577 2.184 . . . . 65.33 113.399 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -153.58 81.59 1.17 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.847 -0.615 . . . . 75.52 110.194 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.496 HD12 HG13 ' A' ' 470' ' ' VAL . 96.6 mt -81.34 145.09 31.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.22 0.534 . . . . 72.52 111.833 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.555 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 12.0 t -148.55 156.37 42.34 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.103 0.478 . . . . 64.4 111.672 176.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.514 HG13 HG11 ' A' ' 462' ' ' VAL . 27.9 m -125.76 147.95 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.941 -0.572 . . . . 75.04 110.871 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 40.2 mt-10 -134.57 117.98 16.75 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.854 0.359 . . . . 63.32 111.623 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 59.5 mt -94.21 131.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.406 -0.361 . . . . 72.52 110.727 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -142.44 138.85 31.34 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.632 0.253 . . . . 75.02 111.486 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.62 -162.39 32.44 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.017 -0.611 . . . . 73.33 113.51 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.46 124.52 10.42 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.886 2.391 . . . . 55.54 113.189 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -85.72 -15.81 41.01 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.123 0.416 . . . . 72.42 112.123 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 538' ' ' SER . 87.2 t -133.01 126.61 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 120.711 0.291 . . . . 72.52 110.574 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.61 163.4 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.02 0.438 . . . . 73.41 111.648 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.17 157.52 26.03 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.165 -0.541 . . . . 63.53 113.012 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.549 HG22 ' ND2' ' A' ' 453' ' ' ASN . 8.1 p -72.34 140.49 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.006 0.432 . . . . 65.24 111.393 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . 0.549 ' ND2' HG22 ' A' ' 452' ' ' VAL . 41.9 m-80 60.23 23.81 13.19 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.658 0.383 . . . . 73.41 111.936 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -112.3 155.62 23.78 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.545 -0.298 . . . . 74.35 111.075 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 502' ' ' SER . 33.5 tp -90.55 139.81 30.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.878 0.37 . . . . 74.15 111.568 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -131.89 143.59 50.26 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.847 0.356 . . . . 62.32 111.608 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -111.32 126.09 54.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.103 0.478 . . . . 62.22 111.643 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -121.96 150.27 42.27 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.152 -0.476 . . . . 73.22 110.729 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.521 ' HG2' HG21 ' A' ' 500' ' ' THR . 37.8 mt-10 -121.8 128.08 51.29 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.129 -0.487 . . . . 73.55 111.384 -176.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 42.6 t -107.65 114.74 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.183 -0.462 . . . . 74.02 111.229 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.551 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 42.0 m-70 -90.49 111.55 22.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.722 0.296 . . . . 74.22 110.377 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.665 HG12 HG22 ' A' ' 475' ' ' VAL . 31.6 m -107.82 122.81 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.005 0.431 . . . . 74.5 110.36 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 496' ' ' GLU . 3.6 ptpp? -141.69 152.86 44.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.586 0.707 . . . . 73.21 112.765 -173.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.663 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 49.1 t-20 -100.8 138.68 37.53 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.159 -0.928 . . . . 71.23 109.758 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 94.4 mt -120.94 -5.58 9.58 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.409 0.522 . . . . 73.3 112.409 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -77.83 -25.19 62.96 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.211 -0.518 . . . . 74.34 114.047 -176.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.62 15.98 59.15 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.243 -0.503 . . . . 75.24 113.776 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.2 tt -134.66 142.69 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.113 0.565 . . . . 71.43 110.736 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.82 140.78 35.22 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.322 0.489 . . . . 64.44 114.322 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.496 HG13 HD12 ' A' ' 440' ' ' LEU . 47.0 t -131.85 114.3 15.28 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 122.454 0.301 . . . . 74.01 111.671 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -88.84 -10.57 4.19 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 123.196 2.597 . . . . 71.4 113.281 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 84.9 p -85.0 13.27 6.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.636 0.775 . . . . 72.11 112.876 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 63.3 m -87.4 93.35 9.38 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.909 0.861 . . . . 71.12 112.32 -165.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -97.44 127.28 43.27 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.144 -0.934 . . . . 73.33 110.441 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.665 HG22 HG12 ' A' ' 462' ' ' VAL . 47.7 t -114.06 125.1 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.673 0.273 . . . . 71.22 111.079 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . 0.476 ' HD2' ' OE1' ' A' ' 519' ' ' GLU . 62.8 mtt85 -125.52 149.79 47.99 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.99 0.424 . . . . 75.11 111.812 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.87 127.09 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.125 0.488 . . . . 73.3 111.436 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -120.37 136.8 54.59 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.932 -0.577 . . . . 74.21 111.384 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 60.1 mt -109.0 107.87 23.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.22 -0.446 . . . . 75.43 109.982 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 57.43 34.9 25.3 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.123 0.487 . . . . 74.22 111.214 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.57 -5.86 84.22 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 116.122 -0.49 . . . . 74.01 113.848 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 42.3 m -93.34 125.63 38.04 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.051 0.426 . . . . 53.24 111.33 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.1 tp -65.72 117.56 8.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.115 0.413 . . . . 75.33 112.115 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -88.74 -45.21 9.97 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.535 -0.302 . . . . 75.44 111.449 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -169.99 161.98 8.98 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.671 0.272 . . . . 73.44 111.4 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -131.93 152.04 51.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.038 0.447 . . . . 65.5 111.595 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -134.54 147.27 50.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.029 -0.532 . . . . 74.11 110.864 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.0 m -121.36 119.21 31.48 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.116 -0.328 . . . . 64.45 110.116 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.5 172.81 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.154 0.502 . . . . 75.3 111.476 -176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 91.5 p -126.0 132.44 52.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.252 -0.431 . . . . 55.45 110.649 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.492 HD12 HD22 ' A' ' 440' ' ' LEU . 95.9 mt -118.23 119.74 35.59 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.842 0.353 . . . . 73.34 111.373 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -78.45 -165.49 27.77 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.056 -0.593 . . . . 70.43 112.975 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.24 95.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.084 1.856 . . . . 71.25 112.413 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.0 mttt 65.78 44.05 2.97 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.646 -0.706 . . . . 63.31 112.61 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -98.43 152.57 19.36 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.089 -0.505 . . . . 74.42 111.347 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 463' ' ' LYS . 35.6 tt0 -130.72 138.8 50.16 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.934 0.397 . . . . 72.33 111.694 177.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -119.55 138.76 52.98 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.948 -0.39 . . . . 73.35 109.948 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.01 113.24 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.021 0.439 . . . . 75.0 111.801 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 82.3 mt -103.88 146.46 28.62 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.288 -0.414 . . . . 71.33 111.267 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' THR . . . . . 0.521 HG21 ' HG2' ' A' ' 459' ' ' GLU . 43.4 p -127.06 156.76 41.16 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.189 0.518 . . . . 73.24 111.803 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -155.56 148.23 24.12 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.97 -0.559 . . . . 75.03 111.031 171.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.511 ' HB3' HD11 ' A' ' 455' ' ' LEU . 43.3 m -110.98 115.23 29.13 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.297 -0.411 . . . . 73.34 110.849 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -108.54 135.03 50.48 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.818 0.342 . . . . 73.5 111.763 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.3 m -116.14 100.68 53.7 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 116.39 -0.368 . . . . 71.13 111.262 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 74.5 Cg_endo -76.17 97.36 1.11 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.388 2.059 . . . . 72.53 112.881 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 67.0 p -76.71 -22.61 53.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.104 0.409 . . . . 70.12 112.104 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -107.33 138.58 43.26 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.843 0.354 . . . . 73.31 110.803 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.74 140.41 30.52 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.285 0.565 . . . . 65.04 112.189 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 148.49 -179.13 25.58 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.89 -0.595 . . . . 70.51 112.153 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 67.6 mtp -94.02 126.35 39.19 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.8 -0.824 . . . . 73.55 111.664 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.93 131.61 53.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.122 -0.49 . . . . 71.22 111.126 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -97.24 122.01 39.78 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.914 0.388 . . . . 73.41 111.263 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 63.1 mt -100.58 119.59 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.03 0.443 . . . . 72.45 110.951 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -115.82 151.87 34.41 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.04 0.448 . . . . 75.03 111.712 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -128.12 132.8 48.94 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.063 -0.517 . . . . 63.13 110.547 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 44.0 p -128.89 143.14 50.81 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.317 -0.401 . . . . 75.04 111.292 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.9 141.13 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.019 0.437 . . . . 74.31 111.697 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 21.8 t70 50.23 49.75 19.94 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.632 0.773 . . . . 74.51 112.632 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . 0.476 ' OE1' ' HD2' ' A' ' 476' ' ' ARG . 54.6 mt-10 -53.0 -29.45 29.29 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.247 0.546 . . . . 74.42 111.171 172.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.466 ' HB2' HG22 ' A' ' 522' ' ' THR . 0.0 OUTLIER -65.24 -17.3 64.38 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.655 -0.702 . . . . 72.24 110.933 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.91 56.57 5.27 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.243 0.544 . . . . 73.14 110.394 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' THR . . . . . 0.466 HG22 ' HB2' ' A' ' 520' ' ' GLU . 64.5 p -83.9 -36.66 23.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.207 -0.451 . . . . 71.53 111.413 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.22 141.68 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.459 0.54 . . . . 74.4 112.459 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 57.8 t -85.09 119.43 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.197 -0.456 . . . . 72.52 110.461 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.62 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 25.5 mt-10 -115.14 174.8 5.8 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.992 0.738 . . . . 74.32 112.992 -174.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.06 -39.65 55.0 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.511 -0.768 . . . . 73.54 112.286 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -120.07 118.66 31.19 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.207 0.527 . . . . 63.4 111.346 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.78 -20.84 32.6 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.345 0.593 . . . . 74.32 111.495 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -93.39 -4.38 51.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.227 0.537 . . . . 74.25 111.339 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.555 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 62.5 t30 -86.73 -10.79 52.88 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 120.982 0.42 . . . . 72.03 111.72 -174.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -85.02 1.45 47.57 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.117 0.784 . . . . 74.3 113.117 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.2 t -127.46 136.93 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 112.38 0.511 . . . . 70.53 112.38 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -125.44 141.19 52.19 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.269 -0.423 . . . . 74.33 110.883 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 84.4 m -127.59 119.7 26.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.168 0.433 . . . . 75.3 112.168 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -126.22 123.38 38.05 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.822 0.344 . . . . 74.33 110.847 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -94.38 120.56 34.8 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.877 0.37 . . . . 75.55 111.848 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.9 t -112.68 141.26 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.191 0.519 . . . . 74.54 111.94 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' SER . . . . . 0.455 ' HB3' HG22 ' A' ' 449' ' ' VAL . 40.2 t -113.79 115.88 28.48 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.296 -0.411 . . . . 74.53 111.031 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 43.6 t -99.8 120.83 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.859 0.362 . . . . 73.23 111.05 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.6 164.5 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.498 0.555 . . . . 72.33 112.498 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.4 mt -77.73 -30.86 51.85 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.356 0.502 . . . . 74.04 112.356 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--O 1.251 1.167 0 N-CA-C 112.383 0.512 . . . . 75.25 112.383 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 71.2 mtm . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.911 0.386 . . . . 74.12 111.304 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -88.09 120.39 29.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.381 -0.372 . . . . 60.54 110.391 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -112.93 134.48 21.76 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.645 -0.252 . . . . 74.34 110.461 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.571 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 61.3 Cg_endo -71.73 175.73 9.2 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.711 2.274 . . . . 75.53 112.789 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -151.6 83.66 1.29 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.123 -0.49 . . . . 70.03 109.872 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.506 HD23 HD12 ' A' ' 491' ' ' LEU . 80.0 mt -83.23 99.15 9.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.014 -0.539 . . . . 74.14 111.132 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.475 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 6.5 t -116.64 149.62 39.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.451 . . . . 74.21 111.149 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.517 ' O ' ' HB2' ' A' ' 533' ' ' ALA . 31.4 m -121.37 148.56 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.263 -0.426 . . . . 65.22 111.227 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.3 mt-10 -130.01 117.74 20.51 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.628 0.251 . . . . 71.25 111.388 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 55.4 mt -92.47 131.05 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 110.456 -0.202 . . . . 74.55 110.456 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -142.45 144.51 33.08 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.541 0.21 . . . . 74.32 111.23 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.32 -159.3 29.04 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.989 -0.624 . . . . 74.43 113.38 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.69 134.22 21.71 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.906 2.404 . . . . 75.12 113.22 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -92.3 -20.25 21.3 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.433 0.531 . . . . 73.52 112.433 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.1 t -127.97 125.75 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.959 -0.463 . . . . 75.31 111.241 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 33.6 m -135.65 161.27 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.982 0.42 . . . . 75.44 111.32 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -95.51 166.49 25.39 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.061 -0.59 . . . . 65.14 113.012 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.518 HG23 ' ND2' ' A' ' 453' ' ' ASN . 12.4 p -69.93 139.27 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 O-C-N 122.277 -0.543 . . . . 73.43 111.409 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . 0.518 ' ND2' HG23 ' A' ' 452' ' ' VAL . 48.4 m-80 63.6 17.95 10.75 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.913 0.485 . . . . 75.2 112.166 -177.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.513 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.8 mmmt -95.15 150.85 19.75 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.857 0.361 . . . . 74.34 110.812 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 502' ' ' SER . 37.6 tp -96.69 118.97 34.28 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.7 0.286 . . . . 70.0 111.004 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.06 134.74 54.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.886 0.374 . . . . 73.22 111.715 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -108.55 130.05 55.3 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.0 0.428 . . . . 73.34 111.45 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -122.33 166.44 14.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.088 0.47 . . . . 74.45 111.488 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -121.19 127.5 51.56 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.975 -0.557 . . . . 70.15 111.24 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 29.8 t -104.83 113.04 40.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 75.21 110.024 173.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 29.9 m-70 -98.34 106.22 18.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.648 0.261 . . . . 75.52 110.512 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.519 HG12 HG22 ' A' ' 475' ' ' VAL . 19.4 m -105.8 123.48 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.2 0.524 . . . . 70.34 110.104 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.53 ' HD3' HD22 ' A' ' 465' ' ' LEU . 15.2 ptpt -139.89 144.18 37.05 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.517 0.562 . . . . 74.32 112.517 -170.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.4 t-20 -102.76 126.7 49.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.191 -0.67 . . . . 73.54 109.191 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.53 HD22 ' HD3' ' A' ' 463' ' ' LYS . 67.9 mt -112.69 0.15 15.25 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.011 -0.43 . . . . 75.22 112.034 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -83.87 -21.47 57.5 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.073 -0.584 . . . . 73.02 113.797 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.61 21.4 47.8 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.07 -0.586 . . . . 64.41 113.861 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.409 HG22 ' HB3' ' A' ' 438' ' ' PRO . 3.7 tt -138.1 133.77 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 122.662 -0.316 . . . . 73.54 111.076 175.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.1 141.41 34.28 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 114.684 0.634 . . . . 74.35 114.684 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.67 116.27 16.02 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.834 0.454 . . . . 61.13 111.344 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.71 -12.17 11.19 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.056 2.504 . . . . 74.53 113.086 175.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 50.7 m -81.59 13.51 3.06 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.587 0.755 . . . . 71.05 112.79 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' THR . . . . . 0.421 HG22 HG23 ' A' ' 517' ' ' VAL . 62.9 m -86.56 91.15 8.47 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 122.119 0.962 . . . . 62.44 111.465 -165.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -95.08 121.7 36.99 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.698 -1.137 . . . . 75.34 110.364 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.519 HG22 HG12 ' A' ' 462' ' ' VAL . 41.4 t -104.31 118.24 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.001 0.429 . . . . 64.43 111.291 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -116.58 144.37 44.46 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.642 0.258 . . . . 73.43 111.555 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 95.6 t -120.17 120.25 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.801 0.334 . . . . 70.21 110.881 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -116.08 137.39 52.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.25 -0.432 . . . . 74.11 111.387 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.478 HG12 HG12 ' A' ' 513' ' ' ILE . 63.3 mt -111.85 107.94 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.799 -0.445 . . . . 74.44 109.799 174.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 56.27 34.44 24.04 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.093 0.473 . . . . 75.24 111.183 -173.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.9 -20.65 47.88 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 116.252 -0.431 . . . . 54.42 113.732 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 45.5 m -81.93 121.71 26.84 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.357 -0.496 . . . . 75.41 111.81 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -63.91 120.32 11.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.077 0.465 . . . . 74.51 111.555 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -102.91 -43.89 5.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.201 -0.454 . . . . 74.12 111.982 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -146.91 152.53 38.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.583 0.23 . . . . 75.13 111.107 -174.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -145.3 139.15 26.87 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.103 0.478 . . . . 73.41 111.496 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -129.7 148.86 51.63 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.121 -0.49 . . . . 75.31 110.709 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 78.5 m -117.62 118.48 32.24 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.69 0.281 . . . . 72.21 110.244 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.1 m -141.8 173.43 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.283 0.563 . . . . 71.34 111.765 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 64.9 m -121.35 135.48 55.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.121 -0.49 . . . . 72.31 110.914 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.506 HD12 HD23 ' A' ' 440' ' ' LEU . 85.1 mt -118.11 119.85 35.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.806 0.336 . . . . 70.32 111.072 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -82.72 -169.03 43.6 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.326 -0.464 . . . . 61.02 113.449 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.51 107.88 0.64 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.417 2.078 . . . . 74.35 112.7 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.0 mmtp 68.45 29.21 5.79 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.126 -0.488 . . . . 75.24 111.596 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -92.2 147.4 22.96 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.369 -0.378 . . . . 71.31 111.728 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -135.12 129.35 33.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.605 0.362 . . . . 71.43 111.479 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -116.79 136.63 52.8 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.677 0.275 . . . . 74.14 110.704 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 63.1 t -101.77 113.54 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 121.199 0.523 . . . . 61.34 111.488 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 68.7 mt -110.7 131.15 55.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.97 -0.559 . . . . 65.41 110.489 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 26.6 p -113.9 154.7 27.08 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.267 0.556 . . . . 72.43 112.32 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -144.4 148.8 35.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.645 -0.707 . . . . 64.14 110.816 174.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.5 ' HB2' HD11 ' A' ' 455' ' ' LEU . 76.0 p -115.04 114.36 25.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.065 0.46 . . . . 72.23 110.805 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -113.56 137.18 51.94 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.24 -0.436 . . . . 64.12 112.002 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.4 m -116.24 102.03 53.72 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.093 -0.503 . . . . 75.44 111.222 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 60.7 Cg_endo -71.92 99.38 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.534 2.156 . . . . 74.21 112.955 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 33.1 p -74.04 -21.88 59.77 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.944 0.402 . . . . 75.34 111.907 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -112.36 141.19 46.39 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.413 -0.358 . . . . 71.44 111.107 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.68 151.18 23.64 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.257 0.551 . . . . 75.23 111.926 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 148.02 -170.97 28.6 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.06 -0.591 . . . . 70.15 112.77 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' MET . . . . . 0.411 ' HE2' ' HB2' ' A' ' 536' ' ' ASP . 13.7 tpt -98.76 120.83 39.87 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.503 -0.41 . . . . 74.32 110.729 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -120.23 116.22 25.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.899 0.38 . . . . 74.42 111.701 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -92.47 112.94 25.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.901 0.381 . . . . 74.34 110.482 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.478 HG12 HG12 ' A' ' 479' ' ' ILE . 58.1 mt -93.8 117.34 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.254 0.55 . . . . 75.31 110.907 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -117.05 134.66 54.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 74.53 111.1 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.35 133.16 53.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.733 0.301 . . . . 65.5 110.646 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' THR . . . . . 0.508 HG23 HG22 ' A' ' 532' ' ' VAL . 66.5 p -125.41 140.32 52.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.99 0.424 . . . . 73.33 111.61 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . 0.421 HG23 HG22 ' A' ' 473' ' ' THR . 7.4 p -120.29 140.83 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.814 0.34 . . . . 72.14 111.022 174.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.6 t0 43.43 58.74 3.3 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.393 0.677 . . . . 71.31 112.778 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -57.75 -29.99 65.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.608 0.718 . . . . 74.33 110.475 171.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.62 -17.3 64.56 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.259 -0.882 . . . . 73.44 111.791 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 19.7 m120 51.4 55.4 9.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.671 0.748 . . . . 75.34 111.306 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 51.1 p -67.21 -19.72 65.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.377 -0.829 . . . . 74.22 111.363 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.22 141.13 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.749 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 74.0 t -83.58 119.78 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 110.069 -0.345 . . . . 75.11 110.069 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.571 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 18.9 mt-10 -110.24 -175.03 2.63 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.699 0.629 . . . . 73.04 112.699 -171.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 99.2 mt -69.48 -39.26 77.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.275 -0.42 . . . . 71.41 111.209 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -126.73 124.85 40.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.343 -0.39 . . . . 63.01 110.864 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -83.2 -23.98 32.61 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.848 0.314 . . . . 74.5 111.848 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -103.49 4.2 35.71 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.631 0.604 . . . . 71.33 112.631 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.475 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.7 t30 -86.62 -1.75 57.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.087 0.47 . . . . 74.22 111.373 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -80.85 -1.06 41.69 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.677 0.621 . . . . 74.14 112.677 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.508 HG22 HG23 ' A' ' 516' ' ' THR . 56.6 t -124.53 129.61 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.112 0.412 . . . . 64.02 112.112 -176.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -114.3 142.86 45.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.342 -0.39 . . . . 52.11 111.162 177.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 63.2 m -116.22 130.14 56.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.36 -0.382 . . . . 74.31 111.963 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -142.88 117.64 9.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.443 -0.344 . . . . 71.44 110.28 174.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . 0.411 ' HB2' ' HE2' ' A' ' 510' ' ' MET . 6.5 p-10 -96.34 134.31 39.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.185 0.516 . . . . 61.34 112.277 -176.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.03 138.12 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.086 -0.506 . . . . 74.3 111.52 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.3 t -104.26 127.28 51.87 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.597 -0.274 . . . . 75.04 111.422 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 47.1 t -111.35 126.61 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.803 0.335 . . . . 73.01 111.258 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 28.8 m -121.04 164.3 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.596 0.591 . . . . 72.52 112.596 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 79.6 mt -88.26 11.06 17.55 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.508 0.558 . . . . 74.03 112.508 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--O 1.251 1.179 0 N-CA-C 112.369 0.507 . . . . 53.1 112.369 -176.688 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 59.8 mtt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.873 0.368 . . . . 74.34 111.122 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.76 127.11 35.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.994 0.426 . . . . 73.13 111.295 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -112.18 134.14 21.55 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.451 -0.34 . . . . 71.11 110.759 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.505 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 74.4 Cg_endo -81.77 175.96 8.86 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.944 2.429 . . . . 75.23 113.433 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -155.73 86.79 1.06 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.051 -0.522 . . . . 73.53 109.997 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.507 HD22 HD11 ' A' ' 491' ' ' LEU . 75.7 mt -89.0 105.37 17.74 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.975 0.417 . . . . 70.11 111.981 -176.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.705 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 8.0 t -113.14 152.12 30.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.2 0.524 . . . . 74.14 111.804 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.523 HG13 HG11 ' A' ' 462' ' ' VAL . 33.5 m -124.35 147.88 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.788 -0.642 . . . . 63.55 111.123 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 41.7 mt-10 -133.47 142.31 48.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.691 -0.231 . . . . 73.05 111.263 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 58.2 mt -111.59 129.77 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.723 0.297 . . . . 75.43 111.077 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -133.02 133.9 43.7 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.25 -0.281 . . . . 75.04 111.202 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.38 -170.94 39.75 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.89 -0.672 . . . . 73.04 113.5 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.14 126.87 13.54 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.702 2.268 . . . . 64.03 113.079 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -77.9 -19.99 53.72 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.058 0.392 . . . . 73.11 112.058 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.67 127.94 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.438 0.295 . . . . 74.13 110.38 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.84 163.93 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.28 0.562 . . . . 75.4 111.885 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.14 153.74 20.34 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.229 -0.51 . . . . 72.32 113.253 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.45 HG11 HD21 ' A' ' 541' ' ' LEU . 14.4 p -68.47 141.76 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.626 0.25 . . . . 72.21 111.236 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 59.97 21.44 10.51 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.058 0.456 . . . . 73.15 111.808 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -107.26 165.08 11.64 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.011 0.434 . . . . 75.42 111.483 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 502' ' ' SER . 29.4 tp -103.77 117.37 34.2 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.415 -0.357 . . . . 74.33 111.341 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.94 133.27 56.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.687 0.28 . . . . 71.2 111.509 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -110.7 133.76 53.05 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.081 0.467 . . . . 73.03 111.836 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -123.49 163.25 21.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.94 -0.573 . . . . 72.34 111.144 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -119.86 127.31 52.62 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.854 0.359 . . . . 75.34 110.569 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.47 112.96 36.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.69 -0.485 . . . . 71.4 109.69 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 30.7 m-70 -96.21 107.83 20.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.425 -0.352 . . . . 73.22 110.661 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.552 HG12 HG22 ' A' ' 475' ' ' VAL . 14.4 m -108.97 122.0 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.139 0.495 . . . . 65.12 110.451 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 496' ' ' GLU . 4.6 ptpp? -138.63 144.2 39.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.382 0.611 . . . . 74.43 112.253 -173.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 51.6 t-20 -99.96 127.3 46.17 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.599 -0.728 . . . . 71.4 109.808 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.419 HD21 ' HD3' ' A' ' 463' ' ' LYS . 82.7 mt -111.92 -1.9 15.33 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.958 0.355 . . . . 64.3 111.958 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -81.71 -15.72 74.88 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.388 -0.434 . . . . 74.42 113.831 -178.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.88 20.4 65.57 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 120.938 -0.649 . . . . 73.03 113.854 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.426 HG21 ' HB3' ' A' ' 438' ' ' PRO . 5.8 tt -138.47 135.03 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 122.731 -0.276 . . . . 74.55 111.412 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -66.88 134.88 32.27 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 114.123 0.409 . . . . 52.41 114.123 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.494 HG13 HD12 ' A' ' 440' ' ' LEU . 86.9 t -129.6 116.75 18.41 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 122.651 0.38 . . . . 75.51 111.842 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.2 -10.44 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.085 2.523 . . . . 74.51 113.143 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.8 t -80.62 12.52 3.06 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.149 0.58 . . . . 74.02 112.469 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' THR . . . . . 0.414 HG23 HG23 ' A' ' 517' ' ' VAL . 67.7 m -87.61 91.09 8.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.958 0.885 . . . . 74.3 111.803 -166.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 517' ' ' VAL . 91.4 mttt -94.5 124.15 38.35 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.956 -1.02 . . . . 73.31 110.29 173.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.552 HG22 HG12 ' A' ' 462' ' ' VAL . 41.3 t -110.19 119.61 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.721 0.296 . . . . 75.32 111.005 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . 0.408 ' NH1' ' HB2' ' A' ' 519' ' ' GLU . 71.8 mtt180 -122.5 146.81 47.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 111.79 0.293 . . . . 73.21 111.79 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.8 t -120.65 124.18 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.044 0.45 . . . . 75.13 111.186 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -111.78 137.15 50.1 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.976 -0.557 . . . . 65.03 110.704 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.536 HG12 HG12 ' A' ' 513' ' ' ILE . 59.8 mt -117.37 108.67 25.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.854 0.359 . . . . 74.33 111.34 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 66.2 t30 60.06 34.1 21.31 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.266 0.555 . . . . 72.45 111.462 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 97.65 -12.79 64.47 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.274 -0.489 . . . . 44.33 114.031 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 89.8 m -105.21 127.07 52.75 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.332 0.566 . . . . 74.22 111.75 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.7 tp -61.98 128.0 34.06 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.943 0.401 . . . . 73.53 110.855 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -105.38 -43.6 4.94 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.644 0.609 . . . . 71.11 112.644 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -162.75 159.33 24.05 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.272 -0.267 . . . . 74.4 111.02 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -145.53 157.2 44.03 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.894 0.378 . . . . 62.1 111.753 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 -137.2 148.75 46.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.191 -0.459 . . . . 75.3 110.754 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 51.8 m -117.96 118.04 30.89 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.881 0.372 . . . . 70.32 110.168 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.12 174.55 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.21 0.528 . . . . 72.22 111.752 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 89.9 p -129.39 140.08 51.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.148 -0.478 . . . . 71.51 110.608 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.507 HD11 HD22 ' A' ' 440' ' ' LEU . 79.4 mt -117.44 121.49 41.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.852 0.358 . . . . 75.43 111.752 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -78.41 -172.18 40.1 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.357 -0.449 . . . . 71.12 113.08 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.16 110.54 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.45 2.1 . . . . 73.34 112.906 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 39.5 mmtm 67.0 26.63 9.01 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.986 -0.552 . . . . 75.44 111.929 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -99.2 146.89 25.69 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.109 -0.496 . . . . 73.31 112.064 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 41.6 tt0 -129.07 145.77 51.19 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.103 0.478 . . . . 63.23 111.937 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -121.6 137.18 54.85 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.784 -0.45 . . . . 74.41 109.784 172.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 52.9 t -101.04 112.12 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.139 0.495 . . . . 72.12 110.814 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 57.8 mt -103.15 146.57 28.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.989 -0.551 . . . . 71.34 110.714 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 20.0 p -130.21 155.31 46.47 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.549 0.69 . . . . 75.43 112.591 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.26 148.65 26.1 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.32 -0.855 . . . . 73.22 110.21 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 455' ' ' LEU . 51.8 p -116.88 114.79 24.38 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.911 0.386 . . . . 74.4 110.984 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -104.15 136.72 43.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.262 -0.426 . . . . 73.51 111.896 -174.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.6 m -117.43 100.7 52.86 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 116.39 -0.368 . . . . 74.12 111.096 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.16 100.14 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.751 2.3 . . . . 73.14 113.072 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.9 p -78.57 -29.64 46.35 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.268 0.47 . . . . 74.32 112.268 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -100.43 131.67 46.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.832 0.349 . . . . 64.03 110.73 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.36 150.37 23.88 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.11 0.481 . . . . 73.22 112.068 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.79 -170.38 29.91 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.365 -0.445 . . . . 74.43 112.924 -178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 14.9 tpt -91.6 124.54 35.84 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 122.437 -0.449 . . . . 74.31 111.565 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -128.4 151.96 48.76 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.985 0.421 . . . . 74.33 111.258 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -124.18 119.72 30.22 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.104 -0.372 . . . . 63.01 111.615 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.536 HG12 HG12 ' A' ' 479' ' ' ILE . 52.6 mt -95.95 126.77 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.019 0.438 . . . . 72.14 111.306 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -123.01 145.21 48.7 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.989 0.423 . . . . 75.32 111.575 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.68 134.26 53.76 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.185 -0.461 . . . . 74.43 110.309 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 50.5 p -136.93 151.37 48.96 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.955 0.407 . . . . 73.05 111.945 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 474' ' ' LYS . 7.8 p -128.92 149.8 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 116.26 -0.427 . . . . 72.43 111.722 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 17.2 t70 47.9 43.53 17.57 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.71 0.767 . . . . 65.42 111.741 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . 0.408 ' HB2' ' NH1' ' A' ' 476' ' ' ARG . 6.9 mm-40 -51.4 -30.94 20.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.68 -0.691 . . . . 65.25 111.627 174.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -23.65 66.33 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.807 -0.633 . . . . 75.1 110.678 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 62.59 82.11 0.19 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.249 0.619 . . . . 75.33 110.303 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 53.8 p -109.45 -26.95 9.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 72.41 111.637 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.04 141.59 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 112.978 0.733 . . . . 70.33 112.978 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 99.0 t -84.6 114.5 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.141 -0.481 . . . . 74.44 110.296 172.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.485 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 27.3 mt-10 -101.78 176.8 5.1 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.636 0.606 . . . . 75.43 112.636 -174.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.15 -39.61 86.99 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.904 -0.589 . . . . 71.15 110.944 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . 0.561 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 32.2 t30 -141.55 93.19 2.54 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.371 0.605 . . . . 73.23 110.302 173.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.55 14.95 3.37 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.064 -0.516 . . . . 64.4 112.212 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -104.62 -3.44 23.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.718 0.771 . . . . 72.11 109.67 167.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.705 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.1 t30 -86.55 -0.65 56.56 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.418 -0.81 . . . . 74.4 111.355 -174.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -83.76 -6.86 59.53 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.882 0.697 . . . . 73.44 112.882 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.49 138.45 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.215 0.45 . . . . 75.41 112.215 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.08 142.84 50.57 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.215 -0.448 . . . . 71.22 111.183 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.4 m -126.77 133.91 50.73 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.665 0.269 . . . . 73.34 111.626 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -143.15 129.73 20.19 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.818 0.342 . . . . 74.34 111.08 177.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -93.6 134.7 35.61 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.877 0.37 . . . . 74.11 111.883 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 63.0 t -128.83 128.36 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.044 0.449 . . . . 74.44 111.43 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 46.6 t -103.82 120.88 41.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.77 0.319 . . . . 72.53 111.078 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.23 120.08 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.896 0.379 . . . . 75.11 111.321 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.0 m -119.49 167.74 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.183 0.516 . . . . 74.44 112.116 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . 0.45 HD21 HG11 ' A' ' 452' ' ' VAL . 98.0 mt -80.4 25.94 0.39 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.215 0.45 . . . . 74.3 112.215 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.545 -0.741 . . . . 64.43 111.914 -177.62 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 120.806 0.336 . . . . 72.33 110.106 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -98.64 146.38 25.9 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.229 -0.442 . . . . 71.42 111.569 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -117.07 134.93 22.96 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.335 -0.393 . . . . 74.22 110.425 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.86 174.19 11.93 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.707 2.271 . . . . 65.43 114.046 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.0 93.97 2.99 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.424 -0.807 . . . . 74.13 109.471 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 98.4 mt -98.07 108.21 20.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.872 0.368 . . . . 75.23 111.348 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 8.7 t -123.34 152.68 41.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.136 0.493 . . . . 75.12 111.669 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.485 HG13 HG11 ' A' ' 462' ' ' VAL . 34.8 m -120.87 147.85 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.972 -0.558 . . . . 71.43 110.846 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.605 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 43.1 mt-10 -130.28 137.18 49.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.666 -0.243 . . . . 55.04 110.747 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.05 138.02 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.146 0.498 . . . . 75.01 111.689 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -137.1 146.1 44.7 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.049 -0.523 . . . . 74.45 110.97 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.64 -171.2 33.63 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.674 -0.774 . . . . 61.25 114.025 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.04 123.45 8.38 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.819 2.346 . . . . 73.01 112.712 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.48 -13.32 52.34 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.397 0.517 . . . . 75.41 112.397 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 80.2 t -131.38 122.96 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.653 0.263 . . . . 73.44 110.75 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 31.2 m -135.81 163.19 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.172 0.511 . . . . 73.23 111.802 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -100.78 163.91 18.59 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 116.188 -0.46 . . . . 41.5 112.979 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.464 HG23 ' ND2' ' A' ' 453' ' ' ASN . 8.6 p -68.91 144.01 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 122.496 -0.414 . . . . 74.22 111.339 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . 0.464 ' ND2' HG23 ' A' ' 452' ' ' VAL . 40.2 m-80 60.17 17.61 7.06 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.221 0.452 . . . . 73.25 112.221 -177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.422 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.1 mmmt -103.82 138.84 39.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.923 0.392 . . . . 73.15 111.299 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.507 HD11 ' HB3' ' A' ' 502' ' ' SER . 36.2 tp -85.39 125.35 32.91 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.194 -0.457 . . . . 74.14 111.251 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -124.79 136.66 54.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.917 0.389 . . . . 70.54 111.81 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.33 133.94 46.43 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.049 0.452 . . . . 73.1 111.746 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 86.1 m-85 -122.31 150.93 41.68 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.205 -0.452 . . . . 72.41 111.03 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -120.88 127.23 51.68 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.951 -0.568 . . . . 64.25 110.875 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.6 t -113.68 127.47 71.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 122.785 0.434 . . . . 71.23 111.212 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 77.7 m-70 -107.75 110.67 22.55 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.812 0.339 . . . . 74.11 110.594 176.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.608 HG12 HG22 ' A' ' 475' ' ' VAL . 33.6 m -107.47 124.27 63.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 120.896 0.379 . . . . 64.34 110.304 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.518 ' HD3' HD22 ' A' ' 465' ' ' LEU . 13.4 ptpt -143.73 153.75 42.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.159 0.8 . . . . 64.54 113.159 -170.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 48.9 t-20 -112.0 126.45 55.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.355 -0.839 . . . . 74.35 109.47 173.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.518 HD22 ' HD3' ' A' ' 463' ' ' LYS . 47.1 mt -114.28 5.16 15.69 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.867 0.365 . . . . 73.11 111.658 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -82.36 -20.14 62.96 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.308 -0.472 . . . . 54.41 113.682 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.84 14.91 62.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.021 -0.609 . . . . 73.31 113.603 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.9 tt -135.94 133.46 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 122.52 0.328 . . . . 75.14 111.119 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.36 139.86 28.6 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 114.172 0.429 . . . . 72.24 114.172 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 52.8 t -130.36 114.35 17.12 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 111.95 0.352 . . . . 74.4 111.95 -177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.28 -11.33 13.32 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.982 2.455 . . . . 73.33 112.755 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' SER . . . . . 0.484 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 20.1 m -80.55 11.38 3.77 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.658 0.783 . . . . 65.22 112.773 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 39.9 m -89.53 91.92 8.89 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.652 0.739 . . . . 65.23 112.316 -165.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -101.9 126.75 48.87 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.403 -0.817 . . . . 74.4 110.357 171.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.608 HG22 HG12 ' A' ' 462' ' ' VAL . 55.6 t -112.62 128.97 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.813 0.339 . . . . 61.55 111.286 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . 0.552 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 82.6 mtt180 -115.63 151.22 35.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.78 0.324 . . . . 75.24 111.312 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.3 t -121.31 120.21 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.835 0.35 . . . . 73.42 111.08 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -114.29 144.67 42.87 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.277 -0.419 . . . . 74.43 111.553 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.526 HG12 HG12 ' A' ' 513' ' ' ILE . 55.2 mt -123.6 107.93 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.115 -0.493 . . . . 64.43 109.73 173.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 53.42 39.14 29.48 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 120.88 0.371 . . . . 73.24 111.84 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 85.63 -0.96 88.31 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.097 -0.573 . . . . 73.34 114.066 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 94.4 m -98.51 120.45 38.95 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.25 0.525 . . . . 73.4 111.401 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 59.7 tp -69.7 115.04 8.48 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.189 0.518 . . . . 74.32 111.376 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -90.03 -43.28 10.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.121 -0.491 . . . . 75.31 111.754 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -167.32 162.25 14.72 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.664 0.268 . . . . 73.21 111.516 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -147.49 152.6 38.33 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.688 0.28 . . . . 75.41 111.139 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 24.7 m-90 -130.0 134.77 47.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.818 0.342 . . . . 74.43 110.764 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 57.1 m -104.38 118.12 35.84 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.731 0.3 . . . . 72.33 110.257 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 22.3 m -140.83 172.85 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.343 0.592 . . . . 71.44 111.489 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 79.6 p -118.51 135.05 54.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.94 -0.573 . . . . 73.15 110.281 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.1 mt -116.96 119.68 36.08 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.886 0.374 . . . . 64.44 110.882 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -80.3 -177.35 50.9 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.079 -0.582 . . . . 51.42 113.116 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.56 108.75 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.476 2.117 . . . . 74.22 112.457 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.2 mmtp 67.91 32.98 4.9 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.14 -0.482 . . . . 73.34 111.816 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -101.33 148.61 24.95 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 111.92 0.341 . . . . 74.23 111.92 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . 0.419 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 14.4 tt0 -131.8 143.68 50.38 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.428 -0.351 . . . . 74.54 111.206 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.637 ' HZ2' ' HB3' ' A' ' 497' ' ' LYS . 2.3 mmmp? -124.67 134.85 52.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.72 0.295 . . . . 75.52 110.575 175.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.06 117.57 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.244 0.545 . . . . 71.41 111.295 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 52.4 mt -114.07 146.7 39.87 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.038 -0.528 . . . . 73.23 110.861 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 33.3 p -129.41 154.47 46.91 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.27 0.557 . . . . 72.53 112.026 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.1 p90 -148.01 149.49 32.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.779 -0.646 . . . . 73.02 110.651 173.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.507 ' HB3' HD11 ' A' ' 455' ' ' LEU . 43.0 m -110.11 115.29 29.49 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.013 0.435 . . . . 71.21 110.333 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -118.05 136.58 53.47 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.969 0.414 . . . . 75.22 112.043 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.7 m -119.11 112.27 36.34 Favored Pre-proline 0 N--CA 1.472 0.653 0 CA-C-N 116.17 -0.468 . . . . 74.32 111.121 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 67.4 Cg_endo -75.06 118.85 5.4 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.418 2.079 . . . . 70.41 112.684 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 42.1 p -92.22 0.75 57.47 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.788 0.662 . . . . 65.52 112.788 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -143.75 145.93 32.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.701 0.286 . . . . 75.54 110.835 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -79.32 150.28 31.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.125 0.488 . . . . 71.1 111.148 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.76 -170.31 30.58 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.256 -0.497 . . . . 75.3 112.542 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' MET . . . . . 0.459 ' SD ' ' C ' ' A' ' 510' ' ' MET . 0.0 OUTLIER -96.43 111.14 23.35 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.93 0.395 . . . . 73.0 110.481 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -115.21 111.5 21.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.068 0.461 . . . . 73.34 111.644 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -96.31 124.85 40.46 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.901 0.381 . . . . 70.12 111.135 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.526 HG12 HG12 ' A' ' 479' ' ' ILE . 57.9 mt -98.55 124.1 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.214 -0.448 . . . . 71.44 111.127 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 21.3 m120 -122.61 138.47 54.58 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.026 0.441 . . . . 75.42 111.415 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.08 132.89 54.57 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.596 -0.275 . . . . 75.24 110.443 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' THR . . . . . 0.508 HG23 HG23 ' A' ' 532' ' ' VAL . 54.1 p -123.47 140.34 53.1 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.875 0.369 . . . . 75.43 111.768 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.42 147.73 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.77 0.319 . . . . 74.03 111.319 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 37.9 t70 57.38 42.23 25.14 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.611 0.72 . . . . 74.25 111.81 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . 0.552 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.2 mm-40 -56.22 -32.55 64.54 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.966 -0.459 . . . . 75.33 111.481 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -67.71 -19.39 65.15 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.259 -0.428 . . . . 71.31 111.64 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 65.52 78.94 0.26 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.093 0.473 . . . . 74.5 111.306 -175.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 44.7 p -132.81 -13.54 2.86 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.061 0.763 . . . . 73.12 113.061 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.9 p -134.64 143.63 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.167 0.508 . . . . 62.22 112.272 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 68.0 t -100.73 117.96 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.343 -0.389 . . . . 74.12 111.096 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -92.64 175.31 6.86 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.242 0.544 . . . . 74.22 111.4 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.57 -29.97 59.5 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.114 -0.494 . . . . 73.54 110.828 172.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -135.35 145.42 47.37 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.697 -0.683 . . . . 60.33 110.239 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.23 2.33 10.85 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.303 0.483 . . . . 72.51 112.303 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -87.25 -4.12 59.07 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.791 0.329 . . . . 62.14 111.708 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -111.83 -2.85 15.1 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.442 0.534 . . . . 71.53 112.442 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -69.67 -17.6 63.5 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.213 0.449 . . . . 74.33 112.213 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.508 HG23 HG23 ' A' ' 516' ' ' THR . 41.1 t -124.13 131.99 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.672 0.272 . . . . 73.13 111.121 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -113.63 138.49 50.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.659 0.266 . . . . 64.44 111.083 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 50.0 m -112.18 127.65 56.01 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.123 0.416 . . . . 72.45 112.123 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -134.86 126.85 29.6 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.37 -0.377 . . . . 62.02 110.303 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.98 124.92 39.31 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.081 0.4 . . . . 75.42 112.081 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.18 128.45 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.139 0.495 . . . . 71.4 111.301 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.6 t -105.37 120.12 40.78 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.256 -0.277 . . . . 75.31 110.726 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 53.7 t -104.7 128.58 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.911 0.386 . . . . 75.34 111.871 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.83 160.08 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 116.337 -0.392 . . . . 73.02 111.546 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.57 -17.03 61.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.141 0.423 . . . . 74.13 112.141 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--O 1.252 1.233 0 N-CA-C 112.104 0.409 . . . . 72.44 112.104 -178.845 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 10.6 tpt . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 121.078 0.466 . . . . 74.44 110.821 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -100.18 136.45 40.05 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.015 0.436 . . . . 75.52 111.816 -177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -122.39 131.62 24.37 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.882 -0.599 . . . . 73.53 109.855 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.519 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 60.4 Cg_endo -73.45 173.91 13.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.25 1.966 . . . . 75.21 113.96 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -152.95 109.13 3.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.156 -0.929 . . . . 73.31 109.462 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.512 HD21 HD13 ' A' ' 491' ' ' LEU . 83.1 mt -105.36 156.85 17.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 72.45 111.171 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.624 HG23 ' HG3' ' A' ' 463' ' ' LYS . 2.0 t -161.28 149.89 15.97 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.037 0.446 . . . . 71.11 112.026 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.537 HG13 HG11 ' A' ' 462' ' ' VAL . 35.8 m -121.11 147.67 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.03 -0.532 . . . . 73.31 111.621 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -139.56 135.39 33.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.112 -0.494 . . . . 72.32 111.153 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 59.2 mt -109.18 131.36 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.534 0.206 . . . . 75.54 110.958 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -133.78 145.17 49.53 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.479 0.181 . . . . 64.24 110.952 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.39 -171.2 34.06 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 120.797 -0.716 . . . . 53.33 113.999 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.54 123.1 9.84 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.956 2.437 . . . . 73.11 112.991 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -83.58 -8.76 59.25 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.286 0.476 . . . . 75.02 112.286 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 73.3 t -131.67 120.87 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 122.342 -0.224 . . . . 71.53 110.783 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 32.9 m -135.4 164.15 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.054 0.454 . . . . 75.31 111.853 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -94.89 162.33 24.03 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.3 -0.476 . . . . 41.23 113.439 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.55 HG21 ' ND2' ' A' ' 453' ' ' ASN . 8.4 p -74.26 140.71 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 O-C-N 122.436 -0.45 . . . . 71.01 111.484 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . 0.55 ' ND2' HG21 ' A' ' 452' ' ' VAL . 46.5 m-80 59.4 16.57 5.22 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.227 0.611 . . . . 70.14 112.056 -177.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -98.75 157.9 15.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.995 0.426 . . . . 75.42 111.394 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 502' ' ' SER . 26.8 tp -96.07 130.94 42.96 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.343 -0.389 . . . . 74.43 111.2 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -134.91 134.39 40.61 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.519 0.2 . . . . 64.24 111.339 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -100.31 133.05 45.3 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.351 0.596 . . . . 62.33 111.921 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -122.66 164.0 19.04 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.735 -0.666 . . . . 71.31 110.633 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -121.32 127.7 51.56 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.108 0.48 . . . . 75.51 111.965 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 52.7 t -100.03 113.78 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.068 -0.514 . . . . 74.12 110.062 172.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -99.35 110.45 22.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 74.13 110.699 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.75 HG12 HG22 ' A' ' 475' ' ' VAL . 30.5 m -110.72 122.95 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.079 0.466 . . . . 71.23 110.517 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.624 ' HG3' HG23 ' A' ' 441' ' ' THR . 3.0 ptpp? -135.44 151.39 50.37 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.785 0.661 . . . . 73.31 112.785 -173.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 51.2 t-20 -106.19 128.37 53.88 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.296 -0.865 . . . . 72.11 109.761 175.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.413 HD21 ' HD3' ' A' ' 463' ' ' LYS . 73.6 mt -107.61 -23.32 12.18 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.91 0.337 . . . . 71.11 111.91 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -60.22 -25.97 63.16 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 114.604 0.602 . . . . 44.44 114.604 -173.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.53 17.49 58.47 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.831 -0.7 . . . . 74.45 113.271 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.6 tt -137.73 140.92 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 122.785 0.434 . . . . 72.35 110.85 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . 0.431 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -67.43 136.29 31.89 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.204 0.442 . . . . 65.15 114.204 -176.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 46.7 t -127.4 113.7 21.27 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-O 120.799 0.333 . . . . 74.13 111.339 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -88.36 -9.73 4.95 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.267 2.645 . . . . 74.2 113.095 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' SER . . . . . 0.463 ' HB2' ' OG1' ' A' ' 522' ' ' THR . 93.2 p -87.79 11.95 14.16 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.5 0.926 . . . . 64.51 113.5 -173.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 60.3 m -87.85 108.58 19.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.605 0.717 . . . . 72.11 112.825 -164.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -112.12 131.03 55.69 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.437 -0.801 . . . . 64.44 111.181 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.75 HG22 HG12 ' A' ' 462' ' ' VAL . 41.5 t -111.23 137.24 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 122.458 0.303 . . . . 74.5 111.564 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -131.52 143.08 50.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.468 0.307 . . . . 74.43 111.495 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 96.5 t -120.96 122.89 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.863 0.363 . . . . 73.22 111.278 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -113.37 139.29 49.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.867 0.467 . . . . 75.53 110.831 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 513' ' ' ILE . 56.7 mt -119.65 111.15 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.68 0.276 . . . . 75.21 110.28 176.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 55.05 34.02 21.61 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.297 -0.41 . . . . 63.23 111.807 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 101.06 -29.14 13.16 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 116.327 -0.397 . . . . 63.42 113.581 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 91.0 m -81.92 125.82 31.19 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 122.411 -0.464 . . . . 74.4 111.899 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.79 114.54 5.12 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.267 0.556 . . . . 73.23 110.815 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -88.43 -43.97 11.08 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.319 0.489 . . . . 73.5 112.319 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -167.02 160.51 14.17 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.589 0.218 . . . . 71.11 111.589 -175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -141.65 152.94 44.39 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.914 0.388 . . . . 74.51 111.741 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -131.84 148.94 52.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.76 0.424 . . . . 74.21 111.346 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 81.4 m -115.46 119.19 35.38 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.487 -0.324 . . . . 74.4 110.147 173.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.34 173.86 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.442 0.639 . . . . 64.12 112.261 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 88.1 p -129.28 133.6 47.55 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.866 -0.606 . . . . 74.15 110.378 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.512 HD13 HD21 ' A' ' 440' ' ' LEU . 96.1 mt -117.26 120.45 38.28 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.985 0.422 . . . . 74.24 111.45 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.431 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -84.09 -177.62 51.47 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.066 -0.588 . . . . 73.24 112.882 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.53 107.68 0.22 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.876 2.384 . . . . 71.54 113.04 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 74.3 mmtt 67.01 34.43 5.16 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.045 -0.525 . . . . 73.53 112.04 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -102.41 151.85 21.79 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.372 0.508 . . . . 72.21 112.372 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 34.9 tt0 -133.87 141.44 47.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.089 0.471 . . . . 73.43 111.345 173.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -116.85 131.65 56.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.149 -0.478 . . . . 75.24 109.835 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 57.2 t -100.03 113.26 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.234 0.54 . . . . 73.25 111.312 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 47.6 mt -105.87 146.15 30.31 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.834 -0.621 . . . . 74.34 111.106 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 32.0 p -125.23 154.84 41.01 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.274 0.559 . . . . 74.32 111.947 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -154.76 150.54 27.67 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.829 -0.623 . . . . 73.03 110.588 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.525 ' HB2' HD11 ' A' ' 455' ' ' LEU . 79.6 p -109.93 114.3 27.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.018 0.437 . . . . 71.33 110.641 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 33.0 t90 -108.59 138.19 45.3 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.884 -0.598 . . . . 74.42 111.947 -174.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 94.7 m -124.31 109.0 29.25 Favored Pre-proline 0 N--CA 1.473 0.69 0 CA-C-N 116.109 -0.496 . . . . 73.23 111.56 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.37 119.32 3.77 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.787 2.324 . . . . 75.54 112.918 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 66.5 p -89.31 13.77 12.69 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.255 0.465 . . . . 73.31 112.255 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . 0.614 ' HB3' ' OH ' ' A' ' 511' ' ' TYR . 25.9 tt0 -143.14 142.02 31.36 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.746 0.418 . . . . 74.11 110.474 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -88.47 135.87 33.27 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.105 0.479 . . . . 74.41 110.883 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.85 -166.99 29.9 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.087 -0.577 . . . . 70.32 112.872 -175.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 96.2 mmm -83.97 120.62 26.33 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.167 0.508 . . . . 73.53 112.319 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . 0.614 ' OH ' ' HB3' ' A' ' 507' ' ' GLN . 48.9 m-85 -118.62 113.62 21.51 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.155 -0.475 . . . . 71.41 111.446 175.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 512' ' ' ARG . 15.7 ttm180 -96.48 111.38 23.51 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.914 0.388 . . . . 75.34 110.687 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 479' ' ' ILE . 57.6 mt -96.52 113.81 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.023 0.44 . . . . 75.02 111.409 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 21.5 m120 -107.59 151.84 25.08 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.929 0.395 . . . . 53.42 111.725 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -134.79 136.87 42.89 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.767 0.317 . . . . 63.22 111.074 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 58.1 p -129.17 152.37 48.83 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.215 -0.448 . . . . 72.13 111.034 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.14 141.82 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.212 0.529 . . . . 73.2 111.898 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 2.8 t0 48.78 44.33 21.66 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.832 0.853 . . . . 71.42 112.471 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -51.75 -30.06 21.12 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.232 0.539 . . . . 64.02 111.181 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.451 ' HB2' HG21 ' A' ' 522' ' ' THR . 0.9 OUTLIER -66.92 -16.99 64.69 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.66 -0.7 . . . . 71.12 111.431 -176.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 27.4 m120 59.75 44.82 13.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.379 0.609 . . . . 64.13 111.213 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 472' ' ' SER . 57.0 p -67.03 -39.47 87.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.83 -0.623 . . . . 75.51 111.581 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 12.5 p -115.28 143.57 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 116.146 -0.479 . . . . 73.43 111.844 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . 0.519 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 52.2 t -83.27 117.05 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 122.164 -0.335 . . . . 74.45 111.007 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -103.35 177.63 4.79 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.789 0.662 . . . . 74.45 112.789 -175.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.16 -39.06 18.29 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.662 -0.699 . . . . 74.45 112.339 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -114.97 164.2 14.49 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.216 0.531 . . . . 72.54 112.284 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -125.01 -7.43 7.19 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.088 0.47 . . . . 72.31 111.695 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -107.46 16.88 23.4 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.63 0.604 . . . . 74.43 112.63 -173.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.553 ' HB2' ' HB ' ' A' ' 441' ' ' THR . 6.8 p-10 -114.78 -17.77 11.51 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.258 1.207 . . . . 62.45 114.258 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -89.37 17.81 5.82 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.62 0.97 . . . . 74.34 113.62 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.41 134.27 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.062 0.458 . . . . 73.04 111.511 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -128.37 141.89 51.28 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.501 -0.318 . . . . 54.23 111.176 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.0 m -129.32 121.6 27.83 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.889 0.329 . . . . 73.53 111.889 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -121.78 126.11 48.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.804 0.335 . . . . 75.44 110.873 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.75 119.21 32.43 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.888 0.375 . . . . 74.43 111.742 -177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.66 134.99 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.269 0.557 . . . . 75.1 111.924 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 31.0 t -108.83 114.32 28.0 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.965 -0.561 . . . . 55.13 110.543 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 40.4 t -102.19 125.79 56.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.994 0.426 . . . . 74.35 111.775 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.17 168.34 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 115.89 -0.595 . . . . 73.15 111.434 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 70.9 mt -71.38 1.34 6.41 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.132 0.79 . . . . 74.53 113.132 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 112.318 0.488 . . . . 74.05 112.318 -176.848 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.633 0.254 . . . . 75.54 111.102 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -90.5 145.5 24.84 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.933 0.397 . . . . 71.54 111.92 -175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.25 134.49 25.81 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.209 -0.45 . . . . 75.41 110.793 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.703 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 58.9 Cg_endo -73.05 175.63 10.22 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.158 2.572 . . . . 55.41 114.236 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -153.7 86.84 1.21 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.578 -0.737 . . . . 72.02 109.706 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.51 HD23 HD11 ' A' ' 491' ' ' LEU . 88.7 mt -90.09 109.68 20.72 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.119 0.485 . . . . 64.22 112.193 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.419 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.6 t -113.2 152.84 29.23 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.127 -0.358 . . . . 72.54 111.722 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.515 HG13 HG11 ' A' ' 462' ' ' VAL . 28.3 m -128.42 148.86 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.18 0.514 . . . . 64.45 112.154 -176.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 44.2 mt-10 -129.35 146.66 51.18 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.177 -0.465 . . . . 72.41 111.47 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 62.1 mt -110.01 135.16 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.026 0.441 . . . . 75.34 110.722 173.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 63.6 tttp -135.12 145.03 47.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.357 -0.383 . . . . 73.13 110.521 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 154.64 -167.08 32.51 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.282 -0.961 . . . . 63.14 114.341 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.48 ' HD2' ' CZ ' ' A' ' 458' ' ' TYR . 16.5 Cg_exo -65.66 141.02 64.6 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.312 2.675 . . . . 72.11 113.776 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.28 -52.2 5.34 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.84 0.456 . . . . 74.24 111.236 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 538' ' ' SER . 59.4 t -116.31 127.15 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.691 -0.231 . . . . 63.24 110.717 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.15 163.21 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.007 0.432 . . . . 74.22 111.972 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.69 155.81 25.1 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.2 -0.455 . . . . 74.22 112.921 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.507 HG23 ' ND2' ' A' ' 453' ' ' ASN . 13.2 p -67.96 143.61 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.119 0.485 . . . . 75.11 111.839 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . 0.507 ' ND2' HG23 ' A' ' 452' ' ' VAL . 55.7 m-80 61.81 21.26 12.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.018 -0.537 . . . . 75.23 112.268 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.532 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.7 mmmt -103.18 150.75 23.37 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.017 0.437 . . . . 75.31 111.732 177.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 502' ' ' SER . 48.7 tp -93.86 119.38 32.72 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.338 -0.392 . . . . 73.21 111.344 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.59 133.03 54.99 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.706 0.288 . . . . 63.35 111.584 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.95 137.73 38.93 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.115 0.483 . . . . 65.32 111.688 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . 0.48 ' CZ ' ' HD2' ' A' ' 447' ' ' PRO . 10.3 m-85 -122.27 162.23 21.85 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.67 -0.696 . . . . 74.05 110.76 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 445' ' ' LYS . 51.9 mt-10 -120.38 127.3 52.17 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.998 0.427 . . . . 72.21 111.661 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 28.9 t -101.95 114.02 40.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.212 -0.449 . . . . 73.1 109.9 171.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 12.2 m-70 -101.3 110.6 22.63 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.702 0.287 . . . . 75.41 110.736 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.515 HG11 HG13 ' A' ' 442' ' ' VAL . 14.5 m -119.59 137.54 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.069 0.461 . . . . 74.11 110.917 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.22 152.87 37.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.1 0.476 . . . . 75.32 111.764 -176.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.5 t-20 -99.87 127.44 46.04 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.052 -0.522 . . . . 75.3 110.12 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 82.0 mt -110.29 -7.93 14.78 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.971 0.36 . . . . 73.43 111.971 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -76.59 -23.12 70.98 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.182 -0.533 . . . . 72.4 113.447 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.48 22.7 53.27 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.021 -0.609 . . . . 72.12 113.546 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.2 tt -139.71 136.96 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.594 0.358 . . . . 74.22 111.362 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . 0.537 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -69.57 135.54 27.06 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 114.94 0.736 . . . . 74.12 114.94 -175.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.41 115.37 16.08 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 122.816 0.446 . . . . 74.33 111.632 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.38 -11.46 10.7 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.052 2.502 . . . . 71.33 113.251 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 45.6 m -81.14 11.35 4.26 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.256 0.622 . . . . 72.41 112.592 -175.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' THR . . . . . 0.438 HG21 HD13 ' A' ' 440' ' ' LEU . 56.5 m -86.88 98.98 11.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.828 0.823 . . . . 63.41 111.973 -162.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -108.24 123.04 48.16 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.119 -0.946 . . . . 74.41 111.195 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.481 HG22 HG12 ' A' ' 462' ' ' VAL . 46.2 t -104.24 123.7 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.379 -0.373 . . . . 73.03 110.72 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 515' ' ' ALA . 83.2 mtt180 -114.9 145.99 41.61 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.713 0.292 . . . . 74.23 111.75 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.63 119.73 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.995 0.426 . . . . 63.54 111.085 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -112.2 145.11 40.47 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.37 -0.377 . . . . 73.55 111.149 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.77 107.54 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.952 -0.388 . . . . 74.22 109.952 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 56.63 33.87 23.51 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.054 0.454 . . . . 75.45 111.365 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 100.08 -30.97 9.02 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.432 -0.414 . . . . 43.22 113.679 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 85.4 m -82.02 119.2 23.69 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.393 -0.475 . . . . 74.02 111.787 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.4 tp -62.57 115.03 3.91 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.063 0.458 . . . . 75.12 111.342 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -87.29 -43.4 12.19 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.373 -0.376 . . . . 72.5 111.854 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -166.11 161.1 16.93 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.357 -0.214 . . . . 72.4 111.324 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . 0.402 HD21 ' N ' ' A' ' 486' ' ' ASN . 0.1 OUTLIER -155.24 159.63 40.21 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.798 0.332 . . . . 75.32 111.613 177.229 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -133.41 149.36 51.82 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.33 -0.395 . . . . 71.53 111.12 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 38.5 m -115.32 118.63 33.8 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.89 0.376 . . . . 74.15 110.589 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.6 173.42 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.197 0.522 . . . . 74.43 111.424 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 92.6 p -120.59 132.59 55.22 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.356 -0.384 . . . . 71.5 110.139 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.51 HD11 HD23 ' A' ' 440' ' ' LEU . 96.5 mt -118.22 119.05 33.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.818 0.342 . . . . 72.34 110.948 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.537 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -80.52 -167.07 35.95 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.992 -0.549 . . . . 70.14 113.082 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.95 105.72 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.596 2.197 . . . . 73.2 112.426 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 33.9 mmtp 67.67 29.93 6.73 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.342 0.591 . . . . 75.32 111.461 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -83.47 152.71 24.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.502 -0.772 . . . . 62.24 111.13 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -135.0 150.7 50.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.839 0.352 . . . . 73.1 111.68 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 462' ' ' VAL . 23.8 mmtm -145.25 127.16 15.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.078 0.466 . . . . 73.51 111.32 176.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.48 112.93 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.127 0.489 . . . . 72.24 110.805 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 27.5 mt -107.93 137.14 46.45 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.051 -0.522 . . . . 75.25 111.209 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 22.4 p -112.89 149.49 33.09 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.653 0.612 . . . . 74.31 112.653 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -144.33 148.56 34.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.764 -0.653 . . . . 65.33 110.909 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.514 ' HB2' HD11 ' A' ' 455' ' ' LEU . 83.0 p -115.82 115.27 25.99 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.891 0.377 . . . . 75.24 111.214 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -116.51 137.98 51.75 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.456 -0.338 . . . . 73.31 111.808 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 85.9 m -111.98 101.04 50.83 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-N 116.538 -0.301 . . . . 74.1 111.681 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 59.5 Cg_endo -71.61 88.67 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.155 1.904 . . . . 74.53 112.417 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 19.2 p -76.2 -0.99 24.2 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.102 0.408 . . . . 61.33 112.102 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -129.54 135.88 49.14 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.519 -0.309 . . . . 74.32 110.44 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -83.27 151.18 25.73 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.766 0.654 . . . . 64.03 112.766 -174.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 141.9 -179.82 19.56 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.999 -0.546 . . . . 64.05 112.518 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' MET . . . . . 0.409 ' HE3' ' HB3' ' A' ' 510' ' ' MET . 56.1 mtp -93.11 115.88 28.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.486 0.643 . . . . 74.43 111.655 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -110.49 129.84 55.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.19 -0.459 . . . . 74.25 111.321 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -99.45 116.41 31.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.056 0.455 . . . . 74.5 111.598 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.73 127.65 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.847 -0.615 . . . . 73.21 110.948 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -122.42 131.42 53.87 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.494 -0.321 . . . . 74.15 111.472 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 476' ' ' ARG . . . -111.82 133.08 54.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.711 0.291 . . . . 75.23 110.37 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' THR . . . . . 0.47 HG23 HG22 ' A' ' 532' ' ' VAL . 71.5 p -133.74 155.9 48.93 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.778 0.323 . . . . 65.21 111.517 -176.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.1 p -130.38 140.53 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.831 0.348 . . . . 73.25 111.62 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 1.6 t70 41.13 50.39 3.29 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.884 0.874 . . . . 62.21 112.754 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -53.97 -32.93 55.54 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.048 0.451 . . . . 75.13 112.178 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.561 ' HG3' HG22 ' A' ' 522' ' ' THR . 7.4 pt-20 -81.49 2.65 27.92 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.809 -0.632 . . . . 74.3 112.603 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 55.74 36.22 26.83 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.404 0.89 . . . . 71.32 113.404 171.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' THR . . . . . 0.561 HG22 ' HG3' ' A' ' 520' ' ' GLU . 75.0 p -63.06 -25.92 68.6 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.059 0.457 . . . . 73.54 111.141 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 10.8 p -107.49 140.76 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 116.201 -0.454 . . . . 71.43 111.271 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 74.6 t -90.77 115.32 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 122.148 -0.345 . . . . 73.34 110.444 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.703 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 15.2 mt-10 -113.02 -174.02 2.37 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.92 0.711 . . . . 65.25 112.92 -174.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 88.0 mt -82.6 -38.81 23.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.587 -0.733 . . . . 63.13 111.271 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -138.77 158.6 43.93 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.982 0.42 . . . . 75.15 110.942 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -129.51 -8.07 4.65 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.981 0.419 . . . . 73.43 111.553 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -77.21 -20.72 54.92 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.339 0.496 . . . . 74.31 112.339 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.419 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 17.4 p-10 -101.75 5.55 41.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.179 0.437 . . . . 64.02 112.179 -177.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -82.2 1.2 37.56 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.181 0.437 . . . . 70.3 112.181 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.47 HG22 HG23 ' A' ' 516' ' ' THR . 58.3 t -131.14 129.37 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.013 0.435 . . . . 53.12 111.644 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -115.26 136.09 53.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.382 -0.372 . . . . 54.43 110.744 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 61.8 m -117.82 129.7 55.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.659 0.266 . . . . 74.33 111.552 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -139.87 129.28 24.1 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.792 0.33 . . . . 74.23 111.244 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -95.42 137.62 34.23 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.692 0.282 . . . . 72.21 111.707 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 53.6 t -123.74 141.13 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.876 0.37 . . . . 72.31 110.991 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' SER . . . . . 0.509 ' HB3' HG22 ' A' ' 449' ' ' VAL . 48.3 t -112.54 114.83 27.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.917 0.389 . . . . 74.31 111.296 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.76 124.1 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.947 0.403 . . . . 74.41 111.357 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.29 163.17 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.299 0.571 . . . . 75.22 112.182 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 97.5 mt -90.4 14.81 11.94 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.133 -0.485 . . . . 75.5 111.83 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 C--O 1.249 1.055 0 N-CA-C 112.609 0.596 . . . . 75.43 112.609 -172.121 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.761 -0.459 . . . . 74.31 109.761 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -98.14 142.94 29.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.118 0.485 . . . . 73.4 112.093 -173.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -113.24 130.72 23.36 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.03 -0.532 . . . . 71.54 110.642 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.435 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 55.5 Cg_endo -72.91 175.37 10.49 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.516 2.144 . . . . 75.31 113.23 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -153.94 81.42 1.14 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.086 0.469 . . . . 74.12 110.113 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.48 HD22 HD11 ' A' ' 491' ' ' LEU . 93.9 mt -87.44 143.76 27.07 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.329 0.585 . . . . 73.23 111.769 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.452 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.9 t -153.4 164.93 37.3 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.076 -0.511 . . . . 73.02 111.403 176.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.507 HG13 HG11 ' A' ' 462' ' ' VAL . 30.9 m -133.71 148.19 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.142 -0.481 . . . . 71.41 111.108 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 53.1 mt-10 -127.05 132.31 50.72 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.509 -0.314 . . . . 61.51 111.113 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 63.2 mt -100.33 125.28 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.02 0.438 . . . . 64.21 110.648 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 26.9 tptp -128.05 131.6 49.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.43 -0.35 . . . . 73.44 110.893 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.75 -172.51 35.01 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 120.667 -0.777 . . . . 37.85 113.956 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.5 135.51 22.25 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.971 2.447 . . . . 71.44 113.244 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.24 -15.71 42.6 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.213 0.449 . . . . 71.41 112.213 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 86.6 t -131.28 131.56 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.59 0.233 . . . . 71.03 110.672 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.34 157.55 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.058 0.456 . . . . 74.24 111.779 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.56 158.87 26.65 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.116 -0.564 . . . . 71.11 113.124 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.543 HG23 ' ND2' ' A' ' 453' ' ' ASN . 9.1 p -66.84 134.49 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.095 0.474 . . . . 73.55 111.575 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . 0.543 ' ND2' HG23 ' A' ' 452' ' ' VAL . 44.1 m-80 64.9 9.16 5.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.542 0.737 . . . . 75.24 112.347 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -87.93 162.24 17.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.042 0.449 . . . . 74.3 111.496 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 502' ' ' SER . 27.1 tp -100.45 121.08 40.96 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.869 0.366 . . . . 74.23 111.188 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -120.34 132.72 55.41 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.569 0.223 . . . . 74.43 111.499 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.89 128.75 49.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.218 0.532 . . . . 73.41 111.919 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -122.45 154.09 38.24 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.79 -0.641 . . . . 62.45 110.803 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.503 ' HG2' HG21 ' A' ' 500' ' ' THR . 41.3 mt-10 -121.29 127.56 51.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 72.13 111.071 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.44 113.45 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.827 0.346 . . . . 62.32 110.507 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.603 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 35.5 m-70 -92.17 110.5 21.88 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.313 -0.254 . . . . 75.04 110.313 176.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.527 HG12 HG22 ' A' ' 475' ' ' VAL . 24.7 m -105.45 123.07 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.098 0.475 . . . . 75.4 109.871 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.531 ' HD3' HD22 ' A' ' 465' ' ' LEU . 15.5 ptpt -141.0 145.69 36.27 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.842 0.682 . . . . 73.03 112.842 -170.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.548 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -102.66 128.4 49.38 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.345 -0.843 . . . . 70.24 109.449 173.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.531 HD22 ' HD3' ' A' ' 463' ' ' LYS . 61.1 mt -117.64 -2.03 11.52 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.097 -0.377 . . . . 74.54 111.845 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -79.69 -21.57 66.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.07 -0.586 . . . . 72.13 113.691 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.5 19.19 55.39 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.199 -0.524 . . . . 64.51 113.57 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 3.1 tt -136.86 133.63 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 122.417 -0.461 . . . . 72.42 111.185 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . 0.476 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -62.94 130.3 42.14 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 114.202 0.441 . . . . 72.23 114.202 -176.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.467 HG13 HD11 ' A' ' 440' ' ' LEU . 61.5 t -126.81 113.6 22.36 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 112.125 0.417 . . . . 74.53 112.125 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.13 -10.28 10.26 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.208 2.605 . . . . 74.33 112.701 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 49.9 m -80.4 12.01 3.27 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.424 0.69 . . . . 72.5 112.678 -175.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 32.6 m -88.51 93.53 9.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.848 0.832 . . . . 75.33 112.257 -167.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -110.39 123.88 50.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.224 -0.898 . . . . 72.21 110.504 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.527 HG22 HG12 ' A' ' 462' ' ' VAL . 63.2 t -115.0 129.49 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.832 0.348 . . . . 75.05 111.742 -174.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -120.08 151.8 38.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.862 0.363 . . . . 75.41 111.326 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 96.6 t -121.15 122.16 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.41 -0.359 . . . . 75.53 111.189 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -116.16 136.84 52.65 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.925 0.393 . . . . 74.14 111.533 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.544 HG12 HG12 ' A' ' 513' ' ' ILE . 51.1 mt -111.86 108.47 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 122.676 0.39 . . . . 71.34 110.043 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 55.03 34.71 23.07 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.996 0.427 . . . . 63.44 111.382 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.27 0.62 84.79 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.3 -0.476 . . . . 37.85 113.652 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 36.9 m -103.31 119.61 39.2 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.373 -0.486 . . . . 70.43 111.113 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.0 tp -63.07 120.43 11.42 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.389 0.515 . . . . 74.51 112.389 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -88.64 -45.38 9.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.332 -0.395 . . . . 75.42 111.305 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . 0.543 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 31.0 ttpt -171.89 162.26 6.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.546 0.213 . . . . 73.52 111.098 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -139.95 150.98 45.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.962 0.411 . . . . 62.44 111.725 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . 0.543 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 18.7 m-90 -130.82 149.23 52.56 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.86 0.464 . . . . 74.4 111.438 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 60.8 m -120.24 118.91 31.69 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.613 0.244 . . . . 74.04 110.436 173.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.2 m -139.87 172.98 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.073 0.463 . . . . 62.41 111.713 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 96.0 p -122.88 133.23 54.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.251 -0.431 . . . . 73.34 110.329 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.48 HD11 HD22 ' A' ' 440' ' ' LEU . 96.0 mt -118.64 119.67 35.16 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.721 0.296 . . . . 73.13 111.246 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.476 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -79.39 -171.52 41.46 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.186 -0.53 . . . . 73.05 113.133 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.44 106.43 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.6 2.2 . . . . 72.35 112.581 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.9 mmtp 69.89 23.38 5.56 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.118 -0.492 . . . . 63.33 111.881 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -89.04 149.97 22.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.039 0.385 . . . . 65.34 112.039 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . 0.431 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 24.1 tt0 -135.09 143.87 46.87 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.785 0.326 . . . . 75.34 111.478 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -126.89 133.59 50.65 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.819 -0.437 . . . . 75.33 109.819 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 37.9 t -101.17 112.76 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.074 0.464 . . . . 73.54 111.591 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 61.9 mt -100.38 147.65 25.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 75.13 110.933 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' THR . . . . . 0.503 HG21 ' HG2' ' A' ' 459' ' ' GLU . 12.0 p -125.66 149.78 48.16 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.952 0.406 . . . . 74.11 111.956 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.72 147.82 27.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.071 0.462 . . . . 71.03 111.149 172.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.485 ' HB2' HD11 ' A' ' 455' ' ' LEU . 83.2 p -111.36 119.12 37.79 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.098 -0.501 . . . . 72.12 111.067 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -107.7 136.64 47.11 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.01 0.433 . . . . 73.12 111.645 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.9 m -122.06 100.88 42.34 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.125 -0.489 . . . . 72.53 110.695 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -81.6 101.46 1.2 Allowed 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.813 2.342 . . . . 72.42 113.228 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.2 p -82.67 6.64 17.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.213 0.449 . . . . 74.25 112.213 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -140.47 127.21 20.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.565 -0.289 . . . . 74.11 110.599 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -73.19 151.62 41.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.21 0.528 . . . . 75.42 112.381 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.94 -168.89 31.88 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.151 -0.547 . . . . 75.25 113.125 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 15.8 tpt -99.2 118.1 35.15 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 122.45 -0.441 . . . . 75.0 110.993 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -123.94 113.09 18.0 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.862 0.363 . . . . 73.32 111.902 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -94.67 115.17 27.21 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.922 0.392 . . . . 72.25 110.785 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.544 HG12 HG12 ' A' ' 479' ' ' ILE . 55.9 mt -95.47 124.03 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.016 0.436 . . . . 71.41 111.045 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -123.15 145.99 48.14 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.966 0.412 . . . . 71.44 111.53 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -122.45 136.87 54.99 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.332 -0.395 . . . . 62.32 110.556 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 475' ' ' VAL . 21.4 p -132.24 141.02 48.88 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.92 0.391 . . . . 73.52 112.032 -177.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.31 142.0 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.78 0.324 . . . . 74.31 111.375 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.53 49.77 15.97 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.788 0.804 . . . . 74.41 111.42 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -51.7 -28.51 15.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.663 -0.699 . . . . 73.41 111.603 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -65.68 -22.21 66.61 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.052 -0.522 . . . . 74.23 111.308 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 55.97 72.14 0.51 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.358 0.599 . . . . 75.33 111.432 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 66.0 p -117.88 -14.19 10.07 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.516 0.561 . . . . 64.12 112.516 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 10.0 p -126.89 141.27 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.797 0.666 . . . . 73.23 112.797 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 87.2 t -94.29 110.76 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.959 -0.564 . . . . 71.2 110.136 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.435 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 24.9 mt-10 -102.94 179.97 4.12 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.744 0.646 . . . . 73.43 112.744 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.95 -39.89 79.26 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.032 -0.531 . . . . 74.15 112.05 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . 0.541 ' HB3' ' HB2' ' A' ' 530' ' ' ASN . 52.3 t-20 -120.26 112.86 19.58 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.924 0.392 . . . . 63.14 110.317 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -83.74 -7.94 59.36 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 120.955 0.407 . . . . 72.43 111.941 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -101.03 8.64 42.86 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.344 0.592 . . . . 73.24 110.821 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.541 ' HB2' ' HB3' ' A' ' 527' ' ' ASN . 57.6 t30 -88.85 -22.59 23.12 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.815 -0.629 . . . . 75.42 112.297 -171.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -78.51 -4.31 47.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.014 1.116 . . . . 72.23 114.014 -168.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 61.5 t -123.16 130.88 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 112.489 0.551 . . . . 74.25 112.489 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -123.82 142.03 51.49 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.298 -0.41 . . . . 73.32 111.104 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 53.1 m -128.86 135.72 49.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.355 0.502 . . . . 74.54 112.355 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -140.69 133.09 28.4 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 120.894 0.378 . . . . 73.21 111.353 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.38 130.5 43.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.928 0.344 . . . . 71.42 111.928 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 60.7 t -124.14 131.88 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.142 0.496 . . . . 74.02 111.582 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.9 t -105.9 121.99 45.21 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.423 -0.353 . . . . 74.35 111.0 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.65 120.72 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.775 0.322 . . . . 74.22 111.402 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.48 165.36 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 121.132 0.492 . . . . 61.23 111.974 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 86.0 mt -85.72 10.28 13.97 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.303 0.483 . . . . 71.24 112.303 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 112.299 0.481 . . . . 73.15 112.299 -175.613 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 11.9 tpt . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.681 0.277 . . . . 72.03 111.255 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -88.17 130.31 35.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.788 0.327 . . . . 63.42 111.165 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -113.05 137.49 21.93 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.359 -0.382 . . . . 73.44 110.297 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.529 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 55.6 Cg_endo -70.99 173.78 11.57 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.597 2.198 . . . . 74.42 113.495 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -153.84 87.59 1.22 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.731 -0.668 . . . . 55.0 109.267 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.502 HD21 HD13 ' A' ' 491' ' ' LEU . 51.5 mt -91.91 111.85 23.54 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.043 -0.526 . . . . 74.35 111.549 -175.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.638 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 13.5 t -120.81 155.99 32.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.159 0.504 . . . . 71.21 111.865 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.524 HG13 HG11 ' A' ' 462' ' ' VAL . 32.2 m -126.63 148.52 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.88 -0.6 . . . . 71.32 111.116 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 41.1 mt-10 -122.97 146.88 47.23 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.715 0.265 . . . . 54.23 111.715 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 515' ' ' ALA . 49.1 mt -124.48 114.62 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.872 0.368 . . . . 73.43 110.547 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -129.62 139.29 51.48 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.863 0.363 . . . . 72.12 111.483 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.32 -171.37 39.83 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.36 -0.448 . . . . 74.34 112.914 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.17 135.16 28.79 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.579 2.186 . . . . 74.3 113.573 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -79.11 -50.6 10.77 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.105 0.409 . . . . 70.41 112.105 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 538' ' ' SER . 87.8 t -110.03 128.53 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.98 0.419 . . . . 70.23 111.198 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.76 160.95 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.057 0.456 . . . . 72.34 111.692 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -87.71 154.99 26.36 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.267 -0.492 . . . . 52.41 113.095 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.439 HG22 ' ND2' ' A' ' 453' ' ' ASN . 12.4 p -69.15 139.27 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 122.383 -0.481 . . . . 72.32 111.103 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . 0.439 ' ND2' HG22 ' A' ' 452' ' ' VAL . 30.9 m-80 66.5 20.18 10.87 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.202 0.601 . . . . 73.1 111.908 -176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.519 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -103.33 159.78 15.26 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.978 0.418 . . . . 73.51 111.516 176.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 502' ' ' SER . 39.2 tp -95.59 122.95 38.89 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.327 -0.397 . . . . 75.34 111.249 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.04 132.73 54.66 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.803 0.335 . . . . 74.33 111.555 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -107.6 136.18 47.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.298 0.57 . . . . 73.55 112.1 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -126.9 159.02 35.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.865 -0.607 . . . . 73.12 110.559 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.463 ' HG2' HG21 ' A' ' 500' ' ' THR . 52.2 mt-10 -119.26 127.5 53.3 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.791 0.329 . . . . 74.34 111.175 177.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 43.9 t -100.8 112.52 33.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.734 -0.469 . . . . 54.35 109.734 170.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.566 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 46.1 m-70 -100.6 109.35 21.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.692 0.282 . . . . 65.32 110.255 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.587 HG12 HG22 ' A' ' 475' ' ' VAL . 10.8 m -110.82 126.37 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.18 0.514 . . . . 62.34 110.556 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.508 ' HB3' ' HZ3' ' A' ' 463' ' ' LYS . 0.0 OUTLIER -144.53 150.2 37.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.223 0.535 . . . . 73.33 112.375 -174.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.9 t-20 -102.61 127.14 49.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.582 -0.735 . . . . 75.12 109.592 174.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.439 HD21 ' HD3' ' A' ' 463' ' ' LYS . 97.8 mt -108.72 -10.29 15.18 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.009 0.374 . . . . 75.45 112.009 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -73.1 -19.16 79.52 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.076 -0.583 . . . . 60.03 114.052 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.71 15.53 63.31 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.032 -0.604 . . . . 60.22 113.954 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.9 tt -137.52 140.08 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 122.69 0.396 . . . . 74.44 110.863 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -75.38 142.55 29.34 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 114.827 0.691 . . . . 74.32 114.827 -172.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 471' ' ' PRO . 59.2 t -131.74 120.12 17.44 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 122.977 0.511 . . . . 73.31 111.282 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 470' ' ' VAL . 4.7 Cg_endo -86.42 -12.05 5.77 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.119 2.546 . . . . 73.1 113.098 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 23.0 t -84.33 13.39 5.4 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.959 0.726 . . . . 73.13 112.959 -175.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' THR . . . . . 0.431 HG21 ' CG2' ' A' ' 517' ' ' VAL . 90.5 m -86.47 91.81 8.66 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.016 0.912 . . . . 72.4 112.126 -165.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -97.69 131.01 44.62 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.123 -0.944 . . . . 75.33 110.681 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.587 HG22 HG12 ' A' ' 462' ' ' VAL . 45.2 t -113.07 127.26 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.596 0.358 . . . . 72.25 110.898 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -130.17 148.02 51.96 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.898 0.38 . . . . 72.21 111.917 -175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 72.0 t -120.25 122.21 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.862 0.363 . . . . 74.14 111.134 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -113.25 136.82 52.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.357 -0.383 . . . . 70.43 111.308 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 513' ' ' ILE . 62.0 mt -110.68 112.02 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 110.068 -0.345 . . . . 72.42 110.068 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 54.77 34.93 22.91 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.901 0.381 . . . . 72.22 111.461 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 100.37 -36.33 4.21 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.189 -0.529 . . . . 63.5 113.96 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 52.2 m -82.45 131.59 35.22 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 117.163 0.481 . . . . 74.13 111.795 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.22 132.94 54.38 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.216 0.532 . . . . 71.21 111.852 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -105.19 -43.89 4.9 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.161 -0.472 . . . . 73.24 111.852 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -161.3 151.06 16.93 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.647 -0.251 . . . . 73.53 110.497 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -140.12 152.01 45.78 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.32 0.581 . . . . 71.11 112.522 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -136.62 149.42 47.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.528 -0.76 . . . . 75.15 111.063 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 63.1 m -122.97 119.13 29.48 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.14 -0.318 . . . . 74.51 110.14 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.93 173.42 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.304 0.573 . . . . 72.2 111.569 -177.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.4 p -120.45 135.02 55.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.976 -0.556 . . . . 75.14 110.479 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.502 HD13 HD21 ' A' ' 440' ' ' LEU . 74.7 mt -117.33 120.15 37.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.84 0.353 . . . . 64.42 111.315 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -83.06 -170.31 45.91 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.948 -0.644 . . . . 61.2 113.091 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.02 109.34 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.423 2.082 . . . . 75.34 112.491 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.3 mmtm 70.19 19.23 6.72 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.954 0.501 . . . . 75.14 112.176 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -80.08 150.96 30.12 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.175 0.435 . . . . 75.43 112.175 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -135.5 134.12 39.18 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.341 -0.391 . . . . 64.22 111.358 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -116.9 129.83 56.31 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.801 -0.444 . . . . 75.41 109.801 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.16 115.81 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.176 0.512 . . . . 74.34 111.303 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 76.7 mt -105.38 143.53 33.42 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.979 -0.555 . . . . 74.21 110.986 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' THR . . . . . 0.463 HG21 ' HG2' ' A' ' 459' ' ' GLU . 6.9 p -129.29 147.12 51.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.069 0.461 . . . . 72.53 111.409 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -149.48 148.44 29.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 75.43 110.463 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.478 ' HB2' HD11 ' A' ' 455' ' ' LEU . 79.4 p -115.6 114.18 24.58 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.222 0.534 . . . . 65.11 110.995 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -102.14 134.07 45.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 73.4 111.323 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 37.0 m -113.29 100.76 52.39 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-N 116.366 -0.379 . . . . 74.31 110.701 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . 0.519 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.4 Cg_endo -76.06 95.4 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.485 2.123 . . . . 62.34 113.088 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 65.6 p -80.43 5.98 13.55 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.994 0.426 . . . . 75.31 111.66 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -133.56 142.53 48.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.841 0.457 . . . . 75.51 109.94 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.9 150.92 20.26 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.099 0.476 . . . . 74.24 112.168 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.96 -169.73 30.04 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.222 -0.514 . . . . 64.5 112.952 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 14.0 tpt -98.65 112.87 24.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.987 0.422 . . . . 73.35 110.447 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.26 112.37 21.49 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.907 0.384 . . . . 71.23 111.682 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -92.37 115.05 27.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.18 0.514 . . . . 71.55 110.943 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.467 HG12 HG12 ' A' ' 479' ' ' ILE . 60.6 mt -98.1 125.55 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.99 -0.55 . . . . 73.13 111.453 -178.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -120.84 143.79 48.7 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.988 0.423 . . . . 73.32 111.683 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . 0.484 ' N ' HD12 ' A' ' 444' ' ' ILE . . . -120.47 138.75 53.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.322 -0.399 . . . . 61.24 110.365 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' THR . . . . . 0.411 HG23 HG23 ' A' ' 532' ' ' VAL . 48.8 p -133.1 158.0 43.88 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.019 0.438 . . . . 54.42 111.593 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . 0.431 ' CG2' HG21 ' A' ' 473' ' ' THR . 7.6 p -132.53 140.49 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.163 -0.471 . . . . 73.11 111.423 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 28.1 t70 42.73 54.76 4.51 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.474 0.654 . . . . 75.31 111.952 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -55.17 -32.85 62.49 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.199 0.524 . . . . 71.4 111.522 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -67.89 -5.76 18.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.282 -0.872 . . . . 74.1 112.457 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.2 t30 53.07 55.09 9.37 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.501 0.667 . . . . 73.34 111.221 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 34.9 p -88.44 -35.44 17.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 72.31 111.449 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 12.5 p -103.72 144.14 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 116.091 -0.504 . . . . 73.43 111.829 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . 0.513 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 75.4 t -83.41 114.87 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.758 0.314 . . . . 74.04 110.953 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.28 176.08 6.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.498 0.666 . . . . 75.13 112.617 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 87.4 mt -82.26 -25.65 33.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.793 -0.64 . . . . 72.32 109.947 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 26.2 t30 -155.39 110.64 3.02 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.565 -0.743 . . . . 73.15 110.447 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 38.0 mp0 -82.81 -1.61 52.28 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.985 0.421 . . . . 55.13 111.719 -173.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -93.08 -8.84 41.61 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.273 0.559 . . . . 75.33 110.973 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.638 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 65.3 t30 -86.53 -6.78 58.8 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.051 0.453 . . . . 73.31 111.743 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -79.06 8.22 6.09 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.844 0.683 . . . . 75.54 112.844 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.411 HG23 HG23 ' A' ' 516' ' ' THR . 48.5 t -132.46 145.84 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.321 0.489 . . . . 75.14 112.321 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -133.9 142.31 47.71 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.288 -0.415 . . . . 72.03 110.757 172.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 90.6 m -121.89 125.38 46.29 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.354 0.501 . . . . 71.34 112.354 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -133.12 141.06 47.96 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.886 0.374 . . . . 73.11 110.495 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -116.72 126.62 53.42 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.045 0.45 . . . . 75.13 112.161 -176.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.5 t -117.21 143.72 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 116.033 -0.53 . . . . 74.31 111.783 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' SER . . . . . 0.402 ' HB3' HG22 ' A' ' 449' ' ' VAL . 46.6 t -118.02 120.73 38.69 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.332 -0.394 . . . . 71.04 110.996 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 44.5 t -103.42 123.38 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.692 0.282 . . . . 70.4 111.23 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.7 m -109.28 160.25 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 112.612 0.597 . . . . 73.4 112.612 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.71 -5.98 57.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.296 -0.411 . . . . 71.23 112.101 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.253 1.238 0 N-CA-C 112.594 0.59 . . . . 74.31 112.594 -177.059 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 34.9 tpp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.811 0.339 . . . . 74.14 111.424 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -88.12 125.35 34.54 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.802 0.334 . . . . 72.32 111.251 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -115.34 136.56 22.73 Favored Pre-proline 0 N--CA 1.469 0.523 0 CA-C-O 120.573 0.225 . . . . 75.15 111.153 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.486 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 24.5 Cg_exo -64.86 173.03 6.23 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.026 2.484 . . . . 74.24 114.417 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -161.25 86.81 0.69 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.897 -1.047 . . . . 74.45 108.462 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 74.8 mt -97.41 132.39 43.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.233 0.54 . . . . 74.32 112.006 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.509 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.0 t -132.85 151.74 51.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.03 0.443 . . . . 65.54 111.906 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.565 HG11 HG13 ' A' ' 462' ' ' VAL . 32.2 m -123.23 148.66 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.95 -0.568 . . . . 62.12 111.439 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 44.4 mt-10 -130.99 129.68 42.41 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.551 -0.295 . . . . 65.53 111.68 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.6 mt -101.99 126.94 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 120.659 0.266 . . . . 74.14 110.798 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -131.68 134.58 46.09 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.411 -0.181 . . . . 74.24 111.135 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.37 -169.88 35.57 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.603 -0.808 . . . . 54.2 113.762 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.3 127.41 14.12 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.809 2.339 . . . . 73.45 113.058 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -85.86 -20.78 28.58 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.135 0.42 . . . . 52.21 112.135 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.23 121.32 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 120.625 0.25 . . . . 74.35 110.801 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 30.1 m -130.72 162.74 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.207 0.527 . . . . 73.31 111.852 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.62 163.27 28.42 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.1 -0.571 . . . . 62.21 113.246 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.541 HG23 ' ND2' ' A' ' 453' ' ' ASN . 10.8 p -70.31 140.22 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.037 0.446 . . . . 72.42 111.578 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . 0.541 ' ND2' HG23 ' A' ' 452' ' ' VAL . 42.3 m-80 63.63 18.22 10.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.084 0.554 . . . . 74.22 112.136 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -102.35 164.72 11.52 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.193 0.521 . . . . 74.12 111.937 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 502' ' ' SER . 53.2 tp -95.29 136.8 35.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.13 -0.486 . . . . 75.04 111.493 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -135.49 132.22 37.08 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.906 0.384 . . . . 71.55 110.96 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -113.49 131.96 55.85 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.045 0.45 . . . . 73.25 111.364 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 74.8 m-85 -122.28 159.49 27.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 75.12 110.957 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -120.11 127.18 52.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.994 -0.548 . . . . 74.34 110.942 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 42.1 t -102.69 112.65 36.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.829 -0.434 . . . . 73.22 109.829 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 40.2 m-70 -100.04 112.72 25.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.748 0.309 . . . . 71.51 110.315 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.565 HG13 HG11 ' A' ' 442' ' ' VAL . 24.5 m -113.12 124.45 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.212 0.529 . . . . 73.42 110.828 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.432 ' HD3' HD21 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -136.4 151.67 49.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.258 0.552 . . . . 74.42 112.284 -176.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.573 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.2 t-20 -99.9 128.5 45.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.639 -0.71 . . . . 63.24 110.225 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.432 HD21 ' HD3' ' A' ' 463' ' ' LYS . 89.5 mt -113.71 -6.4 13.32 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.023 -0.423 . . . . 73.3 112.034 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -75.37 -18.89 79.82 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.971 -0.633 . . . . 74.2 113.556 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.39 19.35 69.17 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.126 -0.559 . . . . 61.42 113.383 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 10.1 tt -135.35 138.67 48.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 122.554 0.341 . . . . 74.2 110.803 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . 0.513 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -66.73 122.86 21.04 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.402 -0.428 . . . . 65.23 113.784 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 438' ' ' PRO . 48.0 t -119.68 113.72 34.59 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 122.615 -0.344 . . . . 71.12 111.841 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.08 -11.12 10.01 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.94 2.426 . . . . 74.51 112.394 172.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' SER . . . . . 0.599 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 47.8 m -81.23 12.04 3.82 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.857 0.863 . . . . 73.4 113.033 -173.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 88.1 m -88.91 99.71 12.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.773 0.797 . . . . 62.41 112.332 -167.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -105.13 130.65 53.26 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.675 -0.693 . . . . 64.12 110.895 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.404 ' CG2' HG11 ' A' ' 462' ' ' VAL . 25.9 t -105.31 118.72 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.439 0.296 . . . . 74.52 111.03 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . 0.506 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 86.3 mtt180 -116.54 138.15 51.62 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.107 -0.371 . . . . 74.32 111.121 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 89.6 t -120.88 130.47 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.975 0.417 . . . . 71.05 111.466 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -121.68 139.29 53.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.19 -0.459 . . . . 75.43 111.257 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.496 HG12 HG12 ' A' ' 513' ' ' ILE . 55.6 mt -118.83 115.95 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 110.139 -0.319 . . . . 75.2 110.139 172.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 52.67 38.87 27.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.122 0.487 . . . . 74.22 111.573 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.91 -17.51 50.26 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.227 -0.511 . . . . 55.32 113.829 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 73.2 m -88.94 130.82 35.37 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 117.168 0.484 . . . . 74.11 111.623 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.4 tp -64.33 115.06 4.7 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.946 0.403 . . . . 72.55 111.233 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -89.99 -43.86 10.26 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.171 -0.468 . . . . 75.34 112.141 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -168.5 160.03 10.72 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.518 -0.31 . . . . 74.33 110.456 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -150.83 149.87 30.24 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.057 0.456 . . . . 70.3 112.072 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . 0.401 ' CD2' HD11 ' A' ' 499' ' ' LEU . 24.5 m-90 -129.79 144.01 51.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.848 0.459 . . . . 72.03 110.716 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 38.5 m -111.02 117.79 34.29 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.859 -0.423 . . . . 73.01 109.859 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.49 174.34 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.277 0.56 . . . . 72.43 112.02 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 83.0 p -122.55 134.99 54.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.986 -0.552 . . . . 73.44 111.046 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 94.5 mt -120.18 119.45 33.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.648 0.261 . . . . 75.53 111.084 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.513 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -79.63 -171.52 41.96 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.086 -0.578 . . . . 75.13 113.205 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.63 103.5 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.668 2.245 . . . . 65.23 112.524 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.1 mttt 63.63 36.97 10.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.266 0.555 . . . . 75.21 112.117 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -95.96 155.48 16.73 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.966 -0.561 . . . . 73.4 110.845 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -134.82 143.29 46.96 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.842 0.353 . . . . 71.23 111.76 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -126.35 132.33 51.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.194 -0.457 . . . . 75.23 110.867 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 50.3 t -101.39 117.62 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.007 0.432 . . . . 73.2 111.435 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . 0.401 HD11 ' CD2' ' A' ' 487' ' ' TRP . 49.7 mt -111.85 146.12 38.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.201 -0.454 . . . . 74.42 110.815 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 16.7 p -135.46 152.3 51.23 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.366 0.603 . . . . 74.33 112.354 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 47.9 p90 -145.36 154.39 42.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.768 -0.651 . . . . 75.32 111.073 175.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.498 ' HB2' HD11 ' A' ' 455' ' ' LEU . 32.3 p -112.58 114.7 27.47 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.049 0.452 . . . . 75.51 111.229 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . 0.424 ' CZ2' ' HB3' ' A' ' 505' ' ' PRO . 31.1 t90 -114.38 137.47 51.78 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.08 0.552 . . . . 74.4 111.341 -175.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 96.7 m -126.14 103.47 26.53 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 120.751 0.31 . . . . 74.14 111.749 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . 0.424 ' HB3' ' CZ2' ' A' ' 503' ' ' TRP . 98.7 Cg_endo -80.9 97.92 1.03 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.495 2.13 . . . . 71.13 112.905 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 68.4 p -77.33 -6.78 54.52 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.071 0.462 . . . . 75.12 111.121 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . 0.449 ' HB3' ' OH ' ' A' ' 511' ' ' TYR . 51.1 tt0 -114.48 141.29 47.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.122 -0.49 . . . . 74.4 110.238 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.13 149.88 21.62 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.861 0.362 . . . . 65.4 111.194 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 140.39 -171.62 23.89 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.328 -0.463 . . . . 62.31 112.883 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 94.6 mmm -83.9 127.58 33.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.076 0.465 . . . . 72.22 111.975 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . 0.449 ' OH ' ' HB3' ' A' ' 507' ' ' GLN . 76.9 m-85 -126.32 111.94 15.11 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.992 -0.549 . . . . 63.42 110.923 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -93.79 115.44 27.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.01 0.434 . . . . 75.01 111.307 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.496 HG12 HG12 ' A' ' 479' ' ' ILE . 60.3 mt -96.2 128.43 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.864 -0.607 . . . . 75.4 110.962 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -124.81 132.31 53.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.5 -0.318 . . . . 74.31 111.294 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.33 134.4 53.89 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.469 -0.332 . . . . 64.2 110.283 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' THR . . . . . 0.442 HG23 HG23 ' A' ' 532' ' ' VAL . 80.2 p -133.62 141.01 47.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.918 0.39 . . . . 74.02 111.257 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.5 p -109.22 139.26 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.928 0.394 . . . . 73.24 110.96 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 34.5 t0 38.74 64.89 0.71 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.798 0.839 . . . . 73.24 112.685 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . 0.506 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.1 mm-40 -52.54 -33.7 46.76 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.498 0.666 . . . . 71.52 111.048 172.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.61 -24.28 61.05 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.18 -0.918 . . . . 74.22 111.633 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 14.7 m120 54.15 55.52 8.14 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.886 0.85 . . . . 75.04 110.521 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' THR . . . . . 0.599 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 60.5 p -73.34 -6.06 43.67 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.888 -1.051 . . . . 75.24 111.628 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 14.5 p -134.34 143.25 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.255 -0.43 . . . . 72.41 110.9 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . 0.486 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 48.1 t -81.52 109.57 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.027 0.441 . . . . 74.45 110.998 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.472 ' HG2' ' HB2' ' A' ' 438' ' ' PRO . 37.1 mt-10 -98.58 177.02 5.45 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.274 0.559 . . . . 75.13 112.141 -175.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.03 -38.75 17.55 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.208 -0.451 . . . . 73.33 112.204 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . 0.498 HD22 ' HB2' ' A' ' 529' ' ' ASN . 7.2 t30 -142.07 120.0 12.0 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.868 0.322 . . . . 75.34 111.868 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . 0.538 ' HA ' ' OD1' ' A' ' 531' ' ' ASN . 11.4 pt-20 -93.5 14.2 19.46 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.337 0.495 . . . . 73.34 112.337 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . 0.498 ' HB2' HD22 ' A' ' 527' ' ' ASN . 73.1 m-20 -90.66 -26.38 19.62 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.335 0.494 . . . . 64.14 112.335 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.509 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 17.1 p-10 -97.89 -5.05 35.29 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 111.974 0.361 . . . . 75.22 111.974 -175.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . 0.538 ' OD1' ' HA ' ' A' ' 528' ' ' GLU . 12.3 m120 -62.96 -24.73 68.02 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.125 0.417 . . . . 74.44 112.125 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.442 HG23 HG23 ' A' ' 516' ' ' THR . 47.3 t -115.51 137.36 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.876 0.369 . . . . 74.2 111.706 -176.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.51 127.31 43.77 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.455 -0.339 . . . . 73.41 110.872 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 57.2 m -105.39 132.89 51.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.856 0.36 . . . . 70.35 111.628 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -139.7 117.28 11.47 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.765 0.317 . . . . 70.32 110.803 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.94 127.33 39.65 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.99 0.424 . . . . 64.22 111.924 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.96 137.63 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.109 -0.496 . . . . 72.0 111.235 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.8 t -107.44 122.42 46.59 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.826 0.346 . . . . 72.32 111.009 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.1 t -108.19 129.99 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.102 0.477 . . . . 74.54 111.305 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 21.5 m -125.33 162.74 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.157 0.503 . . . . 73.31 112.257 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.93 -12.23 60.11 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.945 0.402 . . . . 75.15 111.995 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 119.24 -0.409 . . . . 74.45 111.724 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' MET . . . . . 0.657 ' HE2' ' HZ ' ' A' ' 437' ' ' PHE . 22.6 ttt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 121.267 0.556 . . . . 71.15 109.868 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -104.74 131.3 52.36 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.897 -0.592 . . . . 74.35 111.798 -171.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . 0.657 ' HZ ' ' HE2' ' A' ' 435' ' ' MET . 52.6 m-85 -114.06 140.0 24.36 Favored Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 116.284 -0.416 . . . . 74.22 110.469 177.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.467 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 58.5 Cg_endo -72.67 173.34 13.51 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.216 1.944 . . . . 74.31 113.152 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -153.29 87.99 1.28 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.892 -0.595 . . . . 63.04 109.59 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.1 mt -89.15 112.0 22.89 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.278 -0.419 . . . . 75.24 111.548 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.552 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.0 t -120.84 158.97 26.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.067 0.46 . . . . 72.41 111.688 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.527 HG11 HG11 ' A' ' 462' ' ' VAL . 35.2 m -134.31 148.59 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.062 -0.517 . . . . 71.24 111.537 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.3 mt-10 -125.45 136.3 53.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.479 -0.328 . . . . 72.52 111.258 177.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . 0.416 HD13 ' N ' ' A' ' 515' ' ' ALA . 56.2 mt -105.41 124.61 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.733 0.301 . . . . 75.22 110.536 174.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 29.1 tptp -132.88 131.99 41.57 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.616 -0.266 . . . . 75.25 110.931 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 166.32 -175.06 41.85 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.743 -0.742 . . . . 50.14 113.801 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.03 134.16 31.05 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.983 2.455 . . . . 74.03 113.537 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.6 -38.53 65.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.192 -0.458 . . . . 71.12 111.911 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.18 131.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.642 0.258 . . . . 73.42 111.31 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.61 163.53 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 121.176 0.512 . . . . 75.24 111.672 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.43 158.44 21.01 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.183 -0.532 . . . . 71.11 113.341 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.421 HG13 HD21 ' A' ' 541' ' ' LEU . 14.0 p -64.9 137.94 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 O-C-N 122.54 -0.388 . . . . 73.33 111.598 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . 0.411 ' OD1' ' HA ' ' A' ' 506' ' ' THR . 92.9 m-20 62.6 14.62 7.27 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.511 0.56 . . . . 71.23 112.511 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.466 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.5 mmmt -94.33 150.02 20.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.818 0.342 . . . . 75.34 111.155 175.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 502' ' ' SER . 32.2 tp -92.77 117.07 29.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.872 0.368 . . . . 72.14 110.936 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -120.67 132.69 55.23 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.901 0.382 . . . . 74.12 111.679 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -102.16 139.15 38.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.154 0.502 . . . . 71.11 111.84 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -123.66 165.14 17.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.862 -0.608 . . . . 62.31 111.26 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 445' ' ' LYS . 51.5 mt-10 -119.95 127.49 52.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.911 -0.586 . . . . 74.53 110.907 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.5 t -108.27 112.78 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.668 -0.493 . . . . 74.34 109.668 170.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.602 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 48.3 m-70 -97.92 107.65 20.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.737 0.303 . . . . 75.41 110.641 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.743 HG12 HG22 ' A' ' 475' ' ' VAL . 14.0 m -108.34 125.98 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.01 0.433 . . . . 74.02 110.55 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.572 ' HD3' HD23 ' A' ' 465' ' ' LEU . 16.0 ptpt -145.76 147.02 31.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.549 0.574 . . . . 75.54 112.549 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.9 t-20 -100.31 126.99 46.71 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.756 -0.657 . . . . 75.02 109.557 174.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.572 HD23 ' HD3' ' A' ' 463' ' ' LYS . 85.6 mt -116.26 8.65 14.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.037 0.384 . . . . 73.52 112.037 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -86.59 -20.89 53.15 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.099 -0.572 . . . . 73.12 113.02 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.74 14.34 63.33 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.116 -0.564 . . . . 44.45 113.591 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 7.4 tt -136.42 133.78 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 122.608 -0.348 . . . . 75.04 110.934 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.43 143.84 37.92 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 114.824 0.69 . . . . 44.43 114.824 -172.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.27 113.53 15.82 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 122.702 0.401 . . . . 74.2 111.41 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.79 -10.57 10.55 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.093 2.529 . . . . 74.34 113.324 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 65.6 m -87.87 13.22 11.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.602 0.761 . . . . 51.54 112.839 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 96.9 m -87.86 106.87 18.38 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.678 0.752 . . . . 71.52 112.649 -165.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -107.42 131.26 54.47 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.551 -0.749 . . . . 70.12 111.243 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.743 HG22 HG12 ' A' ' 462' ' ' VAL . 45.6 t -114.79 127.86 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 122.609 0.364 . . . . 74.54 110.823 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . 0.445 ' NH2' ' HB2' ' A' ' 519' ' ' GLU . 20.9 mtm180 -130.53 152.94 49.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.068 0.461 . . . . 72.34 112.16 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.21 122.73 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.111 -0.495 . . . . 75.13 111.319 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -113.93 137.53 51.56 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.2 -0.454 . . . . 72.53 111.388 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 513' ' ' ILE . 58.9 mt -114.38 111.07 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 109.909 -0.404 . . . . 75.0 109.909 174.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 58.01 33.53 23.29 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.265 0.555 . . . . 75.12 110.8 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 91.79 -19.51 47.98 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.073 -0.512 . . . . 74.52 113.783 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 34.3 m -82.23 124.46 29.94 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.331 -0.511 . . . . 75.14 111.41 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.9 tp -64.91 115.16 5.08 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.083 0.468 . . . . 74.11 111.186 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -91.23 -44.03 9.47 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.15 -0.477 . . . . 75.33 111.979 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -162.98 155.49 18.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.648 0.261 . . . . 75.13 111.159 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.23 143.35 31.71 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.744 0.646 . . . . 74.32 112.744 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -129.52 146.61 51.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.751 -0.659 . . . . 73.43 110.786 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 66.4 m -115.87 118.09 32.0 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.012 -0.366 . . . . 73.5 110.012 170.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.35 173.22 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.343 0.592 . . . . 75.24 112.022 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 72.0 p -124.76 132.93 53.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.06 -0.518 . . . . 73.33 110.569 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.26 121.52 38.88 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.894 0.378 . . . . 73.13 111.203 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -79.7 -170.51 40.41 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.318 -0.467 . . . . 37.34 113.429 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.03 110.6 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.573 2.182 . . . . 72.31 112.626 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.9 mmtp 62.82 37.76 12.08 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.086 0.469 . . . . 74.04 111.428 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -105.03 147.34 27.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.187 -0.46 . . . . 74.22 111.554 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -132.51 143.44 49.75 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.161 0.505 . . . . 61.54 112.332 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -126.37 144.05 50.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.938 -0.573 . . . . 74.13 110.775 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.64 112.01 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 121.033 0.444 . . . . 75.21 110.696 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.4 mt -106.41 125.61 51.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.351 -0.386 . . . . 75.33 110.315 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 35.2 p -113.39 153.33 28.75 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.238 0.542 . . . . 74.2 112.165 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -144.51 150.9 38.33 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.824 -0.625 . . . . 72.45 110.382 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.517 ' HB2' HD11 ' A' ' 455' ' ' LEU . 87.3 p -110.19 114.32 27.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.797 0.332 . . . . 74.45 110.585 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -106.26 130.24 54.15 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.017 0.437 . . . . 75.2 111.936 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 85.5 m -113.97 100.96 53.47 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 115.97 -0.559 . . . . 73.12 110.86 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 72.0 Cg_endo -74.26 91.05 0.96 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.426 2.084 . . . . 72.21 113.018 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' THR . . . . . 0.411 ' HA ' ' OD1' ' A' ' 453' ' ' ASN . 58.0 p -67.97 -16.92 64.27 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.193 0.442 . . . . 74.24 112.193 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -119.34 132.86 55.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.441 -0.345 . . . . 74.41 110.499 174.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.32 150.87 22.39 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.533 0.682 . . . . 65.13 112.469 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.45 -168.43 30.94 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.691 -0.686 . . . . 51.42 112.249 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 13.8 tpt -94.68 124.46 38.73 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 122.332 -0.51 . . . . 73.4 111.076 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -127.92 152.95 47.23 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.042 0.448 . . . . 74.34 112.007 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -123.78 122.31 37.7 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.206 -0.452 . . . . 74.45 110.87 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 479' ' ' ILE . 59.8 mt -103.1 123.93 56.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.968 0.414 . . . . 73.33 111.125 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -119.73 138.9 53.03 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.398 -0.364 . . . . 75.03 111.419 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . 0.416 ' N ' HD13 ' A' ' 444' ' ' ILE . . . -112.44 134.02 54.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.925 0.393 . . . . 73.52 110.481 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 82.4 p -123.34 144.43 49.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.169 -0.469 . . . . 74.53 111.254 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.83 139.61 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.594 0.235 . . . . 64.3 111.133 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 35.8 t0 36.28 60.97 0.83 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.876 0.87 . . . . 74.31 112.855 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . 0.445 ' HB2' ' NH2' ' A' ' 476' ' ' ARG . 39.9 mt-10 -58.63 -32.66 69.24 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.044 0.45 . . . . 75.21 110.985 173.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -66.23 -24.21 66.56 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.357 -0.608 . . . . 70.24 109.357 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' ' 521' ' ' ASN . 1.2 t-20 51.04 74.15 0.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.965 -1.016 . . . . 72.43 110.809 177.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 30.3 p -84.83 -10.64 56.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.879 -1.055 . . . . 64.13 111.408 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.4 HG21 ' HG3' ' A' ' 438' ' ' PRO . 11.3 p -135.24 143.61 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.914 -0.585 . . . . 64.4 112.255 -172.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.2 t -82.47 115.48 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.074 0.464 . . . . 75.31 110.709 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -107.2 -179.84 4.05 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.821 0.674 . . . . 63.32 112.821 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.98 -39.06 51.86 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.983 -0.553 . . . . 74.35 112.237 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -142.54 124.19 14.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.225 0.536 . . . . 75.2 111.432 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -84.08 -20.2 33.03 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.965 -0.562 . . . . 70.51 111.956 -175.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -85.48 3.42 40.37 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.11 0.481 . . . . 72.11 111.092 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.552 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 66.7 t30 -92.16 -13.24 30.95 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.21 0.528 . . . . 72.15 111.376 -176.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -78.81 0.22 27.89 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.368 0.877 . . . . 73.33 113.368 -174.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.6 t -130.68 135.38 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.588 0.588 . . . . 75.2 112.588 -175.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -122.11 142.85 49.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.148 -0.478 . . . . 73.44 110.859 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 92.7 m -124.01 126.13 45.76 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.617 0.599 . . . . 73.41 112.617 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -139.67 123.44 17.48 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.517 -0.31 . . . . 74.11 110.964 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -93.64 137.3 33.04 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.984 0.421 . . . . 71.11 111.96 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.38 132.29 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.227 -0.442 . . . . 74.42 111.444 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.0 t -100.44 117.76 35.27 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.319 -0.4 . . . . 70.14 110.993 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' A' ' 505' ' ' PRO . 38.2 t -106.21 130.65 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.96 0.41 . . . . 71.35 111.466 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 16.2 m -133.27 168.23 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 120.978 0.418 . . . . 72.31 111.993 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . 0.421 HD21 HG13 ' A' ' 452' ' ' VAL . 83.7 mt -74.58 -36.98 63.03 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.495 0.554 . . . . 73.12 112.495 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--O 1.253 1.259 0 N-CA-C 112.83 0.678 . . . . 65.12 112.83 -176.666 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 23.1 ptt? . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.173 0.511 . . . . 75.31 111.135 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -111.85 123.69 50.77 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.249 -0.432 . . . . 72.12 111.168 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -112.81 124.17 32.28 Favored Pre-proline 0 N--CA 1.468 0.471 0 N-CA-C 110.014 -0.365 . . . . 72.12 110.014 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.517 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 55.3 Cg_endo -80.13 174.86 10.96 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.552 2.168 . . . . 74.11 113.746 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -147.81 93.39 2.19 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.29 -0.868 . . . . 62.14 109.651 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.404 HD12 HG13 ' A' ' 470' ' ' VAL . 79.3 mt -91.81 111.87 23.57 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.098 0.475 . . . . 74.35 111.357 -177.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.406 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.0 t -114.47 148.36 37.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.165 0.507 . . . . 72.45 111.35 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.511 HG11 HG11 ' A' ' 462' ' ' VAL . 33.8 m -121.99 148.13 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.079 -0.51 . . . . 72.41 111.069 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 36.6 mt-10 -131.81 139.76 48.97 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.415 -0.357 . . . . 63.25 110.563 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 56.1 mt -114.16 132.69 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.899 0.381 . . . . 71.52 111.381 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -135.27 147.07 49.12 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.403 -0.362 . . . . 75.42 111.308 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.0 -173.35 35.86 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.001 -0.619 . . . . 63.01 113.103 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.18 129.61 18.52 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.63 2.22 . . . . 74.13 113.306 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.33 -41.9 65.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.044 0.449 . . . . 70.44 111.475 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.31 129.48 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.339 -0.391 . . . . 72.4 111.111 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.22 163.15 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.91 0.385 . . . . 74.45 111.509 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -92.92 153.36 21.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.306 -0.473 . . . . 74.55 112.99 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.556 HG23 ' ND2' ' A' ' 453' ' ' ASN . 12.1 p -67.43 136.66 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.001 0.429 . . . . 74.01 111.745 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . 0.556 ' ND2' HG23 ' A' ' 452' ' ' VAL . 46.6 m-80 65.07 17.57 11.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.239 0.616 . . . . 75.5 112.298 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -104.38 167.17 9.92 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.13 0.49 . . . . 74.54 111.75 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 502' ' ' SER . 31.6 tp -100.34 131.3 46.34 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.268 -0.424 . . . . 72.43 111.423 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.45 132.39 45.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.844 0.354 . . . . 74.12 111.796 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -103.68 135.55 45.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.866 0.365 . . . . 74.44 111.278 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -125.54 161.6 26.79 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.449 -0.342 . . . . 74.25 110.909 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -119.67 127.93 53.34 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.782 0.325 . . . . 74.41 111.234 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 50.4 t -102.44 113.11 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.95 0.405 . . . . 75.33 110.012 170.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 41.1 m-70 -96.57 105.71 17.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.454 -0.339 . . . . 62.25 110.857 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 475' ' ' VAL . 17.5 m -106.52 123.69 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.15 0.5 . . . . 74.34 110.476 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.445 ' HD3' HD21 ' A' ' 465' ' ' LEU . 3.7 ptpp? -142.52 148.21 37.26 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.878 0.695 . . . . 75.2 112.878 -173.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.1 t-20 -99.42 128.55 45.55 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.347 -0.842 . . . . 71.13 109.814 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.445 HD21 ' HD3' ' A' ' 463' ' ' LYS . 81.8 mt -111.71 -14.73 13.56 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.092 0.405 . . . . 75.42 112.092 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -66.27 -22.7 71.2 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 121.479 -0.391 . . . . 64.23 113.947 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.45 18.79 56.41 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.178 -0.534 . . . . 38.12 113.912 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.429 HG21 ' HB3' ' A' ' 438' ' ' PRO . 5.5 tt -137.44 138.1 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 122.795 0.438 . . . . 75.11 111.001 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -65.19 135.08 36.82 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.485 -0.388 . . . . 73.11 113.87 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.404 HG13 HD12 ' A' ' 440' ' ' LEU . 60.3 t -129.0 114.71 18.81 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 112.16 0.43 . . . . 63.21 112.16 -176.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.58 -10.94 14.4 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.037 2.491 . . . . 73.41 112.504 173.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' SER . . . . . 0.455 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 50.3 m -81.15 11.84 3.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.617 0.767 . . . . 72.44 112.976 -175.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 48.6 m -88.95 94.05 9.81 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.798 0.809 . . . . 75.21 112.183 -169.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -111.67 123.38 50.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.293 -0.867 . . . . 73.13 110.507 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.651 HG22 HG12 ' A' ' 462' ' ' VAL . 29.6 t -105.49 132.49 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 111.873 0.323 . . . . 73.22 111.873 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -128.25 144.53 51.13 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.901 0.381 . . . . 75.21 111.366 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -121.19 126.7 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.895 0.379 . . . . 75.12 111.266 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 482' ' ' THR . 82.6 m-85 -121.93 137.03 54.95 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.309 -0.405 . . . . 75.45 111.426 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 513' ' ' ILE . 59.0 mt -108.73 107.5 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 110.091 -0.337 . . . . 73.23 110.091 173.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 57.66 34.1 24.07 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.896 0.379 . . . . 75.03 111.289 -174.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.23 -10.36 74.47 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.207 -0.52 . . . . 64.51 113.537 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 478' ' ' TYR . 40.9 m -85.14 127.32 34.21 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.603 -0.351 . . . . 73.23 111.17 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.8 tp -69.15 118.41 12.01 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.853 0.359 . . . . 73.14 111.331 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -94.79 -45.1 7.47 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.818 0.342 . . . . 74.3 111.743 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -170.52 160.08 7.16 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.564 0.221 . . . . 74.42 111.073 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -132.1 157.2 44.81 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.088 0.47 . . . . 75.44 111.52 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 30.9 m-90 -135.99 143.78 44.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.095 0.558 . . . . 74.05 110.785 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 98.8 m -122.09 116.97 25.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.711 0.291 . . . . 70.34 110.422 173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.7 173.93 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.363 0.601 . . . . 64.23 111.872 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 55.1 p -125.68 133.68 52.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.958 -0.565 . . . . 75.13 110.693 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.404 HD23 ' HG2' ' A' ' 497' ' ' LYS . 75.3 mt -116.94 120.46 38.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.796 0.331 . . . . 74.44 111.502 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -75.35 -170.51 27.77 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.052 -0.594 . . . . 65.34 112.746 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.89 118.08 4.95 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.175 1.917 . . . . 73.13 112.364 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 74.4 mmtt 65.32 21.8 12.01 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.111 -0.495 . . . . 72.43 112.109 175.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -89.98 154.74 19.6 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.454 0.539 . . . . 71.42 112.454 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -135.0 145.09 47.75 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.855 0.359 . . . . 70.21 111.927 177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.404 ' HG2' HD23 ' A' ' 491' ' ' LEU . 31.6 mmmt -122.31 129.83 52.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.2 -0.454 . . . . 74.01 109.887 170.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.2 t -100.28 117.31 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.183 0.516 . . . . 73.32 111.213 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 50.9 mt -106.61 146.46 30.67 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.027 -0.533 . . . . 63.11 111.05 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 21.3 p -127.06 147.02 50.16 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.005 0.431 . . . . 71.1 111.657 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -147.87 148.67 31.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.113 -0.494 . . . . 75.24 110.648 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.498 ' HB2' HD11 ' A' ' 455' ' ' LEU . 68.3 p -113.0 114.07 26.38 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.269 0.557 . . . . 75.43 111.419 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -106.2 137.2 44.56 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.643 -0.708 . . . . 75.25 111.341 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.7 m -119.35 100.8 49.7 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.606 -0.27 . . . . 71.55 111.125 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.47 108.43 1.72 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.624 2.216 . . . . 73.41 113.353 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 58.7 p -85.16 -13.43 50.11 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.108 0.41 . . . . 73.14 112.108 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -113.55 134.87 54.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.66 0.266 . . . . 75.41 111.183 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.74 151.55 37.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.6 0.714 . . . . 72.5 112.387 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 135.97 175.76 14.0 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.815 -0.629 . . . . 61.44 112.538 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 65.0 mtp -88.35 128.13 35.5 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.176 0.512 . . . . 65.02 111.542 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -120.05 119.48 33.49 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.15 -0.477 . . . . 60.42 110.762 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -92.75 114.37 26.91 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.059 0.457 . . . . 74.4 110.857 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 479' ' ' ILE . 59.0 mt -98.77 123.64 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.039 -0.528 . . . . 70.21 111.277 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -120.72 136.82 54.76 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.87 0.367 . . . . 73.4 111.806 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.27 143.99 42.43 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.327 -0.397 . . . . 72.23 110.917 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' THR . . . . . 0.403 HG23 HG22 ' A' ' 532' ' ' VAL . 60.8 p -131.14 157.0 44.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.253 -0.43 . . . . 73.41 111.427 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.74 140.18 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 121.005 0.431 . . . . 73.42 111.403 171.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 25.2 t0 41.51 62.48 1.52 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.138 0.975 . . . . 70.33 113.159 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.7 -30.86 71.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.015 0.436 . . . . 65.44 111.317 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.12 -9.38 39.1 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.254 -0.43 . . . . 72.22 112.121 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 57.61 49.69 12.15 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.141 0.496 . . . . 62.22 111.383 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 60.1 p -88.03 -12.31 44.71 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.294 -0.412 . . . . 64.33 111.773 -178.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.28 142.34 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.877 0.37 . . . . 71.12 111.242 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . 0.437 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 74.8 t -82.75 110.25 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.023 0.44 . . . . 72.02 111.218 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.69 162.12 13.91 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.845 -0.616 . . . . 74.43 112.117 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.72 -38.79 73.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.83 -0.623 . . . . 74.4 111.564 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -137.82 126.4 23.59 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.802 -0.181 . . . . 62.14 111.16 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -83.47 -24.88 31.6 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 73.22 111.109 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -81.34 -0.66 42.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.181 -0.463 . . . . 61.13 112.088 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.406 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 57.8 t30 -96.47 -23.0 16.78 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.897 0.379 . . . . 74.13 111.765 -177.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.78 16.37 1.16 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.058 0.762 . . . . 62.12 113.058 -174.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.403 HG22 HG23 ' A' ' 516' ' ' THR . 77.0 t -135.08 142.5 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 120.896 0.379 . . . . 73.23 111.62 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . 0.453 ' HB3' HG23 ' A' ' 442' ' ' VAL . . . -127.25 144.03 51.12 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.545 0.338 . . . . 73.01 111.103 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.9 m -123.42 124.99 44.14 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.559 0.578 . . . . 75.24 112.559 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -134.13 124.22 25.73 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.682 0.277 . . . . 74.43 110.545 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.17 130.19 45.46 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.361 0.6 . . . . 72.14 112.132 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.38 145.02 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.729 -0.669 . . . . 75.33 111.413 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 48.3 t -117.68 113.99 22.71 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.853 0.358 . . . . 61.42 111.236 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.91 120.16 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.503 -0.317 . . . . 73.21 111.223 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.8 m -114.84 165.38 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.099 0.476 . . . . 74.33 112.231 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.8 mt -82.24 -1.26 48.72 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.204 0.446 . . . . 75.14 112.204 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--O 1.253 1.27 0 N-CA-C 112.126 0.417 . . . . 72.32 112.126 -179.138 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.135 0.493 . . . . 74.44 110.74 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -96.35 156.25 16.42 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.052 -0.522 . . . . 73.31 111.344 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -124.66 128.15 25.0 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.467 -0.333 . . . . 71.43 110.933 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 60.5 Cg_endo -72.13 174.92 10.62 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.794 2.329 . . . . 71.32 113.02 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 25.4 t70 -150.0 81.22 1.38 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.866 -0.606 . . . . 62.3 109.901 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.498 HD22 HD11 ' A' ' 491' ' ' LEU . 43.7 mt -84.45 105.72 15.48 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.858 -0.61 . . . . 75.24 111.487 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.457 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 8.1 t -113.08 148.08 35.97 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.079 0.466 . . . . 74.33 111.334 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.55 HG13 HG11 ' A' ' 462' ' ' VAL . 27.3 m -121.08 146.91 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.226 -0.443 . . . . 75.14 111.108 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 46.3 mt-10 -137.0 136.35 38.4 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.252 -0.431 . . . . 73.11 111.305 -175.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.2 mt -110.14 132.51 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.914 0.388 . . . . 75.52 111.62 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -136.61 136.39 39.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.45 -0.341 . . . . 74.04 111.093 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.51 -170.76 39.79 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.209 -0.52 . . . . 73.22 112.97 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.77 121.21 7.7 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.574 2.183 . . . . 72.42 112.921 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.4 -16.75 44.68 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.041 0.385 . . . . 73.52 112.041 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 63.6 t -129.33 123.97 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.682 0.277 . . . . 72.4 110.676 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.41 160.99 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.281 0.562 . . . . 75.35 112.27 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.43 158.19 26.28 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.049 -0.523 . . . . 72.43 112.8 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.4 HG12 HD22 ' A' ' 541' ' ' LEU . 13.8 p -69.21 140.54 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 120.95 0.405 . . . . 74.33 111.948 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 68.1 12.35 8.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.178 0.591 . . . . 73.52 112.405 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -93.58 174.63 7.09 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.0 0.429 . . . . 73.22 111.476 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 502' ' ' SER . 40.3 tp -108.15 119.39 39.34 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.894 0.378 . . . . 74.24 111.338 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.05 131.55 56.33 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.026 0.441 . . . . 75.13 111.54 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -116.65 130.44 56.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.281 0.562 . . . . 73.11 111.658 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -122.56 162.37 21.94 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.786 -0.643 . . . . 75.23 111.089 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -120.34 127.55 52.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.828 0.347 . . . . 72.54 111.151 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.3 t -100.49 113.25 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.077 0.465 . . . . 75.31 110.151 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 52.2 m-70 -94.27 105.85 17.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.29 -0.413 . . . . 74.22 110.341 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.57 HG12 HG22 ' A' ' 475' ' ' VAL . 8.7 m -106.19 123.12 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.119 0.485 . . . . 74.24 110.246 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.417 ' HG3' HG23 ' A' ' 441' ' ' THR . 3.5 ptpp? -139.39 147.05 40.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.158 0.504 . . . . 74.3 112.276 -173.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 53.5 t-20 -104.69 126.91 52.23 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.801 -0.636 . . . . 71.43 109.877 175.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 89.3 mt -103.97 -20.61 13.82 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.051 -0.406 . . . . 72.33 111.972 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -60.94 -26.01 64.89 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.309 -0.472 . . . . 74.14 114.016 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.81 18.35 56.49 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.986 -0.626 . . . . 65.43 113.471 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.6 tt -137.07 133.8 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 122.613 0.365 . . . . 73.4 110.705 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.9 145.31 41.39 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 114.718 0.647 . . . . 62.41 114.718 -174.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.8 117.9 16.42 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 122.817 0.447 . . . . 74.13 111.44 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.67 -12.19 11.23 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.752 2.302 . . . . 72.33 112.594 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 17.3 m -81.02 11.63 3.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.812 0.845 . . . . 74.02 112.804 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 74.1 m -88.57 93.83 9.68 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.952 0.882 . . . . 75.33 112.591 -166.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -99.02 126.37 44.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.203 -0.908 . . . . 73.35 110.176 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.57 HG22 HG12 ' A' ' 462' ' ' VAL . 47.3 t -112.17 118.81 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.754 0.312 . . . . 70.44 110.97 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -125.25 152.64 44.33 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.123 0.487 . . . . 72.21 111.785 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 99.3 t -121.21 130.07 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.108 -0.496 . . . . 72.33 111.33 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -123.39 136.46 54.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.077 -0.51 . . . . 74.21 111.592 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 65.6 mt -109.33 112.33 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 110.076 -0.342 . . . . 71.31 110.076 174.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 53.87 33.75 17.85 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.974 0.416 . . . . 64.22 111.45 -175.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 99.54 -23.67 35.26 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.252 -0.499 . . . . 64.03 113.91 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 85.3 m -82.86 133.52 35.12 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.338 0.569 . . . . 75.22 111.763 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.5 tp -68.01 116.84 9.1 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.008 0.432 . . . . 74.44 111.495 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -96.5 -43.57 7.56 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.957 0.354 . . . . 71.35 111.957 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . 0.485 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 8.9 tppt? -150.23 155.26 39.39 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.593 -0.276 . . . . 71.13 110.822 -174.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . 0.432 ' N ' ' HG3' ' A' ' 485' ' ' LYS . 8.1 p30 -143.97 141.99 30.49 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.995 0.426 . . . . 74.35 111.525 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . 0.485 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 8.6 m-90 -133.19 148.7 52.06 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.145 -0.479 . . . . 73.33 111.126 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 65.1 m -120.34 119.04 31.96 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.234 -0.284 . . . . 74.53 110.234 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.5 174.79 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.132 0.492 . . . . 73.11 111.491 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 92.5 p -121.64 139.4 53.59 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.527 -0.306 . . . . 72.14 110.332 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.498 HD11 HD22 ' A' ' 440' ' ' LEU . 68.1 mt -117.78 120.6 38.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.884 0.374 . . . . 71.42 111.105 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -84.37 -169.37 45.47 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.239 -0.505 . . . . 42.24 112.939 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.27 111.95 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.399 2.066 . . . . 74.24 112.519 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 45.5 mmtm 66.46 18.41 10.82 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.267 -0.424 . . . . 74.41 112.01 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -86.39 149.14 25.22 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.064 0.394 . . . . 71.52 112.064 -176.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -133.84 135.7 43.92 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.235 -0.439 . . . . 75.33 111.618 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.508 ' HZ2' ' HB3' ' A' ' 497' ' ' LYS . 2.3 mmmp? -122.39 134.09 54.63 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.44 -0.345 . . . . 72.11 110.582 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.73 115.67 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.979 0.418 . . . . 74.14 111.247 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 72.0 mt -107.92 128.93 55.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.247 -0.433 . . . . 63.13 110.801 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 36.5 p -113.08 150.01 32.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.546 0.688 . . . . 75.51 112.617 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -145.65 148.34 32.98 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.586 -0.734 . . . . 74.11 110.982 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.496 ' HB2' HD11 ' A' ' 455' ' ' LEU . 78.5 p -111.69 113.57 26.02 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.182 0.515 . . . . 51.12 111.216 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -108.63 134.27 51.6 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.391 -0.368 . . . . 71.4 110.993 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.3 m -111.08 100.72 47.94 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-N 116.37 -0.377 . . . . 72.54 110.946 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . 0.456 ' HB2' HG11 ' A' ' 539' ' ' VAL . 71.6 Cg_endo -74.06 88.77 1.07 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.258 1.972 . . . . 73.31 112.693 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 22.4 p -73.97 -14.24 61.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.211 0.448 . . . . 74.34 112.211 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -115.75 146.21 42.11 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.706 0.288 . . . . 74.15 110.711 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.12 149.55 21.49 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.83 0.348 . . . . 53.33 111.87 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.3 -167.62 27.92 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.998 -0.62 . . . . 63.35 113.416 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' MET . . . . . 0.545 ' HE2' ' HA ' ' A' ' 510' ' ' MET . 2.4 tpt -90.91 107.63 19.32 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.795 0.331 . . . . 74.3 111.503 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -114.17 146.84 39.8 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.051 -0.406 . . . . 72.52 111.526 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 35.5 ttp180 -124.42 116.78 23.09 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.554 -0.293 . . . . 73.03 111.268 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 63.2 mt -96.4 130.16 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.843 0.354 . . . . 72.42 111.249 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -125.41 147.79 49.05 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.869 0.366 . . . . 71.34 111.567 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -121.63 133.68 54.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.317 -0.401 . . . . 60.32 110.604 174.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.0 p -127.57 142.65 51.31 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.813 0.339 . . . . 52.34 111.726 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.43 139.66 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 120.733 0.302 . . . . 74.34 111.3 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 46.6 t0 38.96 66.59 0.52 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.682 0.793 . . . . 74.42 112.595 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.95 -31.81 72.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.097 -0.501 . . . . 71.34 111.655 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.88 -19.63 62.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.352 -0.386 . . . . 74.14 111.044 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.1 m120 59.74 51.88 5.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.46 0.648 . . . . 72.14 110.917 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 68.5 p -67.02 -29.09 68.81 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.76 -0.654 . . . . 73.15 111.205 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 9.8 p -114.88 143.41 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.03 -0.532 . . . . 74.21 111.032 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . 0.491 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 51.4 t -82.62 118.18 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.071 0.462 . . . . 74.1 111.227 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -92.38 162.01 14.43 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.775 -0.648 . . . . 71.14 112.593 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 87.5 mt -70.05 -38.12 75.71 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.134 -0.485 . . . . 74.1 110.814 172.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -130.53 118.17 20.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.089 -0.505 . . . . 74.34 111.079 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.39 3.16 32.99 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.007 0.432 . . . . 73.2 112.106 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -107.19 16.78 23.71 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.542 0.687 . . . . 71.22 110.03 173.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.457 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.4 t30 -100.18 -22.44 15.16 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.514 -0.766 . . . . 74.21 112.41 -170.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -81.58 11.54 4.57 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.913 1.079 . . . . 72.35 113.913 -167.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.73 144.22 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.501 0.556 . . . . 73.52 112.501 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . 0.503 ' HB2' HG23 ' A' ' 442' ' ' VAL . . . -129.28 142.75 50.75 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.997 -0.547 . . . . 62.04 110.957 173.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.0 m -128.49 123.3 33.25 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.975 0.417 . . . . 73.13 111.872 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -142.74 117.72 10.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.881 0.372 . . . . 74.21 110.652 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 0.5 OUTLIER -97.24 137.21 36.6 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.485 0.66 . . . . 72.1 112.561 -177.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.58 132.38 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.653 -0.703 . . . . 74.53 111.558 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.3 t -99.27 122.04 41.88 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.893 0.377 . . . . 63.1 111.07 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.456 HG11 ' HB2' ' A' ' 505' ' ' PRO . 26.1 t -103.85 132.42 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.441 -0.345 . . . . 71.43 110.688 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.83 164.37 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.092 0.472 . . . . 71.3 112.241 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . 0.4 HD22 HG12 ' A' ' 452' ' ' VAL . 95.4 mt -78.42 -1.9 35.77 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.265 0.468 . . . . 73.33 112.265 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.254 1.332 0 N-CA-C 112.434 0.531 . . . . 75.33 112.434 -175.707 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 120.928 0.394 . . . . 74.23 111.134 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -95.6 143.04 27.23 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.066 0.46 . . . . 72.44 111.584 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -116.17 134.97 22.72 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 116.028 -0.533 . . . . 73.12 110.495 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 72.0 Cg_endo -77.0 173.85 13.8 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.506 2.137 . . . . 73.22 114.241 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -145.17 94.93 2.59 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.161 -0.927 . . . . 75.43 108.679 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.516 HD23 HD12 ' A' ' 491' ' ' LEU . 66.5 mt -100.25 120.66 40.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.076 0.465 . . . . 75.03 111.579 -172.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.625 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.5 t -129.36 159.55 35.85 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.319 0.58 . . . . 75.33 112.375 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.556 HG11 HG11 ' A' ' 462' ' ' VAL . 28.7 m -122.42 148.37 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.772 -0.649 . . . . 74.54 111.473 -178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 37.6 mt-10 -132.27 136.87 47.24 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.406 -0.361 . . . . 74.3 110.241 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 56.6 mt -112.88 126.95 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 120.934 0.397 . . . . 63.33 111.8 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -131.0 144.05 51.18 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.198 -0.455 . . . . 62.45 110.334 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.9 -176.35 36.63 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.653 -0.784 . . . . 63.4 113.317 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.52 114.86 3.43 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.842 2.362 . . . . 74.22 113.122 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -74.93 -14.49 60.65 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.611 0.597 . . . . 72.31 112.611 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.65 126.48 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 122.171 -0.331 . . . . 64.12 110.76 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.93 162.09 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.261 0.553 . . . . 75.41 111.796 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.96 153.91 20.14 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.213 -0.518 . . . . 62.21 112.957 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.543 HG13 HD22 ' A' ' 541' ' ' LEU . 14.5 p -64.0 142.22 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 O-C-N 122.619 -0.342 . . . . 72.44 111.414 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 65.82 13.45 9.0 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.628 0.603 . . . . 75.21 112.628 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -105.29 162.75 13.15 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.059 0.457 . . . . 74.41 111.943 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 502' ' ' SER . 49.2 tp -92.94 133.54 36.01 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.468 -0.333 . . . . 73.21 111.634 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -131.4 132.58 44.49 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.797 0.332 . . . . 73.42 111.46 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -112.92 131.88 55.56 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.804 0.335 . . . . 74.12 111.183 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -121.59 157.61 30.39 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.235 -0.438 . . . . 75.11 111.013 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.479 ' HG2' HG21 ' A' ' 500' ' ' THR . 41.9 mt-10 -120.26 127.02 52.01 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.997 -0.547 . . . . 63.14 111.344 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.62 113.68 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.165 173.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 44.8 m-70 -95.09 111.63 23.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.869 0.366 . . . . 75.32 110.267 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.556 HG11 HG11 ' A' ' 442' ' ' VAL . 33.1 m -106.57 122.71 60.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.99 0.424 . . . . 75.22 110.652 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.493 ' HD3' HD22 ' A' ' 465' ' ' LEU . 1.4 ptpp? -130.42 148.55 52.25 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.295 0.569 . . . . 74.41 112.282 -174.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.7 t-20 -99.64 128.07 45.75 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.668 -0.696 . . . . 73.32 110.014 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.493 HD22 ' HD3' ' A' ' 463' ' ' LYS . 79.9 mt -109.45 -10.7 14.88 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.752 0.311 . . . . 73.24 111.747 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -76.26 -28.48 60.0 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.294 -0.479 . . . . 40.55 113.566 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.13 22.39 45.27 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.955 -0.64 . . . . 72.04 113.389 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.6 tt -137.73 135.82 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 122.738 0.415 . . . . 75.43 111.102 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . 0.404 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -70.02 133.08 24.32 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 114.608 0.603 . . . . 62.4 114.608 -174.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.39 118.48 17.09 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.21 0.604 . . . . 63.22 111.306 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -88.85 -9.86 4.47 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.074 2.516 . . . . 73.12 113.851 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.3 p -81.65 11.95 4.29 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.83 0.678 . . . . 74.32 112.83 -177.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' THR . . . . . 0.492 ' HA ' ' OD1' ' A' ' 518' ' ' ASP . 98.7 m -87.24 109.96 19.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.072 0.939 . . . . 75.33 112.094 -164.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -119.99 128.14 53.28 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.009 -0.996 . . . . 75.03 110.892 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.545 HG22 HG12 ' A' ' 462' ' ' VAL . 25.1 t -104.59 135.83 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.404 -0.362 . . . . 62.04 111.902 -175.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . 0.553 ' NH1' ' HB2' ' A' ' 519' ' ' GLU . 59.2 mtt85 -123.64 143.39 50.27 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.369 -0.378 . . . . 75.31 111.273 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.52 123.18 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 120.996 0.427 . . . . 73.03 111.123 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -111.55 137.82 48.9 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.042 -0.526 . . . . 74.32 110.7 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 62.5 mt -115.99 109.66 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 110.025 -0.361 . . . . 75.43 110.025 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 55.16 34.62 23.04 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.089 0.471 . . . . 73.41 111.292 -174.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 97.39 -24.09 33.0 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.049 -0.523 . . . . 72.0 113.699 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 66.0 m -82.67 120.4 25.52 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.394 -0.474 . . . . 73.45 111.76 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -62.8 115.05 4.0 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.054 0.454 . . . . 75.15 110.971 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -89.74 -43.54 10.62 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.382 0.512 . . . . 72.51 112.382 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -164.45 161.23 21.31 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.19 -0.319 . . . . 73.02 111.454 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.58 154.98 42.75 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.936 0.398 . . . . 74.51 111.941 177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -135.02 148.87 50.05 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.848 0.459 . . . . 74.43 111.431 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 79.6 m -105.64 119.24 38.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 110.156 -0.313 . . . . 75.44 110.156 171.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.07 173.34 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.394 0.616 . . . . 72.42 111.876 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 75.1 p -126.58 134.71 50.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.081 -0.508 . . . . 65.21 110.686 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.516 HD12 HD23 ' A' ' 440' ' ' LEU . 92.1 mt -117.38 118.89 33.48 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.875 0.369 . . . . 74.44 111.275 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.404 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -81.47 -166.56 36.95 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.193 -0.527 . . . . 71.23 112.652 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.03 107.12 0.73 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.15 1.9 . . . . 74.43 112.172 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 41.6 mmtm 68.66 22.9 7.32 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.204 -0.453 . . . . 75.0 111.772 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -81.81 149.88 28.14 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.892 0.33 . . . . 74.21 111.892 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 462' ' ' VAL . 41.5 tt0 -135.38 134.59 39.91 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.744 0.307 . . . . 63.12 111.286 176.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -118.91 149.79 40.98 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.639 -0.255 . . . . 73.5 110.621 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.92 113.22 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.001 0.429 . . . . 71.42 111.48 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 50.6 mt -105.71 146.23 30.05 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.242 -0.436 . . . . 75.13 111.047 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' THR . . . . . 0.479 HG21 ' HG2' ' A' ' 459' ' ' GLU . 20.9 p -129.47 149.8 51.09 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.367 0.603 . . . . 72.44 112.611 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -144.33 148.46 34.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.793 -0.639 . . . . 72.23 111.156 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 455' ' ' LEU . 24.8 p -110.96 115.06 28.85 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.207 0.527 . . . . 75.41 111.577 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -120.88 137.44 54.58 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.008 -0.542 . . . . 75.31 111.601 -174.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 92.9 m -120.61 102.05 45.32 Favored Pre-proline 0 N--CA 1.473 0.688 0 CA-C-N 116.458 -0.337 . . . . 65.11 111.282 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.97 104.43 1.91 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.578 2.185 . . . . 74.52 113.068 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 77.0 p -86.82 -15.76 38.23 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.021 0.438 . . . . 73.22 111.995 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.22 137.13 42.59 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.731 0.301 . . . . 71.1 110.837 171.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.17 150.21 25.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.009 0.433 . . . . 74.25 112.151 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 143.98 -167.73 26.7 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.177 -0.535 . . . . 75.02 113.181 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 89.6 mmm -89.57 121.1 31.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.064 0.459 . . . . 74.5 111.395 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -121.58 111.7 17.55 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.427 0.632 . . . . 74.52 111.207 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -104.02 120.34 40.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.805 -0.634 . . . . 72.32 111.308 -177.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 62.2 mt -95.73 128.44 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.841 -0.618 . . . . 75.11 111.473 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -122.95 135.3 54.43 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.196 -0.457 . . . . 74.24 111.041 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.56 139.53 48.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.784 0.325 . . . . 62.41 111.416 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' THR . . . . . 0.5 HG23 HG23 ' A' ' 532' ' ' VAL . 71.2 p -129.26 151.85 49.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.921 0.391 . . . . 73.02 111.035 177.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.5 p -130.0 141.8 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.525 -0.307 . . . . 52.23 111.524 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . 0.492 ' OD1' ' HA ' ' A' ' 473' ' ' THR . 1.3 m-20 50.17 47.91 22.9 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.456 0.539 . . . . 72.53 112.456 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . 0.553 ' HB2' ' NH1' ' A' ' 476' ' ' ARG . 6.0 mm-40 -53.62 -32.78 52.67 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.283 0.475 . . . . 74.13 112.283 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.42 -17.05 64.12 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.171 0.434 . . . . 72.21 112.171 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 49.84 37.17 12.81 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.742 0.645 . . . . 64.3 112.742 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 38.5 p -72.38 -16.66 61.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.858 0.361 . . . . 72.22 111.78 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 8.3 p -108.01 136.53 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.417 -0.356 . . . . 75.23 111.07 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . 0.424 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 90.7 t -84.23 113.3 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.873 0.368 . . . . 75.33 110.879 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -100.61 174.23 6.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.259 0.552 . . . . 71.52 112.269 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.7 mt -82.85 -24.39 33.29 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.68 -0.691 . . . . 72.21 111.675 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . 0.555 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 25.0 t-20 -118.6 158.24 25.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.145 0.498 . . . . 75.01 111.579 -174.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -118.35 -23.8 7.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.165 -0.471 . . . . 74.43 111.981 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -105.89 -7.39 18.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.3 0.481 . . . . 72.42 112.3 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.625 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 58.2 t30 -86.77 -7.7 58.02 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.713 0.634 . . . . 72.43 112.713 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -75.42 -0.27 19.44 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.159 0.799 . . . . 73.33 113.159 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.5 HG23 HG23 ' A' ' 516' ' ' THR . 48.4 t -126.86 146.05 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.439 0.533 . . . . 62.43 112.439 -175.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . 0.401 ' CB ' HG21 ' A' ' 442' ' ' VAL . . . -136.14 142.69 44.25 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.245 -0.434 . . . . 72.22 111.276 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.8 m -117.3 134.83 54.34 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.404 0.52 . . . . 75.31 112.404 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -138.54 126.64 22.71 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.369 -0.378 . . . . 63.25 110.363 174.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -102.6 123.44 46.34 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.825 0.345 . . . . 74.32 111.85 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.47 144.45 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.996 0.427 . . . . 73.23 111.667 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.0 t -112.95 127.03 56.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.776 0.322 . . . . 75.14 111.413 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.1 120.51 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.85 0.357 . . . . 74.41 111.066 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.74 158.91 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.442 0.534 . . . . 63.21 112.442 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . 0.543 HD22 HG13 ' A' ' 452' ' ' VAL . 89.9 mt -81.3 -28.43 34.62 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.251 -0.431 . . . . 74.14 111.632 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.254 1.339 0 N-CA-C 112.725 0.639 . . . . 75.31 112.725 -176.893 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' MET . . . . . 0.57 ' N ' ' SD ' ' A' ' 435' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.46 0.171 . . . . 73.03 111.168 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -96.77 131.99 42.92 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.977 0.418 . . . . 63.05 111.571 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -128.28 146.1 58.26 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 116.139 -0.482 . . . . 75.34 110.474 177.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.408 ' HG2' HG21 ' A' ' 523' ' ' VAL . 2.6 Cg_exo -75.03 173.91 13.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.922 2.415 . . . . 75.21 114.223 -176.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -152.87 78.2 1.18 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.784 -1.098 . . . . 73.41 108.972 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.417 HD22 HD13 ' A' ' 491' ' ' LEU . 70.4 mt -84.12 110.48 18.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.669 -0.696 . . . . 73.4 111.416 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.466 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 13.7 t -115.57 149.32 38.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.146 0.498 . . . . 70.31 111.459 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.522 HG11 HG11 ' A' ' 462' ' ' VAL . 27.1 m -121.02 148.41 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.966 -0.561 . . . . 73.13 111.144 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 43.7 mt-10 -139.69 131.58 27.65 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.496 -0.32 . . . . 73.32 110.872 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 53.8 mt -105.55 138.69 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 122.129 -0.357 . . . . 75.2 111.463 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -141.59 134.97 29.56 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 120.563 0.221 . . . . 74.35 111.287 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.68 -164.87 37.63 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.947 -0.644 . . . . 64.54 113.678 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.2 136.84 32.81 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.743 2.296 . . . . 74.31 113.44 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -82.95 -44.94 14.73 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.898 0.38 . . . . 70.44 111.751 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.16 133.72 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 120.989 0.423 . . . . 75.23 111.278 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.5 m -135.7 162.99 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.068 0.461 . . . . 75.1 111.539 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -98.34 165.65 21.66 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.178 -0.534 . . . . 71.44 113.056 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.511 HG22 ' ND2' ' A' ' 453' ' ' ASN . 11.9 p -69.44 136.76 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 120.853 0.359 . . . . 63.14 111.591 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . 0.511 ' ND2' HG22 ' A' ' 452' ' ' VAL . 53.3 m-80 64.67 15.65 9.87 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.151 0.58 . . . . 71.32 112.547 -176.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -95.82 143.93 26.62 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.13 0.49 . . . . 70.44 111.656 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 502' ' ' SER . 43.1 tp -81.75 123.14 28.51 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.277 -0.42 . . . . 73.14 111.159 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -118.36 132.31 56.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.84 0.352 . . . . 75.12 111.288 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -120.7 132.03 54.86 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.201 0.524 . . . . 71.21 111.747 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -123.76 159.42 29.51 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.739 -0.664 . . . . 75.45 110.96 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.451 ' HG3' HG21 ' A' ' 500' ' ' THR . 1.9 mp0 -120.22 127.46 52.45 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.069 0.462 . . . . 74.44 110.745 175.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.7 t -100.52 121.46 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.274 -0.421 . . . . 63.03 111.48 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 11.6 m-70 -96.22 110.58 22.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.081 -0.509 . . . . 74.11 110.522 176.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.522 HG11 HG11 ' A' ' 442' ' ' VAL . 19.8 m -114.4 123.42 70.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.962 0.411 . . . . 75.33 110.342 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.543 ' HD3' HD21 ' A' ' 465' ' ' LEU . 4.5 ptpp? -139.17 148.37 43.1 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.467 0.651 . . . . 75.32 112.705 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 49.4 t-20 -100.23 127.58 46.48 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.495 -0.775 . . . . 71.22 109.873 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.543 HD21 ' HD3' ' A' ' 463' ' ' LYS . 77.9 mt -115.02 -2.66 12.76 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.364 0.505 . . . . 71.12 112.364 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -72.88 -22.85 78.8 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.979 -0.629 . . . . 53.14 113.174 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.75 16.42 59.92 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.255 -0.498 . . . . 73.24 113.307 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 10.2 tt -135.69 139.73 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 122.729 -0.277 . . . . 74.42 110.942 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.4 137.08 25.65 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.171 -0.538 . . . . 55.15 114.079 -176.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 57.7 t -131.68 112.9 15.16 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 120.802 0.334 . . . . 75.33 111.796 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -88.01 -10.9 4.78 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.3 2.667 . . . . 71.1 113.057 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 79.9 p -81.95 13.3 3.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.534 0.734 . . . . 72.21 112.674 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 91.0 m -87.42 108.82 19.18 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.755 0.788 . . . . 71.51 112.436 -164.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -110.57 130.59 55.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.352 -0.84 . . . . 75.23 111.42 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.506 HG22 HG12 ' A' ' 462' ' ' VAL . 47.3 t -111.53 130.74 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 122.314 0.246 . . . . 63.1 110.981 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . 0.594 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 96.0 mtt180 -124.2 150.11 45.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.945 0.402 . . . . 74.41 111.418 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.98 120.71 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.218 -0.446 . . . . 71.33 111.085 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -113.75 137.1 52.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.473 -0.33 . . . . 75.11 110.99 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.529 HG12 HG12 ' A' ' 513' ' ' ILE . 63.2 mt -113.34 111.89 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 110.166 -0.309 . . . . 61.02 110.166 174.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 54.46 34.38 20.84 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.108 0.48 . . . . 64.34 111.77 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.18 -19.06 55.35 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.382 -0.437 . . . . 75.12 113.482 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 89.7 m -87.11 124.38 33.18 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.543 -0.386 . . . . 62.13 111.693 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.6 tp -62.7 120.4 11.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.1 0.476 . . . . 72.44 111.774 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . 0.446 ' CE2' ' HE2' ' A' ' 485' ' ' LYS . 19.3 t80 -94.81 -43.07 8.39 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.19 -0.459 . . . . 74.33 112.124 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . 0.446 ' HE2' ' CE2' ' A' ' 484' ' ' TYR . 4.5 ttpt -167.67 159.78 12.21 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 122.235 -0.291 . . . . 74.54 111.464 -177.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -143.17 144.12 32.06 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.939 0.4 . . . . 75.05 112.037 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -132.78 149.6 52.25 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.991 0.516 . . . . 75.42 111.208 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.0 m -118.06 119.95 36.31 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 110.202 -0.295 . . . . 74.33 110.202 170.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.48 172.98 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.32 0.581 . . . . 73.11 111.966 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 79.1 p -111.9 137.4 49.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.04 -0.527 . . . . 74.43 110.752 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.417 HD13 HD22 ' A' ' 440' ' ' LEU . 69.0 mt -127.55 118.99 25.01 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.828 0.347 . . . . 73.34 110.721 174.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -84.43 -174.79 50.53 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.951 -0.642 . . . . 74.32 112.702 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.97 105.84 0.23 Allowed 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.365 2.043 . . . . 70.23 112.052 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.7 mmtp 71.59 29.19 2.67 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.154 0.427 . . . . 75.23 112.154 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.95 155.31 17.14 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.814 0.34 . . . . 70.41 111.869 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -130.34 143.21 50.63 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.215 -0.448 . . . . 64.44 111.393 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 462' ' ' VAL . 43.6 mmtm -117.21 146.85 42.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.052 0.541 . . . . 65.32 110.039 172.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.57 113.14 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.047 0.451 . . . . 74.43 110.938 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 56.7 mt -110.84 141.24 44.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.405 -0.362 . . . . 73.52 111.166 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' THR . . . . . 0.451 HG21 ' HG3' ' A' ' 459' ' ' GLU . 21.5 p -113.81 151.7 31.69 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.493 0.553 . . . . 74.14 112.493 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -150.84 148.51 28.56 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.019 -0.537 . . . . 75.13 111.311 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.524 ' HB2' HD11 ' A' ' 455' ' ' LEU . 89.9 p -118.42 125.89 50.91 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.271 -0.422 . . . . 75.53 111.111 -178.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -125.97 136.8 53.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.914 0.388 . . . . 74.04 111.136 -177.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.4 m -121.31 100.77 44.71 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.694 0.283 . . . . 64.33 111.016 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -77.64 106.3 2.17 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.623 2.215 . . . . 62.03 113.108 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.8 p -87.54 12.17 13.09 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.042 0.386 . . . . 72.25 112.042 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -142.74 132.72 24.31 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.711 0.404 . . . . 61.44 110.967 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -73.68 150.73 41.07 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.475 0.546 . . . . 73.22 112.475 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 145.76 -173.35 26.15 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.879 -0.676 . . . . 54.22 113.397 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 95.9 mmm -99.31 112.61 24.74 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.049 0.452 . . . . 72.12 111.032 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -115.05 119.21 35.68 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.2 0.524 . . . . 75.33 111.431 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -97.72 117.91 33.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.104 -0.498 . . . . 74.34 111.153 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.529 HG12 HG12 ' A' ' 479' ' ' ILE . 65.0 mt -95.29 120.01 44.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.0 -0.545 . . . . 74.32 111.119 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.48 137.35 52.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.934 0.397 . . . . 72.52 111.341 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.1 132.96 54.54 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.299 -0.409 . . . . 72.52 110.738 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' THR . . . . . 0.481 HG23 HG23 ' A' ' 532' ' ' VAL . 43.9 p -126.03 141.14 52.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.887 0.375 . . . . 73.52 111.244 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.36 141.89 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.95 0.405 . . . . 74.52 111.43 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.3 t0 49.89 58.66 5.21 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.643 0.735 . . . . 64.31 111.919 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . 0.594 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.9 mm-40 -59.12 -32.69 70.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.284 0.564 . . . . 75.51 111.322 174.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.55 -18.05 64.27 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.763 -0.653 . . . . 71.41 111.68 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 52.02 70.22 0.58 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.719 0.771 . . . . 65.24 110.8 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 67.4 p -96.76 -10.87 25.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.472 -0.785 . . . . 73.33 111.689 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.408 HG21 ' HG2' ' A' ' 438' ' ' PRO . 11.7 p -141.66 144.15 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.057 0.456 . . . . 74.42 111.736 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.5 t -82.79 116.27 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.968 0.413 . . . . 74.31 111.528 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.88 156.25 17.62 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.888 -0.597 . . . . 73.22 112.423 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.84 -38.85 70.05 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.765 -0.652 . . . . 72.45 111.329 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -119.81 122.07 40.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.842 0.353 . . . . 74.12 110.703 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -83.05 -17.55 42.84 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.006 0.431 . . . . 70.12 111.934 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -102.08 14.98 30.46 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.102 -0.374 . . . . 74.34 111.669 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.466 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 66.3 t30 -104.93 -11.39 16.72 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.289 0.477 . . . . 73.35 112.289 -172.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -86.56 6.11 32.33 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.923 0.712 . . . . 72.23 112.923 -172.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.481 HG23 HG23 ' A' ' 516' ' ' THR . 51.4 t -130.42 143.15 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.018 0.437 . . . . 54.05 112.107 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -129.73 143.2 50.7 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.386 -0.37 . . . . 72.41 111.023 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 56.9 m -117.78 135.48 54.03 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.856 0.36 . . . . 63.33 111.909 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -141.98 116.91 9.9 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.51 -0.552 . . . . 74.23 109.51 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -101.62 124.34 47.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.201 0.524 . . . . 60.34 111.813 -175.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.7 t -112.32 144.44 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.961 -0.563 . . . . 73.44 111.64 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 30.1 t -112.38 128.53 56.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.525 -0.307 . . . . 62.02 111.131 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.6 t -111.12 125.59 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 120.827 0.346 . . . . 73.24 111.691 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.75 161.12 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.165 0.507 . . . . 73.13 111.893 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.0 -14.37 58.0 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.754 0.65 . . . . 73.45 112.754 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 112.856 0.687 . . . . 62.21 112.856 -176.298 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.708 0.289 . . . . 74.4 111.016 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -101.29 130.94 47.54 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.841 0.353 . . . . 75.31 111.142 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -118.24 143.56 33.24 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.557 -0.292 . . . . 74.35 110.788 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.541 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 20.6 Cg_endo -79.99 174.37 11.63 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.334 2.022 . . . . 52.31 113.53 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 11.7 t70 -149.38 82.96 1.42 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.686 -0.688 . . . . 73.2 109.794 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.493 HD12 HG13 ' A' ' 470' ' ' VAL . 92.1 mt -84.73 114.76 22.28 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.105 -0.498 . . . . 72.2 111.771 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.478 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.2 t -126.37 158.6 35.47 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.009 0.433 . . . . 65.14 111.382 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.51 HG13 HG11 ' A' ' 462' ' ' VAL . 33.8 m -132.1 148.13 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 116.112 -0.495 . . . . 65.32 111.319 -177.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.5 mt-10 -125.08 137.15 54.2 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.421 0.288 . . . . 71.01 110.994 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.8 mt -108.76 127.68 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.919 0.39 . . . . 72.22 111.471 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -128.37 132.04 48.55 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.673 -0.239 . . . . 75.33 111.15 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 172.15 -173.77 45.27 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.654 -0.784 . . . . 75.13 113.678 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.75 136.48 23.26 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.774 2.316 . . . . 73.3 113.395 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.57 -47.89 58.04 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.966 -0.561 . . . . 65.45 111.898 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.1 t -117.83 125.83 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.765 0.317 . . . . 74.23 111.078 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.3 160.77 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.179 0.514 . . . . 74.53 111.867 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.53 148.56 19.34 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.074 -0.584 . . . . 63.14 113.323 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.511 HG23 ' ND2' ' A' ' 453' ' ' ASN . 11.0 p -64.39 138.42 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 120.857 0.361 . . . . 73.52 111.284 177.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . 0.511 ' ND2' HG23 ' A' ' 452' ' ' VAL . 45.0 m-80 63.56 18.68 11.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.959 0.504 . . . . 74.42 111.951 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -108.9 161.38 15.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.194 0.521 . . . . 71.21 111.623 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 502' ' ' SER . 37.8 tp -99.0 126.24 44.65 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.004 -0.544 . . . . 75.22 111.745 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.51 132.69 45.75 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.814 0.34 . . . . 54.21 111.582 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -104.98 138.58 40.97 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.42 0.629 . . . . 74.23 112.098 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 59.1 m-85 -122.84 151.34 41.79 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.554 -0.748 . . . . 71.55 110.302 177.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -120.02 127.2 52.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.094 0.474 . . . . 75.22 111.029 -175.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 21.6 t -105.07 114.78 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.101 -0.5 . . . . 75.21 111.124 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 46.8 m-70 -92.16 107.56 19.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.851 0.358 . . . . 74.43 110.299 174.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.602 HG12 HG22 ' A' ' 475' ' ' VAL . 20.2 m -105.55 133.21 50.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.927 0.394 . . . . 71.43 110.193 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.555 ' HB3' ' HZ2' ' A' ' 463' ' ' LYS . 0.1 OUTLIER -148.2 152.3 36.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.585 0.587 . . . . 70.23 112.585 -172.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.551 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.8 t-20 -107.72 127.46 53.7 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.634 -0.712 . . . . 73.52 109.524 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.535 HD21 ' HD3' ' A' ' 463' ' ' LYS . 79.9 mt -111.86 0.05 16.02 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.172 0.434 . . . . 72.35 112.172 -176.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -82.91 -25.38 49.61 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.92 -0.657 . . . . 63.34 113.632 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.88 22.73 41.22 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.101 -0.571 . . . . 73.2 113.577 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 9.5 tt -138.18 144.18 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 122.51 -0.406 . . . . 74.51 110.763 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . 0.463 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -71.82 138.72 27.51 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.154 -0.546 . . . . 62.14 114.059 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.493 HG13 HD12 ' A' ' 440' ' ' LEU . 40.7 t -129.71 117.36 18.44 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 112.34 0.496 . . . . 72.51 112.34 -177.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.2 -11.0 8.77 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.105 2.537 . . . . 74.4 112.759 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 57.7 m -80.98 11.44 4.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.457 0.703 . . . . 55.32 112.685 -176.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 39.3 m -88.97 91.1 8.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.661 0.743 . . . . 63.23 112.422 -166.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 517' ' ' VAL . 95.9 mttt -96.81 131.33 43.65 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.514 -0.766 . . . . 71.32 110.152 171.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.602 HG22 HG12 ' A' ' 462' ' ' VAL . 49.4 t -117.89 118.36 58.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 122.12 -0.363 . . . . 75.41 110.709 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -126.43 153.47 44.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.276 0.56 . . . . 63.23 112.076 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 84.8 t -120.41 135.79 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.006 -0.543 . . . . 75.14 111.141 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . 0.4 ' HE1' ' OG1' ' A' ' 516' ' ' THR . 25.1 m-85 -124.51 142.09 51.59 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.188 -0.46 . . . . 74.41 111.196 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.453 HG12 HG12 ' A' ' 513' ' ' ILE . 64.5 mt -114.82 111.55 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.295 -0.412 . . . . 74.13 109.998 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 54.34 34.03 19.74 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.195 0.521 . . . . 72.21 111.278 -173.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 98.07 -25.69 26.58 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.177 -0.465 . . . . 72.34 113.765 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 28.0 m -82.04 129.75 34.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.327 0.563 . . . . 74.15 111.851 -174.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.3 tp -62.48 124.23 20.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.096 0.474 . . . . 71.42 111.689 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . 0.457 ' HH ' ' HA ' ' A' ' 503' ' ' TRP . 82.2 t80 -105.58 -43.72 4.87 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.518 0.562 . . . . 74.02 112.518 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -155.45 152.55 29.12 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 110.324 -0.25 . . . . 74.31 110.324 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -141.09 147.89 39.27 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.434 0.531 . . . . 75.04 112.434 -176.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.5 m-90 -132.69 148.81 52.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.949 -0.569 . . . . 74.54 110.94 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.9 m -124.88 117.12 23.39 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.557 -0.534 . . . . 75.02 109.557 167.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.42 172.87 11.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.139 0.495 . . . . 75.41 111.587 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 30.3 m -116.93 133.89 55.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.186 -0.461 . . . . 70.35 110.335 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 72.8 mt -120.53 120.48 35.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.941 0.401 . . . . 74.41 110.978 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.463 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -80.85 -168.83 40.14 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.176 -0.535 . . . . 52.51 113.141 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -63.08 109.95 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.463 2.109 . . . . 72.22 112.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.5 mttt 63.45 37.48 10.62 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.618 0.723 . . . . 75.45 111.239 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -85.98 149.35 25.24 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.208 -0.905 . . . . 75.13 111.419 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -136.09 145.42 45.91 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.839 0.352 . . . . 71.12 111.473 172.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -141.6 147.33 37.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.002 0.521 . . . . 74.32 111.018 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 42.3 t -111.15 112.99 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.209 0.528 . . . . 72.12 111.54 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.7 127.85 55.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.178 -0.465 . . . . 74.23 110.268 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 76.0 p -112.96 163.05 15.14 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.136 0.791 . . . . 73.22 113.136 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 47.8 p90 -152.23 148.29 27.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.305 -0.861 . . . . 74.34 110.906 172.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 455' ' ' LEU . 78.6 p -114.9 114.72 25.86 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.072 0.463 . . . . 64.04 111.08 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . 0.46 ' CZ2' ' HB3' ' A' ' 505' ' ' PRO . 25.1 t90 -107.73 137.33 45.94 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.069 0.547 . . . . 75.14 111.776 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 93.4 m -125.9 101.47 29.39 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 116.407 -0.36 . . . . 73.3 111.02 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . 0.46 ' HB3' ' CZ2' ' A' ' 503' ' ' TRP . 85.5 Cg_endo -82.22 102.18 1.18 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.528 2.152 . . . . 74.21 113.321 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 63.4 p -76.38 -21.77 55.63 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.856 0.36 . . . . 74.44 111.185 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -107.91 125.76 51.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.932 0.396 . . . . 65.43 111.373 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.06 150.86 46.15 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.4 0.519 . . . . 74.31 112.4 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.83 -173.12 33.23 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.083 -0.579 . . . . 75.53 113.061 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 8.8 tpt -99.71 126.94 45.83 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.577 -0.366 . . . . 74.55 110.727 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -132.86 112.0 11.54 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.337 0.495 . . . . 75.33 112.337 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -93.03 118.23 30.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.869 0.366 . . . . 74.23 110.776 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.453 HG12 HG12 ' A' ' 479' ' ' ILE . 64.2 mt -95.47 127.93 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.093 0.473 . . . . 75.01 111.507 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -121.43 152.57 38.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.926 0.393 . . . . 73.4 111.194 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -128.9 135.35 48.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.769 0.318 . . . . 63.34 111.135 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' THR . . . . . 0.518 HG22 HG23 ' A' ' 532' ' ' VAL . 38.5 p -123.73 149.44 45.55 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.326 -0.397 . . . . 71.24 111.431 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 474' ' ' LYS . 7.3 p -119.4 139.56 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 116.422 -0.354 . . . . 75.51 111.459 170.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.9 t70 43.8 70.41 0.32 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.609 0.764 . . . . 73.03 111.687 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -61.97 -33.06 73.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.792 -0.64 . . . . 71.24 111.437 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.34 -13.66 62.5 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.651 0.612 . . . . 72.43 112.651 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.1 t30 56.34 55.9 6.22 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.535 0.683 . . . . 73.21 110.428 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 68.5 p -85.25 -31.73 22.96 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.923 -0.58 . . . . 72.41 111.133 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.56 141.75 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.01 -0.541 . . . . 70.25 111.034 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.8 112.13 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.844 0.354 . . . . 74.34 111.557 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.48 ' OE2' ' HG2' ' A' ' 438' ' ' PRO . 13.5 mm-40 -91.22 163.7 14.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.258 0.551 . . . . 73.24 112.124 -176.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.6 mt -71.98 -39.14 69.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.279 0.561 . . . . 72.34 110.854 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -129.46 110.48 11.91 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.945 -0.57 . . . . 73.42 110.271 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -83.09 -21.8 33.6 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.989 0.423 . . . . 73.24 111.4 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -75.39 -12.31 60.23 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.147 0.499 . . . . 72.33 110.821 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.478 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 41.7 t30 -86.72 -14.62 41.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.999 -0.546 . . . . 74.14 111.145 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -69.0 -13.97 62.77 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.08 0.77 . . . . 72.14 113.08 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.518 HG23 HG22 ' A' ' 516' ' ' THR . 57.7 t -116.57 134.0 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.528 0.566 . . . . 73.22 112.528 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -114.42 143.07 45.52 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.218 -0.446 . . . . 63.15 110.54 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 70.0 m -125.76 125.86 43.64 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.022 0.439 . . . . 70.42 111.888 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -137.65 122.98 19.44 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.042 0.449 . . . . 74.11 110.781 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -93.36 129.12 39.6 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.411 -0.359 . . . . 64.22 111.386 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.87 142.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.332 0.587 . . . . 75.41 111.93 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 22.8 t -118.38 127.2 53.45 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.343 -0.389 . . . . 75.41 111.189 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.0 t -104.85 123.62 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.825 0.345 . . . . 71.43 111.31 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 31.0 m -116.1 161.75 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.795 0.665 . . . . 64.15 112.795 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.02 -17.38 43.54 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.037 -0.529 . . . . 74.31 111.737 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.253 1.267 0 CA-C-N 116.031 -0.531 . . . . 73.2 112.176 178.499 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.735 0.302 . . . . 74.23 110.78 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . 0.478 ' HB2' HD12 ' A' ' 468' ' ' ILE . 5.9 mp0 -95.2 146.53 24.26 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.192 0.52 . . . . 75.13 112.023 -174.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -118.87 113.68 35.85 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.237 -0.438 . . . . 71.12 110.392 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.553 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 72.9 Cg_endo -74.27 169.53 22.27 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.344 2.029 . . . . 64.4 113.567 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . 0.434 ' HB2' HD13 ' A' ' 526' ' ' LEU . 37.3 t70 -128.74 96.05 4.27 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.727 -0.669 . . . . 74.03 109.833 176.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.494 HD22 HD11 ' A' ' 491' ' ' LEU . 88.7 mt -94.36 112.81 24.61 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.873 0.368 . . . . 73.44 111.077 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.507 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 6.8 t -122.46 153.42 39.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.994 0.426 . . . . 73.41 111.92 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.53 HG13 HG11 ' A' ' 462' ' ' VAL . 32.2 m -129.79 150.16 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.131 -0.486 . . . . 74.05 111.814 -177.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 49.6 mt-10 -130.23 144.81 51.58 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.21 -0.45 . . . . 73.04 110.918 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 53.4 mt -116.27 129.66 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.931 0.395 . . . . 74.14 111.199 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -134.19 137.43 44.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.414 -0.357 . . . . 74.11 110.981 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.29 -176.87 40.86 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.265 -0.969 . . . . 64.11 114.074 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.62 117.18 5.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.831 2.354 . . . . 73.52 113.071 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -71.85 -30.37 65.37 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.783 0.66 . . . . 70.05 112.783 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 94.6 t -120.73 122.98 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.885 -0.51 . . . . 75.54 111.503 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.97 163.28 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.084 0.469 . . . . 72.32 112.059 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.75 156.91 24.13 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.346 -0.454 . . . . 50.05 113.296 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.569 HG22 ' ND2' ' A' ' 453' ' ' ASN . 10.7 p -69.95 140.41 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.015 0.436 . . . . 71.05 111.807 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . 0.569 ' ND2' HG22 ' A' ' 452' ' ' VAL . 56.4 m-80 60.7 24.4 14.22 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.52 0.563 . . . . 62.33 112.52 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -105.94 176.13 5.27 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.125 0.488 . . . . 75.11 111.733 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 41.9 tp -105.09 120.2 40.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.338 -0.392 . . . . 75.1 111.431 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -129.25 132.78 47.27 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.739 0.304 . . . . 74.42 111.647 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -112.28 139.85 47.49 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.294 0.569 . . . . 72.5 111.548 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 53.7 m-85 -121.97 157.51 31.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.752 -0.658 . . . . 65.22 110.726 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -121.0 129.01 53.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.922 0.489 . . . . 75.24 111.079 -174.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 41.0 t -115.26 119.25 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.758 0.313 . . . . 74.32 111.353 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 49.3 m-70 -96.26 104.6 16.57 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.6 -0.273 . . . . 75.43 110.98 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.568 HG12 HG22 ' A' ' 475' ' ' VAL . 18.7 m -106.77 124.76 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.856 0.36 . . . . 72.13 110.988 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.441 ' HG3' HG23 ' A' ' 441' ' ' THR . 6.6 pttm -140.92 158.73 43.53 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.31 0.856 . . . . 75.13 113.31 -175.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.5 t-20 -107.94 128.7 54.86 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.677 -1.147 . . . . 63.34 109.468 175.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 86.4 mt -119.17 16.75 13.21 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.785 0.326 . . . . 75.21 111.86 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -100.81 -12.48 37.25 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.114 -0.565 . . . . 74.31 113.331 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.83 21.15 69.16 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.149 -0.548 . . . . 71.45 113.735 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.491 HG21 ' HB3' ' A' ' 438' ' ' PRO . 3.7 tt -134.67 132.99 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 122.602 -0.352 . . . . 73.42 111.048 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -66.43 134.61 33.37 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.367 -0.444 . . . . 74.51 113.679 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.94 116.06 16.82 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 122.562 0.345 . . . . 61.31 111.74 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.99 -11.21 12.42 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.117 2.544 . . . . 64.01 112.593 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' SER . . . . . 0.422 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 50.8 m -80.65 11.78 3.58 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.043 0.757 . . . . 73.21 113.043 -174.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.1 m -88.61 95.12 10.12 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.951 0.882 . . . . 62.13 111.937 -169.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -106.5 126.54 52.39 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.24 -0.891 . . . . 74.23 110.558 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.568 HG22 HG12 ' A' ' 462' ' ' VAL . 44.6 t -106.8 122.98 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 122.3 -0.25 . . . . 73.41 111.614 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . 0.62 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 46.9 mtt180 -115.75 146.9 41.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.746 0.308 . . . . 62.34 111.339 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 77.9 t -121.6 121.86 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.917 0.389 . . . . 73.14 111.308 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -112.1 141.12 46.17 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.305 -0.407 . . . . 72.31 111.826 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.543 HG12 HG12 ' A' ' 513' ' ' ILE . 53.8 mt -124.24 111.77 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.552 -0.295 . . . . 74.52 110.811 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 52.77 34.83 17.15 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.532 0.567 . . . . 74.41 112.532 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 90.41 3.05 72.55 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 120.858 -0.686 . . . . 72.31 113.887 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.7 m -110.73 121.61 45.76 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.423 -0.457 . . . . 75.35 111.432 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.6 tp -64.17 114.8 4.44 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.923 0.392 . . . . 74.42 110.643 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -84.33 -45.09 13.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.492 -0.322 . . . . 64.23 111.673 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -171.27 159.25 5.71 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.786 0.327 . . . . 72.03 111.449 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.87 153.81 42.72 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.324 0.49 . . . . 73.43 112.324 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -129.56 149.53 51.28 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.083 -0.508 . . . . 70.33 110.864 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 91.2 m -114.46 119.46 36.96 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.768 0.318 . . . . 55.52 110.766 174.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.77 173.59 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.366 0.603 . . . . 72.4 111.747 -177.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.0 p -123.43 138.09 54.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.055 -0.52 . . . . 75.5 110.456 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.494 HD11 HD22 ' A' ' 440' ' ' LEU . 90.7 mt -117.54 119.06 33.87 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.736 0.303 . . . . 72.05 111.141 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -77.25 -171.6 35.85 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.208 -0.52 . . . . 73.24 112.994 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.09 100.63 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.378 2.052 . . . . 74.52 112.329 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.6 mttt 66.64 40.39 3.36 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.494 -0.775 . . . . 72.05 112.068 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -99.69 151.4 21.26 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.941 -0.572 . . . . 72.14 111.136 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . 0.423 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 32.8 tt0 -132.47 137.39 47.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.899 0.381 . . . . 64.13 111.419 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -120.03 146.54 45.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.506 -0.316 . . . . 73.24 110.262 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 49.1 t -113.79 115.04 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.929 0.395 . . . . 64.25 111.311 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 69.4 mt -107.39 130.81 54.76 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.415 -0.357 . . . . 72.52 111.438 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 51.5 p -113.86 150.75 33.13 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.221 0.534 . . . . 73.2 112.001 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 49.5 p90 -144.36 148.56 34.87 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.127 -0.488 . . . . 73.34 111.395 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 78.5 p -110.48 115.28 29.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.26 0.553 . . . . 60.21 110.957 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -112.36 136.88 51.28 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.288 -0.415 . . . . 74.31 111.363 -176.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.0 m -118.18 103.9 49.01 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.345 -0.389 . . . . 74.22 111.047 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.13 99.37 1.17 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.708 2.272 . . . . 71.23 112.711 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.6 p -78.23 -12.83 60.03 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.589 0.589 . . . . 75.32 112.589 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -122.17 141.63 51.25 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.762 0.315 . . . . 75.14 110.884 174.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.87 151.86 31.56 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.179 0.514 . . . . 64.14 112.083 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 145.43 -173.51 25.8 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.043 -0.598 . . . . 70.1 113.175 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 511' ' ' TYR . 0.0 OUTLIER -90.63 133.8 34.86 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.014 0.435 . . . . 75.32 110.839 179.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . 0.462 ' N ' ' SD ' ' A' ' 510' ' ' MET . 96.0 m-85 -132.25 120.46 22.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.133 0.492 . . . . 73.24 111.791 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 479' ' ' ILE . 47.9 ttp85 -94.15 118.37 31.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.224 -0.444 . . . . 74.41 111.072 177.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.543 HG12 HG12 ' A' ' 479' ' ' ILE . 55.6 mt -103.9 126.03 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.985 0.421 . . . . 74.14 111.48 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -125.8 142.55 51.46 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.979 0.418 . . . . 64.13 111.681 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -119.09 133.56 55.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.261 -0.427 . . . . 64.5 110.758 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' THR . . . . . 0.509 HG23 HG23 ' A' ' 532' ' ' VAL . 33.9 p -130.82 140.71 50.29 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.323 -0.398 . . . . 73.15 111.689 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.02 140.67 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.933 0.397 . . . . 72.21 111.226 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 39.7 t0 42.53 66.61 0.72 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.62 -0.718 . . . . 63.44 111.685 -174.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . 0.62 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.8 mm-40 -57.5 -31.94 66.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.0 -0.546 . . . . 74.03 111.293 173.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.4 ' HB2' HG22 ' A' ' 522' ' ' THR . 6.7 mm-40 -68.5 -25.78 65.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.85 -0.614 . . . . 75.24 110.761 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 56.59 63.85 1.84 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.808 0.813 . . . . 74.5 110.663 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 67.0 p -94.86 -15.66 23.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.503 -0.771 . . . . 71.53 111.892 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.5 p -118.68 142.53 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.665 0.269 . . . . 53.33 111.056 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . 0.404 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 50.4 t -82.68 121.04 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.847 0.356 . . . . 74.12 111.2 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.96 159.31 15.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.068 -0.514 . . . . 62.02 112.285 -171.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 439' ' ' ASP . 94.4 mt -68.57 -33.5 74.18 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.961 0.41 . . . . 74.23 111.521 174.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -145.56 129.31 17.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.377 -0.374 . . . . 73.15 110.795 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -83.15 -24.93 32.33 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.177 0.513 . . . . 74.34 111.542 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -86.91 13.98 8.1 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.901 0.381 . . . . 71.32 111.453 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.507 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 62.7 t30 -106.82 -15.02 14.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.103 0.477 . . . . 74.22 111.001 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -73.19 -16.86 61.41 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.724 0.638 . . . . 70.21 112.724 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.509 HG23 HG23 ' A' ' 516' ' ' THR . 45.2 t -111.69 133.33 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.754 0.65 . . . . 72.34 112.754 -171.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -123.52 139.0 54.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.166 -0.47 . . . . 52.31 110.719 173.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 87.5 m -119.86 134.71 55.14 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.033 0.383 . . . . 71.33 112.033 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -139.8 136.54 34.17 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.868 0.366 . . . . 65.3 110.527 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.63 133.32 50.57 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.09 0.472 . . . . 75.31 112.17 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 64.0 t -124.74 141.21 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.286 -0.415 . . . . 74.14 111.65 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.9 t -118.19 117.54 29.43 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.472 -0.331 . . . . 74.14 110.679 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 66.5 t -101.31 123.02 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.026 0.441 . . . . 74.31 111.801 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.42 167.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 116.023 -0.535 . . . . 75.25 112.248 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.03 10.33 16.83 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.914 0.387 . . . . 73.44 111.684 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.254 1.322 0 CA-C-N 116.304 -0.407 . . . . 71.54 112.086 -176.567 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 50.7 tpp . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 121.155 0.502 . . . . 71.25 109.982 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -89.08 141.65 28.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.175 -0.466 . . . . 72.42 111.857 -171.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -119.72 129.92 25.11 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.547 -0.297 . . . . 75.3 110.756 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.509 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 64.3 Cg_endo -72.41 173.65 12.82 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.493 2.129 . . . . 72.32 113.208 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -140.61 87.36 2.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.548 -0.538 . . . . 70.44 109.548 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.452 ' HB3' HG21 ' A' ' 517' ' ' VAL . 79.4 mt -90.58 137.9 31.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.092 -0.504 . . . . 75.44 111.364 -175.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.446 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.6 t -148.81 165.32 31.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.079 0.466 . . . . 73.15 112.014 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.552 HG13 HG12 ' A' ' 462' ' ' VAL . 27.5 m -133.72 149.19 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.83 -0.623 . . . . 75.33 111.569 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 6.5 mm-40 -130.99 129.76 42.51 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.229 -0.441 . . . . 72.11 111.519 176.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 50.1 mt -107.99 117.77 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.181 -0.463 . . . . 61.42 110.591 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -136.01 139.29 43.02 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.925 0.393 . . . . 75.22 111.73 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.66 -163.31 36.18 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.091 -0.504 . . . . 53.41 112.885 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.04 118.77 5.7 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.779 2.319 . . . . 71.41 113.027 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -86.74 -14.26 42.92 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.299 0.481 . . . . 64.51 112.299 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.0 t -128.87 117.85 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 122.146 -0.346 . . . . 73.53 110.704 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.94 164.21 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.241 0.543 . . . . 63.44 112.178 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -96.46 163.48 22.85 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 116.195 -0.457 . . . . 54.52 112.998 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.7 p -71.53 140.05 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 120.861 0.362 . . . . 75.44 111.214 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 65.87 17.33 10.8 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.656 0.613 . . . . 71.45 112.656 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.411 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -98.33 176.3 5.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.863 0.363 . . . . 73.53 111.457 176.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 502' ' ' SER . 40.4 tp -115.28 130.14 56.82 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.747 0.308 . . . . 75.14 111.33 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.07 134.22 47.23 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.881 0.326 . . . . 73.22 111.881 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.3 128.31 53.89 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.108 0.48 . . . . 72.31 111.934 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -122.01 154.88 36.66 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.961 -0.563 . . . . 75.31 110.274 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.528 ' HG2' HG21 ' A' ' 500' ' ' THR . 54.8 mt-10 -120.34 127.74 52.62 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.899 0.38 . . . . 74.33 111.631 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 24.2 t -96.8 112.56 29.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.008 -0.542 . . . . 64.2 109.651 169.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 35.2 m-70 -94.13 108.95 20.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.832 0.348 . . . . 72.12 110.39 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.774 HG13 HG22 ' A' ' 475' ' ' VAL . 14.4 m -106.1 126.88 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 71.31 110.079 -176.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.526 ' HD3' HD22 ' A' ' 465' ' ' LEU . 15.7 ptpt -144.03 148.92 35.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.791 0.663 . . . . 74.51 112.791 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.517 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -105.91 127.42 53.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.273 -0.876 . . . . 72.24 109.314 174.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.526 HD22 ' HD3' ' A' ' 463' ' ' LYS . 73.5 mt -118.05 8.7 12.52 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.825 0.306 . . . . 74.11 111.825 -177.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -87.87 -16.16 60.13 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.247 -0.501 . . . . 75.01 113.769 -177.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 83.0 17.17 67.99 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 120.911 -0.661 . . . . 51.15 113.468 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.4 tt -134.66 135.58 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 122.909 0.484 . . . . 71.24 111.035 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . 0.48 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -70.95 132.62 21.91 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.474 -0.393 . . . . 71.4 113.701 -176.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 62.6 t -128.23 114.0 19.97 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 111.984 0.364 . . . . 73.31 111.984 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.87 -9.84 11.85 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.091 2.527 . . . . 73.1 112.739 174.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' SER . . . . . 0.461 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 39.0 m -80.87 10.6 4.81 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.688 0.996 . . . . 70.2 113.688 -171.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' THR . . . . . 0.419 HG23 HG22 ' A' ' 517' ' ' VAL . 94.3 m -88.14 100.59 13.07 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.86 0.838 . . . . 72.32 112.629 -166.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -114.4 117.54 31.31 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.291 -0.868 . . . . 75.32 110.746 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.774 HG22 HG13 ' A' ' 462' ' ' VAL . 45.3 t -104.17 132.72 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.063 0.394 . . . . 74.45 112.063 -173.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . 0.677 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 93.7 mtt180 -114.47 152.42 31.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.965 0.412 . . . . 74.33 111.832 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 82.5 t -122.43 126.27 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.056 -0.52 . . . . 75.44 111.008 173.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 513' ' ' ILE . 95.3 m-85 -115.47 138.83 50.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.851 0.357 . . . . 75.13 111.775 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 64.2 mt -115.0 107.93 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.954 -0.387 . . . . 72.51 109.954 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 55.94 34.76 24.23 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.088 0.47 . . . . 73.32 111.708 -173.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.13 -6.64 83.26 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 121.344 -0.455 . . . . 55.3 113.693 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.0 m -92.38 124.8 36.7 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 122.388 -0.478 . . . . 74.2 111.31 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.42 122.6 16.64 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.177 0.513 . . . . 75.13 111.579 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -101.97 -45.37 5.21 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.098 -0.501 . . . . 74.02 112.187 -178.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . 0.469 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 33.6 ttpt -171.01 160.09 6.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.242 0.217 . . . . 72.42 110.869 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.31 154.16 38.58 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.832 0.349 . . . . 64.11 111.863 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . 0.469 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 19.3 m-90 -129.83 147.22 51.58 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.313 -0.403 . . . . 74.24 111.362 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 34.6 m -110.28 118.57 36.69 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 110.326 -0.25 . . . . 72.02 110.326 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.56 172.17 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.49 0.662 . . . . 70.3 111.858 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 77.6 p -120.0 133.42 55.55 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.887 -0.597 . . . . 61.21 110.955 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.9 mt -118.48 118.93 33.06 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.861 0.362 . . . . 75.23 111.31 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.48 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -82.21 -166.39 37.95 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.164 -0.541 . . . . 63.53 113.62 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.98 105.87 0.49 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.622 2.215 . . . . 73.04 112.518 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.5 mmtp 67.46 30.97 6.57 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.114 0.483 . . . . 72.12 111.573 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -94.33 149.45 21.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.325 -0.398 . . . . 52.12 111.97 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . 0.508 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 32.7 tt0 -134.58 139.1 45.12 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.004 0.431 . . . . 74.42 111.554 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -125.67 140.65 52.53 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.325 -0.398 . . . . 75.54 110.273 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.32 117.37 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.894 0.378 . . . . 74.12 111.428 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.53 138.96 41.75 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.35 -0.386 . . . . 73.11 110.698 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' THR . . . . . 0.528 HG21 ' HG2' ' A' ' 459' ' ' GLU . 42.6 p -120.55 155.46 33.62 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.349 0.595 . . . . 65.45 112.125 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -152.29 148.28 27.35 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.688 -0.687 . . . . 75.35 110.831 170.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.512 ' HB2' HD12 ' A' ' 455' ' ' LEU . 20.4 p -117.19 114.96 24.41 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.156 0.503 . . . . 71.12 110.949 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -109.06 136.7 48.14 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.217 -0.447 . . . . 73.02 111.9 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 87.9 m -113.24 101.32 53.34 Favored Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.974 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 61.1 Cg_endo -72.38 88.48 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.472 2.115 . . . . 75.52 112.925 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.2 p -75.67 6.73 4.48 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.786 0.662 . . . . 64.33 112.786 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -143.5 135.75 26.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 110.483 -0.192 . . . . 63.11 110.483 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.76 151.32 37.61 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.092 0.472 . . . . 74.2 112.238 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.95 -169.08 28.09 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.16 -0.543 . . . . 71.33 113.064 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 12.5 tpt -99.46 124.53 44.7 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.733 0.301 . . . . 64.13 110.859 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -128.32 111.95 13.92 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.179 0.514 . . . . 75.42 111.688 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 32.8 ttm180 -94.66 120.82 35.48 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.119 -0.492 . . . . 75.12 111.141 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 478' ' ' TYR . 67.6 mt -95.41 126.05 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.087 0.47 . . . . 75.22 111.523 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -124.95 129.15 49.78 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.289 -0.414 . . . . 74.45 111.324 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.3 146.3 38.48 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.846 0.355 . . . . 55.52 111.326 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' THR . . . . . 0.51 HG23 HG23 ' A' ' 532' ' ' VAL . 76.4 p -130.19 140.92 50.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.18 -0.464 . . . . 75.02 111.011 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . 0.503 ' HB ' HG12 ' A' ' 442' ' ' VAL . 7.4 p -100.51 138.42 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 110.207 -0.294 . . . . 75.23 110.207 174.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.5 t0 35.46 71.58 0.12 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.604 0.716 . . . . 73.43 110.961 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . 0.677 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.4 tm-20 -51.29 -45.52 62.16 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.098 -0.955 . . . . 62.13 111.71 -176.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -69.72 -17.29 63.45 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.411 -0.359 . . . . 74.01 111.49 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 51.51 79.36 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.798 0.809 . . . . 54.31 111.394 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 81.9 p -97.34 2.59 50.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.156 -0.929 . . . . 73.42 110.861 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.57 142.03 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.832 -0.622 . . . . 73.2 110.51 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.58 116.02 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.782 0.325 . . . . 72.31 111.847 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -92.59 170.33 9.82 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.349 0.595 . . . . 71.12 111.903 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.48 -29.25 67.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.853 -0.612 . . . . 75.13 111.978 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -141.38 128.33 20.64 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.773 0.32 . . . . 74.24 111.42 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.75 -24.17 31.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.131 0.491 . . . . 75.12 111.643 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -79.76 4.32 16.72 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.659 0.742 . . . . 73.35 110.767 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.446 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 56.0 t30 -92.16 -20.16 21.52 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.878 -0.601 . . . . 73.1 111.553 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . 0.455 ' HA ' HG13 ' A' ' 517' ' ' VAL . 12.9 m120 -72.8 -25.48 61.17 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.922 1.082 . . . . 72.44 113.922 -172.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.51 HG23 HG23 ' A' ' 516' ' ' THR . 42.9 t -109.32 143.37 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.922 0.712 . . . . 75.42 112.922 -172.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . 0.41 ' HB2' HG22 ' A' ' 442' ' ' VAL . . . -129.95 142.81 50.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.172 -0.467 . . . . 62.32 111.043 174.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 72.4 m -118.9 129.24 55.08 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.134 0.42 . . . . 74.13 112.134 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -143.17 117.67 9.73 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.648 0.261 . . . . 74.34 110.849 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 10.3 p-10 -93.42 137.78 32.38 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.246 0.461 . . . . 63.42 112.246 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 56.1 t -125.95 134.56 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.392 -0.367 . . . . 74.45 111.672 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 45.5 t -104.08 126.26 51.05 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.56 -0.291 . . . . 73.31 111.297 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.12 121.93 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.975 0.416 . . . . 65.33 111.465 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.9 m -111.83 161.74 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.367 0.506 . . . . 75.24 112.367 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 86.7 mt -82.66 16.92 1.97 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.264 0.468 . . . . 73.2 112.264 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 119.324 -0.37 . . . . 75.35 111.83 -179.705 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 47.3 ttm . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.033 0.444 . . . . 74.33 111.222 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -97.97 138.64 34.99 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.824 0.345 . . . . 63.41 111.136 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -113.04 131.65 22.72 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.376 -0.375 . . . . 75.51 110.935 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.91 173.39 14.55 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.434 2.09 . . . . 73.22 113.474 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -157.2 94.08 1.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.369 -0.832 . . . . 61.23 109.447 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.524 HD22 HD11 ' A' ' 491' ' ' LEU . 53.4 mt -98.26 114.54 26.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.045 0.45 . . . . 74.13 111.382 -175.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.527 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.9 t -122.67 150.6 42.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.179 0.514 . . . . 72.2 112.116 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.512 HG13 HG11 ' A' ' 462' ' ' VAL . 28.8 m -121.31 148.88 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.064 -0.516 . . . . 74.44 111.286 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.9 mt-10 -136.83 143.18 42.97 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.655 -0.248 . . . . 71.42 110.911 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 57.7 mt -120.39 135.5 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 120.974 0.416 . . . . 73.12 111.599 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -137.23 147.05 45.53 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.29 -0.414 . . . . 73.3 110.652 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 160.51 -166.46 35.37 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.676 -0.774 . . . . 72.53 113.489 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.9 132.55 24.99 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.985 2.456 . . . . 74.54 113.491 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -78.66 -43.51 25.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.14 -0.482 . . . . 73.41 112.173 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 538' ' ' SER . 44.1 t -123.7 129.78 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.767 0.318 . . . . 54.44 111.082 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.47 163.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.147 0.498 . . . . 71.34 111.74 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -95.25 162.89 23.9 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.279 -0.486 . . . . 62.31 113.196 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.529 HG22 ' ND2' ' A' ' 453' ' ' ASN . 12.9 p -67.65 136.18 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 121.228 0.537 . . . . 75.35 111.625 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . 0.529 ' ND2' HG22 ' A' ' 452' ' ' VAL . 51.7 m-80 65.2 14.75 9.61 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.858 -0.61 . . . . 73.33 112.479 -177.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.492 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.2 mmmt -97.07 153.84 17.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.068 0.461 . . . . 74.11 111.645 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 502' ' ' SER . 46.3 tp -90.19 138.79 31.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.019 0.438 . . . . 75.55 111.569 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -135.86 133.02 37.33 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.824 0.345 . . . . 73.32 111.656 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -109.45 134.58 51.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.849 0.357 . . . . 72.31 111.657 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -125.53 154.62 41.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.28 -0.418 . . . . 64.44 111.176 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -119.59 127.75 53.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.159 0.504 . . . . 75.31 110.719 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 39.8 t -105.54 115.34 47.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.997 -0.547 . . . . 73.13 110.949 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 27.1 m-70 -92.6 105.34 17.52 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.654 0.264 . . . . 71.04 110.643 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.512 HG11 HG13 ' A' ' 442' ' ' VAL . 33.8 m -106.24 122.74 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.075 0.464 . . . . 71.31 110.178 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -139.09 153.09 47.98 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.84 0.682 . . . . 74.04 112.84 -173.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.569 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 53.4 t-20 -106.1 128.64 54.02 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.256 -0.883 . . . . 75.44 110.025 176.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 90.7 mt -113.83 -2.42 13.65 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.023 0.379 . . . . 71.45 112.023 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -81.17 -16.44 74.38 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.247 -0.501 . . . . 54.14 113.884 -177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.42 21.89 68.74 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.077 -0.582 . . . . 73.02 113.737 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 3.2 tt -137.68 133.3 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.577 0.351 . . . . 73.42 111.405 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.36 134.54 22.9 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 114.214 0.445 . . . . 74.0 114.214 -176.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 50.7 t -131.14 114.54 16.21 Favored Pre-proline 0 CA--C 1.547 0.833 0 O-C-N 122.585 -0.362 . . . . 62.21 111.663 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -83.93 -10.24 9.41 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.151 2.567 . . . . 75.44 113.004 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 20.3 t -81.95 11.83 4.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.548 0.739 . . . . 64.1 112.328 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.2 m -88.82 97.39 11.13 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.719 0.771 . . . . 73.24 112.27 -167.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -101.87 130.63 48.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.357 -0.838 . . . . 73.11 110.66 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.486 HG22 HG12 ' A' ' 462' ' ' VAL . 60.4 t -115.37 133.41 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 122.793 0.437 . . . . 75.54 111.058 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . 0.503 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 90.6 mtt180 -126.66 149.04 49.75 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.828 0.347 . . . . 74.12 111.557 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.28 120.54 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.466 -0.334 . . . . 73.21 111.182 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -112.46 139.02 48.38 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.987 0.422 . . . . 74.21 111.699 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.512 HG12 HG12 ' A' ' 513' ' ' ILE . 54.0 mt -114.13 107.58 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 109.855 -0.424 . . . . 73.23 109.855 172.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 54.57 34.47 21.36 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.262 -0.426 . . . . 73.25 112.04 -175.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 103.29 -30.06 11.12 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.125 -0.56 . . . . 75.22 113.75 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.9 m -82.35 125.47 31.05 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.42 -0.459 . . . . 75.23 112.004 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.0 tp -65.57 115.73 6.08 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.01 0.433 . . . . 65.35 111.319 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -82.67 -44.14 16.07 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.355 -0.384 . . . . 72.31 111.38 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . 0.416 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 32.6 ttpt -170.38 157.83 6.28 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.672 -0.24 . . . . 75.31 110.876 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -137.38 156.69 47.91 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.095 0.474 . . . . 73.52 111.945 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . 0.416 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 18.2 m-90 -137.3 149.12 46.85 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.118 -0.492 . . . . 75.52 110.79 177.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 89.6 m -121.54 119.24 31.4 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 110.057 -0.349 . . . . 61.13 110.057 174.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.0 m -139.83 172.74 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.369 0.604 . . . . 75.25 112.115 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.7 p -115.1 133.88 55.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.925 -0.579 . . . . 72.02 110.474 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.524 HD11 HD22 ' A' ' 440' ' ' LEU . 73.5 mt -116.75 120.43 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.858 0.361 . . . . 63.23 111.098 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.47 -173.88 48.54 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.163 -0.541 . . . . 72.55 113.264 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.9 99.53 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.532 2.155 . . . . 74.12 112.484 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 98.0 mttt 67.57 50.45 0.91 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.918 -0.583 . . . . 64.51 111.796 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -110.39 148.36 32.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.516 -0.765 . . . . 73.13 111.27 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -130.04 136.87 49.87 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.058 0.456 . . . . 75.11 111.444 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -118.87 135.63 54.46 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.544 -0.539 . . . . 74.2 109.544 173.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 89.9 t -100.96 113.12 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.266 0.555 . . . . 73.33 111.116 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 63.6 mt -105.82 126.68 52.45 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.844 -0.616 . . . . 75.43 110.711 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 22.1 p -112.3 154.36 25.78 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.317 0.579 . . . . 71.02 111.909 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -145.64 148.9 33.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.608 -0.724 . . . . 72.43 110.701 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.555 ' HB2' HD11 ' A' ' 455' ' ' LEU . 24.0 p -110.24 113.75 26.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.308 0.575 . . . . 64.13 110.642 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -110.48 137.12 48.6 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.865 -0.607 . . . . 73.23 111.192 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 36.5 m -122.65 100.3 41.17 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 116.475 -0.329 . . . . 73.55 111.073 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.3 Cg_endo -76.52 106.8 2.32 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.318 2.012 . . . . 71.14 112.638 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 64.4 p -89.08 -5.88 57.5 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.817 0.342 . . . . 73.54 111.913 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -125.68 136.04 52.79 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.605 -0.27 . . . . 74.52 110.9 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -73.34 151.08 41.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.936 0.398 . . . . 74.25 111.93 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.8 178.33 24.65 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.223 -0.513 . . . . 54.24 112.913 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' MET . . . . . 0.484 ' HE2' ' HB2' ' A' ' 536' ' ' ASP . 14.4 tpt -92.74 114.58 27.17 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.877 0.37 . . . . 73.13 111.061 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -111.22 144.9 39.64 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.678 0.275 . . . . 75.14 111.447 -178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . 0.453 ' HG2' ' OD1' ' A' ' 514' ' ' ASN . 16.2 ttm180 -123.19 115.45 21.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.735 0.302 . . . . 75.22 111.075 176.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.512 HG12 HG12 ' A' ' 479' ' ' ILE . 59.9 mt -96.05 113.7 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.135 -0.484 . . . . 75.4 111.21 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.453 ' OD1' ' HG2' ' A' ' 512' ' ' ARG . 4.0 m-20 -118.91 145.79 45.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.405 -0.361 . . . . 73.13 111.469 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 532' ' ' VAL . . . -115.48 145.15 42.87 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.779 0.324 . . . . 71.03 111.274 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' THR . . . . . 0.5 HG23 HG23 ' A' ' 532' ' ' VAL . 58.9 p -132.82 148.76 52.31 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.183 -0.462 . . . . 65.34 111.643 -178.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.23 152.69 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 120.756 0.312 . . . . 72.01 111.243 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 35.8 t70 54.72 39.99 31.65 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.702 0.763 . . . . 75.13 111.369 -176.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . 0.503 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 8.5 mm-40 -52.6 -31.6 37.16 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.802 -0.636 . . . . 75.24 111.315 172.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.422 ' HB2' HG21 ' A' ' 522' ' ' THR . 4.2 mm-40 -67.67 -25.39 65.68 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.732 -0.667 . . . . 74.34 111.153 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.6 m120 59.31 71.92 0.56 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.419 0.628 . . . . 74.1 110.614 -176.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' THR . . . . . 0.422 HG21 ' HB2' ' A' ' 520' ' ' GLU . 82.6 p -107.41 -32.89 7.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.581 -0.736 . . . . 75.11 112.355 -174.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 14.4 p -124.37 143.31 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.589 0.588 . . . . 72.41 112.589 -172.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.3 111.69 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.45 -0.341 . . . . 73.42 110.716 176.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -99.73 -179.49 4.2 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.427 0.528 . . . . 74.45 112.427 -175.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.58 -41.08 24.66 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.251 -0.431 . . . . 74.42 111.552 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -130.31 98.49 4.73 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.124 0.488 . . . . 53.44 111.006 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -84.3 10.19 11.14 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.274 0.559 . . . . 71.14 111.502 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -108.16 0.62 21.66 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.467 0.651 . . . . 73.42 110.131 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.527 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.4 t30 -95.54 -0.84 51.64 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.85 -0.614 . . . . 74.13 111.551 -174.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -81.95 -19.25 41.06 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.424 0.898 . . . . 74.42 113.424 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.5 HG23 HG23 ' A' ' 516' ' ' THR . 39.9 t -112.42 141.19 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 112.365 0.506 . . . . 74.54 112.365 -174.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -132.49 135.52 46.07 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.597 -0.274 . . . . 71.12 111.439 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 30.6 m -106.53 134.91 48.95 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.472 0.545 . . . . 72.32 112.472 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -142.99 117.5 9.72 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.174 -0.467 . . . . 73.42 110.28 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . 0.484 ' HB2' ' HE2' ' A' ' 510' ' ' MET . 6.6 p-10 -94.34 137.45 33.47 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.253 0.549 . . . . 70.33 112.155 -177.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.21 130.64 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.95 -0.568 . . . . 73.34 111.518 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' SER . . . . . 0.412 ' HB3' HG22 ' A' ' 449' ' ' VAL . 41.3 t -96.97 117.97 32.34 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.527 -0.306 . . . . 70.33 111.351 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.95 120.47 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.935 0.398 . . . . 73.42 111.077 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.58 166.54 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 112.498 0.555 . . . . 72.54 112.498 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.87 -12.3 55.72 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.177 0.436 . . . . 73.35 112.177 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.252 1.206 0 N-CA-C 112.513 0.56 . . . . 55.12 112.513 178.748 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 50.8 tpp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.192 0.52 . . . . 73.33 110.23 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -92.25 126.34 37.3 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.965 -0.561 . . . . 74.13 112.063 -171.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -112.62 124.27 32.21 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.034 -0.53 . . . . 71.41 110.146 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.61 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 56.9 Cg_endo -72.16 174.41 11.44 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.269 1.979 . . . . 73.24 112.92 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -154.06 80.29 1.13 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.365 0.602 . . . . 73.13 110.041 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.452 HD22 HD13 ' A' ' 491' ' ' LEU . 61.1 mt -80.05 116.54 20.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.953 -0.567 . . . . 71.31 111.596 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 8.1 t -126.38 153.53 44.82 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.859 0.361 . . . . 72.44 111.096 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.501 HG13 HG11 ' A' ' 462' ' ' VAL . 21.0 m -131.84 149.58 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.193 0.52 . . . . 74.05 112.358 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 49.4 mt-10 -128.47 144.03 51.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.883 -0.599 . . . . 72.11 110.843 175.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 65.8 mt -114.75 132.73 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.635 0.255 . . . . 73.05 110.766 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -132.81 145.87 51.35 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.579 0.228 . . . . 74.4 110.929 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.77 -173.66 36.51 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.672 -0.775 . . . . 74.21 113.752 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.62 126.43 12.09 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.991 2.461 . . . . 71.3 112.993 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -76.37 -21.47 56.04 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.153 -0.476 . . . . 64.14 112.218 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.6 t -131.0 128.82 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.754 0.312 . . . . 74.42 111.09 176.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.78 156.41 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 120.997 0.427 . . . . 75.51 111.682 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.34 154.57 24.37 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.319 -0.467 . . . . 71.14 113.25 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 11.7 p -65.62 141.46 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.889 0.376 . . . . 75.32 111.781 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 65.53 8.54 5.15 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.257 0.623 . . . . 70.32 112.272 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.54 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 31.3 mmmt -96.13 167.15 11.38 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.943 0.402 . . . . 74.31 111.473 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 502' ' ' SER . 33.4 tp -103.81 134.06 47.75 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.68 0.276 . . . . 73.35 111.35 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -133.57 140.13 46.98 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.799 0.333 . . . . 75.32 111.774 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -100.53 138.15 37.98 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.907 0.384 . . . . 75.53 111.595 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -129.66 155.15 46.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.943 0.401 . . . . 71.5 111.084 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -119.73 127.55 52.94 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.096 -0.502 . . . . 55.32 111.379 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 29.9 t -104.54 113.01 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.271 -0.422 . . . . 74.42 110.046 171.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 41.9 m-70 -94.81 105.13 17.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.519 -0.31 . . . . 73.04 110.31 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.586 HG12 HG22 ' A' ' 475' ' ' VAL . 26.4 m -106.14 126.02 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.087 0.47 . . . . 72.31 110.346 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.42 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.8 ptpt -146.69 157.32 43.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.297 0.57 . . . . 71.04 112.315 -175.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -114.32 127.17 55.73 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.552 -0.749 . . . . 64.44 109.662 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.42 HD21 ' HD3' ' A' ' 463' ' ' LYS . 85.2 mt -113.28 0.91 14.99 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.843 0.354 . . . . 73.41 111.844 -177.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -76.99 -19.44 77.46 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.039 -0.6 . . . . 54.44 113.32 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.16 13.31 64.21 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.319 -0.467 . . . . 73.31 113.87 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.7 tt -137.35 133.26 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 122.575 0.35 . . . . 72.42 110.651 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.38 137.77 20.17 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.775 0.67 . . . . 71.21 114.775 -173.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 46.8 t -123.76 113.19 28.74 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 122.76 0.424 . . . . 62.41 111.184 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.78 -10.79 9.34 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.93 2.42 . . . . 75.12 112.807 175.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 29.0 t -83.28 11.21 6.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.229 0.612 . . . . 74.12 112.467 -176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 97.6 m -90.17 113.55 25.34 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.093 0.775 . . . . 74.44 113.093 -166.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -103.89 131.24 51.3 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.964 -0.562 . . . . 73.22 111.617 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.586 HG22 HG12 ' A' ' 462' ' ' VAL . 53.7 t -110.36 130.58 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 122.885 0.474 . . . . 72.3 111.264 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . 0.701 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 68.2 mtt180 -125.97 152.54 45.55 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.133 0.492 . . . . 75.12 111.755 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 75.9 t -120.89 128.75 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.117 -0.492 . . . . 71.34 110.818 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -118.68 136.52 53.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.835 0.35 . . . . 63.12 111.569 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 66.2 mt -108.1 108.05 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.965 -0.383 . . . . 74.25 109.965 173.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 56.68 33.64 23.19 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.099 0.476 . . . . 73.44 111.413 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 99.71 -26.56 23.95 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.409 -0.424 . . . . 51.31 113.76 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 86.1 m -81.88 129.72 34.84 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 117.078 0.439 . . . . 71.25 111.727 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 54.8 tp -65.65 121.36 14.8 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.199 0.523 . . . . 75.33 111.831 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -92.75 -43.79 8.86 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.791 -0.641 . . . . 72.15 111.686 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -161.77 154.5 20.27 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.69 -0.232 . . . . 74.22 110.826 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.62 147.87 47.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.362 0.504 . . . . 61.23 112.362 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -133.23 146.79 51.77 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.04 -0.527 . . . . 74.41 110.844 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.2 m -115.0 118.74 34.27 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.9 -0.408 . . . . 74.34 109.9 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.37 172.5 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.576 0.703 . . . . 74.4 112.471 -172.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 87.2 p -116.06 134.01 55.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.649 -0.705 . . . . 71.3 110.594 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.452 HD13 HD22 ' A' ' 440' ' ' LEU . 92.6 mt -124.41 119.18 28.47 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.814 0.34 . . . . 72.04 111.066 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.07 -174.08 48.43 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.126 -0.488 . . . . 75.43 113.622 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.68 106.07 0.58 Allowed 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.619 2.213 . . . . 45.14 112.416 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.9 mttt 66.25 36.23 5.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.364 0.602 . . . . 75.4 111.653 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -95.85 142.77 27.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.757 -0.656 . . . . 64.33 111.165 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -128.15 133.56 48.96 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.915 0.388 . . . . 75.41 111.416 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -126.74 134.2 50.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.281 -0.418 . . . . 72.32 111.208 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 51.3 t -102.61 113.08 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.047 0.451 . . . . 52.34 111.414 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 57.5 mt -104.05 126.57 51.27 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.231 -0.441 . . . . 63.2 110.323 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 32.9 p -113.46 151.09 31.88 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.356 0.598 . . . . 75.41 112.361 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -146.58 148.99 32.69 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.635 -0.711 . . . . 72.13 110.875 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.483 ' HB2' HD11 ' A' ' 455' ' ' LEU . 86.1 p -110.19 115.55 29.92 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.324 0.583 . . . . 74.12 110.669 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -107.82 137.23 46.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.983 -0.553 . . . . 74.1 111.757 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 86.0 m -109.05 101.37 44.5 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.298 -0.41 . . . . 74.13 111.307 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.9 Cg_endo -75.56 92.19 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.324 2.016 . . . . 63.52 112.722 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 40.0 p -82.38 12.32 4.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.275 0.472 . . . . 72.54 112.275 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -143.56 130.99 21.0 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.406 -0.361 . . . . 74.11 110.644 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.1 150.87 33.63 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.498 0.555 . . . . 72.1 112.498 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 143.13 -170.2 25.46 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.817 -0.706 . . . . 74.32 113.94 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' MET . . . . . 0.512 ' HE2' ' HA ' ' A' ' 510' ' ' MET . 0.1 OUTLIER -89.85 117.13 28.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.776 0.43 . . . . 72.51 111.033 178.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -119.02 143.28 47.16 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.059 0.457 . . . . 73.42 111.347 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 57.5 ttp180 -123.52 120.16 32.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.562 -0.29 . . . . 71.52 110.748 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 62.6 mt -95.07 120.45 44.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 73.2 110.755 178.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 18.2 m120 -118.92 132.98 56.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.311 -0.404 . . . . 65.44 111.093 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.8 137.39 49.8 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.8 0.333 . . . . 75.34 110.774 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' THR . . . . . 0.535 HG23 HG23 ' A' ' 532' ' ' VAL . 39.7 p -122.81 140.37 52.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.017 -0.538 . . . . 75.21 110.936 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 440' ' ' LEU . 14.9 p -115.53 141.69 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.538 -0.301 . . . . 72.35 111.353 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.1 t70 48.1 58.58 4.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.946 0.879 . . . . 72.14 110.199 -170.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . 0.701 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 2.6 mm-40 -55.33 -32.89 62.86 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.925 -1.034 . . . . 73.23 113.172 -176.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -77.22 -12.55 59.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.541 0.21 . . . . 74.34 111.493 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 54.63 69.75 0.69 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.687 0.756 . . . . 64.11 110.847 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 80.4 p -100.3 -7.0 25.05 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.234 -0.894 . . . . 72.13 112.01 -174.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.3 p -140.12 142.01 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.954 0.407 . . . . 74.32 111.926 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 80.3 t -83.89 118.87 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.477 -0.329 . . . . 64.14 110.523 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.61 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 19.7 mt-10 -110.71 174.62 5.78 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.044 0.757 . . . . 73.33 113.044 -173.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.32 -39.36 93.74 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.771 -0.65 . . . . 73.3 112.304 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -145.15 108.62 4.64 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.895 0.379 . . . . 74.14 111.325 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . 0.448 ' HA ' ' OD1' ' A' ' 531' ' ' ASN . 12.6 pt-20 -83.68 21.84 1.19 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.979 0.419 . . . . 73.24 111.796 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -107.49 -19.19 13.64 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.453 0.538 . . . . 75.11 112.453 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -99.71 12.73 35.86 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.571 0.582 . . . . 71.41 112.571 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 528' ' ' GLU . 15.0 m120 -77.79 -5.02 49.38 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.325 0.491 . . . . 72.03 112.325 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . 0.535 HG23 HG23 ' A' ' 516' ' ' THR . 41.2 t -127.94 133.25 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 120.901 0.382 . . . . 72.12 111.639 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -114.33 141.81 47.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.546 -0.297 . . . . 65.31 111.057 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 52.4 m -122.67 122.33 38.54 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.205 0.446 . . . . 70.33 112.205 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -137.74 117.16 12.82 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.286 -0.415 . . . . 74.42 110.041 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 1.1 p30 -97.88 136.32 38.35 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.511 0.672 . . . . 75.32 112.302 -177.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.59 142.1 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.317 -0.856 . . . . 71.31 111.515 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.5 t -104.05 123.31 46.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.161 -0.472 . . . . 73.53 110.977 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 50.6 t -103.15 120.72 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.767 0.317 . . . . 73.14 111.373 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.7 m -114.36 159.55 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.269 0.557 . . . . 72.52 112.194 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 90.2 mt -82.36 0.21 42.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.123 -0.489 . . . . 74.43 112.192 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 C--O 1.251 1.147 0 N-CA-C 112.471 0.545 . . . . 73.44 112.471 -174.472 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.598 0.237 . . . . 75.14 110.96 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -86.6 124.68 33.16 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.808 0.337 . . . . 55.04 110.928 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -114.11 144.34 31.43 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.398 -0.364 . . . . 75.14 110.891 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.482 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 2.8 Cg_exo -74.99 174.41 12.83 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.014 2.476 . . . . 64.05 113.69 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -154.85 81.64 1.09 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.296 -0.866 . . . . 75.15 109.003 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.497 HD12 HG13 ' A' ' 470' ' ' VAL . 69.5 mt -86.72 127.94 34.99 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.857 -0.611 . . . . 74.51 111.811 -173.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.596 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.5 t -130.48 156.28 45.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.046 0.45 . . . . 74.35 111.762 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.545 HG13 HG11 ' A' ' 462' ' ' VAL . 31.6 m -132.8 147.78 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.972 -0.558 . . . . 74.43 111.586 -177.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 54.9 mt-10 -133.04 139.64 47.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.453 -0.34 . . . . 74.52 111.151 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 58.4 mt -109.21 129.22 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.972 0.415 . . . . 74.0 111.472 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -131.28 131.0 43.54 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.508 -0.315 . . . . 75.22 111.335 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 167.11 -168.49 40.42 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.486 -0.864 . . . . 74.34 113.871 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.52 122.8 7.67 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.802 2.335 . . . . 64.41 113.179 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -70.72 -33.19 70.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.234 -0.439 . . . . 75.22 111.501 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.3 t -120.83 132.01 71.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.775 0.321 . . . . 64.44 111.267 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.2 m -132.56 163.29 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.112 0.482 . . . . 65.33 111.712 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -94.71 149.49 19.38 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.234 -0.508 . . . . 71.54 112.849 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.494 HG22 ' ND2' ' A' ' 453' ' ' ASN . 11.2 p -63.28 137.46 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-O 120.906 0.384 . . . . 73.21 111.829 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . 0.494 ' ND2' HG22 ' A' ' 452' ' ' VAL . 55.4 m-80 62.07 25.23 15.11 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.996 0.519 . . . . 64.44 112.392 -178.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -111.73 162.46 15.2 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.964 0.411 . . . . 72.15 111.577 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 502' ' ' SER . 50.6 tp -90.5 128.04 36.42 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.843 0.354 . . . . 73.34 111.583 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.33 143.05 49.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.793 0.33 . . . . 74.12 111.38 177.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -122.74 144.51 49.11 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.945 0.402 . . . . 70.12 111.491 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -132.05 157.55 43.86 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.007 0.432 . . . . 72.24 111.296 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -120.52 127.74 52.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.858 -0.61 . . . . 75.12 110.738 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.95 116.13 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.37 -0.377 . . . . 64.21 111.319 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.553 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 30.2 m-70 -93.22 113.98 26.33 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.399 -0.364 . . . . 74.42 110.652 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.598 HG12 HG22 ' A' ' 475' ' ' VAL . 17.8 m -116.08 122.42 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.781 0.324 . . . . 62.35 110.751 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 496' ' ' GLU . 0.7 OUTLIER -139.93 154.47 47.23 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.064 0.765 . . . . 74.01 113.064 -176.768 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.545 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.4 t-20 -103.03 128.6 49.82 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.119 -0.946 . . . . 74.5 110.386 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 88.6 mt -115.32 4.87 14.52 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.078 0.399 . . . . 73.0 112.078 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -85.75 -23.86 44.52 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.248 -0.501 . . . . 74.44 113.43 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.44 17.8 58.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.959 -0.639 . . . . 75.31 113.68 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 12.2 tt -137.37 141.73 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 122.57 0.348 . . . . 72.5 110.617 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . 0.46 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -65.68 136.31 36.1 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.139 -0.553 . . . . 74.31 113.612 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.497 HG13 HD12 ' A' ' 440' ' ' LEU . 38.5 t -129.88 112.97 17.48 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 112.515 0.561 . . . . 63.21 112.515 -176.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.77 -11.41 12.64 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.236 2.624 . . . . 63.43 112.22 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 70.1 m -80.18 11.61 3.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.5 0.72 . . . . 73.34 112.161 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 33.5 m -88.28 90.83 8.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.849 0.833 . . . . 75.14 111.073 -169.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -106.02 123.16 47.56 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.194 -0.912 . . . . 61.11 110.272 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.598 HG22 HG12 ' A' ' 462' ' ' VAL . 39.2 t -103.71 121.02 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.826 0.346 . . . . 70.34 110.904 -177.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 476' ' ' ARG . 33.3 ttm180 -129.13 144.96 51.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.694 0.283 . . . . 75.31 111.656 -174.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 66.3 t -120.5 130.27 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.071 0.463 . . . . 71.2 111.722 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -119.52 137.04 54.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.96 -0.564 . . . . 74.4 111.177 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.492 HG12 HG12 ' A' ' 513' ' ' ILE . 59.2 mt -111.94 107.76 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.712 0.292 . . . . 72.34 110.32 174.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 57.29 34.87 25.38 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.929 0.395 . . . . 52.14 111.31 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.95 -2.18 85.47 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.336 -0.459 . . . . 37.34 113.398 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 63.1 m -90.25 123.42 34.03 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.606 -0.349 . . . . 71.45 111.389 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 44.4 tp -63.88 115.06 4.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.98 0.419 . . . . 74.14 111.0 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -105.05 -44.05 4.89 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.102 0.779 . . . . 72.0 113.102 -175.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -165.88 161.02 17.45 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 122.168 -0.332 . . . . 72.4 111.17 -172.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . 0.537 ' N ' HD21 ' A' ' 486' ' ' ASN . 0.0 OUTLIER -161.1 154.32 21.46 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.826 0.676 . . . . 74.02 112.826 177.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -136.0 149.79 48.97 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.687 0.795 . . . . 72.4 110.44 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.2 m -115.08 119.41 36.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.9 0.381 . . . . 74.45 111.21 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.9 m -137.57 173.56 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.158 0.504 . . . . 73.22 111.695 -176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 95.3 p -125.57 135.11 51.88 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.871 0.367 . . . . 75.25 110.882 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.477 HD11 HD23 ' A' ' 440' ' ' LEU . 94.9 mt -117.63 120.1 37.01 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.455 -0.339 . . . . 75.31 111.24 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.46 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -77.78 -170.09 34.62 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.223 -0.513 . . . . 42.41 113.279 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.56 97.03 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.341 2.027 . . . . 74.45 112.445 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.6 mttt 66.29 59.61 0.65 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.853 0.835 . . . . 74.55 111.791 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -120.85 152.94 37.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.046 -0.979 . . . . 74.31 110.651 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 39.5 tt0 -134.63 137.25 43.5 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.936 0.398 . . . . 71.04 111.931 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.425 ' HG2' ' CD2' ' A' ' 491' ' ' LEU . 28.5 mmmt -116.94 150.3 38.74 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.203 -0.453 . . . . 75.45 110.241 174.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.4 113.56 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.925 0.393 . . . . 72.14 111.555 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 77.9 mt -110.51 136.07 50.21 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.24 -0.436 . . . . 74.51 111.314 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 41.0 p -117.91 150.62 38.91 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.094 0.473 . . . . 70.24 111.943 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -145.63 151.61 38.35 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.248 -0.433 . . . . 74.42 111.02 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.522 ' HB2' HD11 ' A' ' 455' ' ' LEU . 72.9 p -111.67 141.47 45.22 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.28 -0.418 . . . . 75.33 111.297 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.5 t90 -139.34 137.49 35.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.281 -0.418 . . . . 74.35 111.094 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.1 m -118.2 100.43 51.75 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-O 120.758 0.313 . . . . 74.14 111.277 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.99 102.99 1.63 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.519 2.146 . . . . 75.14 112.841 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 81.1 p -81.58 -1.21 45.57 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.167 0.432 . . . . 74.55 112.167 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -137.24 145.74 43.94 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.711 0.291 . . . . 74.3 111.316 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.459 ' HA ' ' HB ' ' A' ' 539' ' ' VAL . 0.3 OUTLIER -83.19 152.03 25.41 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.516 0.561 . . . . 74.53 112.516 -177.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.63 -176.32 30.07 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.038 -0.601 . . . . 63.12 113.694 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' MET . . . . . 0.523 ' HE2' ' HA ' ' A' ' 510' ' ' MET . 1.2 tpt -92.56 106.28 18.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.536 0.335 . . . . 72.43 110.669 178.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -107.66 121.9 45.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.179 0.514 . . . . 74.3 111.795 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . 0.489 ' HD2' HG21 ' A' ' 534' ' ' THR . 19.6 tpp85 -94.21 112.74 24.56 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.188 -0.46 . . . . 74.14 111.52 177.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.492 HG12 HG12 ' A' ' 479' ' ' ILE . 40.6 mt -98.75 127.24 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.068 0.461 . . . . 74.3 110.858 175.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -124.09 138.15 54.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.335 -0.393 . . . . 73.54 111.553 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.94 132.48 54.73 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.832 -0.433 . . . . 75.15 109.832 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 38.9 p -132.93 141.1 48.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.352 -0.385 . . . . 75.51 111.497 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.7 p -110.55 140.05 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.762 0.315 . . . . 72.24 110.949 175.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.2 t0 43.98 67.9 0.6 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.517 0.675 . . . . 75.21 111.594 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -55.8 -31.67 62.85 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.821 -0.627 . . . . 72.54 112.246 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.435 ' HB2' HG23 ' A' ' 522' ' ' THR . 8.4 mm-40 -78.17 -19.29 54.25 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.276 -0.42 . . . . 73.44 111.518 -178.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 62.16 46.62 6.14 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.742 0.782 . . . . 73.15 110.011 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' THR . . . . . 0.435 HG23 ' HB2' ' A' ' 520' ' ' GLU . 52.1 p -67.59 -37.76 83.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.486 -0.779 . . . . 73.35 111.588 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.426 HG21 ' HG2' ' A' ' 438' ' ' PRO . 10.7 p -102.33 143.91 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 116.096 -0.502 . . . . 74.45 110.993 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . 0.438 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 59.1 t -81.87 115.62 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.992 0.425 . . . . 74.13 111.119 -177.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -91.75 155.96 17.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.888 -0.596 . . . . 73.22 112.32 -173.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.19 -39.53 78.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.145 0.498 . . . . 73.53 110.472 173.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -133.92 113.35 12.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.832 -0.622 . . . . 73.3 110.495 174.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -83.17 -3.43 57.36 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.318 0.58 . . . . 74.12 111.379 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -92.54 -1.64 56.79 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.982 0.42 . . . . 75.43 111.306 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.596 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 65.5 t30 -95.82 -6.65 39.0 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 116.345 -0.388 . . . . 70.34 112.0 -174.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -83.66 3.92 30.83 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.54 0.941 . . . . 71.21 113.54 -173.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 52.4 t -126.86 142.21 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 112.798 0.666 . . . . 74.22 112.798 -173.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . 0.464 ' HB2' HG23 ' A' ' 442' ' ' VAL . . . -128.58 143.96 51.06 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.119 -0.491 . . . . 71.41 111.232 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' THR . . . . . 0.489 HG21 ' HD2' ' A' ' 512' ' ' ARG . 59.6 m -120.66 134.12 55.31 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 111.94 0.348 . . . . 72.01 111.94 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -142.5 136.88 29.8 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 120.713 0.292 . . . . 74.31 111.067 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -104.87 125.01 50.45 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.662 0.268 . . . . 70.32 111.692 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.6 t -114.3 128.77 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.8 0.333 . . . . 73.4 111.28 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 30.1 t -112.88 121.59 45.12 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.655 0.264 . . . . 71.31 111.02 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 508' ' ' GLU . 41.9 t -98.93 131.43 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.691 0.281 . . . . 73.15 111.353 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.42 ' HB ' ' HG2' ' A' ' 542' ' ' GLU . 28.8 m -113.16 156.32 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.226 0.454 . . . . 74.21 112.226 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 94.9 mt -95.57 -13.36 24.48 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.323 -0.399 . . . . 74.3 111.652 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . 0.42 ' HG2' ' HB ' ' A' ' 540' ' ' VAL . 8.3 pt-20 . . . . . 0 C--O 1.249 1.055 0 N-CA-C 112.449 0.537 . . . . 61.21 112.449 -176.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 110.226 -0.287 . . . . 72.31 110.226 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.625 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 59.2 Cg_endo -75.41 175.18 11.6 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.577 2.184 . . . . 65.22 113.399 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -153.58 81.59 1.17 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.847 -0.615 . . . . 75.52 110.194 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.514 HD22 HD12 ' A' ' 491' ' ' LEU . 96.6 mt -81.34 145.09 31.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.22 0.534 . . . . 63.22 111.833 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.556 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 12.0 t -148.55 156.37 42.34 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.103 0.478 . . . . 64.4 111.672 176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.537 HG12 HG12 ' A' ' 462' ' ' VAL . 27.9 m -125.76 147.95 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.941 -0.572 . . . . 71.54 110.871 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 40.2 mt-10 -134.57 117.98 16.75 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.854 0.359 . . . . 63.32 111.623 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 59.5 mt -94.21 131.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.406 -0.361 . . . . 72.52 110.727 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -142.44 138.85 31.34 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.632 0.253 . . . . 75.02 111.486 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.62 -162.39 32.44 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.017 -0.611 . . . . 73.33 113.51 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.46 124.52 10.42 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.886 2.391 . . . . 55.54 113.189 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -85.72 -15.81 41.01 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.123 0.416 . . . . 62.15 112.123 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.483 HG22 ' HB3' ' A' ' 538' ' ' SER . 87.2 t -133.01 126.61 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 120.711 0.291 . . . . 72.52 110.574 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.61 163.4 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.02 0.438 . . . . 71.22 111.648 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.17 157.52 26.03 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.165 -0.541 . . . . 63.53 113.012 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.1 p -72.34 140.49 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.006 0.432 . . . . 65.24 111.393 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 19.6 m120 60.23 23.81 13.19 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.658 0.383 . . . . 73.41 111.936 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' LYS . . . . . 0.569 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -112.3 155.62 23.78 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.545 -0.298 . . . . 74.35 111.075 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 502' ' ' SER . 33.5 tp -90.55 139.81 30.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.878 0.37 . . . . 72.45 111.568 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -131.89 143.59 50.26 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.847 0.356 . . . . 60.34 111.608 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -111.32 126.09 54.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.103 0.478 . . . . 62.22 111.643 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -121.96 150.27 42.27 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.152 -0.476 . . . . 73.22 110.729 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.553 ' HG2' HG22 ' A' ' 500' ' ' THR . 37.8 mt-10 -121.8 128.08 51.29 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.129 -0.487 . . . . 73.55 111.384 -176.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 42.6 t -107.65 114.74 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.183 -0.462 . . . . 62.22 111.229 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 42.0 m-70 -90.49 111.55 22.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.722 0.296 . . . . 74.22 110.377 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.681 HG11 HG21 ' A' ' 475' ' ' VAL . 31.6 m -107.82 122.81 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.005 0.431 . . . . 71.22 110.36 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -141.69 152.86 44.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.586 0.707 . . . . 73.21 112.765 -173.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 49.1 t-20 -100.8 138.68 37.53 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.159 -0.928 . . . . 71.23 109.758 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 94.4 mt -120.94 -5.58 9.58 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.409 0.522 . . . . 73.3 112.409 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -77.83 -25.19 62.96 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.211 -0.518 . . . . 34.22 114.047 -176.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.62 15.98 59.15 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.243 -0.503 . . . . 74.12 113.776 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.2 tt -134.66 142.69 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.113 0.565 . . . . 71.43 110.736 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.82 140.78 35.22 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.322 0.489 . . . . 64.44 114.322 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.508 HG11 HD11 ' A' ' 440' ' ' LEU . 47.0 t -131.85 114.3 15.28 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 122.454 0.301 . . . . 55.35 111.671 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -88.84 -10.57 4.19 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 123.196 2.597 . . . . 70.01 113.281 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 84.9 p -85.0 13.27 6.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.636 0.775 . . . . 72.11 112.876 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 63.3 m -87.4 93.35 9.38 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.909 0.861 . . . . 70.32 112.32 -165.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -97.44 127.28 43.27 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.144 -0.934 . . . . 52.0 110.441 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.681 HG21 HG11 ' A' ' 462' ' ' VAL . 47.7 t -114.06 125.1 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.673 0.273 . . . . 71.22 111.079 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 476' ' ' ARG . . . . . 0.491 ' HD2' ' OE1' ' A' ' 519' ' ' GLU . 62.8 mtt85 -125.52 149.79 47.99 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.99 0.424 . . . . 55.43 111.812 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.87 127.09 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.125 0.488 . . . . 73.3 111.436 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -120.37 136.8 54.59 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.932 -0.577 . . . . 70.54 111.384 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.414 HG12 HG12 ' A' ' 513' ' ' ILE . 60.1 mt -109.0 107.87 23.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.22 -0.446 . . . . 74.22 109.982 175.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 57.43 34.9 25.3 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.123 0.487 . . . . 74.22 111.214 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.57 -5.86 84.22 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 116.122 -0.49 . . . . 74.01 113.848 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 42.3 m -93.34 125.63 38.04 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.051 0.426 . . . . 53.24 111.33 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.1 tp -65.72 117.56 8.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.115 0.413 . . . . 62.33 112.115 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -88.74 -45.21 9.97 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.535 -0.302 . . . . 74.22 111.449 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -169.99 161.98 8.98 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.671 0.272 . . . . 54.03 111.4 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -131.93 152.04 51.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.038 0.447 . . . . 64.24 111.595 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -134.54 147.27 50.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.029 -0.532 . . . . 74.11 110.864 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.0 m -121.36 119.21 31.48 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.116 -0.328 . . . . 44.42 110.116 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.5 172.81 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.154 0.502 . . . . 75.3 111.476 -176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 91.5 p -126.0 132.44 52.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.252 -0.431 . . . . 55.45 110.649 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.514 HD12 HD22 ' A' ' 440' ' ' LEU . 95.9 mt -118.23 119.74 35.59 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.842 0.353 . . . . 73.34 111.373 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -78.45 -165.49 27.77 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.056 -0.593 . . . . 70.43 112.975 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.24 95.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.084 1.856 . . . . 63.45 112.413 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.0 mttt 65.78 44.05 2.97 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.646 -0.706 . . . . 60.41 112.61 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -98.43 152.57 19.36 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.089 -0.505 . . . . 73.53 111.347 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -130.72 138.8 50.16 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.934 0.397 . . . . 72.33 111.694 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -119.55 138.76 52.98 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.948 -0.39 . . . . 61.2 109.948 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.01 113.24 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.021 0.439 . . . . 51.24 111.801 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 82.3 mt -103.88 146.46 28.62 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.288 -0.414 . . . . 71.33 111.267 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.553 HG22 ' HG2' ' A' ' 459' ' ' GLU . 43.4 p -127.06 156.76 41.16 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.189 0.518 . . . . 64.01 111.803 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -155.56 148.23 24.12 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.97 -0.559 . . . . 75.03 111.031 171.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.558 ' HB3' HD11 ' A' ' 455' ' ' LEU . 43.3 m -110.98 115.23 29.13 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.297 -0.411 . . . . 72.54 110.849 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -108.54 135.03 50.48 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.818 0.342 . . . . 73.5 111.763 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.3 m -116.14 100.68 53.7 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 116.39 -0.368 . . . . 71.13 111.262 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 505' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 74.5 Cg_endo -76.17 97.36 1.11 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.388 2.059 . . . . 72.53 112.881 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 67.0 p -76.71 -22.61 53.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.104 0.409 . . . . 70.12 112.104 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -107.33 138.58 43.26 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.843 0.354 . . . . 73.31 110.803 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' A' ' 508' ' ' GLU . 0.2 OUTLIER -85.74 140.41 30.52 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.285 0.565 . . . . 65.04 112.189 -174.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 148.49 -179.13 25.58 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.89 -0.595 . . . . 70.51 112.153 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 67.6 mtp -94.02 126.35 39.19 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.8 -0.824 . . . . 51.3 111.664 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.93 131.61 53.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.122 -0.49 . . . . 71.22 111.126 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 512' ' ' ARG . . . . . 0.515 ' HG2' ' ND2' ' A' ' 514' ' ' ASN . 33.0 ttm180 -97.24 122.01 39.78 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.914 0.388 . . . . 73.41 111.263 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.414 HG12 HG12 ' A' ' 479' ' ' ILE . 63.1 mt -100.58 119.59 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.03 0.443 . . . . 63.43 110.951 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.515 ' ND2' ' HG2' ' A' ' 512' ' ' ARG . 44.4 m-80 -115.82 151.87 34.41 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.04 0.448 . . . . 74.32 111.712 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -128.12 132.8 48.94 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.063 -0.517 . . . . 43.45 110.547 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 44.0 p -128.89 143.14 50.81 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.317 -0.401 . . . . 75.04 111.292 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.415 HG13 HD22 ' A' ' 531' ' ' ASN . 7.4 p -119.9 141.13 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.019 0.437 . . . . 61.1 111.697 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 21.8 t70 50.23 49.75 19.94 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.632 0.773 . . . . 72.2 112.632 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 519' ' ' GLU . . . . . 0.491 ' OE1' ' HD2' ' A' ' 476' ' ' ARG . 54.6 mt-10 -53.0 -29.45 29.29 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.247 0.546 . . . . 73.11 111.171 172.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.47 ' HB2' HG23 ' A' ' 522' ' ' THR . 0.0 OUTLIER -65.24 -17.3 64.38 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.655 -0.702 . . . . 64.13 110.933 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 56.91 56.57 5.27 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.243 0.544 . . . . 64.15 110.394 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 522' ' ' THR . . . . . 0.47 HG23 ' HB2' ' A' ' 520' ' ' GLU . 64.5 p -83.9 -36.66 23.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.207 -0.451 . . . . 71.53 111.413 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.22 141.68 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.459 0.54 . . . . 74.4 112.459 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 57.8 t -85.09 119.43 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.197 -0.456 . . . . 70.32 110.461 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.625 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 25.5 mt-10 -115.14 174.8 5.8 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.992 0.738 . . . . 74.32 112.992 -174.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.06 -39.65 55.0 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.511 -0.768 . . . . 73.54 112.286 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -120.07 118.66 31.19 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.207 0.527 . . . . 45.35 111.346 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.78 -20.84 32.6 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.345 0.593 . . . . 64.44 111.495 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -93.39 -4.38 51.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.227 0.537 . . . . 74.25 111.339 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.556 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 62.5 t30 -86.73 -10.79 52.88 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 120.982 0.42 . . . . 63.22 111.72 -174.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 531' ' ' ASN . . . . . 0.415 HD22 HG13 ' A' ' 517' ' ' VAL . 12.4 m120 -85.02 1.45 47.57 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.117 0.784 . . . . 74.3 113.117 -173.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.2 t -127.46 136.93 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 112.38 0.511 . . . . 62.21 112.38 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -125.44 141.19 52.19 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.269 -0.423 . . . . 55.01 110.883 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 84.4 m -127.59 119.7 26.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.168 0.433 . . . . 61.2 112.168 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -126.22 123.38 38.05 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.822 0.344 . . . . 71.5 110.847 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -94.38 120.56 34.8 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.877 0.37 . . . . 75.55 111.848 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.9 t -112.68 141.26 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.191 0.519 . . . . 72.52 111.94 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 538' ' ' SER . . . . . 0.483 ' HB3' HG22 ' A' ' 449' ' ' VAL . 40.2 t -113.79 115.88 28.48 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.296 -0.411 . . . . 74.53 111.031 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 43.6 t -99.8 120.83 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.859 0.362 . . . . 73.23 111.05 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.6 164.5 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.498 0.555 . . . . 72.33 112.498 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.4 mt -77.73 -30.86 51.85 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.356 0.502 . . . . 71.12 112.356 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--O 1.251 1.167 0 N-CA-C 112.383 0.512 . . . . 75.25 112.383 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 CA--C 1.533 0.291 0 CA-C-O 120.547 0.213 . . . . 74.34 110.461 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.576 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 61.3 Cg_endo -71.73 175.73 9.2 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.711 2.274 . . . . 75.53 112.789 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -151.6 83.66 1.29 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.123 -0.49 . . . . 70.03 109.872 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.532 HD22 HD12 ' A' ' 491' ' ' LEU . 80.0 mt -83.23 99.15 9.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.014 -0.539 . . . . 73.34 111.132 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.479 HG23 ' HG3' ' A' ' 463' ' ' LYS . 6.5 t -116.64 149.62 39.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.451 . . . . 51.13 111.149 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.602 HG12 HG12 ' A' ' 462' ' ' VAL . 31.4 m -121.37 148.56 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.263 -0.426 . . . . 63.43 111.227 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.3 mt-10 -130.01 117.74 20.51 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.628 0.251 . . . . 71.25 111.388 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 55.4 mt -92.47 131.05 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 110.456 -0.202 . . . . 63.11 110.456 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -142.45 144.51 33.08 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.541 0.21 . . . . 74.32 111.23 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.32 -159.3 29.04 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.989 -0.624 . . . . 74.43 113.38 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.69 134.22 21.71 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.906 2.404 . . . . 71.24 113.22 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -92.3 -20.25 21.3 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.433 0.531 . . . . 73.52 112.433 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.1 t -127.97 125.75 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.959 -0.463 . . . . 75.31 111.241 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 33.6 m -135.65 161.27 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.982 0.42 . . . . 75.11 111.32 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -95.51 166.49 25.39 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.061 -0.59 . . . . 65.14 113.012 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 12.4 p -69.93 139.27 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 O-C-N 122.277 -0.543 . . . . 73.43 111.409 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 20.2 m120 63.6 17.95 10.75 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.913 0.485 . . . . 43.4 112.166 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' LYS . . . . . 0.534 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.8 mmmt -95.15 150.85 19.75 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.857 0.361 . . . . 70.55 110.812 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' A' ' 502' ' ' SER . 37.6 tp -96.69 118.97 34.28 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.7 0.286 . . . . 64.12 111.004 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.06 134.74 54.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.886 0.374 . . . . 73.22 111.715 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -108.55 130.05 55.3 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.0 0.428 . . . . 73.34 111.45 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -122.33 166.44 14.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.088 0.47 . . . . 74.45 111.488 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -121.19 127.5 51.56 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.975 -0.557 . . . . 53.43 111.24 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 29.8 t -104.83 113.04 40.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 41.43 110.024 173.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 29.9 m-70 -98.34 106.22 18.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.648 0.261 . . . . 75.52 110.512 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.602 HG12 HG12 ' A' ' 442' ' ' VAL . 19.4 m -105.8 123.48 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.2 0.524 . . . . 64.12 110.104 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.548 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.2 ptpt -139.89 144.18 37.05 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.517 0.562 . . . . 62.14 112.517 -170.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.4 t-20 -102.76 126.7 49.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.191 -0.67 . . . . 71.11 109.191 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.548 HD21 ' HD3' ' A' ' 463' ' ' LYS . 67.9 mt -112.69 0.15 15.25 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.011 -0.43 . . . . 75.22 112.034 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -83.87 -21.47 57.5 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.073 -0.584 . . . . 63.12 113.797 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.61 21.4 47.8 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.07 -0.586 . . . . 34.31 113.861 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.402 HG23 ' HB3' ' A' ' 438' ' ' PRO . 3.7 tt -138.1 133.77 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 122.662 -0.316 . . . . 70.53 111.076 175.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.1 141.41 34.28 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 114.684 0.634 . . . . 72.23 114.684 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.67 116.27 16.02 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.834 0.454 . . . . 61.13 111.344 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.71 -12.17 11.19 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.056 2.504 . . . . 74.4 113.086 175.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 50.7 m -81.59 13.51 3.06 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.587 0.755 . . . . 71.05 112.79 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' THR . . . . . 0.424 HG23 HG21 ' A' ' 517' ' ' VAL . 62.9 m -86.56 91.15 8.47 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 122.119 0.962 . . . . 62.44 111.465 -165.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -95.08 121.7 36.99 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.698 -1.137 . . . . 74.34 110.364 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.544 HG21 HG11 ' A' ' 462' ' ' VAL . 41.4 t -104.31 118.24 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.001 0.429 . . . . 54.32 111.291 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -116.58 144.37 44.46 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.642 0.258 . . . . 72.42 111.555 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 95.6 t -120.17 120.25 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.801 0.334 . . . . 64.44 110.881 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -116.08 137.39 52.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.25 -0.432 . . . . 74.05 111.387 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.485 HG12 HG12 ' A' ' 513' ' ' ILE . 63.3 mt -111.85 107.94 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.799 -0.445 . . . . 42.03 109.799 174.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 480' ' ' ASN . . . . . 0.401 HD21 ' HA ' ' A' ' 511' ' ' TYR . 95.9 m-20 56.27 34.44 24.04 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.093 0.473 . . . . 75.24 111.183 -173.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.9 -20.65 47.88 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 116.252 -0.431 . . . . 54.42 113.732 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 45.5 m -81.93 121.71 26.84 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.357 -0.496 . . . . 75.41 111.81 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -63.91 120.32 11.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.077 0.465 . . . . 65.34 111.555 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -102.91 -43.89 5.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.201 -0.454 . . . . 74.12 111.982 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -146.91 152.53 38.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.583 0.23 . . . . 65.22 111.107 -174.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -145.3 139.15 26.87 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.103 0.478 . . . . 73.41 111.496 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -129.7 148.86 51.63 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.121 -0.49 . . . . 75.31 110.709 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 78.5 m -117.62 118.48 32.24 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.69 0.281 . . . . 72.21 110.244 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.1 m -141.8 173.43 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.283 0.563 . . . . 61.43 111.765 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 64.9 m -121.35 135.48 55.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.121 -0.49 . . . . 72.31 110.914 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.532 HD12 HD22 ' A' ' 440' ' ' LEU . 85.1 mt -118.11 119.85 35.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.806 0.336 . . . . 65.33 111.072 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -82.72 -169.03 43.6 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.326 -0.464 . . . . 61.02 113.449 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.51 107.88 0.64 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.417 2.078 . . . . 54.12 112.7 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.0 mmtp 68.45 29.21 5.79 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.126 -0.488 . . . . 75.24 111.596 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -92.2 147.4 22.96 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.369 -0.378 . . . . 71.31 111.728 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -135.12 129.35 33.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.605 0.362 . . . . 71.43 111.479 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.404 ' HG2' ' CD2' ' A' ' 491' ' ' LEU . 30.2 mmmt -116.79 136.63 52.8 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.677 0.275 . . . . 74.12 110.704 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 63.1 t -101.77 113.54 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 121.199 0.523 . . . . 61.34 111.488 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 68.7 mt -110.7 131.15 55.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.97 -0.559 . . . . 45.14 110.489 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 26.6 p -113.9 154.7 27.08 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.267 0.556 . . . . 71.22 112.32 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -144.4 148.8 35.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.645 -0.707 . . . . 64.14 110.816 174.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.509 ' HB2' HD11 ' A' ' 455' ' ' LEU . 76.0 p -115.04 114.36 25.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.065 0.46 . . . . 72.23 110.805 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -113.56 137.18 51.94 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.24 -0.436 . . . . 61.24 112.002 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.4 m -116.24 102.03 53.72 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.093 -0.503 . . . . 51.41 111.222 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 505' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 60.7 Cg_endo -71.92 99.38 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.534 2.156 . . . . 74.21 112.955 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 33.1 p -74.04 -21.88 59.77 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.944 0.402 . . . . 75.34 111.907 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -112.36 141.19 46.39 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.413 -0.358 . . . . 71.44 111.107 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.68 151.18 23.64 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.257 0.551 . . . . 75.23 111.926 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 148.02 -170.97 28.6 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.06 -0.591 . . . . 70.15 112.77 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 13.7 tpt -98.76 120.83 39.87 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.503 -0.41 . . . . 74.32 110.729 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 511' ' ' TYR . . . . . 0.401 ' HA ' HD21 ' A' ' 480' ' ' ASN . 96.1 m-85 -120.23 116.22 25.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.899 0.38 . . . . 71.21 111.701 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -92.47 112.94 25.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.901 0.381 . . . . 72.14 110.482 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.485 HG12 HG12 ' A' ' 479' ' ' ILE . 58.1 mt -93.8 117.34 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.254 0.55 . . . . 75.31 110.907 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -117.05 134.66 54.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 73.42 111.1 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.35 133.16 53.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.733 0.301 . . . . 53.53 110.646 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 516' ' ' THR . . . . . 0.575 HG22 HG22 ' A' ' 532' ' ' VAL . 66.5 p -125.41 140.32 52.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.99 0.424 . . . . 73.33 111.61 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.424 HG21 HG23 ' A' ' 473' ' ' THR . 7.4 p -120.29 140.83 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.814 0.34 . . . . 72.14 111.022 174.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.6 t0 43.43 58.74 3.3 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.393 0.677 . . . . 71.31 112.778 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -57.75 -29.99 65.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.608 0.718 . . . . 74.33 110.475 171.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.62 -17.3 64.56 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.259 -0.882 . . . . 73.44 111.791 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 19.7 m120 51.4 55.4 9.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.671 0.748 . . . . 70.43 111.306 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 51.1 p -67.21 -19.72 65.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.377 -0.829 . . . . 74.22 111.363 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.22 141.13 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.188 -0.46 . . . . 61.31 111.749 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 74.0 t -83.58 119.78 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 110.069 -0.345 . . . . 74.31 110.069 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.576 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 18.9 mt-10 -110.24 -175.03 2.63 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.699 0.629 . . . . 73.04 112.699 -171.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 99.2 mt -69.48 -39.26 77.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.275 -0.42 . . . . 64.15 111.209 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -126.73 124.85 40.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.343 -0.39 . . . . 63.01 110.864 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -83.2 -23.98 32.61 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.848 0.314 . . . . 74.5 111.848 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -103.49 4.2 35.71 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.631 0.604 . . . . 71.33 112.631 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.474 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.7 t30 -86.62 -1.75 57.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.087 0.47 . . . . 74.22 111.373 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -80.85 -1.06 41.69 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.677 0.621 . . . . 74.14 112.677 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 516' ' ' THR . 56.6 t -124.53 129.61 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.112 0.412 . . . . 61.12 112.112 -176.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 533' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -114.3 142.86 45.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.342 -0.39 . . . . 42.32 111.162 177.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 63.2 m -116.22 130.14 56.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.36 -0.382 . . . . 51.21 111.963 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -142.88 117.64 9.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.443 -0.344 . . . . 71.24 110.28 174.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -96.34 134.31 39.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.185 0.516 . . . . 60.43 112.277 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.03 138.12 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.086 -0.506 . . . . 74.21 111.52 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.3 t -104.26 127.28 51.87 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.597 -0.274 . . . . 75.04 111.422 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 47.1 t -111.35 126.61 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.803 0.335 . . . . 73.01 111.258 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 28.8 m -121.04 164.3 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.596 0.591 . . . . 72.52 112.596 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 79.6 mt -88.26 11.06 17.55 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.508 0.558 . . . . 72.54 112.508 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--O 1.251 1.179 0 N-CA-C 112.369 0.507 . . . . 52.3 112.369 -176.688 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 120.597 0.236 . . . . 71.11 110.759 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.587 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 74.4 Cg_endo -81.77 175.96 8.86 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.944 2.429 . . . . 75.23 113.433 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -155.73 86.79 1.06 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.051 -0.522 . . . . 73.31 109.997 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.531 HD22 HD12 ' A' ' 491' ' ' LEU . 75.7 mt -89.0 105.37 17.74 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.975 0.417 . . . . 62.32 111.981 -176.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.707 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 8.0 t -113.14 152.12 30.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.2 0.524 . . . . 74.14 111.804 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.633 HG12 HG12 ' A' ' 462' ' ' VAL . 33.5 m -124.35 147.88 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.788 -0.642 . . . . 63.55 111.123 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 41.7 mt-10 -133.47 142.31 48.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.691 -0.231 . . . . 73.05 111.263 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 58.2 mt -111.59 129.77 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.723 0.297 . . . . 75.43 111.077 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -133.02 133.9 43.7 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.25 -0.281 . . . . 75.04 111.202 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.38 -170.94 39.75 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.89 -0.672 . . . . 65.33 113.5 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.14 126.87 13.54 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.702 2.268 . . . . 64.03 113.079 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -77.9 -19.99 53.72 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.058 0.392 . . . . 73.04 112.058 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.67 127.94 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.438 0.295 . . . . 54.51 110.38 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.84 163.93 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.28 0.562 . . . . 72.02 111.885 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.14 153.74 20.34 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.229 -0.51 . . . . 72.32 113.253 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.461 HG11 HD23 ' A' ' 541' ' ' LEU . 14.4 p -68.47 141.76 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.626 0.25 . . . . 72.21 111.236 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 59.97 21.44 10.51 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.058 0.456 . . . . 73.15 111.808 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -107.26 165.08 11.64 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.011 0.434 . . . . 75.42 111.483 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 502' ' ' SER . 29.4 tp -103.77 117.37 34.2 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.415 -0.357 . . . . 74.33 111.341 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.94 133.27 56.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.687 0.28 . . . . 71.2 111.509 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -110.7 133.76 53.05 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.081 0.467 . . . . 72.22 111.836 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -123.49 163.25 21.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.94 -0.573 . . . . 72.34 111.144 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -119.86 127.31 52.62 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.854 0.359 . . . . 75.34 110.569 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.47 112.96 36.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.69 -0.485 . . . . 71.4 109.69 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 30.7 m-70 -96.21 107.83 20.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.425 -0.352 . . . . 73.22 110.661 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.633 HG12 HG12 ' A' ' 442' ' ' VAL . 14.4 m -108.97 122.0 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.139 0.495 . . . . 51.24 110.451 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.481 ' HG3' HG23 ' A' ' 441' ' ' THR . 4.6 ptpp? -138.63 144.2 39.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.382 0.611 . . . . 71.41 112.253 -173.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 51.6 t-20 -99.96 127.3 46.17 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.599 -0.728 . . . . 71.4 109.808 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.427 HD21 ' HD3' ' A' ' 463' ' ' LYS . 82.7 mt -111.92 -1.9 15.33 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.958 0.355 . . . . 63.12 111.958 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -81.71 -15.72 74.88 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.388 -0.434 . . . . 63.35 113.831 -178.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.88 20.4 65.57 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 120.938 -0.649 . . . . 73.03 113.854 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.418 HG23 ' HB3' ' A' ' 438' ' ' PRO . 5.8 tt -138.47 135.03 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 122.731 -0.276 . . . . 74.55 111.412 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -66.88 134.88 32.27 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 114.123 0.409 . . . . 52.41 114.123 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 440' ' ' LEU . 86.9 t -129.6 116.75 18.41 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 122.651 0.38 . . . . 71.31 111.842 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.2 -10.44 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.085 2.523 . . . . 65.32 113.143 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.8 t -80.62 12.52 3.06 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.149 0.58 . . . . 71.24 112.469 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' THR . . . . . 0.432 HG23 HG21 ' A' ' 517' ' ' VAL . 67.7 m -87.61 91.09 8.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.958 0.885 . . . . 74.3 111.803 -166.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 517' ' ' VAL . 91.4 mttt -94.5 124.15 38.35 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.956 -1.02 . . . . 64.41 110.29 173.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.589 HG21 HG11 ' A' ' 462' ' ' VAL . 41.3 t -110.19 119.61 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.721 0.296 . . . . 70.42 111.005 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 476' ' ' ARG . . . . . 0.419 ' NH1' ' HB2' ' A' ' 519' ' ' GLU . 71.8 mtt180 -122.5 146.81 47.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 111.79 0.293 . . . . 73.04 111.79 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.8 t -120.65 124.18 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.044 0.45 . . . . 75.13 111.186 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -111.78 137.15 50.1 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.976 -0.557 . . . . 65.03 110.704 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.542 HG12 HG12 ' A' ' 513' ' ' ILE . 59.8 mt -117.37 108.67 25.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.854 0.359 . . . . 65.34 111.34 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 66.2 t30 60.06 34.1 21.31 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.266 0.555 . . . . 72.45 111.462 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 97.65 -12.79 64.47 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.274 -0.489 . . . . 44.33 114.031 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 89.8 m -105.21 127.07 52.75 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.332 0.566 . . . . 62.45 111.75 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.7 tp -61.98 128.0 34.06 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.943 0.401 . . . . 73.53 110.855 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -105.38 -43.6 4.94 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.644 0.609 . . . . 61.01 112.644 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -162.75 159.33 24.05 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.272 -0.267 . . . . 74.32 111.02 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -145.53 157.2 44.03 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.894 0.378 . . . . 61.23 111.753 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 -137.2 148.75 46.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.191 -0.459 . . . . 75.3 110.754 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 51.8 m -117.96 118.04 30.89 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.881 0.372 . . . . 64.31 110.168 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.12 174.55 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.21 0.528 . . . . 72.22 111.752 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 89.9 p -129.39 140.08 51.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.148 -0.478 . . . . 71.51 110.608 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.531 HD12 HD22 ' A' ' 440' ' ' LEU . 79.4 mt -117.44 121.49 41.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.852 0.358 . . . . 70.11 111.752 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -78.41 -172.18 40.1 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.357 -0.449 . . . . 71.12 113.08 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.16 110.54 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.45 2.1 . . . . 53.44 112.906 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 39.5 mmtm 67.0 26.63 9.01 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.986 -0.552 . . . . 74.21 111.929 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -99.2 146.89 25.69 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.109 -0.496 . . . . 73.31 112.064 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 496' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 41.6 tt0 -129.07 145.77 51.19 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.103 0.478 . . . . 63.23 111.937 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.417 ' HG2' ' CD2' ' A' ' 491' ' ' LEU . 31.8 mmmt -121.6 137.18 54.85 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.784 -0.45 . . . . 74.41 109.784 172.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 52.9 t -101.04 112.12 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.139 0.495 . . . . 72.12 110.814 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 57.8 mt -103.15 146.57 28.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.989 -0.551 . . . . 62.22 110.714 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 20.0 p -130.21 155.31 46.47 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.549 0.69 . . . . 63.43 112.591 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.26 148.65 26.1 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.32 -0.855 . . . . 60.12 110.21 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.521 ' HB2' HD11 ' A' ' 455' ' ' LEU . 51.8 p -116.88 114.79 24.38 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.911 0.386 . . . . 44.31 110.984 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -104.15 136.72 43.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.262 -0.426 . . . . 73.51 111.896 -174.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.6 m -117.43 100.7 52.86 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 116.39 -0.368 . . . . 52.42 111.096 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 505' ' ' PRO . . . . . 0.424 ' HB2' HG11 ' A' ' 539' ' ' VAL . 90.7 Cg_endo -81.16 100.14 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.751 2.3 . . . . 64.11 113.072 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.9 p -78.57 -29.64 46.35 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.268 0.47 . . . . 74.32 112.268 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -100.43 131.67 46.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.832 0.349 . . . . 64.03 110.73 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.412 ' HG2' HD21 ' A' ' 541' ' ' LEU . 0.3 OUTLIER -87.36 150.37 23.88 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.11 0.481 . . . . 73.22 112.068 -176.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.79 -170.38 29.91 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.365 -0.445 . . . . 51.35 112.924 -178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 14.9 tpt -91.6 124.54 35.84 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 122.437 -0.449 . . . . 74.31 111.565 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -128.4 151.96 48.76 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.985 0.421 . . . . 74.33 111.258 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 512' ' ' ARG . . . . . 0.424 ' HG2' ' ND2' ' A' ' 514' ' ' ASN . 40.2 ttm180 -124.18 119.72 30.22 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.104 -0.372 . . . . 52.22 111.615 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.542 HG12 HG12 ' A' ' 479' ' ' ILE . 52.6 mt -95.95 126.77 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.019 0.438 . . . . 61.22 111.306 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.424 ' ND2' ' HG2' ' A' ' 512' ' ' ARG . 40.5 m-80 -123.01 145.21 48.7 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.989 0.423 . . . . 75.32 111.575 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.68 134.26 53.76 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.185 -0.461 . . . . 74.43 110.309 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 50.5 p -136.93 151.37 48.96 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.955 0.407 . . . . 71.4 111.945 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 474' ' ' LYS . 7.8 p -128.92 149.8 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 116.26 -0.427 . . . . 72.43 111.722 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 17.2 t70 47.9 43.53 17.57 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.71 0.767 . . . . 65.42 111.741 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 519' ' ' GLU . . . . . 0.419 ' HB2' ' NH1' ' A' ' 476' ' ' ARG . 6.9 mm-40 -51.4 -30.94 20.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.68 -0.691 . . . . 65.25 111.627 174.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -23.65 66.33 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.807 -0.633 . . . . 75.1 110.678 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 62.59 82.11 0.19 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.249 0.619 . . . . 75.33 110.303 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 53.8 p -109.45 -26.95 9.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 72.41 111.637 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.04 141.59 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 112.978 0.733 . . . . 62.11 112.978 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 99.0 t -84.6 114.5 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.141 -0.481 . . . . 74.44 110.296 172.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 27.3 mt-10 -101.78 176.8 5.1 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.636 0.606 . . . . 74.35 112.636 -174.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.15 -39.61 86.99 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.904 -0.589 . . . . 71.15 110.944 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 527' ' ' ASN . . . . . 0.561 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 32.2 t30 -141.55 93.19 2.54 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.371 0.605 . . . . 64.15 110.302 173.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.55 14.95 3.37 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.064 -0.516 . . . . 64.4 112.212 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -104.62 -3.44 23.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.718 0.771 . . . . 72.11 109.67 167.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.707 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.1 t30 -86.55 -0.65 56.56 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.418 -0.81 . . . . 74.4 111.355 -174.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -83.76 -6.86 59.53 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.882 0.697 . . . . 73.44 112.882 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.49 138.45 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.215 0.45 . . . . 75.41 112.215 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.08 142.84 50.57 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.215 -0.448 . . . . 63.2 111.183 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.4 m -126.77 133.91 50.73 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.665 0.269 . . . . 73.34 111.626 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -143.15 129.73 20.19 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.818 0.342 . . . . 74.34 111.08 177.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -93.6 134.7 35.61 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.877 0.37 . . . . 74.11 111.883 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 63.0 t -128.83 128.36 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.044 0.449 . . . . 44.04 111.43 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 46.6 t -103.82 120.88 41.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.77 0.319 . . . . 72.53 111.078 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.424 HG11 ' HB2' ' A' ' 505' ' ' PRO . 48.7 t -99.23 120.08 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.896 0.379 . . . . 72.24 111.321 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.442 HG23 ' H ' ' A' ' 542' ' ' GLU . 35.0 m -119.49 167.74 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.183 0.516 . . . . 74.44 112.116 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 541' ' ' LEU . . . . . 0.461 HD23 HG11 ' A' ' 452' ' ' VAL . 98.0 mt -80.4 25.94 0.39 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.215 0.45 . . . . 74.3 112.215 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 542' ' ' GLU . . . . . 0.442 ' H ' HG23 ' A' ' 540' ' ' VAL . 41.7 mt-10 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.545 -0.741 . . . . 64.43 111.914 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 120.756 0.313 . . . . 74.02 110.425 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.424 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 86.7 Cg_endo -79.86 174.19 11.93 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.707 2.271 . . . . 65.43 114.046 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.0 93.97 2.99 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.424 -0.807 . . . . 74.13 109.471 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.4 HD11 HG11 ' A' ' 470' ' ' VAL . 98.4 mt -98.07 108.21 20.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.872 0.368 . . . . 71.15 111.348 -175.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 8.7 t -123.34 152.68 41.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.136 0.493 . . . . 61.13 111.669 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.516 HG12 HG12 ' A' ' 462' ' ' VAL . 34.8 m -120.87 147.85 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.972 -0.558 . . . . 51.03 110.846 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.629 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 43.1 mt-10 -130.28 137.18 49.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.666 -0.243 . . . . 55.04 110.747 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.05 138.02 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.146 0.498 . . . . 61.34 111.689 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -137.1 146.1 44.7 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.049 -0.523 . . . . 74.45 110.97 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.64 -171.2 33.63 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.674 -0.774 . . . . 61.25 114.025 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.04 123.45 8.38 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.819 2.346 . . . . 73.01 112.712 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.48 -13.32 52.34 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.397 0.517 . . . . 72.21 112.397 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 80.2 t -131.38 122.96 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.653 0.263 . . . . 73.44 110.75 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 31.2 m -135.81 163.19 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.172 0.511 . . . . 54.34 111.802 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -100.78 163.91 18.59 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 116.188 -0.46 . . . . 41.5 112.979 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.91 144.01 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 122.496 -0.414 . . . . 74.22 111.339 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 17.8 m120 60.17 17.61 7.06 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.221 0.452 . . . . 73.25 112.221 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' LYS . . . . . 0.442 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.1 mmmt -103.82 138.84 39.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.923 0.392 . . . . 62.2 111.299 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 502' ' ' SER . 36.2 tp -85.39 125.35 32.91 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.194 -0.457 . . . . 52.32 111.251 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -124.79 136.66 54.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.917 0.389 . . . . 70.54 111.81 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.33 133.94 46.43 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.049 0.452 . . . . 65.44 111.746 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' TYR . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 86.1 m-85 -122.31 150.93 41.68 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.205 -0.452 . . . . 70.34 111.03 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -120.88 127.23 51.68 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.951 -0.568 . . . . 41.23 110.875 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.6 t -113.68 127.47 71.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 122.785 0.434 . . . . 64.25 111.212 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.629 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 77.7 m-70 -107.75 110.67 22.55 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.812 0.339 . . . . 72.55 110.594 176.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.617 HG11 HG21 ' A' ' 475' ' ' VAL . 33.6 m -107.47 124.27 63.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 120.896 0.379 . . . . 64.33 110.304 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.543 ' HD3' HD21 ' A' ' 465' ' ' LEU . 13.4 ptpt -143.73 153.75 42.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.159 0.8 . . . . 64.54 113.159 -170.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 48.9 t-20 -112.0 126.45 55.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.355 -0.839 . . . . 70.23 109.47 173.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.543 HD21 ' HD3' ' A' ' 463' ' ' LYS . 47.1 mt -114.28 5.16 15.69 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.867 0.365 . . . . 52.55 111.658 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -82.36 -20.14 62.96 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.308 -0.472 . . . . 54.41 113.682 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.84 14.91 62.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.021 -0.609 . . . . 42.14 113.603 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.9 tt -135.94 133.46 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 122.52 0.328 . . . . 43.55 111.119 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.36 139.86 28.6 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 114.172 0.429 . . . . 72.24 114.172 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 440' ' ' LEU . 52.8 t -130.36 114.35 17.12 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 111.95 0.352 . . . . 65.12 111.95 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.28 -11.33 13.32 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.982 2.455 . . . . 73.33 112.755 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 472' ' ' SER . . . . . 0.494 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 20.1 m -80.55 11.38 3.77 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.658 0.783 . . . . 65.22 112.773 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 39.9 m -89.53 91.92 8.89 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.652 0.739 . . . . 65.23 112.316 -165.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -101.9 126.75 48.87 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.403 -0.817 . . . . 71.15 110.357 171.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.617 HG21 HG11 ' A' ' 462' ' ' VAL . 55.6 t -112.62 128.97 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.813 0.339 . . . . 54.14 111.286 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 476' ' ' ARG . . . . . 0.543 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 82.6 mtt180 -115.63 151.22 35.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.78 0.324 . . . . 75.24 111.312 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.3 t -121.31 120.21 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.835 0.35 . . . . 53.5 111.08 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -114.29 144.67 42.87 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.277 -0.419 . . . . 74.11 111.553 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.538 HG12 HG12 ' A' ' 513' ' ' ILE . 55.2 mt -123.6 107.93 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.115 -0.493 . . . . 60.34 109.73 173.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 53.42 39.14 29.48 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 120.88 0.371 . . . . 72.14 111.84 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 85.63 -0.96 88.31 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.097 -0.573 . . . . 52.51 114.066 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 94.4 m -98.51 120.45 38.95 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.25 0.525 . . . . 73.0 111.401 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 59.7 tp -69.7 115.04 8.48 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.189 0.518 . . . . 73.3 111.376 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -90.03 -43.28 10.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.121 -0.491 . . . . 75.31 111.754 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -167.32 162.25 14.72 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.664 0.268 . . . . 64.44 111.516 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -147.49 152.6 38.33 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.688 0.28 . . . . 73.2 111.139 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 24.7 m-90 -130.0 134.77 47.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.818 0.342 . . . . 74.43 110.764 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 57.1 m -104.38 118.12 35.84 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.731 0.3 . . . . 72.33 110.257 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 22.3 m -140.83 172.85 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.343 0.592 . . . . 71.44 111.489 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 79.6 p -118.51 135.05 54.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.94 -0.573 . . . . 72.12 110.281 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.1 mt -116.96 119.68 36.08 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.886 0.374 . . . . 64.44 110.882 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -80.3 -177.35 50.9 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.079 -0.582 . . . . 51.42 113.116 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.56 108.75 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.476 2.117 . . . . 73.32 112.457 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.2 mmtp 67.91 32.98 4.9 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.14 -0.482 . . . . 72.14 111.816 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -101.33 148.61 24.95 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 111.92 0.341 . . . . 61.12 111.92 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 496' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 14.4 tt0 -131.8 143.68 50.38 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.428 -0.351 . . . . 70.42 111.206 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.406 ' HB3' ' NZ ' ' A' ' 497' ' ' LYS . 2.3 mmmp? -124.67 134.85 52.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.72 0.295 . . . . 74.13 110.575 175.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.06 117.57 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.244 0.545 . . . . 71.14 111.295 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 52.4 mt -114.07 146.7 39.87 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.038 -0.528 . . . . 73.23 110.861 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 33.3 p -129.41 154.47 46.91 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.27 0.557 . . . . 64.02 112.026 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 501' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.1 p90 -148.01 149.49 32.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.779 -0.646 . . . . 73.02 110.651 173.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.552 ' HB3' HD11 ' A' ' 455' ' ' LEU . 43.0 m -110.11 115.29 29.49 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.013 0.435 . . . . 62.34 110.333 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -118.05 136.58 53.47 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.969 0.414 . . . . 75.22 112.043 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.7 m -119.11 112.27 36.34 Favored Pre-proline 0 N--CA 1.472 0.653 0 CA-C-N 116.17 -0.468 . . . . 74.32 111.121 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 505' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 67.4 Cg_endo -75.06 118.85 5.4 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.418 2.079 . . . . 70.41 112.684 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 42.1 p -92.22 0.75 57.47 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.788 0.662 . . . . 64.11 112.788 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -143.75 145.93 32.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.701 0.286 . . . . 65.21 110.835 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -79.32 150.28 31.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.125 0.488 . . . . 71.1 111.148 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.76 -170.31 30.58 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.256 -0.497 . . . . 75.3 112.542 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 510' ' ' MET . . . . . 0.459 ' SD ' ' C ' ' A' ' 510' ' ' MET . 0.0 OUTLIER -96.43 111.14 23.35 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.93 0.395 . . . . 51.1 110.481 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -115.21 111.5 21.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.068 0.461 . . . . 61.31 111.644 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -96.31 124.85 40.46 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.901 0.381 . . . . 70.12 111.135 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.538 HG12 HG12 ' A' ' 479' ' ' ILE . 57.9 mt -98.55 124.1 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.214 -0.448 . . . . 70.22 111.127 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 52.1 m-80 -122.61 138.47 54.58 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.026 0.441 . . . . 71.53 111.415 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.08 132.89 54.57 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.596 -0.275 . . . . 62.43 110.443 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 516' ' ' THR . . . . . 0.541 HG22 HG22 ' A' ' 532' ' ' VAL . 54.1 p -123.47 140.34 53.1 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.875 0.369 . . . . 73.44 111.768 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.42 147.73 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.77 0.319 . . . . 74.03 111.319 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 37.9 t70 57.38 42.23 25.14 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.611 0.72 . . . . 74.03 111.81 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 519' ' ' GLU . . . . . 0.543 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.2 mm-40 -56.22 -32.55 64.54 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.966 -0.459 . . . . 71.24 111.481 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -67.71 -19.39 65.15 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.259 -0.428 . . . . 71.31 111.64 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 65.52 78.94 0.26 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.093 0.473 . . . . 71.14 111.306 -175.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 522' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 44.7 p -132.81 -13.54 2.86 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.061 0.763 . . . . 71.51 113.061 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.9 p -134.64 143.63 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.167 0.508 . . . . 62.22 112.272 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 68.0 t -100.73 117.96 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.343 -0.389 . . . . 74.12 111.096 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -92.64 175.31 6.86 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.242 0.544 . . . . 73.33 111.4 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.57 -29.97 59.5 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.114 -0.494 . . . . 73.54 110.828 172.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -135.35 145.42 47.37 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.697 -0.683 . . . . 60.33 110.239 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.23 2.33 10.85 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.303 0.483 . . . . 54.21 112.303 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -87.25 -4.12 59.07 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.791 0.329 . . . . 61.1 111.708 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -111.83 -2.85 15.1 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.442 0.534 . . . . 63.35 112.442 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -69.67 -17.6 63.5 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.213 0.449 . . . . 74.33 112.213 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 516' ' ' THR . 41.1 t -124.13 131.99 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.672 0.272 . . . . 54.11 111.121 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 533' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -113.63 138.49 50.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.659 0.266 . . . . 54.1 111.083 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 50.0 m -112.18 127.65 56.01 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.123 0.416 . . . . 72.45 112.123 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -134.86 126.85 29.6 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.37 -0.377 . . . . 62.02 110.303 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.98 124.92 39.31 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.081 0.4 . . . . 53.1 112.081 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.18 128.45 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.139 0.495 . . . . 71.4 111.301 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.6 t -105.37 120.12 40.78 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.256 -0.277 . . . . 75.31 110.726 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 53.7 t -104.7 128.58 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.911 0.386 . . . . 75.34 111.871 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.83 160.08 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 116.337 -0.392 . . . . 73.02 111.546 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.57 -17.03 61.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.141 0.423 . . . . 74.13 112.141 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--O 1.252 1.233 0 N-CA-C 112.104 0.409 . . . . 72.44 112.104 -178.845 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 109.855 -0.424 . . . . 73.53 109.855 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 60.4 Cg_endo -73.45 173.91 13.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.25 1.966 . . . . 71.44 113.96 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -152.95 109.13 3.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.156 -0.929 . . . . 73.31 109.462 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 491' ' ' LEU . 83.1 mt -105.36 156.85 17.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 72.45 111.171 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.642 HG23 ' HG3' ' A' ' 463' ' ' LYS . 2.0 t -161.28 149.89 15.97 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.037 0.446 . . . . 71.11 112.026 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.577 HG12 HG12 ' A' ' 462' ' ' VAL . 35.8 m -121.11 147.67 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.03 -0.532 . . . . 73.13 111.621 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -139.56 135.39 33.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.112 -0.494 . . . . 64.3 111.153 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 59.2 mt -109.18 131.36 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.534 0.206 . . . . 61.55 110.958 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -133.78 145.17 49.53 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.479 0.181 . . . . 63.13 110.952 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.39 -171.2 34.06 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 120.797 -0.716 . . . . 52.43 113.999 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.54 123.1 9.84 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.956 2.437 . . . . 71.31 112.991 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -83.58 -8.76 59.25 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.286 0.476 . . . . 75.02 112.286 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 73.3 t -131.67 120.87 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 122.342 -0.224 . . . . 71.53 110.783 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 450' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 32.9 m -135.4 164.15 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.054 0.454 . . . . 75.31 111.853 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -94.89 162.33 24.03 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.3 -0.476 . . . . 34.14 113.439 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.407 HG22 ' OD1' ' A' ' 453' ' ' ASN . 8.4 p -74.26 140.71 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 O-C-N 122.436 -0.45 . . . . 71.01 111.484 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 453' ' ' ASN . . . . . 0.407 ' OD1' HG22 ' A' ' 452' ' ' VAL . 22.2 m120 59.4 16.57 5.22 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.227 0.611 . . . . 70.14 112.056 -177.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -98.75 157.9 15.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.995 0.426 . . . . 75.42 111.394 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 502' ' ' SER . 26.8 tp -96.07 130.94 42.96 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.343 -0.389 . . . . 72.14 111.2 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -134.91 134.39 40.61 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.519 0.2 . . . . 63.24 111.339 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -100.31 133.05 45.3 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.351 0.596 . . . . 62.33 111.921 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -122.66 164.0 19.04 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.735 -0.666 . . . . 64.44 110.633 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' A' ' 500' ' ' THR . 57.2 mt-10 -121.32 127.7 51.56 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.108 0.48 . . . . 75.51 111.965 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 52.7 t -100.03 113.78 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.068 -0.514 . . . . 74.12 110.062 172.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -99.35 110.45 22.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 74.13 110.699 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.75 HG11 HG21 ' A' ' 475' ' ' VAL . 30.5 m -110.72 122.95 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.079 0.466 . . . . 63.51 110.517 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.642 ' HG3' HG23 ' A' ' 441' ' ' THR . 3.0 ptpp? -135.44 151.39 50.37 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.785 0.661 . . . . 53.14 112.785 -173.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 51.2 t-20 -106.19 128.37 53.88 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.296 -0.865 . . . . 72.11 109.761 175.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.443 HD21 ' HD3' ' A' ' 463' ' ' LYS . 73.6 mt -107.61 -23.32 12.18 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.91 0.337 . . . . 63.41 111.91 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -60.22 -25.97 63.16 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 114.604 0.602 . . . . 44.44 114.604 -173.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.53 17.49 58.47 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.831 -0.7 . . . . 74.41 113.271 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.6 tt -137.73 140.92 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 122.785 0.434 . . . . 72.35 110.85 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.441 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -67.43 136.29 31.89 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.204 0.442 . . . . 44.31 114.204 -176.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.405 HG11 HD11 ' A' ' 440' ' ' LEU . 46.7 t -127.4 113.7 21.27 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-O 120.799 0.333 . . . . 72.14 111.339 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -88.36 -9.73 4.95 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.267 2.645 . . . . 74.2 113.095 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 472' ' ' SER . . . . . 0.461 ' HB2' ' OG1' ' A' ' 522' ' ' THR . 93.2 p -87.79 11.95 14.16 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.5 0.926 . . . . 43.53 113.5 -173.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 60.3 m -87.85 108.58 19.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.605 0.717 . . . . 63.21 112.825 -164.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -112.12 131.03 55.69 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.437 -0.801 . . . . 62.12 111.181 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.75 HG21 HG11 ' A' ' 462' ' ' VAL . 41.5 t -111.23 137.24 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 122.458 0.303 . . . . 74.5 111.564 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -131.52 143.08 50.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.468 0.307 . . . . 62.52 111.495 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 96.5 t -120.96 122.89 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.863 0.363 . . . . 73.22 111.278 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -113.37 139.29 49.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.867 0.467 . . . . 53.31 110.831 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.423 HG12 HG12 ' A' ' 513' ' ' ILE . 56.7 mt -119.65 111.15 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.68 0.276 . . . . 74.12 110.28 176.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 55.05 34.02 21.61 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.297 -0.41 . . . . 63.23 111.807 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 101.06 -29.14 13.16 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 116.327 -0.397 . . . . 44.25 113.581 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 91.0 m -81.92 125.82 31.19 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 122.411 -0.464 . . . . 74.4 111.899 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.79 114.54 5.12 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.267 0.556 . . . . 73.23 110.815 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -88.43 -43.97 11.08 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.319 0.489 . . . . 73.23 112.319 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -167.02 160.51 14.17 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.589 0.218 . . . . 64.44 111.589 -175.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -141.65 152.94 44.39 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.914 0.388 . . . . 72.41 111.741 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -131.84 148.94 52.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.76 0.424 . . . . 61.31 111.346 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 81.4 m -115.46 119.19 35.38 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.487 -0.324 . . . . 74.4 110.147 173.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.34 173.86 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.442 0.639 . . . . 51.44 112.261 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 88.1 p -129.28 133.6 47.55 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.866 -0.606 . . . . 63.31 110.378 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.536 HD12 HD22 ' A' ' 440' ' ' LEU . 96.1 mt -117.26 120.45 38.28 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.985 0.422 . . . . 74.24 111.45 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 492' ' ' GLY . . . . . 0.441 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -84.09 -177.62 51.47 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.066 -0.588 . . . . 71.22 112.882 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.53 107.68 0.22 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.876 2.384 . . . . 71.54 113.04 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 74.3 mmtt 67.01 34.43 5.16 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.045 -0.525 . . . . 73.3 112.04 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -102.41 151.85 21.79 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.372 0.508 . . . . 72.21 112.372 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 496' ' ' GLU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 34.9 tt0 -133.87 141.44 47.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.089 0.471 . . . . 73.43 111.345 173.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -116.85 131.65 56.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.149 -0.478 . . . . 52.13 109.835 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 57.2 t -100.03 113.26 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.234 0.54 . . . . 64.45 111.312 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 47.6 mt -105.87 146.15 30.31 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.834 -0.621 . . . . 73.43 111.106 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.414 HG22 ' HG2' ' A' ' 459' ' ' GLU . 32.0 p -125.23 154.84 41.01 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.274 0.559 . . . . 70.52 111.947 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -154.76 150.54 27.67 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.829 -0.623 . . . . 72.14 110.588 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.556 ' HB2' HD11 ' A' ' 455' ' ' LEU . 79.6 p -109.93 114.3 27.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.018 0.437 . . . . 71.33 110.641 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 503' ' ' TRP . . . . . 0.403 ' HZ3' HG11 ' A' ' 537' ' ' VAL . 33.0 t90 -108.59 138.19 45.3 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.884 -0.598 . . . . 74.42 111.947 -174.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 94.7 m -124.31 109.0 29.25 Favored Pre-proline 0 N--CA 1.473 0.69 0 CA-C-N 116.109 -0.496 . . . . 73.23 111.56 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.37 119.32 3.77 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.787 2.324 . . . . 75.54 112.918 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 66.5 p -89.31 13.77 12.69 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.255 0.465 . . . . 73.11 112.255 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 507' ' ' GLN . . . . . 0.621 ' HB3' ' OH ' ' A' ' 511' ' ' TYR . 25.9 tt0 -143.14 142.02 31.36 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.746 0.418 . . . . 62.13 110.474 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -88.47 135.87 33.27 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.105 0.479 . . . . 74.41 110.883 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.85 -166.99 29.9 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.087 -0.577 . . . . 70.32 112.872 -175.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 96.2 mmm -83.97 120.62 26.33 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.167 0.508 . . . . 73.53 112.319 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 511' ' ' TYR . . . . . 0.621 ' OH ' ' HB3' ' A' ' 507' ' ' GLN . 48.9 m-85 -118.62 113.62 21.51 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.155 -0.475 . . . . 64.34 111.446 175.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 512' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 512' ' ' ARG . 15.7 ttm180 -96.48 111.38 23.51 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.914 0.388 . . . . 64.32 110.687 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.423 HG12 HG12 ' A' ' 479' ' ' ILE . 57.6 mt -96.52 113.81 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.023 0.44 . . . . 75.02 111.409 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 52.0 m-80 -107.59 151.84 25.08 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.929 0.395 . . . . 53.42 111.725 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -134.79 136.87 42.89 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.767 0.317 . . . . 63.22 111.074 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 58.1 p -129.17 152.37 48.83 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.215 -0.448 . . . . 50.22 111.034 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.14 141.82 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.212 0.529 . . . . 72.24 111.898 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 2.8 t0 48.78 44.33 21.66 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.832 0.853 . . . . 64.54 112.471 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -51.75 -30.06 21.12 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.232 0.539 . . . . 64.02 111.181 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 522' ' ' THR . 0.9 OUTLIER -66.92 -16.99 64.69 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.66 -0.7 . . . . 71.12 111.431 -176.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 27.4 m120 59.75 44.82 13.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.379 0.609 . . . . 64.13 111.213 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 522' ' ' THR . . . . . 0.461 ' OG1' ' HB2' ' A' ' 472' ' ' SER . 57.0 p -67.03 -39.47 87.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.83 -0.623 . . . . 42.54 111.581 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.417 HG21 ' HG3' ' A' ' 438' ' ' PRO . 12.5 p -115.28 143.57 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 116.146 -0.479 . . . . 73.43 111.844 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 524' ' ' VAL . . . . . 0.518 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 52.2 t -83.27 117.05 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 122.164 -0.335 . . . . 65.53 111.007 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -103.35 177.63 4.79 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.789 0.662 . . . . 74.45 112.789 -175.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.16 -39.06 18.29 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.662 -0.699 . . . . 74.45 112.339 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -114.97 164.2 14.49 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.216 0.531 . . . . 72.54 112.284 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -125.01 -7.43 7.19 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.088 0.47 . . . . 72.31 111.695 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -107.46 16.88 23.4 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.63 0.604 . . . . 74.43 112.63 -173.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.565 ' HB2' ' HB ' ' A' ' 441' ' ' THR . 6.8 p-10 -114.78 -17.77 11.51 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.258 1.207 . . . . 62.43 114.258 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -89.37 17.81 5.82 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.62 0.97 . . . . 74.34 113.62 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.41 134.27 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.062 0.458 . . . . 72.54 111.511 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 533' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -128.37 141.89 51.28 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.501 -0.318 . . . . 54.23 111.176 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.0 m -129.32 121.6 27.83 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.889 0.329 . . . . 71.13 111.889 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -121.78 126.11 48.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.804 0.335 . . . . 75.44 110.873 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.75 119.21 32.43 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.888 0.375 . . . . 74.43 111.742 -177.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.403 HG11 ' HZ3' ' A' ' 503' ' ' TRP . 48.2 t -112.66 134.99 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.269 0.557 . . . . 75.1 111.924 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 31.0 t -108.83 114.32 28.0 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.965 -0.561 . . . . 55.13 110.543 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 40.4 t -102.19 125.79 56.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.994 0.426 . . . . 72.23 111.775 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 542' ' ' GLU . 28.2 m -115.17 168.34 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 115.89 -0.595 . . . . 63.14 111.434 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 70.9 mt -71.38 1.34 6.41 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.132 0.79 . . . . 74.53 113.132 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 542' ' ' GLU . . . . . 0.408 ' H ' HG23 ' A' ' 540' ' ' VAL . 6.0 pt-20 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 112.318 0.488 . . . . 74.05 112.318 -176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 CA--C 1.542 0.637 0 CA-C-O 120.703 0.287 . . . . 75.41 110.793 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.706 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 58.9 Cg_endo -73.05 175.63 10.22 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.158 2.572 . . . . 55.41 114.236 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -153.7 86.84 1.21 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.578 -0.737 . . . . 72.02 109.706 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.538 HD22 HD12 ' A' ' 491' ' ' LEU . 88.7 mt -90.09 109.68 20.72 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.119 0.485 . . . . 64.22 112.193 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.424 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.6 t -113.2 152.84 29.23 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.127 -0.358 . . . . 72.54 111.722 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.579 HG12 HG12 ' A' ' 462' ' ' VAL . 28.3 m -128.42 148.86 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.18 0.514 . . . . 64.45 112.154 -176.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.594 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 44.2 mt-10 -129.35 146.66 51.18 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.177 -0.465 . . . . 62.14 111.47 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 62.1 mt -110.01 135.16 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.026 0.441 . . . . 72.51 110.722 173.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.565 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 63.6 tttp -135.12 145.03 47.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.357 -0.383 . . . . 65.43 110.521 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 154.64 -167.08 32.51 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.282 -0.961 . . . . 63.14 114.341 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.474 ' HD2' ' CZ ' ' A' ' 458' ' ' TYR . 16.5 Cg_exo -65.66 141.02 64.6 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.312 2.675 . . . . 53.43 113.776 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.28 -52.2 5.34 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.84 0.456 . . . . 74.24 111.236 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 538' ' ' SER . 59.4 t -116.31 127.15 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.691 -0.231 . . . . 60.1 110.717 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.15 163.21 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.007 0.432 . . . . 61.3 111.972 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.69 155.81 25.1 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.2 -0.455 . . . . 74.22 112.921 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.517 HG22 ' ND2' ' A' ' 453' ' ' ASN . 13.2 p -67.96 143.61 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.119 0.485 . . . . 72.24 111.839 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' ASN . . . . . 0.517 ' ND2' HG22 ' A' ' 452' ' ' VAL . 55.7 m-80 61.81 21.26 12.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.018 -0.537 . . . . 54.25 112.268 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 454' ' ' LYS . . . . . 0.541 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.7 mmmt -103.18 150.75 23.37 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.017 0.437 . . . . 73.21 111.732 177.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 502' ' ' SER . 48.7 tp -93.86 119.38 32.72 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.338 -0.392 . . . . 73.12 111.344 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.59 133.03 54.99 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.706 0.288 . . . . 50.44 111.584 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.95 137.73 38.93 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.115 0.483 . . . . 65.32 111.688 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' TYR . . . . . 0.474 ' CZ ' ' HD2' ' A' ' 447' ' ' PRO . 10.3 m-85 -122.27 162.23 21.85 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.67 -0.696 . . . . 74.05 110.76 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 445' ' ' LYS . 51.9 mt-10 -120.38 127.3 52.17 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.998 0.427 . . . . 72.21 111.661 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 28.9 t -101.95 114.02 40.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.212 -0.449 . . . . 60.22 109.9 171.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.594 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 12.2 m-70 -101.3 110.6 22.63 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.702 0.287 . . . . 74.51 110.736 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.579 HG12 HG12 ' A' ' 442' ' ' VAL . 14.5 m -119.59 137.54 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.069 0.461 . . . . 74.11 110.917 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.22 152.87 37.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.1 0.476 . . . . 75.32 111.764 -176.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.5 t-20 -99.87 127.44 46.04 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.052 -0.522 . . . . 75.3 110.12 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 82.0 mt -110.29 -7.93 14.78 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.971 0.36 . . . . 52.22 111.971 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -76.59 -23.12 70.98 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.182 -0.533 . . . . 41.4 113.447 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.48 22.7 53.27 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.021 -0.609 . . . . 72.12 113.546 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.2 tt -139.71 136.96 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.594 0.358 . . . . 51.34 111.362 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.555 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -69.57 135.54 27.06 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 114.94 0.736 . . . . 74.12 114.94 -175.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.41 115.37 16.08 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 122.816 0.446 . . . . 63.22 111.632 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.38 -11.46 10.7 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.052 2.502 . . . . 64.32 113.251 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 45.6 m -81.14 11.35 4.26 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.256 0.622 . . . . 42.12 112.592 -175.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' THR . . . . . 0.45 HG23 HD13 ' A' ' 440' ' ' LEU . 56.5 m -86.88 98.98 11.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.828 0.823 . . . . 33.12 111.973 -162.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -108.24 123.04 48.16 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.119 -0.946 . . . . 74.41 111.195 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.528 HG21 HG11 ' A' ' 462' ' ' VAL . 46.2 t -104.24 123.7 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.379 -0.373 . . . . 55.21 110.72 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 476' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 515' ' ' ALA . 83.2 mtt180 -114.9 145.99 41.61 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.713 0.292 . . . . 74.23 111.75 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.63 119.73 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.995 0.426 . . . . 63.54 111.085 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -112.2 145.11 40.47 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.37 -0.377 . . . . 73.55 111.149 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.77 107.54 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.952 -0.388 . . . . 74.12 109.952 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 56.63 33.87 23.51 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.054 0.454 . . . . 75.45 111.365 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 100.08 -30.97 9.02 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.432 -0.414 . . . . 41.32 113.679 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 85.4 m -82.02 119.2 23.69 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.393 -0.475 . . . . 74.02 111.787 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.4 tp -62.57 115.03 3.91 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.063 0.458 . . . . 74.33 111.342 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -87.29 -43.4 12.19 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.373 -0.376 . . . . 72.5 111.854 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -166.11 161.1 16.93 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.357 -0.214 . . . . 72.4 111.324 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -155.24 159.63 40.21 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.798 0.332 . . . . 75.32 111.613 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -133.41 149.36 51.82 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.33 -0.395 . . . . 64.41 111.12 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 38.5 m -115.32 118.63 33.8 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.89 0.376 . . . . 72.44 110.589 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.6 173.42 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.197 0.522 . . . . 72.34 111.424 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 92.6 p -120.59 132.59 55.22 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.356 -0.384 . . . . 55.31 110.139 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.538 HD12 HD22 ' A' ' 440' ' ' LEU . 96.5 mt -118.22 119.05 33.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.818 0.342 . . . . 72.34 110.948 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 492' ' ' GLY . . . . . 0.555 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -80.52 -167.07 35.95 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.992 -0.549 . . . . 50.34 113.082 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.95 105.72 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.596 2.197 . . . . 73.2 112.426 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 33.9 mmtp 67.67 29.93 6.73 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.342 0.591 . . . . 75.32 111.461 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -83.47 152.71 24.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.502 -0.772 . . . . 62.03 111.13 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -135.0 150.7 50.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.839 0.352 . . . . 73.1 111.68 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.419 ' O ' HG22 ' A' ' 462' ' ' VAL . 23.8 mmtm -145.25 127.16 15.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.078 0.466 . . . . 73.51 111.32 176.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.48 112.93 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.127 0.489 . . . . 60.25 110.805 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 27.5 mt -107.93 137.14 46.45 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.051 -0.522 . . . . 73.04 111.209 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 22.4 p -112.89 149.49 33.09 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.653 0.612 . . . . 72.5 112.653 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 501' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 55.1 p90 -144.33 148.56 34.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.764 -0.653 . . . . 41.34 110.909 173.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 455' ' ' LEU . 83.0 p -115.82 115.27 25.99 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.891 0.377 . . . . 71.13 111.214 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -116.51 137.98 51.75 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.456 -0.338 . . . . 73.31 111.808 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 85.9 m -111.98 101.04 50.83 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-N 116.538 -0.301 . . . . 74.1 111.681 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 59.5 Cg_endo -71.61 88.67 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.155 1.904 . . . . 74.53 112.417 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 19.2 p -76.2 -0.99 24.2 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.102 0.408 . . . . 61.33 112.102 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -129.54 135.88 49.14 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.519 -0.309 . . . . 63.54 110.44 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -83.27 151.18 25.73 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.766 0.654 . . . . 64.03 112.766 -174.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 141.9 -179.82 19.56 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.999 -0.546 . . . . 64.05 112.518 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 56.1 mtp -93.11 115.88 28.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.486 0.643 . . . . 74.43 111.655 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -110.49 129.84 55.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.19 -0.459 . . . . 71.52 111.321 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -99.45 116.41 31.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.056 0.455 . . . . 74.5 111.598 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.73 127.65 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.847 -0.615 . . . . 64.34 110.948 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -122.42 131.42 53.87 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.494 -0.321 . . . . 74.15 111.472 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 515' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 476' ' ' ARG . . . -111.82 133.08 54.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.711 0.291 . . . . 75.23 110.37 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 516' ' ' THR . . . . . 0.499 HG22 HG22 ' A' ' 532' ' ' VAL . 71.5 p -133.74 155.9 48.93 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.778 0.323 . . . . 65.21 111.517 -176.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.1 p -130.38 140.53 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.831 0.348 . . . . 71.5 111.62 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 1.6 t70 41.13 50.39 3.29 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.884 0.874 . . . . 62.21 112.754 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -53.97 -32.93 55.54 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.048 0.451 . . . . 74.02 112.178 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.58 ' HG3' HG23 ' A' ' 522' ' ' THR . 7.4 pt-20 -81.49 2.65 27.92 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.809 -0.632 . . . . 74.3 112.603 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 55.74 36.22 26.83 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.404 0.89 . . . . 61.53 113.404 171.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 522' ' ' THR . . . . . 0.58 HG23 ' HG3' ' A' ' 520' ' ' GLU . 75.0 p -63.06 -25.92 68.6 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.059 0.457 . . . . 73.54 111.141 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 10.8 p -107.49 140.76 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 116.201 -0.454 . . . . 70.43 111.271 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 524' ' ' VAL . . . . . 0.405 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 74.6 t -90.77 115.32 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 122.148 -0.345 . . . . 60.31 110.444 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.706 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 15.2 mt-10 -113.02 -174.02 2.37 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.92 0.711 . . . . 65.25 112.92 -174.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 88.0 mt -82.6 -38.81 23.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.587 -0.733 . . . . 63.13 111.271 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -138.77 158.6 43.93 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.982 0.42 . . . . 64.2 110.942 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -129.51 -8.07 4.65 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.981 0.419 . . . . 73.43 111.553 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -77.21 -20.72 54.92 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.339 0.496 . . . . 73.32 112.339 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.424 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 17.4 p-10 -101.75 5.55 41.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.179 0.437 . . . . 64.02 112.179 -177.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -82.2 1.2 37.56 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.181 0.437 . . . . 70.3 112.181 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 516' ' ' THR . 58.3 t -131.14 129.37 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.013 0.435 . . . . 53.12 111.644 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -115.26 136.09 53.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.382 -0.372 . . . . 54.43 110.744 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 61.8 m -117.82 129.7 55.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.659 0.266 . . . . 74.33 111.552 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -139.87 129.28 24.1 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.792 0.33 . . . . 74.23 111.244 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -95.42 137.62 34.23 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.692 0.282 . . . . 72.21 111.707 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 53.6 t -123.74 141.13 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.876 0.37 . . . . 60.11 110.991 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 538' ' ' SER . . . . . 0.529 ' HB3' HG22 ' A' ' 449' ' ' VAL . 48.3 t -112.54 114.83 27.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.917 0.389 . . . . 74.31 111.296 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.76 124.1 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.947 0.403 . . . . 73.43 111.357 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.29 163.17 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.299 0.571 . . . . 75.22 112.182 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 97.5 mt -90.4 14.81 11.94 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.133 -0.485 . . . . 75.02 111.83 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 C--O 1.249 1.055 0 N-CA-C 112.609 0.596 . . . . 75.43 112.609 -172.121 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 120.581 0.229 . . . . 54.44 110.642 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.438 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 55.5 Cg_endo -72.91 175.37 10.49 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.516 2.144 . . . . 61.13 113.23 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -153.94 81.42 1.14 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.086 0.469 . . . . 73.32 110.113 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.498 HD22 HD12 ' A' ' 491' ' ' LEU . 93.9 mt -87.44 143.76 27.07 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.329 0.585 . . . . 64.1 111.769 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.462 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.9 t -153.4 164.93 37.3 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.076 -0.511 . . . . 73.02 111.403 176.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 462' ' ' VAL . 30.9 m -133.71 148.19 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.142 -0.481 . . . . 62.53 111.108 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 53.1 mt-10 -127.05 132.31 50.72 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.509 -0.314 . . . . 61.51 111.113 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 63.2 mt -100.33 125.28 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.02 0.438 . . . . 53.13 110.648 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 26.9 tptp -128.05 131.6 49.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.43 -0.35 . . . . 73.44 110.893 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.75 -172.51 35.01 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 120.667 -0.777 . . . . 35.54 113.956 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.5 135.51 22.25 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.971 2.447 . . . . 71.44 113.244 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.24 -15.71 42.6 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.213 0.449 . . . . 71.41 112.213 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 86.6 t -131.28 131.56 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.59 0.233 . . . . 70.32 110.672 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.34 157.55 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.058 0.456 . . . . 73.44 111.779 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.56 158.87 26.65 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.116 -0.564 . . . . 71.11 113.124 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.408 HG22 ' OD1' ' A' ' 453' ' ' ASN . 9.1 p -66.84 134.49 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.095 0.474 . . . . 73.55 111.575 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 453' ' ' ASN . . . . . 0.408 ' OD1' HG22 ' A' ' 452' ' ' VAL . 23.2 m120 64.9 9.16 5.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.542 0.737 . . . . 75.24 112.347 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -87.93 162.24 17.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.042 0.449 . . . . 71.54 111.496 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 502' ' ' SER . 27.1 tp -100.45 121.08 40.96 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.869 0.366 . . . . 72.23 111.188 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -120.34 132.72 55.41 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.569 0.223 . . . . 74.43 111.499 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.89 128.75 49.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.218 0.532 . . . . 72.43 111.919 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -122.45 154.09 38.24 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.79 -0.641 . . . . 62.45 110.803 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.546 ' HG2' HG22 ' A' ' 500' ' ' THR . 41.3 mt-10 -121.29 127.56 51.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 72.13 111.071 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.44 113.45 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.827 0.346 . . . . 62.32 110.507 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 35.5 m-70 -92.17 110.5 21.88 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.313 -0.254 . . . . 74.42 110.313 176.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 442' ' ' VAL . 24.7 m -105.45 123.07 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.098 0.475 . . . . 75.4 109.871 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.554 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.5 ptpt -141.0 145.69 36.27 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.842 0.682 . . . . 44.35 112.842 -170.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -102.66 128.4 49.38 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.345 -0.843 . . . . 70.24 109.449 173.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.554 HD21 ' HD3' ' A' ' 463' ' ' LYS . 61.1 mt -117.64 -2.03 11.52 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.097 -0.377 . . . . 71.24 111.845 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -79.69 -21.57 66.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.07 -0.586 . . . . 72.13 113.691 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.5 19.19 55.39 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.199 -0.524 . . . . 64.51 113.57 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 3.1 tt -136.86 133.63 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 122.417 -0.461 . . . . 70.24 111.185 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.492 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -62.94 130.3 42.14 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 114.202 0.441 . . . . 63.41 114.202 -176.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.477 HG11 HD11 ' A' ' 440' ' ' LEU . 61.5 t -126.81 113.6 22.36 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 112.125 0.417 . . . . 74.53 112.125 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.13 -10.28 10.26 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.208 2.605 . . . . 74.33 112.701 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 49.9 m -80.4 12.01 3.27 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.424 0.69 . . . . 72.5 112.678 -175.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 32.6 m -88.51 93.53 9.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.848 0.832 . . . . 75.33 112.257 -167.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -110.39 123.88 50.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.224 -0.898 . . . . 72.21 110.504 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.486 HG21 HG11 ' A' ' 462' ' ' VAL . 63.2 t -115.0 129.49 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.832 0.348 . . . . 75.05 111.742 -174.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -120.08 151.8 38.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.862 0.363 . . . . 75.41 111.326 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 96.6 t -121.15 122.16 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.41 -0.359 . . . . 75.53 111.189 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -116.16 136.84 52.65 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.925 0.393 . . . . 74.14 111.533 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.548 HG12 HG12 ' A' ' 513' ' ' ILE . 51.1 mt -111.86 108.47 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 122.676 0.39 . . . . 71.31 110.043 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 55.03 34.71 23.07 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.996 0.427 . . . . 63.44 111.382 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.27 0.62 84.79 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.3 -0.476 . . . . 22.51 113.652 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 36.9 m -103.31 119.61 39.2 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.373 -0.486 . . . . 60.15 111.113 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.0 tp -63.07 120.43 11.42 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.389 0.515 . . . . 74.51 112.389 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -88.64 -45.38 9.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.332 -0.395 . . . . 75.42 111.305 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 485' ' ' LYS . . . . . 0.549 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 31.0 ttpt -171.89 162.26 6.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.546 0.213 . . . . 72.45 111.098 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -139.95 150.98 45.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.962 0.411 . . . . 62.44 111.725 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 487' ' ' TRP . . . . . 0.549 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 18.7 m-90 -130.82 149.23 52.56 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.86 0.464 . . . . 74.24 111.438 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 60.8 m -120.24 118.91 31.69 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.613 0.244 . . . . 71.14 110.436 173.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.2 m -139.87 172.98 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.073 0.463 . . . . 55.25 111.713 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 96.0 p -122.88 133.23 54.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.251 -0.431 . . . . 73.34 110.329 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.498 HD12 HD22 ' A' ' 440' ' ' LEU . 96.0 mt -118.64 119.67 35.16 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.721 0.296 . . . . 73.13 111.246 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 492' ' ' GLY . . . . . 0.492 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -79.39 -171.52 41.46 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.186 -0.53 . . . . 73.05 113.133 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.44 106.43 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.6 2.2 . . . . 63.21 112.581 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.9 mmtp 69.89 23.38 5.56 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.118 -0.492 . . . . 62.53 111.881 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -89.04 149.97 22.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.039 0.385 . . . . 65.34 112.039 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 496' ' ' GLU . . . . . 0.42 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 24.1 tt0 -135.09 143.87 46.87 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.785 0.326 . . . . 72.12 111.478 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -126.89 133.59 50.65 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.819 -0.437 . . . . 70.4 109.819 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 37.9 t -101.17 112.76 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.074 0.464 . . . . 73.54 111.591 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 61.9 mt -100.38 147.65 25.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 70.55 110.933 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.546 HG22 ' HG2' ' A' ' 459' ' ' GLU . 12.0 p -125.66 149.78 48.16 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.952 0.406 . . . . 72.12 111.956 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.72 147.82 27.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.071 0.462 . . . . 70.42 111.149 172.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.519 ' HB2' HD11 ' A' ' 455' ' ' LEU . 83.2 p -111.36 119.12 37.79 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.098 -0.501 . . . . 42.1 111.067 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -107.7 136.64 47.11 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.01 0.433 . . . . 70.51 111.645 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.9 m -122.06 100.88 42.34 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.125 -0.489 . . . . 72.53 110.695 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -81.6 101.46 1.2 Allowed 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.813 2.342 . . . . 72.42 113.228 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.2 p -82.67 6.64 17.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.213 0.449 . . . . 71.12 112.213 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -140.47 127.21 20.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.565 -0.289 . . . . 73.43 110.599 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -73.19 151.62 41.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.21 0.528 . . . . 73.25 112.381 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.94 -168.89 31.88 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.151 -0.547 . . . . 75.25 113.125 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 15.8 tpt -99.2 118.1 35.15 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 122.45 -0.441 . . . . 53.15 110.993 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -123.94 113.09 18.0 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.862 0.363 . . . . 73.32 111.902 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -94.67 115.17 27.21 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.922 0.392 . . . . 72.02 110.785 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.548 HG12 HG12 ' A' ' 479' ' ' ILE . 55.9 mt -95.47 124.03 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.016 0.436 . . . . 71.31 111.045 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -123.15 145.99 48.14 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.966 0.412 . . . . 64.5 111.53 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -122.45 136.87 54.99 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.332 -0.395 . . . . 62.32 110.556 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 21.4 p -132.24 141.02 48.88 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.92 0.391 . . . . 73.34 112.032 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.31 142.0 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.78 0.324 . . . . 64.23 111.375 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.53 49.77 15.97 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.788 0.804 . . . . 74.41 111.42 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -51.7 -28.51 15.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.663 -0.699 . . . . 73.41 111.603 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -65.68 -22.21 66.61 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.052 -0.522 . . . . 74.23 111.308 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 55.97 72.14 0.51 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.358 0.599 . . . . 75.33 111.432 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 66.0 p -117.88 -14.19 10.07 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.516 0.561 . . . . 62.42 112.516 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 10.0 p -126.89 141.27 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.797 0.666 . . . . 71.01 112.797 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 87.2 t -94.29 110.76 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.959 -0.564 . . . . 61.32 110.136 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 24.9 mt-10 -102.94 179.97 4.12 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.744 0.646 . . . . 73.43 112.744 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.95 -39.89 79.26 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.032 -0.531 . . . . 73.01 112.05 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 527' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 530' ' ' ASN . 52.3 t-20 -120.26 112.86 19.58 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.924 0.392 . . . . 62.33 110.317 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -83.74 -7.94 59.36 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 120.955 0.407 . . . . 64.41 111.941 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -101.03 8.64 42.86 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.344 0.592 . . . . 73.24 110.821 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.539 ' HB2' ' HB3' ' A' ' 527' ' ' ASN . 57.6 t30 -88.85 -22.59 23.12 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.815 -0.629 . . . . 75.42 112.297 -171.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -78.51 -4.31 47.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.014 1.116 . . . . 72.23 114.014 -168.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 61.5 t -123.16 130.88 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 112.489 0.551 . . . . 74.25 112.489 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -123.82 142.03 51.49 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.298 -0.41 . . . . 54.11 111.104 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 53.1 m -128.86 135.72 49.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.355 0.502 . . . . 74.54 112.355 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -140.69 133.09 28.4 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 120.894 0.378 . . . . 73.21 111.353 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.38 130.5 43.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.928 0.344 . . . . 71.42 111.928 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 60.7 t -124.14 131.88 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.142 0.496 . . . . 74.02 111.582 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.9 t -105.9 121.99 45.21 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.423 -0.353 . . . . 74.35 111.0 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.65 120.72 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.775 0.322 . . . . 74.22 111.402 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.48 165.36 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 121.132 0.492 . . . . 44.14 111.974 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 86.0 mt -85.72 10.28 13.97 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.303 0.483 . . . . 71.24 112.303 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 112.299 0.481 . . . . 73.15 112.299 -175.613 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 110.297 -0.261 . . . . 73.44 110.297 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.616 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 55.6 Cg_endo -70.99 173.78 11.57 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.597 2.198 . . . . 72.12 113.495 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -153.84 87.59 1.22 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.731 -0.668 . . . . 55.0 109.267 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 491' ' ' LEU . 51.5 mt -91.91 111.85 23.54 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.043 -0.526 . . . . 72.14 111.549 -175.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.638 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 13.5 t -120.81 155.99 32.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.159 0.504 . . . . 70.14 111.865 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.627 HG12 HG12 ' A' ' 462' ' ' VAL . 32.2 m -126.63 148.52 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.88 -0.6 . . . . 71.32 111.116 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 41.1 mt-10 -122.97 146.88 47.23 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.715 0.265 . . . . 54.23 111.715 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.495 HD11 ' N ' ' A' ' 515' ' ' ALA . 49.1 mt -124.48 114.62 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.872 0.368 . . . . 61.5 110.547 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -129.62 139.29 51.48 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.863 0.363 . . . . 64.25 111.483 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.32 -171.37 39.83 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.36 -0.448 . . . . 70.33 112.914 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.17 135.16 28.79 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.579 2.186 . . . . 74.3 113.573 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -79.11 -50.6 10.77 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.105 0.409 . . . . 70.41 112.105 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 538' ' ' SER . 87.8 t -110.03 128.53 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.98 0.419 . . . . 70.23 111.198 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.76 160.95 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.057 0.456 . . . . 63.41 111.692 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -87.71 154.99 26.36 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.267 -0.492 . . . . 52.41 113.095 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 12.4 p -69.15 139.27 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 122.383 -0.481 . . . . 72.32 111.103 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 16.6 m120 66.5 20.18 10.87 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.202 0.601 . . . . 73.1 111.908 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' LYS . . . . . 0.532 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -103.33 159.78 15.26 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.978 0.418 . . . . 72.13 111.516 176.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 502' ' ' SER . 39.2 tp -95.59 122.95 38.89 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.327 -0.397 . . . . 75.34 111.249 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.04 132.73 54.66 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.803 0.335 . . . . 74.33 111.555 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -107.6 136.18 47.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.298 0.57 . . . . 73.25 112.1 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -126.9 159.02 35.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.865 -0.607 . . . . 73.12 110.559 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.481 ' HG2' HG22 ' A' ' 500' ' ' THR . 52.2 mt-10 -119.26 127.5 53.3 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.791 0.329 . . . . 53.13 111.175 177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 460' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 43.9 t -100.8 112.52 33.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.734 -0.469 . . . . 54.35 109.734 170.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 46.1 m-70 -100.6 109.35 21.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.692 0.282 . . . . 61.14 110.255 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.648 HG11 HG21 ' A' ' 475' ' ' VAL . 10.8 m -110.82 126.37 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.18 0.514 . . . . 62.34 110.556 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.46 ' HD3' HD21 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -144.53 150.2 37.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.223 0.535 . . . . 63.43 112.375 -174.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.9 t-20 -102.61 127.14 49.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.582 -0.735 . . . . 75.12 109.592 174.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.46 HD21 ' HD3' ' A' ' 463' ' ' LYS . 97.8 mt -108.72 -10.29 15.18 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.009 0.374 . . . . 73.31 112.009 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.616 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -73.1 -19.16 79.52 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.076 -0.583 . . . . 60.03 114.052 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.71 15.53 63.31 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.032 -0.604 . . . . 60.22 113.954 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.9 tt -137.52 140.08 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 122.69 0.396 . . . . 74.44 110.863 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -75.38 142.55 29.34 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 114.827 0.691 . . . . 74.32 114.827 -172.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 471' ' ' PRO . 59.2 t -131.74 120.12 17.44 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 122.977 0.511 . . . . 73.31 111.282 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 471' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 470' ' ' VAL . 4.7 Cg_endo -86.42 -12.05 5.77 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.119 2.546 . . . . 73.1 113.098 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 23.0 t -84.33 13.39 5.4 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.959 0.726 . . . . 61.51 112.959 -175.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' THR . . . . . 0.447 HG23 ' CG2' ' A' ' 517' ' ' VAL . 90.5 m -86.47 91.81 8.66 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.016 0.912 . . . . 72.4 112.126 -165.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -97.69 131.01 44.62 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.123 -0.944 . . . . 55.41 110.681 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.648 HG21 HG11 ' A' ' 462' ' ' VAL . 45.2 t -113.07 127.26 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.596 0.358 . . . . 71.12 110.898 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -130.17 148.02 51.96 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.898 0.38 . . . . 72.21 111.917 -175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 72.0 t -120.25 122.21 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.862 0.363 . . . . 64.53 111.134 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -113.25 136.82 52.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.357 -0.383 . . . . 70.43 111.308 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 513' ' ' ILE . 62.0 mt -110.68 112.02 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 110.068 -0.345 . . . . 71.22 110.068 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 54.77 34.93 22.91 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.901 0.381 . . . . 72.22 111.461 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 100.37 -36.33 4.21 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.189 -0.529 . . . . 43.24 113.96 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 52.2 m -82.45 131.59 35.22 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 117.163 0.481 . . . . 74.13 111.795 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.22 132.94 54.38 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.216 0.532 . . . . 64.24 111.852 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -105.19 -43.89 4.9 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.161 -0.472 . . . . 73.24 111.852 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -161.3 151.06 16.93 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.647 -0.251 . . . . 73.53 110.497 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -140.12 152.01 45.78 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.32 0.581 . . . . 71.11 112.522 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -136.62 149.42 47.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.528 -0.76 . . . . 73.14 111.063 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 63.1 m -122.97 119.13 29.48 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.14 -0.318 . . . . 74.5 110.14 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.93 173.42 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.304 0.573 . . . . 72.2 111.569 -177.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.4 p -120.45 135.02 55.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.976 -0.556 . . . . 75.14 110.479 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.512 HD12 HD22 ' A' ' 440' ' ' LEU . 74.7 mt -117.33 120.15 37.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.84 0.353 . . . . 64.42 111.315 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -83.06 -170.31 45.91 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.948 -0.644 . . . . 61.2 113.091 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.02 109.34 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.423 2.082 . . . . 62.21 112.491 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.3 mmtm 70.19 19.23 6.72 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.954 0.501 . . . . 64.13 112.176 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -80.08 150.96 30.12 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.175 0.435 . . . . 75.43 112.175 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -135.5 134.12 39.18 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.341 -0.391 . . . . 64.22 111.358 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -116.9 129.83 56.31 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.801 -0.444 . . . . 75.41 109.801 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.16 115.81 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.176 0.512 . . . . 73.03 111.303 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 76.7 mt -105.38 143.53 33.42 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.979 -0.555 . . . . 72.13 110.986 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.481 HG22 ' HG2' ' A' ' 459' ' ' GLU . 6.9 p -129.29 147.12 51.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.069 0.461 . . . . 72.53 111.409 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -149.48 148.44 29.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 75.43 110.463 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.48 ' HB2' HD11 ' A' ' 455' ' ' LEU . 79.4 p -115.6 114.18 24.58 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.222 0.534 . . . . 64.44 110.995 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -102.14 134.07 45.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 73.4 111.323 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 37.0 m -113.29 100.76 52.39 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-N 116.366 -0.379 . . . . 74.31 110.701 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 505' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.4 Cg_endo -76.06 95.4 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.485 2.123 . . . . 61.35 113.088 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 65.6 p -80.43 5.98 13.55 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.994 0.426 . . . . 75.31 111.66 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -133.56 142.53 48.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.841 0.457 . . . . 75.51 109.94 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.9 150.92 20.26 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.099 0.476 . . . . 61.25 112.168 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.96 -169.73 30.04 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.222 -0.514 . . . . 43.31 112.952 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 14.0 tpt -98.65 112.87 24.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.987 0.422 . . . . 55.12 110.447 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.26 112.37 21.49 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.907 0.384 . . . . 71.23 111.682 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -92.37 115.05 27.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.18 0.514 . . . . 61.11 110.943 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 479' ' ' ILE . 60.6 mt -98.1 125.55 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.99 -0.55 . . . . 73.01 111.453 -178.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -120.84 143.79 48.7 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.988 0.423 . . . . 73.12 111.683 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 515' ' ' ALA . . . . . 0.495 ' N ' HD11 ' A' ' 444' ' ' ILE . . . -120.47 138.75 53.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.322 -0.399 . . . . 51.51 110.365 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 516' ' ' THR . . . . . 0.433 HG22 HG22 ' A' ' 532' ' ' VAL . 48.8 p -133.1 158.0 43.88 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.019 0.438 . . . . 50.23 111.593 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.447 ' CG2' HG23 ' A' ' 473' ' ' THR . 7.6 p -132.53 140.49 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.163 -0.471 . . . . 73.11 111.423 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 28.1 t70 42.73 54.76 4.51 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.474 0.654 . . . . 74.35 111.952 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -55.17 -32.85 62.49 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.199 0.524 . . . . 71.4 111.522 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -67.89 -5.76 18.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.282 -0.872 . . . . 74.1 112.457 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.2 t30 53.07 55.09 9.37 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.501 0.667 . . . . 73.34 111.221 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 34.9 p -88.44 -35.44 17.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 65.2 111.449 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 12.5 p -103.72 144.14 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 116.091 -0.504 . . . . 72.14 111.829 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 524' ' ' VAL . . . . . 0.512 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 75.4 t -83.41 114.87 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.758 0.314 . . . . 72.22 110.953 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.28 176.08 6.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.498 0.666 . . . . 75.13 112.617 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 87.4 mt -82.26 -25.65 33.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.793 -0.64 . . . . 72.02 109.947 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 527' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 26.2 t30 -155.39 110.64 3.02 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.565 -0.743 . . . . 73.15 110.447 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 38.0 mp0 -82.81 -1.61 52.28 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.985 0.421 . . . . 54.2 111.719 -173.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -93.08 -8.84 41.61 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.273 0.559 . . . . 75.33 110.973 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.638 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 65.3 t30 -86.53 -6.78 58.8 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.051 0.453 . . . . 65.13 111.743 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -79.06 8.22 6.09 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.844 0.683 . . . . 73.42 112.844 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 516' ' ' THR . 48.5 t -132.46 145.84 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.321 0.489 . . . . 73.55 112.321 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -133.9 142.31 47.71 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.288 -0.415 . . . . 72.03 110.757 172.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 90.6 m -121.89 125.38 46.29 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.354 0.501 . . . . 71.34 112.354 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -133.12 141.06 47.96 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.886 0.374 . . . . 73.11 110.495 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -116.72 126.62 53.42 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.045 0.45 . . . . 75.13 112.161 -176.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.5 t -117.21 143.72 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 116.033 -0.53 . . . . 74.31 111.783 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 538' ' ' SER . . . . . 0.425 ' HB3' HG22 ' A' ' 449' ' ' VAL . 46.6 t -118.02 120.73 38.69 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.332 -0.394 . . . . 71.04 110.996 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 44.5 t -103.42 123.38 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.692 0.282 . . . . 53.12 111.23 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.7 m -109.28 160.25 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 112.612 0.597 . . . . 71.42 112.612 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.71 -5.98 57.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.296 -0.411 . . . . 64.54 112.101 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.253 1.238 0 N-CA-C 112.594 0.59 . . . . 53.24 112.594 -177.059 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 437' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 438' ' ' PRO . 98.5 m-85 . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 120.573 0.225 . . . . 75.15 111.153 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 24.5 Cg_exo -64.86 173.03 6.23 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.026 2.484 . . . . 74.24 114.417 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -161.25 86.81 0.69 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.897 -1.047 . . . . 74.45 108.462 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 74.8 mt -97.41 132.39 43.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.233 0.54 . . . . 65.33 112.006 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.519 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.0 t -132.85 151.74 51.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.03 0.443 . . . . 60.13 111.906 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 462' ' ' VAL . 32.2 m -123.23 148.66 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.95 -0.568 . . . . 62.12 111.439 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 44.4 mt-10 -130.99 129.68 42.41 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.551 -0.295 . . . . 65.53 111.68 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.6 mt -101.99 126.94 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 120.659 0.266 . . . . 74.14 110.798 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -131.68 134.58 46.09 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.411 -0.181 . . . . 73.21 111.135 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.37 -169.88 35.57 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.603 -0.808 . . . . 54.2 113.762 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.3 127.41 14.12 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.809 2.339 . . . . 63.31 113.058 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -85.86 -20.78 28.58 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.135 0.42 . . . . 52.21 112.135 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.23 121.32 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 120.625 0.25 . . . . 74.35 110.801 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 30.1 m -130.72 162.74 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.207 0.527 . . . . 73.31 111.852 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.62 163.27 28.42 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.1 -0.571 . . . . 51.31 113.246 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 10.8 p -70.31 140.22 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.037 0.446 . . . . 62.11 111.578 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 22.3 m120 63.63 18.22 10.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.084 0.554 . . . . 74.22 112.136 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -102.35 164.72 11.52 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.193 0.521 . . . . 74.12 111.937 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 502' ' ' SER . 53.2 tp -95.29 136.8 35.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.13 -0.486 . . . . 75.04 111.493 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -135.49 132.22 37.08 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.906 0.384 . . . . 63.22 110.96 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -113.49 131.96 55.85 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.045 0.45 . . . . 73.25 111.364 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' TYR . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 74.8 m-85 -122.28 159.49 27.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 74.34 110.957 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -120.11 127.18 52.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.994 -0.548 . . . . 74.34 110.942 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 42.1 t -102.69 112.65 36.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.829 -0.434 . . . . 24.33 109.829 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 40.2 m-70 -100.04 112.72 25.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.748 0.309 . . . . 71.51 110.315 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 442' ' ' VAL . 24.5 m -113.12 124.45 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.212 0.529 . . . . 62.13 110.828 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.46 ' HD3' HD21 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -136.4 151.67 49.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.258 0.552 . . . . 74.42 112.284 -176.561 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.2 t-20 -99.9 128.5 45.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.639 -0.71 . . . . 63.24 110.225 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.46 HD21 ' HD3' ' A' ' 463' ' ' LYS . 89.5 mt -113.71 -6.4 13.32 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.023 -0.423 . . . . 72.21 112.034 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -75.37 -18.89 79.82 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.971 -0.633 . . . . 74.2 113.556 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.39 19.35 69.17 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.126 -0.559 . . . . 61.42 113.383 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 10.1 tt -135.35 138.67 48.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 122.554 0.341 . . . . 74.2 110.803 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.529 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -66.73 122.86 21.04 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.402 -0.428 . . . . 30.41 113.784 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 438' ' ' PRO . 48.0 t -119.68 113.72 34.59 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 122.615 -0.344 . . . . 50.53 111.841 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.08 -11.12 10.01 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.94 2.426 . . . . 74.51 112.394 172.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 472' ' ' SER . . . . . 0.607 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 47.8 m -81.23 12.04 3.82 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.857 0.863 . . . . 73.4 113.033 -173.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 473' ' ' THR . . . . . 0.406 HG23 ' CG2' ' A' ' 517' ' ' VAL . 88.1 m -88.91 99.71 12.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.773 0.797 . . . . 61.1 112.332 -167.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -105.13 130.65 53.26 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.675 -0.693 . . . . 64.12 110.895 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.423 HG21 HG11 ' A' ' 462' ' ' VAL . 25.9 t -105.31 118.72 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.439 0.296 . . . . 71.02 111.03 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 476' ' ' ARG . . . . . 0.529 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 86.3 mtt180 -116.54 138.15 51.62 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.107 -0.371 . . . . 74.32 111.121 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 89.6 t -120.88 130.47 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.975 0.417 . . . . 71.05 111.466 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -121.68 139.29 53.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.19 -0.459 . . . . 75.43 111.257 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.506 HG12 HG12 ' A' ' 513' ' ' ILE . 55.6 mt -118.83 115.95 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 110.139 -0.319 . . . . 75.2 110.139 172.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 52.67 38.87 27.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.122 0.487 . . . . 74.22 111.573 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.91 -17.51 50.26 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.227 -0.511 . . . . 55.32 113.829 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 73.2 m -88.94 130.82 35.37 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 117.168 0.484 . . . . 74.11 111.623 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.4 tp -64.33 115.06 4.7 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.946 0.403 . . . . 72.55 111.233 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -89.99 -43.86 10.26 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.171 -0.468 . . . . 74.21 112.141 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -168.5 160.03 10.72 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.518 -0.31 . . . . 74.33 110.456 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -150.83 149.87 30.24 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.057 0.456 . . . . 64.0 112.072 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 487' ' ' TRP . . . . . 0.413 ' CD2' HD13 ' A' ' 499' ' ' LEU . 24.5 m-90 -129.79 144.01 51.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.848 0.459 . . . . 72.03 110.716 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 38.5 m -111.02 117.79 34.29 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.859 -0.423 . . . . 73.01 109.859 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.49 174.34 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.277 0.56 . . . . 72.43 112.02 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 83.0 p -122.55 134.99 54.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.986 -0.552 . . . . 71.11 111.046 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 94.5 mt -120.18 119.45 33.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.648 0.261 . . . . 74.21 111.084 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 492' ' ' GLY . . . . . 0.529 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -79.63 -171.52 41.96 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.086 -0.578 . . . . 70.5 113.205 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.63 103.5 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.668 2.245 . . . . 65.23 112.524 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.1 mttt 63.63 36.97 10.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.266 0.555 . . . . 72.44 112.117 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -95.96 155.48 16.73 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.966 -0.561 . . . . 73.4 110.845 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -134.82 143.29 46.96 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.842 0.353 . . . . 71.23 111.76 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -126.35 132.33 51.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.867 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 50.3 t -101.39 117.62 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.007 0.432 . . . . 73.2 111.435 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.413 HD13 ' CD2' ' A' ' 487' ' ' TRP . 49.7 mt -111.85 146.12 38.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.201 -0.454 . . . . 74.42 110.815 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 16.7 p -135.46 152.3 51.23 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.366 0.603 . . . . 74.33 112.354 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 501' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 47.9 p90 -145.36 154.39 42.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.768 -0.651 . . . . 72.14 111.073 175.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.524 ' HB2' HD11 ' A' ' 455' ' ' LEU . 32.3 p -112.58 114.7 27.47 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.049 0.452 . . . . 75.51 111.229 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 503' ' ' TRP . . . . . 0.424 ' CZ2' ' HB3' ' A' ' 505' ' ' PRO . 31.1 t90 -114.38 137.47 51.78 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.08 0.552 . . . . 72.42 111.341 -175.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 96.7 m -126.14 103.47 26.53 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 120.751 0.31 . . . . 71.41 111.749 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 505' ' ' PRO . . . . . 0.424 ' HB3' ' CZ2' ' A' ' 503' ' ' TRP . 98.7 Cg_endo -80.9 97.92 1.03 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.495 2.13 . . . . 70.4 112.905 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 68.4 p -77.33 -6.78 54.52 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.071 0.462 . . . . 75.12 111.121 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 507' ' ' GLN . . . . . 0.445 ' HB3' ' OH ' ' A' ' 511' ' ' TYR . 51.1 tt0 -114.48 141.29 47.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.122 -0.49 . . . . 74.4 110.238 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.13 149.88 21.62 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.861 0.362 . . . . 65.4 111.194 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 140.39 -171.62 23.89 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.328 -0.463 . . . . 62.31 112.883 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 94.6 mmm -83.9 127.58 33.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.076 0.465 . . . . 72.22 111.975 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 511' ' ' TYR . . . . . 0.445 ' OH ' ' HB3' ' A' ' 507' ' ' GLN . 76.9 m-85 -126.32 111.94 15.11 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.992 -0.549 . . . . 63.42 110.923 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -93.79 115.44 27.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.01 0.434 . . . . 51.05 111.307 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.506 HG12 HG12 ' A' ' 479' ' ' ILE . 60.3 mt -96.2 128.43 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.864 -0.607 . . . . 72.53 110.962 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -124.81 132.31 53.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.5 -0.318 . . . . 74.31 111.294 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 515' ' ' ALA . . . . . 0.402 ' O ' HG21 ' A' ' 442' ' ' VAL . . . -112.33 134.4 53.89 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.469 -0.332 . . . . 64.2 110.283 173.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 516' ' ' THR . . . . . 0.453 HG22 HG22 ' A' ' 532' ' ' VAL . 80.2 p -133.62 141.01 47.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.918 0.39 . . . . 74.02 111.257 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.452 HG13 HD22 ' A' ' 531' ' ' ASN . 7.5 p -109.22 139.26 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.928 0.394 . . . . 65.42 110.96 174.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 34.5 t0 38.74 64.89 0.71 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.798 0.839 . . . . 73.24 112.685 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 519' ' ' GLU . . . . . 0.529 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.1 mm-40 -52.54 -33.7 46.76 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.498 0.666 . . . . 71.52 111.048 172.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.61 -24.28 61.05 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.18 -0.918 . . . . 72.21 111.633 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 54.15 55.52 8.14 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.886 0.85 . . . . 74.11 110.521 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 522' ' ' THR . . . . . 0.607 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 60.5 p -73.34 -6.06 43.67 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.888 -1.051 . . . . 63.03 111.628 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 14.5 p -134.34 143.25 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.255 -0.43 . . . . 72.41 110.9 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 524' ' ' VAL . . . . . 0.51 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 48.1 t -81.52 109.57 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.027 0.441 . . . . 74.45 110.998 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.482 ' HG2' ' HB2' ' A' ' 438' ' ' PRO . 37.1 mt-10 -98.58 177.02 5.45 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.274 0.559 . . . . 75.13 112.141 -175.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.03 -38.75 17.55 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.208 -0.451 . . . . 60.53 112.204 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -142.07 120.0 12.0 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.868 0.322 . . . . 75.34 111.868 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 528' ' ' GLU . . . . . 0.557 ' HA ' ' OD1' ' A' ' 531' ' ' ASN . 11.4 pt-20 -93.5 14.2 19.46 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.337 0.495 . . . . 63.14 112.337 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -90.66 -26.38 19.62 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.335 0.494 . . . . 62.0 112.335 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.519 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 17.1 p-10 -97.89 -5.05 35.29 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 111.974 0.361 . . . . 70.33 111.974 -175.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 531' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' A' ' 528' ' ' GLU . 12.3 m120 -62.96 -24.73 68.02 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.125 0.417 . . . . 72.11 112.125 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 516' ' ' THR . 47.3 t -115.51 137.36 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.876 0.369 . . . . 64.14 111.706 -176.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.51 127.31 43.77 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.455 -0.339 . . . . 65.13 110.872 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 57.2 m -105.39 132.89 51.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.856 0.36 . . . . 60.43 111.628 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -139.7 117.28 11.47 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.765 0.317 . . . . 70.32 110.803 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.94 127.33 39.65 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.99 0.424 . . . . 64.22 111.924 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.96 137.63 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.109 -0.496 . . . . 44.52 111.235 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.8 t -107.44 122.42 46.59 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.826 0.346 . . . . 72.32 111.009 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.1 t -108.19 129.99 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.102 0.477 . . . . 54.1 111.305 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 21.5 m -125.33 162.74 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.157 0.503 . . . . 65.0 112.257 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.93 -12.23 60.11 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.945 0.402 . . . . 74.41 111.995 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 119.24 -0.409 . . . . 74.22 111.724 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 110.469 -0.197 . . . . 74.22 110.469 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.553 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 58.5 Cg_endo -72.67 173.34 13.51 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.216 1.944 . . . . 74.31 113.152 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -153.29 87.99 1.28 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.892 -0.595 . . . . 63.04 109.59 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.1 mt -89.15 112.0 22.89 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.278 -0.419 . . . . 75.24 111.548 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.56 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.0 t -120.84 158.97 26.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.067 0.46 . . . . 62.34 111.688 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.622 HG12 HG12 ' A' ' 462' ' ' VAL . 35.2 m -134.31 148.59 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.062 -0.517 . . . . 34.51 111.537 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.624 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.3 mt-10 -125.45 136.3 53.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.479 -0.328 . . . . 72.52 111.258 177.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 515' ' ' ALA . 56.2 mt -105.41 124.61 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.733 0.301 . . . . 70.23 110.536 174.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 29.1 tptp -132.88 131.99 41.57 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.616 -0.266 . . . . 75.25 110.931 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 166.32 -175.06 41.85 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.743 -0.742 . . . . 50.14 113.801 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.03 134.16 31.05 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.983 2.455 . . . . 74.03 113.537 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.6 -38.53 65.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.192 -0.458 . . . . 71.12 111.911 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.18 131.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.642 0.258 . . . . 53.33 111.31 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.61 163.53 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 121.176 0.512 . . . . 64.32 111.672 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.43 158.44 21.01 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.183 -0.532 . . . . 71.11 113.341 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.409 HG11 HD23 ' A' ' 541' ' ' LEU . 14.0 p -64.9 137.94 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 O-C-N 122.54 -0.388 . . . . 73.33 111.598 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 453' ' ' ASN . . . . . 0.401 ' OD1' ' HA ' ' A' ' 506' ' ' THR . 92.9 m-20 62.6 14.62 7.27 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.511 0.56 . . . . 71.23 112.511 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 454' ' ' LYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.5 mmmt -94.33 150.02 20.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.818 0.342 . . . . 64.34 111.155 175.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 502' ' ' SER . 32.2 tp -92.77 117.07 29.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.872 0.368 . . . . 72.14 110.936 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -120.67 132.69 55.23 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.901 0.382 . . . . 72.03 111.679 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -102.16 139.15 38.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.154 0.502 . . . . 71.11 111.84 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -123.66 165.14 17.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.862 -0.608 . . . . 62.31 111.26 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 445' ' ' LYS . 51.5 mt-10 -119.95 127.49 52.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.911 -0.586 . . . . 54.34 110.907 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.5 t -108.27 112.78 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.668 -0.493 . . . . 64.31 109.668 170.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.624 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 48.3 m-70 -97.92 107.65 20.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.737 0.303 . . . . 75.41 110.641 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.756 HG11 HG21 ' A' ' 475' ' ' VAL . 14.0 m -108.34 125.98 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.01 0.433 . . . . 74.02 110.55 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.602 ' HD3' HD21 ' A' ' 465' ' ' LEU . 16.0 ptpt -145.76 147.02 31.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.549 0.574 . . . . 75.54 112.549 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.9 t-20 -100.31 126.99 46.71 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.756 -0.657 . . . . 75.02 109.557 174.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.602 HD21 ' HD3' ' A' ' 463' ' ' LYS . 85.6 mt -116.26 8.65 14.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.037 0.384 . . . . 70.33 112.037 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -86.59 -20.89 53.15 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.099 -0.572 . . . . 52.13 113.02 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.74 14.34 63.33 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.116 -0.564 . . . . 44.45 113.591 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 7.4 tt -136.42 133.78 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 122.608 -0.348 . . . . 75.04 110.934 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.43 143.84 37.92 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 114.824 0.69 . . . . 44.43 114.824 -172.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.27 113.53 15.82 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 122.702 0.401 . . . . 64.44 111.41 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.79 -10.57 10.55 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.093 2.529 . . . . 74.34 113.324 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 65.6 m -87.87 13.22 11.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.602 0.761 . . . . 51.54 112.839 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 96.9 m -87.86 106.87 18.38 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.678 0.752 . . . . 71.52 112.649 -165.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -107.42 131.26 54.47 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.551 -0.749 . . . . 65.25 111.243 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.756 HG21 HG11 ' A' ' 462' ' ' VAL . 45.6 t -114.79 127.86 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 122.609 0.364 . . . . 63.34 110.823 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 476' ' ' ARG . . . . . 0.453 ' NH2' ' HB2' ' A' ' 519' ' ' GLU . 20.9 mtm180 -130.53 152.94 49.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.068 0.461 . . . . 62.14 112.16 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.21 122.73 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.111 -0.495 . . . . 65.24 111.319 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -113.93 137.53 51.56 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.2 -0.454 . . . . 63.14 111.388 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.539 HG12 HG12 ' A' ' 513' ' ' ILE . 58.9 mt -114.38 111.07 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 109.909 -0.404 . . . . 63.42 109.909 174.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 58.01 33.53 23.29 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.265 0.555 . . . . 74.33 110.8 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 91.79 -19.51 47.98 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.073 -0.512 . . . . 74.52 113.783 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 34.3 m -82.23 124.46 29.94 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.331 -0.511 . . . . 74.21 111.41 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.9 tp -64.91 115.16 5.08 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.083 0.468 . . . . 74.11 111.186 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -91.23 -44.03 9.47 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.15 -0.477 . . . . 74.12 111.979 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -162.98 155.49 18.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.648 0.261 . . . . 73.2 111.159 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 486' ' ' ASN . . . . . 0.411 ' HB3' ' HG2' ' A' ' 476' ' ' ARG . 0.8 OUTLIER -143.23 143.35 31.71 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.744 0.646 . . . . 73.22 112.744 -177.152 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -129.52 146.61 51.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.751 -0.659 . . . . 73.43 110.786 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 66.4 m -115.87 118.09 32.0 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.012 -0.366 . . . . 65.32 110.012 170.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.35 173.22 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.343 0.592 . . . . 54.14 112.022 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 72.0 p -124.76 132.93 53.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.06 -0.518 . . . . 73.33 110.569 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.26 121.52 38.88 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.894 0.378 . . . . 41.22 111.203 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -79.7 -170.51 40.41 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.318 -0.467 . . . . 22.22 113.429 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.03 110.6 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.573 2.182 . . . . 62.2 112.626 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.9 mmtp 62.82 37.76 12.08 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.086 0.469 . . . . 74.04 111.428 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -105.03 147.34 27.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.187 -0.46 . . . . 74.22 111.554 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -132.51 143.44 49.75 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.161 0.505 . . . . 61.54 112.332 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -126.37 144.05 50.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.938 -0.573 . . . . 74.13 110.775 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.64 112.01 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 121.033 0.444 . . . . 75.0 110.696 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.4 mt -106.41 125.61 51.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.351 -0.386 . . . . 75.33 110.315 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 35.2 p -113.39 153.33 28.75 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.238 0.542 . . . . 74.2 112.165 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -144.51 150.9 38.33 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.824 -0.625 . . . . 65.21 110.382 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.525 ' HB2' HD11 ' A' ' 455' ' ' LEU . 87.3 p -110.19 114.32 27.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.797 0.332 . . . . 74.45 110.585 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -106.26 130.24 54.15 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.017 0.437 . . . . 75.2 111.936 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 85.5 m -113.97 100.96 53.47 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 115.97 -0.559 . . . . 55.42 110.86 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 505' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 72.0 Cg_endo -74.26 91.05 0.96 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.426 2.084 . . . . 72.21 113.018 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 506' ' ' THR . . . . . 0.401 ' HA ' ' OD1' ' A' ' 453' ' ' ASN . 58.0 p -67.97 -16.92 64.27 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.193 0.442 . . . . 72.2 112.193 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -119.34 132.86 55.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.441 -0.345 . . . . 64.25 110.499 174.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.32 150.87 22.39 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.533 0.682 . . . . 65.13 112.469 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.45 -168.43 30.94 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.691 -0.686 . . . . 44.03 112.249 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 13.8 tpt -94.68 124.46 38.73 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 122.332 -0.51 . . . . 73.4 111.076 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -127.92 152.95 47.23 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.042 0.448 . . . . 74.34 112.007 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 512' ' ' ARG . . . . . 0.484 ' HG2' HD22 ' A' ' 514' ' ' ASN . 26.6 ttm180 -123.78 122.31 37.7 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.206 -0.452 . . . . 74.45 110.87 175.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.539 HG12 HG12 ' A' ' 479' ' ' ILE . 59.8 mt -103.1 123.93 56.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.968 0.414 . . . . 72.14 111.125 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.484 HD22 ' HG2' ' A' ' 512' ' ' ARG . 38.4 m-80 -119.73 138.9 53.03 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.398 -0.364 . . . . 75.03 111.419 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 515' ' ' ALA . . . . . 0.428 ' N ' HD11 ' A' ' 444' ' ' ILE . . . -112.44 134.02 54.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.925 0.393 . . . . 70.31 110.481 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 82.4 p -123.34 144.43 49.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.169 -0.469 . . . . 74.53 111.254 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.83 139.61 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.594 0.235 . . . . 63.15 111.133 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 35.8 t0 36.28 60.97 0.83 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.876 0.87 . . . . 74.31 112.855 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 519' ' ' GLU . . . . . 0.453 ' HB2' ' NH2' ' A' ' 476' ' ' ARG . 39.9 mt-10 -58.63 -32.66 69.24 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.044 0.45 . . . . 75.21 110.985 173.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -66.23 -24.21 66.56 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.357 -0.608 . . . . 65.31 109.357 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 29.4 t30 51.04 74.15 0.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.965 -1.016 . . . . 72.43 110.809 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 30.3 p -84.83 -10.64 56.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.879 -1.055 . . . . 64.13 111.408 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.443 HG21 ' HG3' ' A' ' 438' ' ' PRO . 11.3 p -135.24 143.61 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.914 -0.585 . . . . 43.04 112.255 -172.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.2 t -82.47 115.48 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.074 0.464 . . . . 63.43 110.709 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -107.2 -179.84 4.05 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.821 0.674 . . . . 63.32 112.821 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.98 -39.06 51.86 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.983 -0.553 . . . . 74.21 112.237 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -142.54 124.19 14.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.225 0.536 . . . . 72.1 111.432 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -84.08 -20.2 33.03 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.965 -0.562 . . . . 54.4 111.956 -175.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -85.48 3.42 40.37 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.11 0.481 . . . . 62.23 111.092 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.56 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 66.7 t30 -92.16 -13.24 30.95 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.21 0.528 . . . . 72.15 111.376 -176.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -78.81 0.22 27.89 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.368 0.877 . . . . 64.1 113.368 -174.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.6 t -130.68 135.38 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.588 0.588 . . . . 75.2 112.588 -175.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -122.11 142.85 49.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.148 -0.478 . . . . 73.44 110.859 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 92.7 m -124.01 126.13 45.76 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.617 0.599 . . . . 73.41 112.617 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -139.67 123.44 17.48 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.517 -0.31 . . . . 74.11 110.964 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -93.64 137.3 33.04 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.984 0.421 . . . . 71.11 111.96 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.38 132.29 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.227 -0.442 . . . . 71.5 111.444 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.0 t -100.44 117.76 35.27 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.319 -0.4 . . . . 30.31 110.993 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.481 HG11 ' HB2' ' A' ' 505' ' ' PRO . 38.2 t -106.21 130.65 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.96 0.41 . . . . 64.43 111.466 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 16.2 m -133.27 168.23 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 120.978 0.418 . . . . 72.31 111.993 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 541' ' ' LEU . . . . . 0.409 HD23 HG11 ' A' ' 452' ' ' VAL . 83.7 mt -74.58 -36.98 63.03 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.495 0.554 . . . . 64.11 112.495 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--O 1.253 1.259 0 N-CA-C 112.83 0.678 . . . . 65.12 112.83 -176.666 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 110.014 -0.365 . . . . 63.32 110.014 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.572 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 55.3 Cg_endo -80.13 174.86 10.96 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.552 2.168 . . . . 74.11 113.746 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -147.81 93.39 2.19 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.29 -0.868 . . . . 62.14 109.651 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.417 HD11 HG11 ' A' ' 470' ' ' VAL . 79.3 mt -91.81 111.87 23.57 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.098 0.475 . . . . 74.35 111.357 -177.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.41 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.0 t -114.47 148.36 37.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.165 0.507 . . . . 72.45 111.35 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.554 HG12 HG12 ' A' ' 462' ' ' VAL . 33.8 m -121.99 148.13 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.079 -0.51 . . . . 65.54 111.069 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 36.6 mt-10 -131.81 139.76 48.97 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.415 -0.357 . . . . 63.25 110.563 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 56.1 mt -114.16 132.69 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.899 0.381 . . . . 71.52 111.381 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -135.27 147.07 49.12 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.403 -0.362 . . . . 61.11 111.308 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.0 -173.35 35.86 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.001 -0.619 . . . . 62.31 113.103 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.18 129.61 18.52 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.63 2.22 . . . . 74.13 113.306 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.33 -41.9 65.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.044 0.449 . . . . 70.44 111.475 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.31 129.48 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.339 -0.391 . . . . 72.4 111.111 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.22 163.15 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.91 0.385 . . . . 73.02 111.509 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -92.92 153.36 21.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.306 -0.473 . . . . 74.55 112.99 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.411 HG22 ' OD1' ' A' ' 453' ' ' ASN . 12.1 p -67.43 136.66 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.001 0.429 . . . . 53.05 111.745 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 453' ' ' ASN . . . . . 0.411 ' OD1' HG22 ' A' ' 452' ' ' VAL . 22.2 m120 65.07 17.57 11.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.239 0.616 . . . . 75.5 112.298 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -104.38 167.17 9.92 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.13 0.49 . . . . 70.55 111.75 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 502' ' ' SER . 31.6 tp -100.34 131.3 46.34 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.268 -0.424 . . . . 72.43 111.423 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.45 132.39 45.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.844 0.354 . . . . 74.12 111.796 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -103.68 135.55 45.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.866 0.365 . . . . 74.44 111.278 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -125.54 161.6 26.79 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.449 -0.342 . . . . 73.25 110.909 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -119.67 127.93 53.34 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.782 0.325 . . . . 74.41 111.234 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 460' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 50.4 t -102.44 113.11 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.95 0.405 . . . . 75.33 110.012 170.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 41.1 m-70 -96.57 105.71 17.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.454 -0.339 . . . . 62.25 110.857 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.681 HG11 HG21 ' A' ' 475' ' ' VAL . 17.5 m -106.52 123.69 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.15 0.5 . . . . 64.55 110.476 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.484 ' HD3' HD21 ' A' ' 465' ' ' LEU . 3.7 ptpp? -142.52 148.21 37.26 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.878 0.695 . . . . 72.25 112.878 -173.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.1 t-20 -99.42 128.55 45.55 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.347 -0.842 . . . . 71.13 109.814 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.484 HD21 ' HD3' ' A' ' 463' ' ' LYS . 81.8 mt -111.71 -14.73 13.56 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.092 0.405 . . . . 75.42 112.092 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -66.27 -22.7 71.2 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 121.479 -0.391 . . . . 64.23 113.947 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.45 18.79 56.41 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.178 -0.534 . . . . 23.31 113.912 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.427 HG23 ' HB3' ' A' ' 438' ' ' PRO . 5.5 tt -137.44 138.1 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 122.795 0.438 . . . . 62.24 111.001 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -65.19 135.08 36.82 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.485 -0.388 . . . . 73.11 113.87 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.417 HG11 HD11 ' A' ' 440' ' ' LEU . 60.3 t -129.0 114.71 18.81 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 112.16 0.43 . . . . 63.21 112.16 -176.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.58 -10.94 14.4 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.037 2.491 . . . . 65.15 112.504 173.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 472' ' ' SER . . . . . 0.45 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 50.3 m -81.15 11.84 3.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.617 0.767 . . . . 72.44 112.976 -175.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 48.6 m -88.95 94.05 9.81 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.798 0.809 . . . . 75.21 112.183 -169.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -111.67 123.38 50.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.293 -0.867 . . . . 64.32 110.507 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.681 HG21 HG11 ' A' ' 462' ' ' VAL . 29.6 t -105.49 132.49 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 111.873 0.323 . . . . 73.22 111.873 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -128.25 144.53 51.13 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.901 0.381 . . . . 74.23 111.366 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -121.19 126.7 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.895 0.379 . . . . 74.23 111.266 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 478' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 482' ' ' THR . 82.6 m-85 -121.93 137.03 54.95 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.309 -0.405 . . . . 72.21 111.426 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 513' ' ' ILE . 59.0 mt -108.73 107.5 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 110.091 -0.337 . . . . 73.02 110.091 173.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 57.66 34.1 24.07 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.896 0.379 . . . . 70.54 111.289 -174.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.23 -10.36 74.47 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.207 -0.52 . . . . 64.51 113.537 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 478' ' ' TYR . 40.9 m -85.14 127.32 34.21 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.603 -0.351 . . . . 73.02 111.17 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.8 tp -69.15 118.41 12.01 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.853 0.359 . . . . 53.22 111.331 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -94.79 -45.1 7.47 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.818 0.342 . . . . 72.21 111.743 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -170.52 160.08 7.16 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.564 0.221 . . . . 74.32 111.073 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -132.1 157.2 44.81 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.088 0.47 . . . . 75.44 111.52 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 30.9 m-90 -135.99 143.78 44.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.095 0.558 . . . . 74.05 110.785 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 98.8 m -122.09 116.97 25.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.711 0.291 . . . . 70.34 110.422 173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.7 173.93 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.363 0.601 . . . . 62.23 111.872 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 55.1 p -125.68 133.68 52.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.958 -0.565 . . . . 75.13 110.693 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.437 HD21 ' HG2' ' A' ' 497' ' ' LYS . 75.3 mt -116.94 120.46 38.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.796 0.331 . . . . 74.44 111.502 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -75.35 -170.51 27.77 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.052 -0.594 . . . . 63.2 112.746 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.89 118.08 4.95 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.175 1.917 . . . . 73.13 112.364 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 74.4 mmtt 65.32 21.8 12.01 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.111 -0.495 . . . . 72.21 112.109 175.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -89.98 154.74 19.6 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.454 0.539 . . . . 65.44 112.454 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -135.0 145.09 47.75 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.855 0.359 . . . . 70.21 111.927 177.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.437 ' HG2' HD21 ' A' ' 491' ' ' LEU . 31.6 mmmt -122.31 129.83 52.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.2 -0.454 . . . . 74.01 109.887 170.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.2 t -100.28 117.31 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.183 0.516 . . . . 73.32 111.213 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 50.9 mt -106.61 146.46 30.67 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.027 -0.533 . . . . 54.31 111.05 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 21.3 p -127.06 147.02 50.16 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.005 0.431 . . . . 71.1 111.657 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -147.87 148.67 31.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.113 -0.494 . . . . 62.34 110.648 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.533 ' HB2' HD11 ' A' ' 455' ' ' LEU . 68.3 p -113.0 114.07 26.38 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.269 0.557 . . . . 75.43 111.419 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -106.2 137.2 44.56 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.643 -0.708 . . . . 75.25 111.341 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.7 m -119.35 100.8 49.7 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.606 -0.27 . . . . 63.34 111.125 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.47 108.43 1.72 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.624 2.216 . . . . 72.42 113.353 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 58.7 p -85.16 -13.43 50.11 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.108 0.41 . . . . 73.14 112.108 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -113.55 134.87 54.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.66 0.266 . . . . 75.41 111.183 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.74 151.55 37.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.6 0.714 . . . . 72.5 112.387 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 135.97 175.76 14.0 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.815 -0.629 . . . . 23.52 112.538 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 65.0 mtp -88.35 128.13 35.5 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.176 0.512 . . . . 65.02 111.542 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -120.05 119.48 33.49 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.15 -0.477 . . . . 60.42 110.762 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -92.75 114.37 26.91 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.059 0.457 . . . . 63.41 110.857 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 479' ' ' ILE . 59.0 mt -98.77 123.64 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.039 -0.528 . . . . 70.21 111.277 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -120.72 136.82 54.76 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.87 0.367 . . . . 72.32 111.806 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.27 143.99 42.43 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.327 -0.397 . . . . 72.23 110.917 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 516' ' ' THR . . . . . 0.418 HG22 HG22 ' A' ' 532' ' ' VAL . 60.8 p -131.14 157.0 44.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.253 -0.43 . . . . 73.41 111.427 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.74 140.18 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 121.005 0.431 . . . . 72.34 111.403 171.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 25.2 t0 41.51 62.48 1.52 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.138 0.975 . . . . 70.33 113.159 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.7 -30.86 71.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.015 0.436 . . . . 61.14 111.317 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.12 -9.38 39.1 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.254 -0.43 . . . . 54.51 112.121 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 57.61 49.69 12.15 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.141 0.496 . . . . 62.22 111.383 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 522' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 60.1 p -88.03 -12.31 44.71 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.294 -0.412 . . . . 61.23 111.773 -178.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.28 142.34 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.877 0.37 . . . . 61.52 111.242 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 524' ' ' VAL . . . . . 0.448 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 74.8 t -82.75 110.25 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.023 0.44 . . . . 72.02 111.218 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.69 162.12 13.91 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.845 -0.616 . . . . 74.43 112.117 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.72 -38.79 73.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.83 -0.623 . . . . 74.4 111.564 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -137.82 126.4 23.59 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.802 -0.181 . . . . 42.1 111.16 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -83.47 -24.88 31.6 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 62.41 111.109 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -81.34 -0.66 42.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.181 -0.463 . . . . 61.13 112.088 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.41 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 57.8 t30 -96.47 -23.0 16.78 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.897 0.379 . . . . 72.1 111.765 -177.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.78 16.37 1.16 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.058 0.762 . . . . 62.12 113.058 -174.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.418 HG22 HG22 ' A' ' 516' ' ' THR . 77.0 t -135.08 142.5 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 120.896 0.379 . . . . 73.23 111.62 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 533' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -127.25 144.03 51.12 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.545 0.338 . . . . 71.41 111.103 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.9 m -123.42 124.99 44.14 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.559 0.578 . . . . 75.24 112.559 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -134.13 124.22 25.73 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.682 0.277 . . . . 74.43 110.545 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.17 130.19 45.46 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.361 0.6 . . . . 72.14 112.132 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.38 145.02 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.729 -0.669 . . . . 75.33 111.413 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 48.3 t -117.68 113.99 22.71 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.853 0.358 . . . . 61.42 111.236 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.91 120.16 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.503 -0.317 . . . . 73.21 111.223 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.8 m -114.84 165.38 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.099 0.476 . . . . 61.35 112.231 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.8 mt -82.24 -1.26 48.72 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.204 0.446 . . . . 71.13 112.204 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--O 1.253 1.27 0 N-CA-C 112.126 0.417 . . . . 72.32 112.126 -179.138 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 120.715 0.293 . . . . 71.43 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.526 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 60.5 Cg_endo -72.13 174.92 10.62 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.794 2.329 . . . . 53.52 113.02 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 25.4 t70 -150.0 81.22 1.38 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.866 -0.606 . . . . 62.3 109.901 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.521 HD22 HD12 ' A' ' 491' ' ' LEU . 43.7 mt -84.45 105.72 15.48 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.858 -0.61 . . . . 64.22 111.487 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.472 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 8.1 t -113.08 148.08 35.97 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.079 0.466 . . . . 74.33 111.334 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.629 HG12 HG12 ' A' ' 462' ' ' VAL . 27.3 m -121.08 146.91 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.226 -0.443 . . . . 75.14 111.108 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 46.3 mt-10 -137.0 136.35 38.4 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.252 -0.431 . . . . 65.41 111.305 -175.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.2 mt -110.14 132.51 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.914 0.388 . . . . 74.44 111.62 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -136.61 136.39 39.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.45 -0.341 . . . . 74.04 111.093 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.51 -170.76 39.79 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.209 -0.52 . . . . 73.22 112.97 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.77 121.21 7.7 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.574 2.183 . . . . 72.42 112.921 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.4 -16.75 44.68 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.041 0.385 . . . . 73.52 112.041 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 63.6 t -129.33 123.97 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.682 0.277 . . . . 72.24 110.676 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.41 160.99 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.281 0.562 . . . . 74.53 112.27 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.43 158.19 26.28 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.049 -0.523 . . . . 62.12 112.8 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.411 HG11 HD23 ' A' ' 541' ' ' LEU . 13.8 p -69.21 140.54 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 120.95 0.405 . . . . 63.0 111.948 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 68.1 12.35 8.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.178 0.591 . . . . 73.52 112.405 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -93.58 174.63 7.09 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.0 0.429 . . . . 72.1 111.476 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 502' ' ' SER . 40.3 tp -108.15 119.39 39.34 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.894 0.378 . . . . 74.24 111.338 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.05 131.55 56.33 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.026 0.441 . . . . 64.31 111.54 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -116.65 130.44 56.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.281 0.562 . . . . 53.41 111.658 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -122.56 162.37 21.94 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.786 -0.643 . . . . 75.23 111.089 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -120.34 127.55 52.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.828 0.347 . . . . 72.54 111.151 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.3 t -100.49 113.25 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.077 0.465 . . . . 71.23 110.151 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 52.2 m-70 -94.27 105.85 17.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.29 -0.413 . . . . 74.22 110.341 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.629 HG12 HG12 ' A' ' 442' ' ' VAL . 8.7 m -106.19 123.12 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.119 0.485 . . . . 54.31 110.246 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.457 ' HG3' HG23 ' A' ' 441' ' ' THR . 3.5 ptpp? -139.39 147.05 40.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.158 0.504 . . . . 64.0 112.276 -173.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 53.5 t-20 -104.69 126.91 52.23 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.801 -0.636 . . . . 71.43 109.877 175.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 89.3 mt -103.97 -20.61 13.82 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.051 -0.406 . . . . 72.33 111.972 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -60.94 -26.01 64.89 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.309 -0.472 . . . . 74.14 114.016 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.81 18.35 56.49 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.986 -0.626 . . . . 65.43 113.471 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.6 tt -137.07 133.8 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 122.613 0.365 . . . . 73.4 110.705 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.9 145.31 41.39 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 114.718 0.647 . . . . 62.41 114.718 -174.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.8 117.9 16.42 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 122.817 0.447 . . . . 63.11 111.44 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.67 -12.19 11.23 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.752 2.302 . . . . 72.33 112.594 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 17.3 m -81.02 11.63 3.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.812 0.845 . . . . 74.02 112.804 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 74.1 m -88.57 93.83 9.68 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.952 0.882 . . . . 54.32 112.591 -166.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -99.02 126.37 44.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.203 -0.908 . . . . 73.35 110.176 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.582 HG21 HG11 ' A' ' 462' ' ' VAL . 47.3 t -112.17 118.81 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.754 0.312 . . . . 54.44 110.97 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -125.25 152.64 44.33 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.123 0.487 . . . . 72.21 111.785 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 99.3 t -121.21 130.07 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.108 -0.496 . . . . 43.33 111.33 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -123.39 136.46 54.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.077 -0.51 . . . . 74.04 111.592 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 65.6 mt -109.33 112.33 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 110.076 -0.342 . . . . 64.14 110.076 174.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 53.87 33.75 17.85 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.974 0.416 . . . . 64.22 111.45 -175.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 99.54 -23.67 35.26 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.252 -0.499 . . . . 32.23 113.91 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 85.3 m -82.86 133.52 35.12 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.338 0.569 . . . . 75.22 111.763 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.5 tp -68.01 116.84 9.1 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.008 0.432 . . . . 74.44 111.495 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -96.5 -43.57 7.56 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.957 0.354 . . . . 71.35 111.957 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 485' ' ' LYS . . . . . 0.5 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 8.9 tppt? -150.23 155.26 39.39 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.593 -0.276 . . . . 61.41 110.822 -174.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 486' ' ' ASN . . . . . 0.431 ' N ' ' HG3' ' A' ' 485' ' ' LYS . 8.1 p30 -143.97 141.99 30.49 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.995 0.426 . . . . 74.35 111.525 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 487' ' ' TRP . . . . . 0.5 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 8.6 m-90 -133.19 148.7 52.06 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.145 -0.479 . . . . 73.33 111.126 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 65.1 m -120.34 119.04 31.96 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.234 -0.284 . . . . 74.53 110.234 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.5 174.79 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.132 0.492 . . . . 62.51 111.491 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 92.5 p -121.64 139.4 53.59 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.527 -0.306 . . . . 61.24 110.332 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.521 HD12 HD22 ' A' ' 440' ' ' LEU . 68.1 mt -117.78 120.6 38.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.884 0.374 . . . . 64.24 111.105 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -84.37 -169.37 45.47 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.239 -0.505 . . . . 42.24 112.939 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.27 111.95 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.399 2.066 . . . . 74.24 112.519 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 45.5 mmtm 66.46 18.41 10.82 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.267 -0.424 . . . . 74.41 112.01 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -86.39 149.14 25.22 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.064 0.394 . . . . 63.2 112.064 -176.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -133.84 135.7 43.92 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.235 -0.439 . . . . 75.33 111.618 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.409 ' O ' HG22 ' A' ' 462' ' ' VAL . 2.3 mmmp? -122.39 134.09 54.63 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.44 -0.345 . . . . 50.34 110.582 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.73 115.67 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.979 0.418 . . . . 62.45 111.247 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 72.0 mt -107.92 128.93 55.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.247 -0.433 . . . . 61.44 110.801 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 36.5 p -113.08 150.01 32.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.546 0.688 . . . . 74.14 112.617 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -145.65 148.34 32.98 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.586 -0.734 . . . . 74.11 110.982 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.525 ' HB2' HD11 ' A' ' 455' ' ' LEU . 78.5 p -111.69 113.57 26.02 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.182 0.515 . . . . 43.24 111.216 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -108.63 134.27 51.6 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.391 -0.368 . . . . 71.23 110.993 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.3 m -111.08 100.72 47.94 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-N 116.37 -0.377 . . . . 63.25 110.946 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 505' ' ' PRO . . . . . 0.479 ' HB2' HG11 ' A' ' 539' ' ' VAL . 71.6 Cg_endo -74.06 88.77 1.07 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.258 1.972 . . . . 73.31 112.693 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 22.4 p -73.97 -14.24 61.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.211 0.448 . . . . 74.34 112.211 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -115.75 146.21 42.11 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.706 0.288 . . . . 74.15 110.711 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.12 149.55 21.49 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.83 0.348 . . . . 51.15 111.87 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.3 -167.62 27.92 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.998 -0.62 . . . . 63.35 113.416 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 2.4 tpt -90.91 107.63 19.32 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.795 0.331 . . . . 53.22 111.503 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -114.17 146.84 39.8 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.051 -0.406 . . . . 51.43 111.526 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 512' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 35.5 ttp180 -124.42 116.78 23.09 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.554 -0.293 . . . . 72.24 111.268 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 63.2 mt -96.4 130.16 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.843 0.354 . . . . 60.25 111.249 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -125.41 147.79 49.05 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.869 0.366 . . . . 71.34 111.567 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -121.63 133.68 54.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.317 -0.401 . . . . 60.32 110.604 174.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.0 p -127.57 142.65 51.31 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.813 0.339 . . . . 52.34 111.726 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.43 139.66 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 120.733 0.302 . . . . 74.34 111.3 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 46.6 t0 38.96 66.59 0.52 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.682 0.793 . . . . 63.25 112.595 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.95 -31.81 72.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.097 -0.501 . . . . 63.45 111.655 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.88 -19.63 62.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.352 -0.386 . . . . 74.14 111.044 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 59.74 51.88 5.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.46 0.648 . . . . 71.33 110.917 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 68.5 p -67.02 -29.09 68.81 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.76 -0.654 . . . . 73.15 111.205 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.41 HG21 ' HG3' ' A' ' 438' ' ' PRO . 9.8 p -114.88 143.41 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.03 -0.532 . . . . 43.25 111.032 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 524' ' ' VAL . . . . . 0.492 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 51.4 t -82.62 118.18 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.071 0.462 . . . . 70.33 111.227 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -92.38 162.01 14.43 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.775 -0.648 . . . . 70.12 112.593 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 87.5 mt -70.05 -38.12 75.71 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.134 -0.485 . . . . 71.1 110.814 172.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -130.53 118.17 20.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.089 -0.505 . . . . 74.34 111.079 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.39 3.16 32.99 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.007 0.432 . . . . 73.2 112.106 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -107.19 16.78 23.71 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.542 0.687 . . . . 71.22 110.03 173.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.472 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.4 t30 -100.18 -22.44 15.16 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.514 -0.766 . . . . 54.53 112.41 -170.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -81.58 11.54 4.57 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.913 1.079 . . . . 72.35 113.913 -167.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.73 144.22 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.501 0.556 . . . . 45.24 112.501 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 533' ' ' ALA . . . . . 0.541 ' HB2' HG23 ' A' ' 442' ' ' VAL . . . -129.28 142.75 50.75 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.997 -0.547 . . . . 53.23 110.957 173.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.0 m -128.49 123.3 33.25 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.975 0.417 . . . . 43.31 111.872 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -142.74 117.72 10.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.881 0.372 . . . . 74.21 110.652 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 536' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 0.5 OUTLIER -97.24 137.21 36.6 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.485 0.66 . . . . 72.1 112.561 -177.505 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.58 132.38 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.653 -0.703 . . . . 74.53 111.558 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.3 t -99.27 122.04 41.88 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.893 0.377 . . . . 63.1 111.07 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 505' ' ' PRO . 26.1 t -103.85 132.42 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.441 -0.345 . . . . 71.43 110.688 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.83 164.37 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.092 0.472 . . . . 71.3 112.241 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 541' ' ' LEU . . . . . 0.411 HD23 HG11 ' A' ' 452' ' ' VAL . 95.4 mt -78.42 -1.9 35.77 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.265 0.468 . . . . 65.52 112.265 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.254 1.332 0 N-CA-C 112.434 0.531 . . . . 75.33 112.434 -175.707 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 120.655 0.264 . . . . 53.14 110.495 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 72.0 Cg_endo -77.0 173.85 13.8 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.506 2.137 . . . . 54.5 114.241 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -145.17 94.93 2.59 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.161 -0.927 . . . . 75.21 108.679 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.529 HD22 HD12 ' A' ' 491' ' ' LEU . 66.5 mt -100.25 120.66 40.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.076 0.465 . . . . 73.41 111.579 -172.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.623 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.5 t -129.36 159.55 35.85 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.319 0.58 . . . . 54.12 112.375 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.631 HG12 HG12 ' A' ' 462' ' ' VAL . 28.7 m -122.42 148.37 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.772 -0.649 . . . . 74.54 111.473 -178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 37.6 mt-10 -132.27 136.87 47.24 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.406 -0.361 . . . . 74.3 110.241 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 56.6 mt -112.88 126.95 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 120.934 0.397 . . . . 62.34 111.8 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -131.0 144.05 51.18 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.198 -0.455 . . . . 60.45 110.334 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.9 -176.35 36.63 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.653 -0.784 . . . . 63.4 113.317 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.52 114.86 3.43 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.842 2.362 . . . . 71.12 113.122 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -74.93 -14.49 60.65 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.611 0.597 . . . . 72.31 112.611 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.65 126.48 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 122.171 -0.331 . . . . 45.02 110.76 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.93 162.09 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.261 0.553 . . . . 73.1 111.796 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.96 153.91 20.14 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.213 -0.518 . . . . 52.31 112.957 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.566 HG11 HD23 ' A' ' 541' ' ' LEU . 14.5 p -64.0 142.22 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 O-C-N 122.619 -0.342 . . . . 72.44 111.414 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 65.82 13.45 9.0 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.628 0.603 . . . . 75.21 112.628 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -105.29 162.75 13.15 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.059 0.457 . . . . 61.15 111.943 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 502' ' ' SER . 49.2 tp -92.94 133.54 36.01 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.468 -0.333 . . . . 73.21 111.634 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -131.4 132.58 44.49 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.797 0.332 . . . . 73.42 111.46 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -112.92 131.88 55.56 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.804 0.335 . . . . 53.31 111.183 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' TYR . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 61.6 m-85 -121.59 157.61 30.39 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.235 -0.438 . . . . 75.11 111.013 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.511 ' HG2' HG22 ' A' ' 500' ' ' THR . 41.9 mt-10 -120.26 127.02 52.01 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.997 -0.547 . . . . 63.14 111.344 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.62 113.68 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.165 173.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.546 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 44.8 m-70 -95.09 111.63 23.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.869 0.366 . . . . 75.32 110.267 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.631 HG12 HG12 ' A' ' 442' ' ' VAL . 33.1 m -106.57 122.71 60.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.99 0.424 . . . . 71.44 110.652 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.527 ' HD3' HD21 ' A' ' 465' ' ' LEU . 1.4 ptpp? -130.42 148.55 52.25 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.295 0.569 . . . . 64.55 112.282 -174.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.569 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.7 t-20 -99.64 128.07 45.75 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.668 -0.696 . . . . 73.32 110.014 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.527 HD21 ' HD3' ' A' ' 463' ' ' LYS . 79.9 mt -109.45 -10.7 14.88 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.752 0.311 . . . . 73.2 111.747 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -76.26 -28.48 60.0 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.294 -0.479 . . . . 40.55 113.566 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.13 22.39 45.27 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.955 -0.64 . . . . 72.04 113.389 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.6 tt -137.73 135.82 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 122.738 0.415 . . . . 53.25 111.102 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.413 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -70.02 133.08 24.32 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 114.608 0.603 . . . . 62.4 114.608 -174.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.39 118.48 17.09 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.21 0.604 . . . . 63.22 111.306 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -88.85 -9.86 4.47 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.074 2.516 . . . . 73.12 113.851 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.3 p -81.65 11.95 4.29 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.83 0.678 . . . . 72.15 112.83 -177.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' THR . . . . . 0.486 ' HA ' ' OD1' ' A' ' 518' ' ' ASP . 98.7 m -87.24 109.96 19.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.072 0.939 . . . . 44.35 112.094 -164.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -119.99 128.14 53.28 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.009 -0.996 . . . . 75.03 110.892 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.629 HG21 HG11 ' A' ' 462' ' ' VAL . 25.1 t -104.59 135.83 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.404 -0.362 . . . . 62.04 111.902 -175.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 476' ' ' ARG . . . . . 0.562 ' NH1' ' HB2' ' A' ' 519' ' ' GLU . 59.2 mtt85 -123.64 143.39 50.27 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.369 -0.378 . . . . 75.31 111.273 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.52 123.18 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 120.996 0.427 . . . . 61.33 111.123 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -111.55 137.82 48.9 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.042 -0.526 . . . . 63.45 110.7 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 62.5 mt -115.99 109.66 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 110.025 -0.361 . . . . 75.43 110.025 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 55.16 34.62 23.04 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.089 0.471 . . . . 73.41 111.292 -174.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 97.39 -24.09 33.0 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.049 -0.523 . . . . 72.0 113.699 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 66.0 m -82.67 120.4 25.52 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.394 -0.474 . . . . 55.53 111.76 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -62.8 115.05 4.0 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.054 0.454 . . . . 75.15 110.971 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -89.74 -43.54 10.62 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.382 0.512 . . . . 64.14 112.382 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -164.45 161.23 21.31 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.19 -0.319 . . . . 44.34 111.454 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.58 154.98 42.75 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.936 0.398 . . . . 74.51 111.941 177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -135.02 148.87 50.05 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.848 0.459 . . . . 73.42 111.431 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 79.6 m -105.64 119.24 38.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 110.156 -0.313 . . . . 75.44 110.156 171.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.07 173.34 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.394 0.616 . . . . 62.44 111.876 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 75.1 p -126.58 134.71 50.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.081 -0.508 . . . . 63.4 110.686 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.529 HD12 HD22 ' A' ' 440' ' ' LEU . 92.1 mt -117.38 118.89 33.48 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.875 0.369 . . . . 65.13 111.275 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 492' ' ' GLY . . . . . 0.413 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -81.47 -166.56 36.95 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.193 -0.527 . . . . 60.32 112.652 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.03 107.12 0.73 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.15 1.9 . . . . 74.43 112.172 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 41.6 mmtm 68.66 22.9 7.32 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.204 -0.453 . . . . 52.34 111.772 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -81.81 149.88 28.14 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.892 0.33 . . . . 74.21 111.892 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 496' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 462' ' ' VAL . 41.5 tt0 -135.38 134.59 39.91 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.744 0.307 . . . . 63.12 111.286 176.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -118.91 149.79 40.98 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.639 -0.255 . . . . 73.5 110.621 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.92 113.22 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.001 0.429 . . . . 71.42 111.48 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 50.6 mt -105.71 146.23 30.05 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.242 -0.436 . . . . 65.24 111.047 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.511 HG22 ' HG2' ' A' ' 459' ' ' GLU . 20.9 p -129.47 149.8 51.09 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.367 0.603 . . . . 72.44 112.611 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 501' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 49.0 p90 -144.33 148.46 34.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.793 -0.639 . . . . 70.53 111.156 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.568 ' HB2' HD11 ' A' ' 455' ' ' LEU . 24.8 p -110.96 115.06 28.85 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.207 0.527 . . . . 72.43 111.577 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -120.88 137.44 54.58 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.008 -0.542 . . . . 51.3 111.601 -174.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 92.9 m -120.61 102.05 45.32 Favored Pre-proline 0 N--CA 1.473 0.688 0 CA-C-N 116.458 -0.337 . . . . 65.11 111.282 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.97 104.43 1.91 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.578 2.185 . . . . 74.52 113.068 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 77.0 p -86.82 -15.76 38.23 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.021 0.438 . . . . 73.22 111.995 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.22 137.13 42.59 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.731 0.301 . . . . 71.1 110.837 171.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.17 150.21 25.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.009 0.433 . . . . 74.25 112.151 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 143.98 -167.73 26.7 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.177 -0.535 . . . . 75.02 113.181 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 89.6 mmm -89.57 121.1 31.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.064 0.459 . . . . 74.5 111.395 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -121.58 111.7 17.55 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.427 0.632 . . . . 74.4 111.207 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -104.02 120.34 40.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.805 -0.634 . . . . 72.32 111.308 -177.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 62.2 mt -95.73 128.44 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.841 -0.618 . . . . 73.34 111.473 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -122.95 135.3 54.43 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.196 -0.457 . . . . 74.24 111.041 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.56 139.53 48.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.784 0.325 . . . . 62.41 111.416 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 516' ' ' THR . . . . . 0.527 HG22 HG22 ' A' ' 532' ' ' VAL . 71.2 p -129.26 151.85 49.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.921 0.391 . . . . 73.02 111.035 177.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.5 p -130.0 141.8 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.525 -0.307 . . . . 52.23 111.524 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 518' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' A' ' 473' ' ' THR . 1.3 m-20 50.17 47.91 22.9 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.456 0.539 . . . . 72.53 112.456 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 519' ' ' GLU . . . . . 0.562 ' HB2' ' NH1' ' A' ' 476' ' ' ARG . 6.0 mm-40 -53.62 -32.78 52.67 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.283 0.475 . . . . 74.13 112.283 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.42 -17.05 64.12 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.171 0.434 . . . . 72.21 112.171 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 49.84 37.17 12.81 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.742 0.645 . . . . 64.3 112.742 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 38.5 p -72.38 -16.66 61.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.858 0.361 . . . . 60.44 111.78 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 8.3 p -108.01 136.53 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.417 -0.356 . . . . 74.04 111.07 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 524' ' ' VAL . . . . . 0.434 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 90.7 t -84.23 113.3 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.873 0.368 . . . . 75.33 110.879 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -100.61 174.23 6.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.259 0.552 . . . . 65.41 112.269 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.7 mt -82.85 -24.39 33.29 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.68 -0.691 . . . . 72.21 111.675 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 527' ' ' ASN . . . . . 0.57 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 25.0 t-20 -118.6 158.24 25.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.145 0.498 . . . . 54.34 111.579 -174.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -118.35 -23.8 7.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.165 -0.471 . . . . 74.43 111.981 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -105.89 -7.39 18.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.3 0.481 . . . . 72.42 112.3 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.623 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 58.2 t30 -86.77 -7.7 58.02 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.713 0.634 . . . . 72.43 112.713 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -75.42 -0.27 19.44 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.159 0.799 . . . . 73.33 113.159 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 516' ' ' THR . 48.4 t -126.86 146.05 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.439 0.533 . . . . 53.31 112.439 -175.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 533' ' ' ALA . . . . . 0.407 ' CB ' HG23 ' A' ' 442' ' ' VAL . . . -136.14 142.69 44.25 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.245 -0.434 . . . . 53.31 111.276 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.8 m -117.3 134.83 54.34 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.404 0.52 . . . . 72.53 112.404 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -138.54 126.64 22.71 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.369 -0.378 . . . . 63.03 110.363 174.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -102.6 123.44 46.34 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.825 0.345 . . . . 74.32 111.85 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.47 144.45 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.996 0.427 . . . . 71.4 111.667 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.0 t -112.95 127.03 56.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.776 0.322 . . . . 75.14 111.413 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.1 120.51 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.85 0.357 . . . . 74.41 111.066 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.74 158.91 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.442 0.534 . . . . 55.22 112.442 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 541' ' ' LEU . . . . . 0.566 HD23 HG11 ' A' ' 452' ' ' VAL . 89.9 mt -81.3 -28.43 34.62 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.251 -0.431 . . . . 74.02 111.632 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.254 1.339 0 N-CA-C 112.725 0.639 . . . . 75.31 112.725 -176.893 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 437' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 438' ' ' PRO . 96.5 m-85 . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 120.689 0.28 . . . . 75.34 110.474 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.479 ' HG2' HG21 ' A' ' 523' ' ' VAL . 2.6 Cg_exo -75.03 173.91 13.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.922 2.415 . . . . 71.33 114.223 -176.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -152.87 78.2 1.18 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.784 -1.098 . . . . 73.41 108.972 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.418 HD22 HD12 ' A' ' 491' ' ' LEU . 70.4 mt -84.12 110.48 18.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.669 -0.696 . . . . 73.13 111.416 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.472 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 13.7 t -115.57 149.32 38.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.146 0.498 . . . . 70.31 111.459 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.599 HG12 HG12 ' A' ' 462' ' ' VAL . 27.1 m -121.02 148.41 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.966 -0.561 . . . . 73.13 111.144 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 43.7 mt-10 -139.69 131.58 27.65 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.496 -0.32 . . . . 73.21 110.872 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 53.8 mt -105.55 138.69 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 122.129 -0.357 . . . . 72.12 111.463 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -141.59 134.97 29.56 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 120.563 0.221 . . . . 65.02 111.287 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.68 -164.87 37.63 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.947 -0.644 . . . . 63.31 113.678 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.2 136.84 32.81 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.743 2.296 . . . . 65.03 113.44 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -82.95 -44.94 14.73 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.898 0.38 . . . . 70.44 111.751 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.16 133.72 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 120.989 0.423 . . . . 71.4 111.278 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.5 m -135.7 162.99 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.068 0.461 . . . . 75.1 111.539 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -98.34 165.65 21.66 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.178 -0.534 . . . . 71.44 113.056 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 11.9 p -69.44 136.76 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 120.853 0.359 . . . . 63.13 111.591 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 24.0 m120 64.67 15.65 9.87 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.151 0.58 . . . . 71.32 112.547 -176.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 454' ' ' LYS . . . . . 0.419 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.0 mmmt -95.82 143.93 26.62 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.13 0.49 . . . . 70.44 111.656 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 502' ' ' SER . 43.1 tp -81.75 123.14 28.51 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.277 -0.42 . . . . 71.31 111.159 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -118.36 132.31 56.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.84 0.352 . . . . 75.12 111.288 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -120.7 132.03 54.86 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.201 0.524 . . . . 50.42 111.747 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -123.76 159.42 29.51 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.739 -0.664 . . . . 75.45 110.96 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.471 ' HG3' HG22 ' A' ' 500' ' ' THR . 1.9 mp0 -120.22 127.46 52.45 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.069 0.462 . . . . 74.44 110.745 175.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.7 t -100.52 121.46 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.274 -0.421 . . . . 50.52 111.48 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 11.6 m-70 -96.22 110.58 22.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.081 -0.509 . . . . 74.11 110.522 176.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.599 HG12 HG12 ' A' ' 442' ' ' VAL . 19.8 m -114.4 123.42 70.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.962 0.411 . . . . 75.33 110.342 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.587 ' HD3' HD21 ' A' ' 465' ' ' LEU . 4.5 ptpp? -139.17 148.37 43.1 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.467 0.651 . . . . 75.32 112.705 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 49.4 t-20 -100.23 127.58 46.48 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.495 -0.775 . . . . 61.12 109.873 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.587 HD21 ' HD3' ' A' ' 463' ' ' LYS . 77.9 mt -115.02 -2.66 12.76 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.364 0.505 . . . . 64.02 112.364 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -72.88 -22.85 78.8 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.979 -0.629 . . . . 53.14 113.174 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.75 16.42 59.92 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.255 -0.498 . . . . 73.24 113.307 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 10.2 tt -135.69 139.73 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 122.729 -0.277 . . . . 73.3 110.942 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.4 137.08 25.65 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.171 -0.538 . . . . 55.15 114.079 -176.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 57.7 t -131.68 112.9 15.16 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 120.802 0.334 . . . . 75.33 111.796 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -88.01 -10.9 4.78 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.3 2.667 . . . . 50.44 113.057 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 79.9 p -81.95 13.3 3.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.534 0.734 . . . . 72.21 112.674 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 91.0 m -87.42 108.82 19.18 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.755 0.788 . . . . 62.15 112.436 -164.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -110.57 130.59 55.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.352 -0.84 . . . . 70.33 111.42 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.533 HG21 HG11 ' A' ' 462' ' ' VAL . 47.3 t -111.53 130.74 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 122.314 0.246 . . . . 63.1 110.981 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 476' ' ' ARG . . . . . 0.603 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 96.0 mtt180 -124.2 150.11 45.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.945 0.402 . . . . 65.44 111.418 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.98 120.71 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.218 -0.446 . . . . 55.34 111.085 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -113.75 137.1 52.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.473 -0.33 . . . . 74.35 110.99 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 513' ' ' ILE . 63.2 mt -113.34 111.89 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 110.166 -0.309 . . . . 61.02 110.166 174.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 54.46 34.38 20.84 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.108 0.48 . . . . 64.34 111.77 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.18 -19.06 55.35 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.382 -0.437 . . . . 71.31 113.482 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 89.7 m -87.11 124.38 33.18 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.543 -0.386 . . . . 55.52 111.693 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.6 tp -62.7 120.4 11.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.1 0.476 . . . . 63.11 111.774 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 484' ' ' TYR . . . . . 0.453 ' CE2' ' HE2' ' A' ' 485' ' ' LYS . 19.3 t80 -94.81 -43.07 8.39 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.19 -0.459 . . . . 74.33 112.124 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 485' ' ' LYS . . . . . 0.453 ' HE2' ' CE2' ' A' ' 484' ' ' TYR . 4.5 ttpt -167.67 159.78 12.21 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 122.235 -0.291 . . . . 74.54 111.464 -177.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -143.17 144.12 32.06 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.939 0.4 . . . . 64.23 112.037 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -132.78 149.6 52.25 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.991 0.516 . . . . 75.3 111.208 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.0 m -118.06 119.95 36.31 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 110.202 -0.295 . . . . 74.24 110.202 170.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.48 172.98 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.32 0.581 . . . . 71.11 111.966 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 79.1 p -111.9 137.4 49.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.04 -0.527 . . . . 74.43 110.752 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.418 HD12 HD22 ' A' ' 440' ' ' LEU . 69.0 mt -127.55 118.99 25.01 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.828 0.347 . . . . 73.34 110.721 174.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -84.43 -174.79 50.53 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.951 -0.642 . . . . 74.32 112.702 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.97 105.84 0.23 Allowed 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.365 2.043 . . . . 70.23 112.052 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.7 mmtp 71.59 29.19 2.67 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.154 0.427 . . . . 75.23 112.154 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.95 155.31 17.14 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.814 0.34 . . . . 61.33 111.869 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -130.34 143.21 50.63 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.215 -0.448 . . . . 64.44 111.393 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.445 ' HB2' ' CG2' ' A' ' 462' ' ' VAL . 43.6 mmtm -117.21 146.85 42.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.052 0.541 . . . . 65.32 110.039 172.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.57 113.14 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.047 0.451 . . . . 73.04 110.938 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 56.7 mt -110.84 141.24 44.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.405 -0.362 . . . . 73.52 111.166 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.471 HG22 ' HG3' ' A' ' 459' ' ' GLU . 21.5 p -113.81 151.7 31.69 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.493 0.553 . . . . 74.14 112.493 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -150.84 148.51 28.56 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.019 -0.537 . . . . 63.15 111.311 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.569 ' HB2' HD11 ' A' ' 455' ' ' LEU . 89.9 p -118.42 125.89 50.91 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.271 -0.422 . . . . 75.53 111.111 -178.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -125.97 136.8 53.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.914 0.388 . . . . 74.04 111.136 -177.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.4 m -121.31 100.77 44.71 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.694 0.283 . . . . 64.33 111.016 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 505' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 80.3 Cg_endo -77.64 106.3 2.17 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.623 2.215 . . . . 62.03 113.108 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.8 p -87.54 12.17 13.09 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.042 0.386 . . . . 72.25 112.042 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -142.74 132.72 24.31 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.711 0.404 . . . . 61.31 110.967 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -73.68 150.73 41.07 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.475 0.546 . . . . 73.22 112.475 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 145.76 -173.35 26.15 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.879 -0.676 . . . . 35.4 113.397 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 95.9 mmm -99.31 112.61 24.74 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.049 0.452 . . . . 72.12 111.032 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -115.05 119.21 35.68 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.2 0.524 . . . . 75.33 111.431 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -97.72 117.91 33.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.104 -0.498 . . . . 73.23 111.153 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 479' ' ' ILE . 65.0 mt -95.29 120.01 44.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.0 -0.545 . . . . 73.32 111.119 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.48 137.35 52.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.934 0.397 . . . . 72.52 111.341 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.1 132.96 54.54 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.299 -0.409 . . . . 70.53 110.738 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 516' ' ' THR . . . . . 0.488 HG22 HG22 ' A' ' 532' ' ' VAL . 43.9 p -126.03 141.14 52.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.887 0.375 . . . . 73.34 111.244 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.36 141.89 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.95 0.405 . . . . 74.52 111.43 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.3 t0 49.89 58.66 5.21 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.643 0.735 . . . . 62.44 111.919 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 519' ' ' GLU . . . . . 0.603 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.9 mm-40 -59.12 -32.69 70.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.284 0.564 . . . . 75.51 111.322 174.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.55 -18.05 64.27 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.763 -0.653 . . . . 71.41 111.68 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 52.02 70.22 0.58 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.719 0.771 . . . . 54.51 110.8 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 67.4 p -96.76 -10.87 25.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.472 -0.785 . . . . 73.33 111.689 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.479 HG21 ' HG2' ' A' ' 438' ' ' PRO . 11.7 p -141.66 144.15 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.057 0.456 . . . . 74.42 111.736 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.5 t -82.79 116.27 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.968 0.413 . . . . 74.31 111.528 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.88 156.25 17.62 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.888 -0.597 . . . . 73.22 112.423 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.84 -38.85 70.05 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.765 -0.652 . . . . 65.22 111.329 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -119.81 122.07 40.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.842 0.353 . . . . 72.34 110.703 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -83.05 -17.55 42.84 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.006 0.431 . . . . 70.12 111.934 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -102.08 14.98 30.46 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.102 -0.374 . . . . 74.34 111.669 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.472 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 66.3 t30 -104.93 -11.39 16.72 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.289 0.477 . . . . 73.35 112.289 -172.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -86.56 6.11 32.33 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.923 0.712 . . . . 72.23 112.923 -172.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 516' ' ' THR . 51.4 t -130.42 143.15 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.018 0.437 . . . . 54.05 112.107 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 533' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -129.73 143.2 50.7 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.386 -0.37 . . . . 72.41 111.023 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 56.9 m -117.78 135.48 54.03 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.856 0.36 . . . . 61.34 111.909 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -141.98 116.91 9.9 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.51 -0.552 . . . . 74.23 109.51 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -101.62 124.34 47.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.201 0.524 . . . . 60.34 111.813 -175.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.7 t -112.32 144.44 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.961 -0.563 . . . . 72.42 111.64 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 30.1 t -112.38 128.53 56.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.525 -0.307 . . . . 44.33 111.131 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.6 t -111.12 125.59 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 120.827 0.346 . . . . 73.24 111.691 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.75 161.12 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.165 0.507 . . . . 71.23 111.893 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.0 -14.37 58.0 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.754 0.65 . . . . 65.04 112.754 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 112.856 0.687 . . . . 62.21 112.856 -176.298 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 120.582 0.229 . . . . 73.21 110.788 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.626 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 20.6 Cg_endo -79.99 174.37 11.63 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.334 2.022 . . . . 52.31 113.53 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 11.7 t70 -149.38 82.96 1.42 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.686 -0.688 . . . . 73.2 109.794 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.522 HD11 HG11 ' A' ' 470' ' ' VAL . 92.1 mt -84.73 114.76 22.28 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.105 -0.498 . . . . 72.2 111.771 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.476 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.2 t -126.37 158.6 35.47 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.009 0.433 . . . . 63.13 111.382 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 462' ' ' VAL . 33.8 m -132.1 148.13 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 116.112 -0.495 . . . . 65.32 111.319 -177.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.5 mt-10 -125.08 137.15 54.2 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.421 0.288 . . . . 71.01 110.994 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.8 mt -108.76 127.68 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.919 0.39 . . . . 41.03 111.471 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -128.37 132.04 48.55 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.673 -0.239 . . . . 75.33 111.15 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 172.15 -173.77 45.27 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.654 -0.784 . . . . 75.13 113.678 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.75 136.48 23.26 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.774 2.316 . . . . 73.3 113.395 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.57 -47.89 58.04 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.966 -0.561 . . . . 65.45 111.898 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.1 t -117.83 125.83 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.765 0.317 . . . . 72.11 111.078 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.3 160.77 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.179 0.514 . . . . 73.41 111.867 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.53 148.56 19.34 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.074 -0.584 . . . . 63.14 113.323 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.39 138.42 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 120.857 0.361 . . . . 72.1 111.284 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 22.7 m120 63.56 18.68 11.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.959 0.504 . . . . 72.14 111.951 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -108.9 161.38 15.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.194 0.521 . . . . 71.21 111.623 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 502' ' ' SER . 37.8 tp -99.0 126.24 44.65 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.004 -0.544 . . . . 55.04 111.745 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.51 132.69 45.75 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.814 0.34 . . . . 54.21 111.582 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -104.98 138.58 40.97 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.42 0.629 . . . . 72.15 112.098 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' TYR . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 59.1 m-85 -122.84 151.34 41.79 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.554 -0.748 . . . . 71.55 110.302 177.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -120.02 127.2 52.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.094 0.474 . . . . 75.22 111.029 -175.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 21.6 t -105.07 114.78 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.101 -0.5 . . . . 75.21 111.124 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.591 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 46.8 m-70 -92.16 107.56 19.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.851 0.358 . . . . 74.43 110.299 174.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.621 HG11 HG21 ' A' ' 475' ' ' VAL . 20.2 m -105.55 133.21 50.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.927 0.394 . . . . 71.43 110.193 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.564 ' HD3' HD21 ' A' ' 465' ' ' LEU . 0.1 OUTLIER -148.2 152.3 36.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.585 0.587 . . . . 61.25 112.585 -172.724 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.553 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.8 t-20 -107.72 127.46 53.7 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.634 -0.712 . . . . 73.52 109.524 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.564 HD21 ' HD3' ' A' ' 463' ' ' LYS . 79.9 mt -111.86 0.05 16.02 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.172 0.434 . . . . 62.05 112.172 -176.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -82.91 -25.38 49.61 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.92 -0.657 . . . . 55.0 113.632 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.88 22.73 41.22 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.101 -0.571 . . . . 73.2 113.577 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 9.5 tt -138.18 144.18 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 122.51 -0.406 . . . . 63.14 110.763 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.48 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -71.82 138.72 27.51 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.154 -0.546 . . . . 62.14 114.059 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.522 HG11 HD11 ' A' ' 440' ' ' LEU . 40.7 t -129.71 117.36 18.44 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 112.34 0.496 . . . . 72.51 112.34 -177.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.2 -11.0 8.77 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.105 2.537 . . . . 73.24 112.759 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 57.7 m -80.98 11.44 4.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.457 0.703 . . . . 45.32 112.685 -176.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 39.3 m -88.97 91.1 8.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.661 0.743 . . . . 63.23 112.422 -166.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 474' ' ' LYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 517' ' ' VAL . 95.9 mttt -96.81 131.33 43.65 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.514 -0.766 . . . . 71.32 110.152 171.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.621 HG21 HG11 ' A' ' 462' ' ' VAL . 49.4 t -117.89 118.36 58.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 122.12 -0.363 . . . . 61.0 110.709 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -126.43 153.47 44.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.276 0.56 . . . . 63.23 112.076 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 84.8 t -120.41 135.79 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.006 -0.543 . . . . 75.14 111.141 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 478' ' ' TYR . . . . . 0.403 ' HE1' ' OG1' ' A' ' 516' ' ' THR . 25.1 m-85 -124.51 142.09 51.59 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.188 -0.46 . . . . 74.41 111.196 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 513' ' ' ILE . 64.5 mt -114.82 111.55 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.295 -0.412 . . . . 74.13 109.998 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 54.34 34.03 19.74 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.195 0.521 . . . . 72.21 111.278 -173.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 98.07 -25.69 26.58 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.177 -0.465 . . . . 72.34 113.765 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 28.0 m -82.04 129.75 34.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.327 0.563 . . . . 74.15 111.851 -174.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.3 tp -62.48 124.23 20.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.096 0.474 . . . . 71.42 111.689 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -105.58 -43.72 4.87 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.518 0.562 . . . . 74.02 112.518 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 485' ' ' LYS . . . . . 0.419 ' HD3' ' HB3' ' A' ' 501' ' ' PHE . 83.6 tttt -155.45 152.55 29.12 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 110.324 -0.25 . . . . 74.31 110.324 -176.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -141.09 147.89 39.27 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.434 0.531 . . . . 75.04 112.434 -176.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.5 m-90 -132.69 148.81 52.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.949 -0.569 . . . . 74.54 110.94 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.9 m -124.88 117.12 23.39 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.557 -0.534 . . . . 70.24 109.557 167.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.42 172.87 11.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.139 0.495 . . . . 75.41 111.587 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 30.3 m -116.93 133.89 55.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.186 -0.461 . . . . 70.35 110.335 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 72.8 mt -120.53 120.48 35.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.941 0.401 . . . . 74.41 110.978 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 492' ' ' GLY . . . . . 0.48 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -80.85 -168.83 40.14 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.176 -0.535 . . . . 51.5 113.141 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -63.08 109.95 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.463 2.109 . . . . 71.2 112.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.5 mttt 63.45 37.48 10.62 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.618 0.723 . . . . 75.45 111.239 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -85.98 149.35 25.24 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.208 -0.905 . . . . 71.1 111.419 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -136.09 145.42 45.91 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.839 0.352 . . . . 71.12 111.473 172.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -141.6 147.33 37.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.002 0.521 . . . . 73.22 111.018 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 42.3 t -111.15 112.99 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.209 0.528 . . . . 33.13 111.54 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.7 127.85 55.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.178 -0.465 . . . . 74.23 110.268 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 76.0 p -112.96 163.05 15.14 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.136 0.791 . . . . 73.22 113.136 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 501' ' ' PHE . . . . . 0.419 ' HB3' ' HD3' ' A' ' 485' ' ' LYS . 47.8 p90 -152.23 148.29 27.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.305 -0.861 . . . . 74.34 110.906 172.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.569 ' HB2' HD11 ' A' ' 455' ' ' LEU . 78.6 p -114.9 114.72 25.86 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.072 0.463 . . . . 64.04 111.08 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 503' ' ' TRP . . . . . 0.47 ' CZ2' ' HB3' ' A' ' 505' ' ' PRO . 25.1 t90 -107.73 137.33 45.94 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.069 0.547 . . . . 75.14 111.776 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 93.4 m -125.9 101.47 29.39 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 116.407 -0.36 . . . . 73.3 111.02 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 505' ' ' PRO . . . . . 0.47 ' HB3' ' CZ2' ' A' ' 503' ' ' TRP . 85.5 Cg_endo -82.22 102.18 1.18 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.528 2.152 . . . . 74.21 113.321 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 63.4 p -76.38 -21.77 55.63 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.856 0.36 . . . . 74.44 111.185 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -107.91 125.76 51.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.932 0.396 . . . . 65.43 111.373 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.06 150.86 46.15 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.4 0.519 . . . . 74.31 112.4 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.83 -173.12 33.23 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.083 -0.579 . . . . 74.1 113.061 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 8.8 tpt -99.71 126.94 45.83 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.577 -0.366 . . . . 74.55 110.727 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -132.86 112.0 11.54 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.337 0.495 . . . . 75.33 112.337 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -93.03 118.23 30.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.869 0.366 . . . . 74.23 110.776 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 479' ' ' ILE . 64.2 mt -95.47 127.93 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.093 0.473 . . . . 74.21 111.507 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -121.43 152.57 38.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.926 0.393 . . . . 73.4 111.194 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -128.9 135.35 48.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.769 0.318 . . . . 41.12 111.135 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 516' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 532' ' ' VAL . 38.5 p -123.73 149.44 45.55 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.326 -0.397 . . . . 71.24 111.431 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 474' ' ' LYS . 7.3 p -119.4 139.56 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 116.422 -0.354 . . . . 73.24 111.459 170.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.9 t70 43.8 70.41 0.32 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.609 0.764 . . . . 63.01 111.687 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -61.97 -33.06 73.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.792 -0.64 . . . . 71.24 111.437 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.34 -13.66 62.5 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.651 0.612 . . . . 72.33 112.651 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.1 t30 56.34 55.9 6.22 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.535 0.683 . . . . 71.21 110.428 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 68.5 p -85.25 -31.73 22.96 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.923 -0.58 . . . . 70.34 111.133 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.56 141.75 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.01 -0.541 . . . . 65.54 111.034 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.8 112.13 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.844 0.354 . . . . 74.34 111.557 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.483 ' OE2' ' HG2' ' A' ' 438' ' ' PRO . 13.5 mm-40 -91.22 163.7 14.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.258 0.551 . . . . 73.13 112.124 -176.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.6 mt -71.98 -39.14 69.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.279 0.561 . . . . 72.34 110.854 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -129.46 110.48 11.91 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.945 -0.57 . . . . 54.54 110.271 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 528' ' ' GLU . . . . . 0.553 ' HA ' ' ND2' ' A' ' 531' ' ' ASN . 10.0 pt-20 -83.09 -21.8 33.6 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.989 0.423 . . . . 62.43 111.4 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -75.39 -12.31 60.23 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.147 0.499 . . . . 72.33 110.821 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.476 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 41.7 t30 -86.72 -14.62 41.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.999 -0.546 . . . . 74.14 111.145 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 531' ' ' ASN . . . . . 0.553 ' ND2' ' HA ' ' A' ' 528' ' ' GLU . 8.5 m-80 -69.0 -13.97 62.77 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.08 0.77 . . . . 62.14 113.08 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.531 HG22 HG22 ' A' ' 516' ' ' THR . 57.7 t -116.57 134.0 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.528 0.566 . . . . 73.13 112.528 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 533' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -114.42 143.07 45.52 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.218 -0.446 . . . . 63.15 110.54 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 70.0 m -125.76 125.86 43.64 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.022 0.439 . . . . 60.02 111.888 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -137.65 122.98 19.44 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.042 0.449 . . . . 74.11 110.781 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -93.36 129.12 39.6 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.411 -0.359 . . . . 64.22 111.386 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.87 142.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.332 0.587 . . . . 63.43 111.93 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 22.8 t -118.38 127.2 53.45 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.343 -0.389 . . . . 75.41 111.189 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.0 t -104.85 123.62 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.825 0.345 . . . . 62.34 111.31 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 31.0 m -116.1 161.75 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.795 0.665 . . . . 62.43 112.795 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.02 -17.38 43.54 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.037 -0.529 . . . . 74.31 111.737 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.253 1.267 0 CA-C-N 116.031 -0.531 . . . . 73.2 112.176 178.499 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 110.392 -0.225 . . . . 71.12 110.392 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.595 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 72.9 Cg_endo -74.27 169.53 22.27 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.344 2.029 . . . . 61.43 113.567 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 439' ' ' ASP . . . . . 0.458 ' HB2' HD12 ' A' ' 526' ' ' LEU . 37.3 t70 -128.74 96.05 4.27 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.727 -0.669 . . . . 74.03 109.833 176.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 491' ' ' LEU . 88.7 mt -94.36 112.81 24.61 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.873 0.368 . . . . 61.31 111.077 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.514 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 6.8 t -122.46 153.42 39.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.994 0.426 . . . . 73.41 111.92 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.617 HG12 HG12 ' A' ' 462' ' ' VAL . 32.2 m -129.79 150.16 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.131 -0.486 . . . . 62.53 111.814 -177.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 49.6 mt-10 -130.23 144.81 51.58 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.21 -0.45 . . . . 54.03 110.918 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 53.4 mt -116.27 129.66 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.931 0.395 . . . . 74.14 111.199 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -134.19 137.43 44.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.414 -0.357 . . . . 74.11 110.981 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.29 -176.87 40.86 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.265 -0.969 . . . . 61.34 114.074 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.62 117.18 5.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.831 2.354 . . . . 73.52 113.071 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -71.85 -30.37 65.37 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.783 0.66 . . . . 64.12 112.783 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 94.6 t -120.73 122.98 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.885 -0.51 . . . . 62.15 111.503 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.97 163.28 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.084 0.469 . . . . 71.45 112.059 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.75 156.91 24.13 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.346 -0.454 . . . . 50.05 113.296 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.419 HG22 ' OD1' ' A' ' 453' ' ' ASN . 10.7 p -69.95 140.41 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.015 0.436 . . . . 63.12 111.807 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 453' ' ' ASN . . . . . 0.419 ' OD1' HG22 ' A' ' 452' ' ' VAL . 26.8 m120 60.7 24.4 14.22 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.52 0.563 . . . . 62.33 112.52 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -105.94 176.13 5.27 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.125 0.488 . . . . 74.03 111.733 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 41.9 tp -105.09 120.2 40.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.338 -0.392 . . . . 62.25 111.431 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -129.25 132.78 47.27 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.739 0.304 . . . . 74.42 111.647 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -112.28 139.85 47.49 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.294 0.569 . . . . 61.55 111.548 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' TYR . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 53.7 m-85 -121.97 157.51 31.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.752 -0.658 . . . . 65.22 110.726 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -121.0 129.01 53.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.922 0.489 . . . . 75.24 111.079 -174.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 460' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 41.0 t -115.26 119.25 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.758 0.313 . . . . 74.32 111.353 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.601 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 49.3 m-70 -96.26 104.6 16.57 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.6 -0.273 . . . . 65.45 110.98 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.617 HG12 HG12 ' A' ' 442' ' ' VAL . 18.7 m -106.77 124.76 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.856 0.36 . . . . 72.13 110.988 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.46 ' HG3' HG23 ' A' ' 441' ' ' THR . 6.6 pttm -140.92 158.73 43.53 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.31 0.856 . . . . 65.24 113.31 -175.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.638 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.5 t-20 -107.94 128.7 54.86 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.677 -1.147 . . . . 63.34 109.468 175.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 86.4 mt -119.17 16.75 13.21 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.785 0.326 . . . . 75.21 111.86 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -100.81 -12.48 37.25 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.114 -0.565 . . . . 74.31 113.331 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.83 21.15 69.16 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.149 -0.548 . . . . 71.45 113.735 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.492 HG23 ' HB3' ' A' ' 438' ' ' PRO . 3.7 tt -134.67 132.99 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 122.602 -0.352 . . . . 73.42 111.048 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -66.43 134.61 33.37 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.367 -0.444 . . . . 72.33 113.679 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.94 116.06 16.82 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 122.562 0.345 . . . . 45.4 111.74 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.99 -11.21 12.42 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.117 2.544 . . . . 64.01 112.593 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 472' ' ' SER . . . . . 0.425 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 50.8 m -80.65 11.78 3.58 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.043 0.757 . . . . 71.31 113.043 -174.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.1 m -88.61 95.12 10.12 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.951 0.882 . . . . 61.11 111.937 -169.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -106.5 126.54 52.39 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.24 -0.891 . . . . 74.23 110.558 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.612 HG21 HG11 ' A' ' 462' ' ' VAL . 44.6 t -106.8 122.98 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 122.3 -0.25 . . . . 73.41 111.614 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 476' ' ' ARG . . . . . 0.62 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 46.9 mtt180 -115.75 146.9 41.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.746 0.308 . . . . 54.22 111.339 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 77.9 t -121.6 121.86 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.917 0.389 . . . . 72.23 111.308 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -112.1 141.12 46.17 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.305 -0.407 . . . . 71.14 111.826 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.55 HG12 HG12 ' A' ' 513' ' ' ILE . 53.8 mt -124.24 111.77 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.552 -0.295 . . . . 74.52 110.811 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 52.77 34.83 17.15 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.532 0.567 . . . . 71.21 112.532 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 90.41 3.05 72.55 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 120.858 -0.686 . . . . 54.0 113.887 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.7 m -110.73 121.61 45.76 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.423 -0.457 . . . . 71.34 111.432 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.6 tp -64.17 114.8 4.44 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.923 0.392 . . . . 72.42 110.643 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -84.33 -45.09 13.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.492 -0.322 . . . . 64.13 111.673 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -171.27 159.25 5.71 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.786 0.327 . . . . 72.03 111.449 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.87 153.81 42.72 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.324 0.49 . . . . 73.43 112.324 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -129.56 149.53 51.28 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.083 -0.508 . . . . 65.42 110.864 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 91.2 m -114.46 119.46 36.96 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.768 0.318 . . . . 54.42 110.766 174.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.77 173.59 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.366 0.603 . . . . 64.31 111.747 -177.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.0 p -123.43 138.09 54.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.055 -0.52 . . . . 75.5 110.456 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.512 HD12 HD22 ' A' ' 440' ' ' LEU . 90.7 mt -117.54 119.06 33.87 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.736 0.303 . . . . 44.44 111.141 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -77.25 -171.6 35.85 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.208 -0.52 . . . . 73.24 112.994 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.09 100.63 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.378 2.052 . . . . 54.22 112.329 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.6 mttt 66.64 40.39 3.36 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.494 -0.775 . . . . 72.05 112.068 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -99.69 151.4 21.26 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.941 -0.572 . . . . 60.23 111.136 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -132.47 137.39 47.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.899 0.381 . . . . 64.13 111.419 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -120.03 146.54 45.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.506 -0.316 . . . . 73.24 110.262 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 49.1 t -113.79 115.04 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.929 0.395 . . . . 64.25 111.311 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 69.4 mt -107.39 130.81 54.76 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.415 -0.357 . . . . 71.02 111.438 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 51.5 p -113.86 150.75 33.13 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.221 0.534 . . . . 71.24 112.001 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 501' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 49.5 p90 -144.36 148.56 34.87 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.127 -0.488 . . . . 72.32 111.395 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 78.5 p -110.48 115.28 29.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.26 0.553 . . . . 60.21 110.957 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -112.36 136.88 51.28 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.288 -0.415 . . . . 74.31 111.363 -176.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.0 m -118.18 103.9 49.01 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.345 -0.389 . . . . 74.22 111.047 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 505' ' ' PRO . . . . . 0.418 ' HB2' HG11 ' A' ' 539' ' ' VAL . 98.4 Cg_endo -80.13 99.37 1.17 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.708 2.272 . . . . 62.0 112.711 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.6 p -78.23 -12.83 60.03 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.589 0.589 . . . . 62.13 112.589 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -122.17 141.63 51.25 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.762 0.315 . . . . 64.14 110.884 174.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.87 151.86 31.56 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.179 0.514 . . . . 54.32 112.083 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 145.43 -173.51 25.8 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.043 -0.598 . . . . 61.32 113.175 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 510' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 511' ' ' TYR . 0.0 OUTLIER -90.63 133.8 34.86 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.014 0.435 . . . . 61.32 110.839 179.474 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 511' ' ' TYR . . . . . 0.462 ' N ' ' SD ' ' A' ' 510' ' ' MET . 96.0 m-85 -132.25 120.46 22.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.133 0.492 . . . . 73.24 111.791 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 512' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 479' ' ' ILE . 47.9 ttp85 -94.15 118.37 31.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.224 -0.444 . . . . 74.41 111.072 177.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.55 HG12 HG12 ' A' ' 479' ' ' ILE . 55.6 mt -103.9 126.03 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.985 0.421 . . . . 72.24 111.48 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -125.8 142.55 51.46 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.979 0.418 . . . . 61.22 111.681 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -119.09 133.56 55.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.261 -0.427 . . . . 64.5 110.758 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 516' ' ' THR . . . . . 0.535 HG22 HG22 ' A' ' 532' ' ' VAL . 33.9 p -130.82 140.71 50.29 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.323 -0.398 . . . . 73.15 111.689 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.02 140.67 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.933 0.397 . . . . 71.33 111.226 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 39.7 t0 42.53 66.61 0.72 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.62 -0.718 . . . . 62.21 111.685 -174.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 519' ' ' GLU . . . . . 0.62 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.8 mm-40 -57.5 -31.94 66.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.0 -0.546 . . . . 74.03 111.293 173.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.43 ' HB2' HG23 ' A' ' 522' ' ' THR . 6.7 mm-40 -68.5 -25.78 65.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.85 -0.614 . . . . 74.23 110.761 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 56.59 63.85 1.84 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.808 0.813 . . . . 73.1 110.663 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 522' ' ' THR . . . . . 0.43 HG23 ' HB2' ' A' ' 520' ' ' GLU . 67.0 p -94.86 -15.66 23.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.503 -0.771 . . . . 64.44 111.892 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.5 p -118.68 142.53 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.665 0.269 . . . . 53.33 111.056 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 524' ' ' VAL . . . . . 0.403 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 50.4 t -82.68 121.04 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.847 0.356 . . . . 72.42 111.2 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.96 159.31 15.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.068 -0.514 . . . . 62.02 112.285 -171.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 439' ' ' ASP . 94.4 mt -68.57 -33.5 74.18 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.961 0.41 . . . . 71.04 111.521 174.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -145.56 129.31 17.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.377 -0.374 . . . . 55.45 110.795 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -83.15 -24.93 32.33 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.177 0.513 . . . . 74.34 111.542 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -86.91 13.98 8.1 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.901 0.381 . . . . 71.32 111.453 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.514 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 62.7 t30 -106.82 -15.02 14.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.103 0.477 . . . . 74.14 111.001 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -73.19 -16.86 61.41 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.724 0.638 . . . . 70.21 112.724 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.535 HG22 HG22 ' A' ' 516' ' ' THR . 45.2 t -111.69 133.33 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.754 0.65 . . . . 72.34 112.754 -171.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -123.52 139.0 54.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.166 -0.47 . . . . 52.23 110.719 173.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 87.5 m -119.86 134.71 55.14 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.033 0.383 . . . . 54.12 112.033 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -139.8 136.54 34.17 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.868 0.366 . . . . 65.3 110.527 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.63 133.32 50.57 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.09 0.472 . . . . 75.31 112.17 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 64.0 t -124.74 141.21 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.286 -0.415 . . . . 71.42 111.65 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.9 t -118.19 117.54 29.43 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.472 -0.331 . . . . 25.42 110.679 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 505' ' ' PRO . 66.5 t -101.31 123.02 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.026 0.441 . . . . 61.43 111.801 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.42 167.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 116.023 -0.535 . . . . 75.25 112.248 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.03 10.33 16.83 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.914 0.387 . . . . 61.33 111.684 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.254 1.322 0 CA-C-N 116.304 -0.407 . . . . 71.54 112.086 -176.567 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 120.722 0.296 . . . . 75.3 110.756 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.589 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 64.3 Cg_endo -72.41 173.65 12.82 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.493 2.129 . . . . 72.32 113.208 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -140.61 87.36 2.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.548 -0.538 . . . . 70.44 109.548 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.476 ' HB3' HG21 ' A' ' 517' ' ' VAL . 79.4 mt -90.58 137.9 31.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.092 -0.504 . . . . 75.44 111.364 -175.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.463 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.6 t -148.81 165.32 31.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.079 0.466 . . . . 64.22 112.014 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.604 HG12 HG12 ' A' ' 462' ' ' VAL . 27.5 m -133.72 149.19 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.83 -0.623 . . . . 74.13 111.569 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 6.5 mm-40 -130.99 129.76 42.51 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.229 -0.441 . . . . 72.11 111.519 176.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 50.1 mt -107.99 117.77 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.181 -0.463 . . . . 54.44 110.591 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -136.01 139.29 43.02 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.925 0.393 . . . . 75.22 111.73 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.66 -163.31 36.18 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.091 -0.504 . . . . 53.41 112.885 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.04 118.77 5.7 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.779 2.319 . . . . 64.14 113.027 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -86.74 -14.26 42.92 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.299 0.481 . . . . 64.51 112.299 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.0 t -128.87 117.85 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 122.146 -0.346 . . . . 61.41 110.704 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.94 164.21 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.241 0.543 . . . . 54.34 112.178 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -96.46 163.48 22.85 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 116.195 -0.457 . . . . 44.41 112.998 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.7 p -71.53 140.05 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 120.861 0.362 . . . . 75.44 111.214 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 65.87 17.33 10.8 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.656 0.613 . . . . 71.45 112.656 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' LYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -98.33 176.3 5.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.863 0.363 . . . . 72.13 111.457 176.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 502' ' ' SER . 40.4 tp -115.28 130.14 56.82 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.747 0.308 . . . . 54.33 111.33 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.07 134.22 47.23 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.881 0.326 . . . . 73.22 111.881 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.3 128.31 53.89 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.108 0.48 . . . . 72.31 111.934 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -122.01 154.88 36.66 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.961 -0.563 . . . . 75.31 110.274 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.544 ' HG2' HG22 ' A' ' 500' ' ' THR . 54.8 mt-10 -120.34 127.74 52.62 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.899 0.38 . . . . 74.32 111.631 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 24.2 t -96.8 112.56 29.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.008 -0.542 . . . . 64.2 109.651 169.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 35.2 m-70 -94.13 108.95 20.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.832 0.348 . . . . 72.12 110.39 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.812 HG11 HG21 ' A' ' 475' ' ' VAL . 14.4 m -106.1 126.88 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 63.34 110.079 -176.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.544 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.7 ptpt -144.03 148.92 35.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.791 0.663 . . . . 74.51 112.791 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -105.91 127.42 53.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.273 -0.876 . . . . 52.02 109.314 174.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.544 HD21 ' HD3' ' A' ' 463' ' ' LYS . 73.5 mt -118.05 8.7 12.52 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.825 0.306 . . . . 74.11 111.825 -177.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -87.87 -16.16 60.13 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.247 -0.501 . . . . 75.01 113.769 -177.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 83.0 17.17 67.99 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 120.911 -0.661 . . . . 51.15 113.468 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.4 tt -134.66 135.58 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 122.909 0.484 . . . . 71.24 111.035 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.496 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -70.95 132.62 21.91 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.474 -0.393 . . . . 70.5 113.701 -176.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 62.6 t -128.23 114.0 19.97 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 111.984 0.364 . . . . 64.23 111.984 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.87 -9.84 11.85 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.091 2.527 . . . . 73.1 112.739 174.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 472' ' ' SER . . . . . 0.466 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 39.0 m -80.87 10.6 4.81 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.688 0.996 . . . . 65.34 113.688 -171.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 473' ' ' THR . . . . . 0.421 HG23 HG23 ' A' ' 517' ' ' VAL . 94.3 m -88.14 100.59 13.07 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.86 0.838 . . . . 72.32 112.629 -166.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -114.4 117.54 31.31 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.291 -0.868 . . . . 73.41 110.746 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.812 HG21 HG11 ' A' ' 462' ' ' VAL . 45.3 t -104.17 132.72 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.063 0.394 . . . . 71.15 112.063 -173.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 476' ' ' ARG . . . . . 0.692 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 93.7 mtt180 -114.47 152.42 31.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.965 0.412 . . . . 64.44 111.832 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 82.5 t -122.43 126.27 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.056 -0.52 . . . . 75.44 111.008 173.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 478' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 513' ' ' ILE . 95.3 m-85 -115.47 138.83 50.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.851 0.357 . . . . 74.15 111.775 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 64.2 mt -115.0 107.93 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.954 -0.387 . . . . 54.14 109.954 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 55.94 34.76 24.23 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.088 0.47 . . . . 73.32 111.708 -173.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.13 -6.64 83.26 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 121.344 -0.455 . . . . 55.3 113.693 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.0 m -92.38 124.8 36.7 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 122.388 -0.478 . . . . 74.2 111.31 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.42 122.6 16.64 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.177 0.513 . . . . 54.33 111.579 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -101.97 -45.37 5.21 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.098 -0.501 . . . . 70.25 112.187 -178.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 485' ' ' LYS . . . . . 0.474 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 33.6 ttpt -171.01 160.09 6.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.242 0.217 . . . . 71.54 110.869 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -149.31 154.16 38.58 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.832 0.349 . . . . 53.55 111.863 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 487' ' ' TRP . . . . . 0.474 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 19.3 m-90 -129.83 147.22 51.58 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.313 -0.403 . . . . 74.24 111.362 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 34.6 m -110.28 118.57 36.69 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 110.326 -0.25 . . . . 72.02 110.326 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.56 172.17 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.49 0.662 . . . . 70.3 111.858 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 77.6 p -120.0 133.42 55.55 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.887 -0.597 . . . . 53.52 110.955 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.9 mt -118.48 118.93 33.06 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.861 0.362 . . . . 72.13 111.31 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 492' ' ' GLY . . . . . 0.496 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -82.21 -166.39 37.95 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.164 -0.541 . . . . 63.53 113.62 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.98 105.87 0.49 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.622 2.215 . . . . 63.41 112.518 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.5 mmtp 67.46 30.97 6.57 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.114 0.483 . . . . 72.1 111.573 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -94.33 149.45 21.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.325 -0.398 . . . . 45.03 111.97 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 496' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 32.7 tt0 -134.58 139.1 45.12 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.004 0.431 . . . . 74.42 111.554 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -125.67 140.65 52.53 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.325 -0.398 . . . . 75.54 110.273 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.32 117.37 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.894 0.378 . . . . 74.12 111.428 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.53 138.96 41.75 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.35 -0.386 . . . . 62.34 110.698 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.544 HG22 ' HG2' ' A' ' 459' ' ' GLU . 42.6 p -120.55 155.46 33.62 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.349 0.595 . . . . 65.45 112.125 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -152.29 148.28 27.35 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.688 -0.687 . . . . 75.35 110.831 170.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.533 ' HB2' HD11 ' A' ' 455' ' ' LEU . 20.4 p -117.19 114.96 24.41 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.156 0.503 . . . . 61.34 110.949 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -109.06 136.7 48.14 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.217 -0.447 . . . . 73.02 111.9 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 87.9 m -113.24 101.32 53.34 Favored Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.974 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 505' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 61.1 Cg_endo -72.38 88.48 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.472 2.115 . . . . 71.44 112.925 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.2 p -75.67 6.73 4.48 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.786 0.662 . . . . 54.44 112.786 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -143.5 135.75 26.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 110.483 -0.192 . . . . 63.01 110.483 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.76 151.32 37.61 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.092 0.472 . . . . 71.42 112.238 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.95 -169.08 28.09 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.16 -0.543 . . . . 62.31 113.064 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 12.5 tpt -99.46 124.53 44.7 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.733 0.301 . . . . 63.24 110.859 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -128.32 111.95 13.92 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.179 0.514 . . . . 75.42 111.688 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 512' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 32.8 ttm180 -94.66 120.82 35.48 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.119 -0.492 . . . . 75.12 111.141 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 478' ' ' TYR . 67.6 mt -95.41 126.05 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.087 0.47 . . . . 73.51 111.523 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -124.95 129.15 49.78 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.289 -0.414 . . . . 74.3 111.324 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.3 146.3 38.48 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.846 0.355 . . . . 55.21 111.326 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 516' ' ' THR . . . . . 0.525 HG22 HG22 ' A' ' 532' ' ' VAL . 76.4 p -130.19 140.92 50.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.18 -0.464 . . . . 75.02 111.011 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' ' 442' ' ' VAL . 7.4 p -100.51 138.42 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 110.207 -0.294 . . . . 63.34 110.207 174.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.5 t0 35.46 71.58 0.12 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.604 0.716 . . . . 64.31 110.961 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 519' ' ' GLU . . . . . 0.692 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.4 tm-20 -51.29 -45.52 62.16 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.098 -0.955 . . . . 55.23 111.71 -176.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -69.72 -17.29 63.45 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.411 -0.359 . . . . 62.31 111.49 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 51.51 79.36 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.798 0.809 . . . . 54.31 111.394 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 522' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 81.9 p -97.34 2.59 50.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.156 -0.929 . . . . 62.32 110.861 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.57 142.03 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.832 -0.622 . . . . 63.33 110.51 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.58 116.02 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.782 0.325 . . . . 72.23 111.847 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -92.59 170.33 9.82 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.349 0.595 . . . . 65.44 111.903 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.48 -29.25 67.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.853 -0.612 . . . . 75.13 111.978 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -141.38 128.33 20.64 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.773 0.32 . . . . 74.24 111.42 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.75 -24.17 31.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.131 0.491 . . . . 64.11 111.643 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -79.76 4.32 16.72 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.659 0.742 . . . . 62.21 110.767 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.463 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 56.0 t30 -92.16 -20.16 21.52 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.878 -0.601 . . . . 62.1 111.553 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 531' ' ' ASN . . . . . 0.459 ' HA ' HG12 ' A' ' 517' ' ' VAL . 12.9 m120 -72.8 -25.48 61.17 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.922 1.082 . . . . 72.44 113.922 -172.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 516' ' ' THR . 42.9 t -109.32 143.37 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.922 0.712 . . . . 75.42 112.922 -172.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -129.95 142.81 50.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.172 -0.467 . . . . 43.44 111.043 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 72.4 m -118.9 129.24 55.08 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.134 0.42 . . . . 74.13 112.134 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -143.17 117.67 9.73 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.648 0.261 . . . . 74.34 110.849 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 536' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 10.3 p-10 -93.42 137.78 32.38 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.246 0.461 . . . . 63.42 112.246 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 56.1 t -125.95 134.56 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.392 -0.367 . . . . 74.45 111.672 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 45.5 t -104.08 126.26 51.05 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.56 -0.291 . . . . 72.35 111.297 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.12 121.93 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.975 0.416 . . . . 65.05 111.465 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.9 m -111.83 161.74 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.367 0.506 . . . . 75.24 112.367 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 86.7 mt -82.66 16.92 1.97 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.264 0.468 . . . . 70.31 112.264 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 119.324 -0.37 . . . . 75.35 111.83 -179.705 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 120.405 0.145 . . . . 75.51 110.935 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 64.7 Cg_endo -74.91 173.39 14.55 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.434 2.09 . . . . 65.2 113.474 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -157.2 94.08 1.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.369 -0.832 . . . . 61.23 109.447 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.555 HD22 HD12 ' A' ' 491' ' ' LEU . 53.4 mt -98.26 114.54 26.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.045 0.45 . . . . 53.23 111.382 -175.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.527 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.9 t -122.67 150.6 42.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.179 0.514 . . . . 72.2 112.116 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.552 HG12 HG12 ' A' ' 462' ' ' VAL . 28.8 m -121.31 148.88 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.064 -0.516 . . . . 74.44 111.286 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.9 mt-10 -136.83 143.18 42.97 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.655 -0.248 . . . . 71.42 110.911 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 57.7 mt -120.39 135.5 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 120.974 0.416 . . . . 64.12 111.599 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -137.23 147.05 45.53 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.29 -0.414 . . . . 54.54 110.652 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 160.51 -166.46 35.37 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.676 -0.774 . . . . 72.53 113.489 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.9 132.55 24.99 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.985 2.456 . . . . 74.54 113.491 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -78.66 -43.51 25.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.14 -0.482 . . . . 73.41 112.173 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.433 HG22 ' HB3' ' A' ' 538' ' ' SER . 44.1 t -123.7 129.78 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.767 0.318 . . . . 43.33 111.082 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.47 163.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.147 0.498 . . . . 62.33 111.74 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -95.25 162.89 23.9 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.279 -0.486 . . . . 62.31 113.196 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 12.9 p -67.65 136.18 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 121.228 0.537 . . . . 75.35 111.625 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 24.6 m120 65.2 14.75 9.61 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.858 -0.61 . . . . 73.33 112.479 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' LYS . . . . . 0.503 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.2 mmmt -97.07 153.84 17.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.068 0.461 . . . . 74.11 111.645 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.572 HD11 ' HB2' ' A' ' 502' ' ' SER . 46.3 tp -90.19 138.79 31.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.019 0.438 . . . . 71.23 111.569 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -135.86 133.02 37.33 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.824 0.345 . . . . 73.32 111.656 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -109.45 134.58 51.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.849 0.357 . . . . 72.31 111.657 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -125.53 154.62 41.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.28 -0.418 . . . . 60.1 111.176 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -119.59 127.75 53.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.159 0.504 . . . . 75.31 110.719 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 39.8 t -105.54 115.34 47.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.997 -0.547 . . . . 73.13 110.949 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.595 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 27.1 m-70 -92.6 105.34 17.52 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.654 0.264 . . . . 71.04 110.643 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.552 HG12 HG12 ' A' ' 442' ' ' VAL . 33.8 m -106.24 122.74 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.075 0.464 . . . . 71.31 110.178 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -139.09 153.09 47.98 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.84 0.682 . . . . 74.04 112.84 -173.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 53.4 t-20 -106.1 128.64 54.02 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.256 -0.883 . . . . 71.2 110.025 176.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 90.7 mt -113.83 -2.42 13.65 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.023 0.379 . . . . 63.2 112.023 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -81.17 -16.44 74.38 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.247 -0.501 . . . . 54.14 113.884 -177.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.42 21.89 68.74 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.077 -0.582 . . . . 73.02 113.737 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 3.2 tt -137.68 133.3 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.577 0.351 . . . . 73.42 111.405 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 491' ' ' LEU . . . -71.36 134.54 22.9 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 114.214 0.445 . . . . 74.0 114.214 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 50.7 t -131.14 114.54 16.21 Favored Pre-proline 0 CA--C 1.547 0.833 0 O-C-N 122.585 -0.362 . . . . 62.21 111.663 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -83.93 -10.24 9.41 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.151 2.567 . . . . 75.44 113.004 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 20.3 t -81.95 11.83 4.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.548 0.739 . . . . 64.1 112.328 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.2 m -88.82 97.39 11.13 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.719 0.771 . . . . 54.33 112.27 -167.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -101.87 130.63 48.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.357 -0.838 . . . . 70.34 110.66 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.485 HG21 HG11 ' A' ' 462' ' ' VAL . 60.4 t -115.37 133.41 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 122.793 0.437 . . . . 75.54 111.058 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 476' ' ' ARG . . . . . 0.503 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 90.6 mtt180 -126.66 149.04 49.75 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.828 0.347 . . . . 74.12 111.557 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.28 120.54 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.466 -0.334 . . . . 73.21 111.182 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -112.46 139.02 48.38 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.987 0.422 . . . . 74.21 111.699 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.524 HG12 HG12 ' A' ' 513' ' ' ILE . 54.0 mt -114.13 107.58 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 109.855 -0.424 . . . . 73.23 109.855 172.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 480' ' ' ASN . . . . . 0.436 HD21 ' HA ' ' A' ' 511' ' ' TYR . 94.6 m-20 54.57 34.47 21.36 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.262 -0.426 . . . . 73.25 112.04 -175.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 103.29 -30.06 11.12 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.125 -0.56 . . . . 72.23 113.75 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.9 m -82.35 125.47 31.05 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.42 -0.459 . . . . 44.22 112.004 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.0 tp -65.57 115.73 6.08 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.01 0.433 . . . . 60.35 111.319 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -82.67 -44.14 16.07 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.355 -0.384 . . . . 72.31 111.38 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 485' ' ' LYS . . . . . 0.427 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 32.6 ttpt -170.38 157.83 6.28 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.672 -0.24 . . . . 75.31 110.876 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 486' ' ' ASN . . . . . 0.407 ' HB2' ' HG2' ' A' ' 476' ' ' ARG . 6.6 p30 -137.38 156.69 47.91 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.095 0.474 . . . . 72.42 111.945 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 487' ' ' TRP . . . . . 0.427 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 18.2 m-90 -137.3 149.12 46.85 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.118 -0.492 . . . . 75.52 110.79 177.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 89.6 m -121.54 119.24 31.4 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 110.057 -0.349 . . . . 61.13 110.057 174.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.0 m -139.83 172.74 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.369 0.604 . . . . 75.25 112.115 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.7 p -115.1 133.88 55.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.925 -0.579 . . . . 54.52 110.474 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.555 HD12 HD22 ' A' ' 440' ' ' LEU . 73.5 mt -116.75 120.43 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.858 0.361 . . . . 63.23 111.098 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.47 -173.88 48.54 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.163 -0.541 . . . . 72.55 113.264 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.9 99.53 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.532 2.155 . . . . 74.12 112.484 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 98.0 mttt 67.57 50.45 0.91 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.918 -0.583 . . . . 51.23 111.796 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -110.39 148.36 32.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.516 -0.765 . . . . 60.52 111.27 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -130.04 136.87 49.87 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.058 0.456 . . . . 75.11 111.444 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -118.87 135.63 54.46 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.544 -0.539 . . . . 64.24 109.544 173.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 89.9 t -100.96 113.12 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.266 0.555 . . . . 73.14 111.116 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 63.6 mt -105.82 126.68 52.45 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.844 -0.616 . . . . 71.51 110.711 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 22.1 p -112.3 154.36 25.78 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.317 0.579 . . . . 62.44 111.909 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -145.64 148.9 33.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.608 -0.724 . . . . 72.43 110.701 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.572 ' HB2' HD11 ' A' ' 455' ' ' LEU . 24.0 p -110.24 113.75 26.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.308 0.575 . . . . 64.13 110.642 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -110.48 137.12 48.6 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.865 -0.607 . . . . 73.23 111.192 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 36.5 m -122.65 100.3 41.17 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 116.475 -0.329 . . . . 73.55 111.073 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 505' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.3 Cg_endo -76.52 106.8 2.32 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.318 2.012 . . . . 63.34 112.638 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 64.4 p -89.08 -5.88 57.5 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.817 0.342 . . . . 73.54 111.913 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -125.68 136.04 52.79 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.605 -0.27 . . . . 73.42 110.9 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -73.34 151.08 41.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.936 0.398 . . . . 74.25 111.93 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.8 178.33 24.65 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.223 -0.513 . . . . 54.24 112.913 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 14.4 tpt -92.74 114.58 27.17 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.877 0.37 . . . . 73.13 111.061 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 511' ' ' TYR . . . . . 0.436 ' HA ' HD21 ' A' ' 480' ' ' ASN . 75.3 m-85 -111.22 144.9 39.64 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.678 0.275 . . . . 74.25 111.447 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 512' ' ' ARG . . . . . 0.471 ' HG2' ' OD1' ' A' ' 514' ' ' ASN . 16.2 ttm180 -123.19 115.45 21.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.735 0.302 . . . . 75.22 111.075 176.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.524 HG12 HG12 ' A' ' 479' ' ' ILE . 59.9 mt -96.05 113.7 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.135 -0.484 . . . . 75.4 111.21 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.471 ' OD1' ' HG2' ' A' ' 512' ' ' ARG . 4.0 m-20 -118.91 145.79 45.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.405 -0.361 . . . . 73.13 111.469 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 515' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 532' ' ' VAL . . . -115.48 145.15 42.87 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.779 0.324 . . . . 71.03 111.274 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 516' ' ' THR . . . . . 0.555 HG22 HG22 ' A' ' 532' ' ' VAL . 58.9 p -132.82 148.76 52.31 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.183 -0.462 . . . . 65.34 111.643 -178.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.23 152.69 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 120.756 0.312 . . . . 65.24 111.243 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 35.8 t70 54.72 39.99 31.65 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.702 0.763 . . . . 75.13 111.369 -176.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 519' ' ' GLU . . . . . 0.503 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 8.5 mm-40 -52.6 -31.6 37.16 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.802 -0.636 . . . . 75.24 111.315 172.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.452 ' HB2' HG23 ' A' ' 522' ' ' THR . 4.2 mm-40 -67.67 -25.39 65.68 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.732 -0.667 . . . . 72.32 111.153 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 59.31 71.92 0.56 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.419 0.628 . . . . 74.1 110.614 -176.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 522' ' ' THR . . . . . 0.452 HG23 ' HB2' ' A' ' 520' ' ' GLU . 82.6 p -107.41 -32.89 7.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.581 -0.736 . . . . 75.11 112.355 -174.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.441 HG21 ' HG3' ' A' ' 438' ' ' PRO . 14.4 p -124.37 143.31 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.589 0.588 . . . . 64.21 112.589 -172.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.3 111.69 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.45 -0.341 . . . . 73.42 110.716 176.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -99.73 -179.49 4.2 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.427 0.528 . . . . 74.45 112.427 -175.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.58 -41.08 24.66 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.251 -0.431 . . . . 54.21 111.552 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -130.31 98.49 4.73 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.124 0.488 . . . . 53.44 111.006 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -84.3 10.19 11.14 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.274 0.559 . . . . 71.14 111.502 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -108.16 0.62 21.66 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.467 0.651 . . . . 73.42 110.131 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.527 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.4 t30 -95.54 -0.84 51.64 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.85 -0.614 . . . . 74.13 111.551 -174.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -81.95 -19.25 41.06 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.424 0.898 . . . . 74.42 113.424 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 516' ' ' THR . 39.9 t -112.42 141.19 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 112.365 0.506 . . . . 74.54 112.365 -174.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -132.49 135.52 46.07 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.597 -0.274 . . . . 64.21 111.439 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 30.6 m -106.53 134.91 48.95 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.472 0.545 . . . . 72.32 112.472 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -142.99 117.5 9.72 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.174 -0.467 . . . . 73.42 110.28 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.34 137.45 33.47 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.253 0.549 . . . . 70.33 112.155 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.21 130.64 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.95 -0.568 . . . . 63.41 111.518 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 538' ' ' SER . . . . . 0.433 ' HB3' HG22 ' A' ' 449' ' ' VAL . 41.3 t -96.97 117.97 32.34 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.527 -0.306 . . . . 70.33 111.351 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 505' ' ' PRO . 61.8 t -105.95 120.47 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.935 0.398 . . . . 73.31 111.077 178.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.58 166.54 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 112.498 0.555 . . . . 72.54 112.498 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.87 -12.3 55.72 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.177 0.436 . . . . 72.34 112.177 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.252 1.206 0 N-CA-C 112.513 0.56 . . . . 55.12 112.513 178.748 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 110.146 -0.316 . . . . 71.34 110.146 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.612 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 56.9 Cg_endo -72.16 174.41 11.44 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.269 1.979 . . . . 73.24 112.92 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -154.06 80.29 1.13 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.365 0.602 . . . . 73.13 110.041 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.468 HD22 HD12 ' A' ' 491' ' ' LEU . 61.1 mt -80.05 116.54 20.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.953 -0.567 . . . . 65.33 111.596 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.419 ' HB ' HD22 ' A' ' 530' ' ' ASN . 8.1 t -126.38 153.53 44.82 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.859 0.361 . . . . 72.44 111.096 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.571 HG12 HG12 ' A' ' 462' ' ' VAL . 21.0 m -131.84 149.58 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.193 0.52 . . . . 71.31 112.358 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 49.4 mt-10 -128.47 144.03 51.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.883 -0.599 . . . . 72.11 110.843 175.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.402 HD13 HG22 ' A' ' 513' ' ' ILE . 65.8 mt -114.75 132.73 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.635 0.255 . . . . 65.31 110.766 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -132.81 145.87 51.35 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.579 0.228 . . . . 63.41 110.929 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.77 -173.66 36.51 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.672 -0.775 . . . . 74.21 113.752 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.62 126.43 12.09 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.991 2.461 . . . . 71.3 112.993 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -76.37 -21.47 56.04 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.153 -0.476 . . . . 63.23 112.218 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.6 t -131.0 128.82 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.754 0.312 . . . . 74.33 111.09 176.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.78 156.41 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 120.997 0.427 . . . . 75.51 111.682 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.34 154.57 24.37 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.319 -0.467 . . . . 64.0 113.25 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 11.7 p -65.62 141.46 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.889 0.376 . . . . 75.32 111.781 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 65.53 8.54 5.15 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.257 0.623 . . . . 55.02 112.272 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' LYS . . . . . 0.555 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 31.3 mmmt -96.13 167.15 11.38 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.943 0.402 . . . . 51.44 111.473 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' A' ' 502' ' ' SER . 33.4 tp -103.81 134.06 47.75 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.68 0.276 . . . . 62.2 111.35 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -133.57 140.13 46.98 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.799 0.333 . . . . 75.32 111.774 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -100.53 138.15 37.98 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.907 0.384 . . . . 74.22 111.595 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -129.66 155.15 46.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.943 0.401 . . . . 70.3 111.084 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -119.73 127.55 52.94 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.096 -0.502 . . . . 55.31 111.379 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 29.9 t -104.54 113.01 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.271 -0.422 . . . . 71.4 110.046 171.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 41.9 m-70 -94.81 105.13 17.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.519 -0.31 . . . . 73.04 110.31 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.636 HG11 HG21 ' A' ' 475' ' ' VAL . 26.4 m -106.14 126.02 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.087 0.47 . . . . 72.31 110.346 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.454 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.8 ptpt -146.69 157.32 43.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.297 0.57 . . . . 71.04 112.315 -175.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -114.32 127.17 55.73 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.552 -0.749 . . . . 62.41 109.662 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.454 HD21 ' HD3' ' A' ' 463' ' ' LYS . 85.2 mt -113.28 0.91 14.99 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.843 0.354 . . . . 73.41 111.844 -177.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -76.99 -19.44 77.46 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.039 -0.6 . . . . 54.44 113.32 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.16 13.31 64.21 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.319 -0.467 . . . . 73.31 113.87 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.7 tt -137.35 133.26 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 122.575 0.35 . . . . 72.42 110.651 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.38 137.77 20.17 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.775 0.67 . . . . 71.21 114.775 -173.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 46.8 t -123.76 113.19 28.74 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 122.76 0.424 . . . . 53.42 111.184 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.78 -10.79 9.34 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.93 2.42 . . . . 43.52 112.807 175.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 29.0 t -83.28 11.21 6.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.229 0.612 . . . . 73.14 112.467 -176.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 97.6 m -90.17 113.55 25.34 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.093 0.775 . . . . 74.44 113.093 -166.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -103.89 131.24 51.3 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.964 -0.562 . . . . 73.22 111.617 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.636 HG21 HG11 ' A' ' 462' ' ' VAL . 53.7 t -110.36 130.58 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 122.885 0.474 . . . . 61.44 111.264 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 476' ' ' ARG . . . . . 0.693 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 68.2 mtt180 -125.97 152.54 45.55 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.133 0.492 . . . . 75.12 111.755 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 75.9 t -120.89 128.75 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.117 -0.492 . . . . 51.4 110.818 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -118.68 136.52 53.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.835 0.35 . . . . 55.01 111.569 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 66.2 mt -108.1 108.05 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.965 -0.383 . . . . 73.04 109.965 173.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 56.68 33.64 23.19 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.099 0.476 . . . . 72.14 111.413 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 99.71 -26.56 23.95 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.409 -0.424 . . . . 43.5 113.76 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 86.1 m -81.88 129.72 34.84 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 117.078 0.439 . . . . 71.25 111.727 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 54.8 tp -65.65 121.36 14.8 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.199 0.523 . . . . 75.33 111.831 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -92.75 -43.79 8.86 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.791 -0.641 . . . . 72.15 111.686 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -161.77 154.5 20.27 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.69 -0.232 . . . . 72.53 110.826 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.62 147.87 47.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.362 0.504 . . . . 61.23 112.362 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -133.23 146.79 51.77 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.04 -0.527 . . . . 74.41 110.844 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.2 m -115.0 118.74 34.27 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.9 -0.408 . . . . 74.34 109.9 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.37 172.5 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.576 0.703 . . . . 63.31 112.471 -172.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 87.2 p -116.06 134.01 55.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.649 -0.705 . . . . 71.3 110.594 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.468 HD12 HD22 ' A' ' 440' ' ' LEU . 92.6 mt -124.41 119.18 28.47 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.814 0.34 . . . . 72.01 111.066 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.07 -174.08 48.43 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.126 -0.488 . . . . 53.45 113.622 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.68 106.07 0.58 Allowed 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.619 2.213 . . . . 45.14 112.416 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.9 mttt 66.25 36.23 5.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.364 0.602 . . . . 75.4 111.653 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -95.85 142.77 27.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.757 -0.656 . . . . 64.33 111.165 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -128.15 133.56 48.96 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.915 0.388 . . . . 73.41 111.416 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -126.74 134.2 50.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.281 -0.418 . . . . 55.42 111.208 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 51.3 t -102.61 113.08 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.047 0.451 . . . . 52.34 111.414 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 57.5 mt -104.05 126.57 51.27 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.231 -0.441 . . . . 63.15 110.323 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 32.9 p -113.46 151.09 31.88 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.356 0.598 . . . . 75.41 112.361 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -146.58 148.99 32.69 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.635 -0.711 . . . . 71.44 110.875 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.487 ' HB2' HD11 ' A' ' 455' ' ' LEU . 86.1 p -110.19 115.55 29.92 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.324 0.583 . . . . 74.12 110.669 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -107.82 137.23 46.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.983 -0.553 . . . . 71.53 111.757 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 86.0 m -109.05 101.37 44.5 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.298 -0.41 . . . . 74.13 111.307 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 505' ' ' PRO . . . . . 0.555 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.9 Cg_endo -75.56 92.19 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.324 2.016 . . . . 62.01 112.722 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 40.0 p -82.38 12.32 4.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.275 0.472 . . . . 52.14 112.275 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -143.56 130.99 21.0 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.406 -0.361 . . . . 72.13 110.644 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.1 150.87 33.63 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.498 0.555 . . . . 71.34 112.498 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 143.13 -170.2 25.46 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.817 -0.706 . . . . 72.02 113.94 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.85 117.13 28.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.776 0.43 . . . . 72.51 111.033 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -119.02 143.28 47.16 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.059 0.457 . . . . 73.42 111.347 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 512' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 57.5 ttp180 -123.52 120.16 32.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.562 -0.29 . . . . 71.52 110.748 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.402 HG22 HD13 ' A' ' 444' ' ' ILE . 62.6 mt -95.07 120.45 44.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 73.2 110.755 178.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 18.2 m120 -118.92 132.98 56.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.311 -0.404 . . . . 63.41 111.093 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.8 137.39 49.8 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.8 0.333 . . . . 73.03 110.774 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 516' ' ' THR . . . . . 0.569 HG22 HG22 ' A' ' 532' ' ' VAL . 39.7 p -122.81 140.37 52.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.017 -0.538 . . . . 73.51 110.936 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 440' ' ' LEU . 14.9 p -115.53 141.69 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.538 -0.301 . . . . 72.35 111.353 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.1 t70 48.1 58.58 4.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.946 0.879 . . . . 72.14 110.199 -170.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 519' ' ' GLU . . . . . 0.693 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 2.6 mm-40 -55.33 -32.89 62.86 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.925 -1.034 . . . . 73.23 113.172 -176.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -77.22 -12.55 59.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.541 0.21 . . . . 60.14 111.493 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 54.63 69.75 0.69 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.687 0.756 . . . . 64.11 110.847 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 80.4 p -100.3 -7.0 25.05 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.234 -0.894 . . . . 72.13 112.01 -174.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.3 p -140.12 142.01 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.954 0.407 . . . . 72.45 111.926 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 80.3 t -83.89 118.87 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.477 -0.329 . . . . 64.14 110.523 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.612 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 19.7 mt-10 -110.71 174.62 5.78 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.044 0.757 . . . . 73.33 113.044 -173.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.32 -39.36 93.74 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.771 -0.65 . . . . 64.33 112.304 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -145.15 108.62 4.64 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.895 0.379 . . . . 62.25 111.325 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 528' ' ' GLU . . . . . 0.468 ' HA ' ' OD1' ' A' ' 531' ' ' ASN . 12.6 pt-20 -83.68 21.84 1.19 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.979 0.419 . . . . 73.24 111.796 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -107.49 -19.19 13.64 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.453 0.538 . . . . 71.34 112.453 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.419 HD22 ' HB ' ' A' ' 441' ' ' THR . 1.9 p-10 -99.71 12.73 35.86 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.571 0.582 . . . . 54.44 112.571 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 531' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 528' ' ' GLU . 15.0 m120 -77.79 -5.02 49.38 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.325 0.491 . . . . 62.44 112.325 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 532' ' ' VAL . . . . . 0.569 HG22 HG22 ' A' ' 516' ' ' THR . 41.2 t -127.94 133.25 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 120.901 0.382 . . . . 72.12 111.639 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 533' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -114.33 141.81 47.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.546 -0.297 . . . . 65.31 111.057 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 52.4 m -122.67 122.33 38.54 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.205 0.446 . . . . 54.55 112.205 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -137.74 117.16 12.82 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.286 -0.415 . . . . 74.23 110.041 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 536' ' ' ASP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 1.1 p30 -97.88 136.32 38.35 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.511 0.672 . . . . 75.32 112.302 -177.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.59 142.1 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.317 -0.856 . . . . 64.24 111.515 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.5 t -104.05 123.31 46.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.161 -0.472 . . . . 72.34 110.977 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 50.6 t -103.15 120.72 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.767 0.317 . . . . 72.51 111.373 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.7 m -114.36 159.55 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.269 0.557 . . . . 72.52 112.194 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 90.2 mt -82.36 0.21 42.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.123 -0.489 . . . . 71.34 112.192 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 C--O 1.251 1.147 0 N-CA-C 112.471 0.545 . . . . 73.44 112.471 -174.472 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 437' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 438' ' ' PRO . 97.6 m-85 . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 120.678 0.275 . . . . 71.31 110.891 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.567 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 2.8 Cg_exo -74.99 174.41 12.83 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.014 2.476 . . . . 60.23 113.69 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -154.85 81.64 1.09 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.296 -0.866 . . . . 75.15 109.003 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.513 HD11 HG11 ' A' ' 470' ' ' VAL . 69.5 mt -86.72 127.94 34.99 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.857 -0.611 . . . . 73.22 111.811 -173.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' THR . . . . . 0.603 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.5 t -130.48 156.28 45.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.046 0.45 . . . . 73.43 111.762 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.636 HG12 HG12 ' A' ' 462' ' ' VAL . 31.6 m -132.8 147.78 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.972 -0.558 . . . . 74.43 111.586 -177.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 54.9 mt-10 -133.04 139.64 47.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.453 -0.34 . . . . 74.52 111.151 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 58.4 mt -109.21 129.22 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.972 0.415 . . . . 74.0 111.472 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -131.28 131.0 43.54 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.508 -0.315 . . . . 64.45 111.335 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 167.11 -168.49 40.42 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.486 -0.864 . . . . 74.34 113.871 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.52 122.8 7.67 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.802 2.335 . . . . 54.32 113.179 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -70.72 -33.19 70.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.234 -0.439 . . . . 75.22 111.501 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.3 t -120.83 132.01 71.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.775 0.321 . . . . 52.4 111.267 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.2 m -132.56 163.29 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.112 0.482 . . . . 55.34 111.712 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -94.71 149.49 19.38 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.234 -0.508 . . . . 71.54 112.849 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 11.2 p -63.28 137.46 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-O 120.906 0.384 . . . . 42.34 111.829 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 21.3 m120 62.07 25.23 15.11 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.996 0.519 . . . . 64.41 112.392 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -111.73 162.46 15.2 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.964 0.411 . . . . 72.15 111.577 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 502' ' ' SER . 50.6 tp -90.5 128.04 36.42 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.843 0.354 . . . . 73.31 111.583 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.33 143.05 49.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.793 0.33 . . . . 72.33 111.38 177.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -122.74 144.51 49.11 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.945 0.402 . . . . 44.14 111.491 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -132.05 157.55 43.86 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.007 0.432 . . . . 55.31 111.296 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -120.52 127.74 52.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.858 -0.61 . . . . 75.12 110.738 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.95 116.13 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.37 -0.377 . . . . 64.21 111.319 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 30.2 m-70 -93.22 113.98 26.33 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.399 -0.364 . . . . 63.23 110.652 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.638 HG11 HG21 ' A' ' 475' ' ' VAL . 17.8 m -116.08 122.42 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.781 0.324 . . . . 52.12 110.751 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 496' ' ' GLU . 0.7 OUTLIER -139.93 154.47 47.23 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.064 0.765 . . . . 74.01 113.064 -176.768 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.542 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.4 t-20 -103.03 128.6 49.82 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.119 -0.946 . . . . 70.23 110.386 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.421 HD21 ' HD3' ' A' ' 463' ' ' LYS . 88.6 mt -115.32 4.87 14.52 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.078 0.399 . . . . 73.0 112.078 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -85.75 -23.86 44.52 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.248 -0.501 . . . . 71.21 113.43 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.44 17.8 58.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.959 -0.639 . . . . 75.31 113.68 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 12.2 tt -137.37 141.73 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 122.57 0.348 . . . . 72.5 110.617 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.475 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -65.68 136.31 36.1 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.139 -0.553 . . . . 64.0 113.612 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.513 HG11 HD11 ' A' ' 440' ' ' LEU . 38.5 t -129.88 112.97 17.48 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 112.515 0.561 . . . . 62.43 112.515 -176.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.77 -11.41 12.64 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.236 2.624 . . . . 63.43 112.22 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 70.1 m -80.18 11.61 3.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.5 0.72 . . . . 73.34 112.161 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 33.5 m -88.28 90.83 8.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.849 0.833 . . . . 71.13 111.073 -169.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -106.02 123.16 47.56 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.194 -0.912 . . . . 61.11 110.272 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.638 HG21 HG11 ' A' ' 462' ' ' VAL . 39.2 t -103.71 121.02 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.826 0.346 . . . . 70.34 110.904 -177.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 476' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 476' ' ' ARG . 33.3 ttm180 -129.13 144.96 51.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.694 0.283 . . . . 75.31 111.656 -174.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 66.3 t -120.5 130.27 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.071 0.463 . . . . 71.2 111.722 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -119.52 137.04 54.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.96 -0.564 . . . . 74.4 111.177 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 513' ' ' ILE . 59.2 mt -111.94 107.76 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.712 0.292 . . . . 61.22 110.32 174.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 57.29 34.87 25.38 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.929 0.395 . . . . 52.14 111.31 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.95 -2.18 85.47 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.336 -0.459 . . . . 25.22 113.398 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 63.1 m -90.25 123.42 34.03 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.606 -0.349 . . . . 54.33 111.389 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 483' ' ' LEU . . . . . 0.403 HD13 ' HD3' ' A' ' 476' ' ' ARG . 44.4 tp -63.88 115.06 4.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.98 0.419 . . . . 74.14 111.0 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -105.05 -44.05 4.89 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.102 0.779 . . . . 72.0 113.102 -175.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -165.88 161.02 17.45 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 122.168 -0.332 . . . . 70.12 111.17 -172.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 486' ' ' ASN . . . . . 0.561 HD22 ' N ' ' A' ' 486' ' ' ASN . 0.0 OUTLIER -161.1 154.32 21.46 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.826 0.676 . . . . 74.02 112.826 177.621 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -136.0 149.79 48.97 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.687 0.795 . . . . 72.4 110.44 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.2 m -115.08 119.41 36.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.9 0.381 . . . . 74.45 111.21 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.9 m -137.57 173.56 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.158 0.504 . . . . 73.22 111.695 -176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 95.3 p -125.57 135.11 51.88 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.871 0.367 . . . . 75.25 110.882 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.473 HD12 HD22 ' A' ' 440' ' ' LEU . 94.9 mt -117.63 120.1 37.01 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.455 -0.339 . . . . 75.31 111.24 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 492' ' ' GLY . . . . . 0.475 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -77.78 -170.09 34.62 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.223 -0.513 . . . . 24.44 113.279 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.56 97.03 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.341 2.027 . . . . 74.45 112.445 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.6 mttt 66.29 59.61 0.65 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.853 0.835 . . . . 74.55 111.791 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -120.85 152.94 37.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.046 -0.979 . . . . 74.31 110.651 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 496' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 39.5 tt0 -134.63 137.25 43.5 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.936 0.398 . . . . 64.22 111.931 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.444 ' HG2' ' CD2' ' A' ' 491' ' ' LEU . 28.5 mmmt -116.94 150.3 38.74 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.203 -0.453 . . . . 75.45 110.241 174.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.4 113.56 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.925 0.393 . . . . 72.14 111.555 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 77.9 mt -110.51 136.07 50.21 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.24 -0.436 . . . . 74.51 111.314 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 41.0 p -117.91 150.62 38.91 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.094 0.473 . . . . 62.42 111.943 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -145.63 151.61 38.35 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.248 -0.433 . . . . 74.42 111.02 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.56 ' HB2' HD11 ' A' ' 455' ' ' LEU . 72.9 p -111.67 141.47 45.22 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.28 -0.418 . . . . 53.43 111.297 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.5 t90 -139.34 137.49 35.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.281 -0.418 . . . . 74.35 111.094 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.1 m -118.2 100.43 51.75 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-O 120.758 0.313 . . . . 74.14 111.277 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.99 102.99 1.63 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.519 2.146 . . . . 71.0 112.841 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 81.1 p -81.58 -1.21 45.57 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.167 0.432 . . . . 74.55 112.167 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -137.24 145.74 43.94 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.711 0.291 . . . . 74.3 111.316 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.484 ' HA ' ' HB ' ' A' ' 539' ' ' VAL . 0.3 OUTLIER -83.19 152.03 25.41 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.516 0.561 . . . . 52.32 112.516 -177.519 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.63 -176.32 30.07 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.038 -0.601 . . . . 53.22 113.694 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 1.2 tpt -92.56 106.28 18.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.536 0.335 . . . . 72.43 110.669 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -107.66 121.9 45.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.179 0.514 . . . . 72.32 111.795 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 512' ' ' ARG . . . . . 0.505 ' HD2' HG23 ' A' ' 534' ' ' THR . 19.6 tpp85 -94.21 112.74 24.56 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.188 -0.46 . . . . 74.14 111.52 177.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 479' ' ' ILE . 40.6 mt -98.75 127.24 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.068 0.461 . . . . 74.3 110.858 175.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -124.09 138.15 54.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.335 -0.393 . . . . 72.3 111.553 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.94 132.48 54.73 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.832 -0.433 . . . . 75.15 109.832 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 38.9 p -132.93 141.1 48.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.352 -0.385 . . . . 75.51 111.497 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.419 HG13 HD22 ' A' ' 531' ' ' ASN . 7.7 p -110.55 140.05 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.762 0.315 . . . . 72.24 110.949 175.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.2 t0 43.98 67.9 0.6 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.517 0.675 . . . . 62.11 111.594 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -55.8 -31.67 62.85 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.821 -0.627 . . . . 72.05 112.246 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 520' ' ' GLU . . . . . 0.452 ' HB2' HG23 ' A' ' 522' ' ' THR . 8.4 mm-40 -78.17 -19.29 54.25 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.276 -0.42 . . . . 72.24 111.518 -178.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 62.16 46.62 6.14 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.742 0.782 . . . . 73.15 110.011 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 522' ' ' THR . . . . . 0.452 HG23 ' HB2' ' A' ' 520' ' ' GLU . 52.1 p -67.59 -37.76 83.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.486 -0.779 . . . . 73.35 111.588 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.468 HG21 ' HG2' ' A' ' 438' ' ' PRO . 10.7 p -102.33 143.91 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 116.096 -0.502 . . . . 74.45 110.993 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 524' ' ' VAL . . . . . 0.459 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 59.1 t -81.87 115.62 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.992 0.425 . . . . 74.13 111.119 -177.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -91.75 155.96 17.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.888 -0.596 . . . . 73.22 112.32 -173.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.19 -39.53 78.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.145 0.498 . . . . 73.53 110.472 173.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -133.92 113.35 12.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.832 -0.622 . . . . 73.3 110.495 174.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -83.17 -3.43 57.36 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.318 0.58 . . . . 74.12 111.379 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -92.54 -1.64 56.79 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.982 0.42 . . . . 75.43 111.306 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 530' ' ' ASN . . . . . 0.603 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 65.5 t30 -95.82 -6.65 39.0 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 116.345 -0.388 . . . . 70.34 112.0 -174.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 531' ' ' ASN . . . . . 0.419 HD22 HG13 ' A' ' 517' ' ' VAL . 11.5 m120 -83.66 3.92 30.83 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.54 0.941 . . . . 71.21 113.54 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 52.4 t -126.86 142.21 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 112.798 0.666 . . . . 70.12 112.798 -173.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 533' ' ' ALA . . . . . 0.472 ' HB2' HG23 ' A' ' 442' ' ' VAL . . . -128.58 143.96 51.06 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.119 -0.491 . . . . 71.41 111.232 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 534' ' ' THR . . . . . 0.505 HG23 ' HD2' ' A' ' 512' ' ' ARG . 59.6 m -120.66 134.12 55.31 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 111.94 0.348 . . . . 72.01 111.94 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -142.5 136.88 29.8 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 120.713 0.292 . . . . 74.31 111.067 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -104.87 125.01 50.45 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.662 0.268 . . . . 55.33 111.692 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.6 t -114.3 128.77 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.8 0.333 . . . . 62.35 111.28 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 30.1 t -112.88 121.59 45.12 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.655 0.264 . . . . 65.23 111.02 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.484 ' HB ' ' HA ' ' A' ' 508' ' ' GLU . 41.9 t -98.93 131.43 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.691 0.281 . . . . 54.43 111.353 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.435 ' HB ' ' HG2' ' A' ' 542' ' ' GLU . 28.8 m -113.16 156.32 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.226 0.454 . . . . 74.21 112.226 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 94.9 mt -95.57 -13.36 24.48 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.323 -0.399 . . . . 74.3 111.652 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 542' ' ' GLU . . . . . 0.435 ' HG2' ' HB ' ' A' ' 540' ' ' VAL . 8.3 pt-20 . . . . . 0 C--O 1.249 1.055 0 N-CA-C 112.449 0.537 . . . . 61.21 112.449 -176.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.84 0.352 . . . . 71.22 110.105 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -97.59 117.57 32.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.228 0.537 . . . . 75.11 111.752 -174.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -121.37 128.61 25.6 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.746 -0.661 . . . . 72.31 110.226 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.625 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 59.2 Cg_endo -75.41 175.18 11.6 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.577 2.184 . . . . 65.22 113.399 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -153.58 81.59 1.17 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.847 -0.615 . . . . 75.52 110.194 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.514 HD22 HD12 ' A' ' 491' ' ' LEU . 96.6 mt -81.34 145.09 31.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.22 0.534 . . . . 63.22 111.833 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.556 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 12.0 t -148.55 156.37 42.34 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.103 0.478 . . . . 64.4 111.672 176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.537 HG12 HG12 ' A' ' 462' ' ' VAL . 27.9 m -125.76 147.95 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.941 -0.572 . . . . 71.54 110.871 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 40.2 mt-10 -134.57 117.98 16.75 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.854 0.359 . . . . 63.32 111.623 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 59.5 mt -94.21 131.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.406 -0.361 . . . . 72.52 110.727 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -142.44 138.85 31.34 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.632 0.253 . . . . 75.02 111.486 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.62 -162.39 32.44 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.017 -0.611 . . . . 73.33 113.51 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.46 124.52 10.42 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.886 2.391 . . . . 55.54 113.189 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -85.72 -15.81 41.01 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.123 0.416 . . . . 62.15 112.123 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.483 HG22 ' HB3' ' A' ' 538' ' ' SER . 87.2 t -133.01 126.61 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 120.711 0.291 . . . . 72.52 110.574 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.61 163.4 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.02 0.438 . . . . 71.22 111.648 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.17 157.52 26.03 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.165 -0.541 . . . . 63.53 113.012 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.1 p -72.34 140.49 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.006 0.432 . . . . 65.24 111.393 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 19.6 m120 60.23 23.81 13.19 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.658 0.383 . . . . 73.41 111.936 -177.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.569 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -112.3 155.62 23.78 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.545 -0.298 . . . . 74.35 111.075 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 502' ' ' SER . 33.5 tp -90.55 139.81 30.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.878 0.37 . . . . 72.45 111.568 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -131.89 143.59 50.26 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.847 0.356 . . . . 60.34 111.608 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -111.32 126.09 54.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.103 0.478 . . . . 62.22 111.643 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -121.96 150.27 42.27 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.152 -0.476 . . . . 73.22 110.729 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.553 ' HG2' HG22 ' A' ' 500' ' ' THR . 37.8 mt-10 -121.8 128.08 51.29 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.129 -0.487 . . . . 73.55 111.384 -176.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 42.6 t -107.65 114.74 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.183 -0.462 . . . . 62.22 111.229 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 42.0 m-70 -90.49 111.55 22.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.722 0.296 . . . . 74.22 110.377 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.681 HG11 HG21 ' A' ' 475' ' ' VAL . 31.6 m -107.82 122.81 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.005 0.431 . . . . 71.22 110.36 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -141.69 152.86 44.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.586 0.707 . . . . 73.21 112.765 -173.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 49.1 t-20 -100.8 138.68 37.53 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.159 -0.928 . . . . 71.23 109.758 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 94.4 mt -120.94 -5.58 9.58 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.409 0.522 . . . . 73.3 112.409 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -77.83 -25.19 62.96 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.211 -0.518 . . . . 34.22 114.047 -176.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.62 15.98 59.15 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.243 -0.503 . . . . 74.12 113.776 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.2 tt -134.66 142.69 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.113 0.565 . . . . 71.43 110.736 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.82 140.78 35.22 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.322 0.489 . . . . 64.44 114.322 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.508 HG11 HD11 ' A' ' 440' ' ' LEU . 47.0 t -131.85 114.3 15.28 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 122.454 0.301 . . . . 55.35 111.671 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -88.84 -10.57 4.19 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 123.196 2.597 . . . . 70.01 113.281 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 84.9 p -85.0 13.27 6.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.636 0.775 . . . . 72.11 112.876 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 63.3 m -87.4 93.35 9.38 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.909 0.861 . . . . 70.32 112.32 -165.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -97.44 127.28 43.27 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.144 -0.934 . . . . 52.0 110.441 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.681 HG21 HG11 ' A' ' 462' ' ' VAL . 47.7 t -114.06 125.1 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.673 0.273 . . . . 71.22 111.079 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 476' ' ' ARG . . . . . 0.491 ' HD2' ' OE1' ' A' ' 519' ' ' GLU . 62.8 mtt85 -125.52 149.79 47.99 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.99 0.424 . . . . 55.43 111.812 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.87 127.09 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.125 0.488 . . . . 73.3 111.436 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -120.37 136.8 54.59 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.932 -0.577 . . . . 70.54 111.384 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.414 HG12 HG12 ' A' ' 513' ' ' ILE . 60.1 mt -109.0 107.87 23.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.22 -0.446 . . . . 74.22 109.982 175.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 57.43 34.9 25.3 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.123 0.487 . . . . 74.22 111.214 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.57 -5.86 84.22 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 116.122 -0.49 . . . . 74.01 113.848 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 42.3 m -93.34 125.63 38.04 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.051 0.426 . . . . 53.24 111.33 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.1 tp -65.72 117.56 8.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.115 0.413 . . . . 62.33 112.115 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -88.74 -45.21 9.97 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.535 -0.302 . . . . 74.22 111.449 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -169.99 161.98 8.98 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.671 0.272 . . . . 54.03 111.4 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -131.93 152.04 51.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.038 0.447 . . . . 64.24 111.595 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -134.54 147.27 50.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.029 -0.532 . . . . 74.11 110.864 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.0 m -121.36 119.21 31.48 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.116 -0.328 . . . . 44.42 110.116 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.5 172.81 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.154 0.502 . . . . 75.3 111.476 -176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 91.5 p -126.0 132.44 52.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.252 -0.431 . . . . 55.45 110.649 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.514 HD12 HD22 ' A' ' 440' ' ' LEU . 95.9 mt -118.23 119.74 35.59 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.842 0.353 . . . . 73.34 111.373 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -78.45 -165.49 27.77 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.056 -0.593 . . . . 70.43 112.975 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.24 95.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.084 1.856 . . . . 63.45 112.413 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.0 mttt 65.78 44.05 2.97 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.646 -0.706 . . . . 60.41 112.61 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -98.43 152.57 19.36 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.089 -0.505 . . . . 73.53 111.347 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -130.72 138.8 50.16 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.934 0.397 . . . . 72.33 111.694 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -119.55 138.76 52.98 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.948 -0.39 . . . . 61.2 109.948 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.01 113.24 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.021 0.439 . . . . 51.24 111.801 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 82.3 mt -103.88 146.46 28.62 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.288 -0.414 . . . . 71.33 111.267 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.553 HG22 ' HG2' ' A' ' 459' ' ' GLU . 43.4 p -127.06 156.76 41.16 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.189 0.518 . . . . 64.01 111.803 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -155.56 148.23 24.12 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.97 -0.559 . . . . 75.03 111.031 171.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.558 ' HB3' HD11 ' A' ' 455' ' ' LEU . 43.3 m -110.98 115.23 29.13 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.297 -0.411 . . . . 72.54 110.849 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -108.54 135.03 50.48 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.818 0.342 . . . . 73.5 111.763 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.3 m -116.14 100.68 53.7 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 116.39 -0.368 . . . . 71.13 111.262 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 505' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 74.5 Cg_endo -76.17 97.36 1.11 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.388 2.059 . . . . 72.53 112.881 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 67.0 p -76.71 -22.61 53.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.104 0.409 . . . . 70.12 112.104 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -107.33 138.58 43.26 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.843 0.354 . . . . 73.31 110.803 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' A' ' 508' ' ' GLU . 0.2 OUTLIER -85.74 140.41 30.52 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.285 0.565 . . . . 65.04 112.189 -174.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 148.49 -179.13 25.58 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.89 -0.595 . . . . 70.51 112.153 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 67.6 mtp -94.02 126.35 39.19 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.8 -0.824 . . . . 51.3 111.664 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.93 131.61 53.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.122 -0.49 . . . . 71.22 111.126 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 512' ' ' ARG . . . . . 0.515 ' HG2' ' ND2' ' A' ' 514' ' ' ASN . 33.0 ttm180 -97.24 122.01 39.78 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.914 0.388 . . . . 73.41 111.263 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.414 HG12 HG12 ' A' ' 479' ' ' ILE . 63.1 mt -100.58 119.59 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.03 0.443 . . . . 63.43 110.951 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.515 ' ND2' ' HG2' ' A' ' 512' ' ' ARG . 44.4 m-80 -115.82 151.87 34.41 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.04 0.448 . . . . 74.32 111.712 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -128.12 132.8 48.94 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.063 -0.517 . . . . 43.45 110.547 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 44.0 p -128.89 143.14 50.81 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.317 -0.401 . . . . 75.04 111.292 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.415 HG13 HD22 ' A' ' 531' ' ' ASN . 7.4 p -119.9 141.13 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.019 0.437 . . . . 61.1 111.697 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 21.8 t70 50.23 49.75 19.94 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.632 0.773 . . . . 72.2 112.632 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 519' ' ' GLU . . . . . 0.491 ' OE1' ' HD2' ' A' ' 476' ' ' ARG . 54.6 mt-10 -53.0 -29.45 29.29 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.247 0.546 . . . . 73.11 111.171 172.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.47 ' HB2' HG23 ' A' ' 522' ' ' THR . 0.0 OUTLIER -65.24 -17.3 64.38 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.655 -0.702 . . . . 64.13 110.933 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 56.91 56.57 5.27 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.243 0.544 . . . . 64.15 110.394 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' THR . . . . . 0.47 HG23 ' HB2' ' A' ' 520' ' ' GLU . 64.5 p -83.9 -36.66 23.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.207 -0.451 . . . . 71.53 111.413 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.22 141.68 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.459 0.54 . . . . 74.4 112.459 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 57.8 t -85.09 119.43 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.197 -0.456 . . . . 70.32 110.461 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.625 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 25.5 mt-10 -115.14 174.8 5.8 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.992 0.738 . . . . 74.32 112.992 -174.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.06 -39.65 55.0 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.511 -0.768 . . . . 73.54 112.286 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -120.07 118.66 31.19 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.207 0.527 . . . . 45.35 111.346 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.78 -20.84 32.6 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.345 0.593 . . . . 64.44 111.495 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -93.39 -4.38 51.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.227 0.537 . . . . 74.25 111.339 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.556 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 62.5 t30 -86.73 -10.79 52.88 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 120.982 0.42 . . . . 63.22 111.72 -174.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 531' ' ' ASN . . . . . 0.415 HD22 HG13 ' A' ' 517' ' ' VAL . 12.4 m120 -85.02 1.45 47.57 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.117 0.784 . . . . 74.3 113.117 -173.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.2 t -127.46 136.93 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 112.38 0.511 . . . . 62.21 112.38 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -125.44 141.19 52.19 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.269 -0.423 . . . . 55.01 110.883 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 84.4 m -127.59 119.7 26.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.168 0.433 . . . . 61.2 112.168 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -126.22 123.38 38.05 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.822 0.344 . . . . 71.5 110.847 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -94.38 120.56 34.8 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.877 0.37 . . . . 75.55 111.848 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.9 t -112.68 141.26 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.191 0.519 . . . . 72.52 111.94 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' SER . . . . . 0.483 ' HB3' HG22 ' A' ' 449' ' ' VAL . 40.2 t -113.79 115.88 28.48 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.296 -0.411 . . . . 74.53 111.031 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 43.6 t -99.8 120.83 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.859 0.362 . . . . 73.23 111.05 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.6 164.5 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.498 0.555 . . . . 72.33 112.498 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.4 mt -77.73 -30.86 51.85 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.356 0.502 . . . . 71.12 112.356 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--O 1.251 1.167 0 N-CA-C 112.383 0.512 . . . . 75.25 112.383 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 71.2 mtm . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.911 0.386 . . . . 74.12 111.304 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -88.09 120.39 29.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.381 -0.372 . . . . 60.54 110.391 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -112.93 134.48 21.76 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.645 -0.252 . . . . 74.34 110.461 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.576 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 61.3 Cg_endo -71.73 175.73 9.2 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.711 2.274 . . . . 75.53 112.789 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -151.6 83.66 1.29 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.123 -0.49 . . . . 70.03 109.872 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.532 HD22 HD12 ' A' ' 491' ' ' LEU . 80.0 mt -83.23 99.15 9.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.014 -0.539 . . . . 73.34 111.132 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.479 HG23 ' HG3' ' A' ' 463' ' ' LYS . 6.5 t -116.64 149.62 39.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.451 . . . . 51.13 111.149 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.602 HG12 HG12 ' A' ' 462' ' ' VAL . 31.4 m -121.37 148.56 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.263 -0.426 . . . . 63.43 111.227 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.3 mt-10 -130.01 117.74 20.51 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.628 0.251 . . . . 71.25 111.388 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 55.4 mt -92.47 131.05 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 110.456 -0.202 . . . . 63.11 110.456 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -142.45 144.51 33.08 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.541 0.21 . . . . 74.32 111.23 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.32 -159.3 29.04 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.989 -0.624 . . . . 74.43 113.38 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.69 134.22 21.71 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.906 2.404 . . . . 71.24 113.22 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -92.3 -20.25 21.3 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.433 0.531 . . . . 73.52 112.433 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.1 t -127.97 125.75 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.959 -0.463 . . . . 75.31 111.241 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 33.6 m -135.65 161.27 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.982 0.42 . . . . 75.11 111.32 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -95.51 166.49 25.39 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.061 -0.59 . . . . 65.14 113.012 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 12.4 p -69.93 139.27 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 O-C-N 122.277 -0.543 . . . . 73.43 111.409 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 20.2 m120 63.6 17.95 10.75 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.913 0.485 . . . . 43.4 112.166 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.534 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.8 mmmt -95.15 150.85 19.75 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.857 0.361 . . . . 70.55 110.812 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' A' ' 502' ' ' SER . 37.6 tp -96.69 118.97 34.28 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.7 0.286 . . . . 64.12 111.004 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.06 134.74 54.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.886 0.374 . . . . 73.22 111.715 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -108.55 130.05 55.3 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.0 0.428 . . . . 73.34 111.45 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -122.33 166.44 14.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.088 0.47 . . . . 74.45 111.488 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -121.19 127.5 51.56 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.975 -0.557 . . . . 53.43 111.24 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 29.8 t -104.83 113.04 40.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 41.43 110.024 173.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 29.9 m-70 -98.34 106.22 18.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.648 0.261 . . . . 75.52 110.512 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.602 HG12 HG12 ' A' ' 442' ' ' VAL . 19.4 m -105.8 123.48 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.2 0.524 . . . . 64.12 110.104 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.548 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.2 ptpt -139.89 144.18 37.05 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.517 0.562 . . . . 62.14 112.517 -170.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.4 t-20 -102.76 126.7 49.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.191 -0.67 . . . . 71.11 109.191 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.548 HD21 ' HD3' ' A' ' 463' ' ' LYS . 67.9 mt -112.69 0.15 15.25 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.011 -0.43 . . . . 75.22 112.034 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -83.87 -21.47 57.5 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.073 -0.584 . . . . 63.12 113.797 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.61 21.4 47.8 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.07 -0.586 . . . . 34.31 113.861 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.402 HG23 ' HB3' ' A' ' 438' ' ' PRO . 3.7 tt -138.1 133.77 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 122.662 -0.316 . . . . 70.53 111.076 175.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.1 141.41 34.28 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 114.684 0.634 . . . . 72.23 114.684 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.67 116.27 16.02 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.834 0.454 . . . . 61.13 111.344 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.71 -12.17 11.19 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.056 2.504 . . . . 74.4 113.086 175.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 50.7 m -81.59 13.51 3.06 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.587 0.755 . . . . 71.05 112.79 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' THR . . . . . 0.424 HG23 HG21 ' A' ' 517' ' ' VAL . 62.9 m -86.56 91.15 8.47 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 122.119 0.962 . . . . 62.44 111.465 -165.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -95.08 121.7 36.99 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.698 -1.137 . . . . 74.34 110.364 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.544 HG21 HG11 ' A' ' 462' ' ' VAL . 41.4 t -104.31 118.24 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.001 0.429 . . . . 54.32 111.291 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -116.58 144.37 44.46 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.642 0.258 . . . . 72.42 111.555 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 95.6 t -120.17 120.25 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.801 0.334 . . . . 64.44 110.881 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -116.08 137.39 52.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.25 -0.432 . . . . 74.05 111.387 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.485 HG12 HG12 ' A' ' 513' ' ' ILE . 63.3 mt -111.85 107.94 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.799 -0.445 . . . . 42.03 109.799 174.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 480' ' ' ASN . . . . . 0.401 HD21 ' HA ' ' A' ' 511' ' ' TYR . 95.9 m-20 56.27 34.44 24.04 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.093 0.473 . . . . 75.24 111.183 -173.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.9 -20.65 47.88 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 116.252 -0.431 . . . . 54.42 113.732 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 45.5 m -81.93 121.71 26.84 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.357 -0.496 . . . . 75.41 111.81 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -63.91 120.32 11.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.077 0.465 . . . . 65.34 111.555 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -102.91 -43.89 5.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.201 -0.454 . . . . 74.12 111.982 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -146.91 152.53 38.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.583 0.23 . . . . 65.22 111.107 -174.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -145.3 139.15 26.87 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.103 0.478 . . . . 73.41 111.496 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -129.7 148.86 51.63 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.121 -0.49 . . . . 75.31 110.709 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 78.5 m -117.62 118.48 32.24 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.69 0.281 . . . . 72.21 110.244 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.1 m -141.8 173.43 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.283 0.563 . . . . 61.43 111.765 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 64.9 m -121.35 135.48 55.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.121 -0.49 . . . . 72.31 110.914 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.532 HD12 HD22 ' A' ' 440' ' ' LEU . 85.1 mt -118.11 119.85 35.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.806 0.336 . . . . 65.33 111.072 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -82.72 -169.03 43.6 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.326 -0.464 . . . . 61.02 113.449 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.51 107.88 0.64 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.417 2.078 . . . . 54.12 112.7 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.0 mmtp 68.45 29.21 5.79 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.126 -0.488 . . . . 75.24 111.596 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -92.2 147.4 22.96 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.369 -0.378 . . . . 71.31 111.728 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -135.12 129.35 33.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.605 0.362 . . . . 71.43 111.479 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.404 ' HG2' ' CD2' ' A' ' 491' ' ' LEU . 30.2 mmmt -116.79 136.63 52.8 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.677 0.275 . . . . 74.12 110.704 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 63.1 t -101.77 113.54 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 121.199 0.523 . . . . 61.34 111.488 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 68.7 mt -110.7 131.15 55.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.97 -0.559 . . . . 45.14 110.489 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 26.6 p -113.9 154.7 27.08 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.267 0.556 . . . . 71.22 112.32 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -144.4 148.8 35.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.645 -0.707 . . . . 64.14 110.816 174.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.509 ' HB2' HD11 ' A' ' 455' ' ' LEU . 76.0 p -115.04 114.36 25.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.065 0.46 . . . . 72.23 110.805 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -113.56 137.18 51.94 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.24 -0.436 . . . . 61.24 112.002 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.4 m -116.24 102.03 53.72 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.093 -0.503 . . . . 51.41 111.222 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 505' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 60.7 Cg_endo -71.92 99.38 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.534 2.156 . . . . 74.21 112.955 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 33.1 p -74.04 -21.88 59.77 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.944 0.402 . . . . 75.34 111.907 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -112.36 141.19 46.39 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.413 -0.358 . . . . 71.44 111.107 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.68 151.18 23.64 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.257 0.551 . . . . 75.23 111.926 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 148.02 -170.97 28.6 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.06 -0.591 . . . . 70.15 112.77 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 13.7 tpt -98.76 120.83 39.87 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.503 -0.41 . . . . 74.32 110.729 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 511' ' ' TYR . . . . . 0.401 ' HA ' HD21 ' A' ' 480' ' ' ASN . 96.1 m-85 -120.23 116.22 25.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.899 0.38 . . . . 71.21 111.701 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -92.47 112.94 25.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.901 0.381 . . . . 72.14 110.482 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.485 HG12 HG12 ' A' ' 479' ' ' ILE . 58.1 mt -93.8 117.34 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.254 0.55 . . . . 75.31 110.907 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -117.05 134.66 54.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 73.42 111.1 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.35 133.16 53.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.733 0.301 . . . . 53.53 110.646 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 516' ' ' THR . . . . . 0.575 HG22 HG22 ' A' ' 532' ' ' VAL . 66.5 p -125.41 140.32 52.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.99 0.424 . . . . 73.33 111.61 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.424 HG21 HG23 ' A' ' 473' ' ' THR . 7.4 p -120.29 140.83 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.814 0.34 . . . . 72.14 111.022 174.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.6 t0 43.43 58.74 3.3 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.393 0.677 . . . . 71.31 112.778 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -57.75 -29.99 65.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.608 0.718 . . . . 74.33 110.475 171.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.62 -17.3 64.56 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.259 -0.882 . . . . 73.44 111.791 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 19.7 m120 51.4 55.4 9.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.671 0.748 . . . . 70.43 111.306 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 51.1 p -67.21 -19.72 65.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.377 -0.829 . . . . 74.22 111.363 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.22 141.13 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.188 -0.46 . . . . 61.31 111.749 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 74.0 t -83.58 119.78 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 110.069 -0.345 . . . . 74.31 110.069 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.576 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 18.9 mt-10 -110.24 -175.03 2.63 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.699 0.629 . . . . 73.04 112.699 -171.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 99.2 mt -69.48 -39.26 77.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.275 -0.42 . . . . 64.15 111.209 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -126.73 124.85 40.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.343 -0.39 . . . . 63.01 110.864 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -83.2 -23.98 32.61 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.848 0.314 . . . . 74.5 111.848 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -103.49 4.2 35.71 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.631 0.604 . . . . 71.33 112.631 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.474 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.7 t30 -86.62 -1.75 57.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.087 0.47 . . . . 74.22 111.373 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -80.85 -1.06 41.69 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.677 0.621 . . . . 74.14 112.677 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 516' ' ' THR . 56.6 t -124.53 129.61 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.112 0.412 . . . . 61.12 112.112 -176.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 533' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -114.3 142.86 45.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.342 -0.39 . . . . 42.32 111.162 177.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 63.2 m -116.22 130.14 56.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.36 -0.382 . . . . 51.21 111.963 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -142.88 117.64 9.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.443 -0.344 . . . . 71.24 110.28 174.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -96.34 134.31 39.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.185 0.516 . . . . 60.43 112.277 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.03 138.12 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.086 -0.506 . . . . 74.21 111.52 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.3 t -104.26 127.28 51.87 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.597 -0.274 . . . . 75.04 111.422 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 47.1 t -111.35 126.61 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.803 0.335 . . . . 73.01 111.258 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 28.8 m -121.04 164.3 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.596 0.591 . . . . 72.52 112.596 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 79.6 mt -88.26 11.06 17.55 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.508 0.558 . . . . 72.54 112.508 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--O 1.251 1.179 0 N-CA-C 112.369 0.507 . . . . 52.3 112.369 -176.688 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 59.8 mtt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.873 0.368 . . . . 74.34 111.122 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.76 127.11 35.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.994 0.426 . . . . 73.13 111.295 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -112.18 134.14 21.55 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.451 -0.34 . . . . 71.11 110.759 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.587 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 74.4 Cg_endo -81.77 175.96 8.86 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.944 2.429 . . . . 75.23 113.433 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -155.73 86.79 1.06 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.051 -0.522 . . . . 73.31 109.997 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.531 HD22 HD12 ' A' ' 491' ' ' LEU . 75.7 mt -89.0 105.37 17.74 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.975 0.417 . . . . 62.32 111.981 -176.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.707 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 8.0 t -113.14 152.12 30.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.2 0.524 . . . . 74.14 111.804 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.633 HG12 HG12 ' A' ' 462' ' ' VAL . 33.5 m -124.35 147.88 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.788 -0.642 . . . . 63.55 111.123 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 41.7 mt-10 -133.47 142.31 48.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.691 -0.231 . . . . 73.05 111.263 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 58.2 mt -111.59 129.77 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.723 0.297 . . . . 75.43 111.077 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -133.02 133.9 43.7 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.25 -0.281 . . . . 75.04 111.202 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.38 -170.94 39.75 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.89 -0.672 . . . . 65.33 113.5 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.14 126.87 13.54 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.702 2.268 . . . . 64.03 113.079 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -77.9 -19.99 53.72 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.058 0.392 . . . . 73.04 112.058 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.67 127.94 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.438 0.295 . . . . 54.51 110.38 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.84 163.93 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.28 0.562 . . . . 72.02 111.885 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.14 153.74 20.34 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.229 -0.51 . . . . 72.32 113.253 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.461 HG11 HD23 ' A' ' 541' ' ' LEU . 14.4 p -68.47 141.76 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.626 0.25 . . . . 72.21 111.236 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 59.97 21.44 10.51 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.058 0.456 . . . . 73.15 111.808 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -107.26 165.08 11.64 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.011 0.434 . . . . 75.42 111.483 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 502' ' ' SER . 29.4 tp -103.77 117.37 34.2 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.415 -0.357 . . . . 74.33 111.341 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.94 133.27 56.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.687 0.28 . . . . 71.2 111.509 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -110.7 133.76 53.05 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.081 0.467 . . . . 72.22 111.836 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -123.49 163.25 21.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.94 -0.573 . . . . 72.34 111.144 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -119.86 127.31 52.62 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.854 0.359 . . . . 75.34 110.569 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.47 112.96 36.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.69 -0.485 . . . . 71.4 109.69 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 30.7 m-70 -96.21 107.83 20.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.425 -0.352 . . . . 73.22 110.661 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.633 HG12 HG12 ' A' ' 442' ' ' VAL . 14.4 m -108.97 122.0 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.139 0.495 . . . . 51.24 110.451 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.481 ' HG3' HG23 ' A' ' 441' ' ' THR . 4.6 ptpp? -138.63 144.2 39.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.382 0.611 . . . . 71.41 112.253 -173.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 51.6 t-20 -99.96 127.3 46.17 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.599 -0.728 . . . . 71.4 109.808 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.427 HD21 ' HD3' ' A' ' 463' ' ' LYS . 82.7 mt -111.92 -1.9 15.33 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.958 0.355 . . . . 63.12 111.958 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -81.71 -15.72 74.88 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.388 -0.434 . . . . 63.35 113.831 -178.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.88 20.4 65.57 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 120.938 -0.649 . . . . 73.03 113.854 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.418 HG23 ' HB3' ' A' ' 438' ' ' PRO . 5.8 tt -138.47 135.03 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 122.731 -0.276 . . . . 74.55 111.412 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -66.88 134.88 32.27 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 114.123 0.409 . . . . 52.41 114.123 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 440' ' ' LEU . 86.9 t -129.6 116.75 18.41 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 122.651 0.38 . . . . 71.31 111.842 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.2 -10.44 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.085 2.523 . . . . 65.32 113.143 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.8 t -80.62 12.52 3.06 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.149 0.58 . . . . 71.24 112.469 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' THR . . . . . 0.432 HG23 HG21 ' A' ' 517' ' ' VAL . 67.7 m -87.61 91.09 8.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.958 0.885 . . . . 74.3 111.803 -166.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 517' ' ' VAL . 91.4 mttt -94.5 124.15 38.35 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.956 -1.02 . . . . 64.41 110.29 173.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.589 HG21 HG11 ' A' ' 462' ' ' VAL . 41.3 t -110.19 119.61 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.721 0.296 . . . . 70.42 111.005 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 476' ' ' ARG . . . . . 0.419 ' NH1' ' HB2' ' A' ' 519' ' ' GLU . 71.8 mtt180 -122.5 146.81 47.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 111.79 0.293 . . . . 73.04 111.79 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.8 t -120.65 124.18 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.044 0.45 . . . . 75.13 111.186 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -111.78 137.15 50.1 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.976 -0.557 . . . . 65.03 110.704 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.542 HG12 HG12 ' A' ' 513' ' ' ILE . 59.8 mt -117.37 108.67 25.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.854 0.359 . . . . 65.34 111.34 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 66.2 t30 60.06 34.1 21.31 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.266 0.555 . . . . 72.45 111.462 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 97.65 -12.79 64.47 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.274 -0.489 . . . . 44.33 114.031 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 89.8 m -105.21 127.07 52.75 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.332 0.566 . . . . 62.45 111.75 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.7 tp -61.98 128.0 34.06 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.943 0.401 . . . . 73.53 110.855 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -105.38 -43.6 4.94 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.644 0.609 . . . . 61.01 112.644 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -162.75 159.33 24.05 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.272 -0.267 . . . . 74.32 111.02 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -145.53 157.2 44.03 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.894 0.378 . . . . 61.23 111.753 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 -137.2 148.75 46.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.191 -0.459 . . . . 75.3 110.754 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 51.8 m -117.96 118.04 30.89 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.881 0.372 . . . . 64.31 110.168 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.12 174.55 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.21 0.528 . . . . 72.22 111.752 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 89.9 p -129.39 140.08 51.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.148 -0.478 . . . . 71.51 110.608 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.531 HD12 HD22 ' A' ' 440' ' ' LEU . 79.4 mt -117.44 121.49 41.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.852 0.358 . . . . 70.11 111.752 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -78.41 -172.18 40.1 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.357 -0.449 . . . . 71.12 113.08 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.16 110.54 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.45 2.1 . . . . 53.44 112.906 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 39.5 mmtm 67.0 26.63 9.01 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.986 -0.552 . . . . 74.21 111.929 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -99.2 146.89 25.69 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.109 -0.496 . . . . 73.31 112.064 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 496' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 41.6 tt0 -129.07 145.77 51.19 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.103 0.478 . . . . 63.23 111.937 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.417 ' HG2' ' CD2' ' A' ' 491' ' ' LEU . 31.8 mmmt -121.6 137.18 54.85 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.784 -0.45 . . . . 74.41 109.784 172.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 52.9 t -101.04 112.12 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.139 0.495 . . . . 72.12 110.814 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 57.8 mt -103.15 146.57 28.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.989 -0.551 . . . . 62.22 110.714 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 20.0 p -130.21 155.31 46.47 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.549 0.69 . . . . 63.43 112.591 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.26 148.65 26.1 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.32 -0.855 . . . . 60.12 110.21 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.521 ' HB2' HD11 ' A' ' 455' ' ' LEU . 51.8 p -116.88 114.79 24.38 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.911 0.386 . . . . 44.31 110.984 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -104.15 136.72 43.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.262 -0.426 . . . . 73.51 111.896 -174.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.6 m -117.43 100.7 52.86 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 116.39 -0.368 . . . . 52.42 111.096 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 505' ' ' PRO . . . . . 0.424 ' HB2' HG11 ' A' ' 539' ' ' VAL . 90.7 Cg_endo -81.16 100.14 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.751 2.3 . . . . 64.11 113.072 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.9 p -78.57 -29.64 46.35 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.268 0.47 . . . . 74.32 112.268 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -100.43 131.67 46.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.832 0.349 . . . . 64.03 110.73 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.412 ' HG2' HD21 ' A' ' 541' ' ' LEU . 0.3 OUTLIER -87.36 150.37 23.88 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.11 0.481 . . . . 73.22 112.068 -176.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.79 -170.38 29.91 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.365 -0.445 . . . . 51.35 112.924 -178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 14.9 tpt -91.6 124.54 35.84 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 122.437 -0.449 . . . . 74.31 111.565 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -128.4 151.96 48.76 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.985 0.421 . . . . 74.33 111.258 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' ARG . . . . . 0.424 ' HG2' ' ND2' ' A' ' 514' ' ' ASN . 40.2 ttm180 -124.18 119.72 30.22 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.104 -0.372 . . . . 52.22 111.615 176.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.542 HG12 HG12 ' A' ' 479' ' ' ILE . 52.6 mt -95.95 126.77 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.019 0.438 . . . . 61.22 111.306 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.424 ' ND2' ' HG2' ' A' ' 512' ' ' ARG . 40.5 m-80 -123.01 145.21 48.7 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.989 0.423 . . . . 75.32 111.575 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.68 134.26 53.76 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.185 -0.461 . . . . 74.43 110.309 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 50.5 p -136.93 151.37 48.96 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.955 0.407 . . . . 71.4 111.945 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 474' ' ' LYS . 7.8 p -128.92 149.8 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 116.26 -0.427 . . . . 72.43 111.722 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 17.2 t70 47.9 43.53 17.57 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.71 0.767 . . . . 65.42 111.741 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 519' ' ' GLU . . . . . 0.419 ' HB2' ' NH1' ' A' ' 476' ' ' ARG . 6.9 mm-40 -51.4 -30.94 20.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.68 -0.691 . . . . 65.25 111.627 174.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -23.65 66.33 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.807 -0.633 . . . . 75.1 110.678 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 62.59 82.11 0.19 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.249 0.619 . . . . 75.33 110.303 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 53.8 p -109.45 -26.95 9.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 72.41 111.637 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.04 141.59 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 112.978 0.733 . . . . 62.11 112.978 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 99.0 t -84.6 114.5 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.141 -0.481 . . . . 74.44 110.296 172.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 27.3 mt-10 -101.78 176.8 5.1 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.636 0.606 . . . . 74.35 112.636 -174.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.15 -39.61 86.99 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.904 -0.589 . . . . 71.15 110.944 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 527' ' ' ASN . . . . . 0.561 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 32.2 t30 -141.55 93.19 2.54 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.371 0.605 . . . . 64.15 110.302 173.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.55 14.95 3.37 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.064 -0.516 . . . . 64.4 112.212 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -104.62 -3.44 23.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.718 0.771 . . . . 72.11 109.67 167.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.707 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.1 t30 -86.55 -0.65 56.56 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.418 -0.81 . . . . 74.4 111.355 -174.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -83.76 -6.86 59.53 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.882 0.697 . . . . 73.44 112.882 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.49 138.45 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.215 0.45 . . . . 75.41 112.215 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.08 142.84 50.57 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.215 -0.448 . . . . 63.2 111.183 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.4 m -126.77 133.91 50.73 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.665 0.269 . . . . 73.34 111.626 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -143.15 129.73 20.19 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.818 0.342 . . . . 74.34 111.08 177.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -93.6 134.7 35.61 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.877 0.37 . . . . 74.11 111.883 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 63.0 t -128.83 128.36 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.044 0.449 . . . . 44.04 111.43 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 46.6 t -103.82 120.88 41.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.77 0.319 . . . . 72.53 111.078 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.424 HG11 ' HB2' ' A' ' 505' ' ' PRO . 48.7 t -99.23 120.08 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.896 0.379 . . . . 72.24 111.321 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.442 HG23 ' H ' ' A' ' 542' ' ' GLU . 35.0 m -119.49 167.74 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.183 0.516 . . . . 74.44 112.116 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 541' ' ' LEU . . . . . 0.461 HD23 HG11 ' A' ' 452' ' ' VAL . 98.0 mt -80.4 25.94 0.39 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.215 0.45 . . . . 74.3 112.215 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 542' ' ' GLU . . . . . 0.442 ' H ' HG23 ' A' ' 540' ' ' VAL . 41.7 mt-10 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.545 -0.741 . . . . 64.43 111.914 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 120.806 0.336 . . . . 72.33 110.106 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -98.64 146.38 25.9 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.229 -0.442 . . . . 71.42 111.569 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -117.07 134.93 22.96 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.335 -0.393 . . . . 74.02 110.425 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.424 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 86.7 Cg_endo -79.86 174.19 11.93 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.707 2.271 . . . . 65.43 114.046 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.0 93.97 2.99 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.424 -0.807 . . . . 74.13 109.471 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.4 HD11 HG11 ' A' ' 470' ' ' VAL . 98.4 mt -98.07 108.21 20.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.872 0.368 . . . . 71.15 111.348 -175.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 8.7 t -123.34 152.68 41.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.136 0.493 . . . . 61.13 111.669 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.516 HG12 HG12 ' A' ' 462' ' ' VAL . 34.8 m -120.87 147.85 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.972 -0.558 . . . . 51.03 110.846 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.629 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 43.1 mt-10 -130.28 137.18 49.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.666 -0.243 . . . . 55.04 110.747 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.05 138.02 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.146 0.498 . . . . 61.34 111.689 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -137.1 146.1 44.7 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.049 -0.523 . . . . 74.45 110.97 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.64 -171.2 33.63 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.674 -0.774 . . . . 61.25 114.025 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.04 123.45 8.38 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.819 2.346 . . . . 73.01 112.712 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.48 -13.32 52.34 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.397 0.517 . . . . 72.21 112.397 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 80.2 t -131.38 122.96 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.653 0.263 . . . . 73.44 110.75 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 31.2 m -135.81 163.19 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.172 0.511 . . . . 54.34 111.802 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -100.78 163.91 18.59 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 116.188 -0.46 . . . . 41.5 112.979 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.91 144.01 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 122.496 -0.414 . . . . 74.22 111.339 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 17.8 m120 60.17 17.61 7.06 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.221 0.452 . . . . 73.25 112.221 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.442 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.1 mmmt -103.82 138.84 39.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.923 0.392 . . . . 62.2 111.299 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 502' ' ' SER . 36.2 tp -85.39 125.35 32.91 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.194 -0.457 . . . . 52.32 111.251 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -124.79 136.66 54.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.917 0.389 . . . . 70.54 111.81 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.33 133.94 46.43 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.049 0.452 . . . . 65.44 111.746 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' TYR . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 86.1 m-85 -122.31 150.93 41.68 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.205 -0.452 . . . . 70.34 111.03 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -120.88 127.23 51.68 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.951 -0.568 . . . . 41.23 110.875 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.6 t -113.68 127.47 71.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 122.785 0.434 . . . . 64.25 111.212 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.629 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 77.7 m-70 -107.75 110.67 22.55 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.812 0.339 . . . . 72.55 110.594 176.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.617 HG11 HG21 ' A' ' 475' ' ' VAL . 33.6 m -107.47 124.27 63.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 120.896 0.379 . . . . 64.33 110.304 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.543 ' HD3' HD21 ' A' ' 465' ' ' LEU . 13.4 ptpt -143.73 153.75 42.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.159 0.8 . . . . 64.54 113.159 -170.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 48.9 t-20 -112.0 126.45 55.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.355 -0.839 . . . . 70.23 109.47 173.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.543 HD21 ' HD3' ' A' ' 463' ' ' LYS . 47.1 mt -114.28 5.16 15.69 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.867 0.365 . . . . 52.55 111.658 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -82.36 -20.14 62.96 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.308 -0.472 . . . . 54.41 113.682 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.84 14.91 62.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.021 -0.609 . . . . 42.14 113.603 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.9 tt -135.94 133.46 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 122.52 0.328 . . . . 43.55 111.119 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.36 139.86 28.6 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 114.172 0.429 . . . . 72.24 114.172 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 440' ' ' LEU . 52.8 t -130.36 114.35 17.12 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 111.95 0.352 . . . . 65.12 111.95 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.28 -11.33 13.32 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.982 2.455 . . . . 73.33 112.755 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' SER . . . . . 0.494 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 20.1 m -80.55 11.38 3.77 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.658 0.783 . . . . 65.22 112.773 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 39.9 m -89.53 91.92 8.89 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.652 0.739 . . . . 65.23 112.316 -165.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -101.9 126.75 48.87 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.403 -0.817 . . . . 71.15 110.357 171.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.617 HG21 HG11 ' A' ' 462' ' ' VAL . 55.6 t -112.62 128.97 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.813 0.339 . . . . 54.14 111.286 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 476' ' ' ARG . . . . . 0.543 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 82.6 mtt180 -115.63 151.22 35.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.78 0.324 . . . . 75.24 111.312 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.3 t -121.31 120.21 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.835 0.35 . . . . 53.5 111.08 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -114.29 144.67 42.87 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.277 -0.419 . . . . 74.11 111.553 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.538 HG12 HG12 ' A' ' 513' ' ' ILE . 55.2 mt -123.6 107.93 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.115 -0.493 . . . . 60.34 109.73 173.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 53.42 39.14 29.48 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 120.88 0.371 . . . . 72.14 111.84 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 85.63 -0.96 88.31 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.097 -0.573 . . . . 52.51 114.066 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 94.4 m -98.51 120.45 38.95 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.25 0.525 . . . . 73.0 111.401 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 59.7 tp -69.7 115.04 8.48 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.189 0.518 . . . . 73.3 111.376 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -90.03 -43.28 10.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.121 -0.491 . . . . 75.31 111.754 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -167.32 162.25 14.72 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.664 0.268 . . . . 64.44 111.516 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -147.49 152.6 38.33 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.688 0.28 . . . . 73.2 111.139 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 24.7 m-90 -130.0 134.77 47.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.818 0.342 . . . . 74.43 110.764 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 57.1 m -104.38 118.12 35.84 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.731 0.3 . . . . 72.33 110.257 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 22.3 m -140.83 172.85 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.343 0.592 . . . . 71.44 111.489 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 79.6 p -118.51 135.05 54.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.94 -0.573 . . . . 72.12 110.281 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.1 mt -116.96 119.68 36.08 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.886 0.374 . . . . 64.44 110.882 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -80.3 -177.35 50.9 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.079 -0.582 . . . . 51.42 113.116 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.56 108.75 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.476 2.117 . . . . 73.32 112.457 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.2 mmtp 67.91 32.98 4.9 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.14 -0.482 . . . . 72.14 111.816 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -101.33 148.61 24.95 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 111.92 0.341 . . . . 61.12 111.92 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 14.4 tt0 -131.8 143.68 50.38 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.428 -0.351 . . . . 70.42 111.206 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.406 ' HB3' ' NZ ' ' A' ' 497' ' ' LYS . 2.3 mmmp? -124.67 134.85 52.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.72 0.295 . . . . 74.13 110.575 175.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.06 117.57 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.244 0.545 . . . . 71.14 111.295 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 52.4 mt -114.07 146.7 39.87 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.038 -0.528 . . . . 73.23 110.861 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 33.3 p -129.41 154.47 46.91 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.27 0.557 . . . . 64.02 112.026 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 501' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.1 p90 -148.01 149.49 32.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.779 -0.646 . . . . 73.02 110.651 173.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.552 ' HB3' HD11 ' A' ' 455' ' ' LEU . 43.0 m -110.11 115.29 29.49 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.013 0.435 . . . . 62.34 110.333 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -118.05 136.58 53.47 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.969 0.414 . . . . 75.22 112.043 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.7 m -119.11 112.27 36.34 Favored Pre-proline 0 N--CA 1.472 0.653 0 CA-C-N 116.17 -0.468 . . . . 74.32 111.121 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 505' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 67.4 Cg_endo -75.06 118.85 5.4 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.418 2.079 . . . . 70.41 112.684 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 42.1 p -92.22 0.75 57.47 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.788 0.662 . . . . 64.11 112.788 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -143.75 145.93 32.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.701 0.286 . . . . 65.21 110.835 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -79.32 150.28 31.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.125 0.488 . . . . 71.1 111.148 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.76 -170.31 30.58 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.256 -0.497 . . . . 75.3 112.542 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' MET . . . . . 0.459 ' SD ' ' C ' ' A' ' 510' ' ' MET . 0.0 OUTLIER -96.43 111.14 23.35 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.93 0.395 . . . . 51.1 110.481 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -115.21 111.5 21.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.068 0.461 . . . . 61.31 111.644 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -96.31 124.85 40.46 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.901 0.381 . . . . 70.12 111.135 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.538 HG12 HG12 ' A' ' 479' ' ' ILE . 57.9 mt -98.55 124.1 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.214 -0.448 . . . . 70.22 111.127 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 52.1 m-80 -122.61 138.47 54.58 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.026 0.441 . . . . 71.53 111.415 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.08 132.89 54.57 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.596 -0.275 . . . . 62.43 110.443 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 516' ' ' THR . . . . . 0.541 HG22 HG22 ' A' ' 532' ' ' VAL . 54.1 p -123.47 140.34 53.1 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.875 0.369 . . . . 73.44 111.768 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.42 147.73 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.77 0.319 . . . . 74.03 111.319 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 37.9 t70 57.38 42.23 25.14 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.611 0.72 . . . . 74.03 111.81 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 519' ' ' GLU . . . . . 0.543 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.2 mm-40 -56.22 -32.55 64.54 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.966 -0.459 . . . . 71.24 111.481 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -67.71 -19.39 65.15 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.259 -0.428 . . . . 71.31 111.64 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 65.52 78.94 0.26 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.093 0.473 . . . . 71.14 111.306 -175.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 522' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 44.7 p -132.81 -13.54 2.86 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.061 0.763 . . . . 71.51 113.061 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.9 p -134.64 143.63 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.167 0.508 . . . . 62.22 112.272 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 68.0 t -100.73 117.96 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.343 -0.389 . . . . 74.12 111.096 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -92.64 175.31 6.86 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.242 0.544 . . . . 73.33 111.4 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.57 -29.97 59.5 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.114 -0.494 . . . . 73.54 110.828 172.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -135.35 145.42 47.37 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.697 -0.683 . . . . 60.33 110.239 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.23 2.33 10.85 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.303 0.483 . . . . 54.21 112.303 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -87.25 -4.12 59.07 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.791 0.329 . . . . 61.1 111.708 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -111.83 -2.85 15.1 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.442 0.534 . . . . 63.35 112.442 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -69.67 -17.6 63.5 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.213 0.449 . . . . 74.33 112.213 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 516' ' ' THR . 41.1 t -124.13 131.99 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.672 0.272 . . . . 54.11 111.121 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 533' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -113.63 138.49 50.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.659 0.266 . . . . 54.1 111.083 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 50.0 m -112.18 127.65 56.01 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.123 0.416 . . . . 72.45 112.123 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -134.86 126.85 29.6 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.37 -0.377 . . . . 62.02 110.303 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.98 124.92 39.31 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.081 0.4 . . . . 53.1 112.081 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.18 128.45 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.139 0.495 . . . . 71.4 111.301 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.6 t -105.37 120.12 40.78 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.256 -0.277 . . . . 75.31 110.726 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 53.7 t -104.7 128.58 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.911 0.386 . . . . 75.34 111.871 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.83 160.08 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 116.337 -0.392 . . . . 73.02 111.546 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.57 -17.03 61.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.141 0.423 . . . . 74.13 112.141 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--O 1.252 1.233 0 N-CA-C 112.104 0.409 . . . . 72.44 112.104 -178.845 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 10.6 tpt . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 121.078 0.466 . . . . 74.44 110.821 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -100.18 136.45 40.05 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.015 0.436 . . . . 74.43 111.816 -177.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -122.39 131.62 24.37 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.882 -0.599 . . . . 73.53 109.855 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 60.4 Cg_endo -73.45 173.91 13.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.25 1.966 . . . . 71.44 113.96 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -152.95 109.13 3.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.156 -0.929 . . . . 73.31 109.462 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 491' ' ' LEU . 83.1 mt -105.36 156.85 17.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 72.45 111.171 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.642 HG23 ' HG3' ' A' ' 463' ' ' LYS . 2.0 t -161.28 149.89 15.97 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.037 0.446 . . . . 71.11 112.026 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.577 HG12 HG12 ' A' ' 462' ' ' VAL . 35.8 m -121.11 147.67 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.03 -0.532 . . . . 73.13 111.621 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -139.56 135.39 33.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.112 -0.494 . . . . 64.3 111.153 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 59.2 mt -109.18 131.36 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.534 0.206 . . . . 61.55 110.958 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -133.78 145.17 49.53 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.479 0.181 . . . . 63.13 110.952 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.39 -171.2 34.06 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 120.797 -0.716 . . . . 52.43 113.999 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.54 123.1 9.84 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.956 2.437 . . . . 71.31 112.991 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -83.58 -8.76 59.25 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.286 0.476 . . . . 75.02 112.286 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 73.3 t -131.67 120.87 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 122.342 -0.224 . . . . 71.53 110.783 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 32.9 m -135.4 164.15 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.054 0.454 . . . . 75.31 111.853 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -94.89 162.33 24.03 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.3 -0.476 . . . . 34.14 113.439 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.407 HG22 ' OD1' ' A' ' 453' ' ' ASN . 8.4 p -74.26 140.71 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 O-C-N 122.436 -0.45 . . . . 71.01 111.484 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 453' ' ' ASN . . . . . 0.407 ' OD1' HG22 ' A' ' 452' ' ' VAL . 22.2 m120 59.4 16.57 5.22 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.227 0.611 . . . . 70.14 112.056 -177.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -98.75 157.9 15.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.995 0.426 . . . . 75.42 111.394 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 502' ' ' SER . 26.8 tp -96.07 130.94 42.96 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.343 -0.389 . . . . 72.14 111.2 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -134.91 134.39 40.61 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.519 0.2 . . . . 63.24 111.339 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -100.31 133.05 45.3 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.351 0.596 . . . . 62.33 111.921 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -122.66 164.0 19.04 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.735 -0.666 . . . . 64.44 110.633 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' A' ' 500' ' ' THR . 57.2 mt-10 -121.32 127.7 51.56 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.108 0.48 . . . . 75.51 111.965 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 52.7 t -100.03 113.78 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.068 -0.514 . . . . 74.12 110.062 172.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -99.35 110.45 22.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 74.13 110.699 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.75 HG11 HG21 ' A' ' 475' ' ' VAL . 30.5 m -110.72 122.95 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.079 0.466 . . . . 63.51 110.517 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.642 ' HG3' HG23 ' A' ' 441' ' ' THR . 3.0 ptpp? -135.44 151.39 50.37 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.785 0.661 . . . . 53.14 112.785 -173.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 51.2 t-20 -106.19 128.37 53.88 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.296 -0.865 . . . . 72.11 109.761 175.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.443 HD21 ' HD3' ' A' ' 463' ' ' LYS . 73.6 mt -107.61 -23.32 12.18 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.91 0.337 . . . . 63.41 111.91 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -60.22 -25.97 63.16 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 114.604 0.602 . . . . 44.44 114.604 -173.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.53 17.49 58.47 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.831 -0.7 . . . . 74.41 113.271 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.6 tt -137.73 140.92 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 122.785 0.434 . . . . 72.35 110.85 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.441 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -67.43 136.29 31.89 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.204 0.442 . . . . 44.31 114.204 -176.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.405 HG11 HD11 ' A' ' 440' ' ' LEU . 46.7 t -127.4 113.7 21.27 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-O 120.799 0.333 . . . . 72.14 111.339 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -88.36 -9.73 4.95 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.267 2.645 . . . . 74.2 113.095 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' SER . . . . . 0.461 ' HB2' ' OG1' ' A' ' 522' ' ' THR . 93.2 p -87.79 11.95 14.16 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.5 0.926 . . . . 43.53 113.5 -173.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 60.3 m -87.85 108.58 19.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.605 0.717 . . . . 63.21 112.825 -164.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -112.12 131.03 55.69 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.437 -0.801 . . . . 62.12 111.181 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.75 HG21 HG11 ' A' ' 462' ' ' VAL . 41.5 t -111.23 137.24 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 122.458 0.303 . . . . 74.5 111.564 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -131.52 143.08 50.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.468 0.307 . . . . 62.52 111.495 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 96.5 t -120.96 122.89 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.863 0.363 . . . . 73.22 111.278 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -113.37 139.29 49.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.867 0.467 . . . . 53.31 110.831 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.423 HG12 HG12 ' A' ' 513' ' ' ILE . 56.7 mt -119.65 111.15 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.68 0.276 . . . . 74.12 110.28 176.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 55.05 34.02 21.61 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.297 -0.41 . . . . 63.23 111.807 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 101.06 -29.14 13.16 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 116.327 -0.397 . . . . 44.25 113.581 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 91.0 m -81.92 125.82 31.19 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 122.411 -0.464 . . . . 74.4 111.899 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.79 114.54 5.12 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.267 0.556 . . . . 73.23 110.815 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -88.43 -43.97 11.08 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.319 0.489 . . . . 73.23 112.319 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -167.02 160.51 14.17 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.589 0.218 . . . . 64.44 111.589 -175.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -141.65 152.94 44.39 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.914 0.388 . . . . 72.41 111.741 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -131.84 148.94 52.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.76 0.424 . . . . 61.31 111.346 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 81.4 m -115.46 119.19 35.38 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.487 -0.324 . . . . 74.4 110.147 173.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.34 173.86 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.442 0.639 . . . . 51.44 112.261 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 88.1 p -129.28 133.6 47.55 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.866 -0.606 . . . . 63.31 110.378 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.536 HD12 HD22 ' A' ' 440' ' ' LEU . 96.1 mt -117.26 120.45 38.28 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.985 0.422 . . . . 74.24 111.45 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.441 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -84.09 -177.62 51.47 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.066 -0.588 . . . . 71.22 112.882 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.53 107.68 0.22 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.876 2.384 . . . . 71.54 113.04 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 74.3 mmtt 67.01 34.43 5.16 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.045 -0.525 . . . . 73.3 112.04 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -102.41 151.85 21.79 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.372 0.508 . . . . 72.21 112.372 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' GLU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 34.9 tt0 -133.87 141.44 47.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.089 0.471 . . . . 73.43 111.345 173.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -116.85 131.65 56.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.149 -0.478 . . . . 52.13 109.835 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 57.2 t -100.03 113.26 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.234 0.54 . . . . 64.45 111.312 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 47.6 mt -105.87 146.15 30.31 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.834 -0.621 . . . . 73.43 111.106 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.414 HG22 ' HG2' ' A' ' 459' ' ' GLU . 32.0 p -125.23 154.84 41.01 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.274 0.559 . . . . 70.52 111.947 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -154.76 150.54 27.67 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.829 -0.623 . . . . 72.14 110.588 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.556 ' HB2' HD11 ' A' ' 455' ' ' LEU . 79.6 p -109.93 114.3 27.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.018 0.437 . . . . 71.33 110.641 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 503' ' ' TRP . . . . . 0.403 ' HZ3' HG11 ' A' ' 537' ' ' VAL . 33.0 t90 -108.59 138.19 45.3 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.884 -0.598 . . . . 74.42 111.947 -174.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 94.7 m -124.31 109.0 29.25 Favored Pre-proline 0 N--CA 1.473 0.69 0 CA-C-N 116.109 -0.496 . . . . 73.23 111.56 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.37 119.32 3.77 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.787 2.324 . . . . 75.54 112.918 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 66.5 p -89.31 13.77 12.69 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.255 0.465 . . . . 73.11 112.255 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' GLN . . . . . 0.621 ' HB3' ' OH ' ' A' ' 511' ' ' TYR . 25.9 tt0 -143.14 142.02 31.36 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.746 0.418 . . . . 62.13 110.474 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -88.47 135.87 33.27 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.105 0.479 . . . . 74.41 110.883 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.85 -166.99 29.9 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.087 -0.577 . . . . 70.32 112.872 -175.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 96.2 mmm -83.97 120.62 26.33 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.167 0.508 . . . . 73.53 112.319 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 511' ' ' TYR . . . . . 0.621 ' OH ' ' HB3' ' A' ' 507' ' ' GLN . 48.9 m-85 -118.62 113.62 21.51 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.155 -0.475 . . . . 64.34 111.446 175.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 512' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 512' ' ' ARG . 15.7 ttm180 -96.48 111.38 23.51 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.914 0.388 . . . . 64.32 110.687 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.423 HG12 HG12 ' A' ' 479' ' ' ILE . 57.6 mt -96.52 113.81 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.023 0.44 . . . . 75.02 111.409 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 52.0 m-80 -107.59 151.84 25.08 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.929 0.395 . . . . 53.42 111.725 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -134.79 136.87 42.89 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.767 0.317 . . . . 63.22 111.074 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 58.1 p -129.17 152.37 48.83 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.215 -0.448 . . . . 50.22 111.034 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.14 141.82 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.212 0.529 . . . . 72.24 111.898 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 2.8 t0 48.78 44.33 21.66 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.832 0.853 . . . . 64.54 112.471 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -51.75 -30.06 21.12 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.232 0.539 . . . . 64.02 111.181 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 522' ' ' THR . 0.9 OUTLIER -66.92 -16.99 64.69 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.66 -0.7 . . . . 71.12 111.431 -176.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 27.4 m120 59.75 44.82 13.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.379 0.609 . . . . 64.13 111.213 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' THR . . . . . 0.461 ' OG1' ' HB2' ' A' ' 472' ' ' SER . 57.0 p -67.03 -39.47 87.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.83 -0.623 . . . . 42.54 111.581 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.417 HG21 ' HG3' ' A' ' 438' ' ' PRO . 12.5 p -115.28 143.57 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 116.146 -0.479 . . . . 73.43 111.844 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 524' ' ' VAL . . . . . 0.518 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 52.2 t -83.27 117.05 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 122.164 -0.335 . . . . 65.53 111.007 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -103.35 177.63 4.79 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.789 0.662 . . . . 74.45 112.789 -175.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.16 -39.06 18.29 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.662 -0.699 . . . . 74.45 112.339 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -114.97 164.2 14.49 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.216 0.531 . . . . 72.54 112.284 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -125.01 -7.43 7.19 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.088 0.47 . . . . 72.31 111.695 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -107.46 16.88 23.4 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.63 0.604 . . . . 74.43 112.63 -173.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.565 ' HB2' ' HB ' ' A' ' 441' ' ' THR . 6.8 p-10 -114.78 -17.77 11.51 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.258 1.207 . . . . 62.43 114.258 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -89.37 17.81 5.82 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.62 0.97 . . . . 74.34 113.62 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.41 134.27 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.062 0.458 . . . . 72.54 111.511 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 533' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -128.37 141.89 51.28 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.501 -0.318 . . . . 54.23 111.176 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.0 m -129.32 121.6 27.83 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.889 0.329 . . . . 71.13 111.889 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -121.78 126.11 48.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.804 0.335 . . . . 75.44 110.873 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.75 119.21 32.43 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.888 0.375 . . . . 74.43 111.742 -177.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.403 HG11 ' HZ3' ' A' ' 503' ' ' TRP . 48.2 t -112.66 134.99 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.269 0.557 . . . . 75.1 111.924 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 31.0 t -108.83 114.32 28.0 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.965 -0.561 . . . . 55.13 110.543 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 40.4 t -102.19 125.79 56.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.994 0.426 . . . . 72.23 111.775 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 542' ' ' GLU . 28.2 m -115.17 168.34 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 115.89 -0.595 . . . . 63.14 111.434 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 70.9 mt -71.38 1.34 6.41 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.132 0.79 . . . . 74.53 113.132 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 542' ' ' GLU . . . . . 0.408 ' H ' HG23 ' A' ' 540' ' ' VAL . 6.0 pt-20 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 112.318 0.488 . . . . 74.05 112.318 -176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.633 0.254 . . . . 75.54 111.102 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -90.5 145.5 24.84 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.933 0.397 . . . . 71.54 111.92 -175.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.25 134.49 25.81 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.209 -0.45 . . . . 75.41 110.793 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.706 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 58.9 Cg_endo -73.05 175.63 10.22 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.158 2.572 . . . . 55.41 114.236 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -153.7 86.84 1.21 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.578 -0.737 . . . . 72.02 109.706 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.538 HD22 HD12 ' A' ' 491' ' ' LEU . 88.7 mt -90.09 109.68 20.72 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.119 0.485 . . . . 64.22 112.193 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.424 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.6 t -113.2 152.84 29.23 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.127 -0.358 . . . . 72.54 111.722 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.579 HG12 HG12 ' A' ' 462' ' ' VAL . 28.3 m -128.42 148.86 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.18 0.514 . . . . 64.45 112.154 -176.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.594 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 44.2 mt-10 -129.35 146.66 51.18 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.177 -0.465 . . . . 62.14 111.47 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 62.1 mt -110.01 135.16 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.026 0.441 . . . . 72.51 110.722 173.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.565 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 63.6 tttp -135.12 145.03 47.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.357 -0.383 . . . . 65.43 110.521 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 154.64 -167.08 32.51 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.282 -0.961 . . . . 63.14 114.341 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.474 ' HD2' ' CZ ' ' A' ' 458' ' ' TYR . 16.5 Cg_exo -65.66 141.02 64.6 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.312 2.675 . . . . 53.43 113.776 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.28 -52.2 5.34 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.84 0.456 . . . . 74.24 111.236 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 538' ' ' SER . 59.4 t -116.31 127.15 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.691 -0.231 . . . . 60.1 110.717 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.15 163.21 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.007 0.432 . . . . 61.3 111.972 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.69 155.81 25.1 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.2 -0.455 . . . . 74.22 112.921 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.517 HG22 ' ND2' ' A' ' 453' ' ' ASN . 13.2 p -67.96 143.61 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.119 0.485 . . . . 72.24 111.839 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' ASN . . . . . 0.517 ' ND2' HG22 ' A' ' 452' ' ' VAL . 55.7 m-80 61.81 21.26 12.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.018 -0.537 . . . . 54.25 112.268 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.541 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.7 mmmt -103.18 150.75 23.37 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.017 0.437 . . . . 73.21 111.732 177.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 502' ' ' SER . 48.7 tp -93.86 119.38 32.72 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.338 -0.392 . . . . 73.12 111.344 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.59 133.03 54.99 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.706 0.288 . . . . 50.44 111.584 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.95 137.73 38.93 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.115 0.483 . . . . 65.32 111.688 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' TYR . . . . . 0.474 ' CZ ' ' HD2' ' A' ' 447' ' ' PRO . 10.3 m-85 -122.27 162.23 21.85 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.67 -0.696 . . . . 74.05 110.76 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 445' ' ' LYS . 51.9 mt-10 -120.38 127.3 52.17 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.998 0.427 . . . . 72.21 111.661 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 28.9 t -101.95 114.02 40.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.212 -0.449 . . . . 60.22 109.9 171.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.594 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 12.2 m-70 -101.3 110.6 22.63 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.702 0.287 . . . . 74.51 110.736 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.579 HG12 HG12 ' A' ' 442' ' ' VAL . 14.5 m -119.59 137.54 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.069 0.461 . . . . 74.11 110.917 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.22 152.87 37.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.1 0.476 . . . . 75.32 111.764 -176.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.5 t-20 -99.87 127.44 46.04 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.052 -0.522 . . . . 75.3 110.12 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 82.0 mt -110.29 -7.93 14.78 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.971 0.36 . . . . 52.22 111.971 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -76.59 -23.12 70.98 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.182 -0.533 . . . . 41.4 113.447 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.48 22.7 53.27 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.021 -0.609 . . . . 72.12 113.546 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.2 tt -139.71 136.96 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.594 0.358 . . . . 51.34 111.362 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.555 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -69.57 135.54 27.06 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 114.94 0.736 . . . . 74.12 114.94 -175.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.41 115.37 16.08 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 122.816 0.446 . . . . 63.22 111.632 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.38 -11.46 10.7 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.052 2.502 . . . . 64.32 113.251 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 45.6 m -81.14 11.35 4.26 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.256 0.622 . . . . 42.12 112.592 -175.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' THR . . . . . 0.45 HG23 HD13 ' A' ' 440' ' ' LEU . 56.5 m -86.88 98.98 11.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.828 0.823 . . . . 33.12 111.973 -162.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -108.24 123.04 48.16 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.119 -0.946 . . . . 74.41 111.195 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.528 HG21 HG11 ' A' ' 462' ' ' VAL . 46.2 t -104.24 123.7 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.379 -0.373 . . . . 55.21 110.72 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 476' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 515' ' ' ALA . 83.2 mtt180 -114.9 145.99 41.61 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.713 0.292 . . . . 74.23 111.75 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.63 119.73 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.995 0.426 . . . . 63.54 111.085 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -112.2 145.11 40.47 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.37 -0.377 . . . . 73.55 111.149 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.77 107.54 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.952 -0.388 . . . . 74.12 109.952 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 56.63 33.87 23.51 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.054 0.454 . . . . 75.45 111.365 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 100.08 -30.97 9.02 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.432 -0.414 . . . . 41.32 113.679 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 85.4 m -82.02 119.2 23.69 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.393 -0.475 . . . . 74.02 111.787 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.4 tp -62.57 115.03 3.91 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.063 0.458 . . . . 74.33 111.342 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -87.29 -43.4 12.19 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.373 -0.376 . . . . 72.5 111.854 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -166.11 161.1 16.93 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.357 -0.214 . . . . 72.4 111.324 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -155.24 159.63 40.21 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.798 0.332 . . . . 75.32 111.613 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -133.41 149.36 51.82 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.33 -0.395 . . . . 64.41 111.12 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 38.5 m -115.32 118.63 33.8 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.89 0.376 . . . . 72.44 110.589 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.6 173.42 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.197 0.522 . . . . 72.34 111.424 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 92.6 p -120.59 132.59 55.22 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.356 -0.384 . . . . 55.31 110.139 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.538 HD12 HD22 ' A' ' 440' ' ' LEU . 96.5 mt -118.22 119.05 33.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.818 0.342 . . . . 72.34 110.948 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.555 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -80.52 -167.07 35.95 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.992 -0.549 . . . . 50.34 113.082 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.95 105.72 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.596 2.197 . . . . 73.2 112.426 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 33.9 mmtp 67.67 29.93 6.73 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.342 0.591 . . . . 75.32 111.461 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -83.47 152.71 24.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.502 -0.772 . . . . 62.03 111.13 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -135.0 150.7 50.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.839 0.352 . . . . 73.1 111.68 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.419 ' O ' HG22 ' A' ' 462' ' ' VAL . 23.8 mmtm -145.25 127.16 15.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.078 0.466 . . . . 73.51 111.32 176.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.48 112.93 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.127 0.489 . . . . 60.25 110.805 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 27.5 mt -107.93 137.14 46.45 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.051 -0.522 . . . . 73.04 111.209 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 22.4 p -112.89 149.49 33.09 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.653 0.612 . . . . 72.5 112.653 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 501' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 55.1 p90 -144.33 148.56 34.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.764 -0.653 . . . . 41.34 110.909 173.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 455' ' ' LEU . 83.0 p -115.82 115.27 25.99 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.891 0.377 . . . . 71.13 111.214 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -116.51 137.98 51.75 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.456 -0.338 . . . . 73.31 111.808 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 85.9 m -111.98 101.04 50.83 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-N 116.538 -0.301 . . . . 74.1 111.681 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 59.5 Cg_endo -71.61 88.67 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.155 1.904 . . . . 74.53 112.417 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 19.2 p -76.2 -0.99 24.2 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.102 0.408 . . . . 61.33 112.102 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -129.54 135.88 49.14 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.519 -0.309 . . . . 63.54 110.44 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -83.27 151.18 25.73 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.766 0.654 . . . . 64.03 112.766 -174.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 141.9 -179.82 19.56 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.999 -0.546 . . . . 64.05 112.518 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 56.1 mtp -93.11 115.88 28.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.486 0.643 . . . . 74.43 111.655 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -110.49 129.84 55.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.19 -0.459 . . . . 71.52 111.321 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -99.45 116.41 31.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.056 0.455 . . . . 74.5 111.598 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.73 127.65 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.847 -0.615 . . . . 64.34 110.948 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -122.42 131.42 53.87 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.494 -0.321 . . . . 74.15 111.472 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 515' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 476' ' ' ARG . . . -111.82 133.08 54.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.711 0.291 . . . . 75.23 110.37 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 516' ' ' THR . . . . . 0.499 HG22 HG22 ' A' ' 532' ' ' VAL . 71.5 p -133.74 155.9 48.93 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.778 0.323 . . . . 65.21 111.517 -176.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.1 p -130.38 140.53 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.831 0.348 . . . . 71.5 111.62 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 1.6 t70 41.13 50.39 3.29 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.884 0.874 . . . . 62.21 112.754 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -53.97 -32.93 55.54 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.048 0.451 . . . . 74.02 112.178 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.58 ' HG3' HG23 ' A' ' 522' ' ' THR . 7.4 pt-20 -81.49 2.65 27.92 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.809 -0.632 . . . . 74.3 112.603 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 55.74 36.22 26.83 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.404 0.89 . . . . 61.53 113.404 171.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 522' ' ' THR . . . . . 0.58 HG23 ' HG3' ' A' ' 520' ' ' GLU . 75.0 p -63.06 -25.92 68.6 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.059 0.457 . . . . 73.54 111.141 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 10.8 p -107.49 140.76 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 116.201 -0.454 . . . . 70.43 111.271 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 524' ' ' VAL . . . . . 0.405 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 74.6 t -90.77 115.32 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 122.148 -0.345 . . . . 60.31 110.444 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.706 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 15.2 mt-10 -113.02 -174.02 2.37 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.92 0.711 . . . . 65.25 112.92 -174.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 88.0 mt -82.6 -38.81 23.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.587 -0.733 . . . . 63.13 111.271 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -138.77 158.6 43.93 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.982 0.42 . . . . 64.2 110.942 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -129.51 -8.07 4.65 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.981 0.419 . . . . 73.43 111.553 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -77.21 -20.72 54.92 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.339 0.496 . . . . 73.32 112.339 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.424 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 17.4 p-10 -101.75 5.55 41.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.179 0.437 . . . . 64.02 112.179 -177.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -82.2 1.2 37.56 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.181 0.437 . . . . 70.3 112.181 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 516' ' ' THR . 58.3 t -131.14 129.37 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.013 0.435 . . . . 53.12 111.644 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -115.26 136.09 53.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.382 -0.372 . . . . 54.43 110.744 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 61.8 m -117.82 129.7 55.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.659 0.266 . . . . 74.33 111.552 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -139.87 129.28 24.1 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.792 0.33 . . . . 74.23 111.244 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -95.42 137.62 34.23 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.692 0.282 . . . . 72.21 111.707 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 53.6 t -123.74 141.13 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.876 0.37 . . . . 60.11 110.991 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 538' ' ' SER . . . . . 0.529 ' HB3' HG22 ' A' ' 449' ' ' VAL . 48.3 t -112.54 114.83 27.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.917 0.389 . . . . 74.31 111.296 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.76 124.1 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.947 0.403 . . . . 73.43 111.357 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.29 163.17 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.299 0.571 . . . . 75.22 112.182 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 97.5 mt -90.4 14.81 11.94 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.133 -0.485 . . . . 75.02 111.83 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 C--O 1.249 1.055 0 N-CA-C 112.609 0.596 . . . . 75.43 112.609 -172.121 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.761 -0.459 . . . . 74.31 109.761 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -98.14 142.94 29.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.118 0.485 . . . . 73.4 112.093 -173.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -113.24 130.72 23.36 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.03 -0.532 . . . . 54.44 110.642 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.438 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 55.5 Cg_endo -72.91 175.37 10.49 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.516 2.144 . . . . 61.13 113.23 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -153.94 81.42 1.14 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.086 0.469 . . . . 73.32 110.113 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.498 HD22 HD12 ' A' ' 491' ' ' LEU . 93.9 mt -87.44 143.76 27.07 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.329 0.585 . . . . 64.1 111.769 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.462 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.9 t -153.4 164.93 37.3 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.076 -0.511 . . . . 73.02 111.403 176.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 462' ' ' VAL . 30.9 m -133.71 148.19 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.142 -0.481 . . . . 62.53 111.108 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 53.1 mt-10 -127.05 132.31 50.72 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.509 -0.314 . . . . 61.51 111.113 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 63.2 mt -100.33 125.28 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.02 0.438 . . . . 53.13 110.648 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 26.9 tptp -128.05 131.6 49.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.43 -0.35 . . . . 73.44 110.893 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.75 -172.51 35.01 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 120.667 -0.777 . . . . 35.54 113.956 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.5 135.51 22.25 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.971 2.447 . . . . 71.44 113.244 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.24 -15.71 42.6 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.213 0.449 . . . . 71.41 112.213 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 86.6 t -131.28 131.56 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.59 0.233 . . . . 70.32 110.672 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.34 157.55 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.058 0.456 . . . . 73.44 111.779 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.56 158.87 26.65 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.116 -0.564 . . . . 71.11 113.124 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.408 HG22 ' OD1' ' A' ' 453' ' ' ASN . 9.1 p -66.84 134.49 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.095 0.474 . . . . 73.55 111.575 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 453' ' ' ASN . . . . . 0.408 ' OD1' HG22 ' A' ' 452' ' ' VAL . 23.2 m120 64.9 9.16 5.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.542 0.737 . . . . 75.24 112.347 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -87.93 162.24 17.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.042 0.449 . . . . 71.54 111.496 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 502' ' ' SER . 27.1 tp -100.45 121.08 40.96 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.869 0.366 . . . . 72.23 111.188 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -120.34 132.72 55.41 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.569 0.223 . . . . 74.43 111.499 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.89 128.75 49.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.218 0.532 . . . . 72.43 111.919 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -122.45 154.09 38.24 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.79 -0.641 . . . . 62.45 110.803 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.546 ' HG2' HG22 ' A' ' 500' ' ' THR . 41.3 mt-10 -121.29 127.56 51.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 72.13 111.071 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.44 113.45 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.827 0.346 . . . . 62.32 110.507 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 35.5 m-70 -92.17 110.5 21.88 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.313 -0.254 . . . . 74.42 110.313 176.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 442' ' ' VAL . 24.7 m -105.45 123.07 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.098 0.475 . . . . 75.4 109.871 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.554 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.5 ptpt -141.0 145.69 36.27 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.842 0.682 . . . . 44.35 112.842 -170.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -102.66 128.4 49.38 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.345 -0.843 . . . . 70.24 109.449 173.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.554 HD21 ' HD3' ' A' ' 463' ' ' LYS . 61.1 mt -117.64 -2.03 11.52 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.097 -0.377 . . . . 71.24 111.845 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -79.69 -21.57 66.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.07 -0.586 . . . . 72.13 113.691 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.5 19.19 55.39 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.199 -0.524 . . . . 64.51 113.57 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 3.1 tt -136.86 133.63 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 122.417 -0.461 . . . . 70.24 111.185 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.492 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -62.94 130.3 42.14 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 114.202 0.441 . . . . 63.41 114.202 -176.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.477 HG11 HD11 ' A' ' 440' ' ' LEU . 61.5 t -126.81 113.6 22.36 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 112.125 0.417 . . . . 74.53 112.125 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.13 -10.28 10.26 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.208 2.605 . . . . 74.33 112.701 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 49.9 m -80.4 12.01 3.27 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.424 0.69 . . . . 72.5 112.678 -175.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 32.6 m -88.51 93.53 9.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.848 0.832 . . . . 75.33 112.257 -167.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -110.39 123.88 50.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.224 -0.898 . . . . 72.21 110.504 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.486 HG21 HG11 ' A' ' 462' ' ' VAL . 63.2 t -115.0 129.49 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.832 0.348 . . . . 75.05 111.742 -174.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -120.08 151.8 38.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.862 0.363 . . . . 75.41 111.326 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 96.6 t -121.15 122.16 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.41 -0.359 . . . . 75.53 111.189 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -116.16 136.84 52.65 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.925 0.393 . . . . 74.14 111.533 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.548 HG12 HG12 ' A' ' 513' ' ' ILE . 51.1 mt -111.86 108.47 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 122.676 0.39 . . . . 71.31 110.043 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 55.03 34.71 23.07 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.996 0.427 . . . . 63.44 111.382 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.27 0.62 84.79 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.3 -0.476 . . . . 22.51 113.652 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 36.9 m -103.31 119.61 39.2 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.373 -0.486 . . . . 60.15 111.113 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.0 tp -63.07 120.43 11.42 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.389 0.515 . . . . 74.51 112.389 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -88.64 -45.38 9.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.332 -0.395 . . . . 75.42 111.305 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.549 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 31.0 ttpt -171.89 162.26 6.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.546 0.213 . . . . 72.45 111.098 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -139.95 150.98 45.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.962 0.411 . . . . 62.44 111.725 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 487' ' ' TRP . . . . . 0.549 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 18.7 m-90 -130.82 149.23 52.56 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.86 0.464 . . . . 74.24 111.438 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 60.8 m -120.24 118.91 31.69 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.613 0.244 . . . . 71.14 110.436 173.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.2 m -139.87 172.98 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.073 0.463 . . . . 55.25 111.713 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 96.0 p -122.88 133.23 54.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.251 -0.431 . . . . 73.34 110.329 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.498 HD12 HD22 ' A' ' 440' ' ' LEU . 96.0 mt -118.64 119.67 35.16 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.721 0.296 . . . . 73.13 111.246 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.492 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -79.39 -171.52 41.46 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.186 -0.53 . . . . 73.05 113.133 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.44 106.43 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.6 2.2 . . . . 63.21 112.581 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.9 mmtp 69.89 23.38 5.56 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.118 -0.492 . . . . 62.53 111.881 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -89.04 149.97 22.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.039 0.385 . . . . 65.34 112.039 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' GLU . . . . . 0.42 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 24.1 tt0 -135.09 143.87 46.87 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.785 0.326 . . . . 72.12 111.478 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -126.89 133.59 50.65 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.819 -0.437 . . . . 70.4 109.819 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 37.9 t -101.17 112.76 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.074 0.464 . . . . 73.54 111.591 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 61.9 mt -100.38 147.65 25.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 70.55 110.933 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.546 HG22 ' HG2' ' A' ' 459' ' ' GLU . 12.0 p -125.66 149.78 48.16 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.952 0.406 . . . . 72.12 111.956 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.72 147.82 27.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.071 0.462 . . . . 70.42 111.149 172.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.519 ' HB2' HD11 ' A' ' 455' ' ' LEU . 83.2 p -111.36 119.12 37.79 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.098 -0.501 . . . . 42.1 111.067 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -107.7 136.64 47.11 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.01 0.433 . . . . 70.51 111.645 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.9 m -122.06 100.88 42.34 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.125 -0.489 . . . . 72.53 110.695 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -81.6 101.46 1.2 Allowed 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.813 2.342 . . . . 72.42 113.228 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.2 p -82.67 6.64 17.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.213 0.449 . . . . 71.12 112.213 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -140.47 127.21 20.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.565 -0.289 . . . . 73.43 110.599 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -73.19 151.62 41.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.21 0.528 . . . . 73.25 112.381 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.94 -168.89 31.88 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.151 -0.547 . . . . 75.25 113.125 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 15.8 tpt -99.2 118.1 35.15 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 122.45 -0.441 . . . . 53.15 110.993 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -123.94 113.09 18.0 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.862 0.363 . . . . 73.32 111.902 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -94.67 115.17 27.21 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.922 0.392 . . . . 72.02 110.785 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.548 HG12 HG12 ' A' ' 479' ' ' ILE . 55.9 mt -95.47 124.03 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.016 0.436 . . . . 71.31 111.045 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -123.15 145.99 48.14 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.966 0.412 . . . . 64.5 111.53 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -122.45 136.87 54.99 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.332 -0.395 . . . . 62.32 110.556 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 21.4 p -132.24 141.02 48.88 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.92 0.391 . . . . 73.34 112.032 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.31 142.0 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.78 0.324 . . . . 64.23 111.375 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.53 49.77 15.97 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.788 0.804 . . . . 74.41 111.42 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -51.7 -28.51 15.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.663 -0.699 . . . . 73.41 111.603 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -65.68 -22.21 66.61 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.052 -0.522 . . . . 74.23 111.308 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 55.97 72.14 0.51 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.358 0.599 . . . . 75.33 111.432 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 66.0 p -117.88 -14.19 10.07 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.516 0.561 . . . . 62.42 112.516 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 10.0 p -126.89 141.27 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.797 0.666 . . . . 71.01 112.797 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 87.2 t -94.29 110.76 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.959 -0.564 . . . . 61.32 110.136 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 24.9 mt-10 -102.94 179.97 4.12 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.744 0.646 . . . . 73.43 112.744 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.95 -39.89 79.26 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.032 -0.531 . . . . 73.01 112.05 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 527' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 530' ' ' ASN . 52.3 t-20 -120.26 112.86 19.58 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.924 0.392 . . . . 62.33 110.317 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -83.74 -7.94 59.36 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 120.955 0.407 . . . . 64.41 111.941 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -101.03 8.64 42.86 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.344 0.592 . . . . 73.24 110.821 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.539 ' HB2' ' HB3' ' A' ' 527' ' ' ASN . 57.6 t30 -88.85 -22.59 23.12 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.815 -0.629 . . . . 75.42 112.297 -171.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -78.51 -4.31 47.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.014 1.116 . . . . 72.23 114.014 -168.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 61.5 t -123.16 130.88 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 112.489 0.551 . . . . 74.25 112.489 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -123.82 142.03 51.49 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.298 -0.41 . . . . 54.11 111.104 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 53.1 m -128.86 135.72 49.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.355 0.502 . . . . 74.54 112.355 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -140.69 133.09 28.4 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 120.894 0.378 . . . . 73.21 111.353 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.38 130.5 43.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.928 0.344 . . . . 71.42 111.928 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 60.7 t -124.14 131.88 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.142 0.496 . . . . 74.02 111.582 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.9 t -105.9 121.99 45.21 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.423 -0.353 . . . . 74.35 111.0 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.65 120.72 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.775 0.322 . . . . 74.22 111.402 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.48 165.36 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 121.132 0.492 . . . . 44.14 111.974 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 86.0 mt -85.72 10.28 13.97 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.303 0.483 . . . . 71.24 112.303 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 112.299 0.481 . . . . 73.15 112.299 -175.613 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 11.9 tpt . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.681 0.277 . . . . 71.53 111.255 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -88.17 130.31 35.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.788 0.327 . . . . 63.42 111.165 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -113.05 137.49 21.93 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.359 -0.382 . . . . 73.44 110.297 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.616 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 55.6 Cg_endo -70.99 173.78 11.57 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.597 2.198 . . . . 72.12 113.495 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -153.84 87.59 1.22 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.731 -0.668 . . . . 55.0 109.267 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 491' ' ' LEU . 51.5 mt -91.91 111.85 23.54 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.043 -0.526 . . . . 72.14 111.549 -175.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.638 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 13.5 t -120.81 155.99 32.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.159 0.504 . . . . 70.14 111.865 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.627 HG12 HG12 ' A' ' 462' ' ' VAL . 32.2 m -126.63 148.52 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.88 -0.6 . . . . 71.32 111.116 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 41.1 mt-10 -122.97 146.88 47.23 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.715 0.265 . . . . 54.23 111.715 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.495 HD11 ' N ' ' A' ' 515' ' ' ALA . 49.1 mt -124.48 114.62 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.872 0.368 . . . . 61.5 110.547 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -129.62 139.29 51.48 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.863 0.363 . . . . 64.25 111.483 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.32 -171.37 39.83 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.36 -0.448 . . . . 70.33 112.914 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.17 135.16 28.79 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.579 2.186 . . . . 74.3 113.573 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -79.11 -50.6 10.77 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.105 0.409 . . . . 70.41 112.105 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 538' ' ' SER . 87.8 t -110.03 128.53 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.98 0.419 . . . . 70.23 111.198 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.76 160.95 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.057 0.456 . . . . 63.41 111.692 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -87.71 154.99 26.36 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.267 -0.492 . . . . 52.41 113.095 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 12.4 p -69.15 139.27 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 122.383 -0.481 . . . . 72.32 111.103 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 16.6 m120 66.5 20.18 10.87 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.202 0.601 . . . . 73.1 111.908 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.532 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -103.33 159.78 15.26 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.978 0.418 . . . . 72.13 111.516 176.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 502' ' ' SER . 39.2 tp -95.59 122.95 38.89 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.327 -0.397 . . . . 75.34 111.249 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.04 132.73 54.66 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.803 0.335 . . . . 74.33 111.555 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -107.6 136.18 47.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.298 0.57 . . . . 73.25 112.1 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -126.9 159.02 35.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.865 -0.607 . . . . 73.12 110.559 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.481 ' HG2' HG22 ' A' ' 500' ' ' THR . 52.2 mt-10 -119.26 127.5 53.3 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.791 0.329 . . . . 53.13 111.175 177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 460' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 43.9 t -100.8 112.52 33.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.734 -0.469 . . . . 54.35 109.734 170.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 46.1 m-70 -100.6 109.35 21.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.692 0.282 . . . . 61.14 110.255 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.648 HG11 HG21 ' A' ' 475' ' ' VAL . 10.8 m -110.82 126.37 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.18 0.514 . . . . 62.34 110.556 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.46 ' HD3' HD21 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -144.53 150.2 37.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.223 0.535 . . . . 63.43 112.375 -174.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.9 t-20 -102.61 127.14 49.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.582 -0.735 . . . . 75.12 109.592 174.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.46 HD21 ' HD3' ' A' ' 463' ' ' LYS . 97.8 mt -108.72 -10.29 15.18 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.009 0.374 . . . . 73.31 112.009 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.616 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -73.1 -19.16 79.52 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.076 -0.583 . . . . 60.03 114.052 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.71 15.53 63.31 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.032 -0.604 . . . . 60.22 113.954 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.9 tt -137.52 140.08 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 122.69 0.396 . . . . 74.44 110.863 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -75.38 142.55 29.34 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 114.827 0.691 . . . . 74.32 114.827 -172.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 471' ' ' PRO . 59.2 t -131.74 120.12 17.44 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 122.977 0.511 . . . . 73.31 111.282 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 471' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 470' ' ' VAL . 4.7 Cg_endo -86.42 -12.05 5.77 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.119 2.546 . . . . 73.1 113.098 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 23.0 t -84.33 13.39 5.4 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.959 0.726 . . . . 61.51 112.959 -175.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' THR . . . . . 0.447 HG23 ' CG2' ' A' ' 517' ' ' VAL . 90.5 m -86.47 91.81 8.66 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.016 0.912 . . . . 72.4 112.126 -165.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -97.69 131.01 44.62 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.123 -0.944 . . . . 55.41 110.681 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.648 HG21 HG11 ' A' ' 462' ' ' VAL . 45.2 t -113.07 127.26 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.596 0.358 . . . . 71.12 110.898 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -130.17 148.02 51.96 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.898 0.38 . . . . 72.21 111.917 -175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 72.0 t -120.25 122.21 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.862 0.363 . . . . 64.53 111.134 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -113.25 136.82 52.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.357 -0.383 . . . . 70.43 111.308 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 513' ' ' ILE . 62.0 mt -110.68 112.02 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 110.068 -0.345 . . . . 71.22 110.068 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 54.77 34.93 22.91 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.901 0.381 . . . . 72.22 111.461 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 100.37 -36.33 4.21 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.189 -0.529 . . . . 43.24 113.96 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 52.2 m -82.45 131.59 35.22 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 117.163 0.481 . . . . 74.13 111.795 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.22 132.94 54.38 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.216 0.532 . . . . 64.24 111.852 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -105.19 -43.89 4.9 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.161 -0.472 . . . . 73.24 111.852 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -161.3 151.06 16.93 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.647 -0.251 . . . . 73.53 110.497 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -140.12 152.01 45.78 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.32 0.581 . . . . 71.11 112.522 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -136.62 149.42 47.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.528 -0.76 . . . . 73.14 111.063 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 63.1 m -122.97 119.13 29.48 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.14 -0.318 . . . . 74.5 110.14 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.93 173.42 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.304 0.573 . . . . 72.2 111.569 -177.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.4 p -120.45 135.02 55.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.976 -0.556 . . . . 75.14 110.479 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.512 HD12 HD22 ' A' ' 440' ' ' LEU . 74.7 mt -117.33 120.15 37.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.84 0.353 . . . . 64.42 111.315 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -83.06 -170.31 45.91 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.948 -0.644 . . . . 61.2 113.091 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.02 109.34 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.423 2.082 . . . . 62.21 112.491 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.3 mmtm 70.19 19.23 6.72 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.954 0.501 . . . . 64.13 112.176 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -80.08 150.96 30.12 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.175 0.435 . . . . 75.43 112.175 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -135.5 134.12 39.18 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.341 -0.391 . . . . 64.22 111.358 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -116.9 129.83 56.31 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.801 -0.444 . . . . 75.41 109.801 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.16 115.81 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.176 0.512 . . . . 73.03 111.303 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 76.7 mt -105.38 143.53 33.42 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.979 -0.555 . . . . 72.13 110.986 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.481 HG22 ' HG2' ' A' ' 459' ' ' GLU . 6.9 p -129.29 147.12 51.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.069 0.461 . . . . 72.53 111.409 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -149.48 148.44 29.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 75.43 110.463 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.48 ' HB2' HD11 ' A' ' 455' ' ' LEU . 79.4 p -115.6 114.18 24.58 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.222 0.534 . . . . 64.44 110.995 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -102.14 134.07 45.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 73.4 111.323 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 37.0 m -113.29 100.76 52.39 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-N 116.366 -0.379 . . . . 74.31 110.701 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 505' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.4 Cg_endo -76.06 95.4 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.485 2.123 . . . . 61.35 113.088 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 65.6 p -80.43 5.98 13.55 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.994 0.426 . . . . 75.31 111.66 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -133.56 142.53 48.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.841 0.457 . . . . 75.51 109.94 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.9 150.92 20.26 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.099 0.476 . . . . 61.25 112.168 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.96 -169.73 30.04 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.222 -0.514 . . . . 43.31 112.952 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 14.0 tpt -98.65 112.87 24.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.987 0.422 . . . . 55.12 110.447 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.26 112.37 21.49 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.907 0.384 . . . . 71.23 111.682 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -92.37 115.05 27.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.18 0.514 . . . . 61.11 110.943 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 479' ' ' ILE . 60.6 mt -98.1 125.55 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.99 -0.55 . . . . 73.01 111.453 -178.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -120.84 143.79 48.7 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.988 0.423 . . . . 73.12 111.683 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 515' ' ' ALA . . . . . 0.495 ' N ' HD11 ' A' ' 444' ' ' ILE . . . -120.47 138.75 53.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.322 -0.399 . . . . 51.51 110.365 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 516' ' ' THR . . . . . 0.433 HG22 HG22 ' A' ' 532' ' ' VAL . 48.8 p -133.1 158.0 43.88 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.019 0.438 . . . . 50.23 111.593 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.447 ' CG2' HG23 ' A' ' 473' ' ' THR . 7.6 p -132.53 140.49 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.163 -0.471 . . . . 73.11 111.423 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 28.1 t70 42.73 54.76 4.51 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.474 0.654 . . . . 74.35 111.952 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -55.17 -32.85 62.49 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.199 0.524 . . . . 71.4 111.522 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -67.89 -5.76 18.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.282 -0.872 . . . . 74.1 112.457 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.2 t30 53.07 55.09 9.37 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.501 0.667 . . . . 73.34 111.221 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 34.9 p -88.44 -35.44 17.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 65.2 111.449 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 12.5 p -103.72 144.14 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 116.091 -0.504 . . . . 72.14 111.829 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 524' ' ' VAL . . . . . 0.512 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 75.4 t -83.41 114.87 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.758 0.314 . . . . 72.22 110.953 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.28 176.08 6.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.498 0.666 . . . . 75.13 112.617 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 87.4 mt -82.26 -25.65 33.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.793 -0.64 . . . . 72.02 109.947 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 527' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 26.2 t30 -155.39 110.64 3.02 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.565 -0.743 . . . . 73.15 110.447 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 38.0 mp0 -82.81 -1.61 52.28 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.985 0.421 . . . . 54.2 111.719 -173.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -93.08 -8.84 41.61 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.273 0.559 . . . . 75.33 110.973 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.638 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 65.3 t30 -86.53 -6.78 58.8 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.051 0.453 . . . . 65.13 111.743 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -79.06 8.22 6.09 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.844 0.683 . . . . 73.42 112.844 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 516' ' ' THR . 48.5 t -132.46 145.84 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.321 0.489 . . . . 73.55 112.321 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -133.9 142.31 47.71 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.288 -0.415 . . . . 72.03 110.757 172.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 90.6 m -121.89 125.38 46.29 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.354 0.501 . . . . 71.34 112.354 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -133.12 141.06 47.96 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.886 0.374 . . . . 73.11 110.495 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -116.72 126.62 53.42 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.045 0.45 . . . . 75.13 112.161 -176.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.5 t -117.21 143.72 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 116.033 -0.53 . . . . 74.31 111.783 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' SER . . . . . 0.425 ' HB3' HG22 ' A' ' 449' ' ' VAL . 46.6 t -118.02 120.73 38.69 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.332 -0.394 . . . . 71.04 110.996 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 44.5 t -103.42 123.38 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.692 0.282 . . . . 53.12 111.23 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.7 m -109.28 160.25 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 112.612 0.597 . . . . 71.42 112.612 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.71 -5.98 57.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.296 -0.411 . . . . 64.54 112.101 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.253 1.238 0 N-CA-C 112.594 0.59 . . . . 53.24 112.594 -177.059 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 34.9 tpp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.811 0.339 . . . . 74.14 111.424 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -88.12 125.35 34.54 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.802 0.334 . . . . 72.32 111.251 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 438' ' ' PRO . 98.5 m-85 -115.34 136.56 22.73 Favored Pre-proline 0 N--CA 1.469 0.523 0 CA-C-O 120.573 0.225 . . . . 75.15 111.153 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 24.5 Cg_exo -64.86 173.03 6.23 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.026 2.484 . . . . 74.24 114.417 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -161.25 86.81 0.69 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.897 -1.047 . . . . 74.45 108.462 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 74.8 mt -97.41 132.39 43.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.233 0.54 . . . . 65.33 112.006 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.519 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.0 t -132.85 151.74 51.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.03 0.443 . . . . 60.13 111.906 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 462' ' ' VAL . 32.2 m -123.23 148.66 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.95 -0.568 . . . . 62.12 111.439 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 44.4 mt-10 -130.99 129.68 42.41 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.551 -0.295 . . . . 65.53 111.68 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.6 mt -101.99 126.94 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 120.659 0.266 . . . . 74.14 110.798 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -131.68 134.58 46.09 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.411 -0.181 . . . . 73.21 111.135 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.37 -169.88 35.57 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.603 -0.808 . . . . 54.2 113.762 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.3 127.41 14.12 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.809 2.339 . . . . 63.31 113.058 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -85.86 -20.78 28.58 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.135 0.42 . . . . 52.21 112.135 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.23 121.32 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 120.625 0.25 . . . . 74.35 110.801 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 30.1 m -130.72 162.74 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.207 0.527 . . . . 73.31 111.852 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.62 163.27 28.42 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.1 -0.571 . . . . 51.31 113.246 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 10.8 p -70.31 140.22 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.037 0.446 . . . . 62.11 111.578 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 22.3 m120 63.63 18.22 10.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.084 0.554 . . . . 74.22 112.136 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -102.35 164.72 11.52 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.193 0.521 . . . . 74.12 111.937 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 502' ' ' SER . 53.2 tp -95.29 136.8 35.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.13 -0.486 . . . . 75.04 111.493 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -135.49 132.22 37.08 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.906 0.384 . . . . 63.22 110.96 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -113.49 131.96 55.85 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.045 0.45 . . . . 73.25 111.364 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' TYR . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 74.8 m-85 -122.28 159.49 27.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 74.34 110.957 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -120.11 127.18 52.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.994 -0.548 . . . . 74.34 110.942 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 42.1 t -102.69 112.65 36.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.829 -0.434 . . . . 24.33 109.829 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 40.2 m-70 -100.04 112.72 25.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.748 0.309 . . . . 71.51 110.315 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 442' ' ' VAL . 24.5 m -113.12 124.45 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.212 0.529 . . . . 62.13 110.828 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.46 ' HD3' HD21 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -136.4 151.67 49.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.258 0.552 . . . . 74.42 112.284 -176.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.2 t-20 -99.9 128.5 45.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.639 -0.71 . . . . 63.24 110.225 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.46 HD21 ' HD3' ' A' ' 463' ' ' LYS . 89.5 mt -113.71 -6.4 13.32 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.023 -0.423 . . . . 72.21 112.034 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -75.37 -18.89 79.82 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.971 -0.633 . . . . 74.2 113.556 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.39 19.35 69.17 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.126 -0.559 . . . . 61.42 113.383 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 10.1 tt -135.35 138.67 48.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 122.554 0.341 . . . . 74.2 110.803 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.529 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -66.73 122.86 21.04 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.402 -0.428 . . . . 30.41 113.784 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 438' ' ' PRO . 48.0 t -119.68 113.72 34.59 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 122.615 -0.344 . . . . 50.53 111.841 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.08 -11.12 10.01 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.94 2.426 . . . . 74.51 112.394 172.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' SER . . . . . 0.607 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 47.8 m -81.23 12.04 3.82 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.857 0.863 . . . . 73.4 113.033 -173.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 473' ' ' THR . . . . . 0.406 HG23 ' CG2' ' A' ' 517' ' ' VAL . 88.1 m -88.91 99.71 12.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.773 0.797 . . . . 61.1 112.332 -167.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -105.13 130.65 53.26 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.675 -0.693 . . . . 64.12 110.895 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.423 HG21 HG11 ' A' ' 462' ' ' VAL . 25.9 t -105.31 118.72 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.439 0.296 . . . . 71.02 111.03 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 476' ' ' ARG . . . . . 0.529 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 86.3 mtt180 -116.54 138.15 51.62 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.107 -0.371 . . . . 74.32 111.121 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 89.6 t -120.88 130.47 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.975 0.417 . . . . 71.05 111.466 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -121.68 139.29 53.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.19 -0.459 . . . . 75.43 111.257 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.506 HG12 HG12 ' A' ' 513' ' ' ILE . 55.6 mt -118.83 115.95 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 110.139 -0.319 . . . . 75.2 110.139 172.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 52.67 38.87 27.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.122 0.487 . . . . 74.22 111.573 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.91 -17.51 50.26 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.227 -0.511 . . . . 55.32 113.829 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 73.2 m -88.94 130.82 35.37 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 117.168 0.484 . . . . 74.11 111.623 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.4 tp -64.33 115.06 4.7 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.946 0.403 . . . . 72.55 111.233 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -89.99 -43.86 10.26 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.171 -0.468 . . . . 74.21 112.141 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -168.5 160.03 10.72 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.518 -0.31 . . . . 74.33 110.456 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -150.83 149.87 30.24 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.057 0.456 . . . . 64.0 112.072 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 487' ' ' TRP . . . . . 0.413 ' CD2' HD13 ' A' ' 499' ' ' LEU . 24.5 m-90 -129.79 144.01 51.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.848 0.459 . . . . 72.03 110.716 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 38.5 m -111.02 117.79 34.29 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.859 -0.423 . . . . 73.01 109.859 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.49 174.34 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.277 0.56 . . . . 72.43 112.02 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 83.0 p -122.55 134.99 54.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.986 -0.552 . . . . 71.11 111.046 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 94.5 mt -120.18 119.45 33.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.648 0.261 . . . . 74.21 111.084 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.529 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -79.63 -171.52 41.96 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.086 -0.578 . . . . 70.5 113.205 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.63 103.5 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.668 2.245 . . . . 65.23 112.524 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.1 mttt 63.63 36.97 10.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.266 0.555 . . . . 72.44 112.117 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -95.96 155.48 16.73 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.966 -0.561 . . . . 73.4 110.845 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -134.82 143.29 46.96 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.842 0.353 . . . . 71.23 111.76 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -126.35 132.33 51.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.867 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 50.3 t -101.39 117.62 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.007 0.432 . . . . 73.2 111.435 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.413 HD13 ' CD2' ' A' ' 487' ' ' TRP . 49.7 mt -111.85 146.12 38.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.201 -0.454 . . . . 74.42 110.815 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 16.7 p -135.46 152.3 51.23 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.366 0.603 . . . . 74.33 112.354 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 501' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 47.9 p90 -145.36 154.39 42.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.768 -0.651 . . . . 72.14 111.073 175.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.524 ' HB2' HD11 ' A' ' 455' ' ' LEU . 32.3 p -112.58 114.7 27.47 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.049 0.452 . . . . 75.51 111.229 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 503' ' ' TRP . . . . . 0.424 ' CZ2' ' HB3' ' A' ' 505' ' ' PRO . 31.1 t90 -114.38 137.47 51.78 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.08 0.552 . . . . 72.42 111.341 -175.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 96.7 m -126.14 103.47 26.53 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 120.751 0.31 . . . . 71.41 111.749 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 505' ' ' PRO . . . . . 0.424 ' HB3' ' CZ2' ' A' ' 503' ' ' TRP . 98.7 Cg_endo -80.9 97.92 1.03 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.495 2.13 . . . . 70.4 112.905 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 68.4 p -77.33 -6.78 54.52 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.071 0.462 . . . . 75.12 111.121 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' GLN . . . . . 0.445 ' HB3' ' OH ' ' A' ' 511' ' ' TYR . 51.1 tt0 -114.48 141.29 47.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.122 -0.49 . . . . 74.4 110.238 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.13 149.88 21.62 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.861 0.362 . . . . 65.4 111.194 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 140.39 -171.62 23.89 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.328 -0.463 . . . . 62.31 112.883 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 94.6 mmm -83.9 127.58 33.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.076 0.465 . . . . 72.22 111.975 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' TYR . . . . . 0.445 ' OH ' ' HB3' ' A' ' 507' ' ' GLN . 76.9 m-85 -126.32 111.94 15.11 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.992 -0.549 . . . . 63.42 110.923 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -93.79 115.44 27.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.01 0.434 . . . . 51.05 111.307 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.506 HG12 HG12 ' A' ' 479' ' ' ILE . 60.3 mt -96.2 128.43 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.864 -0.607 . . . . 72.53 110.962 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -124.81 132.31 53.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.5 -0.318 . . . . 74.31 111.294 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 515' ' ' ALA . . . . . 0.402 ' O ' HG21 ' A' ' 442' ' ' VAL . . . -112.33 134.4 53.89 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.469 -0.332 . . . . 64.2 110.283 173.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 516' ' ' THR . . . . . 0.453 HG22 HG22 ' A' ' 532' ' ' VAL . 80.2 p -133.62 141.01 47.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.918 0.39 . . . . 74.02 111.257 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.452 HG13 HD22 ' A' ' 531' ' ' ASN . 7.5 p -109.22 139.26 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.928 0.394 . . . . 65.42 110.96 174.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 34.5 t0 38.74 64.89 0.71 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.798 0.839 . . . . 73.24 112.685 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 519' ' ' GLU . . . . . 0.529 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.1 mm-40 -52.54 -33.7 46.76 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.498 0.666 . . . . 71.52 111.048 172.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.61 -24.28 61.05 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.18 -0.918 . . . . 72.21 111.633 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 54.15 55.52 8.14 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.886 0.85 . . . . 74.11 110.521 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 522' ' ' THR . . . . . 0.607 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 60.5 p -73.34 -6.06 43.67 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.888 -1.051 . . . . 63.03 111.628 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 14.5 p -134.34 143.25 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.255 -0.43 . . . . 72.41 110.9 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 524' ' ' VAL . . . . . 0.51 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 48.1 t -81.52 109.57 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.027 0.441 . . . . 74.45 110.998 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.482 ' HG2' ' HB2' ' A' ' 438' ' ' PRO . 37.1 mt-10 -98.58 177.02 5.45 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.274 0.559 . . . . 75.13 112.141 -175.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.03 -38.75 17.55 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.208 -0.451 . . . . 60.53 112.204 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -142.07 120.0 12.0 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.868 0.322 . . . . 75.34 111.868 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 528' ' ' GLU . . . . . 0.557 ' HA ' ' OD1' ' A' ' 531' ' ' ASN . 11.4 pt-20 -93.5 14.2 19.46 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.337 0.495 . . . . 63.14 112.337 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -90.66 -26.38 19.62 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.335 0.494 . . . . 62.0 112.335 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.519 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 17.1 p-10 -97.89 -5.05 35.29 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 111.974 0.361 . . . . 70.33 111.974 -175.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 531' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' A' ' 528' ' ' GLU . 12.3 m120 -62.96 -24.73 68.02 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.125 0.417 . . . . 72.11 112.125 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 516' ' ' THR . 47.3 t -115.51 137.36 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.876 0.369 . . . . 64.14 111.706 -176.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.51 127.31 43.77 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.455 -0.339 . . . . 65.13 110.872 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 57.2 m -105.39 132.89 51.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.856 0.36 . . . . 60.43 111.628 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -139.7 117.28 11.47 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.765 0.317 . . . . 70.32 110.803 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.94 127.33 39.65 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.99 0.424 . . . . 64.22 111.924 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.96 137.63 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.109 -0.496 . . . . 44.52 111.235 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.8 t -107.44 122.42 46.59 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.826 0.346 . . . . 72.32 111.009 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.1 t -108.19 129.99 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.102 0.477 . . . . 54.1 111.305 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 21.5 m -125.33 162.74 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.157 0.503 . . . . 65.0 112.257 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.93 -12.23 60.11 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.945 0.402 . . . . 74.41 111.995 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 119.24 -0.409 . . . . 74.22 111.724 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 22.6 ttt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 121.267 0.556 . . . . 64.41 109.868 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -104.74 131.3 52.36 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.897 -0.592 . . . . 74.35 111.798 -171.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -114.06 140.0 24.36 Favored Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 116.284 -0.416 . . . . 74.22 110.469 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.553 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 58.5 Cg_endo -72.67 173.34 13.51 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.216 1.944 . . . . 74.31 113.152 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -153.29 87.99 1.28 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.892 -0.595 . . . . 63.04 109.59 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.1 mt -89.15 112.0 22.89 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.278 -0.419 . . . . 75.24 111.548 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.56 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.0 t -120.84 158.97 26.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.067 0.46 . . . . 62.34 111.688 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.622 HG12 HG12 ' A' ' 462' ' ' VAL . 35.2 m -134.31 148.59 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.062 -0.517 . . . . 34.51 111.537 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.624 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.3 mt-10 -125.45 136.3 53.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.479 -0.328 . . . . 72.52 111.258 177.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 515' ' ' ALA . 56.2 mt -105.41 124.61 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.733 0.301 . . . . 70.23 110.536 174.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 29.1 tptp -132.88 131.99 41.57 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.616 -0.266 . . . . 75.25 110.931 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 166.32 -175.06 41.85 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.743 -0.742 . . . . 50.14 113.801 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.03 134.16 31.05 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.983 2.455 . . . . 74.03 113.537 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.6 -38.53 65.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.192 -0.458 . . . . 71.12 111.911 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.18 131.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.642 0.258 . . . . 53.33 111.31 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.61 163.53 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 121.176 0.512 . . . . 64.32 111.672 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.43 158.44 21.01 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.183 -0.532 . . . . 71.11 113.341 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.409 HG11 HD23 ' A' ' 541' ' ' LEU . 14.0 p -64.9 137.94 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 O-C-N 122.54 -0.388 . . . . 73.33 111.598 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 453' ' ' ASN . . . . . 0.401 ' OD1' ' HA ' ' A' ' 506' ' ' THR . 92.9 m-20 62.6 14.62 7.27 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.511 0.56 . . . . 71.23 112.511 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.5 mmmt -94.33 150.02 20.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.818 0.342 . . . . 64.34 111.155 175.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 502' ' ' SER . 32.2 tp -92.77 117.07 29.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.872 0.368 . . . . 72.14 110.936 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -120.67 132.69 55.23 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.901 0.382 . . . . 72.03 111.679 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -102.16 139.15 38.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.154 0.502 . . . . 71.11 111.84 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -123.66 165.14 17.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.862 -0.608 . . . . 62.31 111.26 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 445' ' ' LYS . 51.5 mt-10 -119.95 127.49 52.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.911 -0.586 . . . . 54.34 110.907 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.5 t -108.27 112.78 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.668 -0.493 . . . . 64.31 109.668 170.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.624 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 48.3 m-70 -97.92 107.65 20.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.737 0.303 . . . . 75.41 110.641 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.756 HG11 HG21 ' A' ' 475' ' ' VAL . 14.0 m -108.34 125.98 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.01 0.433 . . . . 74.02 110.55 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.602 ' HD3' HD21 ' A' ' 465' ' ' LEU . 16.0 ptpt -145.76 147.02 31.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.549 0.574 . . . . 75.54 112.549 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.9 t-20 -100.31 126.99 46.71 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.756 -0.657 . . . . 75.02 109.557 174.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.602 HD21 ' HD3' ' A' ' 463' ' ' LYS . 85.6 mt -116.26 8.65 14.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.037 0.384 . . . . 70.33 112.037 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -86.59 -20.89 53.15 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.099 -0.572 . . . . 52.13 113.02 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.74 14.34 63.33 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.116 -0.564 . . . . 44.45 113.591 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 7.4 tt -136.42 133.78 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 122.608 -0.348 . . . . 75.04 110.934 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.43 143.84 37.92 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 114.824 0.69 . . . . 44.43 114.824 -172.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.27 113.53 15.82 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 122.702 0.401 . . . . 64.44 111.41 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.79 -10.57 10.55 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.093 2.529 . . . . 74.34 113.324 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 65.6 m -87.87 13.22 11.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.602 0.761 . . . . 51.54 112.839 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 96.9 m -87.86 106.87 18.38 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.678 0.752 . . . . 71.52 112.649 -165.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -107.42 131.26 54.47 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.551 -0.749 . . . . 65.25 111.243 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.756 HG21 HG11 ' A' ' 462' ' ' VAL . 45.6 t -114.79 127.86 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 122.609 0.364 . . . . 63.34 110.823 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 476' ' ' ARG . . . . . 0.453 ' NH2' ' HB2' ' A' ' 519' ' ' GLU . 20.9 mtm180 -130.53 152.94 49.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.068 0.461 . . . . 62.14 112.16 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.21 122.73 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.111 -0.495 . . . . 65.24 111.319 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -113.93 137.53 51.56 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.2 -0.454 . . . . 63.14 111.388 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.539 HG12 HG12 ' A' ' 513' ' ' ILE . 58.9 mt -114.38 111.07 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 109.909 -0.404 . . . . 63.42 109.909 174.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 58.01 33.53 23.29 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.265 0.555 . . . . 74.33 110.8 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 91.79 -19.51 47.98 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.073 -0.512 . . . . 74.52 113.783 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 34.3 m -82.23 124.46 29.94 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.331 -0.511 . . . . 74.21 111.41 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.9 tp -64.91 115.16 5.08 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.083 0.468 . . . . 74.11 111.186 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -91.23 -44.03 9.47 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.15 -0.477 . . . . 74.12 111.979 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -162.98 155.49 18.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.648 0.261 . . . . 73.2 111.159 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' ASN . . . . . 0.411 ' HB3' ' HG2' ' A' ' 476' ' ' ARG . 0.8 OUTLIER -143.23 143.35 31.71 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.744 0.646 . . . . 73.22 112.744 -177.152 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -129.52 146.61 51.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.751 -0.659 . . . . 73.43 110.786 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 66.4 m -115.87 118.09 32.0 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.012 -0.366 . . . . 65.32 110.012 170.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.35 173.22 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.343 0.592 . . . . 54.14 112.022 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 72.0 p -124.76 132.93 53.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.06 -0.518 . . . . 73.33 110.569 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.26 121.52 38.88 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.894 0.378 . . . . 41.22 111.203 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -79.7 -170.51 40.41 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.318 -0.467 . . . . 22.22 113.429 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.03 110.6 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.573 2.182 . . . . 62.2 112.626 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.9 mmtp 62.82 37.76 12.08 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.086 0.469 . . . . 74.04 111.428 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -105.03 147.34 27.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.187 -0.46 . . . . 74.22 111.554 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -132.51 143.44 49.75 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.161 0.505 . . . . 61.54 112.332 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -126.37 144.05 50.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.938 -0.573 . . . . 74.13 110.775 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.64 112.01 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 121.033 0.444 . . . . 75.0 110.696 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.4 mt -106.41 125.61 51.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.351 -0.386 . . . . 75.33 110.315 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 35.2 p -113.39 153.33 28.75 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.238 0.542 . . . . 74.2 112.165 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -144.51 150.9 38.33 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.824 -0.625 . . . . 65.21 110.382 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.525 ' HB2' HD11 ' A' ' 455' ' ' LEU . 87.3 p -110.19 114.32 27.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.797 0.332 . . . . 74.45 110.585 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -106.26 130.24 54.15 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.017 0.437 . . . . 75.2 111.936 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 85.5 m -113.97 100.96 53.47 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 115.97 -0.559 . . . . 55.42 110.86 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 505' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 72.0 Cg_endo -74.26 91.05 0.96 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.426 2.084 . . . . 72.21 113.018 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 506' ' ' THR . . . . . 0.401 ' HA ' ' OD1' ' A' ' 453' ' ' ASN . 58.0 p -67.97 -16.92 64.27 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.193 0.442 . . . . 72.2 112.193 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -119.34 132.86 55.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.441 -0.345 . . . . 64.25 110.499 174.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.32 150.87 22.39 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.533 0.682 . . . . 65.13 112.469 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.45 -168.43 30.94 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.691 -0.686 . . . . 44.03 112.249 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 13.8 tpt -94.68 124.46 38.73 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 122.332 -0.51 . . . . 73.4 111.076 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -127.92 152.95 47.23 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.042 0.448 . . . . 74.34 112.007 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 512' ' ' ARG . . . . . 0.484 ' HG2' HD22 ' A' ' 514' ' ' ASN . 26.6 ttm180 -123.78 122.31 37.7 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.206 -0.452 . . . . 74.45 110.87 175.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.539 HG12 HG12 ' A' ' 479' ' ' ILE . 59.8 mt -103.1 123.93 56.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.968 0.414 . . . . 72.14 111.125 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.484 HD22 ' HG2' ' A' ' 512' ' ' ARG . 38.4 m-80 -119.73 138.9 53.03 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.398 -0.364 . . . . 75.03 111.419 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 515' ' ' ALA . . . . . 0.428 ' N ' HD11 ' A' ' 444' ' ' ILE . . . -112.44 134.02 54.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.925 0.393 . . . . 70.31 110.481 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 82.4 p -123.34 144.43 49.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.169 -0.469 . . . . 74.53 111.254 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.83 139.61 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.594 0.235 . . . . 63.15 111.133 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 35.8 t0 36.28 60.97 0.83 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.876 0.87 . . . . 74.31 112.855 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 519' ' ' GLU . . . . . 0.453 ' HB2' ' NH2' ' A' ' 476' ' ' ARG . 39.9 mt-10 -58.63 -32.66 69.24 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.044 0.45 . . . . 75.21 110.985 173.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -66.23 -24.21 66.56 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.357 -0.608 . . . . 65.31 109.357 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 29.4 t30 51.04 74.15 0.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.965 -1.016 . . . . 72.43 110.809 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 30.3 p -84.83 -10.64 56.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.879 -1.055 . . . . 64.13 111.408 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.443 HG21 ' HG3' ' A' ' 438' ' ' PRO . 11.3 p -135.24 143.61 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.914 -0.585 . . . . 43.04 112.255 -172.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.2 t -82.47 115.48 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.074 0.464 . . . . 63.43 110.709 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -107.2 -179.84 4.05 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.821 0.674 . . . . 63.32 112.821 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.98 -39.06 51.86 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.983 -0.553 . . . . 74.21 112.237 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -142.54 124.19 14.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.225 0.536 . . . . 72.1 111.432 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -84.08 -20.2 33.03 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.965 -0.562 . . . . 54.4 111.956 -175.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -85.48 3.42 40.37 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.11 0.481 . . . . 62.23 111.092 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.56 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 66.7 t30 -92.16 -13.24 30.95 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.21 0.528 . . . . 72.15 111.376 -176.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -78.81 0.22 27.89 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.368 0.877 . . . . 64.1 113.368 -174.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.6 t -130.68 135.38 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.588 0.588 . . . . 75.2 112.588 -175.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -122.11 142.85 49.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.148 -0.478 . . . . 73.44 110.859 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 92.7 m -124.01 126.13 45.76 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.617 0.599 . . . . 73.41 112.617 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -139.67 123.44 17.48 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.517 -0.31 . . . . 74.11 110.964 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -93.64 137.3 33.04 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.984 0.421 . . . . 71.11 111.96 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.38 132.29 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.227 -0.442 . . . . 71.5 111.444 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.0 t -100.44 117.76 35.27 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.319 -0.4 . . . . 30.31 110.993 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.481 HG11 ' HB2' ' A' ' 505' ' ' PRO . 38.2 t -106.21 130.65 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.96 0.41 . . . . 64.43 111.466 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 16.2 m -133.27 168.23 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 120.978 0.418 . . . . 72.31 111.993 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 541' ' ' LEU . . . . . 0.409 HD23 HG11 ' A' ' 452' ' ' VAL . 83.7 mt -74.58 -36.98 63.03 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.495 0.554 . . . . 64.11 112.495 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--O 1.253 1.259 0 N-CA-C 112.83 0.678 . . . . 65.12 112.83 -176.666 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 23.1 ptt? . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.173 0.511 . . . . 65.3 111.135 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -111.85 123.69 50.77 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.249 -0.432 . . . . 72.12 111.168 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -112.81 124.17 32.28 Favored Pre-proline 0 N--CA 1.468 0.471 0 N-CA-C 110.014 -0.365 . . . . 63.32 110.014 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.572 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 55.3 Cg_endo -80.13 174.86 10.96 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.552 2.168 . . . . 74.11 113.746 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -147.81 93.39 2.19 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.29 -0.868 . . . . 62.14 109.651 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.417 HD11 HG11 ' A' ' 470' ' ' VAL . 79.3 mt -91.81 111.87 23.57 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.098 0.475 . . . . 74.35 111.357 -177.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.41 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.0 t -114.47 148.36 37.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.165 0.507 . . . . 72.45 111.35 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.554 HG12 HG12 ' A' ' 462' ' ' VAL . 33.8 m -121.99 148.13 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.079 -0.51 . . . . 65.54 111.069 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 36.6 mt-10 -131.81 139.76 48.97 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.415 -0.357 . . . . 63.25 110.563 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 56.1 mt -114.16 132.69 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.899 0.381 . . . . 71.52 111.381 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -135.27 147.07 49.12 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.403 -0.362 . . . . 61.11 111.308 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.0 -173.35 35.86 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.001 -0.619 . . . . 62.31 113.103 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.18 129.61 18.52 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.63 2.22 . . . . 74.13 113.306 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.33 -41.9 65.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.044 0.449 . . . . 70.44 111.475 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.31 129.48 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.339 -0.391 . . . . 72.4 111.111 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.22 163.15 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.91 0.385 . . . . 73.02 111.509 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -92.92 153.36 21.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.306 -0.473 . . . . 74.55 112.99 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.411 HG22 ' OD1' ' A' ' 453' ' ' ASN . 12.1 p -67.43 136.66 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.001 0.429 . . . . 53.05 111.745 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 453' ' ' ASN . . . . . 0.411 ' OD1' HG22 ' A' ' 452' ' ' VAL . 22.2 m120 65.07 17.57 11.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.239 0.616 . . . . 75.5 112.298 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -104.38 167.17 9.92 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.13 0.49 . . . . 70.55 111.75 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 502' ' ' SER . 31.6 tp -100.34 131.3 46.34 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.268 -0.424 . . . . 72.43 111.423 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.45 132.39 45.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.844 0.354 . . . . 74.12 111.796 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -103.68 135.55 45.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.866 0.365 . . . . 74.44 111.278 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -125.54 161.6 26.79 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.449 -0.342 . . . . 73.25 110.909 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -119.67 127.93 53.34 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.782 0.325 . . . . 74.41 111.234 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 460' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 50.4 t -102.44 113.11 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.95 0.405 . . . . 75.33 110.012 170.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 41.1 m-70 -96.57 105.71 17.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.454 -0.339 . . . . 62.25 110.857 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.681 HG11 HG21 ' A' ' 475' ' ' VAL . 17.5 m -106.52 123.69 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.15 0.5 . . . . 64.55 110.476 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.484 ' HD3' HD21 ' A' ' 465' ' ' LEU . 3.7 ptpp? -142.52 148.21 37.26 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.878 0.695 . . . . 72.25 112.878 -173.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.1 t-20 -99.42 128.55 45.55 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.347 -0.842 . . . . 71.13 109.814 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.484 HD21 ' HD3' ' A' ' 463' ' ' LYS . 81.8 mt -111.71 -14.73 13.56 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.092 0.405 . . . . 75.42 112.092 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -66.27 -22.7 71.2 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 121.479 -0.391 . . . . 64.23 113.947 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.45 18.79 56.41 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.178 -0.534 . . . . 23.31 113.912 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.427 HG23 ' HB3' ' A' ' 438' ' ' PRO . 5.5 tt -137.44 138.1 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 122.795 0.438 . . . . 62.24 111.001 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -65.19 135.08 36.82 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.485 -0.388 . . . . 73.11 113.87 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.417 HG11 HD11 ' A' ' 440' ' ' LEU . 60.3 t -129.0 114.71 18.81 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 112.16 0.43 . . . . 63.21 112.16 -176.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.58 -10.94 14.4 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.037 2.491 . . . . 65.15 112.504 173.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' SER . . . . . 0.45 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 50.3 m -81.15 11.84 3.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.617 0.767 . . . . 72.44 112.976 -175.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 48.6 m -88.95 94.05 9.81 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.798 0.809 . . . . 75.21 112.183 -169.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -111.67 123.38 50.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.293 -0.867 . . . . 64.32 110.507 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.681 HG21 HG11 ' A' ' 462' ' ' VAL . 29.6 t -105.49 132.49 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 111.873 0.323 . . . . 73.22 111.873 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -128.25 144.53 51.13 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.901 0.381 . . . . 74.23 111.366 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -121.19 126.7 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.895 0.379 . . . . 74.23 111.266 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 482' ' ' THR . 82.6 m-85 -121.93 137.03 54.95 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.309 -0.405 . . . . 72.21 111.426 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 513' ' ' ILE . 59.0 mt -108.73 107.5 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 110.091 -0.337 . . . . 73.02 110.091 173.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 57.66 34.1 24.07 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.896 0.379 . . . . 70.54 111.289 -174.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.23 -10.36 74.47 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.207 -0.52 . . . . 64.51 113.537 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 478' ' ' TYR . 40.9 m -85.14 127.32 34.21 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.603 -0.351 . . . . 73.02 111.17 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.8 tp -69.15 118.41 12.01 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.853 0.359 . . . . 53.22 111.331 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -94.79 -45.1 7.47 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.818 0.342 . . . . 72.21 111.743 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -170.52 160.08 7.16 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.564 0.221 . . . . 74.32 111.073 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -132.1 157.2 44.81 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.088 0.47 . . . . 75.44 111.52 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 30.9 m-90 -135.99 143.78 44.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.095 0.558 . . . . 74.05 110.785 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 98.8 m -122.09 116.97 25.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.711 0.291 . . . . 70.34 110.422 173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.7 173.93 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.363 0.601 . . . . 62.23 111.872 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 55.1 p -125.68 133.68 52.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.958 -0.565 . . . . 75.13 110.693 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.437 HD21 ' HG2' ' A' ' 497' ' ' LYS . 75.3 mt -116.94 120.46 38.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.796 0.331 . . . . 74.44 111.502 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -75.35 -170.51 27.77 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.052 -0.594 . . . . 63.2 112.746 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.89 118.08 4.95 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.175 1.917 . . . . 73.13 112.364 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 74.4 mmtt 65.32 21.8 12.01 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.111 -0.495 . . . . 72.21 112.109 175.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -89.98 154.74 19.6 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.454 0.539 . . . . 65.44 112.454 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -135.0 145.09 47.75 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.855 0.359 . . . . 70.21 111.927 177.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.437 ' HG2' HD21 ' A' ' 491' ' ' LEU . 31.6 mmmt -122.31 129.83 52.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.2 -0.454 . . . . 74.01 109.887 170.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.2 t -100.28 117.31 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.183 0.516 . . . . 73.32 111.213 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 50.9 mt -106.61 146.46 30.67 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.027 -0.533 . . . . 54.31 111.05 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 21.3 p -127.06 147.02 50.16 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.005 0.431 . . . . 71.1 111.657 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -147.87 148.67 31.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.113 -0.494 . . . . 62.34 110.648 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.533 ' HB2' HD11 ' A' ' 455' ' ' LEU . 68.3 p -113.0 114.07 26.38 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.269 0.557 . . . . 75.43 111.419 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -106.2 137.2 44.56 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.643 -0.708 . . . . 75.25 111.341 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.7 m -119.35 100.8 49.7 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.606 -0.27 . . . . 63.34 111.125 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.47 108.43 1.72 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.624 2.216 . . . . 72.42 113.353 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 58.7 p -85.16 -13.43 50.11 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.108 0.41 . . . . 73.14 112.108 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -113.55 134.87 54.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.66 0.266 . . . . 75.41 111.183 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.74 151.55 37.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.6 0.714 . . . . 72.5 112.387 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 135.97 175.76 14.0 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.815 -0.629 . . . . 23.52 112.538 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 65.0 mtp -88.35 128.13 35.5 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.176 0.512 . . . . 65.02 111.542 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -120.05 119.48 33.49 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.15 -0.477 . . . . 60.42 110.762 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -92.75 114.37 26.91 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.059 0.457 . . . . 63.41 110.857 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 479' ' ' ILE . 59.0 mt -98.77 123.64 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.039 -0.528 . . . . 70.21 111.277 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -120.72 136.82 54.76 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.87 0.367 . . . . 72.32 111.806 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.27 143.99 42.43 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.327 -0.397 . . . . 72.23 110.917 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 516' ' ' THR . . . . . 0.418 HG22 HG22 ' A' ' 532' ' ' VAL . 60.8 p -131.14 157.0 44.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.253 -0.43 . . . . 73.41 111.427 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.74 140.18 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 121.005 0.431 . . . . 72.34 111.403 171.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 25.2 t0 41.51 62.48 1.52 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.138 0.975 . . . . 70.33 113.159 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.7 -30.86 71.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.015 0.436 . . . . 61.14 111.317 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.12 -9.38 39.1 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.254 -0.43 . . . . 54.51 112.121 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 57.61 49.69 12.15 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.141 0.496 . . . . 62.22 111.383 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 522' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 60.1 p -88.03 -12.31 44.71 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.294 -0.412 . . . . 61.23 111.773 -178.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.28 142.34 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.877 0.37 . . . . 61.52 111.242 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 524' ' ' VAL . . . . . 0.448 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 74.8 t -82.75 110.25 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.023 0.44 . . . . 72.02 111.218 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.69 162.12 13.91 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.845 -0.616 . . . . 74.43 112.117 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.72 -38.79 73.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.83 -0.623 . . . . 74.4 111.564 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -137.82 126.4 23.59 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.802 -0.181 . . . . 42.1 111.16 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -83.47 -24.88 31.6 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 62.41 111.109 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -81.34 -0.66 42.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.181 -0.463 . . . . 61.13 112.088 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.41 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 57.8 t30 -96.47 -23.0 16.78 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.897 0.379 . . . . 72.1 111.765 -177.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.78 16.37 1.16 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.058 0.762 . . . . 62.12 113.058 -174.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.418 HG22 HG22 ' A' ' 516' ' ' THR . 77.0 t -135.08 142.5 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 120.896 0.379 . . . . 73.23 111.62 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 533' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -127.25 144.03 51.12 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.545 0.338 . . . . 71.41 111.103 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.9 m -123.42 124.99 44.14 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.559 0.578 . . . . 75.24 112.559 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -134.13 124.22 25.73 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.682 0.277 . . . . 74.43 110.545 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.17 130.19 45.46 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.361 0.6 . . . . 72.14 112.132 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.38 145.02 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.729 -0.669 . . . . 75.33 111.413 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 48.3 t -117.68 113.99 22.71 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.853 0.358 . . . . 61.42 111.236 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.91 120.16 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.503 -0.317 . . . . 73.21 111.223 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.8 m -114.84 165.38 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.099 0.476 . . . . 61.35 112.231 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.8 mt -82.24 -1.26 48.72 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.204 0.446 . . . . 71.13 112.204 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--O 1.253 1.27 0 N-CA-C 112.126 0.417 . . . . 72.32 112.126 -179.138 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.135 0.493 . . . . 74.44 110.74 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -96.35 156.25 16.42 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.052 -0.522 . . . . 73.31 111.344 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -124.66 128.15 25.0 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.467 -0.333 . . . . 71.43 110.933 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.526 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 60.5 Cg_endo -72.13 174.92 10.62 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.794 2.329 . . . . 53.52 113.02 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 25.4 t70 -150.0 81.22 1.38 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.866 -0.606 . . . . 62.3 109.901 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.521 HD22 HD12 ' A' ' 491' ' ' LEU . 43.7 mt -84.45 105.72 15.48 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.858 -0.61 . . . . 64.22 111.487 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.472 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 8.1 t -113.08 148.08 35.97 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.079 0.466 . . . . 74.33 111.334 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.629 HG12 HG12 ' A' ' 462' ' ' VAL . 27.3 m -121.08 146.91 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.226 -0.443 . . . . 75.14 111.108 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 46.3 mt-10 -137.0 136.35 38.4 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.252 -0.431 . . . . 65.41 111.305 -175.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.2 mt -110.14 132.51 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.914 0.388 . . . . 74.44 111.62 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -136.61 136.39 39.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.45 -0.341 . . . . 74.04 111.093 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.51 -170.76 39.79 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.209 -0.52 . . . . 73.22 112.97 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.77 121.21 7.7 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.574 2.183 . . . . 72.42 112.921 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.4 -16.75 44.68 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.041 0.385 . . . . 73.52 112.041 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 63.6 t -129.33 123.97 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.682 0.277 . . . . 72.24 110.676 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.41 160.99 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.281 0.562 . . . . 74.53 112.27 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.43 158.19 26.28 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.049 -0.523 . . . . 62.12 112.8 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.411 HG11 HD23 ' A' ' 541' ' ' LEU . 13.8 p -69.21 140.54 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 120.95 0.405 . . . . 63.0 111.948 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 68.1 12.35 8.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.178 0.591 . . . . 73.52 112.405 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -93.58 174.63 7.09 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.0 0.429 . . . . 72.1 111.476 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 502' ' ' SER . 40.3 tp -108.15 119.39 39.34 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.894 0.378 . . . . 74.24 111.338 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.05 131.55 56.33 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.026 0.441 . . . . 64.31 111.54 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -116.65 130.44 56.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.281 0.562 . . . . 53.41 111.658 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -122.56 162.37 21.94 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.786 -0.643 . . . . 75.23 111.089 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -120.34 127.55 52.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.828 0.347 . . . . 72.54 111.151 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.3 t -100.49 113.25 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.077 0.465 . . . . 71.23 110.151 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 52.2 m-70 -94.27 105.85 17.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.29 -0.413 . . . . 74.22 110.341 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.629 HG12 HG12 ' A' ' 442' ' ' VAL . 8.7 m -106.19 123.12 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.119 0.485 . . . . 54.31 110.246 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.457 ' HG3' HG23 ' A' ' 441' ' ' THR . 3.5 ptpp? -139.39 147.05 40.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.158 0.504 . . . . 64.0 112.276 -173.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 53.5 t-20 -104.69 126.91 52.23 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.801 -0.636 . . . . 71.43 109.877 175.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 89.3 mt -103.97 -20.61 13.82 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.051 -0.406 . . . . 72.33 111.972 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -60.94 -26.01 64.89 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.309 -0.472 . . . . 74.14 114.016 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.81 18.35 56.49 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.986 -0.626 . . . . 65.43 113.471 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.6 tt -137.07 133.8 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 122.613 0.365 . . . . 73.4 110.705 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.9 145.31 41.39 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 114.718 0.647 . . . . 62.41 114.718 -174.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.8 117.9 16.42 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 122.817 0.447 . . . . 63.11 111.44 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.67 -12.19 11.23 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.752 2.302 . . . . 72.33 112.594 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 17.3 m -81.02 11.63 3.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.812 0.845 . . . . 74.02 112.804 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 74.1 m -88.57 93.83 9.68 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.952 0.882 . . . . 54.32 112.591 -166.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -99.02 126.37 44.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.203 -0.908 . . . . 73.35 110.176 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.582 HG21 HG11 ' A' ' 462' ' ' VAL . 47.3 t -112.17 118.81 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.754 0.312 . . . . 54.44 110.97 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -125.25 152.64 44.33 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.123 0.487 . . . . 72.21 111.785 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 99.3 t -121.21 130.07 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.108 -0.496 . . . . 43.33 111.33 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -123.39 136.46 54.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.077 -0.51 . . . . 74.04 111.592 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 65.6 mt -109.33 112.33 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 110.076 -0.342 . . . . 64.14 110.076 174.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 53.87 33.75 17.85 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.974 0.416 . . . . 64.22 111.45 -175.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 99.54 -23.67 35.26 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.252 -0.499 . . . . 32.23 113.91 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 85.3 m -82.86 133.52 35.12 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.338 0.569 . . . . 75.22 111.763 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.5 tp -68.01 116.84 9.1 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.008 0.432 . . . . 74.44 111.495 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -96.5 -43.57 7.56 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.957 0.354 . . . . 71.35 111.957 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.5 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 8.9 tppt? -150.23 155.26 39.39 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.593 -0.276 . . . . 61.41 110.822 -174.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 486' ' ' ASN . . . . . 0.431 ' N ' ' HG3' ' A' ' 485' ' ' LYS . 8.1 p30 -143.97 141.99 30.49 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.995 0.426 . . . . 74.35 111.525 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 487' ' ' TRP . . . . . 0.5 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 8.6 m-90 -133.19 148.7 52.06 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.145 -0.479 . . . . 73.33 111.126 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 65.1 m -120.34 119.04 31.96 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.234 -0.284 . . . . 74.53 110.234 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.5 174.79 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.132 0.492 . . . . 62.51 111.491 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 92.5 p -121.64 139.4 53.59 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.527 -0.306 . . . . 61.24 110.332 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.521 HD12 HD22 ' A' ' 440' ' ' LEU . 68.1 mt -117.78 120.6 38.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.884 0.374 . . . . 64.24 111.105 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -84.37 -169.37 45.47 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.239 -0.505 . . . . 42.24 112.939 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.27 111.95 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.399 2.066 . . . . 74.24 112.519 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 45.5 mmtm 66.46 18.41 10.82 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.267 -0.424 . . . . 74.41 112.01 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -86.39 149.14 25.22 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.064 0.394 . . . . 63.2 112.064 -176.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -133.84 135.7 43.92 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.235 -0.439 . . . . 75.33 111.618 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.409 ' O ' HG22 ' A' ' 462' ' ' VAL . 2.3 mmmp? -122.39 134.09 54.63 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.44 -0.345 . . . . 50.34 110.582 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.73 115.67 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.979 0.418 . . . . 62.45 111.247 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 72.0 mt -107.92 128.93 55.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.247 -0.433 . . . . 61.44 110.801 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 36.5 p -113.08 150.01 32.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.546 0.688 . . . . 74.14 112.617 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -145.65 148.34 32.98 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.586 -0.734 . . . . 74.11 110.982 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.525 ' HB2' HD11 ' A' ' 455' ' ' LEU . 78.5 p -111.69 113.57 26.02 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.182 0.515 . . . . 43.24 111.216 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -108.63 134.27 51.6 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.391 -0.368 . . . . 71.23 110.993 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.3 m -111.08 100.72 47.94 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-N 116.37 -0.377 . . . . 63.25 110.946 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 505' ' ' PRO . . . . . 0.479 ' HB2' HG11 ' A' ' 539' ' ' VAL . 71.6 Cg_endo -74.06 88.77 1.07 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.258 1.972 . . . . 73.31 112.693 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 22.4 p -73.97 -14.24 61.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.211 0.448 . . . . 74.34 112.211 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -115.75 146.21 42.11 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.706 0.288 . . . . 74.15 110.711 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.12 149.55 21.49 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.83 0.348 . . . . 51.15 111.87 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.3 -167.62 27.92 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.998 -0.62 . . . . 63.35 113.416 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 2.4 tpt -90.91 107.63 19.32 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.795 0.331 . . . . 53.22 111.503 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -114.17 146.84 39.8 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.051 -0.406 . . . . 51.43 111.526 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 512' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 35.5 ttp180 -124.42 116.78 23.09 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.554 -0.293 . . . . 72.24 111.268 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 63.2 mt -96.4 130.16 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.843 0.354 . . . . 60.25 111.249 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -125.41 147.79 49.05 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.869 0.366 . . . . 71.34 111.567 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -121.63 133.68 54.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.317 -0.401 . . . . 60.32 110.604 174.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.0 p -127.57 142.65 51.31 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.813 0.339 . . . . 52.34 111.726 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.43 139.66 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 120.733 0.302 . . . . 74.34 111.3 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 46.6 t0 38.96 66.59 0.52 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.682 0.793 . . . . 63.25 112.595 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.95 -31.81 72.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.097 -0.501 . . . . 63.45 111.655 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.88 -19.63 62.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.352 -0.386 . . . . 74.14 111.044 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 59.74 51.88 5.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.46 0.648 . . . . 71.33 110.917 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 68.5 p -67.02 -29.09 68.81 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.76 -0.654 . . . . 73.15 111.205 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.41 HG21 ' HG3' ' A' ' 438' ' ' PRO . 9.8 p -114.88 143.41 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.03 -0.532 . . . . 43.25 111.032 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 524' ' ' VAL . . . . . 0.492 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 51.4 t -82.62 118.18 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.071 0.462 . . . . 70.33 111.227 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -92.38 162.01 14.43 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.775 -0.648 . . . . 70.12 112.593 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 87.5 mt -70.05 -38.12 75.71 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.134 -0.485 . . . . 71.1 110.814 172.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -130.53 118.17 20.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.089 -0.505 . . . . 74.34 111.079 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.39 3.16 32.99 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.007 0.432 . . . . 73.2 112.106 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -107.19 16.78 23.71 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.542 0.687 . . . . 71.22 110.03 173.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.472 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.4 t30 -100.18 -22.44 15.16 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.514 -0.766 . . . . 54.53 112.41 -170.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -81.58 11.54 4.57 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.913 1.079 . . . . 72.35 113.913 -167.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.73 144.22 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.501 0.556 . . . . 45.24 112.501 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 533' ' ' ALA . . . . . 0.541 ' HB2' HG23 ' A' ' 442' ' ' VAL . . . -129.28 142.75 50.75 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.997 -0.547 . . . . 53.23 110.957 173.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.0 m -128.49 123.3 33.25 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.975 0.417 . . . . 43.31 111.872 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -142.74 117.72 10.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.881 0.372 . . . . 74.21 110.652 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 536' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 0.5 OUTLIER -97.24 137.21 36.6 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.485 0.66 . . . . 72.1 112.561 -177.505 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.58 132.38 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.653 -0.703 . . . . 74.53 111.558 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.3 t -99.27 122.04 41.88 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.893 0.377 . . . . 63.1 111.07 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 505' ' ' PRO . 26.1 t -103.85 132.42 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.441 -0.345 . . . . 71.43 110.688 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.83 164.37 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.092 0.472 . . . . 71.3 112.241 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 541' ' ' LEU . . . . . 0.411 HD23 HG11 ' A' ' 452' ' ' VAL . 95.4 mt -78.42 -1.9 35.77 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.265 0.468 . . . . 65.52 112.265 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.254 1.332 0 N-CA-C 112.434 0.531 . . . . 75.33 112.434 -175.707 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 120.928 0.394 . . . . 63.21 111.134 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -95.6 143.04 27.23 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.066 0.46 . . . . 72.44 111.584 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -116.17 134.97 22.72 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 116.028 -0.533 . . . . 53.14 110.495 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 72.0 Cg_endo -77.0 173.85 13.8 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.506 2.137 . . . . 54.5 114.241 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -145.17 94.93 2.59 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.161 -0.927 . . . . 75.21 108.679 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.529 HD22 HD12 ' A' ' 491' ' ' LEU . 66.5 mt -100.25 120.66 40.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.076 0.465 . . . . 73.41 111.579 -172.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.623 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.5 t -129.36 159.55 35.85 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.319 0.58 . . . . 54.12 112.375 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.631 HG12 HG12 ' A' ' 462' ' ' VAL . 28.7 m -122.42 148.37 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.772 -0.649 . . . . 74.54 111.473 -178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 37.6 mt-10 -132.27 136.87 47.24 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.406 -0.361 . . . . 74.3 110.241 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 56.6 mt -112.88 126.95 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 120.934 0.397 . . . . 62.34 111.8 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -131.0 144.05 51.18 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.198 -0.455 . . . . 60.45 110.334 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.9 -176.35 36.63 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.653 -0.784 . . . . 63.4 113.317 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.52 114.86 3.43 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.842 2.362 . . . . 71.12 113.122 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -74.93 -14.49 60.65 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.611 0.597 . . . . 72.31 112.611 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.65 126.48 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 122.171 -0.331 . . . . 45.02 110.76 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.93 162.09 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.261 0.553 . . . . 73.1 111.796 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.96 153.91 20.14 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.213 -0.518 . . . . 52.31 112.957 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.566 HG11 HD23 ' A' ' 541' ' ' LEU . 14.5 p -64.0 142.22 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 O-C-N 122.619 -0.342 . . . . 72.44 111.414 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 65.82 13.45 9.0 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.628 0.603 . . . . 75.21 112.628 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -105.29 162.75 13.15 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.059 0.457 . . . . 61.15 111.943 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 502' ' ' SER . 49.2 tp -92.94 133.54 36.01 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.468 -0.333 . . . . 73.21 111.634 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -131.4 132.58 44.49 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.797 0.332 . . . . 73.42 111.46 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -112.92 131.88 55.56 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.804 0.335 . . . . 53.31 111.183 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' TYR . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 61.6 m-85 -121.59 157.61 30.39 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.235 -0.438 . . . . 75.11 111.013 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.511 ' HG2' HG22 ' A' ' 500' ' ' THR . 41.9 mt-10 -120.26 127.02 52.01 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.997 -0.547 . . . . 63.14 111.344 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.62 113.68 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.165 173.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.546 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 44.8 m-70 -95.09 111.63 23.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.869 0.366 . . . . 75.32 110.267 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.631 HG12 HG12 ' A' ' 442' ' ' VAL . 33.1 m -106.57 122.71 60.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.99 0.424 . . . . 71.44 110.652 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.527 ' HD3' HD21 ' A' ' 465' ' ' LEU . 1.4 ptpp? -130.42 148.55 52.25 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.295 0.569 . . . . 64.55 112.282 -174.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.569 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.7 t-20 -99.64 128.07 45.75 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.668 -0.696 . . . . 73.32 110.014 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.527 HD21 ' HD3' ' A' ' 463' ' ' LYS . 79.9 mt -109.45 -10.7 14.88 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.752 0.311 . . . . 73.2 111.747 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -76.26 -28.48 60.0 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.294 -0.479 . . . . 40.55 113.566 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.13 22.39 45.27 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.955 -0.64 . . . . 72.04 113.389 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.6 tt -137.73 135.82 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 122.738 0.415 . . . . 53.25 111.102 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.413 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -70.02 133.08 24.32 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 114.608 0.603 . . . . 62.4 114.608 -174.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.39 118.48 17.09 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.21 0.604 . . . . 63.22 111.306 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -88.85 -9.86 4.47 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.074 2.516 . . . . 73.12 113.851 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.3 p -81.65 11.95 4.29 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.83 0.678 . . . . 72.15 112.83 -177.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' THR . . . . . 0.486 ' HA ' ' OD1' ' A' ' 518' ' ' ASP . 98.7 m -87.24 109.96 19.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.072 0.939 . . . . 44.35 112.094 -164.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -119.99 128.14 53.28 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.009 -0.996 . . . . 75.03 110.892 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.629 HG21 HG11 ' A' ' 462' ' ' VAL . 25.1 t -104.59 135.83 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.404 -0.362 . . . . 62.04 111.902 -175.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 476' ' ' ARG . . . . . 0.562 ' NH1' ' HB2' ' A' ' 519' ' ' GLU . 59.2 mtt85 -123.64 143.39 50.27 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.369 -0.378 . . . . 75.31 111.273 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.52 123.18 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 120.996 0.427 . . . . 61.33 111.123 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -111.55 137.82 48.9 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.042 -0.526 . . . . 63.45 110.7 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 62.5 mt -115.99 109.66 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 110.025 -0.361 . . . . 75.43 110.025 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 55.16 34.62 23.04 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.089 0.471 . . . . 73.41 111.292 -174.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 97.39 -24.09 33.0 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.049 -0.523 . . . . 72.0 113.699 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 66.0 m -82.67 120.4 25.52 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.394 -0.474 . . . . 55.53 111.76 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -62.8 115.05 4.0 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.054 0.454 . . . . 75.15 110.971 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -89.74 -43.54 10.62 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.382 0.512 . . . . 64.14 112.382 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -164.45 161.23 21.31 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.19 -0.319 . . . . 44.34 111.454 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.58 154.98 42.75 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.936 0.398 . . . . 74.51 111.941 177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -135.02 148.87 50.05 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.848 0.459 . . . . 73.42 111.431 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 79.6 m -105.64 119.24 38.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 110.156 -0.313 . . . . 75.44 110.156 171.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.07 173.34 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.394 0.616 . . . . 62.44 111.876 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 75.1 p -126.58 134.71 50.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.081 -0.508 . . . . 63.4 110.686 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.529 HD12 HD22 ' A' ' 440' ' ' LEU . 92.1 mt -117.38 118.89 33.48 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.875 0.369 . . . . 65.13 111.275 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.413 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -81.47 -166.56 36.95 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.193 -0.527 . . . . 60.32 112.652 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.03 107.12 0.73 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.15 1.9 . . . . 74.43 112.172 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 41.6 mmtm 68.66 22.9 7.32 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.204 -0.453 . . . . 52.34 111.772 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -81.81 149.88 28.14 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.892 0.33 . . . . 74.21 111.892 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 496' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 462' ' ' VAL . 41.5 tt0 -135.38 134.59 39.91 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.744 0.307 . . . . 63.12 111.286 176.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -118.91 149.79 40.98 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.639 -0.255 . . . . 73.5 110.621 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.92 113.22 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.001 0.429 . . . . 71.42 111.48 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 50.6 mt -105.71 146.23 30.05 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.242 -0.436 . . . . 65.24 111.047 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.511 HG22 ' HG2' ' A' ' 459' ' ' GLU . 20.9 p -129.47 149.8 51.09 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.367 0.603 . . . . 72.44 112.611 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 501' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 49.0 p90 -144.33 148.46 34.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.793 -0.639 . . . . 70.53 111.156 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.568 ' HB2' HD11 ' A' ' 455' ' ' LEU . 24.8 p -110.96 115.06 28.85 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.207 0.527 . . . . 72.43 111.577 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -120.88 137.44 54.58 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.008 -0.542 . . . . 51.3 111.601 -174.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 92.9 m -120.61 102.05 45.32 Favored Pre-proline 0 N--CA 1.473 0.688 0 CA-C-N 116.458 -0.337 . . . . 65.11 111.282 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.97 104.43 1.91 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.578 2.185 . . . . 74.52 113.068 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 77.0 p -86.82 -15.76 38.23 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.021 0.438 . . . . 73.22 111.995 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.22 137.13 42.59 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.731 0.301 . . . . 71.1 110.837 171.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.17 150.21 25.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.009 0.433 . . . . 74.25 112.151 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 143.98 -167.73 26.7 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.177 -0.535 . . . . 75.02 113.181 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 89.6 mmm -89.57 121.1 31.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.064 0.459 . . . . 74.5 111.395 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -121.58 111.7 17.55 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.427 0.632 . . . . 74.4 111.207 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -104.02 120.34 40.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.805 -0.634 . . . . 72.32 111.308 -177.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 62.2 mt -95.73 128.44 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.841 -0.618 . . . . 73.34 111.473 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -122.95 135.3 54.43 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.196 -0.457 . . . . 74.24 111.041 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.56 139.53 48.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.784 0.325 . . . . 62.41 111.416 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 516' ' ' THR . . . . . 0.527 HG22 HG22 ' A' ' 532' ' ' VAL . 71.2 p -129.26 151.85 49.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.921 0.391 . . . . 73.02 111.035 177.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.5 p -130.0 141.8 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.525 -0.307 . . . . 52.23 111.524 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' A' ' 473' ' ' THR . 1.3 m-20 50.17 47.91 22.9 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.456 0.539 . . . . 72.53 112.456 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 519' ' ' GLU . . . . . 0.562 ' HB2' ' NH1' ' A' ' 476' ' ' ARG . 6.0 mm-40 -53.62 -32.78 52.67 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.283 0.475 . . . . 74.13 112.283 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.42 -17.05 64.12 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.171 0.434 . . . . 72.21 112.171 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 49.84 37.17 12.81 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.742 0.645 . . . . 64.3 112.742 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 38.5 p -72.38 -16.66 61.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.858 0.361 . . . . 60.44 111.78 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 8.3 p -108.01 136.53 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.417 -0.356 . . . . 74.04 111.07 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 524' ' ' VAL . . . . . 0.434 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 90.7 t -84.23 113.3 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.873 0.368 . . . . 75.33 110.879 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -100.61 174.23 6.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.259 0.552 . . . . 65.41 112.269 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.7 mt -82.85 -24.39 33.29 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.68 -0.691 . . . . 72.21 111.675 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 527' ' ' ASN . . . . . 0.57 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 25.0 t-20 -118.6 158.24 25.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.145 0.498 . . . . 54.34 111.579 -174.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -118.35 -23.8 7.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.165 -0.471 . . . . 74.43 111.981 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -105.89 -7.39 18.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.3 0.481 . . . . 72.42 112.3 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.623 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 58.2 t30 -86.77 -7.7 58.02 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.713 0.634 . . . . 72.43 112.713 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -75.42 -0.27 19.44 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.159 0.799 . . . . 73.33 113.159 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 516' ' ' THR . 48.4 t -126.86 146.05 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.439 0.533 . . . . 53.31 112.439 -175.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 533' ' ' ALA . . . . . 0.407 ' CB ' HG23 ' A' ' 442' ' ' VAL . . . -136.14 142.69 44.25 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.245 -0.434 . . . . 53.31 111.276 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.8 m -117.3 134.83 54.34 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.404 0.52 . . . . 72.53 112.404 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -138.54 126.64 22.71 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.369 -0.378 . . . . 63.03 110.363 174.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -102.6 123.44 46.34 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.825 0.345 . . . . 74.32 111.85 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.47 144.45 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.996 0.427 . . . . 71.4 111.667 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.0 t -112.95 127.03 56.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.776 0.322 . . . . 75.14 111.413 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.1 120.51 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.85 0.357 . . . . 74.41 111.066 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.74 158.91 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.442 0.534 . . . . 55.22 112.442 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 541' ' ' LEU . . . . . 0.566 HD23 HG11 ' A' ' 452' ' ' VAL . 89.9 mt -81.3 -28.43 34.62 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.251 -0.431 . . . . 74.02 111.632 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.254 1.339 0 N-CA-C 112.725 0.639 . . . . 75.31 112.725 -176.893 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 435' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 435' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.46 0.171 . . . . 71.32 111.168 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -96.77 131.99 42.92 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.977 0.418 . . . . 63.05 111.571 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 438' ' ' PRO . 96.5 m-85 -128.28 146.1 58.26 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 116.139 -0.482 . . . . 75.34 110.474 177.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.479 ' HG2' HG21 ' A' ' 523' ' ' VAL . 2.6 Cg_exo -75.03 173.91 13.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.922 2.415 . . . . 71.33 114.223 -176.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -152.87 78.2 1.18 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.784 -1.098 . . . . 73.41 108.972 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.418 HD22 HD12 ' A' ' 491' ' ' LEU . 70.4 mt -84.12 110.48 18.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.669 -0.696 . . . . 73.13 111.416 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.472 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 13.7 t -115.57 149.32 38.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.146 0.498 . . . . 70.31 111.459 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.599 HG12 HG12 ' A' ' 462' ' ' VAL . 27.1 m -121.02 148.41 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.966 -0.561 . . . . 73.13 111.144 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 43.7 mt-10 -139.69 131.58 27.65 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.496 -0.32 . . . . 73.21 110.872 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 53.8 mt -105.55 138.69 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 122.129 -0.357 . . . . 72.12 111.463 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -141.59 134.97 29.56 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 120.563 0.221 . . . . 65.02 111.287 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.68 -164.87 37.63 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.947 -0.644 . . . . 63.31 113.678 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.2 136.84 32.81 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.743 2.296 . . . . 65.03 113.44 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -82.95 -44.94 14.73 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.898 0.38 . . . . 70.44 111.751 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.16 133.72 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 120.989 0.423 . . . . 71.4 111.278 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.5 m -135.7 162.99 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.068 0.461 . . . . 75.1 111.539 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -98.34 165.65 21.66 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.178 -0.534 . . . . 71.44 113.056 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 11.9 p -69.44 136.76 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 120.853 0.359 . . . . 63.13 111.591 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 24.0 m120 64.67 15.65 9.87 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.151 0.58 . . . . 71.32 112.547 -176.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.419 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.0 mmmt -95.82 143.93 26.62 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.13 0.49 . . . . 70.44 111.656 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 502' ' ' SER . 43.1 tp -81.75 123.14 28.51 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.277 -0.42 . . . . 71.31 111.159 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -118.36 132.31 56.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.84 0.352 . . . . 75.12 111.288 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -120.7 132.03 54.86 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.201 0.524 . . . . 50.42 111.747 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -123.76 159.42 29.51 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.739 -0.664 . . . . 75.45 110.96 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.471 ' HG3' HG22 ' A' ' 500' ' ' THR . 1.9 mp0 -120.22 127.46 52.45 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.069 0.462 . . . . 74.44 110.745 175.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.7 t -100.52 121.46 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.274 -0.421 . . . . 50.52 111.48 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 11.6 m-70 -96.22 110.58 22.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.081 -0.509 . . . . 74.11 110.522 176.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.599 HG12 HG12 ' A' ' 442' ' ' VAL . 19.8 m -114.4 123.42 70.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.962 0.411 . . . . 75.33 110.342 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.587 ' HD3' HD21 ' A' ' 465' ' ' LEU . 4.5 ptpp? -139.17 148.37 43.1 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.467 0.651 . . . . 75.32 112.705 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 49.4 t-20 -100.23 127.58 46.48 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.495 -0.775 . . . . 61.12 109.873 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.587 HD21 ' HD3' ' A' ' 463' ' ' LYS . 77.9 mt -115.02 -2.66 12.76 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.364 0.505 . . . . 64.02 112.364 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -72.88 -22.85 78.8 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.979 -0.629 . . . . 53.14 113.174 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.75 16.42 59.92 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.255 -0.498 . . . . 73.24 113.307 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 10.2 tt -135.69 139.73 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 122.729 -0.277 . . . . 73.3 110.942 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.4 137.08 25.65 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.171 -0.538 . . . . 55.15 114.079 -176.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 57.7 t -131.68 112.9 15.16 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 120.802 0.334 . . . . 75.33 111.796 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -88.01 -10.9 4.78 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.3 2.667 . . . . 50.44 113.057 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 79.9 p -81.95 13.3 3.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.534 0.734 . . . . 72.21 112.674 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 91.0 m -87.42 108.82 19.18 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.755 0.788 . . . . 62.15 112.436 -164.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -110.57 130.59 55.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.352 -0.84 . . . . 70.33 111.42 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.533 HG21 HG11 ' A' ' 462' ' ' VAL . 47.3 t -111.53 130.74 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 122.314 0.246 . . . . 63.1 110.981 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 476' ' ' ARG . . . . . 0.603 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 96.0 mtt180 -124.2 150.11 45.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.945 0.402 . . . . 65.44 111.418 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.98 120.71 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.218 -0.446 . . . . 55.34 111.085 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -113.75 137.1 52.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.473 -0.33 . . . . 74.35 110.99 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 513' ' ' ILE . 63.2 mt -113.34 111.89 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 110.166 -0.309 . . . . 61.02 110.166 174.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 54.46 34.38 20.84 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.108 0.48 . . . . 64.34 111.77 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.18 -19.06 55.35 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.382 -0.437 . . . . 71.31 113.482 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 89.7 m -87.11 124.38 33.18 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.543 -0.386 . . . . 55.52 111.693 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.6 tp -62.7 120.4 11.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.1 0.476 . . . . 63.11 111.774 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' TYR . . . . . 0.453 ' CE2' ' HE2' ' A' ' 485' ' ' LYS . 19.3 t80 -94.81 -43.07 8.39 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.19 -0.459 . . . . 74.33 112.124 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.453 ' HE2' ' CE2' ' A' ' 484' ' ' TYR . 4.5 ttpt -167.67 159.78 12.21 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 122.235 -0.291 . . . . 74.54 111.464 -177.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -143.17 144.12 32.06 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.939 0.4 . . . . 64.23 112.037 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -132.78 149.6 52.25 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.991 0.516 . . . . 75.3 111.208 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.0 m -118.06 119.95 36.31 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 110.202 -0.295 . . . . 74.24 110.202 170.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.48 172.98 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.32 0.581 . . . . 71.11 111.966 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 79.1 p -111.9 137.4 49.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.04 -0.527 . . . . 74.43 110.752 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.418 HD12 HD22 ' A' ' 440' ' ' LEU . 69.0 mt -127.55 118.99 25.01 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.828 0.347 . . . . 73.34 110.721 174.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -84.43 -174.79 50.53 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.951 -0.642 . . . . 74.32 112.702 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.97 105.84 0.23 Allowed 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.365 2.043 . . . . 70.23 112.052 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.7 mmtp 71.59 29.19 2.67 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.154 0.427 . . . . 75.23 112.154 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.95 155.31 17.14 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.814 0.34 . . . . 61.33 111.869 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -130.34 143.21 50.63 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.215 -0.448 . . . . 64.44 111.393 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.445 ' HB2' ' CG2' ' A' ' 462' ' ' VAL . 43.6 mmtm -117.21 146.85 42.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.052 0.541 . . . . 65.32 110.039 172.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.57 113.14 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.047 0.451 . . . . 73.04 110.938 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 56.7 mt -110.84 141.24 44.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.405 -0.362 . . . . 73.52 111.166 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.471 HG22 ' HG3' ' A' ' 459' ' ' GLU . 21.5 p -113.81 151.7 31.69 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.493 0.553 . . . . 74.14 112.493 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -150.84 148.51 28.56 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.019 -0.537 . . . . 63.15 111.311 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.569 ' HB2' HD11 ' A' ' 455' ' ' LEU . 89.9 p -118.42 125.89 50.91 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.271 -0.422 . . . . 75.53 111.111 -178.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -125.97 136.8 53.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.914 0.388 . . . . 74.04 111.136 -177.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.4 m -121.31 100.77 44.71 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.694 0.283 . . . . 64.33 111.016 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 505' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 80.3 Cg_endo -77.64 106.3 2.17 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.623 2.215 . . . . 62.03 113.108 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.8 p -87.54 12.17 13.09 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.042 0.386 . . . . 72.25 112.042 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -142.74 132.72 24.31 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.711 0.404 . . . . 61.31 110.967 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -73.68 150.73 41.07 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.475 0.546 . . . . 73.22 112.475 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 145.76 -173.35 26.15 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.879 -0.676 . . . . 35.4 113.397 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 95.9 mmm -99.31 112.61 24.74 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.049 0.452 . . . . 72.12 111.032 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -115.05 119.21 35.68 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.2 0.524 . . . . 75.33 111.431 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -97.72 117.91 33.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.104 -0.498 . . . . 73.23 111.153 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 479' ' ' ILE . 65.0 mt -95.29 120.01 44.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.0 -0.545 . . . . 73.32 111.119 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.48 137.35 52.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.934 0.397 . . . . 72.52 111.341 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.1 132.96 54.54 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.299 -0.409 . . . . 70.53 110.738 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 516' ' ' THR . . . . . 0.488 HG22 HG22 ' A' ' 532' ' ' VAL . 43.9 p -126.03 141.14 52.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.887 0.375 . . . . 73.34 111.244 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.36 141.89 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.95 0.405 . . . . 74.52 111.43 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.3 t0 49.89 58.66 5.21 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.643 0.735 . . . . 62.44 111.919 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 519' ' ' GLU . . . . . 0.603 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.9 mm-40 -59.12 -32.69 70.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.284 0.564 . . . . 75.51 111.322 174.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.55 -18.05 64.27 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.763 -0.653 . . . . 71.41 111.68 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 52.02 70.22 0.58 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.719 0.771 . . . . 54.51 110.8 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 67.4 p -96.76 -10.87 25.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.472 -0.785 . . . . 73.33 111.689 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.479 HG21 ' HG2' ' A' ' 438' ' ' PRO . 11.7 p -141.66 144.15 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.057 0.456 . . . . 74.42 111.736 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.5 t -82.79 116.27 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.968 0.413 . . . . 74.31 111.528 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.88 156.25 17.62 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.888 -0.597 . . . . 73.22 112.423 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.84 -38.85 70.05 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.765 -0.652 . . . . 65.22 111.329 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -119.81 122.07 40.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.842 0.353 . . . . 72.34 110.703 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -83.05 -17.55 42.84 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.006 0.431 . . . . 70.12 111.934 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -102.08 14.98 30.46 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.102 -0.374 . . . . 74.34 111.669 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.472 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 66.3 t30 -104.93 -11.39 16.72 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.289 0.477 . . . . 73.35 112.289 -172.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -86.56 6.11 32.33 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.923 0.712 . . . . 72.23 112.923 -172.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 516' ' ' THR . 51.4 t -130.42 143.15 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.018 0.437 . . . . 54.05 112.107 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 533' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -129.73 143.2 50.7 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.386 -0.37 . . . . 72.41 111.023 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 56.9 m -117.78 135.48 54.03 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.856 0.36 . . . . 61.34 111.909 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -141.98 116.91 9.9 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.51 -0.552 . . . . 74.23 109.51 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -101.62 124.34 47.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.201 0.524 . . . . 60.34 111.813 -175.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.7 t -112.32 144.44 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.961 -0.563 . . . . 72.42 111.64 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 30.1 t -112.38 128.53 56.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.525 -0.307 . . . . 44.33 111.131 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.6 t -111.12 125.59 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 120.827 0.346 . . . . 73.24 111.691 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.75 161.12 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.165 0.507 . . . . 71.23 111.893 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.0 -14.37 58.0 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.754 0.65 . . . . 65.04 112.754 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 112.856 0.687 . . . . 62.21 112.856 -176.298 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.708 0.289 . . . . 74.4 111.016 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -101.29 130.94 47.54 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.841 0.353 . . . . 75.31 111.142 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -118.24 143.56 33.24 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.557 -0.292 . . . . 73.21 110.788 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.626 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 20.6 Cg_endo -79.99 174.37 11.63 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.334 2.022 . . . . 52.31 113.53 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 11.7 t70 -149.38 82.96 1.42 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.686 -0.688 . . . . 73.2 109.794 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.522 HD11 HG11 ' A' ' 470' ' ' VAL . 92.1 mt -84.73 114.76 22.28 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.105 -0.498 . . . . 72.2 111.771 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.476 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.2 t -126.37 158.6 35.47 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.009 0.433 . . . . 63.13 111.382 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 462' ' ' VAL . 33.8 m -132.1 148.13 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 116.112 -0.495 . . . . 65.32 111.319 -177.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.5 mt-10 -125.08 137.15 54.2 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.421 0.288 . . . . 71.01 110.994 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.8 mt -108.76 127.68 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.919 0.39 . . . . 41.03 111.471 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -128.37 132.04 48.55 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.673 -0.239 . . . . 75.33 111.15 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 172.15 -173.77 45.27 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.654 -0.784 . . . . 75.13 113.678 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.75 136.48 23.26 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.774 2.316 . . . . 73.3 113.395 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.57 -47.89 58.04 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.966 -0.561 . . . . 65.45 111.898 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.1 t -117.83 125.83 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.765 0.317 . . . . 72.11 111.078 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.3 160.77 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.179 0.514 . . . . 73.41 111.867 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.53 148.56 19.34 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.074 -0.584 . . . . 63.14 113.323 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 11.0 p -64.39 138.42 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 120.857 0.361 . . . . 72.1 111.284 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 22.7 m120 63.56 18.68 11.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.959 0.504 . . . . 72.14 111.951 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -108.9 161.38 15.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.194 0.521 . . . . 71.21 111.623 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 502' ' ' SER . 37.8 tp -99.0 126.24 44.65 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.004 -0.544 . . . . 55.04 111.745 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.51 132.69 45.75 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.814 0.34 . . . . 54.21 111.582 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -104.98 138.58 40.97 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.42 0.629 . . . . 72.15 112.098 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' TYR . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 59.1 m-85 -122.84 151.34 41.79 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.554 -0.748 . . . . 71.55 110.302 177.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -120.02 127.2 52.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.094 0.474 . . . . 75.22 111.029 -175.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 21.6 t -105.07 114.78 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.101 -0.5 . . . . 75.21 111.124 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.591 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 46.8 m-70 -92.16 107.56 19.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.851 0.358 . . . . 74.43 110.299 174.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.621 HG11 HG21 ' A' ' 475' ' ' VAL . 20.2 m -105.55 133.21 50.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.927 0.394 . . . . 71.43 110.193 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.564 ' HD3' HD21 ' A' ' 465' ' ' LEU . 0.1 OUTLIER -148.2 152.3 36.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.585 0.587 . . . . 61.25 112.585 -172.724 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.553 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.8 t-20 -107.72 127.46 53.7 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.634 -0.712 . . . . 73.52 109.524 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.564 HD21 ' HD3' ' A' ' 463' ' ' LYS . 79.9 mt -111.86 0.05 16.02 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.172 0.434 . . . . 62.05 112.172 -176.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -82.91 -25.38 49.61 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.92 -0.657 . . . . 55.0 113.632 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.88 22.73 41.22 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.101 -0.571 . . . . 73.2 113.577 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 9.5 tt -138.18 144.18 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 122.51 -0.406 . . . . 63.14 110.763 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.48 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -71.82 138.72 27.51 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.154 -0.546 . . . . 62.14 114.059 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.522 HG11 HD11 ' A' ' 440' ' ' LEU . 40.7 t -129.71 117.36 18.44 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 112.34 0.496 . . . . 72.51 112.34 -177.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.2 -11.0 8.77 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.105 2.537 . . . . 73.24 112.759 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 57.7 m -80.98 11.44 4.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.457 0.703 . . . . 45.32 112.685 -176.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 39.3 m -88.97 91.1 8.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.661 0.743 . . . . 63.23 112.422 -166.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 474' ' ' LYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 517' ' ' VAL . 95.9 mttt -96.81 131.33 43.65 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.514 -0.766 . . . . 71.32 110.152 171.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.621 HG21 HG11 ' A' ' 462' ' ' VAL . 49.4 t -117.89 118.36 58.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 122.12 -0.363 . . . . 61.0 110.709 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -126.43 153.47 44.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.276 0.56 . . . . 63.23 112.076 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 84.8 t -120.41 135.79 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.006 -0.543 . . . . 75.14 111.141 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' TYR . . . . . 0.403 ' HE1' ' OG1' ' A' ' 516' ' ' THR . 25.1 m-85 -124.51 142.09 51.59 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.188 -0.46 . . . . 74.41 111.196 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 513' ' ' ILE . 64.5 mt -114.82 111.55 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.295 -0.412 . . . . 74.13 109.998 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 54.34 34.03 19.74 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.195 0.521 . . . . 72.21 111.278 -173.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 98.07 -25.69 26.58 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.177 -0.465 . . . . 72.34 113.765 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 28.0 m -82.04 129.75 34.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.327 0.563 . . . . 74.15 111.851 -174.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.3 tp -62.48 124.23 20.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.096 0.474 . . . . 71.42 111.689 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -105.58 -43.72 4.87 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.518 0.562 . . . . 74.02 112.518 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.419 ' HD3' ' HB3' ' A' ' 501' ' ' PHE . 83.6 tttt -155.45 152.55 29.12 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 110.324 -0.25 . . . . 74.31 110.324 -176.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -141.09 147.89 39.27 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.434 0.531 . . . . 75.04 112.434 -176.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.5 m-90 -132.69 148.81 52.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.949 -0.569 . . . . 74.54 110.94 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.9 m -124.88 117.12 23.39 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.557 -0.534 . . . . 70.24 109.557 167.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.42 172.87 11.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.139 0.495 . . . . 75.41 111.587 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 30.3 m -116.93 133.89 55.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.186 -0.461 . . . . 70.35 110.335 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 72.8 mt -120.53 120.48 35.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.941 0.401 . . . . 74.41 110.978 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.48 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -80.85 -168.83 40.14 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.176 -0.535 . . . . 51.5 113.141 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -63.08 109.95 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.463 2.109 . . . . 71.2 112.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.5 mttt 63.45 37.48 10.62 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.618 0.723 . . . . 75.45 111.239 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -85.98 149.35 25.24 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.208 -0.905 . . . . 71.1 111.419 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -136.09 145.42 45.91 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.839 0.352 . . . . 71.12 111.473 172.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -141.6 147.33 37.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.002 0.521 . . . . 73.22 111.018 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 42.3 t -111.15 112.99 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.209 0.528 . . . . 33.13 111.54 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.7 127.85 55.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.178 -0.465 . . . . 74.23 110.268 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 76.0 p -112.96 163.05 15.14 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.136 0.791 . . . . 73.22 113.136 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 501' ' ' PHE . . . . . 0.419 ' HB3' ' HD3' ' A' ' 485' ' ' LYS . 47.8 p90 -152.23 148.29 27.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.305 -0.861 . . . . 74.34 110.906 172.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.569 ' HB2' HD11 ' A' ' 455' ' ' LEU . 78.6 p -114.9 114.72 25.86 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.072 0.463 . . . . 64.04 111.08 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 503' ' ' TRP . . . . . 0.47 ' CZ2' ' HB3' ' A' ' 505' ' ' PRO . 25.1 t90 -107.73 137.33 45.94 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.069 0.547 . . . . 75.14 111.776 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 93.4 m -125.9 101.47 29.39 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 116.407 -0.36 . . . . 73.3 111.02 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 505' ' ' PRO . . . . . 0.47 ' HB3' ' CZ2' ' A' ' 503' ' ' TRP . 85.5 Cg_endo -82.22 102.18 1.18 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.528 2.152 . . . . 74.21 113.321 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 63.4 p -76.38 -21.77 55.63 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.856 0.36 . . . . 74.44 111.185 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -107.91 125.76 51.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.932 0.396 . . . . 65.43 111.373 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.06 150.86 46.15 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.4 0.519 . . . . 74.31 112.4 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.83 -173.12 33.23 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.083 -0.579 . . . . 74.1 113.061 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 8.8 tpt -99.71 126.94 45.83 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.577 -0.366 . . . . 74.55 110.727 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -132.86 112.0 11.54 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.337 0.495 . . . . 75.33 112.337 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -93.03 118.23 30.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.869 0.366 . . . . 74.23 110.776 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 479' ' ' ILE . 64.2 mt -95.47 127.93 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.093 0.473 . . . . 74.21 111.507 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -121.43 152.57 38.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.926 0.393 . . . . 73.4 111.194 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -128.9 135.35 48.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.769 0.318 . . . . 41.12 111.135 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 516' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 532' ' ' VAL . 38.5 p -123.73 149.44 45.55 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.326 -0.397 . . . . 71.24 111.431 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 474' ' ' LYS . 7.3 p -119.4 139.56 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 116.422 -0.354 . . . . 73.24 111.459 170.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.9 t70 43.8 70.41 0.32 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.609 0.764 . . . . 63.01 111.687 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -61.97 -33.06 73.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.792 -0.64 . . . . 71.24 111.437 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.34 -13.66 62.5 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.651 0.612 . . . . 72.33 112.651 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.1 t30 56.34 55.9 6.22 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.535 0.683 . . . . 71.21 110.428 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 68.5 p -85.25 -31.73 22.96 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.923 -0.58 . . . . 70.34 111.133 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.56 141.75 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.01 -0.541 . . . . 65.54 111.034 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.8 112.13 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.844 0.354 . . . . 74.34 111.557 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.483 ' OE2' ' HG2' ' A' ' 438' ' ' PRO . 13.5 mm-40 -91.22 163.7 14.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.258 0.551 . . . . 73.13 112.124 -176.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.6 mt -71.98 -39.14 69.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.279 0.561 . . . . 72.34 110.854 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -129.46 110.48 11.91 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.945 -0.57 . . . . 54.54 110.271 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 528' ' ' GLU . . . . . 0.553 ' HA ' ' ND2' ' A' ' 531' ' ' ASN . 10.0 pt-20 -83.09 -21.8 33.6 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.989 0.423 . . . . 62.43 111.4 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -75.39 -12.31 60.23 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.147 0.499 . . . . 72.33 110.821 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.476 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 41.7 t30 -86.72 -14.62 41.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.999 -0.546 . . . . 74.14 111.145 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 531' ' ' ASN . . . . . 0.553 ' ND2' ' HA ' ' A' ' 528' ' ' GLU . 8.5 m-80 -69.0 -13.97 62.77 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.08 0.77 . . . . 62.14 113.08 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.531 HG22 HG22 ' A' ' 516' ' ' THR . 57.7 t -116.57 134.0 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.528 0.566 . . . . 73.13 112.528 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 533' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -114.42 143.07 45.52 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.218 -0.446 . . . . 63.15 110.54 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 70.0 m -125.76 125.86 43.64 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.022 0.439 . . . . 60.02 111.888 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -137.65 122.98 19.44 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.042 0.449 . . . . 74.11 110.781 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -93.36 129.12 39.6 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.411 -0.359 . . . . 64.22 111.386 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.87 142.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.332 0.587 . . . . 63.43 111.93 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 22.8 t -118.38 127.2 53.45 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.343 -0.389 . . . . 75.41 111.189 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.0 t -104.85 123.62 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.825 0.345 . . . . 62.34 111.31 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 31.0 m -116.1 161.75 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.795 0.665 . . . . 62.43 112.795 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.02 -17.38 43.54 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.037 -0.529 . . . . 74.31 111.737 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.253 1.267 0 CA-C-N 116.031 -0.531 . . . . 73.2 112.176 178.499 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.735 0.302 . . . . 74.21 110.78 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 436' ' ' GLU . . . . . 0.496 ' HB2' HD12 ' A' ' 468' ' ' ILE . 5.9 mp0 -95.2 146.53 24.26 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.192 0.52 . . . . 75.13 112.023 -174.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -118.87 113.68 35.85 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.237 -0.438 . . . . 71.12 110.392 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.595 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 72.9 Cg_endo -74.27 169.53 22.27 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.344 2.029 . . . . 61.43 113.567 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 439' ' ' ASP . . . . . 0.458 ' HB2' HD12 ' A' ' 526' ' ' LEU . 37.3 t70 -128.74 96.05 4.27 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.727 -0.669 . . . . 74.03 109.833 176.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 491' ' ' LEU . 88.7 mt -94.36 112.81 24.61 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.873 0.368 . . . . 61.31 111.077 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.514 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 6.8 t -122.46 153.42 39.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.994 0.426 . . . . 73.41 111.92 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.617 HG12 HG12 ' A' ' 462' ' ' VAL . 32.2 m -129.79 150.16 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.131 -0.486 . . . . 62.53 111.814 -177.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 49.6 mt-10 -130.23 144.81 51.58 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.21 -0.45 . . . . 54.03 110.918 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 53.4 mt -116.27 129.66 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.931 0.395 . . . . 74.14 111.199 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -134.19 137.43 44.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.414 -0.357 . . . . 74.11 110.981 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.29 -176.87 40.86 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.265 -0.969 . . . . 61.34 114.074 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.62 117.18 5.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.831 2.354 . . . . 73.52 113.071 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -71.85 -30.37 65.37 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.783 0.66 . . . . 64.12 112.783 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 94.6 t -120.73 122.98 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.885 -0.51 . . . . 62.15 111.503 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.97 163.28 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.084 0.469 . . . . 71.45 112.059 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.75 156.91 24.13 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.346 -0.454 . . . . 50.05 113.296 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.419 HG22 ' OD1' ' A' ' 453' ' ' ASN . 10.7 p -69.95 140.41 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.015 0.436 . . . . 63.12 111.807 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 453' ' ' ASN . . . . . 0.419 ' OD1' HG22 ' A' ' 452' ' ' VAL . 26.8 m120 60.7 24.4 14.22 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.52 0.563 . . . . 62.33 112.52 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -105.94 176.13 5.27 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.125 0.488 . . . . 74.03 111.733 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 41.9 tp -105.09 120.2 40.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.338 -0.392 . . . . 62.25 111.431 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -129.25 132.78 47.27 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.739 0.304 . . . . 74.42 111.647 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -112.28 139.85 47.49 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.294 0.569 . . . . 61.55 111.548 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' TYR . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 53.7 m-85 -121.97 157.51 31.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.752 -0.658 . . . . 65.22 110.726 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -121.0 129.01 53.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.922 0.489 . . . . 75.24 111.079 -174.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 460' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 41.0 t -115.26 119.25 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.758 0.313 . . . . 74.32 111.353 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.601 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 49.3 m-70 -96.26 104.6 16.57 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.6 -0.273 . . . . 65.45 110.98 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.617 HG12 HG12 ' A' ' 442' ' ' VAL . 18.7 m -106.77 124.76 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.856 0.36 . . . . 72.13 110.988 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.46 ' HG3' HG23 ' A' ' 441' ' ' THR . 6.6 pttm -140.92 158.73 43.53 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.31 0.856 . . . . 65.24 113.31 -175.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.638 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.5 t-20 -107.94 128.7 54.86 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.677 -1.147 . . . . 63.34 109.468 175.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 86.4 mt -119.17 16.75 13.21 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.785 0.326 . . . . 75.21 111.86 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -100.81 -12.48 37.25 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.114 -0.565 . . . . 74.31 113.331 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.83 21.15 69.16 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.149 -0.548 . . . . 71.45 113.735 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.496 HD12 ' HB2' ' A' ' 436' ' ' GLU . 3.7 tt -134.67 132.99 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 122.602 -0.352 . . . . 73.42 111.048 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -66.43 134.61 33.37 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.367 -0.444 . . . . 72.33 113.679 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.94 116.06 16.82 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 122.562 0.345 . . . . 45.4 111.74 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.99 -11.21 12.42 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.117 2.544 . . . . 64.01 112.593 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' SER . . . . . 0.425 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 50.8 m -80.65 11.78 3.58 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.043 0.757 . . . . 71.31 113.043 -174.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.1 m -88.61 95.12 10.12 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.951 0.882 . . . . 61.11 111.937 -169.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -106.5 126.54 52.39 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.24 -0.891 . . . . 74.23 110.558 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.612 HG21 HG11 ' A' ' 462' ' ' VAL . 44.6 t -106.8 122.98 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 122.3 -0.25 . . . . 73.41 111.614 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 476' ' ' ARG . . . . . 0.62 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 46.9 mtt180 -115.75 146.9 41.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.746 0.308 . . . . 54.22 111.339 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 77.9 t -121.6 121.86 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.917 0.389 . . . . 72.23 111.308 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -112.1 141.12 46.17 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.305 -0.407 . . . . 71.14 111.826 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.55 HG12 HG12 ' A' ' 513' ' ' ILE . 53.8 mt -124.24 111.77 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.552 -0.295 . . . . 74.52 110.811 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 52.77 34.83 17.15 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.532 0.567 . . . . 71.21 112.532 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 90.41 3.05 72.55 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 120.858 -0.686 . . . . 54.0 113.887 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.7 m -110.73 121.61 45.76 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.423 -0.457 . . . . 71.34 111.432 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.6 tp -64.17 114.8 4.44 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.923 0.392 . . . . 72.42 110.643 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -84.33 -45.09 13.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.492 -0.322 . . . . 64.13 111.673 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -171.27 159.25 5.71 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.786 0.327 . . . . 72.03 111.449 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.87 153.81 42.72 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.324 0.49 . . . . 73.43 112.324 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -129.56 149.53 51.28 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.083 -0.508 . . . . 65.42 110.864 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 91.2 m -114.46 119.46 36.96 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.768 0.318 . . . . 54.42 110.766 174.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.77 173.59 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.366 0.603 . . . . 64.31 111.747 -177.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.0 p -123.43 138.09 54.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.055 -0.52 . . . . 75.5 110.456 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.512 HD12 HD22 ' A' ' 440' ' ' LEU . 90.7 mt -117.54 119.06 33.87 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.736 0.303 . . . . 44.44 111.141 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -77.25 -171.6 35.85 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.208 -0.52 . . . . 73.24 112.994 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.09 100.63 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.378 2.052 . . . . 54.22 112.329 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.6 mttt 66.64 40.39 3.36 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.494 -0.775 . . . . 72.05 112.068 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -99.69 151.4 21.26 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.941 -0.572 . . . . 60.23 111.136 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -132.47 137.39 47.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.899 0.381 . . . . 64.13 111.419 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -120.03 146.54 45.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.506 -0.316 . . . . 73.24 110.262 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 49.1 t -113.79 115.04 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.929 0.395 . . . . 64.25 111.311 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 69.4 mt -107.39 130.81 54.76 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.415 -0.357 . . . . 71.02 111.438 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 51.5 p -113.86 150.75 33.13 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.221 0.534 . . . . 71.24 112.001 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 501' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 49.5 p90 -144.36 148.56 34.87 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.127 -0.488 . . . . 72.32 111.395 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 78.5 p -110.48 115.28 29.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.26 0.553 . . . . 60.21 110.957 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -112.36 136.88 51.28 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.288 -0.415 . . . . 74.31 111.363 -176.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.0 m -118.18 103.9 49.01 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.345 -0.389 . . . . 74.22 111.047 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 505' ' ' PRO . . . . . 0.418 ' HB2' HG11 ' A' ' 539' ' ' VAL . 98.4 Cg_endo -80.13 99.37 1.17 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.708 2.272 . . . . 62.0 112.711 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.6 p -78.23 -12.83 60.03 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.589 0.589 . . . . 62.13 112.589 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -122.17 141.63 51.25 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.762 0.315 . . . . 64.14 110.884 174.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.87 151.86 31.56 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.179 0.514 . . . . 54.32 112.083 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 145.43 -173.51 25.8 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.043 -0.598 . . . . 61.32 113.175 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 510' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 511' ' ' TYR . 0.0 OUTLIER -90.63 133.8 34.86 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.014 0.435 . . . . 61.32 110.839 179.474 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 511' ' ' TYR . . . . . 0.462 ' N ' ' SD ' ' A' ' 510' ' ' MET . 96.0 m-85 -132.25 120.46 22.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.133 0.492 . . . . 73.24 111.791 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 512' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 479' ' ' ILE . 47.9 ttp85 -94.15 118.37 31.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.224 -0.444 . . . . 74.41 111.072 177.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.55 HG12 HG12 ' A' ' 479' ' ' ILE . 55.6 mt -103.9 126.03 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.985 0.421 . . . . 72.24 111.48 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -125.8 142.55 51.46 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.979 0.418 . . . . 61.22 111.681 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -119.09 133.56 55.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.261 -0.427 . . . . 64.5 110.758 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 516' ' ' THR . . . . . 0.535 HG22 HG22 ' A' ' 532' ' ' VAL . 33.9 p -130.82 140.71 50.29 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.323 -0.398 . . . . 73.15 111.689 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.02 140.67 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.933 0.397 . . . . 71.33 111.226 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 39.7 t0 42.53 66.61 0.72 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.62 -0.718 . . . . 62.21 111.685 -174.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 519' ' ' GLU . . . . . 0.62 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.8 mm-40 -57.5 -31.94 66.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.0 -0.546 . . . . 74.03 111.293 173.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.43 ' HB2' HG23 ' A' ' 522' ' ' THR . 6.7 mm-40 -68.5 -25.78 65.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.85 -0.614 . . . . 74.23 110.761 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 56.59 63.85 1.84 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.808 0.813 . . . . 73.1 110.663 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 522' ' ' THR . . . . . 0.43 HG23 ' HB2' ' A' ' 520' ' ' GLU . 67.0 p -94.86 -15.66 23.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.503 -0.771 . . . . 64.44 111.892 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.5 p -118.68 142.53 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.665 0.269 . . . . 53.33 111.056 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 524' ' ' VAL . . . . . 0.403 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 50.4 t -82.68 121.04 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.847 0.356 . . . . 72.42 111.2 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.96 159.31 15.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.068 -0.514 . . . . 62.02 112.285 -171.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 439' ' ' ASP . 94.4 mt -68.57 -33.5 74.18 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.961 0.41 . . . . 71.04 111.521 174.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -145.56 129.31 17.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.377 -0.374 . . . . 55.45 110.795 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -83.15 -24.93 32.33 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.177 0.513 . . . . 74.34 111.542 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -86.91 13.98 8.1 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.901 0.381 . . . . 71.32 111.453 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.514 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 62.7 t30 -106.82 -15.02 14.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.103 0.477 . . . . 74.14 111.001 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -73.19 -16.86 61.41 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.724 0.638 . . . . 70.21 112.724 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.535 HG22 HG22 ' A' ' 516' ' ' THR . 45.2 t -111.69 133.33 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.754 0.65 . . . . 72.34 112.754 -171.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -123.52 139.0 54.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.166 -0.47 . . . . 52.23 110.719 173.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 87.5 m -119.86 134.71 55.14 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.033 0.383 . . . . 54.12 112.033 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -139.8 136.54 34.17 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.868 0.366 . . . . 65.3 110.527 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.63 133.32 50.57 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.09 0.472 . . . . 75.31 112.17 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 64.0 t -124.74 141.21 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.286 -0.415 . . . . 71.42 111.65 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.9 t -118.19 117.54 29.43 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.472 -0.331 . . . . 25.42 110.679 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 505' ' ' PRO . 66.5 t -101.31 123.02 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.026 0.441 . . . . 61.43 111.801 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.42 167.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 116.023 -0.535 . . . . 75.25 112.248 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.03 10.33 16.83 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.914 0.387 . . . . 61.33 111.684 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.254 1.322 0 CA-C-N 116.304 -0.407 . . . . 71.54 112.086 -176.567 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 50.7 tpp . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 121.155 0.502 . . . . 70.24 109.982 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -89.08 141.65 28.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.175 -0.466 . . . . 71.51 111.857 -171.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -119.72 129.92 25.11 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.547 -0.297 . . . . 75.3 110.756 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.589 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 64.3 Cg_endo -72.41 173.65 12.82 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.493 2.129 . . . . 72.32 113.208 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -140.61 87.36 2.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.548 -0.538 . . . . 70.44 109.548 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.476 ' HB3' HG21 ' A' ' 517' ' ' VAL . 79.4 mt -90.58 137.9 31.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.092 -0.504 . . . . 75.44 111.364 -175.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.463 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.6 t -148.81 165.32 31.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.079 0.466 . . . . 64.22 112.014 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.604 HG12 HG12 ' A' ' 462' ' ' VAL . 27.5 m -133.72 149.19 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.83 -0.623 . . . . 74.13 111.569 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 6.5 mm-40 -130.99 129.76 42.51 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.229 -0.441 . . . . 72.11 111.519 176.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 50.1 mt -107.99 117.77 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.181 -0.463 . . . . 54.44 110.591 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -136.01 139.29 43.02 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.925 0.393 . . . . 75.22 111.73 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.66 -163.31 36.18 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.091 -0.504 . . . . 53.41 112.885 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.04 118.77 5.7 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.779 2.319 . . . . 64.14 113.027 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -86.74 -14.26 42.92 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.299 0.481 . . . . 64.51 112.299 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.0 t -128.87 117.85 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 122.146 -0.346 . . . . 61.41 110.704 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.94 164.21 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.241 0.543 . . . . 54.34 112.178 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -96.46 163.48 22.85 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 116.195 -0.457 . . . . 44.41 112.998 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.7 p -71.53 140.05 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 120.861 0.362 . . . . 75.44 111.214 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 65.87 17.33 10.8 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.656 0.613 . . . . 71.45 112.656 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -98.33 176.3 5.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.863 0.363 . . . . 72.13 111.457 176.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 502' ' ' SER . 40.4 tp -115.28 130.14 56.82 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.747 0.308 . . . . 54.33 111.33 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.07 134.22 47.23 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.881 0.326 . . . . 73.22 111.881 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.3 128.31 53.89 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.108 0.48 . . . . 72.31 111.934 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -122.01 154.88 36.66 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.961 -0.563 . . . . 75.31 110.274 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.544 ' HG2' HG22 ' A' ' 500' ' ' THR . 54.8 mt-10 -120.34 127.74 52.62 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.899 0.38 . . . . 74.32 111.631 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 24.2 t -96.8 112.56 29.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.008 -0.542 . . . . 64.2 109.651 169.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 35.2 m-70 -94.13 108.95 20.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.832 0.348 . . . . 72.12 110.39 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.812 HG11 HG21 ' A' ' 475' ' ' VAL . 14.4 m -106.1 126.88 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 63.34 110.079 -176.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.544 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.7 ptpt -144.03 148.92 35.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.791 0.663 . . . . 74.51 112.791 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -105.91 127.42 53.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.273 -0.876 . . . . 52.02 109.314 174.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.544 HD21 ' HD3' ' A' ' 463' ' ' LYS . 73.5 mt -118.05 8.7 12.52 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.825 0.306 . . . . 74.11 111.825 -177.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -87.87 -16.16 60.13 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.247 -0.501 . . . . 75.01 113.769 -177.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 83.0 17.17 67.99 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 120.911 -0.661 . . . . 51.15 113.468 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.4 tt -134.66 135.58 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 122.909 0.484 . . . . 71.24 111.035 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.496 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -70.95 132.62 21.91 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.474 -0.393 . . . . 70.5 113.701 -176.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 62.6 t -128.23 114.0 19.97 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 111.984 0.364 . . . . 64.23 111.984 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.87 -9.84 11.85 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.091 2.527 . . . . 73.1 112.739 174.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' SER . . . . . 0.466 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 39.0 m -80.87 10.6 4.81 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.688 0.996 . . . . 65.34 113.688 -171.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 473' ' ' THR . . . . . 0.421 HG23 HG23 ' A' ' 517' ' ' VAL . 94.3 m -88.14 100.59 13.07 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.86 0.838 . . . . 72.32 112.629 -166.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -114.4 117.54 31.31 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.291 -0.868 . . . . 73.41 110.746 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.812 HG21 HG11 ' A' ' 462' ' ' VAL . 45.3 t -104.17 132.72 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.063 0.394 . . . . 71.15 112.063 -173.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 476' ' ' ARG . . . . . 0.692 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 93.7 mtt180 -114.47 152.42 31.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.965 0.412 . . . . 64.44 111.832 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 82.5 t -122.43 126.27 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.056 -0.52 . . . . 75.44 111.008 173.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 513' ' ' ILE . 95.3 m-85 -115.47 138.83 50.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.851 0.357 . . . . 74.15 111.775 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 64.2 mt -115.0 107.93 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.954 -0.387 . . . . 54.14 109.954 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 55.94 34.76 24.23 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.088 0.47 . . . . 73.32 111.708 -173.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.13 -6.64 83.26 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 121.344 -0.455 . . . . 55.3 113.693 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.0 m -92.38 124.8 36.7 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 122.388 -0.478 . . . . 74.2 111.31 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.42 122.6 16.64 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.177 0.513 . . . . 54.33 111.579 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -101.97 -45.37 5.21 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.098 -0.501 . . . . 70.25 112.187 -178.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.474 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 33.6 ttpt -171.01 160.09 6.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.242 0.217 . . . . 71.54 110.869 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -149.31 154.16 38.58 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.832 0.349 . . . . 53.55 111.863 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 487' ' ' TRP . . . . . 0.474 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 19.3 m-90 -129.83 147.22 51.58 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.313 -0.403 . . . . 74.24 111.362 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 34.6 m -110.28 118.57 36.69 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 110.326 -0.25 . . . . 72.02 110.326 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.56 172.17 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.49 0.662 . . . . 70.3 111.858 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 77.6 p -120.0 133.42 55.55 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.887 -0.597 . . . . 53.52 110.955 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.9 mt -118.48 118.93 33.06 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.861 0.362 . . . . 72.13 111.31 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.496 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -82.21 -166.39 37.95 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.164 -0.541 . . . . 63.53 113.62 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.98 105.87 0.49 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.622 2.215 . . . . 63.41 112.518 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.5 mmtp 67.46 30.97 6.57 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.114 0.483 . . . . 72.1 111.573 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -94.33 149.45 21.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.325 -0.398 . . . . 45.03 111.97 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 32.7 tt0 -134.58 139.1 45.12 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.004 0.431 . . . . 74.42 111.554 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -125.67 140.65 52.53 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.325 -0.398 . . . . 75.54 110.273 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.32 117.37 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.894 0.378 . . . . 74.12 111.428 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.53 138.96 41.75 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.35 -0.386 . . . . 62.34 110.698 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.544 HG22 ' HG2' ' A' ' 459' ' ' GLU . 42.6 p -120.55 155.46 33.62 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.349 0.595 . . . . 65.45 112.125 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -152.29 148.28 27.35 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.688 -0.687 . . . . 75.35 110.831 170.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.533 ' HB2' HD11 ' A' ' 455' ' ' LEU . 20.4 p -117.19 114.96 24.41 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.156 0.503 . . . . 61.34 110.949 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -109.06 136.7 48.14 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.217 -0.447 . . . . 73.02 111.9 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 87.9 m -113.24 101.32 53.34 Favored Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.974 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 505' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 61.1 Cg_endo -72.38 88.48 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.472 2.115 . . . . 71.44 112.925 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.2 p -75.67 6.73 4.48 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.786 0.662 . . . . 54.44 112.786 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -143.5 135.75 26.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 110.483 -0.192 . . . . 63.01 110.483 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.76 151.32 37.61 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.092 0.472 . . . . 71.42 112.238 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.95 -169.08 28.09 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.16 -0.543 . . . . 62.31 113.064 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 12.5 tpt -99.46 124.53 44.7 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.733 0.301 . . . . 63.24 110.859 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -128.32 111.95 13.92 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.179 0.514 . . . . 75.42 111.688 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 512' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 32.8 ttm180 -94.66 120.82 35.48 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.119 -0.492 . . . . 75.12 111.141 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 478' ' ' TYR . 67.6 mt -95.41 126.05 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.087 0.47 . . . . 73.51 111.523 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -124.95 129.15 49.78 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.289 -0.414 . . . . 74.3 111.324 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.3 146.3 38.48 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.846 0.355 . . . . 55.21 111.326 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 516' ' ' THR . . . . . 0.525 HG22 HG22 ' A' ' 532' ' ' VAL . 76.4 p -130.19 140.92 50.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.18 -0.464 . . . . 75.02 111.011 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' ' 442' ' ' VAL . 7.4 p -100.51 138.42 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 110.207 -0.294 . . . . 63.34 110.207 174.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.5 t0 35.46 71.58 0.12 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.604 0.716 . . . . 64.31 110.961 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 519' ' ' GLU . . . . . 0.692 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.4 tm-20 -51.29 -45.52 62.16 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.098 -0.955 . . . . 55.23 111.71 -176.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -69.72 -17.29 63.45 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.411 -0.359 . . . . 62.31 111.49 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 51.51 79.36 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.798 0.809 . . . . 54.31 111.394 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 522' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 81.9 p -97.34 2.59 50.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.156 -0.929 . . . . 62.32 110.861 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.57 142.03 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.832 -0.622 . . . . 63.33 110.51 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.58 116.02 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.782 0.325 . . . . 72.23 111.847 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -92.59 170.33 9.82 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.349 0.595 . . . . 65.44 111.903 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.48 -29.25 67.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.853 -0.612 . . . . 75.13 111.978 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -141.38 128.33 20.64 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.773 0.32 . . . . 74.24 111.42 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.75 -24.17 31.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.131 0.491 . . . . 64.11 111.643 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -79.76 4.32 16.72 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.659 0.742 . . . . 62.21 110.767 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.463 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 56.0 t30 -92.16 -20.16 21.52 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.878 -0.601 . . . . 62.1 111.553 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 531' ' ' ASN . . . . . 0.459 ' HA ' HG12 ' A' ' 517' ' ' VAL . 12.9 m120 -72.8 -25.48 61.17 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.922 1.082 . . . . 72.44 113.922 -172.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 516' ' ' THR . 42.9 t -109.32 143.37 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.922 0.712 . . . . 75.42 112.922 -172.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -129.95 142.81 50.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.172 -0.467 . . . . 43.44 111.043 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 72.4 m -118.9 129.24 55.08 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.134 0.42 . . . . 74.13 112.134 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -143.17 117.67 9.73 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.648 0.261 . . . . 74.34 110.849 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 536' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 10.3 p-10 -93.42 137.78 32.38 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.246 0.461 . . . . 63.42 112.246 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 56.1 t -125.95 134.56 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.392 -0.367 . . . . 74.45 111.672 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 45.5 t -104.08 126.26 51.05 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.56 -0.291 . . . . 72.35 111.297 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.12 121.93 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.975 0.416 . . . . 65.05 111.465 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.9 m -111.83 161.74 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.367 0.506 . . . . 75.24 112.367 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 86.7 mt -82.66 16.92 1.97 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.264 0.468 . . . . 70.31 112.264 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 119.324 -0.37 . . . . 75.35 111.83 -179.705 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 47.3 ttm . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.033 0.444 . . . . 74.33 111.222 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -97.97 138.64 34.99 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.824 0.345 . . . . 63.41 111.136 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -113.04 131.65 22.72 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.376 -0.375 . . . . 75.51 110.935 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 64.7 Cg_endo -74.91 173.39 14.55 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.434 2.09 . . . . 65.2 113.474 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -157.2 94.08 1.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.369 -0.832 . . . . 61.23 109.447 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.555 HD22 HD12 ' A' ' 491' ' ' LEU . 53.4 mt -98.26 114.54 26.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.045 0.45 . . . . 53.23 111.382 -175.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.527 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.9 t -122.67 150.6 42.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.179 0.514 . . . . 72.2 112.116 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.552 HG12 HG12 ' A' ' 462' ' ' VAL . 28.8 m -121.31 148.88 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.064 -0.516 . . . . 74.44 111.286 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.9 mt-10 -136.83 143.18 42.97 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.655 -0.248 . . . . 71.42 110.911 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 57.7 mt -120.39 135.5 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 120.974 0.416 . . . . 64.12 111.599 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -137.23 147.05 45.53 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.29 -0.414 . . . . 54.54 110.652 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 160.51 -166.46 35.37 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.676 -0.774 . . . . 72.53 113.489 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.9 132.55 24.99 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.985 2.456 . . . . 74.54 113.491 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -78.66 -43.51 25.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.14 -0.482 . . . . 73.41 112.173 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.433 HG22 ' HB3' ' A' ' 538' ' ' SER . 44.1 t -123.7 129.78 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.767 0.318 . . . . 43.33 111.082 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.47 163.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.147 0.498 . . . . 62.33 111.74 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -95.25 162.89 23.9 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.279 -0.486 . . . . 62.31 113.196 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 12.9 p -67.65 136.18 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 121.228 0.537 . . . . 75.35 111.625 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 24.6 m120 65.2 14.75 9.61 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.858 -0.61 . . . . 73.33 112.479 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.503 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.2 mmmt -97.07 153.84 17.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.068 0.461 . . . . 74.11 111.645 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.572 HD11 ' HB2' ' A' ' 502' ' ' SER . 46.3 tp -90.19 138.79 31.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.019 0.438 . . . . 71.23 111.569 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -135.86 133.02 37.33 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.824 0.345 . . . . 73.32 111.656 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -109.45 134.58 51.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.849 0.357 . . . . 72.31 111.657 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -125.53 154.62 41.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.28 -0.418 . . . . 60.1 111.176 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -119.59 127.75 53.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.159 0.504 . . . . 75.31 110.719 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 39.8 t -105.54 115.34 47.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.997 -0.547 . . . . 73.13 110.949 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.595 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 27.1 m-70 -92.6 105.34 17.52 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.654 0.264 . . . . 71.04 110.643 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.552 HG12 HG12 ' A' ' 442' ' ' VAL . 33.8 m -106.24 122.74 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.075 0.464 . . . . 71.31 110.178 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -139.09 153.09 47.98 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.84 0.682 . . . . 74.04 112.84 -173.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 53.4 t-20 -106.1 128.64 54.02 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.256 -0.883 . . . . 71.2 110.025 176.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 90.7 mt -113.83 -2.42 13.65 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.023 0.379 . . . . 63.2 112.023 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -81.17 -16.44 74.38 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.247 -0.501 . . . . 54.14 113.884 -177.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.42 21.89 68.74 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.077 -0.582 . . . . 73.02 113.737 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 3.2 tt -137.68 133.3 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.577 0.351 . . . . 73.42 111.405 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 491' ' ' LEU . . . -71.36 134.54 22.9 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 114.214 0.445 . . . . 74.0 114.214 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 50.7 t -131.14 114.54 16.21 Favored Pre-proline 0 CA--C 1.547 0.833 0 O-C-N 122.585 -0.362 . . . . 62.21 111.663 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -83.93 -10.24 9.41 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.151 2.567 . . . . 75.44 113.004 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 20.3 t -81.95 11.83 4.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.548 0.739 . . . . 64.1 112.328 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.2 m -88.82 97.39 11.13 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.719 0.771 . . . . 54.33 112.27 -167.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -101.87 130.63 48.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.357 -0.838 . . . . 70.34 110.66 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.485 HG21 HG11 ' A' ' 462' ' ' VAL . 60.4 t -115.37 133.41 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 122.793 0.437 . . . . 75.54 111.058 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 476' ' ' ARG . . . . . 0.503 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 90.6 mtt180 -126.66 149.04 49.75 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.828 0.347 . . . . 74.12 111.557 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.28 120.54 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.466 -0.334 . . . . 73.21 111.182 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -112.46 139.02 48.38 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.987 0.422 . . . . 74.21 111.699 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.524 HG12 HG12 ' A' ' 513' ' ' ILE . 54.0 mt -114.13 107.58 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 109.855 -0.424 . . . . 73.23 109.855 172.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 480' ' ' ASN . . . . . 0.436 HD21 ' HA ' ' A' ' 511' ' ' TYR . 94.6 m-20 54.57 34.47 21.36 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.262 -0.426 . . . . 73.25 112.04 -175.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 103.29 -30.06 11.12 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.125 -0.56 . . . . 72.23 113.75 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.9 m -82.35 125.47 31.05 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.42 -0.459 . . . . 44.22 112.004 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.0 tp -65.57 115.73 6.08 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.01 0.433 . . . . 60.35 111.319 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -82.67 -44.14 16.07 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.355 -0.384 . . . . 72.31 111.38 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.427 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 32.6 ttpt -170.38 157.83 6.28 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.672 -0.24 . . . . 75.31 110.876 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 486' ' ' ASN . . . . . 0.407 ' HB2' ' HG2' ' A' ' 476' ' ' ARG . 6.6 p30 -137.38 156.69 47.91 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.095 0.474 . . . . 72.42 111.945 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 487' ' ' TRP . . . . . 0.427 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 18.2 m-90 -137.3 149.12 46.85 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.118 -0.492 . . . . 75.52 110.79 177.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 89.6 m -121.54 119.24 31.4 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 110.057 -0.349 . . . . 61.13 110.057 174.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.0 m -139.83 172.74 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.369 0.604 . . . . 75.25 112.115 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.7 p -115.1 133.88 55.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.925 -0.579 . . . . 54.52 110.474 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.555 HD12 HD22 ' A' ' 440' ' ' LEU . 73.5 mt -116.75 120.43 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.858 0.361 . . . . 63.23 111.098 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.47 -173.88 48.54 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.163 -0.541 . . . . 72.55 113.264 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.9 99.53 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.532 2.155 . . . . 74.12 112.484 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 98.0 mttt 67.57 50.45 0.91 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.918 -0.583 . . . . 51.23 111.796 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -110.39 148.36 32.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.516 -0.765 . . . . 60.52 111.27 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -130.04 136.87 49.87 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.058 0.456 . . . . 75.11 111.444 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -118.87 135.63 54.46 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.544 -0.539 . . . . 64.24 109.544 173.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 89.9 t -100.96 113.12 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.266 0.555 . . . . 73.14 111.116 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 63.6 mt -105.82 126.68 52.45 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.844 -0.616 . . . . 71.51 110.711 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 22.1 p -112.3 154.36 25.78 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.317 0.579 . . . . 62.44 111.909 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -145.64 148.9 33.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.608 -0.724 . . . . 72.43 110.701 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.572 ' HB2' HD11 ' A' ' 455' ' ' LEU . 24.0 p -110.24 113.75 26.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.308 0.575 . . . . 64.13 110.642 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -110.48 137.12 48.6 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.865 -0.607 . . . . 73.23 111.192 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 36.5 m -122.65 100.3 41.17 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 116.475 -0.329 . . . . 73.55 111.073 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 505' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.3 Cg_endo -76.52 106.8 2.32 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.318 2.012 . . . . 63.34 112.638 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 64.4 p -89.08 -5.88 57.5 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.817 0.342 . . . . 73.54 111.913 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -125.68 136.04 52.79 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.605 -0.27 . . . . 73.42 110.9 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -73.34 151.08 41.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.936 0.398 . . . . 74.25 111.93 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.8 178.33 24.65 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.223 -0.513 . . . . 54.24 112.913 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 14.4 tpt -92.74 114.58 27.17 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.877 0.37 . . . . 73.13 111.061 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 511' ' ' TYR . . . . . 0.436 ' HA ' HD21 ' A' ' 480' ' ' ASN . 75.3 m-85 -111.22 144.9 39.64 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.678 0.275 . . . . 74.25 111.447 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 512' ' ' ARG . . . . . 0.471 ' HG2' ' OD1' ' A' ' 514' ' ' ASN . 16.2 ttm180 -123.19 115.45 21.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.735 0.302 . . . . 75.22 111.075 176.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.524 HG12 HG12 ' A' ' 479' ' ' ILE . 59.9 mt -96.05 113.7 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.135 -0.484 . . . . 75.4 111.21 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.471 ' OD1' ' HG2' ' A' ' 512' ' ' ARG . 4.0 m-20 -118.91 145.79 45.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.405 -0.361 . . . . 73.13 111.469 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 515' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 532' ' ' VAL . . . -115.48 145.15 42.87 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.779 0.324 . . . . 71.03 111.274 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 516' ' ' THR . . . . . 0.555 HG22 HG22 ' A' ' 532' ' ' VAL . 58.9 p -132.82 148.76 52.31 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.183 -0.462 . . . . 65.34 111.643 -178.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.23 152.69 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 120.756 0.312 . . . . 65.24 111.243 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 35.8 t70 54.72 39.99 31.65 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.702 0.763 . . . . 75.13 111.369 -176.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 519' ' ' GLU . . . . . 0.503 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 8.5 mm-40 -52.6 -31.6 37.16 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.802 -0.636 . . . . 75.24 111.315 172.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.452 ' HB2' HG23 ' A' ' 522' ' ' THR . 4.2 mm-40 -67.67 -25.39 65.68 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.732 -0.667 . . . . 72.32 111.153 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 59.31 71.92 0.56 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.419 0.628 . . . . 74.1 110.614 -176.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 522' ' ' THR . . . . . 0.452 HG23 ' HB2' ' A' ' 520' ' ' GLU . 82.6 p -107.41 -32.89 7.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.581 -0.736 . . . . 75.11 112.355 -174.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.441 HG21 ' HG3' ' A' ' 438' ' ' PRO . 14.4 p -124.37 143.31 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.589 0.588 . . . . 64.21 112.589 -172.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.3 111.69 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.45 -0.341 . . . . 73.42 110.716 176.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -99.73 -179.49 4.2 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.427 0.528 . . . . 74.45 112.427 -175.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.58 -41.08 24.66 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.251 -0.431 . . . . 54.21 111.552 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -130.31 98.49 4.73 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.124 0.488 . . . . 53.44 111.006 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -84.3 10.19 11.14 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.274 0.559 . . . . 71.14 111.502 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -108.16 0.62 21.66 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.467 0.651 . . . . 73.42 110.131 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.527 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.4 t30 -95.54 -0.84 51.64 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.85 -0.614 . . . . 74.13 111.551 -174.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -81.95 -19.25 41.06 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.424 0.898 . . . . 74.42 113.424 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 516' ' ' THR . 39.9 t -112.42 141.19 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 112.365 0.506 . . . . 74.54 112.365 -174.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -132.49 135.52 46.07 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.597 -0.274 . . . . 64.21 111.439 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 30.6 m -106.53 134.91 48.95 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.472 0.545 . . . . 72.32 112.472 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -142.99 117.5 9.72 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.174 -0.467 . . . . 73.42 110.28 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.34 137.45 33.47 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.253 0.549 . . . . 70.33 112.155 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.21 130.64 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.95 -0.568 . . . . 63.41 111.518 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 538' ' ' SER . . . . . 0.433 ' HB3' HG22 ' A' ' 449' ' ' VAL . 41.3 t -96.97 117.97 32.34 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.527 -0.306 . . . . 70.33 111.351 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 505' ' ' PRO . 61.8 t -105.95 120.47 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.935 0.398 . . . . 73.31 111.077 178.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.58 166.54 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 112.498 0.555 . . . . 72.54 112.498 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.87 -12.3 55.72 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.177 0.436 . . . . 72.34 112.177 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.252 1.206 0 N-CA-C 112.513 0.56 . . . . 55.12 112.513 178.748 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 50.8 tpp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.192 0.52 . . . . 52.14 110.23 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -92.25 126.34 37.3 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.965 -0.561 . . . . 74.13 112.063 -171.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -112.62 124.27 32.21 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.034 -0.53 . . . . 71.34 110.146 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.612 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 56.9 Cg_endo -72.16 174.41 11.44 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.269 1.979 . . . . 73.24 112.92 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -154.06 80.29 1.13 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.365 0.602 . . . . 73.13 110.041 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.468 HD22 HD12 ' A' ' 491' ' ' LEU . 61.1 mt -80.05 116.54 20.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.953 -0.567 . . . . 65.33 111.596 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.419 ' HB ' HD22 ' A' ' 530' ' ' ASN . 8.1 t -126.38 153.53 44.82 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.859 0.361 . . . . 72.44 111.096 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.571 HG12 HG12 ' A' ' 462' ' ' VAL . 21.0 m -131.84 149.58 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.193 0.52 . . . . 71.31 112.358 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 49.4 mt-10 -128.47 144.03 51.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.883 -0.599 . . . . 72.11 110.843 175.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.402 HD13 HG22 ' A' ' 513' ' ' ILE . 65.8 mt -114.75 132.73 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.635 0.255 . . . . 65.31 110.766 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -132.81 145.87 51.35 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.579 0.228 . . . . 63.41 110.929 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.77 -173.66 36.51 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.672 -0.775 . . . . 74.21 113.752 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.62 126.43 12.09 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.991 2.461 . . . . 71.3 112.993 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -76.37 -21.47 56.04 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.153 -0.476 . . . . 63.23 112.218 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.6 t -131.0 128.82 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.754 0.312 . . . . 74.33 111.09 176.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.78 156.41 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 120.997 0.427 . . . . 75.51 111.682 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.34 154.57 24.37 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.319 -0.467 . . . . 64.0 113.25 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 11.7 p -65.62 141.46 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.889 0.376 . . . . 75.32 111.781 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 65.53 8.54 5.15 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.257 0.623 . . . . 55.02 112.272 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.555 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 31.3 mmmt -96.13 167.15 11.38 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.943 0.402 . . . . 51.44 111.473 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' A' ' 502' ' ' SER . 33.4 tp -103.81 134.06 47.75 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.68 0.276 . . . . 62.2 111.35 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -133.57 140.13 46.98 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.799 0.333 . . . . 75.32 111.774 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -100.53 138.15 37.98 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.907 0.384 . . . . 74.22 111.595 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -129.66 155.15 46.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.943 0.401 . . . . 70.3 111.084 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -119.73 127.55 52.94 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.096 -0.502 . . . . 55.31 111.379 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 29.9 t -104.54 113.01 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.271 -0.422 . . . . 71.4 110.046 171.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 41.9 m-70 -94.81 105.13 17.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.519 -0.31 . . . . 73.04 110.31 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.636 HG11 HG21 ' A' ' 475' ' ' VAL . 26.4 m -106.14 126.02 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.087 0.47 . . . . 72.31 110.346 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.454 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.8 ptpt -146.69 157.32 43.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.297 0.57 . . . . 71.04 112.315 -175.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -114.32 127.17 55.73 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.552 -0.749 . . . . 62.41 109.662 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.454 HD21 ' HD3' ' A' ' 463' ' ' LYS . 85.2 mt -113.28 0.91 14.99 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.843 0.354 . . . . 73.41 111.844 -177.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -76.99 -19.44 77.46 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.039 -0.6 . . . . 54.44 113.32 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.16 13.31 64.21 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.319 -0.467 . . . . 73.31 113.87 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.7 tt -137.35 133.26 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 122.575 0.35 . . . . 72.42 110.651 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.38 137.77 20.17 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.775 0.67 . . . . 71.21 114.775 -173.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 46.8 t -123.76 113.19 28.74 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 122.76 0.424 . . . . 53.42 111.184 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.78 -10.79 9.34 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.93 2.42 . . . . 43.52 112.807 175.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 29.0 t -83.28 11.21 6.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.229 0.612 . . . . 73.14 112.467 -176.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 97.6 m -90.17 113.55 25.34 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.093 0.775 . . . . 74.44 113.093 -166.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -103.89 131.24 51.3 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.964 -0.562 . . . . 73.22 111.617 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.636 HG21 HG11 ' A' ' 462' ' ' VAL . 53.7 t -110.36 130.58 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 122.885 0.474 . . . . 61.44 111.264 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 476' ' ' ARG . . . . . 0.693 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 68.2 mtt180 -125.97 152.54 45.55 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.133 0.492 . . . . 75.12 111.755 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 75.9 t -120.89 128.75 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.117 -0.492 . . . . 51.4 110.818 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -118.68 136.52 53.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.835 0.35 . . . . 55.01 111.569 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 66.2 mt -108.1 108.05 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.965 -0.383 . . . . 73.04 109.965 173.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 56.68 33.64 23.19 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.099 0.476 . . . . 72.14 111.413 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 99.71 -26.56 23.95 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.409 -0.424 . . . . 43.5 113.76 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 86.1 m -81.88 129.72 34.84 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 117.078 0.439 . . . . 71.25 111.727 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 54.8 tp -65.65 121.36 14.8 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.199 0.523 . . . . 75.33 111.831 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -92.75 -43.79 8.86 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.791 -0.641 . . . . 72.15 111.686 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -161.77 154.5 20.27 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.69 -0.232 . . . . 72.53 110.826 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.62 147.87 47.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.362 0.504 . . . . 61.23 112.362 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -133.23 146.79 51.77 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.04 -0.527 . . . . 74.41 110.844 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.2 m -115.0 118.74 34.27 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.9 -0.408 . . . . 74.34 109.9 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.37 172.5 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.576 0.703 . . . . 63.31 112.471 -172.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 87.2 p -116.06 134.01 55.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.649 -0.705 . . . . 71.3 110.594 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.468 HD12 HD22 ' A' ' 440' ' ' LEU . 92.6 mt -124.41 119.18 28.47 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.814 0.34 . . . . 72.01 111.066 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.07 -174.08 48.43 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.126 -0.488 . . . . 53.45 113.622 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.68 106.07 0.58 Allowed 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.619 2.213 . . . . 45.14 112.416 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.9 mttt 66.25 36.23 5.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.364 0.602 . . . . 75.4 111.653 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -95.85 142.77 27.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.757 -0.656 . . . . 64.33 111.165 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -128.15 133.56 48.96 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.915 0.388 . . . . 73.41 111.416 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -126.74 134.2 50.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.281 -0.418 . . . . 55.42 111.208 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 51.3 t -102.61 113.08 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.047 0.451 . . . . 52.34 111.414 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 57.5 mt -104.05 126.57 51.27 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.231 -0.441 . . . . 63.15 110.323 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 32.9 p -113.46 151.09 31.88 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.356 0.598 . . . . 75.41 112.361 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -146.58 148.99 32.69 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.635 -0.711 . . . . 71.44 110.875 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.487 ' HB2' HD11 ' A' ' 455' ' ' LEU . 86.1 p -110.19 115.55 29.92 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.324 0.583 . . . . 74.12 110.669 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -107.82 137.23 46.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.983 -0.553 . . . . 71.53 111.757 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 86.0 m -109.05 101.37 44.5 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.298 -0.41 . . . . 74.13 111.307 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 505' ' ' PRO . . . . . 0.555 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.9 Cg_endo -75.56 92.19 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.324 2.016 . . . . 62.01 112.722 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 40.0 p -82.38 12.32 4.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.275 0.472 . . . . 52.14 112.275 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -143.56 130.99 21.0 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.406 -0.361 . . . . 72.13 110.644 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.1 150.87 33.63 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.498 0.555 . . . . 71.34 112.498 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 143.13 -170.2 25.46 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.817 -0.706 . . . . 72.02 113.94 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.85 117.13 28.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.776 0.43 . . . . 72.51 111.033 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -119.02 143.28 47.16 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.059 0.457 . . . . 73.42 111.347 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 512' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 57.5 ttp180 -123.52 120.16 32.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.562 -0.29 . . . . 71.52 110.748 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.402 HG22 HD13 ' A' ' 444' ' ' ILE . 62.6 mt -95.07 120.45 44.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 73.2 110.755 178.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 18.2 m120 -118.92 132.98 56.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.311 -0.404 . . . . 63.41 111.093 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.8 137.39 49.8 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.8 0.333 . . . . 73.03 110.774 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 516' ' ' THR . . . . . 0.569 HG22 HG22 ' A' ' 532' ' ' VAL . 39.7 p -122.81 140.37 52.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.017 -0.538 . . . . 73.51 110.936 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 440' ' ' LEU . 14.9 p -115.53 141.69 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.538 -0.301 . . . . 72.35 111.353 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.1 t70 48.1 58.58 4.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.946 0.879 . . . . 72.14 110.199 -170.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 519' ' ' GLU . . . . . 0.693 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 2.6 mm-40 -55.33 -32.89 62.86 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.925 -1.034 . . . . 73.23 113.172 -176.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -77.22 -12.55 59.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.541 0.21 . . . . 60.14 111.493 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 54.63 69.75 0.69 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.687 0.756 . . . . 64.11 110.847 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 80.4 p -100.3 -7.0 25.05 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.234 -0.894 . . . . 72.13 112.01 -174.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.3 p -140.12 142.01 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.954 0.407 . . . . 72.45 111.926 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 80.3 t -83.89 118.87 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.477 -0.329 . . . . 64.14 110.523 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.612 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 19.7 mt-10 -110.71 174.62 5.78 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.044 0.757 . . . . 73.33 113.044 -173.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.32 -39.36 93.74 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.771 -0.65 . . . . 64.33 112.304 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -145.15 108.62 4.64 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.895 0.379 . . . . 62.25 111.325 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 528' ' ' GLU . . . . . 0.468 ' HA ' ' OD1' ' A' ' 531' ' ' ASN . 12.6 pt-20 -83.68 21.84 1.19 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.979 0.419 . . . . 73.24 111.796 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -107.49 -19.19 13.64 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.453 0.538 . . . . 71.34 112.453 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.419 HD22 ' HB ' ' A' ' 441' ' ' THR . 1.9 p-10 -99.71 12.73 35.86 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.571 0.582 . . . . 54.44 112.571 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 531' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 528' ' ' GLU . 15.0 m120 -77.79 -5.02 49.38 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.325 0.491 . . . . 62.44 112.325 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.569 HG22 HG22 ' A' ' 516' ' ' THR . 41.2 t -127.94 133.25 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 120.901 0.382 . . . . 72.12 111.639 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 533' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -114.33 141.81 47.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.546 -0.297 . . . . 65.31 111.057 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 52.4 m -122.67 122.33 38.54 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.205 0.446 . . . . 54.55 112.205 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -137.74 117.16 12.82 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.286 -0.415 . . . . 74.23 110.041 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 536' ' ' ASP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 1.1 p30 -97.88 136.32 38.35 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.511 0.672 . . . . 75.32 112.302 -177.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.59 142.1 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.317 -0.856 . . . . 64.24 111.515 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.5 t -104.05 123.31 46.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.161 -0.472 . . . . 72.34 110.977 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 50.6 t -103.15 120.72 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.767 0.317 . . . . 72.51 111.373 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.7 m -114.36 159.55 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.269 0.557 . . . . 72.52 112.194 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 90.2 mt -82.36 0.21 42.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.123 -0.489 . . . . 71.34 112.192 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 C--O 1.251 1.147 0 N-CA-C 112.471 0.545 . . . . 73.44 112.471 -174.472 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.598 0.237 . . . . 71.52 110.96 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -86.6 124.68 33.16 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.808 0.337 . . . . 55.04 110.928 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 438' ' ' PRO . 97.6 m-85 -114.11 144.34 31.43 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.398 -0.364 . . . . 71.31 110.891 177.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.567 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 2.8 Cg_exo -74.99 174.41 12.83 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.014 2.476 . . . . 60.23 113.69 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -154.85 81.64 1.09 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.296 -0.866 . . . . 75.15 109.003 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.513 HD11 HG11 ' A' ' 470' ' ' VAL . 69.5 mt -86.72 127.94 34.99 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.857 -0.611 . . . . 73.22 111.811 -173.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.603 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.5 t -130.48 156.28 45.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.046 0.45 . . . . 73.43 111.762 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.636 HG12 HG12 ' A' ' 462' ' ' VAL . 31.6 m -132.8 147.78 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.972 -0.558 . . . . 74.43 111.586 -177.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 54.9 mt-10 -133.04 139.64 47.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.453 -0.34 . . . . 74.52 111.151 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 58.4 mt -109.21 129.22 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.972 0.415 . . . . 74.0 111.472 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -131.28 131.0 43.54 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.508 -0.315 . . . . 64.45 111.335 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 167.11 -168.49 40.42 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.486 -0.864 . . . . 74.34 113.871 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.52 122.8 7.67 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.802 2.335 . . . . 54.32 113.179 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -70.72 -33.19 70.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.234 -0.439 . . . . 75.22 111.501 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.3 t -120.83 132.01 71.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.775 0.321 . . . . 52.4 111.267 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.2 m -132.56 163.29 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.112 0.482 . . . . 55.34 111.712 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -94.71 149.49 19.38 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.234 -0.508 . . . . 71.54 112.849 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 11.2 p -63.28 137.46 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-O 120.906 0.384 . . . . 42.34 111.829 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 21.3 m120 62.07 25.23 15.11 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.996 0.519 . . . . 64.41 112.392 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -111.73 162.46 15.2 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.964 0.411 . . . . 72.15 111.577 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 502' ' ' SER . 50.6 tp -90.5 128.04 36.42 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.843 0.354 . . . . 73.31 111.583 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.33 143.05 49.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.793 0.33 . . . . 72.33 111.38 177.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -122.74 144.51 49.11 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.945 0.402 . . . . 44.14 111.491 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -132.05 157.55 43.86 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.007 0.432 . . . . 55.31 111.296 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -120.52 127.74 52.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.858 -0.61 . . . . 75.12 110.738 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.95 116.13 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.37 -0.377 . . . . 64.21 111.319 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 30.2 m-70 -93.22 113.98 26.33 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.399 -0.364 . . . . 63.23 110.652 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.638 HG11 HG21 ' A' ' 475' ' ' VAL . 17.8 m -116.08 122.42 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.781 0.324 . . . . 52.12 110.751 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 496' ' ' GLU . 0.7 OUTLIER -139.93 154.47 47.23 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.064 0.765 . . . . 74.01 113.064 -176.768 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.542 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.4 t-20 -103.03 128.6 49.82 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.119 -0.946 . . . . 70.23 110.386 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.421 HD21 ' HD3' ' A' ' 463' ' ' LYS . 88.6 mt -115.32 4.87 14.52 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.078 0.399 . . . . 73.0 112.078 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -85.75 -23.86 44.52 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.248 -0.501 . . . . 71.21 113.43 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.44 17.8 58.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.959 -0.639 . . . . 75.31 113.68 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 12.2 tt -137.37 141.73 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 122.57 0.348 . . . . 72.5 110.617 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.475 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -65.68 136.31 36.1 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.139 -0.553 . . . . 64.0 113.612 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.513 HG11 HD11 ' A' ' 440' ' ' LEU . 38.5 t -129.88 112.97 17.48 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 112.515 0.561 . . . . 62.43 112.515 -176.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.77 -11.41 12.64 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.236 2.624 . . . . 63.43 112.22 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 70.1 m -80.18 11.61 3.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.5 0.72 . . . . 73.34 112.161 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 33.5 m -88.28 90.83 8.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.849 0.833 . . . . 71.13 111.073 -169.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -106.02 123.16 47.56 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.194 -0.912 . . . . 61.11 110.272 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.638 HG21 HG11 ' A' ' 462' ' ' VAL . 39.2 t -103.71 121.02 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.826 0.346 . . . . 70.34 110.904 -177.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 476' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 476' ' ' ARG . 33.3 ttm180 -129.13 144.96 51.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.694 0.283 . . . . 75.31 111.656 -174.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 66.3 t -120.5 130.27 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.071 0.463 . . . . 71.2 111.722 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -119.52 137.04 54.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.96 -0.564 . . . . 74.4 111.177 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 513' ' ' ILE . 59.2 mt -111.94 107.76 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.712 0.292 . . . . 61.22 110.32 174.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 57.29 34.87 25.38 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.929 0.395 . . . . 52.14 111.31 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.95 -2.18 85.47 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.336 -0.459 . . . . 25.22 113.398 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 63.1 m -90.25 123.42 34.03 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.606 -0.349 . . . . 54.33 111.389 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' LEU . . . . . 0.403 HD13 ' HD3' ' A' ' 476' ' ' ARG . 44.4 tp -63.88 115.06 4.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.98 0.419 . . . . 74.14 111.0 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -105.05 -44.05 4.89 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.102 0.779 . . . . 72.0 113.102 -175.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -165.88 161.02 17.45 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 122.168 -0.332 . . . . 70.12 111.17 -172.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' ASN . . . . . 0.561 HD22 ' N ' ' A' ' 486' ' ' ASN . 0.0 OUTLIER -161.1 154.32 21.46 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.826 0.676 . . . . 74.02 112.826 177.621 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -136.0 149.79 48.97 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.687 0.795 . . . . 72.4 110.44 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.2 m -115.08 119.41 36.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.9 0.381 . . . . 74.45 111.21 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.9 m -137.57 173.56 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.158 0.504 . . . . 73.22 111.695 -176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 95.3 p -125.57 135.11 51.88 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.871 0.367 . . . . 75.25 110.882 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.473 HD12 HD22 ' A' ' 440' ' ' LEU . 94.9 mt -117.63 120.1 37.01 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.455 -0.339 . . . . 75.31 111.24 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.475 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -77.78 -170.09 34.62 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.223 -0.513 . . . . 24.44 113.279 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.56 97.03 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.341 2.027 . . . . 74.45 112.445 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.6 mttt 66.29 59.61 0.65 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.853 0.835 . . . . 74.55 111.791 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -120.85 152.94 37.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.046 -0.979 . . . . 74.31 110.651 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 496' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 39.5 tt0 -134.63 137.25 43.5 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.936 0.398 . . . . 64.22 111.931 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.444 ' HG2' ' CD2' ' A' ' 491' ' ' LEU . 28.5 mmmt -116.94 150.3 38.74 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.203 -0.453 . . . . 75.45 110.241 174.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.4 113.56 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.925 0.393 . . . . 72.14 111.555 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 77.9 mt -110.51 136.07 50.21 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.24 -0.436 . . . . 74.51 111.314 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 41.0 p -117.91 150.62 38.91 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.094 0.473 . . . . 62.42 111.943 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -145.63 151.61 38.35 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.248 -0.433 . . . . 74.42 111.02 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.56 ' HB2' HD11 ' A' ' 455' ' ' LEU . 72.9 p -111.67 141.47 45.22 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.28 -0.418 . . . . 53.43 111.297 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.5 t90 -139.34 137.49 35.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.281 -0.418 . . . . 74.35 111.094 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.1 m -118.2 100.43 51.75 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-O 120.758 0.313 . . . . 74.14 111.277 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.99 102.99 1.63 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.519 2.146 . . . . 71.0 112.841 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 81.1 p -81.58 -1.21 45.57 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.167 0.432 . . . . 74.55 112.167 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -137.24 145.74 43.94 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.711 0.291 . . . . 74.3 111.316 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.484 ' HA ' ' HB ' ' A' ' 539' ' ' VAL . 0.3 OUTLIER -83.19 152.03 25.41 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.516 0.561 . . . . 52.32 112.516 -177.519 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.63 -176.32 30.07 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.038 -0.601 . . . . 53.22 113.694 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 1.2 tpt -92.56 106.28 18.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.536 0.335 . . . . 72.43 110.669 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -107.66 121.9 45.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.179 0.514 . . . . 72.32 111.795 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 512' ' ' ARG . . . . . 0.505 ' HD2' HG23 ' A' ' 534' ' ' THR . 19.6 tpp85 -94.21 112.74 24.56 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.188 -0.46 . . . . 74.14 111.52 177.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 479' ' ' ILE . 40.6 mt -98.75 127.24 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.068 0.461 . . . . 74.3 110.858 175.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -124.09 138.15 54.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.335 -0.393 . . . . 72.3 111.553 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.94 132.48 54.73 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.832 -0.433 . . . . 75.15 109.832 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 38.9 p -132.93 141.1 48.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.352 -0.385 . . . . 75.51 111.497 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.419 HG13 HD22 ' A' ' 531' ' ' ASN . 7.7 p -110.55 140.05 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.762 0.315 . . . . 72.24 110.949 175.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.2 t0 43.98 67.9 0.6 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.517 0.675 . . . . 62.11 111.594 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -55.8 -31.67 62.85 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.821 -0.627 . . . . 72.05 112.246 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.452 ' HB2' HG23 ' A' ' 522' ' ' THR . 8.4 mm-40 -78.17 -19.29 54.25 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.276 -0.42 . . . . 72.24 111.518 -178.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 62.16 46.62 6.14 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.742 0.782 . . . . 73.15 110.011 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 522' ' ' THR . . . . . 0.452 HG23 ' HB2' ' A' ' 520' ' ' GLU . 52.1 p -67.59 -37.76 83.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.486 -0.779 . . . . 73.35 111.588 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.468 HG21 ' HG2' ' A' ' 438' ' ' PRO . 10.7 p -102.33 143.91 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 116.096 -0.502 . . . . 74.45 110.993 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 524' ' ' VAL . . . . . 0.459 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 59.1 t -81.87 115.62 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.992 0.425 . . . . 74.13 111.119 -177.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -91.75 155.96 17.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.888 -0.596 . . . . 73.22 112.32 -173.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.19 -39.53 78.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.145 0.498 . . . . 73.53 110.472 173.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -133.92 113.35 12.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.832 -0.622 . . . . 73.3 110.495 174.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -83.17 -3.43 57.36 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.318 0.58 . . . . 74.12 111.379 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -92.54 -1.64 56.79 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.982 0.42 . . . . 75.43 111.306 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.603 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 65.5 t30 -95.82 -6.65 39.0 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 116.345 -0.388 . . . . 70.34 112.0 -174.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 531' ' ' ASN . . . . . 0.419 HD22 HG13 ' A' ' 517' ' ' VAL . 11.5 m120 -83.66 3.92 30.83 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.54 0.941 . . . . 71.21 113.54 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 52.4 t -126.86 142.21 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 112.798 0.666 . . . . 70.12 112.798 -173.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 533' ' ' ALA . . . . . 0.472 ' HB2' HG23 ' A' ' 442' ' ' VAL . . . -128.58 143.96 51.06 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.119 -0.491 . . . . 71.41 111.232 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 534' ' ' THR . . . . . 0.505 HG23 ' HD2' ' A' ' 512' ' ' ARG . 59.6 m -120.66 134.12 55.31 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 111.94 0.348 . . . . 72.01 111.94 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -142.5 136.88 29.8 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 120.713 0.292 . . . . 74.31 111.067 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -104.87 125.01 50.45 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.662 0.268 . . . . 55.33 111.692 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.6 t -114.3 128.77 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.8 0.333 . . . . 62.35 111.28 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 30.1 t -112.88 121.59 45.12 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.655 0.264 . . . . 65.23 111.02 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.484 ' HB ' ' HA ' ' A' ' 508' ' ' GLU . 41.9 t -98.93 131.43 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.691 0.281 . . . . 54.43 111.353 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.435 ' HB ' ' HG2' ' A' ' 542' ' ' GLU . 28.8 m -113.16 156.32 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.226 0.454 . . . . 74.21 112.226 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 94.9 mt -95.57 -13.36 24.48 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.323 -0.399 . . . . 74.3 111.652 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 542' ' ' GLU . . . . . 0.435 ' HG2' ' HB ' ' A' ' 540' ' ' VAL . 8.3 pt-20 . . . . . 0 C--O 1.249 1.055 0 N-CA-C 112.449 0.537 . . . . 61.21 112.449 -176.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 110.226 -0.287 . . . . 72.31 110.226 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.625 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 59.2 Cg_endo -75.41 175.18 11.6 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.577 2.184 . . . . 65.22 113.399 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -153.58 81.59 1.17 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.847 -0.615 . . . . 75.52 110.194 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.514 HD22 HD12 ' A' ' 491' ' ' LEU . 96.6 mt -81.34 145.09 31.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.22 0.534 . . . . 63.22 111.833 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.556 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 12.0 t -148.55 156.37 42.34 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.103 0.478 . . . . 64.4 111.672 176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.537 HG12 HG12 ' A' ' 462' ' ' VAL . 27.9 m -125.76 147.95 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.941 -0.572 . . . . 71.54 110.871 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 40.2 mt-10 -134.57 117.98 16.75 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.854 0.359 . . . . 63.32 111.623 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 59.5 mt -94.21 131.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.406 -0.361 . . . . 72.52 110.727 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -142.44 138.85 31.34 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.632 0.253 . . . . 75.02 111.486 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.62 -162.39 32.44 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.017 -0.611 . . . . 73.33 113.51 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.46 124.52 10.42 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.886 2.391 . . . . 55.54 113.189 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -85.72 -15.81 41.01 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.123 0.416 . . . . 62.15 112.123 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.483 HG22 ' HB3' ' A' ' 538' ' ' SER . 87.2 t -133.01 126.61 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 120.711 0.291 . . . . 72.52 110.574 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.61 163.4 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.02 0.438 . . . . 71.22 111.648 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.17 157.52 26.03 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.165 -0.541 . . . . 63.53 113.012 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.542 HG22 ' ND2' ' A' ' 453' ' ' ASN . 8.1 p -72.34 140.49 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.006 0.432 . . . . 65.24 111.393 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . 0.542 ' ND2' HG22 ' A' ' 452' ' ' VAL . 41.9 m-80 60.23 23.81 13.19 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.658 0.383 . . . . 73.41 111.936 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . 0.569 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -112.3 155.62 23.78 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.545 -0.298 . . . . 74.35 111.075 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 502' ' ' SER . 33.5 tp -90.55 139.81 30.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.878 0.37 . . . . 72.45 111.568 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -131.89 143.59 50.26 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.847 0.356 . . . . 60.34 111.608 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -111.32 126.09 54.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.103 0.478 . . . . 62.22 111.643 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -121.96 150.27 42.27 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.152 -0.476 . . . . 73.22 110.729 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.553 ' HG2' HG22 ' A' ' 500' ' ' THR . 37.8 mt-10 -121.8 128.08 51.29 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.129 -0.487 . . . . 73.55 111.384 -176.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 42.6 t -107.65 114.74 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.183 -0.462 . . . . 62.22 111.229 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 42.0 m-70 -90.49 111.55 22.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.722 0.296 . . . . 74.22 110.377 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.681 HG11 HG21 ' A' ' 475' ' ' VAL . 31.6 m -107.82 122.81 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.005 0.431 . . . . 71.22 110.36 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -141.69 152.86 44.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.586 0.707 . . . . 73.21 112.765 -173.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 49.1 t-20 -100.8 138.68 37.53 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.159 -0.928 . . . . 71.23 109.758 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 94.4 mt -120.94 -5.58 9.58 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.409 0.522 . . . . 73.3 112.409 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -77.83 -25.19 62.96 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.211 -0.518 . . . . 34.22 114.047 -176.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.62 15.98 59.15 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.243 -0.503 . . . . 74.12 113.776 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.2 tt -134.66 142.69 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.113 0.565 . . . . 71.43 110.736 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.82 140.78 35.22 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.322 0.489 . . . . 64.44 114.322 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.508 HG11 HD11 ' A' ' 440' ' ' LEU . 47.0 t -131.85 114.3 15.28 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 122.454 0.301 . . . . 55.35 111.671 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -88.84 -10.57 4.19 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 123.196 2.597 . . . . 70.01 113.281 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 84.9 p -85.0 13.27 6.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.636 0.775 . . . . 72.11 112.876 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 63.3 m -87.4 93.35 9.38 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.909 0.861 . . . . 70.32 112.32 -165.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -97.44 127.28 43.27 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.144 -0.934 . . . . 52.0 110.441 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.681 HG21 HG11 ' A' ' 462' ' ' VAL . 47.7 t -114.06 125.1 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.673 0.273 . . . . 71.22 111.079 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . 0.491 ' HD2' ' OE1' ' A' ' 519' ' ' GLU . 62.8 mtt85 -125.52 149.79 47.99 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.99 0.424 . . . . 55.43 111.812 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.87 127.09 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.125 0.488 . . . . 73.3 111.436 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -120.37 136.8 54.59 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.932 -0.577 . . . . 70.54 111.384 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.414 HG12 HG12 ' A' ' 513' ' ' ILE . 60.1 mt -109.0 107.87 23.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.22 -0.446 . . . . 74.22 109.982 175.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 57.43 34.9 25.3 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.123 0.487 . . . . 74.22 111.214 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.57 -5.86 84.22 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 116.122 -0.49 . . . . 74.01 113.848 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 42.3 m -93.34 125.63 38.04 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.051 0.426 . . . . 53.24 111.33 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.1 tp -65.72 117.56 8.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.115 0.413 . . . . 62.33 112.115 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -88.74 -45.21 9.97 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.535 -0.302 . . . . 74.22 111.449 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -169.99 161.98 8.98 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.671 0.272 . . . . 54.03 111.4 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -131.93 152.04 51.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.038 0.447 . . . . 64.24 111.595 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -134.54 147.27 50.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.029 -0.532 . . . . 74.11 110.864 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.0 m -121.36 119.21 31.48 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.116 -0.328 . . . . 44.42 110.116 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.5 172.81 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.154 0.502 . . . . 75.3 111.476 -176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 91.5 p -126.0 132.44 52.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.252 -0.431 . . . . 55.45 110.649 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.514 HD12 HD22 ' A' ' 440' ' ' LEU . 95.9 mt -118.23 119.74 35.59 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.842 0.353 . . . . 73.34 111.373 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -78.45 -165.49 27.77 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.056 -0.593 . . . . 70.43 112.975 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.24 95.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.084 1.856 . . . . 63.45 112.413 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.0 mttt 65.78 44.05 2.97 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.646 -0.706 . . . . 60.41 112.61 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -98.43 152.57 19.36 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.089 -0.505 . . . . 73.53 111.347 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -130.72 138.8 50.16 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.934 0.397 . . . . 72.33 111.694 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -119.55 138.76 52.98 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.948 -0.39 . . . . 61.2 109.948 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.01 113.24 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.021 0.439 . . . . 51.24 111.801 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 82.3 mt -103.88 146.46 28.62 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.288 -0.414 . . . . 71.33 111.267 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.553 HG22 ' HG2' ' A' ' 459' ' ' GLU . 43.4 p -127.06 156.76 41.16 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.189 0.518 . . . . 64.01 111.803 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -155.56 148.23 24.12 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.97 -0.559 . . . . 75.03 111.031 171.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.558 ' HB3' HD11 ' A' ' 455' ' ' LEU . 43.3 m -110.98 115.23 29.13 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.297 -0.411 . . . . 72.54 110.849 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -108.54 135.03 50.48 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.818 0.342 . . . . 73.5 111.763 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.3 m -116.14 100.68 53.7 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 116.39 -0.368 . . . . 71.13 111.262 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 74.5 Cg_endo -76.17 97.36 1.11 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.388 2.059 . . . . 72.53 112.881 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 67.0 p -76.71 -22.61 53.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.104 0.409 . . . . 70.12 112.104 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -107.33 138.58 43.26 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.843 0.354 . . . . 73.31 110.803 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' A' ' 508' ' ' GLU . 0.2 OUTLIER -85.74 140.41 30.52 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.285 0.565 . . . . 65.04 112.189 -174.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 148.49 -179.13 25.58 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.89 -0.595 . . . . 70.51 112.153 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 67.6 mtp -94.02 126.35 39.19 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.8 -0.824 . . . . 51.3 111.664 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.93 131.61 53.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.122 -0.49 . . . . 71.22 111.126 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -97.24 122.01 39.78 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.914 0.388 . . . . 73.41 111.263 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.414 HG12 HG12 ' A' ' 479' ' ' ILE . 63.1 mt -100.58 119.59 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.03 0.443 . . . . 63.43 110.951 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -115.82 151.87 34.41 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.04 0.448 . . . . 74.32 111.712 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -128.12 132.8 48.94 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.063 -0.517 . . . . 43.45 110.547 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 44.0 p -128.89 143.14 50.81 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.317 -0.401 . . . . 75.04 111.292 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.415 HG13 HD22 ' A' ' 531' ' ' ASN . 7.4 p -119.9 141.13 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.019 0.437 . . . . 61.1 111.697 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 21.8 t70 50.23 49.75 19.94 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.632 0.773 . . . . 72.2 112.632 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . 0.491 ' OE1' ' HD2' ' A' ' 476' ' ' ARG . 54.6 mt-10 -53.0 -29.45 29.29 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.247 0.546 . . . . 73.11 111.171 172.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.47 ' HB2' HG23 ' A' ' 522' ' ' THR . 0.0 OUTLIER -65.24 -17.3 64.38 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.655 -0.702 . . . . 64.13 110.933 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.91 56.57 5.27 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.243 0.544 . . . . 64.15 110.394 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . 0.47 HG23 ' HB2' ' A' ' 520' ' ' GLU . 64.5 p -83.9 -36.66 23.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.207 -0.451 . . . . 71.53 111.413 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.22 141.68 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.459 0.54 . . . . 74.4 112.459 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 57.8 t -85.09 119.43 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.197 -0.456 . . . . 70.32 110.461 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.625 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 25.5 mt-10 -115.14 174.8 5.8 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.992 0.738 . . . . 74.32 112.992 -174.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.06 -39.65 55.0 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.511 -0.768 . . . . 73.54 112.286 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -120.07 118.66 31.19 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.207 0.527 . . . . 45.35 111.346 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.78 -20.84 32.6 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.345 0.593 . . . . 64.44 111.495 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -93.39 -4.38 51.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.227 0.537 . . . . 74.25 111.339 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.556 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 62.5 t30 -86.73 -10.79 52.88 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 120.982 0.42 . . . . 63.22 111.72 -174.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . 0.415 HD22 HG13 ' A' ' 517' ' ' VAL . 12.4 m120 -85.02 1.45 47.57 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.117 0.784 . . . . 74.3 113.117 -173.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.2 t -127.46 136.93 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 112.38 0.511 . . . . 62.21 112.38 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -125.44 141.19 52.19 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.269 -0.423 . . . . 55.01 110.883 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 84.4 m -127.59 119.7 26.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.168 0.433 . . . . 61.2 112.168 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -126.22 123.38 38.05 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.822 0.344 . . . . 71.5 110.847 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -94.38 120.56 34.8 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.877 0.37 . . . . 75.55 111.848 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.9 t -112.68 141.26 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.191 0.519 . . . . 72.52 111.94 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . 0.483 ' HB3' HG22 ' A' ' 449' ' ' VAL . 40.2 t -113.79 115.88 28.48 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.296 -0.411 . . . . 74.53 111.031 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 43.6 t -99.8 120.83 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.859 0.362 . . . . 73.23 111.05 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.6 164.5 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.498 0.555 . . . . 72.33 112.498 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.4 mt -77.73 -30.86 51.85 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.356 0.502 . . . . 71.12 112.356 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--O 1.251 1.167 0 N-CA-C 112.383 0.512 . . . . 75.25 112.383 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 CA--C 1.533 0.291 0 CA-C-O 120.547 0.213 . . . . 74.34 110.461 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.576 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 61.3 Cg_endo -71.73 175.73 9.2 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.711 2.274 . . . . 75.53 112.789 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -151.6 83.66 1.29 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.123 -0.49 . . . . 70.03 109.872 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.532 HD22 HD12 ' A' ' 491' ' ' LEU . 80.0 mt -83.23 99.15 9.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.014 -0.539 . . . . 73.34 111.132 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.479 HG23 ' HG3' ' A' ' 463' ' ' LYS . 6.5 t -116.64 149.62 39.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.451 . . . . 51.13 111.149 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.602 HG12 HG12 ' A' ' 462' ' ' VAL . 31.4 m -121.37 148.56 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.263 -0.426 . . . . 63.43 111.227 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.3 mt-10 -130.01 117.74 20.51 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.628 0.251 . . . . 71.25 111.388 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 55.4 mt -92.47 131.05 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 110.456 -0.202 . . . . 63.11 110.456 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -142.45 144.51 33.08 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.541 0.21 . . . . 74.32 111.23 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.32 -159.3 29.04 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.989 -0.624 . . . . 74.43 113.38 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.69 134.22 21.71 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.906 2.404 . . . . 71.24 113.22 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -92.3 -20.25 21.3 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.433 0.531 . . . . 73.52 112.433 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.1 t -127.97 125.75 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.959 -0.463 . . . . 75.31 111.241 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 33.6 m -135.65 161.27 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.982 0.42 . . . . 75.11 111.32 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -95.51 166.49 25.39 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.061 -0.59 . . . . 65.14 113.012 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.521 HG22 ' ND2' ' A' ' 453' ' ' ASN . 12.4 p -69.93 139.27 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 O-C-N 122.277 -0.543 . . . . 73.43 111.409 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . 0.521 ' ND2' HG22 ' A' ' 452' ' ' VAL . 48.4 m-80 63.6 17.95 10.75 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.913 0.485 . . . . 43.4 112.166 -177.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . 0.534 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.8 mmmt -95.15 150.85 19.75 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.857 0.361 . . . . 70.55 110.812 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' A' ' 502' ' ' SER . 37.6 tp -96.69 118.97 34.28 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.7 0.286 . . . . 64.12 111.004 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.06 134.74 54.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.886 0.374 . . . . 73.22 111.715 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -108.55 130.05 55.3 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.0 0.428 . . . . 73.34 111.45 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -122.33 166.44 14.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.088 0.47 . . . . 74.45 111.488 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -121.19 127.5 51.56 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.975 -0.557 . . . . 53.43 111.24 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 29.8 t -104.83 113.04 40.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 41.43 110.024 173.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 29.9 m-70 -98.34 106.22 18.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.648 0.261 . . . . 75.52 110.512 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.602 HG12 HG12 ' A' ' 442' ' ' VAL . 19.4 m -105.8 123.48 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.2 0.524 . . . . 64.12 110.104 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.548 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.2 ptpt -139.89 144.18 37.05 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.517 0.562 . . . . 62.14 112.517 -170.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.4 t-20 -102.76 126.7 49.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.191 -0.67 . . . . 71.11 109.191 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.548 HD21 ' HD3' ' A' ' 463' ' ' LYS . 67.9 mt -112.69 0.15 15.25 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.011 -0.43 . . . . 75.22 112.034 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -83.87 -21.47 57.5 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.073 -0.584 . . . . 63.12 113.797 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.61 21.4 47.8 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.07 -0.586 . . . . 34.31 113.861 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.402 HG23 ' HB3' ' A' ' 438' ' ' PRO . 3.7 tt -138.1 133.77 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 122.662 -0.316 . . . . 70.53 111.076 175.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.1 141.41 34.28 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 114.684 0.634 . . . . 72.23 114.684 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.67 116.27 16.02 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.834 0.454 . . . . 61.13 111.344 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.71 -12.17 11.19 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.056 2.504 . . . . 74.4 113.086 175.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 50.7 m -81.59 13.51 3.06 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.587 0.755 . . . . 71.05 112.79 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . 0.424 HG23 HG21 ' A' ' 517' ' ' VAL . 62.9 m -86.56 91.15 8.47 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 122.119 0.962 . . . . 62.44 111.465 -165.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -95.08 121.7 36.99 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.698 -1.137 . . . . 74.34 110.364 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.544 HG21 HG11 ' A' ' 462' ' ' VAL . 41.4 t -104.31 118.24 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.001 0.429 . . . . 54.32 111.291 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -116.58 144.37 44.46 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.642 0.258 . . . . 72.42 111.555 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 95.6 t -120.17 120.25 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.801 0.334 . . . . 64.44 110.881 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -116.08 137.39 52.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.25 -0.432 . . . . 74.05 111.387 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.485 HG12 HG12 ' A' ' 513' ' ' ILE . 63.3 mt -111.85 107.94 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.799 -0.445 . . . . 42.03 109.799 174.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . 0.401 HD21 ' HA ' ' A' ' 511' ' ' TYR . 95.9 m-20 56.27 34.44 24.04 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.093 0.473 . . . . 75.24 111.183 -173.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.9 -20.65 47.88 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 116.252 -0.431 . . . . 54.42 113.732 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 45.5 m -81.93 121.71 26.84 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.357 -0.496 . . . . 75.41 111.81 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -63.91 120.32 11.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.077 0.465 . . . . 65.34 111.555 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -102.91 -43.89 5.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.201 -0.454 . . . . 74.12 111.982 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -146.91 152.53 38.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.583 0.23 . . . . 65.22 111.107 -174.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -145.3 139.15 26.87 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.103 0.478 . . . . 73.41 111.496 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -129.7 148.86 51.63 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.121 -0.49 . . . . 75.31 110.709 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 78.5 m -117.62 118.48 32.24 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.69 0.281 . . . . 72.21 110.244 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.1 m -141.8 173.43 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.283 0.563 . . . . 61.43 111.765 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 64.9 m -121.35 135.48 55.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.121 -0.49 . . . . 72.31 110.914 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.532 HD12 HD22 ' A' ' 440' ' ' LEU . 85.1 mt -118.11 119.85 35.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.806 0.336 . . . . 65.33 111.072 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -82.72 -169.03 43.6 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.326 -0.464 . . . . 61.02 113.449 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.51 107.88 0.64 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.417 2.078 . . . . 54.12 112.7 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.0 mmtp 68.45 29.21 5.79 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.126 -0.488 . . . . 75.24 111.596 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -92.2 147.4 22.96 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.369 -0.378 . . . . 71.31 111.728 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -135.12 129.35 33.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.605 0.362 . . . . 71.43 111.479 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.404 ' HG2' ' CD2' ' A' ' 491' ' ' LEU . 30.2 mmmt -116.79 136.63 52.8 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.677 0.275 . . . . 74.12 110.704 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 63.1 t -101.77 113.54 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 121.199 0.523 . . . . 61.34 111.488 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 68.7 mt -110.7 131.15 55.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.97 -0.559 . . . . 45.14 110.489 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 26.6 p -113.9 154.7 27.08 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.267 0.556 . . . . 71.22 112.32 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -144.4 148.8 35.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.645 -0.707 . . . . 64.14 110.816 174.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.509 ' HB2' HD11 ' A' ' 455' ' ' LEU . 76.0 p -115.04 114.36 25.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.065 0.46 . . . . 72.23 110.805 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -113.56 137.18 51.94 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.24 -0.436 . . . . 61.24 112.002 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.4 m -116.24 102.03 53.72 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.093 -0.503 . . . . 51.41 111.222 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 60.7 Cg_endo -71.92 99.38 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.534 2.156 . . . . 74.21 112.955 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 33.1 p -74.04 -21.88 59.77 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.944 0.402 . . . . 75.34 111.907 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -112.36 141.19 46.39 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.413 -0.358 . . . . 71.44 111.107 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.68 151.18 23.64 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.257 0.551 . . . . 75.23 111.926 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 148.02 -170.97 28.6 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.06 -0.591 . . . . 70.15 112.77 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 13.7 tpt -98.76 120.83 39.87 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.503 -0.41 . . . . 74.32 110.729 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . 0.401 ' HA ' HD21 ' A' ' 480' ' ' ASN . 96.1 m-85 -120.23 116.22 25.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.899 0.38 . . . . 71.21 111.701 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -92.47 112.94 25.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.901 0.381 . . . . 72.14 110.482 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.485 HG12 HG12 ' A' ' 479' ' ' ILE . 58.1 mt -93.8 117.34 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.254 0.55 . . . . 75.31 110.907 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -117.05 134.66 54.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 73.42 111.1 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.35 133.16 53.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.733 0.301 . . . . 53.53 110.646 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . 0.575 HG22 HG22 ' A' ' 532' ' ' VAL . 66.5 p -125.41 140.32 52.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.99 0.424 . . . . 73.33 111.61 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.424 HG21 HG23 ' A' ' 473' ' ' THR . 7.4 p -120.29 140.83 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.814 0.34 . . . . 72.14 111.022 174.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.6 t0 43.43 58.74 3.3 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.393 0.677 . . . . 71.31 112.778 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -57.75 -29.99 65.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.608 0.718 . . . . 74.33 110.475 171.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.62 -17.3 64.56 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.259 -0.882 . . . . 73.44 111.791 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 19.7 m120 51.4 55.4 9.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.671 0.748 . . . . 70.43 111.306 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 51.1 p -67.21 -19.72 65.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.377 -0.829 . . . . 74.22 111.363 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.22 141.13 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.188 -0.46 . . . . 61.31 111.749 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 74.0 t -83.58 119.78 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 110.069 -0.345 . . . . 74.31 110.069 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.576 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 18.9 mt-10 -110.24 -175.03 2.63 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.699 0.629 . . . . 73.04 112.699 -171.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 99.2 mt -69.48 -39.26 77.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.275 -0.42 . . . . 64.15 111.209 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -126.73 124.85 40.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.343 -0.39 . . . . 63.01 110.864 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -83.2 -23.98 32.61 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.848 0.314 . . . . 74.5 111.848 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -103.49 4.2 35.71 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.631 0.604 . . . . 71.33 112.631 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.474 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.7 t30 -86.62 -1.75 57.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.087 0.47 . . . . 74.22 111.373 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -80.85 -1.06 41.69 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.677 0.621 . . . . 74.14 112.677 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 516' ' ' THR . 56.6 t -124.53 129.61 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.112 0.412 . . . . 61.12 112.112 -176.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -114.3 142.86 45.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.342 -0.39 . . . . 42.32 111.162 177.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 63.2 m -116.22 130.14 56.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.36 -0.382 . . . . 51.21 111.963 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -142.88 117.64 9.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.443 -0.344 . . . . 71.24 110.28 174.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -96.34 134.31 39.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.185 0.516 . . . . 60.43 112.277 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.03 138.12 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.086 -0.506 . . . . 74.21 111.52 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.3 t -104.26 127.28 51.87 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.597 -0.274 . . . . 75.04 111.422 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 47.1 t -111.35 126.61 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.803 0.335 . . . . 73.01 111.258 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 28.8 m -121.04 164.3 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.596 0.591 . . . . 72.52 112.596 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 79.6 mt -88.26 11.06 17.55 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.508 0.558 . . . . 72.54 112.508 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--O 1.251 1.179 0 N-CA-C 112.369 0.507 . . . . 52.3 112.369 -176.688 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 N--CA 1.469 0.475 0 CA-C-O 120.597 0.236 . . . . 71.11 110.759 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.587 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 74.4 Cg_endo -81.77 175.96 8.86 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.944 2.429 . . . . 75.23 113.433 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -155.73 86.79 1.06 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.051 -0.522 . . . . 73.31 109.997 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.531 HD22 HD12 ' A' ' 491' ' ' LEU . 75.7 mt -89.0 105.37 17.74 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.975 0.417 . . . . 62.32 111.981 -176.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.707 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 8.0 t -113.14 152.12 30.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.2 0.524 . . . . 74.14 111.804 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.633 HG12 HG12 ' A' ' 462' ' ' VAL . 33.5 m -124.35 147.88 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.788 -0.642 . . . . 63.55 111.123 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 41.7 mt-10 -133.47 142.31 48.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.691 -0.231 . . . . 73.05 111.263 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 58.2 mt -111.59 129.77 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.723 0.297 . . . . 75.43 111.077 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -133.02 133.9 43.7 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.25 -0.281 . . . . 75.04 111.202 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.38 -170.94 39.75 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.89 -0.672 . . . . 65.33 113.5 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.14 126.87 13.54 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.702 2.268 . . . . 64.03 113.079 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -77.9 -19.99 53.72 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.058 0.392 . . . . 73.04 112.058 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.67 127.94 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.438 0.295 . . . . 54.51 110.38 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.84 163.93 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.28 0.562 . . . . 72.02 111.885 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.14 153.74 20.34 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.229 -0.51 . . . . 72.32 113.253 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.461 HG11 HD23 ' A' ' 541' ' ' LEU . 14.4 p -68.47 141.76 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.626 0.25 . . . . 72.21 111.236 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 59.97 21.44 10.51 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.058 0.456 . . . . 73.15 111.808 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -107.26 165.08 11.64 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.011 0.434 . . . . 75.42 111.483 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 502' ' ' SER . 29.4 tp -103.77 117.37 34.2 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.415 -0.357 . . . . 74.33 111.341 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.94 133.27 56.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.687 0.28 . . . . 71.2 111.509 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -110.7 133.76 53.05 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.081 0.467 . . . . 72.22 111.836 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -123.49 163.25 21.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.94 -0.573 . . . . 72.34 111.144 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -119.86 127.31 52.62 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.854 0.359 . . . . 75.34 110.569 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.47 112.96 36.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.69 -0.485 . . . . 71.4 109.69 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 30.7 m-70 -96.21 107.83 20.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.425 -0.352 . . . . 73.22 110.661 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.633 HG12 HG12 ' A' ' 442' ' ' VAL . 14.4 m -108.97 122.0 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.139 0.495 . . . . 51.24 110.451 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.481 ' HG3' HG23 ' A' ' 441' ' ' THR . 4.6 ptpp? -138.63 144.2 39.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.382 0.611 . . . . 71.41 112.253 -173.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 51.6 t-20 -99.96 127.3 46.17 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.599 -0.728 . . . . 71.4 109.808 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.427 HD21 ' HD3' ' A' ' 463' ' ' LYS . 82.7 mt -111.92 -1.9 15.33 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.958 0.355 . . . . 63.12 111.958 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -81.71 -15.72 74.88 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.388 -0.434 . . . . 63.35 113.831 -178.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.88 20.4 65.57 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 120.938 -0.649 . . . . 73.03 113.854 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.418 HG23 ' HB3' ' A' ' 438' ' ' PRO . 5.8 tt -138.47 135.03 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 122.731 -0.276 . . . . 74.55 111.412 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -66.88 134.88 32.27 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 114.123 0.409 . . . . 52.41 114.123 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 440' ' ' LEU . 86.9 t -129.6 116.75 18.41 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 122.651 0.38 . . . . 71.31 111.842 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.2 -10.44 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.085 2.523 . . . . 65.32 113.143 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.8 t -80.62 12.52 3.06 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.149 0.58 . . . . 71.24 112.469 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . 0.432 HG23 HG21 ' A' ' 517' ' ' VAL . 67.7 m -87.61 91.09 8.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.958 0.885 . . . . 74.3 111.803 -166.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 517' ' ' VAL . 91.4 mttt -94.5 124.15 38.35 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.956 -1.02 . . . . 64.41 110.29 173.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.589 HG21 HG11 ' A' ' 462' ' ' VAL . 41.3 t -110.19 119.61 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.721 0.296 . . . . 70.42 111.005 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . 0.419 ' NH1' ' HB2' ' A' ' 519' ' ' GLU . 71.8 mtt180 -122.5 146.81 47.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 111.79 0.293 . . . . 73.04 111.79 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.8 t -120.65 124.18 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.044 0.45 . . . . 75.13 111.186 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -111.78 137.15 50.1 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.976 -0.557 . . . . 65.03 110.704 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.542 HG12 HG12 ' A' ' 513' ' ' ILE . 59.8 mt -117.37 108.67 25.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.854 0.359 . . . . 65.34 111.34 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 66.2 t30 60.06 34.1 21.31 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.266 0.555 . . . . 72.45 111.462 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 97.65 -12.79 64.47 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.274 -0.489 . . . . 44.33 114.031 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 89.8 m -105.21 127.07 52.75 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.332 0.566 . . . . 62.45 111.75 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.7 tp -61.98 128.0 34.06 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.943 0.401 . . . . 73.53 110.855 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -105.38 -43.6 4.94 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.644 0.609 . . . . 61.01 112.644 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -162.75 159.33 24.05 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.272 -0.267 . . . . 74.32 111.02 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -145.53 157.2 44.03 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.894 0.378 . . . . 61.23 111.753 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 -137.2 148.75 46.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.191 -0.459 . . . . 75.3 110.754 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 51.8 m -117.96 118.04 30.89 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.881 0.372 . . . . 64.31 110.168 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.12 174.55 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.21 0.528 . . . . 72.22 111.752 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 89.9 p -129.39 140.08 51.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.148 -0.478 . . . . 71.51 110.608 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.531 HD12 HD22 ' A' ' 440' ' ' LEU . 79.4 mt -117.44 121.49 41.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.852 0.358 . . . . 70.11 111.752 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -78.41 -172.18 40.1 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.357 -0.449 . . . . 71.12 113.08 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.16 110.54 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.45 2.1 . . . . 53.44 112.906 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 39.5 mmtm 67.0 26.63 9.01 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.986 -0.552 . . . . 74.21 111.929 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -99.2 146.89 25.69 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.109 -0.496 . . . . 73.31 112.064 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 41.6 tt0 -129.07 145.77 51.19 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.103 0.478 . . . . 63.23 111.937 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.417 ' HG2' ' CD2' ' A' ' 491' ' ' LEU . 31.8 mmmt -121.6 137.18 54.85 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.784 -0.45 . . . . 74.41 109.784 172.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 52.9 t -101.04 112.12 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.139 0.495 . . . . 72.12 110.814 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 57.8 mt -103.15 146.57 28.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.989 -0.551 . . . . 62.22 110.714 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 20.0 p -130.21 155.31 46.47 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.549 0.69 . . . . 63.43 112.591 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.26 148.65 26.1 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.32 -0.855 . . . . 60.12 110.21 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.521 ' HB2' HD11 ' A' ' 455' ' ' LEU . 51.8 p -116.88 114.79 24.38 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.911 0.386 . . . . 44.31 110.984 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -104.15 136.72 43.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.262 -0.426 . . . . 73.51 111.896 -174.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.6 m -117.43 100.7 52.86 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 116.39 -0.368 . . . . 52.42 111.096 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . 0.424 ' HB2' HG11 ' A' ' 539' ' ' VAL . 90.7 Cg_endo -81.16 100.14 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.751 2.3 . . . . 64.11 113.072 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.9 p -78.57 -29.64 46.35 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.268 0.47 . . . . 74.32 112.268 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -100.43 131.67 46.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.832 0.349 . . . . 64.03 110.73 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.412 ' HG2' HD21 ' A' ' 541' ' ' LEU . 0.3 OUTLIER -87.36 150.37 23.88 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.11 0.481 . . . . 73.22 112.068 -176.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.79 -170.38 29.91 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.365 -0.445 . . . . 51.35 112.924 -178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 14.9 tpt -91.6 124.54 35.84 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 122.437 -0.449 . . . . 74.31 111.565 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -128.4 151.96 48.76 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.985 0.421 . . . . 74.33 111.258 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -124.18 119.72 30.22 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.104 -0.372 . . . . 52.22 111.615 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.542 HG12 HG12 ' A' ' 479' ' ' ILE . 52.6 mt -95.95 126.77 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.019 0.438 . . . . 61.22 111.306 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -123.01 145.21 48.7 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.989 0.423 . . . . 75.32 111.575 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.68 134.26 53.76 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.185 -0.461 . . . . 74.43 110.309 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 50.5 p -136.93 151.37 48.96 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.955 0.407 . . . . 71.4 111.945 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 474' ' ' LYS . 7.8 p -128.92 149.8 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 116.26 -0.427 . . . . 72.43 111.722 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 17.2 t70 47.9 43.53 17.57 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.71 0.767 . . . . 65.42 111.741 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . 0.419 ' HB2' ' NH1' ' A' ' 476' ' ' ARG . 6.9 mm-40 -51.4 -30.94 20.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.68 -0.691 . . . . 65.25 111.627 174.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -23.65 66.33 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.807 -0.633 . . . . 75.1 110.678 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 62.59 82.11 0.19 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.249 0.619 . . . . 75.33 110.303 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 53.8 p -109.45 -26.95 9.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 72.41 111.637 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.04 141.59 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 112.978 0.733 . . . . 62.11 112.978 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 99.0 t -84.6 114.5 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.141 -0.481 . . . . 74.44 110.296 172.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 27.3 mt-10 -101.78 176.8 5.1 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.636 0.606 . . . . 74.35 112.636 -174.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.15 -39.61 86.99 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.904 -0.589 . . . . 71.15 110.944 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . 0.561 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 32.2 t30 -141.55 93.19 2.54 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.371 0.605 . . . . 64.15 110.302 173.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.55 14.95 3.37 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.064 -0.516 . . . . 64.4 112.212 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -104.62 -3.44 23.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.718 0.771 . . . . 72.11 109.67 167.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.707 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.1 t30 -86.55 -0.65 56.56 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.418 -0.81 . . . . 74.4 111.355 -174.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -83.76 -6.86 59.53 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.882 0.697 . . . . 73.44 112.882 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.49 138.45 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.215 0.45 . . . . 75.41 112.215 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.08 142.84 50.57 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.215 -0.448 . . . . 63.2 111.183 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.4 m -126.77 133.91 50.73 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.665 0.269 . . . . 73.34 111.626 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -143.15 129.73 20.19 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.818 0.342 . . . . 74.34 111.08 177.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -93.6 134.7 35.61 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.877 0.37 . . . . 74.11 111.883 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 63.0 t -128.83 128.36 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.044 0.449 . . . . 44.04 111.43 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 46.6 t -103.82 120.88 41.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.77 0.319 . . . . 72.53 111.078 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.424 HG11 ' HB2' ' A' ' 505' ' ' PRO . 48.7 t -99.23 120.08 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.896 0.379 . . . . 72.24 111.321 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.442 HG23 ' H ' ' A' ' 542' ' ' GLU . 35.0 m -119.49 167.74 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.183 0.516 . . . . 74.44 112.116 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . 0.461 HD23 HG11 ' A' ' 452' ' ' VAL . 98.0 mt -80.4 25.94 0.39 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.215 0.45 . . . . 74.3 112.215 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . 0.442 ' H ' HG23 ' A' ' 540' ' ' VAL . 41.7 mt-10 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.545 -0.741 . . . . 64.43 111.914 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 120.756 0.313 . . . . 74.02 110.425 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.424 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 86.7 Cg_endo -79.86 174.19 11.93 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.707 2.271 . . . . 65.43 114.046 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.0 93.97 2.99 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.424 -0.807 . . . . 74.13 109.471 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.4 HD11 HG11 ' A' ' 470' ' ' VAL . 98.4 mt -98.07 108.21 20.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.872 0.368 . . . . 71.15 111.348 -175.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 8.7 t -123.34 152.68 41.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.136 0.493 . . . . 61.13 111.669 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.516 HG12 HG12 ' A' ' 462' ' ' VAL . 34.8 m -120.87 147.85 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.972 -0.558 . . . . 51.03 110.846 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.629 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 43.1 mt-10 -130.28 137.18 49.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.666 -0.243 . . . . 55.04 110.747 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.05 138.02 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.146 0.498 . . . . 61.34 111.689 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -137.1 146.1 44.7 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.049 -0.523 . . . . 74.45 110.97 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.64 -171.2 33.63 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.674 -0.774 . . . . 61.25 114.025 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.04 123.45 8.38 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.819 2.346 . . . . 73.01 112.712 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.48 -13.32 52.34 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.397 0.517 . . . . 72.21 112.397 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 80.2 t -131.38 122.96 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.653 0.263 . . . . 73.44 110.75 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 31.2 m -135.81 163.19 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.172 0.511 . . . . 54.34 111.802 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -100.78 163.91 18.59 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 116.188 -0.46 . . . . 41.5 112.979 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.464 HG22 ' ND2' ' A' ' 453' ' ' ASN . 8.6 p -68.91 144.01 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 122.496 -0.414 . . . . 74.22 111.339 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . 0.464 ' ND2' HG22 ' A' ' 452' ' ' VAL . 40.2 m-80 60.17 17.61 7.06 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.221 0.452 . . . . 73.25 112.221 -177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . 0.442 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.1 mmmt -103.82 138.84 39.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.923 0.392 . . . . 62.2 111.299 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 502' ' ' SER . 36.2 tp -85.39 125.35 32.91 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.194 -0.457 . . . . 52.32 111.251 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -124.79 136.66 54.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.917 0.389 . . . . 70.54 111.81 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.33 133.94 46.43 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.049 0.452 . . . . 65.44 111.746 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 86.1 m-85 -122.31 150.93 41.68 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.205 -0.452 . . . . 70.34 111.03 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -120.88 127.23 51.68 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.951 -0.568 . . . . 41.23 110.875 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.6 t -113.68 127.47 71.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 122.785 0.434 . . . . 64.25 111.212 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.629 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 77.7 m-70 -107.75 110.67 22.55 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.812 0.339 . . . . 72.55 110.594 176.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.617 HG11 HG21 ' A' ' 475' ' ' VAL . 33.6 m -107.47 124.27 63.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 120.896 0.379 . . . . 64.33 110.304 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.543 ' HD3' HD21 ' A' ' 465' ' ' LEU . 13.4 ptpt -143.73 153.75 42.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.159 0.8 . . . . 64.54 113.159 -170.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 48.9 t-20 -112.0 126.45 55.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.355 -0.839 . . . . 70.23 109.47 173.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.543 HD21 ' HD3' ' A' ' 463' ' ' LYS . 47.1 mt -114.28 5.16 15.69 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.867 0.365 . . . . 52.55 111.658 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -82.36 -20.14 62.96 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.308 -0.472 . . . . 54.41 113.682 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.84 14.91 62.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.021 -0.609 . . . . 42.14 113.603 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.9 tt -135.94 133.46 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 122.52 0.328 . . . . 43.55 111.119 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.36 139.86 28.6 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 114.172 0.429 . . . . 72.24 114.172 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 440' ' ' LEU . 52.8 t -130.36 114.35 17.12 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 111.95 0.352 . . . . 65.12 111.95 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.28 -11.33 13.32 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.982 2.455 . . . . 73.33 112.755 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . 0.494 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 20.1 m -80.55 11.38 3.77 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.658 0.783 . . . . 65.22 112.773 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 39.9 m -89.53 91.92 8.89 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.652 0.739 . . . . 65.23 112.316 -165.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -101.9 126.75 48.87 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.403 -0.817 . . . . 71.15 110.357 171.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.617 HG21 HG11 ' A' ' 462' ' ' VAL . 55.6 t -112.62 128.97 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.813 0.339 . . . . 54.14 111.286 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . 0.543 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 82.6 mtt180 -115.63 151.22 35.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.78 0.324 . . . . 75.24 111.312 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.3 t -121.31 120.21 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.835 0.35 . . . . 53.5 111.08 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -114.29 144.67 42.87 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.277 -0.419 . . . . 74.11 111.553 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.538 HG12 HG12 ' A' ' 513' ' ' ILE . 55.2 mt -123.6 107.93 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.115 -0.493 . . . . 60.34 109.73 173.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 53.42 39.14 29.48 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 120.88 0.371 . . . . 72.14 111.84 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 85.63 -0.96 88.31 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.097 -0.573 . . . . 52.51 114.066 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 94.4 m -98.51 120.45 38.95 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.25 0.525 . . . . 73.0 111.401 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 59.7 tp -69.7 115.04 8.48 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.189 0.518 . . . . 73.3 111.376 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -90.03 -43.28 10.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.121 -0.491 . . . . 75.31 111.754 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -167.32 162.25 14.72 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.664 0.268 . . . . 64.44 111.516 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -147.49 152.6 38.33 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.688 0.28 . . . . 73.2 111.139 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 24.7 m-90 -130.0 134.77 47.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.818 0.342 . . . . 74.43 110.764 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 57.1 m -104.38 118.12 35.84 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.731 0.3 . . . . 72.33 110.257 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 22.3 m -140.83 172.85 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.343 0.592 . . . . 71.44 111.489 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 79.6 p -118.51 135.05 54.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.94 -0.573 . . . . 72.12 110.281 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.1 mt -116.96 119.68 36.08 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.886 0.374 . . . . 64.44 110.882 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -80.3 -177.35 50.9 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.079 -0.582 . . . . 51.42 113.116 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.56 108.75 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.476 2.117 . . . . 73.32 112.457 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.2 mmtp 67.91 32.98 4.9 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.14 -0.482 . . . . 72.14 111.816 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -101.33 148.61 24.95 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 111.92 0.341 . . . . 61.12 111.92 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 14.4 tt0 -131.8 143.68 50.38 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.428 -0.351 . . . . 70.42 111.206 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.406 ' HB3' ' NZ ' ' A' ' 497' ' ' LYS . 2.3 mmmp? -124.67 134.85 52.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.72 0.295 . . . . 74.13 110.575 175.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.06 117.57 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.244 0.545 . . . . 71.14 111.295 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 52.4 mt -114.07 146.7 39.87 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.038 -0.528 . . . . 73.23 110.861 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 33.3 p -129.41 154.47 46.91 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.27 0.557 . . . . 64.02 112.026 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.1 p90 -148.01 149.49 32.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.779 -0.646 . . . . 73.02 110.651 173.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.552 ' HB3' HD11 ' A' ' 455' ' ' LEU . 43.0 m -110.11 115.29 29.49 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.013 0.435 . . . . 62.34 110.333 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -118.05 136.58 53.47 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.969 0.414 . . . . 75.22 112.043 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.7 m -119.11 112.27 36.34 Favored Pre-proline 0 N--CA 1.472 0.653 0 CA-C-N 116.17 -0.468 . . . . 74.32 111.121 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 67.4 Cg_endo -75.06 118.85 5.4 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.418 2.079 . . . . 70.41 112.684 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 42.1 p -92.22 0.75 57.47 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.788 0.662 . . . . 64.11 112.788 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -143.75 145.93 32.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.701 0.286 . . . . 65.21 110.835 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -79.32 150.28 31.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.125 0.488 . . . . 71.1 111.148 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.76 -170.31 30.58 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.256 -0.497 . . . . 75.3 112.542 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 510' ' ' MET . 0.0 OUTLIER -96.43 111.14 23.35 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.93 0.395 . . . . 51.1 110.481 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -115.21 111.5 21.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.068 0.461 . . . . 61.31 111.644 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -96.31 124.85 40.46 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.901 0.381 . . . . 70.12 111.135 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.538 HG12 HG12 ' A' ' 479' ' ' ILE . 57.9 mt -98.55 124.1 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.214 -0.448 . . . . 70.22 111.127 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 21.3 m120 -122.61 138.47 54.58 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.026 0.441 . . . . 71.53 111.415 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.08 132.89 54.57 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.596 -0.275 . . . . 62.43 110.443 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . 0.541 HG22 HG22 ' A' ' 532' ' ' VAL . 54.1 p -123.47 140.34 53.1 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.875 0.369 . . . . 73.44 111.768 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.42 147.73 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.77 0.319 . . . . 74.03 111.319 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 37.9 t70 57.38 42.23 25.14 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.611 0.72 . . . . 74.03 111.81 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . 0.543 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.2 mm-40 -56.22 -32.55 64.54 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.966 -0.459 . . . . 71.24 111.481 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -67.71 -19.39 65.15 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.259 -0.428 . . . . 71.31 111.64 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 65.52 78.94 0.26 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.093 0.473 . . . . 71.14 111.306 -175.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 44.7 p -132.81 -13.54 2.86 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.061 0.763 . . . . 71.51 113.061 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.9 p -134.64 143.63 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.167 0.508 . . . . 62.22 112.272 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 68.0 t -100.73 117.96 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.343 -0.389 . . . . 74.12 111.096 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -92.64 175.31 6.86 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.242 0.544 . . . . 73.33 111.4 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.57 -29.97 59.5 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.114 -0.494 . . . . 73.54 110.828 172.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -135.35 145.42 47.37 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.697 -0.683 . . . . 60.33 110.239 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.23 2.33 10.85 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.303 0.483 . . . . 54.21 112.303 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -87.25 -4.12 59.07 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.791 0.329 . . . . 61.1 111.708 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -111.83 -2.85 15.1 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.442 0.534 . . . . 63.35 112.442 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -69.67 -17.6 63.5 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.213 0.449 . . . . 74.33 112.213 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 516' ' ' THR . 41.1 t -124.13 131.99 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.672 0.272 . . . . 54.11 111.121 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -113.63 138.49 50.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.659 0.266 . . . . 54.1 111.083 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 50.0 m -112.18 127.65 56.01 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.123 0.416 . . . . 72.45 112.123 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -134.86 126.85 29.6 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.37 -0.377 . . . . 62.02 110.303 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.98 124.92 39.31 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.081 0.4 . . . . 53.1 112.081 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.18 128.45 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.139 0.495 . . . . 71.4 111.301 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.6 t -105.37 120.12 40.78 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.256 -0.277 . . . . 75.31 110.726 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 53.7 t -104.7 128.58 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.911 0.386 . . . . 75.34 111.871 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.83 160.08 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 116.337 -0.392 . . . . 73.02 111.546 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.57 -17.03 61.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.141 0.423 . . . . 74.13 112.141 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--O 1.252 1.233 0 N-CA-C 112.104 0.409 . . . . 72.44 112.104 -178.845 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 109.855 -0.424 . . . . 73.53 109.855 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 60.4 Cg_endo -73.45 173.91 13.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.25 1.966 . . . . 71.44 113.96 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -152.95 109.13 3.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.156 -0.929 . . . . 73.31 109.462 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 491' ' ' LEU . 83.1 mt -105.36 156.85 17.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 72.45 111.171 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.642 HG23 ' HG3' ' A' ' 463' ' ' LYS . 2.0 t -161.28 149.89 15.97 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.037 0.446 . . . . 71.11 112.026 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.577 HG12 HG12 ' A' ' 462' ' ' VAL . 35.8 m -121.11 147.67 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.03 -0.532 . . . . 73.13 111.621 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -139.56 135.39 33.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.112 -0.494 . . . . 64.3 111.153 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 59.2 mt -109.18 131.36 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.534 0.206 . . . . 61.55 110.958 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -133.78 145.17 49.53 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.479 0.181 . . . . 63.13 110.952 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.39 -171.2 34.06 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 120.797 -0.716 . . . . 52.43 113.999 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.54 123.1 9.84 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.956 2.437 . . . . 71.31 112.991 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -83.58 -8.76 59.25 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.286 0.476 . . . . 75.02 112.286 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 73.3 t -131.67 120.87 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 122.342 -0.224 . . . . 71.53 110.783 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 32.9 m -135.4 164.15 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.054 0.454 . . . . 75.31 111.853 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -94.89 162.33 24.03 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.3 -0.476 . . . . 34.14 113.439 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.557 HG22 ' ND2' ' A' ' 453' ' ' ASN . 8.4 p -74.26 140.71 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 O-C-N 122.436 -0.45 . . . . 71.01 111.484 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . 0.557 ' ND2' HG22 ' A' ' 452' ' ' VAL . 46.5 m-80 59.4 16.57 5.22 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.227 0.611 . . . . 70.14 112.056 -177.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -98.75 157.9 15.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.995 0.426 . . . . 75.42 111.394 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 502' ' ' SER . 26.8 tp -96.07 130.94 42.96 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.343 -0.389 . . . . 72.14 111.2 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -134.91 134.39 40.61 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.519 0.2 . . . . 63.24 111.339 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -100.31 133.05 45.3 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.351 0.596 . . . . 62.33 111.921 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -122.66 164.0 19.04 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.735 -0.666 . . . . 64.44 110.633 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' A' ' 500' ' ' THR . 57.2 mt-10 -121.32 127.7 51.56 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.108 0.48 . . . . 75.51 111.965 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 52.7 t -100.03 113.78 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.068 -0.514 . . . . 74.12 110.062 172.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -99.35 110.45 22.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 74.13 110.699 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.75 HG11 HG21 ' A' ' 475' ' ' VAL . 30.5 m -110.72 122.95 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.079 0.466 . . . . 63.51 110.517 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.642 ' HG3' HG23 ' A' ' 441' ' ' THR . 3.0 ptpp? -135.44 151.39 50.37 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.785 0.661 . . . . 53.14 112.785 -173.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 51.2 t-20 -106.19 128.37 53.88 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.296 -0.865 . . . . 72.11 109.761 175.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.443 HD21 ' HD3' ' A' ' 463' ' ' LYS . 73.6 mt -107.61 -23.32 12.18 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.91 0.337 . . . . 63.41 111.91 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -60.22 -25.97 63.16 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 114.604 0.602 . . . . 44.44 114.604 -173.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.53 17.49 58.47 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.831 -0.7 . . . . 74.41 113.271 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.6 tt -137.73 140.92 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 122.785 0.434 . . . . 72.35 110.85 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.441 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -67.43 136.29 31.89 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.204 0.442 . . . . 44.31 114.204 -176.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.405 HG11 HD11 ' A' ' 440' ' ' LEU . 46.7 t -127.4 113.7 21.27 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-O 120.799 0.333 . . . . 72.14 111.339 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -88.36 -9.73 4.95 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.267 2.645 . . . . 74.2 113.095 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . 0.461 ' HB2' ' OG1' ' A' ' 522' ' ' THR . 93.2 p -87.79 11.95 14.16 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.5 0.926 . . . . 43.53 113.5 -173.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 60.3 m -87.85 108.58 19.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.605 0.717 . . . . 63.21 112.825 -164.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -112.12 131.03 55.69 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.437 -0.801 . . . . 62.12 111.181 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.75 HG21 HG11 ' A' ' 462' ' ' VAL . 41.5 t -111.23 137.24 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 122.458 0.303 . . . . 74.5 111.564 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -131.52 143.08 50.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.468 0.307 . . . . 62.52 111.495 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 96.5 t -120.96 122.89 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.863 0.363 . . . . 73.22 111.278 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -113.37 139.29 49.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.867 0.467 . . . . 53.31 110.831 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.423 HG12 HG12 ' A' ' 513' ' ' ILE . 56.7 mt -119.65 111.15 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.68 0.276 . . . . 74.12 110.28 176.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 55.05 34.02 21.61 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.297 -0.41 . . . . 63.23 111.807 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 101.06 -29.14 13.16 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 116.327 -0.397 . . . . 44.25 113.581 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 91.0 m -81.92 125.82 31.19 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 122.411 -0.464 . . . . 74.4 111.899 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.79 114.54 5.12 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.267 0.556 . . . . 73.23 110.815 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -88.43 -43.97 11.08 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.319 0.489 . . . . 73.23 112.319 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -167.02 160.51 14.17 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.589 0.218 . . . . 64.44 111.589 -175.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -141.65 152.94 44.39 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.914 0.388 . . . . 72.41 111.741 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -131.84 148.94 52.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.76 0.424 . . . . 61.31 111.346 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 81.4 m -115.46 119.19 35.38 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.487 -0.324 . . . . 74.4 110.147 173.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.34 173.86 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.442 0.639 . . . . 51.44 112.261 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 88.1 p -129.28 133.6 47.55 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.866 -0.606 . . . . 63.31 110.378 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.536 HD12 HD22 ' A' ' 440' ' ' LEU . 96.1 mt -117.26 120.45 38.28 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.985 0.422 . . . . 74.24 111.45 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . 0.441 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -84.09 -177.62 51.47 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.066 -0.588 . . . . 71.22 112.882 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.53 107.68 0.22 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.876 2.384 . . . . 71.54 113.04 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 74.3 mmtt 67.01 34.43 5.16 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.045 -0.525 . . . . 73.3 112.04 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -102.41 151.85 21.79 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.372 0.508 . . . . 72.21 112.372 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 34.9 tt0 -133.87 141.44 47.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.089 0.471 . . . . 73.43 111.345 173.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -116.85 131.65 56.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.149 -0.478 . . . . 52.13 109.835 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 57.2 t -100.03 113.26 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.234 0.54 . . . . 64.45 111.312 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 47.6 mt -105.87 146.15 30.31 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.834 -0.621 . . . . 73.43 111.106 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.414 HG22 ' HG2' ' A' ' 459' ' ' GLU . 32.0 p -125.23 154.84 41.01 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.274 0.559 . . . . 70.52 111.947 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -154.76 150.54 27.67 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.829 -0.623 . . . . 72.14 110.588 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.556 ' HB2' HD11 ' A' ' 455' ' ' LEU . 79.6 p -109.93 114.3 27.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.018 0.437 . . . . 71.33 110.641 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . 0.403 ' HZ3' HG11 ' A' ' 537' ' ' VAL . 33.0 t90 -108.59 138.19 45.3 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.884 -0.598 . . . . 74.42 111.947 -174.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 94.7 m -124.31 109.0 29.25 Favored Pre-proline 0 N--CA 1.473 0.69 0 CA-C-N 116.109 -0.496 . . . . 73.23 111.56 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.37 119.32 3.77 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.787 2.324 . . . . 75.54 112.918 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 66.5 p -89.31 13.77 12.69 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.255 0.465 . . . . 73.11 112.255 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . 0.621 ' HB3' ' OH ' ' A' ' 511' ' ' TYR . 25.9 tt0 -143.14 142.02 31.36 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.746 0.418 . . . . 62.13 110.474 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -88.47 135.87 33.27 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.105 0.479 . . . . 74.41 110.883 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.85 -166.99 29.9 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.087 -0.577 . . . . 70.32 112.872 -175.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 96.2 mmm -83.97 120.62 26.33 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.167 0.508 . . . . 73.53 112.319 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . 0.621 ' OH ' ' HB3' ' A' ' 507' ' ' GLN . 48.9 m-85 -118.62 113.62 21.51 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.155 -0.475 . . . . 64.34 111.446 175.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 512' ' ' ARG . 15.7 ttm180 -96.48 111.38 23.51 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.914 0.388 . . . . 64.32 110.687 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.423 HG12 HG12 ' A' ' 479' ' ' ILE . 57.6 mt -96.52 113.81 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.023 0.44 . . . . 75.02 111.409 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 21.5 m120 -107.59 151.84 25.08 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.929 0.395 . . . . 53.42 111.725 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -134.79 136.87 42.89 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.767 0.317 . . . . 63.22 111.074 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 58.1 p -129.17 152.37 48.83 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.215 -0.448 . . . . 50.22 111.034 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.14 141.82 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.212 0.529 . . . . 72.24 111.898 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 2.8 t0 48.78 44.33 21.66 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.832 0.853 . . . . 64.54 112.471 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -51.75 -30.06 21.12 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.232 0.539 . . . . 64.02 111.181 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 522' ' ' THR . 0.9 OUTLIER -66.92 -16.99 64.69 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.66 -0.7 . . . . 71.12 111.431 -176.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 27.4 m120 59.75 44.82 13.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.379 0.609 . . . . 64.13 111.213 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . 0.461 ' OG1' ' HB2' ' A' ' 472' ' ' SER . 57.0 p -67.03 -39.47 87.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.83 -0.623 . . . . 42.54 111.581 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.417 HG21 ' HG3' ' A' ' 438' ' ' PRO . 12.5 p -115.28 143.57 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 116.146 -0.479 . . . . 73.43 111.844 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . 0.518 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 52.2 t -83.27 117.05 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 122.164 -0.335 . . . . 65.53 111.007 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -103.35 177.63 4.79 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.789 0.662 . . . . 74.45 112.789 -175.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.16 -39.06 18.29 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.662 -0.699 . . . . 74.45 112.339 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -114.97 164.2 14.49 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.216 0.531 . . . . 72.54 112.284 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -125.01 -7.43 7.19 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.088 0.47 . . . . 72.31 111.695 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -107.46 16.88 23.4 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.63 0.604 . . . . 74.43 112.63 -173.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.565 ' HB2' ' HB ' ' A' ' 441' ' ' THR . 6.8 p-10 -114.78 -17.77 11.51 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.258 1.207 . . . . 62.43 114.258 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -89.37 17.81 5.82 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.62 0.97 . . . . 74.34 113.62 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.41 134.27 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.062 0.458 . . . . 72.54 111.511 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -128.37 141.89 51.28 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.501 -0.318 . . . . 54.23 111.176 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.0 m -129.32 121.6 27.83 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.889 0.329 . . . . 71.13 111.889 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -121.78 126.11 48.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.804 0.335 . . . . 75.44 110.873 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.75 119.21 32.43 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.888 0.375 . . . . 74.43 111.742 -177.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.403 HG11 ' HZ3' ' A' ' 503' ' ' TRP . 48.2 t -112.66 134.99 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.269 0.557 . . . . 75.1 111.924 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 31.0 t -108.83 114.32 28.0 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.965 -0.561 . . . . 55.13 110.543 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 40.4 t -102.19 125.79 56.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.994 0.426 . . . . 72.23 111.775 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 542' ' ' GLU . 28.2 m -115.17 168.34 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 115.89 -0.595 . . . . 63.14 111.434 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 70.9 mt -71.38 1.34 6.41 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.132 0.79 . . . . 74.53 113.132 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . 0.408 ' H ' HG23 ' A' ' 540' ' ' VAL . 6.0 pt-20 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 112.318 0.488 . . . . 74.05 112.318 -176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 CA--C 1.542 0.637 0 CA-C-O 120.703 0.287 . . . . 75.41 110.793 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.706 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 58.9 Cg_endo -73.05 175.63 10.22 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.158 2.572 . . . . 55.41 114.236 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -153.7 86.84 1.21 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.578 -0.737 . . . . 72.02 109.706 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.538 HD22 HD12 ' A' ' 491' ' ' LEU . 88.7 mt -90.09 109.68 20.72 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.119 0.485 . . . . 64.22 112.193 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.424 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.6 t -113.2 152.84 29.23 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.127 -0.358 . . . . 72.54 111.722 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.579 HG12 HG12 ' A' ' 462' ' ' VAL . 28.3 m -128.42 148.86 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.18 0.514 . . . . 64.45 112.154 -176.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.594 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 44.2 mt-10 -129.35 146.66 51.18 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.177 -0.465 . . . . 62.14 111.47 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 62.1 mt -110.01 135.16 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.026 0.441 . . . . 72.51 110.722 173.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.565 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 63.6 tttp -135.12 145.03 47.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.357 -0.383 . . . . 65.43 110.521 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 154.64 -167.08 32.51 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.282 -0.961 . . . . 63.14 114.341 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.474 ' HD2' ' CZ ' ' A' ' 458' ' ' TYR . 16.5 Cg_exo -65.66 141.02 64.6 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.312 2.675 . . . . 53.43 113.776 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.28 -52.2 5.34 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.84 0.456 . . . . 74.24 111.236 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 538' ' ' SER . 59.4 t -116.31 127.15 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.691 -0.231 . . . . 60.1 110.717 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.15 163.21 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.007 0.432 . . . . 61.3 111.972 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.69 155.81 25.1 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.2 -0.455 . . . . 74.22 112.921 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.517 HG22 ' ND2' ' A' ' 453' ' ' ASN . 13.2 p -67.96 143.61 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.119 0.485 . . . . 72.24 111.839 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . 0.517 ' ND2' HG22 ' A' ' 452' ' ' VAL . 55.7 m-80 61.81 21.26 12.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.018 -0.537 . . . . 54.25 112.268 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . 0.541 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.7 mmmt -103.18 150.75 23.37 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.017 0.437 . . . . 73.21 111.732 177.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 502' ' ' SER . 48.7 tp -93.86 119.38 32.72 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.338 -0.392 . . . . 73.12 111.344 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.59 133.03 54.99 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.706 0.288 . . . . 50.44 111.584 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.95 137.73 38.93 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.115 0.483 . . . . 65.32 111.688 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . 0.474 ' CZ ' ' HD2' ' A' ' 447' ' ' PRO . 10.3 m-85 -122.27 162.23 21.85 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.67 -0.696 . . . . 74.05 110.76 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 445' ' ' LYS . 51.9 mt-10 -120.38 127.3 52.17 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.998 0.427 . . . . 72.21 111.661 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 28.9 t -101.95 114.02 40.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.212 -0.449 . . . . 60.22 109.9 171.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.594 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 12.2 m-70 -101.3 110.6 22.63 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.702 0.287 . . . . 74.51 110.736 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.579 HG12 HG12 ' A' ' 442' ' ' VAL . 14.5 m -119.59 137.54 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.069 0.461 . . . . 74.11 110.917 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.22 152.87 37.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.1 0.476 . . . . 75.32 111.764 -176.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.5 t-20 -99.87 127.44 46.04 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.052 -0.522 . . . . 75.3 110.12 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 82.0 mt -110.29 -7.93 14.78 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.971 0.36 . . . . 52.22 111.971 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -76.59 -23.12 70.98 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.182 -0.533 . . . . 41.4 113.447 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.48 22.7 53.27 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.021 -0.609 . . . . 72.12 113.546 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.2 tt -139.71 136.96 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.594 0.358 . . . . 51.34 111.362 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.555 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -69.57 135.54 27.06 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 114.94 0.736 . . . . 74.12 114.94 -175.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.41 115.37 16.08 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 122.816 0.446 . . . . 63.22 111.632 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.38 -11.46 10.7 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.052 2.502 . . . . 64.32 113.251 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 45.6 m -81.14 11.35 4.26 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.256 0.622 . . . . 42.12 112.592 -175.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . 0.45 HG23 HD13 ' A' ' 440' ' ' LEU . 56.5 m -86.88 98.98 11.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.828 0.823 . . . . 33.12 111.973 -162.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -108.24 123.04 48.16 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.119 -0.946 . . . . 74.41 111.195 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.528 HG21 HG11 ' A' ' 462' ' ' VAL . 46.2 t -104.24 123.7 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.379 -0.373 . . . . 55.21 110.72 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 515' ' ' ALA . 83.2 mtt180 -114.9 145.99 41.61 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.713 0.292 . . . . 74.23 111.75 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.63 119.73 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.995 0.426 . . . . 63.54 111.085 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -112.2 145.11 40.47 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.37 -0.377 . . . . 73.55 111.149 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.77 107.54 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.952 -0.388 . . . . 74.12 109.952 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 56.63 33.87 23.51 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.054 0.454 . . . . 75.45 111.365 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 100.08 -30.97 9.02 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.432 -0.414 . . . . 41.32 113.679 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 85.4 m -82.02 119.2 23.69 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.393 -0.475 . . . . 74.02 111.787 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.4 tp -62.57 115.03 3.91 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.063 0.458 . . . . 74.33 111.342 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -87.29 -43.4 12.19 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.373 -0.376 . . . . 72.5 111.854 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -166.11 161.1 16.93 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.357 -0.214 . . . . 72.4 111.324 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . 0.42 HD22 ' N ' ' A' ' 486' ' ' ASN . 0.1 OUTLIER -155.24 159.63 40.21 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.798 0.332 . . . . 75.32 111.613 177.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -133.41 149.36 51.82 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.33 -0.395 . . . . 64.41 111.12 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 38.5 m -115.32 118.63 33.8 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.89 0.376 . . . . 72.44 110.589 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.6 173.42 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.197 0.522 . . . . 72.34 111.424 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 92.6 p -120.59 132.59 55.22 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.356 -0.384 . . . . 55.31 110.139 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.538 HD12 HD22 ' A' ' 440' ' ' LEU . 96.5 mt -118.22 119.05 33.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.818 0.342 . . . . 72.34 110.948 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . 0.555 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -80.52 -167.07 35.95 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.992 -0.549 . . . . 50.34 113.082 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.95 105.72 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.596 2.197 . . . . 73.2 112.426 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 33.9 mmtp 67.67 29.93 6.73 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.342 0.591 . . . . 75.32 111.461 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -83.47 152.71 24.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.502 -0.772 . . . . 62.03 111.13 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -135.0 150.7 50.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.839 0.352 . . . . 73.1 111.68 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.419 ' O ' HG22 ' A' ' 462' ' ' VAL . 23.8 mmtm -145.25 127.16 15.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.078 0.466 . . . . 73.51 111.32 176.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.48 112.93 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.127 0.489 . . . . 60.25 110.805 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 27.5 mt -107.93 137.14 46.45 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.051 -0.522 . . . . 73.04 111.209 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 22.4 p -112.89 149.49 33.09 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.653 0.612 . . . . 72.5 112.653 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 55.1 p90 -144.33 148.56 34.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.764 -0.653 . . . . 41.34 110.909 173.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 455' ' ' LEU . 83.0 p -115.82 115.27 25.99 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.891 0.377 . . . . 71.13 111.214 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -116.51 137.98 51.75 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.456 -0.338 . . . . 73.31 111.808 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 85.9 m -111.98 101.04 50.83 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-N 116.538 -0.301 . . . . 74.1 111.681 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 59.5 Cg_endo -71.61 88.67 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.155 1.904 . . . . 74.53 112.417 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 19.2 p -76.2 -0.99 24.2 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.102 0.408 . . . . 61.33 112.102 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -129.54 135.88 49.14 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.519 -0.309 . . . . 63.54 110.44 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -83.27 151.18 25.73 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.766 0.654 . . . . 64.03 112.766 -174.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 141.9 -179.82 19.56 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.999 -0.546 . . . . 64.05 112.518 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 56.1 mtp -93.11 115.88 28.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.486 0.643 . . . . 74.43 111.655 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -110.49 129.84 55.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.19 -0.459 . . . . 71.52 111.321 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -99.45 116.41 31.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.056 0.455 . . . . 74.5 111.598 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.73 127.65 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.847 -0.615 . . . . 64.34 110.948 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -122.42 131.42 53.87 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.494 -0.321 . . . . 74.15 111.472 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 476' ' ' ARG . . . -111.82 133.08 54.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.711 0.291 . . . . 75.23 110.37 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . 0.499 HG22 HG22 ' A' ' 532' ' ' VAL . 71.5 p -133.74 155.9 48.93 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.778 0.323 . . . . 65.21 111.517 -176.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.1 p -130.38 140.53 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.831 0.348 . . . . 71.5 111.62 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 1.6 t70 41.13 50.39 3.29 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.884 0.874 . . . . 62.21 112.754 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -53.97 -32.93 55.54 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.048 0.451 . . . . 74.02 112.178 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.58 ' HG3' HG23 ' A' ' 522' ' ' THR . 7.4 pt-20 -81.49 2.65 27.92 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.809 -0.632 . . . . 74.3 112.603 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 55.74 36.22 26.83 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.404 0.89 . . . . 61.53 113.404 171.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . 0.58 HG23 ' HG3' ' A' ' 520' ' ' GLU . 75.0 p -63.06 -25.92 68.6 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.059 0.457 . . . . 73.54 111.141 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 10.8 p -107.49 140.76 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 116.201 -0.454 . . . . 70.43 111.271 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . 0.405 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 74.6 t -90.77 115.32 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 122.148 -0.345 . . . . 60.31 110.444 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.706 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 15.2 mt-10 -113.02 -174.02 2.37 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.92 0.711 . . . . 65.25 112.92 -174.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 88.0 mt -82.6 -38.81 23.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.587 -0.733 . . . . 63.13 111.271 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -138.77 158.6 43.93 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.982 0.42 . . . . 64.2 110.942 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -129.51 -8.07 4.65 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.981 0.419 . . . . 73.43 111.553 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -77.21 -20.72 54.92 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.339 0.496 . . . . 73.32 112.339 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.424 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 17.4 p-10 -101.75 5.55 41.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.179 0.437 . . . . 64.02 112.179 -177.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -82.2 1.2 37.56 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.181 0.437 . . . . 70.3 112.181 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 516' ' ' THR . 58.3 t -131.14 129.37 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.013 0.435 . . . . 53.12 111.644 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -115.26 136.09 53.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.382 -0.372 . . . . 54.43 110.744 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 61.8 m -117.82 129.7 55.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.659 0.266 . . . . 74.33 111.552 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -139.87 129.28 24.1 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.792 0.33 . . . . 74.23 111.244 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -95.42 137.62 34.23 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.692 0.282 . . . . 72.21 111.707 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 53.6 t -123.74 141.13 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.876 0.37 . . . . 60.11 110.991 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . 0.529 ' HB3' HG22 ' A' ' 449' ' ' VAL . 48.3 t -112.54 114.83 27.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.917 0.389 . . . . 74.31 111.296 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.76 124.1 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.947 0.403 . . . . 73.43 111.357 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.29 163.17 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.299 0.571 . . . . 75.22 112.182 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 97.5 mt -90.4 14.81 11.94 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.133 -0.485 . . . . 75.02 111.83 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 C--O 1.249 1.055 0 N-CA-C 112.609 0.596 . . . . 75.43 112.609 -172.121 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 120.581 0.229 . . . . 54.44 110.642 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.438 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 55.5 Cg_endo -72.91 175.37 10.49 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.516 2.144 . . . . 61.13 113.23 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -153.94 81.42 1.14 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.086 0.469 . . . . 73.32 110.113 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.498 HD22 HD12 ' A' ' 491' ' ' LEU . 93.9 mt -87.44 143.76 27.07 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.329 0.585 . . . . 64.1 111.769 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.462 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.9 t -153.4 164.93 37.3 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.076 -0.511 . . . . 73.02 111.403 176.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 462' ' ' VAL . 30.9 m -133.71 148.19 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.142 -0.481 . . . . 62.53 111.108 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 53.1 mt-10 -127.05 132.31 50.72 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.509 -0.314 . . . . 61.51 111.113 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 63.2 mt -100.33 125.28 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.02 0.438 . . . . 53.13 110.648 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 26.9 tptp -128.05 131.6 49.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.43 -0.35 . . . . 73.44 110.893 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.75 -172.51 35.01 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 120.667 -0.777 . . . . 35.54 113.956 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.5 135.51 22.25 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.971 2.447 . . . . 71.44 113.244 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.24 -15.71 42.6 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.213 0.449 . . . . 71.41 112.213 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 86.6 t -131.28 131.56 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.59 0.233 . . . . 70.32 110.672 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.34 157.55 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.058 0.456 . . . . 73.44 111.779 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.56 158.87 26.65 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.116 -0.564 . . . . 71.11 113.124 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.558 HG22 ' ND2' ' A' ' 453' ' ' ASN . 9.1 p -66.84 134.49 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.095 0.474 . . . . 73.55 111.575 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . 0.558 ' ND2' HG22 ' A' ' 452' ' ' VAL . 44.1 m-80 64.9 9.16 5.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.542 0.737 . . . . 75.24 112.347 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -87.93 162.24 17.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.042 0.449 . . . . 71.54 111.496 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 502' ' ' SER . 27.1 tp -100.45 121.08 40.96 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.869 0.366 . . . . 72.23 111.188 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -120.34 132.72 55.41 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.569 0.223 . . . . 74.43 111.499 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.89 128.75 49.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.218 0.532 . . . . 72.43 111.919 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -122.45 154.09 38.24 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.79 -0.641 . . . . 62.45 110.803 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.546 ' HG2' HG22 ' A' ' 500' ' ' THR . 41.3 mt-10 -121.29 127.56 51.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 72.13 111.071 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.44 113.45 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.827 0.346 . . . . 62.32 110.507 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 35.5 m-70 -92.17 110.5 21.88 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.313 -0.254 . . . . 74.42 110.313 176.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 442' ' ' VAL . 24.7 m -105.45 123.07 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.098 0.475 . . . . 75.4 109.871 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.554 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.5 ptpt -141.0 145.69 36.27 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.842 0.682 . . . . 44.35 112.842 -170.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -102.66 128.4 49.38 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.345 -0.843 . . . . 70.24 109.449 173.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.554 HD21 ' HD3' ' A' ' 463' ' ' LYS . 61.1 mt -117.64 -2.03 11.52 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.097 -0.377 . . . . 71.24 111.845 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -79.69 -21.57 66.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.07 -0.586 . . . . 72.13 113.691 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.5 19.19 55.39 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.199 -0.524 . . . . 64.51 113.57 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 3.1 tt -136.86 133.63 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 122.417 -0.461 . . . . 70.24 111.185 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.492 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -62.94 130.3 42.14 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 114.202 0.441 . . . . 63.41 114.202 -176.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.477 HG11 HD11 ' A' ' 440' ' ' LEU . 61.5 t -126.81 113.6 22.36 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 112.125 0.417 . . . . 74.53 112.125 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.13 -10.28 10.26 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.208 2.605 . . . . 74.33 112.701 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 49.9 m -80.4 12.01 3.27 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.424 0.69 . . . . 72.5 112.678 -175.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 32.6 m -88.51 93.53 9.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.848 0.832 . . . . 75.33 112.257 -167.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -110.39 123.88 50.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.224 -0.898 . . . . 72.21 110.504 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.486 HG21 HG11 ' A' ' 462' ' ' VAL . 63.2 t -115.0 129.49 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.832 0.348 . . . . 75.05 111.742 -174.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -120.08 151.8 38.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.862 0.363 . . . . 75.41 111.326 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 96.6 t -121.15 122.16 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.41 -0.359 . . . . 75.53 111.189 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -116.16 136.84 52.65 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.925 0.393 . . . . 74.14 111.533 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.548 HG12 HG12 ' A' ' 513' ' ' ILE . 51.1 mt -111.86 108.47 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 122.676 0.39 . . . . 71.31 110.043 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 55.03 34.71 23.07 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.996 0.427 . . . . 63.44 111.382 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.27 0.62 84.79 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.3 -0.476 . . . . 22.51 113.652 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 36.9 m -103.31 119.61 39.2 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.373 -0.486 . . . . 60.15 111.113 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.0 tp -63.07 120.43 11.42 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.389 0.515 . . . . 74.51 112.389 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -88.64 -45.38 9.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.332 -0.395 . . . . 75.42 111.305 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . 0.549 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 31.0 ttpt -171.89 162.26 6.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.546 0.213 . . . . 72.45 111.098 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -139.95 150.98 45.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.962 0.411 . . . . 62.44 111.725 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . 0.549 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 18.7 m-90 -130.82 149.23 52.56 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.86 0.464 . . . . 74.24 111.438 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 60.8 m -120.24 118.91 31.69 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.613 0.244 . . . . 71.14 110.436 173.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.2 m -139.87 172.98 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.073 0.463 . . . . 55.25 111.713 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 96.0 p -122.88 133.23 54.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.251 -0.431 . . . . 73.34 110.329 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.498 HD12 HD22 ' A' ' 440' ' ' LEU . 96.0 mt -118.64 119.67 35.16 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.721 0.296 . . . . 73.13 111.246 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . 0.492 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -79.39 -171.52 41.46 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.186 -0.53 . . . . 73.05 113.133 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.44 106.43 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.6 2.2 . . . . 63.21 112.581 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.9 mmtp 69.89 23.38 5.56 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.118 -0.492 . . . . 62.53 111.881 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -89.04 149.97 22.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.039 0.385 . . . . 65.34 112.039 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . 0.42 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 24.1 tt0 -135.09 143.87 46.87 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.785 0.326 . . . . 72.12 111.478 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -126.89 133.59 50.65 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.819 -0.437 . . . . 70.4 109.819 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 37.9 t -101.17 112.76 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.074 0.464 . . . . 73.54 111.591 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 61.9 mt -100.38 147.65 25.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 70.55 110.933 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.546 HG22 ' HG2' ' A' ' 459' ' ' GLU . 12.0 p -125.66 149.78 48.16 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.952 0.406 . . . . 72.12 111.956 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.72 147.82 27.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.071 0.462 . . . . 70.42 111.149 172.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.519 ' HB2' HD11 ' A' ' 455' ' ' LEU . 83.2 p -111.36 119.12 37.79 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.098 -0.501 . . . . 42.1 111.067 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -107.7 136.64 47.11 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.01 0.433 . . . . 70.51 111.645 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.9 m -122.06 100.88 42.34 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.125 -0.489 . . . . 72.53 110.695 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -81.6 101.46 1.2 Allowed 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.813 2.342 . . . . 72.42 113.228 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.2 p -82.67 6.64 17.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.213 0.449 . . . . 71.12 112.213 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -140.47 127.21 20.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.565 -0.289 . . . . 73.43 110.599 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -73.19 151.62 41.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.21 0.528 . . . . 73.25 112.381 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.94 -168.89 31.88 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.151 -0.547 . . . . 75.25 113.125 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 15.8 tpt -99.2 118.1 35.15 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 122.45 -0.441 . . . . 53.15 110.993 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -123.94 113.09 18.0 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.862 0.363 . . . . 73.32 111.902 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -94.67 115.17 27.21 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.922 0.392 . . . . 72.02 110.785 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.548 HG12 HG12 ' A' ' 479' ' ' ILE . 55.9 mt -95.47 124.03 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.016 0.436 . . . . 71.31 111.045 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -123.15 145.99 48.14 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.966 0.412 . . . . 64.5 111.53 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -122.45 136.87 54.99 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.332 -0.395 . . . . 62.32 110.556 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 21.4 p -132.24 141.02 48.88 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.92 0.391 . . . . 73.34 112.032 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.31 142.0 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.78 0.324 . . . . 64.23 111.375 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.53 49.77 15.97 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.788 0.804 . . . . 74.41 111.42 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -51.7 -28.51 15.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.663 -0.699 . . . . 73.41 111.603 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -65.68 -22.21 66.61 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.052 -0.522 . . . . 74.23 111.308 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 55.97 72.14 0.51 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.358 0.599 . . . . 75.33 111.432 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 66.0 p -117.88 -14.19 10.07 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.516 0.561 . . . . 62.42 112.516 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 10.0 p -126.89 141.27 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.797 0.666 . . . . 71.01 112.797 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 87.2 t -94.29 110.76 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.959 -0.564 . . . . 61.32 110.136 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 24.9 mt-10 -102.94 179.97 4.12 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.744 0.646 . . . . 73.43 112.744 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.95 -39.89 79.26 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.032 -0.531 . . . . 73.01 112.05 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 530' ' ' ASN . 52.3 t-20 -120.26 112.86 19.58 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.924 0.392 . . . . 62.33 110.317 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -83.74 -7.94 59.36 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 120.955 0.407 . . . . 64.41 111.941 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -101.03 8.64 42.86 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.344 0.592 . . . . 73.24 110.821 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.539 ' HB2' ' HB3' ' A' ' 527' ' ' ASN . 57.6 t30 -88.85 -22.59 23.12 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.815 -0.629 . . . . 75.42 112.297 -171.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -78.51 -4.31 47.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.014 1.116 . . . . 72.23 114.014 -168.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 61.5 t -123.16 130.88 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 112.489 0.551 . . . . 74.25 112.489 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -123.82 142.03 51.49 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.298 -0.41 . . . . 54.11 111.104 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 53.1 m -128.86 135.72 49.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.355 0.502 . . . . 74.54 112.355 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -140.69 133.09 28.4 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 120.894 0.378 . . . . 73.21 111.353 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.38 130.5 43.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.928 0.344 . . . . 71.42 111.928 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 60.7 t -124.14 131.88 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.142 0.496 . . . . 74.02 111.582 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.9 t -105.9 121.99 45.21 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.423 -0.353 . . . . 74.35 111.0 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.65 120.72 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.775 0.322 . . . . 74.22 111.402 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.48 165.36 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 121.132 0.492 . . . . 44.14 111.974 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 86.0 mt -85.72 10.28 13.97 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.303 0.483 . . . . 71.24 112.303 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 112.299 0.481 . . . . 73.15 112.299 -175.613 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 110.297 -0.261 . . . . 73.44 110.297 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.616 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 55.6 Cg_endo -70.99 173.78 11.57 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.597 2.198 . . . . 72.12 113.495 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -153.84 87.59 1.22 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.731 -0.668 . . . . 55.0 109.267 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 491' ' ' LEU . 51.5 mt -91.91 111.85 23.54 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.043 -0.526 . . . . 72.14 111.549 -175.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.638 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 13.5 t -120.81 155.99 32.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.159 0.504 . . . . 70.14 111.865 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.627 HG12 HG12 ' A' ' 462' ' ' VAL . 32.2 m -126.63 148.52 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.88 -0.6 . . . . 71.32 111.116 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 41.1 mt-10 -122.97 146.88 47.23 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.715 0.265 . . . . 54.23 111.715 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.495 HD11 ' N ' ' A' ' 515' ' ' ALA . 49.1 mt -124.48 114.62 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.872 0.368 . . . . 61.5 110.547 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -129.62 139.29 51.48 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.863 0.363 . . . . 64.25 111.483 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.32 -171.37 39.83 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.36 -0.448 . . . . 70.33 112.914 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.17 135.16 28.79 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.579 2.186 . . . . 74.3 113.573 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -79.11 -50.6 10.77 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.105 0.409 . . . . 70.41 112.105 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 538' ' ' SER . 87.8 t -110.03 128.53 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.98 0.419 . . . . 70.23 111.198 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.76 160.95 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.057 0.456 . . . . 63.41 111.692 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -87.71 154.99 26.36 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.267 -0.492 . . . . 52.41 113.095 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.419 HG22 ' ND2' ' A' ' 453' ' ' ASN . 12.4 p -69.15 139.27 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 122.383 -0.481 . . . . 72.32 111.103 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . 0.419 ' ND2' HG22 ' A' ' 452' ' ' VAL . 30.9 m-80 66.5 20.18 10.87 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.202 0.601 . . . . 73.1 111.908 -176.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . 0.532 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -103.33 159.78 15.26 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.978 0.418 . . . . 72.13 111.516 176.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 502' ' ' SER . 39.2 tp -95.59 122.95 38.89 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.327 -0.397 . . . . 75.34 111.249 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.04 132.73 54.66 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.803 0.335 . . . . 74.33 111.555 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -107.6 136.18 47.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.298 0.57 . . . . 73.25 112.1 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -126.9 159.02 35.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.865 -0.607 . . . . 73.12 110.559 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.481 ' HG2' HG22 ' A' ' 500' ' ' THR . 52.2 mt-10 -119.26 127.5 53.3 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.791 0.329 . . . . 53.13 111.175 177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 43.9 t -100.8 112.52 33.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.734 -0.469 . . . . 54.35 109.734 170.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 46.1 m-70 -100.6 109.35 21.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.692 0.282 . . . . 61.14 110.255 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.648 HG11 HG21 ' A' ' 475' ' ' VAL . 10.8 m -110.82 126.37 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.18 0.514 . . . . 62.34 110.556 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.46 ' HD3' HD21 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -144.53 150.2 37.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.223 0.535 . . . . 63.43 112.375 -174.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.9 t-20 -102.61 127.14 49.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.582 -0.735 . . . . 75.12 109.592 174.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.46 HD21 ' HD3' ' A' ' 463' ' ' LYS . 97.8 mt -108.72 -10.29 15.18 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.009 0.374 . . . . 73.31 112.009 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.616 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -73.1 -19.16 79.52 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.076 -0.583 . . . . 60.03 114.052 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.71 15.53 63.31 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.032 -0.604 . . . . 60.22 113.954 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.9 tt -137.52 140.08 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 122.69 0.396 . . . . 74.44 110.863 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -75.38 142.55 29.34 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 114.827 0.691 . . . . 74.32 114.827 -172.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 471' ' ' PRO . 59.2 t -131.74 120.12 17.44 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 122.977 0.511 . . . . 73.31 111.282 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 470' ' ' VAL . 4.7 Cg_endo -86.42 -12.05 5.77 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.119 2.546 . . . . 73.1 113.098 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 23.0 t -84.33 13.39 5.4 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.959 0.726 . . . . 61.51 112.959 -175.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . 0.447 HG23 ' CG2' ' A' ' 517' ' ' VAL . 90.5 m -86.47 91.81 8.66 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.016 0.912 . . . . 72.4 112.126 -165.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -97.69 131.01 44.62 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.123 -0.944 . . . . 55.41 110.681 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.648 HG21 HG11 ' A' ' 462' ' ' VAL . 45.2 t -113.07 127.26 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.596 0.358 . . . . 71.12 110.898 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -130.17 148.02 51.96 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.898 0.38 . . . . 72.21 111.917 -175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 72.0 t -120.25 122.21 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.862 0.363 . . . . 64.53 111.134 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -113.25 136.82 52.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.357 -0.383 . . . . 70.43 111.308 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 513' ' ' ILE . 62.0 mt -110.68 112.02 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 110.068 -0.345 . . . . 71.22 110.068 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 54.77 34.93 22.91 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.901 0.381 . . . . 72.22 111.461 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 100.37 -36.33 4.21 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.189 -0.529 . . . . 43.24 113.96 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 52.2 m -82.45 131.59 35.22 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 117.163 0.481 . . . . 74.13 111.795 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.22 132.94 54.38 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.216 0.532 . . . . 64.24 111.852 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -105.19 -43.89 4.9 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.161 -0.472 . . . . 73.24 111.852 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -161.3 151.06 16.93 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.647 -0.251 . . . . 73.53 110.497 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -140.12 152.01 45.78 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.32 0.581 . . . . 71.11 112.522 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -136.62 149.42 47.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.528 -0.76 . . . . 73.14 111.063 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 63.1 m -122.97 119.13 29.48 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.14 -0.318 . . . . 74.5 110.14 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.93 173.42 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.304 0.573 . . . . 72.2 111.569 -177.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.4 p -120.45 135.02 55.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.976 -0.556 . . . . 75.14 110.479 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.512 HD12 HD22 ' A' ' 440' ' ' LEU . 74.7 mt -117.33 120.15 37.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.84 0.353 . . . . 64.42 111.315 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -83.06 -170.31 45.91 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.948 -0.644 . . . . 61.2 113.091 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.02 109.34 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.423 2.082 . . . . 62.21 112.491 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.3 mmtm 70.19 19.23 6.72 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.954 0.501 . . . . 64.13 112.176 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -80.08 150.96 30.12 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.175 0.435 . . . . 75.43 112.175 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -135.5 134.12 39.18 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.341 -0.391 . . . . 64.22 111.358 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -116.9 129.83 56.31 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.801 -0.444 . . . . 75.41 109.801 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.16 115.81 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.176 0.512 . . . . 73.03 111.303 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 76.7 mt -105.38 143.53 33.42 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.979 -0.555 . . . . 72.13 110.986 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.481 HG22 ' HG2' ' A' ' 459' ' ' GLU . 6.9 p -129.29 147.12 51.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.069 0.461 . . . . 72.53 111.409 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -149.48 148.44 29.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 75.43 110.463 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.48 ' HB2' HD11 ' A' ' 455' ' ' LEU . 79.4 p -115.6 114.18 24.58 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.222 0.534 . . . . 64.44 110.995 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -102.14 134.07 45.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 73.4 111.323 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 37.0 m -113.29 100.76 52.39 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-N 116.366 -0.379 . . . . 74.31 110.701 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.4 Cg_endo -76.06 95.4 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.485 2.123 . . . . 61.35 113.088 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 65.6 p -80.43 5.98 13.55 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.994 0.426 . . . . 75.31 111.66 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -133.56 142.53 48.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.841 0.457 . . . . 75.51 109.94 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.9 150.92 20.26 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.099 0.476 . . . . 61.25 112.168 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.96 -169.73 30.04 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.222 -0.514 . . . . 43.31 112.952 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 14.0 tpt -98.65 112.87 24.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.987 0.422 . . . . 55.12 110.447 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.26 112.37 21.49 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.907 0.384 . . . . 71.23 111.682 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -92.37 115.05 27.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.18 0.514 . . . . 61.11 110.943 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 479' ' ' ILE . 60.6 mt -98.1 125.55 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.99 -0.55 . . . . 73.01 111.453 -178.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -120.84 143.79 48.7 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.988 0.423 . . . . 73.12 111.683 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . 0.495 ' N ' HD11 ' A' ' 444' ' ' ILE . . . -120.47 138.75 53.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.322 -0.399 . . . . 51.51 110.365 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . 0.433 HG22 HG22 ' A' ' 532' ' ' VAL . 48.8 p -133.1 158.0 43.88 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.019 0.438 . . . . 50.23 111.593 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.447 ' CG2' HG23 ' A' ' 473' ' ' THR . 7.6 p -132.53 140.49 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.163 -0.471 . . . . 73.11 111.423 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 28.1 t70 42.73 54.76 4.51 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.474 0.654 . . . . 74.35 111.952 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -55.17 -32.85 62.49 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.199 0.524 . . . . 71.4 111.522 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -67.89 -5.76 18.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.282 -0.872 . . . . 74.1 112.457 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.2 t30 53.07 55.09 9.37 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.501 0.667 . . . . 73.34 111.221 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 34.9 p -88.44 -35.44 17.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 65.2 111.449 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 12.5 p -103.72 144.14 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 116.091 -0.504 . . . . 72.14 111.829 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . 0.512 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 75.4 t -83.41 114.87 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.758 0.314 . . . . 72.22 110.953 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.28 176.08 6.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.498 0.666 . . . . 75.13 112.617 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 87.4 mt -82.26 -25.65 33.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.793 -0.64 . . . . 72.02 109.947 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 26.2 t30 -155.39 110.64 3.02 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.565 -0.743 . . . . 73.15 110.447 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 38.0 mp0 -82.81 -1.61 52.28 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.985 0.421 . . . . 54.2 111.719 -173.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -93.08 -8.84 41.61 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.273 0.559 . . . . 75.33 110.973 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.638 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 65.3 t30 -86.53 -6.78 58.8 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.051 0.453 . . . . 65.13 111.743 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -79.06 8.22 6.09 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.844 0.683 . . . . 73.42 112.844 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 516' ' ' THR . 48.5 t -132.46 145.84 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.321 0.489 . . . . 73.55 112.321 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -133.9 142.31 47.71 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.288 -0.415 . . . . 72.03 110.757 172.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 90.6 m -121.89 125.38 46.29 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.354 0.501 . . . . 71.34 112.354 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -133.12 141.06 47.96 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.886 0.374 . . . . 73.11 110.495 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -116.72 126.62 53.42 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.045 0.45 . . . . 75.13 112.161 -176.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.5 t -117.21 143.72 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 116.033 -0.53 . . . . 74.31 111.783 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . 0.425 ' HB3' HG22 ' A' ' 449' ' ' VAL . 46.6 t -118.02 120.73 38.69 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.332 -0.394 . . . . 71.04 110.996 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 44.5 t -103.42 123.38 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.692 0.282 . . . . 53.12 111.23 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.7 m -109.28 160.25 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 112.612 0.597 . . . . 71.42 112.612 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.71 -5.98 57.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.296 -0.411 . . . . 64.54 112.101 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.253 1.238 0 N-CA-C 112.594 0.59 . . . . 53.24 112.594 -177.059 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 438' ' ' PRO . 98.5 m-85 . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 120.573 0.225 . . . . 75.15 111.153 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 24.5 Cg_exo -64.86 173.03 6.23 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.026 2.484 . . . . 74.24 114.417 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -161.25 86.81 0.69 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.897 -1.047 . . . . 74.45 108.462 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 74.8 mt -97.41 132.39 43.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.233 0.54 . . . . 65.33 112.006 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.519 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.0 t -132.85 151.74 51.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.03 0.443 . . . . 60.13 111.906 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 462' ' ' VAL . 32.2 m -123.23 148.66 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.95 -0.568 . . . . 62.12 111.439 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 44.4 mt-10 -130.99 129.68 42.41 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.551 -0.295 . . . . 65.53 111.68 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.6 mt -101.99 126.94 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 120.659 0.266 . . . . 74.14 110.798 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -131.68 134.58 46.09 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.411 -0.181 . . . . 73.21 111.135 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.37 -169.88 35.57 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.603 -0.808 . . . . 54.2 113.762 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.3 127.41 14.12 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.809 2.339 . . . . 63.31 113.058 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -85.86 -20.78 28.58 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.135 0.42 . . . . 52.21 112.135 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.23 121.32 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 120.625 0.25 . . . . 74.35 110.801 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 30.1 m -130.72 162.74 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.207 0.527 . . . . 73.31 111.852 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.62 163.27 28.42 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.1 -0.571 . . . . 51.31 113.246 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.545 HG22 ' ND2' ' A' ' 453' ' ' ASN . 10.8 p -70.31 140.22 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.037 0.446 . . . . 62.11 111.578 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . 0.545 ' ND2' HG22 ' A' ' 452' ' ' VAL . 42.3 m-80 63.63 18.22 10.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.084 0.554 . . . . 74.22 112.136 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -102.35 164.72 11.52 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.193 0.521 . . . . 74.12 111.937 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 502' ' ' SER . 53.2 tp -95.29 136.8 35.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.13 -0.486 . . . . 75.04 111.493 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -135.49 132.22 37.08 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.906 0.384 . . . . 63.22 110.96 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -113.49 131.96 55.85 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.045 0.45 . . . . 73.25 111.364 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 74.8 m-85 -122.28 159.49 27.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 74.34 110.957 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -120.11 127.18 52.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.994 -0.548 . . . . 74.34 110.942 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 42.1 t -102.69 112.65 36.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.829 -0.434 . . . . 24.33 109.829 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 40.2 m-70 -100.04 112.72 25.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.748 0.309 . . . . 71.51 110.315 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 442' ' ' VAL . 24.5 m -113.12 124.45 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.212 0.529 . . . . 62.13 110.828 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.46 ' HD3' HD21 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -136.4 151.67 49.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.258 0.552 . . . . 74.42 112.284 -176.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.2 t-20 -99.9 128.5 45.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.639 -0.71 . . . . 63.24 110.225 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.46 HD21 ' HD3' ' A' ' 463' ' ' LYS . 89.5 mt -113.71 -6.4 13.32 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.023 -0.423 . . . . 72.21 112.034 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -75.37 -18.89 79.82 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.971 -0.633 . . . . 74.2 113.556 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.39 19.35 69.17 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.126 -0.559 . . . . 61.42 113.383 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 10.1 tt -135.35 138.67 48.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 122.554 0.341 . . . . 74.2 110.803 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.529 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -66.73 122.86 21.04 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.402 -0.428 . . . . 30.41 113.784 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 438' ' ' PRO . 48.0 t -119.68 113.72 34.59 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 122.615 -0.344 . . . . 50.53 111.841 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.08 -11.12 10.01 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.94 2.426 . . . . 74.51 112.394 172.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . 0.607 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 47.8 m -81.23 12.04 3.82 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.857 0.863 . . . . 73.4 113.033 -173.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . 0.406 HG23 ' CG2' ' A' ' 517' ' ' VAL . 88.1 m -88.91 99.71 12.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.773 0.797 . . . . 61.1 112.332 -167.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -105.13 130.65 53.26 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.675 -0.693 . . . . 64.12 110.895 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.423 HG21 HG11 ' A' ' 462' ' ' VAL . 25.9 t -105.31 118.72 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.439 0.296 . . . . 71.02 111.03 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . 0.529 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 86.3 mtt180 -116.54 138.15 51.62 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.107 -0.371 . . . . 74.32 111.121 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 89.6 t -120.88 130.47 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.975 0.417 . . . . 71.05 111.466 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -121.68 139.29 53.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.19 -0.459 . . . . 75.43 111.257 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.506 HG12 HG12 ' A' ' 513' ' ' ILE . 55.6 mt -118.83 115.95 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 110.139 -0.319 . . . . 75.2 110.139 172.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 52.67 38.87 27.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.122 0.487 . . . . 74.22 111.573 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.91 -17.51 50.26 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.227 -0.511 . . . . 55.32 113.829 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 73.2 m -88.94 130.82 35.37 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 117.168 0.484 . . . . 74.11 111.623 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.4 tp -64.33 115.06 4.7 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.946 0.403 . . . . 72.55 111.233 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -89.99 -43.86 10.26 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.171 -0.468 . . . . 74.21 112.141 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -168.5 160.03 10.72 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.518 -0.31 . . . . 74.33 110.456 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -150.83 149.87 30.24 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.057 0.456 . . . . 64.0 112.072 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . 0.413 ' CD2' HD13 ' A' ' 499' ' ' LEU . 24.5 m-90 -129.79 144.01 51.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.848 0.459 . . . . 72.03 110.716 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 38.5 m -111.02 117.79 34.29 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.859 -0.423 . . . . 73.01 109.859 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.49 174.34 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.277 0.56 . . . . 72.43 112.02 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 83.0 p -122.55 134.99 54.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.986 -0.552 . . . . 71.11 111.046 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 94.5 mt -120.18 119.45 33.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.648 0.261 . . . . 74.21 111.084 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . 0.529 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -79.63 -171.52 41.96 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.086 -0.578 . . . . 70.5 113.205 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.63 103.5 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.668 2.245 . . . . 65.23 112.524 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.1 mttt 63.63 36.97 10.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.266 0.555 . . . . 72.44 112.117 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -95.96 155.48 16.73 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.966 -0.561 . . . . 73.4 110.845 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -134.82 143.29 46.96 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.842 0.353 . . . . 71.23 111.76 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -126.35 132.33 51.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.867 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 50.3 t -101.39 117.62 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.007 0.432 . . . . 73.2 111.435 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.413 HD13 ' CD2' ' A' ' 487' ' ' TRP . 49.7 mt -111.85 146.12 38.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.201 -0.454 . . . . 74.42 110.815 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 16.7 p -135.46 152.3 51.23 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.366 0.603 . . . . 74.33 112.354 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 47.9 p90 -145.36 154.39 42.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.768 -0.651 . . . . 72.14 111.073 175.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.524 ' HB2' HD11 ' A' ' 455' ' ' LEU . 32.3 p -112.58 114.7 27.47 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.049 0.452 . . . . 75.51 111.229 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . 0.424 ' CZ2' ' HB3' ' A' ' 505' ' ' PRO . 31.1 t90 -114.38 137.47 51.78 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.08 0.552 . . . . 72.42 111.341 -175.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 96.7 m -126.14 103.47 26.53 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 120.751 0.31 . . . . 71.41 111.749 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . 0.424 ' HB3' ' CZ2' ' A' ' 503' ' ' TRP . 98.7 Cg_endo -80.9 97.92 1.03 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.495 2.13 . . . . 70.4 112.905 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 68.4 p -77.33 -6.78 54.52 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.071 0.462 . . . . 75.12 111.121 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . 0.445 ' HB3' ' OH ' ' A' ' 511' ' ' TYR . 51.1 tt0 -114.48 141.29 47.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.122 -0.49 . . . . 74.4 110.238 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.13 149.88 21.62 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.861 0.362 . . . . 65.4 111.194 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 140.39 -171.62 23.89 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.328 -0.463 . . . . 62.31 112.883 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 94.6 mmm -83.9 127.58 33.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.076 0.465 . . . . 72.22 111.975 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . 0.445 ' OH ' ' HB3' ' A' ' 507' ' ' GLN . 76.9 m-85 -126.32 111.94 15.11 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.992 -0.549 . . . . 63.42 110.923 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -93.79 115.44 27.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.01 0.434 . . . . 51.05 111.307 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.506 HG12 HG12 ' A' ' 479' ' ' ILE . 60.3 mt -96.2 128.43 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.864 -0.607 . . . . 72.53 110.962 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -124.81 132.31 53.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.5 -0.318 . . . . 74.31 111.294 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . 0.402 ' O ' HG21 ' A' ' 442' ' ' VAL . . . -112.33 134.4 53.89 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.469 -0.332 . . . . 64.2 110.283 173.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . 0.453 HG22 HG22 ' A' ' 532' ' ' VAL . 80.2 p -133.62 141.01 47.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.918 0.39 . . . . 74.02 111.257 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.452 HG13 HD22 ' A' ' 531' ' ' ASN . 7.5 p -109.22 139.26 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.928 0.394 . . . . 65.42 110.96 174.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 34.5 t0 38.74 64.89 0.71 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.798 0.839 . . . . 73.24 112.685 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . 0.529 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.1 mm-40 -52.54 -33.7 46.76 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.498 0.666 . . . . 71.52 111.048 172.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.61 -24.28 61.05 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.18 -0.918 . . . . 72.21 111.633 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 14.7 m120 54.15 55.52 8.14 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.886 0.85 . . . . 74.11 110.521 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . 0.607 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 60.5 p -73.34 -6.06 43.67 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.888 -1.051 . . . . 63.03 111.628 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 14.5 p -134.34 143.25 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.255 -0.43 . . . . 72.41 110.9 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . 0.51 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 48.1 t -81.52 109.57 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.027 0.441 . . . . 74.45 110.998 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.482 ' HG2' ' HB2' ' A' ' 438' ' ' PRO . 37.1 mt-10 -98.58 177.02 5.45 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.274 0.559 . . . . 75.13 112.141 -175.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.03 -38.75 17.55 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.208 -0.451 . . . . 60.53 112.204 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . 0.524 HD21 ' HB2' ' A' ' 529' ' ' ASN . 7.2 t30 -142.07 120.0 12.0 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.868 0.322 . . . . 75.34 111.868 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . 0.557 ' HA ' ' OD1' ' A' ' 531' ' ' ASN . 11.4 pt-20 -93.5 14.2 19.46 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.337 0.495 . . . . 63.14 112.337 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . 0.524 ' HB2' HD21 ' A' ' 527' ' ' ASN . 73.1 m-20 -90.66 -26.38 19.62 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.335 0.494 . . . . 62.0 112.335 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.519 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 17.1 p-10 -97.89 -5.05 35.29 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 111.974 0.361 . . . . 70.33 111.974 -175.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' A' ' 528' ' ' GLU . 12.3 m120 -62.96 -24.73 68.02 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.125 0.417 . . . . 72.11 112.125 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 516' ' ' THR . 47.3 t -115.51 137.36 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.876 0.369 . . . . 64.14 111.706 -176.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.51 127.31 43.77 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.455 -0.339 . . . . 65.13 110.872 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 57.2 m -105.39 132.89 51.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.856 0.36 . . . . 60.43 111.628 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -139.7 117.28 11.47 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.765 0.317 . . . . 70.32 110.803 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.94 127.33 39.65 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.99 0.424 . . . . 64.22 111.924 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.96 137.63 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.109 -0.496 . . . . 44.52 111.235 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.8 t -107.44 122.42 46.59 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.826 0.346 . . . . 72.32 111.009 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.1 t -108.19 129.99 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.102 0.477 . . . . 54.1 111.305 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 21.5 m -125.33 162.74 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.157 0.503 . . . . 65.0 112.257 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.93 -12.23 60.11 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.945 0.402 . . . . 74.41 111.995 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 119.24 -0.409 . . . . 74.22 111.724 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 110.469 -0.197 . . . . 74.22 110.469 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.553 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 58.5 Cg_endo -72.67 173.34 13.51 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.216 1.944 . . . . 74.31 113.152 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -153.29 87.99 1.28 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.892 -0.595 . . . . 63.04 109.59 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.1 mt -89.15 112.0 22.89 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.278 -0.419 . . . . 75.24 111.548 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.56 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.0 t -120.84 158.97 26.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.067 0.46 . . . . 62.34 111.688 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.622 HG12 HG12 ' A' ' 462' ' ' VAL . 35.2 m -134.31 148.59 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.062 -0.517 . . . . 34.51 111.537 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.624 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.3 mt-10 -125.45 136.3 53.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.479 -0.328 . . . . 72.52 111.258 177.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 515' ' ' ALA . 56.2 mt -105.41 124.61 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.733 0.301 . . . . 70.23 110.536 174.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 29.1 tptp -132.88 131.99 41.57 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.616 -0.266 . . . . 75.25 110.931 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 166.32 -175.06 41.85 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.743 -0.742 . . . . 50.14 113.801 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.03 134.16 31.05 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.983 2.455 . . . . 74.03 113.537 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.6 -38.53 65.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.192 -0.458 . . . . 71.12 111.911 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.18 131.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.642 0.258 . . . . 53.33 111.31 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.61 163.53 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 121.176 0.512 . . . . 64.32 111.672 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.43 158.44 21.01 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.183 -0.532 . . . . 71.11 113.341 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.409 HG11 HD23 ' A' ' 541' ' ' LEU . 14.0 p -64.9 137.94 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 O-C-N 122.54 -0.388 . . . . 73.33 111.598 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . 0.401 ' OD1' ' HA ' ' A' ' 506' ' ' THR . 92.9 m-20 62.6 14.62 7.27 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.511 0.56 . . . . 71.23 112.511 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.5 mmmt -94.33 150.02 20.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.818 0.342 . . . . 64.34 111.155 175.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 502' ' ' SER . 32.2 tp -92.77 117.07 29.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.872 0.368 . . . . 72.14 110.936 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -120.67 132.69 55.23 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.901 0.382 . . . . 72.03 111.679 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -102.16 139.15 38.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.154 0.502 . . . . 71.11 111.84 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -123.66 165.14 17.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.862 -0.608 . . . . 62.31 111.26 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 445' ' ' LYS . 51.5 mt-10 -119.95 127.49 52.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.911 -0.586 . . . . 54.34 110.907 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.5 t -108.27 112.78 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.668 -0.493 . . . . 64.31 109.668 170.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.624 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 48.3 m-70 -97.92 107.65 20.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.737 0.303 . . . . 75.41 110.641 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.756 HG11 HG21 ' A' ' 475' ' ' VAL . 14.0 m -108.34 125.98 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.01 0.433 . . . . 74.02 110.55 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.602 ' HD3' HD21 ' A' ' 465' ' ' LEU . 16.0 ptpt -145.76 147.02 31.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.549 0.574 . . . . 75.54 112.549 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.9 t-20 -100.31 126.99 46.71 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.756 -0.657 . . . . 75.02 109.557 174.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.602 HD21 ' HD3' ' A' ' 463' ' ' LYS . 85.6 mt -116.26 8.65 14.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.037 0.384 . . . . 70.33 112.037 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -86.59 -20.89 53.15 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.099 -0.572 . . . . 52.13 113.02 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.74 14.34 63.33 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.116 -0.564 . . . . 44.45 113.591 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 7.4 tt -136.42 133.78 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 122.608 -0.348 . . . . 75.04 110.934 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.43 143.84 37.92 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 114.824 0.69 . . . . 44.43 114.824 -172.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.27 113.53 15.82 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 122.702 0.401 . . . . 64.44 111.41 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.79 -10.57 10.55 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.093 2.529 . . . . 74.34 113.324 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 65.6 m -87.87 13.22 11.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.602 0.761 . . . . 51.54 112.839 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 96.9 m -87.86 106.87 18.38 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.678 0.752 . . . . 71.52 112.649 -165.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -107.42 131.26 54.47 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.551 -0.749 . . . . 65.25 111.243 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.756 HG21 HG11 ' A' ' 462' ' ' VAL . 45.6 t -114.79 127.86 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 122.609 0.364 . . . . 63.34 110.823 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . 0.453 ' NH2' ' HB2' ' A' ' 519' ' ' GLU . 20.9 mtm180 -130.53 152.94 49.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.068 0.461 . . . . 62.14 112.16 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.21 122.73 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.111 -0.495 . . . . 65.24 111.319 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -113.93 137.53 51.56 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.2 -0.454 . . . . 63.14 111.388 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.539 HG12 HG12 ' A' ' 513' ' ' ILE . 58.9 mt -114.38 111.07 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 109.909 -0.404 . . . . 63.42 109.909 174.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 58.01 33.53 23.29 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.265 0.555 . . . . 74.33 110.8 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 91.79 -19.51 47.98 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.073 -0.512 . . . . 74.52 113.783 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 34.3 m -82.23 124.46 29.94 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.331 -0.511 . . . . 74.21 111.41 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.9 tp -64.91 115.16 5.08 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.083 0.468 . . . . 74.11 111.186 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -91.23 -44.03 9.47 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.15 -0.477 . . . . 74.12 111.979 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -162.98 155.49 18.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.648 0.261 . . . . 73.2 111.159 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . 0.411 ' HB3' ' HG2' ' A' ' 476' ' ' ARG . 0.8 OUTLIER -143.23 143.35 31.71 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.744 0.646 . . . . 73.22 112.744 -177.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -129.52 146.61 51.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.751 -0.659 . . . . 73.43 110.786 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 66.4 m -115.87 118.09 32.0 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.012 -0.366 . . . . 65.32 110.012 170.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.35 173.22 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.343 0.592 . . . . 54.14 112.022 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 72.0 p -124.76 132.93 53.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.06 -0.518 . . . . 73.33 110.569 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.26 121.52 38.88 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.894 0.378 . . . . 41.22 111.203 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -79.7 -170.51 40.41 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.318 -0.467 . . . . 22.22 113.429 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.03 110.6 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.573 2.182 . . . . 62.2 112.626 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.9 mmtp 62.82 37.76 12.08 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.086 0.469 . . . . 74.04 111.428 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -105.03 147.34 27.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.187 -0.46 . . . . 74.22 111.554 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -132.51 143.44 49.75 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.161 0.505 . . . . 61.54 112.332 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -126.37 144.05 50.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.938 -0.573 . . . . 74.13 110.775 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.64 112.01 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 121.033 0.444 . . . . 75.0 110.696 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.4 mt -106.41 125.61 51.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.351 -0.386 . . . . 75.33 110.315 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 35.2 p -113.39 153.33 28.75 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.238 0.542 . . . . 74.2 112.165 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -144.51 150.9 38.33 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.824 -0.625 . . . . 65.21 110.382 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.525 ' HB2' HD11 ' A' ' 455' ' ' LEU . 87.3 p -110.19 114.32 27.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.797 0.332 . . . . 74.45 110.585 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -106.26 130.24 54.15 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.017 0.437 . . . . 75.2 111.936 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 85.5 m -113.97 100.96 53.47 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 115.97 -0.559 . . . . 55.42 110.86 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 72.0 Cg_endo -74.26 91.05 0.96 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.426 2.084 . . . . 72.21 113.018 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . 0.401 ' HA ' ' OD1' ' A' ' 453' ' ' ASN . 58.0 p -67.97 -16.92 64.27 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.193 0.442 . . . . 72.2 112.193 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -119.34 132.86 55.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.441 -0.345 . . . . 64.25 110.499 174.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.32 150.87 22.39 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.533 0.682 . . . . 65.13 112.469 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.45 -168.43 30.94 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.691 -0.686 . . . . 44.03 112.249 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 13.8 tpt -94.68 124.46 38.73 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 122.332 -0.51 . . . . 73.4 111.076 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -127.92 152.95 47.23 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.042 0.448 . . . . 74.34 112.007 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -123.78 122.31 37.7 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.206 -0.452 . . . . 74.45 110.87 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.539 HG12 HG12 ' A' ' 479' ' ' ILE . 59.8 mt -103.1 123.93 56.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.968 0.414 . . . . 72.14 111.125 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -119.73 138.9 53.03 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.398 -0.364 . . . . 75.03 111.419 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . 0.428 ' N ' HD11 ' A' ' 444' ' ' ILE . . . -112.44 134.02 54.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.925 0.393 . . . . 70.31 110.481 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 82.4 p -123.34 144.43 49.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.169 -0.469 . . . . 74.53 111.254 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.405 HG13 HD22 ' A' ' 531' ' ' ASN . 7.1 p -120.83 139.61 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.594 0.235 . . . . 63.15 111.133 174.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 35.8 t0 36.28 60.97 0.83 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.876 0.87 . . . . 74.31 112.855 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . 0.453 ' HB2' ' NH2' ' A' ' 476' ' ' ARG . 39.9 mt-10 -58.63 -32.66 69.24 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.044 0.45 . . . . 75.21 110.985 173.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -66.23 -24.21 66.56 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.357 -0.608 . . . . 65.31 109.357 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . 0.436 HD22 ' HA ' ' A' ' 521' ' ' ASN . 1.2 t-20 51.04 74.15 0.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.965 -1.016 . . . . 72.43 110.809 177.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 30.3 p -84.83 -10.64 56.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.879 -1.055 . . . . 64.13 111.408 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.443 HG21 ' HG3' ' A' ' 438' ' ' PRO . 11.3 p -135.24 143.61 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.914 -0.585 . . . . 43.04 112.255 -172.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.2 t -82.47 115.48 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.074 0.464 . . . . 63.43 110.709 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -107.2 -179.84 4.05 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.821 0.674 . . . . 63.32 112.821 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.98 -39.06 51.86 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.983 -0.553 . . . . 74.21 112.237 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -142.54 124.19 14.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.225 0.536 . . . . 72.1 111.432 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -84.08 -20.2 33.03 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.965 -0.562 . . . . 54.4 111.956 -175.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -85.48 3.42 40.37 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.11 0.481 . . . . 62.23 111.092 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.56 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 66.7 t30 -92.16 -13.24 30.95 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.21 0.528 . . . . 72.15 111.376 -176.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . 0.405 HD22 HG13 ' A' ' 517' ' ' VAL . 11.6 m120 -78.81 0.22 27.89 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.368 0.877 . . . . 64.1 113.368 -174.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.6 t -130.68 135.38 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.588 0.588 . . . . 75.2 112.588 -175.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -122.11 142.85 49.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.148 -0.478 . . . . 73.44 110.859 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 92.7 m -124.01 126.13 45.76 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.617 0.599 . . . . 73.41 112.617 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -139.67 123.44 17.48 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.517 -0.31 . . . . 74.11 110.964 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -93.64 137.3 33.04 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.984 0.421 . . . . 71.11 111.96 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.38 132.29 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.227 -0.442 . . . . 71.5 111.444 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.0 t -100.44 117.76 35.27 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.319 -0.4 . . . . 30.31 110.993 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.481 HG11 ' HB2' ' A' ' 505' ' ' PRO . 38.2 t -106.21 130.65 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.96 0.41 . . . . 64.43 111.466 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 16.2 m -133.27 168.23 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 120.978 0.418 . . . . 72.31 111.993 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . 0.409 HD23 HG11 ' A' ' 452' ' ' VAL . 83.7 mt -74.58 -36.98 63.03 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.495 0.554 . . . . 64.11 112.495 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--O 1.253 1.259 0 N-CA-C 112.83 0.678 . . . . 65.12 112.83 -176.666 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 110.014 -0.365 . . . . 63.32 110.014 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.572 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 55.3 Cg_endo -80.13 174.86 10.96 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.552 2.168 . . . . 74.11 113.746 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -147.81 93.39 2.19 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.29 -0.868 . . . . 62.14 109.651 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.417 HD11 HG11 ' A' ' 470' ' ' VAL . 79.3 mt -91.81 111.87 23.57 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.098 0.475 . . . . 74.35 111.357 -177.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.41 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.0 t -114.47 148.36 37.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.165 0.507 . . . . 72.45 111.35 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.554 HG12 HG12 ' A' ' 462' ' ' VAL . 33.8 m -121.99 148.13 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.079 -0.51 . . . . 65.54 111.069 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 36.6 mt-10 -131.81 139.76 48.97 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.415 -0.357 . . . . 63.25 110.563 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 56.1 mt -114.16 132.69 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.899 0.381 . . . . 71.52 111.381 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -135.27 147.07 49.12 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.403 -0.362 . . . . 61.11 111.308 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.0 -173.35 35.86 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.001 -0.619 . . . . 62.31 113.103 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.18 129.61 18.52 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.63 2.22 . . . . 74.13 113.306 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.33 -41.9 65.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.044 0.449 . . . . 70.44 111.475 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.31 129.48 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.339 -0.391 . . . . 72.4 111.111 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.22 163.15 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.91 0.385 . . . . 73.02 111.509 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -92.92 153.36 21.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.306 -0.473 . . . . 74.55 112.99 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.561 HG22 ' ND2' ' A' ' 453' ' ' ASN . 12.1 p -67.43 136.66 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.001 0.429 . . . . 53.05 111.745 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . 0.561 ' ND2' HG22 ' A' ' 452' ' ' VAL . 46.6 m-80 65.07 17.57 11.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.239 0.616 . . . . 75.5 112.298 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -104.38 167.17 9.92 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.13 0.49 . . . . 70.55 111.75 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 502' ' ' SER . 31.6 tp -100.34 131.3 46.34 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.268 -0.424 . . . . 72.43 111.423 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.45 132.39 45.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.844 0.354 . . . . 74.12 111.796 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -103.68 135.55 45.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.866 0.365 . . . . 74.44 111.278 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -125.54 161.6 26.79 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.449 -0.342 . . . . 73.25 110.909 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -119.67 127.93 53.34 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.782 0.325 . . . . 74.41 111.234 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 50.4 t -102.44 113.11 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.95 0.405 . . . . 75.33 110.012 170.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 41.1 m-70 -96.57 105.71 17.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.454 -0.339 . . . . 62.25 110.857 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.681 HG11 HG21 ' A' ' 475' ' ' VAL . 17.5 m -106.52 123.69 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.15 0.5 . . . . 64.55 110.476 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.484 ' HD3' HD21 ' A' ' 465' ' ' LEU . 3.7 ptpp? -142.52 148.21 37.26 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.878 0.695 . . . . 72.25 112.878 -173.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.1 t-20 -99.42 128.55 45.55 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.347 -0.842 . . . . 71.13 109.814 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.484 HD21 ' HD3' ' A' ' 463' ' ' LYS . 81.8 mt -111.71 -14.73 13.56 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.092 0.405 . . . . 75.42 112.092 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -66.27 -22.7 71.2 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 121.479 -0.391 . . . . 64.23 113.947 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.45 18.79 56.41 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.178 -0.534 . . . . 23.31 113.912 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.427 HG23 ' HB3' ' A' ' 438' ' ' PRO . 5.5 tt -137.44 138.1 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 122.795 0.438 . . . . 62.24 111.001 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -65.19 135.08 36.82 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.485 -0.388 . . . . 73.11 113.87 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.417 HG11 HD11 ' A' ' 440' ' ' LEU . 60.3 t -129.0 114.71 18.81 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 112.16 0.43 . . . . 63.21 112.16 -176.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.58 -10.94 14.4 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.037 2.491 . . . . 65.15 112.504 173.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . 0.45 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 50.3 m -81.15 11.84 3.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.617 0.767 . . . . 72.44 112.976 -175.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 48.6 m -88.95 94.05 9.81 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.798 0.809 . . . . 75.21 112.183 -169.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -111.67 123.38 50.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.293 -0.867 . . . . 64.32 110.507 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.681 HG21 HG11 ' A' ' 462' ' ' VAL . 29.6 t -105.49 132.49 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 111.873 0.323 . . . . 73.22 111.873 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -128.25 144.53 51.13 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.901 0.381 . . . . 74.23 111.366 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -121.19 126.7 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.895 0.379 . . . . 74.23 111.266 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 482' ' ' THR . 82.6 m-85 -121.93 137.03 54.95 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.309 -0.405 . . . . 72.21 111.426 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 513' ' ' ILE . 59.0 mt -108.73 107.5 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 110.091 -0.337 . . . . 73.02 110.091 173.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 57.66 34.1 24.07 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.896 0.379 . . . . 70.54 111.289 -174.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.23 -10.36 74.47 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.207 -0.52 . . . . 64.51 113.537 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 478' ' ' TYR . 40.9 m -85.14 127.32 34.21 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.603 -0.351 . . . . 73.02 111.17 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.8 tp -69.15 118.41 12.01 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.853 0.359 . . . . 53.22 111.331 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -94.79 -45.1 7.47 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.818 0.342 . . . . 72.21 111.743 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -170.52 160.08 7.16 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.564 0.221 . . . . 74.32 111.073 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -132.1 157.2 44.81 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.088 0.47 . . . . 75.44 111.52 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 30.9 m-90 -135.99 143.78 44.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.095 0.558 . . . . 74.05 110.785 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 98.8 m -122.09 116.97 25.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.711 0.291 . . . . 70.34 110.422 173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.7 173.93 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.363 0.601 . . . . 62.23 111.872 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 55.1 p -125.68 133.68 52.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.958 -0.565 . . . . 75.13 110.693 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.437 HD21 ' HG2' ' A' ' 497' ' ' LYS . 75.3 mt -116.94 120.46 38.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.796 0.331 . . . . 74.44 111.502 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -75.35 -170.51 27.77 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.052 -0.594 . . . . 63.2 112.746 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.89 118.08 4.95 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.175 1.917 . . . . 73.13 112.364 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 74.4 mmtt 65.32 21.8 12.01 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.111 -0.495 . . . . 72.21 112.109 175.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -89.98 154.74 19.6 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.454 0.539 . . . . 65.44 112.454 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -135.0 145.09 47.75 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.855 0.359 . . . . 70.21 111.927 177.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.437 ' HG2' HD21 ' A' ' 491' ' ' LEU . 31.6 mmmt -122.31 129.83 52.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.2 -0.454 . . . . 74.01 109.887 170.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.2 t -100.28 117.31 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.183 0.516 . . . . 73.32 111.213 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 50.9 mt -106.61 146.46 30.67 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.027 -0.533 . . . . 54.31 111.05 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 21.3 p -127.06 147.02 50.16 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.005 0.431 . . . . 71.1 111.657 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -147.87 148.67 31.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.113 -0.494 . . . . 62.34 110.648 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.533 ' HB2' HD11 ' A' ' 455' ' ' LEU . 68.3 p -113.0 114.07 26.38 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.269 0.557 . . . . 75.43 111.419 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -106.2 137.2 44.56 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.643 -0.708 . . . . 75.25 111.341 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.7 m -119.35 100.8 49.7 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.606 -0.27 . . . . 63.34 111.125 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.47 108.43 1.72 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.624 2.216 . . . . 72.42 113.353 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 58.7 p -85.16 -13.43 50.11 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.108 0.41 . . . . 73.14 112.108 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -113.55 134.87 54.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.66 0.266 . . . . 75.41 111.183 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.74 151.55 37.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.6 0.714 . . . . 72.5 112.387 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 135.97 175.76 14.0 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.815 -0.629 . . . . 23.52 112.538 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 65.0 mtp -88.35 128.13 35.5 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.176 0.512 . . . . 65.02 111.542 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -120.05 119.48 33.49 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.15 -0.477 . . . . 60.42 110.762 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -92.75 114.37 26.91 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.059 0.457 . . . . 63.41 110.857 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 479' ' ' ILE . 59.0 mt -98.77 123.64 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.039 -0.528 . . . . 70.21 111.277 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -120.72 136.82 54.76 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.87 0.367 . . . . 72.32 111.806 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.27 143.99 42.43 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.327 -0.397 . . . . 72.23 110.917 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . 0.418 HG22 HG22 ' A' ' 532' ' ' VAL . 60.8 p -131.14 157.0 44.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.253 -0.43 . . . . 73.41 111.427 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.74 140.18 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 121.005 0.431 . . . . 72.34 111.403 171.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 25.2 t0 41.51 62.48 1.52 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.138 0.975 . . . . 70.33 113.159 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.7 -30.86 71.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.015 0.436 . . . . 61.14 111.317 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.12 -9.38 39.1 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.254 -0.43 . . . . 54.51 112.121 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 57.61 49.69 12.15 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.141 0.496 . . . . 62.22 111.383 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 60.1 p -88.03 -12.31 44.71 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.294 -0.412 . . . . 61.23 111.773 -178.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.28 142.34 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.877 0.37 . . . . 61.52 111.242 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . 0.448 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 74.8 t -82.75 110.25 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.023 0.44 . . . . 72.02 111.218 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.69 162.12 13.91 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.845 -0.616 . . . . 74.43 112.117 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.72 -38.79 73.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.83 -0.623 . . . . 74.4 111.564 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -137.82 126.4 23.59 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.802 -0.181 . . . . 42.1 111.16 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -83.47 -24.88 31.6 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 62.41 111.109 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -81.34 -0.66 42.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.181 -0.463 . . . . 61.13 112.088 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.41 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 57.8 t30 -96.47 -23.0 16.78 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.897 0.379 . . . . 72.1 111.765 -177.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.78 16.37 1.16 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.058 0.762 . . . . 62.12 113.058 -174.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.418 HG22 HG22 ' A' ' 516' ' ' THR . 77.0 t -135.08 142.5 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 120.896 0.379 . . . . 73.23 111.62 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -127.25 144.03 51.12 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.545 0.338 . . . . 71.41 111.103 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.9 m -123.42 124.99 44.14 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.559 0.578 . . . . 75.24 112.559 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -134.13 124.22 25.73 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.682 0.277 . . . . 74.43 110.545 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.17 130.19 45.46 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.361 0.6 . . . . 72.14 112.132 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.38 145.02 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.729 -0.669 . . . . 75.33 111.413 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 48.3 t -117.68 113.99 22.71 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.853 0.358 . . . . 61.42 111.236 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.91 120.16 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.503 -0.317 . . . . 73.21 111.223 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.8 m -114.84 165.38 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.099 0.476 . . . . 61.35 112.231 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.8 mt -82.24 -1.26 48.72 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.204 0.446 . . . . 71.13 112.204 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--O 1.253 1.27 0 N-CA-C 112.126 0.417 . . . . 72.32 112.126 -179.138 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 120.715 0.293 . . . . 71.43 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.526 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 60.5 Cg_endo -72.13 174.92 10.62 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.794 2.329 . . . . 53.52 113.02 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 25.4 t70 -150.0 81.22 1.38 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.866 -0.606 . . . . 62.3 109.901 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.521 HD22 HD12 ' A' ' 491' ' ' LEU . 43.7 mt -84.45 105.72 15.48 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.858 -0.61 . . . . 64.22 111.487 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.472 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 8.1 t -113.08 148.08 35.97 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.079 0.466 . . . . 74.33 111.334 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.629 HG12 HG12 ' A' ' 462' ' ' VAL . 27.3 m -121.08 146.91 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.226 -0.443 . . . . 75.14 111.108 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 46.3 mt-10 -137.0 136.35 38.4 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.252 -0.431 . . . . 65.41 111.305 -175.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.2 mt -110.14 132.51 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.914 0.388 . . . . 74.44 111.62 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -136.61 136.39 39.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.45 -0.341 . . . . 74.04 111.093 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.51 -170.76 39.79 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.209 -0.52 . . . . 73.22 112.97 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.77 121.21 7.7 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.574 2.183 . . . . 72.42 112.921 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.4 -16.75 44.68 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.041 0.385 . . . . 73.52 112.041 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 63.6 t -129.33 123.97 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.682 0.277 . . . . 72.24 110.676 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.41 160.99 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.281 0.562 . . . . 74.53 112.27 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.43 158.19 26.28 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.049 -0.523 . . . . 62.12 112.8 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.411 HG11 HD23 ' A' ' 541' ' ' LEU . 13.8 p -69.21 140.54 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 120.95 0.405 . . . . 63.0 111.948 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 68.1 12.35 8.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.178 0.591 . . . . 73.52 112.405 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -93.58 174.63 7.09 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.0 0.429 . . . . 72.1 111.476 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 502' ' ' SER . 40.3 tp -108.15 119.39 39.34 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.894 0.378 . . . . 74.24 111.338 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.05 131.55 56.33 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.026 0.441 . . . . 64.31 111.54 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -116.65 130.44 56.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.281 0.562 . . . . 53.41 111.658 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -122.56 162.37 21.94 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.786 -0.643 . . . . 75.23 111.089 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -120.34 127.55 52.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.828 0.347 . . . . 72.54 111.151 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.3 t -100.49 113.25 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.077 0.465 . . . . 71.23 110.151 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 52.2 m-70 -94.27 105.85 17.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.29 -0.413 . . . . 74.22 110.341 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.629 HG12 HG12 ' A' ' 442' ' ' VAL . 8.7 m -106.19 123.12 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.119 0.485 . . . . 54.31 110.246 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.457 ' HG3' HG23 ' A' ' 441' ' ' THR . 3.5 ptpp? -139.39 147.05 40.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.158 0.504 . . . . 64.0 112.276 -173.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 53.5 t-20 -104.69 126.91 52.23 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.801 -0.636 . . . . 71.43 109.877 175.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 89.3 mt -103.97 -20.61 13.82 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.051 -0.406 . . . . 72.33 111.972 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -60.94 -26.01 64.89 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.309 -0.472 . . . . 74.14 114.016 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.81 18.35 56.49 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.986 -0.626 . . . . 65.43 113.471 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.6 tt -137.07 133.8 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 122.613 0.365 . . . . 73.4 110.705 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.9 145.31 41.39 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 114.718 0.647 . . . . 62.41 114.718 -174.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.8 117.9 16.42 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 122.817 0.447 . . . . 63.11 111.44 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.67 -12.19 11.23 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.752 2.302 . . . . 72.33 112.594 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 17.3 m -81.02 11.63 3.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.812 0.845 . . . . 74.02 112.804 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 74.1 m -88.57 93.83 9.68 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.952 0.882 . . . . 54.32 112.591 -166.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -99.02 126.37 44.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.203 -0.908 . . . . 73.35 110.176 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.582 HG21 HG11 ' A' ' 462' ' ' VAL . 47.3 t -112.17 118.81 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.754 0.312 . . . . 54.44 110.97 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -125.25 152.64 44.33 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.123 0.487 . . . . 72.21 111.785 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 99.3 t -121.21 130.07 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.108 -0.496 . . . . 43.33 111.33 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -123.39 136.46 54.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.077 -0.51 . . . . 74.04 111.592 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 65.6 mt -109.33 112.33 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 110.076 -0.342 . . . . 64.14 110.076 174.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 53.87 33.75 17.85 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.974 0.416 . . . . 64.22 111.45 -175.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 99.54 -23.67 35.26 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.252 -0.499 . . . . 32.23 113.91 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 85.3 m -82.86 133.52 35.12 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.338 0.569 . . . . 75.22 111.763 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.5 tp -68.01 116.84 9.1 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.008 0.432 . . . . 74.44 111.495 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -96.5 -43.57 7.56 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.957 0.354 . . . . 71.35 111.957 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . 0.5 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 8.9 tppt? -150.23 155.26 39.39 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.593 -0.276 . . . . 61.41 110.822 -174.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . 0.431 ' N ' ' HG3' ' A' ' 485' ' ' LYS . 8.1 p30 -143.97 141.99 30.49 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.995 0.426 . . . . 74.35 111.525 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . 0.5 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 8.6 m-90 -133.19 148.7 52.06 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.145 -0.479 . . . . 73.33 111.126 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 65.1 m -120.34 119.04 31.96 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.234 -0.284 . . . . 74.53 110.234 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.5 174.79 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.132 0.492 . . . . 62.51 111.491 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 92.5 p -121.64 139.4 53.59 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.527 -0.306 . . . . 61.24 110.332 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.521 HD12 HD22 ' A' ' 440' ' ' LEU . 68.1 mt -117.78 120.6 38.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.884 0.374 . . . . 64.24 111.105 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -84.37 -169.37 45.47 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.239 -0.505 . . . . 42.24 112.939 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.27 111.95 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.399 2.066 . . . . 74.24 112.519 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 45.5 mmtm 66.46 18.41 10.82 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.267 -0.424 . . . . 74.41 112.01 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -86.39 149.14 25.22 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.064 0.394 . . . . 63.2 112.064 -176.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -133.84 135.7 43.92 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.235 -0.439 . . . . 75.33 111.618 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.409 ' O ' HG22 ' A' ' 462' ' ' VAL . 2.3 mmmp? -122.39 134.09 54.63 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.44 -0.345 . . . . 50.34 110.582 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.73 115.67 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.979 0.418 . . . . 62.45 111.247 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 72.0 mt -107.92 128.93 55.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.247 -0.433 . . . . 61.44 110.801 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 36.5 p -113.08 150.01 32.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.546 0.688 . . . . 74.14 112.617 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -145.65 148.34 32.98 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.586 -0.734 . . . . 74.11 110.982 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.525 ' HB2' HD11 ' A' ' 455' ' ' LEU . 78.5 p -111.69 113.57 26.02 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.182 0.515 . . . . 43.24 111.216 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -108.63 134.27 51.6 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.391 -0.368 . . . . 71.23 110.993 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.3 m -111.08 100.72 47.94 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-N 116.37 -0.377 . . . . 63.25 110.946 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . 0.479 ' HB2' HG11 ' A' ' 539' ' ' VAL . 71.6 Cg_endo -74.06 88.77 1.07 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.258 1.972 . . . . 73.31 112.693 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 22.4 p -73.97 -14.24 61.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.211 0.448 . . . . 74.34 112.211 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -115.75 146.21 42.11 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.706 0.288 . . . . 74.15 110.711 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.12 149.55 21.49 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.83 0.348 . . . . 51.15 111.87 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.3 -167.62 27.92 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.998 -0.62 . . . . 63.35 113.416 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 2.4 tpt -90.91 107.63 19.32 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.795 0.331 . . . . 53.22 111.503 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -114.17 146.84 39.8 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.051 -0.406 . . . . 51.43 111.526 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 35.5 ttp180 -124.42 116.78 23.09 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.554 -0.293 . . . . 72.24 111.268 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 63.2 mt -96.4 130.16 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.843 0.354 . . . . 60.25 111.249 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -125.41 147.79 49.05 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.869 0.366 . . . . 71.34 111.567 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -121.63 133.68 54.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.317 -0.401 . . . . 60.32 110.604 174.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.0 p -127.57 142.65 51.31 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.813 0.339 . . . . 52.34 111.726 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.43 139.66 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 120.733 0.302 . . . . 74.34 111.3 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 46.6 t0 38.96 66.59 0.52 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.682 0.793 . . . . 63.25 112.595 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.95 -31.81 72.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.097 -0.501 . . . . 63.45 111.655 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.88 -19.63 62.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.352 -0.386 . . . . 74.14 111.044 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.1 m120 59.74 51.88 5.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.46 0.648 . . . . 71.33 110.917 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 68.5 p -67.02 -29.09 68.81 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.76 -0.654 . . . . 73.15 111.205 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.41 HG21 ' HG3' ' A' ' 438' ' ' PRO . 9.8 p -114.88 143.41 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.03 -0.532 . . . . 43.25 111.032 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . 0.492 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 51.4 t -82.62 118.18 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.071 0.462 . . . . 70.33 111.227 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -92.38 162.01 14.43 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.775 -0.648 . . . . 70.12 112.593 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 87.5 mt -70.05 -38.12 75.71 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.134 -0.485 . . . . 71.1 110.814 172.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -130.53 118.17 20.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.089 -0.505 . . . . 74.34 111.079 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.39 3.16 32.99 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.007 0.432 . . . . 73.2 112.106 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -107.19 16.78 23.71 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.542 0.687 . . . . 71.22 110.03 173.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.472 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.4 t30 -100.18 -22.44 15.16 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.514 -0.766 . . . . 54.53 112.41 -170.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -81.58 11.54 4.57 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.913 1.079 . . . . 72.35 113.913 -167.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.73 144.22 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.501 0.556 . . . . 45.24 112.501 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . 0.541 ' HB2' HG23 ' A' ' 442' ' ' VAL . . . -129.28 142.75 50.75 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.997 -0.547 . . . . 53.23 110.957 173.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.0 m -128.49 123.3 33.25 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.975 0.417 . . . . 43.31 111.872 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -142.74 117.72 10.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.881 0.372 . . . . 74.21 110.652 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 0.5 OUTLIER -97.24 137.21 36.6 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.485 0.66 . . . . 72.1 112.561 -177.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.58 132.38 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.653 -0.703 . . . . 74.53 111.558 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.3 t -99.27 122.04 41.88 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.893 0.377 . . . . 63.1 111.07 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 505' ' ' PRO . 26.1 t -103.85 132.42 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.441 -0.345 . . . . 71.43 110.688 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.83 164.37 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.092 0.472 . . . . 71.3 112.241 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . 0.411 HD23 HG11 ' A' ' 452' ' ' VAL . 95.4 mt -78.42 -1.9 35.77 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.265 0.468 . . . . 65.52 112.265 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.254 1.332 0 N-CA-C 112.434 0.531 . . . . 75.33 112.434 -175.707 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 120.655 0.264 . . . . 53.14 110.495 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 72.0 Cg_endo -77.0 173.85 13.8 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.506 2.137 . . . . 54.5 114.241 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -145.17 94.93 2.59 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.161 -0.927 . . . . 75.21 108.679 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.529 HD22 HD12 ' A' ' 491' ' ' LEU . 66.5 mt -100.25 120.66 40.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.076 0.465 . . . . 73.41 111.579 -172.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.623 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.5 t -129.36 159.55 35.85 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.319 0.58 . . . . 54.12 112.375 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.631 HG12 HG12 ' A' ' 462' ' ' VAL . 28.7 m -122.42 148.37 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.772 -0.649 . . . . 74.54 111.473 -178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 37.6 mt-10 -132.27 136.87 47.24 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.406 -0.361 . . . . 74.3 110.241 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 56.6 mt -112.88 126.95 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 120.934 0.397 . . . . 62.34 111.8 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -131.0 144.05 51.18 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.198 -0.455 . . . . 60.45 110.334 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.9 -176.35 36.63 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.653 -0.784 . . . . 63.4 113.317 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.52 114.86 3.43 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.842 2.362 . . . . 71.12 113.122 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -74.93 -14.49 60.65 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.611 0.597 . . . . 72.31 112.611 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.65 126.48 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 122.171 -0.331 . . . . 45.02 110.76 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.93 162.09 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.261 0.553 . . . . 73.1 111.796 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.96 153.91 20.14 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.213 -0.518 . . . . 52.31 112.957 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.566 HG11 HD23 ' A' ' 541' ' ' LEU . 14.5 p -64.0 142.22 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 O-C-N 122.619 -0.342 . . . . 72.44 111.414 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 65.82 13.45 9.0 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.628 0.603 . . . . 75.21 112.628 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -105.29 162.75 13.15 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.059 0.457 . . . . 61.15 111.943 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 502' ' ' SER . 49.2 tp -92.94 133.54 36.01 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.468 -0.333 . . . . 73.21 111.634 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -131.4 132.58 44.49 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.797 0.332 . . . . 73.42 111.46 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -112.92 131.88 55.56 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.804 0.335 . . . . 53.31 111.183 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 61.6 m-85 -121.59 157.61 30.39 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.235 -0.438 . . . . 75.11 111.013 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.511 ' HG2' HG22 ' A' ' 500' ' ' THR . 41.9 mt-10 -120.26 127.02 52.01 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.997 -0.547 . . . . 63.14 111.344 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.62 113.68 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.165 173.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.546 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 44.8 m-70 -95.09 111.63 23.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.869 0.366 . . . . 75.32 110.267 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.631 HG12 HG12 ' A' ' 442' ' ' VAL . 33.1 m -106.57 122.71 60.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.99 0.424 . . . . 71.44 110.652 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.527 ' HD3' HD21 ' A' ' 465' ' ' LEU . 1.4 ptpp? -130.42 148.55 52.25 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.295 0.569 . . . . 64.55 112.282 -174.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.569 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.7 t-20 -99.64 128.07 45.75 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.668 -0.696 . . . . 73.32 110.014 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.527 HD21 ' HD3' ' A' ' 463' ' ' LYS . 79.9 mt -109.45 -10.7 14.88 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.752 0.311 . . . . 73.2 111.747 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -76.26 -28.48 60.0 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.294 -0.479 . . . . 40.55 113.566 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.13 22.39 45.27 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.955 -0.64 . . . . 72.04 113.389 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.6 tt -137.73 135.82 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 122.738 0.415 . . . . 53.25 111.102 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.413 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -70.02 133.08 24.32 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 114.608 0.603 . . . . 62.4 114.608 -174.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.39 118.48 17.09 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.21 0.604 . . . . 63.22 111.306 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -88.85 -9.86 4.47 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.074 2.516 . . . . 73.12 113.851 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.3 p -81.65 11.95 4.29 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.83 0.678 . . . . 72.15 112.83 -177.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . 0.486 ' HA ' ' OD1' ' A' ' 518' ' ' ASP . 98.7 m -87.24 109.96 19.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.072 0.939 . . . . 44.35 112.094 -164.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -119.99 128.14 53.28 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.009 -0.996 . . . . 75.03 110.892 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.629 HG21 HG11 ' A' ' 462' ' ' VAL . 25.1 t -104.59 135.83 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.404 -0.362 . . . . 62.04 111.902 -175.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . 0.562 ' NH1' ' HB2' ' A' ' 519' ' ' GLU . 59.2 mtt85 -123.64 143.39 50.27 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.369 -0.378 . . . . 75.31 111.273 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.52 123.18 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 120.996 0.427 . . . . 61.33 111.123 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -111.55 137.82 48.9 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.042 -0.526 . . . . 63.45 110.7 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 62.5 mt -115.99 109.66 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 110.025 -0.361 . . . . 75.43 110.025 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 55.16 34.62 23.04 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.089 0.471 . . . . 73.41 111.292 -174.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 97.39 -24.09 33.0 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.049 -0.523 . . . . 72.0 113.699 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 66.0 m -82.67 120.4 25.52 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.394 -0.474 . . . . 55.53 111.76 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -62.8 115.05 4.0 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.054 0.454 . . . . 75.15 110.971 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -89.74 -43.54 10.62 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.382 0.512 . . . . 64.14 112.382 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -164.45 161.23 21.31 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.19 -0.319 . . . . 44.34 111.454 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.58 154.98 42.75 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.936 0.398 . . . . 74.51 111.941 177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -135.02 148.87 50.05 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.848 0.459 . . . . 73.42 111.431 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 79.6 m -105.64 119.24 38.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 110.156 -0.313 . . . . 75.44 110.156 171.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.07 173.34 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.394 0.616 . . . . 62.44 111.876 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 75.1 p -126.58 134.71 50.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.081 -0.508 . . . . 63.4 110.686 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.529 HD12 HD22 ' A' ' 440' ' ' LEU . 92.1 mt -117.38 118.89 33.48 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.875 0.369 . . . . 65.13 111.275 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . 0.413 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -81.47 -166.56 36.95 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.193 -0.527 . . . . 60.32 112.652 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.03 107.12 0.73 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.15 1.9 . . . . 74.43 112.172 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 41.6 mmtm 68.66 22.9 7.32 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.204 -0.453 . . . . 52.34 111.772 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -81.81 149.88 28.14 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.892 0.33 . . . . 74.21 111.892 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 462' ' ' VAL . 41.5 tt0 -135.38 134.59 39.91 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.744 0.307 . . . . 63.12 111.286 176.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -118.91 149.79 40.98 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.639 -0.255 . . . . 73.5 110.621 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.92 113.22 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.001 0.429 . . . . 71.42 111.48 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 50.6 mt -105.71 146.23 30.05 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.242 -0.436 . . . . 65.24 111.047 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.511 HG22 ' HG2' ' A' ' 459' ' ' GLU . 20.9 p -129.47 149.8 51.09 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.367 0.603 . . . . 72.44 112.611 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 49.0 p90 -144.33 148.46 34.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.793 -0.639 . . . . 70.53 111.156 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.568 ' HB2' HD11 ' A' ' 455' ' ' LEU . 24.8 p -110.96 115.06 28.85 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.207 0.527 . . . . 72.43 111.577 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -120.88 137.44 54.58 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.008 -0.542 . . . . 51.3 111.601 -174.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 92.9 m -120.61 102.05 45.32 Favored Pre-proline 0 N--CA 1.473 0.688 0 CA-C-N 116.458 -0.337 . . . . 65.11 111.282 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.97 104.43 1.91 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.578 2.185 . . . . 74.52 113.068 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 77.0 p -86.82 -15.76 38.23 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.021 0.438 . . . . 73.22 111.995 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.22 137.13 42.59 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.731 0.301 . . . . 71.1 110.837 171.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.17 150.21 25.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.009 0.433 . . . . 74.25 112.151 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 143.98 -167.73 26.7 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.177 -0.535 . . . . 75.02 113.181 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 89.6 mmm -89.57 121.1 31.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.064 0.459 . . . . 74.5 111.395 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -121.58 111.7 17.55 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.427 0.632 . . . . 74.4 111.207 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -104.02 120.34 40.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.805 -0.634 . . . . 72.32 111.308 -177.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 62.2 mt -95.73 128.44 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.841 -0.618 . . . . 73.34 111.473 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -122.95 135.3 54.43 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.196 -0.457 . . . . 74.24 111.041 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.56 139.53 48.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.784 0.325 . . . . 62.41 111.416 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . 0.527 HG22 HG22 ' A' ' 532' ' ' VAL . 71.2 p -129.26 151.85 49.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.921 0.391 . . . . 73.02 111.035 177.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.5 p -130.0 141.8 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.525 -0.307 . . . . 52.23 111.524 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' A' ' 473' ' ' THR . 1.3 m-20 50.17 47.91 22.9 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.456 0.539 . . . . 72.53 112.456 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . 0.562 ' HB2' ' NH1' ' A' ' 476' ' ' ARG . 6.0 mm-40 -53.62 -32.78 52.67 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.283 0.475 . . . . 74.13 112.283 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.42 -17.05 64.12 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.171 0.434 . . . . 72.21 112.171 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 49.84 37.17 12.81 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.742 0.645 . . . . 64.3 112.742 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 38.5 p -72.38 -16.66 61.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.858 0.361 . . . . 60.44 111.78 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 8.3 p -108.01 136.53 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.417 -0.356 . . . . 74.04 111.07 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . 0.434 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 90.7 t -84.23 113.3 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.873 0.368 . . . . 75.33 110.879 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -100.61 174.23 6.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.259 0.552 . . . . 65.41 112.269 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.7 mt -82.85 -24.39 33.29 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.68 -0.691 . . . . 72.21 111.675 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . 0.57 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 25.0 t-20 -118.6 158.24 25.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.145 0.498 . . . . 54.34 111.579 -174.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -118.35 -23.8 7.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.165 -0.471 . . . . 74.43 111.981 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -105.89 -7.39 18.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.3 0.481 . . . . 72.42 112.3 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.623 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 58.2 t30 -86.77 -7.7 58.02 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.713 0.634 . . . . 72.43 112.713 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -75.42 -0.27 19.44 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.159 0.799 . . . . 73.33 113.159 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 516' ' ' THR . 48.4 t -126.86 146.05 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.439 0.533 . . . . 53.31 112.439 -175.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . 0.407 ' CB ' HG23 ' A' ' 442' ' ' VAL . . . -136.14 142.69 44.25 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.245 -0.434 . . . . 53.31 111.276 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.8 m -117.3 134.83 54.34 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.404 0.52 . . . . 72.53 112.404 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -138.54 126.64 22.71 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.369 -0.378 . . . . 63.03 110.363 174.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -102.6 123.44 46.34 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.825 0.345 . . . . 74.32 111.85 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.47 144.45 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.996 0.427 . . . . 71.4 111.667 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.0 t -112.95 127.03 56.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.776 0.322 . . . . 75.14 111.413 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.1 120.51 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.85 0.357 . . . . 74.41 111.066 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.74 158.91 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.442 0.534 . . . . 55.22 112.442 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . 0.566 HD23 HG11 ' A' ' 452' ' ' VAL . 89.9 mt -81.3 -28.43 34.62 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.251 -0.431 . . . . 74.02 111.632 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.254 1.339 0 N-CA-C 112.725 0.639 . . . . 75.31 112.725 -176.893 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 438' ' ' PRO . 96.5 m-85 . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 120.689 0.28 . . . . 75.34 110.474 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.479 ' HG2' HG21 ' A' ' 523' ' ' VAL . 2.6 Cg_exo -75.03 173.91 13.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.922 2.415 . . . . 71.33 114.223 -176.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -152.87 78.2 1.18 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.784 -1.098 . . . . 73.41 108.972 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.418 HD22 HD12 ' A' ' 491' ' ' LEU . 70.4 mt -84.12 110.48 18.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.669 -0.696 . . . . 73.13 111.416 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.472 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 13.7 t -115.57 149.32 38.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.146 0.498 . . . . 70.31 111.459 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.599 HG12 HG12 ' A' ' 462' ' ' VAL . 27.1 m -121.02 148.41 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.966 -0.561 . . . . 73.13 111.144 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 43.7 mt-10 -139.69 131.58 27.65 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.496 -0.32 . . . . 73.21 110.872 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 53.8 mt -105.55 138.69 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 122.129 -0.357 . . . . 72.12 111.463 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -141.59 134.97 29.56 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 120.563 0.221 . . . . 65.02 111.287 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.68 -164.87 37.63 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.947 -0.644 . . . . 63.31 113.678 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.2 136.84 32.81 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.743 2.296 . . . . 65.03 113.44 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -82.95 -44.94 14.73 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.898 0.38 . . . . 70.44 111.751 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.16 133.72 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 120.989 0.423 . . . . 71.4 111.278 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.5 m -135.7 162.99 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.068 0.461 . . . . 75.1 111.539 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -98.34 165.65 21.66 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.178 -0.534 . . . . 71.44 113.056 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.523 HG22 ' ND2' ' A' ' 453' ' ' ASN . 11.9 p -69.44 136.76 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 120.853 0.359 . . . . 63.13 111.591 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . 0.523 ' ND2' HG22 ' A' ' 452' ' ' VAL . 53.3 m-80 64.67 15.65 9.87 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.151 0.58 . . . . 71.32 112.547 -176.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . 0.419 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.0 mmmt -95.82 143.93 26.62 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.13 0.49 . . . . 70.44 111.656 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 502' ' ' SER . 43.1 tp -81.75 123.14 28.51 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.277 -0.42 . . . . 71.31 111.159 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -118.36 132.31 56.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.84 0.352 . . . . 75.12 111.288 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -120.7 132.03 54.86 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.201 0.524 . . . . 50.42 111.747 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -123.76 159.42 29.51 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.739 -0.664 . . . . 75.45 110.96 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.471 ' HG3' HG22 ' A' ' 500' ' ' THR . 1.9 mp0 -120.22 127.46 52.45 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.069 0.462 . . . . 74.44 110.745 175.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.7 t -100.52 121.46 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.274 -0.421 . . . . 50.52 111.48 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 11.6 m-70 -96.22 110.58 22.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.081 -0.509 . . . . 74.11 110.522 176.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.599 HG12 HG12 ' A' ' 442' ' ' VAL . 19.8 m -114.4 123.42 70.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.962 0.411 . . . . 75.33 110.342 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.587 ' HD3' HD21 ' A' ' 465' ' ' LEU . 4.5 ptpp? -139.17 148.37 43.1 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.467 0.651 . . . . 75.32 112.705 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 49.4 t-20 -100.23 127.58 46.48 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.495 -0.775 . . . . 61.12 109.873 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.587 HD21 ' HD3' ' A' ' 463' ' ' LYS . 77.9 mt -115.02 -2.66 12.76 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.364 0.505 . . . . 64.02 112.364 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -72.88 -22.85 78.8 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.979 -0.629 . . . . 53.14 113.174 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.75 16.42 59.92 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.255 -0.498 . . . . 73.24 113.307 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 10.2 tt -135.69 139.73 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 122.729 -0.277 . . . . 73.3 110.942 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.4 137.08 25.65 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.171 -0.538 . . . . 55.15 114.079 -176.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 57.7 t -131.68 112.9 15.16 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 120.802 0.334 . . . . 75.33 111.796 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -88.01 -10.9 4.78 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.3 2.667 . . . . 50.44 113.057 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 79.9 p -81.95 13.3 3.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.534 0.734 . . . . 72.21 112.674 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 91.0 m -87.42 108.82 19.18 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.755 0.788 . . . . 62.15 112.436 -164.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -110.57 130.59 55.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.352 -0.84 . . . . 70.33 111.42 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.533 HG21 HG11 ' A' ' 462' ' ' VAL . 47.3 t -111.53 130.74 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 122.314 0.246 . . . . 63.1 110.981 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . 0.603 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 96.0 mtt180 -124.2 150.11 45.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.945 0.402 . . . . 65.44 111.418 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.98 120.71 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.218 -0.446 . . . . 55.34 111.085 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -113.75 137.1 52.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.473 -0.33 . . . . 74.35 110.99 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 513' ' ' ILE . 63.2 mt -113.34 111.89 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 110.166 -0.309 . . . . 61.02 110.166 174.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 54.46 34.38 20.84 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.108 0.48 . . . . 64.34 111.77 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.18 -19.06 55.35 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.382 -0.437 . . . . 71.31 113.482 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 89.7 m -87.11 124.38 33.18 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.543 -0.386 . . . . 55.52 111.693 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.6 tp -62.7 120.4 11.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.1 0.476 . . . . 63.11 111.774 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . 0.453 ' CE2' ' HE2' ' A' ' 485' ' ' LYS . 19.3 t80 -94.81 -43.07 8.39 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.19 -0.459 . . . . 74.33 112.124 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . 0.453 ' HE2' ' CE2' ' A' ' 484' ' ' TYR . 4.5 ttpt -167.67 159.78 12.21 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 122.235 -0.291 . . . . 74.54 111.464 -177.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -143.17 144.12 32.06 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.939 0.4 . . . . 64.23 112.037 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -132.78 149.6 52.25 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.991 0.516 . . . . 75.3 111.208 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.0 m -118.06 119.95 36.31 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 110.202 -0.295 . . . . 74.24 110.202 170.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.48 172.98 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.32 0.581 . . . . 71.11 111.966 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 79.1 p -111.9 137.4 49.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.04 -0.527 . . . . 74.43 110.752 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.418 HD12 HD22 ' A' ' 440' ' ' LEU . 69.0 mt -127.55 118.99 25.01 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.828 0.347 . . . . 73.34 110.721 174.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -84.43 -174.79 50.53 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.951 -0.642 . . . . 74.32 112.702 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.97 105.84 0.23 Allowed 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.365 2.043 . . . . 70.23 112.052 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.7 mmtp 71.59 29.19 2.67 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.154 0.427 . . . . 75.23 112.154 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.95 155.31 17.14 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.814 0.34 . . . . 61.33 111.869 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -130.34 143.21 50.63 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.215 -0.448 . . . . 64.44 111.393 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.445 ' HB2' ' CG2' ' A' ' 462' ' ' VAL . 43.6 mmtm -117.21 146.85 42.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.052 0.541 . . . . 65.32 110.039 172.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.57 113.14 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.047 0.451 . . . . 73.04 110.938 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 56.7 mt -110.84 141.24 44.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.405 -0.362 . . . . 73.52 111.166 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.471 HG22 ' HG3' ' A' ' 459' ' ' GLU . 21.5 p -113.81 151.7 31.69 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.493 0.553 . . . . 74.14 112.493 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -150.84 148.51 28.56 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.019 -0.537 . . . . 63.15 111.311 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.569 ' HB2' HD11 ' A' ' 455' ' ' LEU . 89.9 p -118.42 125.89 50.91 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.271 -0.422 . . . . 75.53 111.111 -178.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -125.97 136.8 53.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.914 0.388 . . . . 74.04 111.136 -177.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.4 m -121.31 100.77 44.71 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.694 0.283 . . . . 64.33 111.016 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 80.3 Cg_endo -77.64 106.3 2.17 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.623 2.215 . . . . 62.03 113.108 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.8 p -87.54 12.17 13.09 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.042 0.386 . . . . 72.25 112.042 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -142.74 132.72 24.31 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.711 0.404 . . . . 61.31 110.967 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -73.68 150.73 41.07 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.475 0.546 . . . . 73.22 112.475 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 145.76 -173.35 26.15 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.879 -0.676 . . . . 35.4 113.397 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 95.9 mmm -99.31 112.61 24.74 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.049 0.452 . . . . 72.12 111.032 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -115.05 119.21 35.68 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.2 0.524 . . . . 75.33 111.431 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -97.72 117.91 33.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.104 -0.498 . . . . 73.23 111.153 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 479' ' ' ILE . 65.0 mt -95.29 120.01 44.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.0 -0.545 . . . . 73.32 111.119 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.48 137.35 52.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.934 0.397 . . . . 72.52 111.341 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.1 132.96 54.54 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.299 -0.409 . . . . 70.53 110.738 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . 0.488 HG22 HG22 ' A' ' 532' ' ' VAL . 43.9 p -126.03 141.14 52.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.887 0.375 . . . . 73.34 111.244 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.36 141.89 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.95 0.405 . . . . 74.52 111.43 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.3 t0 49.89 58.66 5.21 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.643 0.735 . . . . 62.44 111.919 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . 0.603 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.9 mm-40 -59.12 -32.69 70.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.284 0.564 . . . . 75.51 111.322 174.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.55 -18.05 64.27 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.763 -0.653 . . . . 71.41 111.68 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 52.02 70.22 0.58 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.719 0.771 . . . . 54.51 110.8 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 67.4 p -96.76 -10.87 25.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.472 -0.785 . . . . 73.33 111.689 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.479 HG21 ' HG2' ' A' ' 438' ' ' PRO . 11.7 p -141.66 144.15 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.057 0.456 . . . . 74.42 111.736 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.5 t -82.79 116.27 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.968 0.413 . . . . 74.31 111.528 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.88 156.25 17.62 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.888 -0.597 . . . . 73.22 112.423 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.84 -38.85 70.05 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.765 -0.652 . . . . 65.22 111.329 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -119.81 122.07 40.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.842 0.353 . . . . 72.34 110.703 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -83.05 -17.55 42.84 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.006 0.431 . . . . 70.12 111.934 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -102.08 14.98 30.46 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.102 -0.374 . . . . 74.34 111.669 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.472 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 66.3 t30 -104.93 -11.39 16.72 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.289 0.477 . . . . 73.35 112.289 -172.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -86.56 6.11 32.33 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.923 0.712 . . . . 72.23 112.923 -172.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 516' ' ' THR . 51.4 t -130.42 143.15 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.018 0.437 . . . . 54.05 112.107 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -129.73 143.2 50.7 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.386 -0.37 . . . . 72.41 111.023 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 56.9 m -117.78 135.48 54.03 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.856 0.36 . . . . 61.34 111.909 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -141.98 116.91 9.9 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.51 -0.552 . . . . 74.23 109.51 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -101.62 124.34 47.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.201 0.524 . . . . 60.34 111.813 -175.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.7 t -112.32 144.44 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.961 -0.563 . . . . 72.42 111.64 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 30.1 t -112.38 128.53 56.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.525 -0.307 . . . . 44.33 111.131 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.6 t -111.12 125.59 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 120.827 0.346 . . . . 73.24 111.691 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.75 161.12 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.165 0.507 . . . . 71.23 111.893 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.0 -14.37 58.0 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.754 0.65 . . . . 65.04 112.754 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 112.856 0.687 . . . . 62.21 112.856 -176.298 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 120.582 0.229 . . . . 73.21 110.788 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.626 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 20.6 Cg_endo -79.99 174.37 11.63 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.334 2.022 . . . . 52.31 113.53 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 11.7 t70 -149.38 82.96 1.42 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.686 -0.688 . . . . 73.2 109.794 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.522 HD11 HG11 ' A' ' 470' ' ' VAL . 92.1 mt -84.73 114.76 22.28 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.105 -0.498 . . . . 72.2 111.771 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.476 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.2 t -126.37 158.6 35.47 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.009 0.433 . . . . 63.13 111.382 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 462' ' ' VAL . 33.8 m -132.1 148.13 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 116.112 -0.495 . . . . 65.32 111.319 -177.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.5 mt-10 -125.08 137.15 54.2 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.421 0.288 . . . . 71.01 110.994 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.8 mt -108.76 127.68 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.919 0.39 . . . . 41.03 111.471 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -128.37 132.04 48.55 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.673 -0.239 . . . . 75.33 111.15 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 172.15 -173.77 45.27 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.654 -0.784 . . . . 75.13 113.678 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.75 136.48 23.26 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.774 2.316 . . . . 73.3 113.395 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.57 -47.89 58.04 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.966 -0.561 . . . . 65.45 111.898 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.1 t -117.83 125.83 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.765 0.317 . . . . 72.11 111.078 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.3 160.77 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.179 0.514 . . . . 73.41 111.867 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.53 148.56 19.34 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.074 -0.584 . . . . 63.14 113.323 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.526 HG22 ' ND2' ' A' ' 453' ' ' ASN . 11.0 p -64.39 138.42 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 120.857 0.361 . . . . 72.1 111.284 177.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . 0.526 ' ND2' HG22 ' A' ' 452' ' ' VAL . 45.0 m-80 63.56 18.68 11.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.959 0.504 . . . . 72.14 111.951 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -108.9 161.38 15.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.194 0.521 . . . . 71.21 111.623 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 502' ' ' SER . 37.8 tp -99.0 126.24 44.65 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.004 -0.544 . . . . 55.04 111.745 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.51 132.69 45.75 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.814 0.34 . . . . 54.21 111.582 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -104.98 138.58 40.97 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.42 0.629 . . . . 72.15 112.098 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 59.1 m-85 -122.84 151.34 41.79 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.554 -0.748 . . . . 71.55 110.302 177.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -120.02 127.2 52.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.094 0.474 . . . . 75.22 111.029 -175.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 21.6 t -105.07 114.78 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.101 -0.5 . . . . 75.21 111.124 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.591 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 46.8 m-70 -92.16 107.56 19.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.851 0.358 . . . . 74.43 110.299 174.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.621 HG11 HG21 ' A' ' 475' ' ' VAL . 20.2 m -105.55 133.21 50.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.927 0.394 . . . . 71.43 110.193 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.564 ' HD3' HD21 ' A' ' 465' ' ' LEU . 0.1 OUTLIER -148.2 152.3 36.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.585 0.587 . . . . 61.25 112.585 -172.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.553 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.8 t-20 -107.72 127.46 53.7 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.634 -0.712 . . . . 73.52 109.524 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.564 HD21 ' HD3' ' A' ' 463' ' ' LYS . 79.9 mt -111.86 0.05 16.02 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.172 0.434 . . . . 62.05 112.172 -176.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -82.91 -25.38 49.61 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.92 -0.657 . . . . 55.0 113.632 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.88 22.73 41.22 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.101 -0.571 . . . . 73.2 113.577 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 9.5 tt -138.18 144.18 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 122.51 -0.406 . . . . 63.14 110.763 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.48 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -71.82 138.72 27.51 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.154 -0.546 . . . . 62.14 114.059 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.522 HG11 HD11 ' A' ' 440' ' ' LEU . 40.7 t -129.71 117.36 18.44 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 112.34 0.496 . . . . 72.51 112.34 -177.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.2 -11.0 8.77 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.105 2.537 . . . . 73.24 112.759 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 57.7 m -80.98 11.44 4.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.457 0.703 . . . . 45.32 112.685 -176.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 39.3 m -88.97 91.1 8.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.661 0.743 . . . . 63.23 112.422 -166.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 517' ' ' VAL . 95.9 mttt -96.81 131.33 43.65 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.514 -0.766 . . . . 71.32 110.152 171.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.621 HG21 HG11 ' A' ' 462' ' ' VAL . 49.4 t -117.89 118.36 58.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 122.12 -0.363 . . . . 61.0 110.709 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -126.43 153.47 44.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.276 0.56 . . . . 63.23 112.076 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 84.8 t -120.41 135.79 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.006 -0.543 . . . . 75.14 111.141 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . 0.403 ' HE1' ' OG1' ' A' ' 516' ' ' THR . 25.1 m-85 -124.51 142.09 51.59 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.188 -0.46 . . . . 74.41 111.196 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 513' ' ' ILE . 64.5 mt -114.82 111.55 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.295 -0.412 . . . . 74.13 109.998 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 54.34 34.03 19.74 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.195 0.521 . . . . 72.21 111.278 -173.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 98.07 -25.69 26.58 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.177 -0.465 . . . . 72.34 113.765 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 28.0 m -82.04 129.75 34.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.327 0.563 . . . . 74.15 111.851 -174.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.3 tp -62.48 124.23 20.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.096 0.474 . . . . 71.42 111.689 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -105.58 -43.72 4.87 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.518 0.562 . . . . 74.02 112.518 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . 0.419 ' HD3' ' HB3' ' A' ' 501' ' ' PHE . 83.6 tttt -155.45 152.55 29.12 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 110.324 -0.25 . . . . 74.31 110.324 -176.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -141.09 147.89 39.27 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.434 0.531 . . . . 75.04 112.434 -176.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.5 m-90 -132.69 148.81 52.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.949 -0.569 . . . . 74.54 110.94 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.9 m -124.88 117.12 23.39 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.557 -0.534 . . . . 70.24 109.557 167.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.42 172.87 11.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.139 0.495 . . . . 75.41 111.587 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 30.3 m -116.93 133.89 55.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.186 -0.461 . . . . 70.35 110.335 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 72.8 mt -120.53 120.48 35.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.941 0.401 . . . . 74.41 110.978 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . 0.48 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -80.85 -168.83 40.14 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.176 -0.535 . . . . 51.5 113.141 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -63.08 109.95 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.463 2.109 . . . . 71.2 112.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.5 mttt 63.45 37.48 10.62 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.618 0.723 . . . . 75.45 111.239 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -85.98 149.35 25.24 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.208 -0.905 . . . . 71.1 111.419 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -136.09 145.42 45.91 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.839 0.352 . . . . 71.12 111.473 172.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -141.6 147.33 37.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.002 0.521 . . . . 73.22 111.018 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 42.3 t -111.15 112.99 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.209 0.528 . . . . 33.13 111.54 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.7 127.85 55.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.178 -0.465 . . . . 74.23 110.268 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 76.0 p -112.96 163.05 15.14 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.136 0.791 . . . . 73.22 113.136 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . 0.419 ' HB3' ' HD3' ' A' ' 485' ' ' LYS . 47.8 p90 -152.23 148.29 27.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.305 -0.861 . . . . 74.34 110.906 172.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.569 ' HB2' HD11 ' A' ' 455' ' ' LEU . 78.6 p -114.9 114.72 25.86 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.072 0.463 . . . . 64.04 111.08 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . 0.47 ' CZ2' ' HB3' ' A' ' 505' ' ' PRO . 25.1 t90 -107.73 137.33 45.94 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.069 0.547 . . . . 75.14 111.776 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 93.4 m -125.9 101.47 29.39 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 116.407 -0.36 . . . . 73.3 111.02 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . 0.47 ' HB3' ' CZ2' ' A' ' 503' ' ' TRP . 85.5 Cg_endo -82.22 102.18 1.18 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.528 2.152 . . . . 74.21 113.321 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 63.4 p -76.38 -21.77 55.63 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.856 0.36 . . . . 74.44 111.185 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -107.91 125.76 51.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.932 0.396 . . . . 65.43 111.373 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.06 150.86 46.15 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.4 0.519 . . . . 74.31 112.4 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.83 -173.12 33.23 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.083 -0.579 . . . . 74.1 113.061 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 8.8 tpt -99.71 126.94 45.83 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.577 -0.366 . . . . 74.55 110.727 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -132.86 112.0 11.54 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.337 0.495 . . . . 75.33 112.337 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -93.03 118.23 30.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.869 0.366 . . . . 74.23 110.776 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 479' ' ' ILE . 64.2 mt -95.47 127.93 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.093 0.473 . . . . 74.21 111.507 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -121.43 152.57 38.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.926 0.393 . . . . 73.4 111.194 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -128.9 135.35 48.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.769 0.318 . . . . 41.12 111.135 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 532' ' ' VAL . 38.5 p -123.73 149.44 45.55 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.326 -0.397 . . . . 71.24 111.431 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 474' ' ' LYS . 7.3 p -119.4 139.56 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 116.422 -0.354 . . . . 73.24 111.459 170.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.9 t70 43.8 70.41 0.32 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.609 0.764 . . . . 63.01 111.687 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -61.97 -33.06 73.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.792 -0.64 . . . . 71.24 111.437 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.34 -13.66 62.5 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.651 0.612 . . . . 72.33 112.651 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.1 t30 56.34 55.9 6.22 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.535 0.683 . . . . 71.21 110.428 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 68.5 p -85.25 -31.73 22.96 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.923 -0.58 . . . . 70.34 111.133 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.56 141.75 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.01 -0.541 . . . . 65.54 111.034 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.8 112.13 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.844 0.354 . . . . 74.34 111.557 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.483 ' OE2' ' HG2' ' A' ' 438' ' ' PRO . 13.5 mm-40 -91.22 163.7 14.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.258 0.551 . . . . 73.13 112.124 -176.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.6 mt -71.98 -39.14 69.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.279 0.561 . . . . 72.34 110.854 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -129.46 110.48 11.91 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.945 -0.57 . . . . 54.54 110.271 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . 0.403 ' HA ' ' OD1' ' A' ' 531' ' ' ASN . 10.0 pt-20 -83.09 -21.8 33.6 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.989 0.423 . . . . 62.43 111.4 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -75.39 -12.31 60.23 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.147 0.499 . . . . 72.33 110.821 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.476 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 41.7 t30 -86.72 -14.62 41.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.999 -0.546 . . . . 74.14 111.145 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . 0.463 HD22 HG13 ' A' ' 517' ' ' VAL . 11.8 m120 -69.0 -13.97 62.77 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.08 0.77 . . . . 62.14 113.08 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.531 HG22 HG22 ' A' ' 516' ' ' THR . 57.7 t -116.57 134.0 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.528 0.566 . . . . 73.13 112.528 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -114.42 143.07 45.52 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.218 -0.446 . . . . 63.15 110.54 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 70.0 m -125.76 125.86 43.64 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.022 0.439 . . . . 60.02 111.888 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -137.65 122.98 19.44 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.042 0.449 . . . . 74.11 110.781 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -93.36 129.12 39.6 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.411 -0.359 . . . . 64.22 111.386 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.87 142.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.332 0.587 . . . . 63.43 111.93 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 22.8 t -118.38 127.2 53.45 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.343 -0.389 . . . . 75.41 111.189 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.0 t -104.85 123.62 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.825 0.345 . . . . 62.34 111.31 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 31.0 m -116.1 161.75 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.795 0.665 . . . . 62.43 112.795 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.02 -17.38 43.54 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.037 -0.529 . . . . 74.31 111.737 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.253 1.267 0 CA-C-N 116.031 -0.531 . . . . 73.2 112.176 178.499 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 110.392 -0.225 . . . . 71.12 110.392 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.595 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 72.9 Cg_endo -74.27 169.53 22.27 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.344 2.029 . . . . 61.43 113.567 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . 0.458 ' HB2' HD12 ' A' ' 526' ' ' LEU . 37.3 t70 -128.74 96.05 4.27 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.727 -0.669 . . . . 74.03 109.833 176.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 491' ' ' LEU . 88.7 mt -94.36 112.81 24.61 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.873 0.368 . . . . 61.31 111.077 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.514 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 6.8 t -122.46 153.42 39.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.994 0.426 . . . . 73.41 111.92 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.617 HG12 HG12 ' A' ' 462' ' ' VAL . 32.2 m -129.79 150.16 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.131 -0.486 . . . . 62.53 111.814 -177.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 49.6 mt-10 -130.23 144.81 51.58 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.21 -0.45 . . . . 54.03 110.918 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 53.4 mt -116.27 129.66 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.931 0.395 . . . . 74.14 111.199 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -134.19 137.43 44.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.414 -0.357 . . . . 74.11 110.981 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.29 -176.87 40.86 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.265 -0.969 . . . . 61.34 114.074 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.62 117.18 5.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.831 2.354 . . . . 73.52 113.071 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -71.85 -30.37 65.37 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.783 0.66 . . . . 64.12 112.783 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 94.6 t -120.73 122.98 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.885 -0.51 . . . . 62.15 111.503 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.97 163.28 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.084 0.469 . . . . 71.45 112.059 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.75 156.91 24.13 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.346 -0.454 . . . . 50.05 113.296 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.569 HG22 ' ND2' ' A' ' 453' ' ' ASN . 10.7 p -69.95 140.41 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.015 0.436 . . . . 63.12 111.807 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . 0.569 ' ND2' HG22 ' A' ' 452' ' ' VAL . 56.4 m-80 60.7 24.4 14.22 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.52 0.563 . . . . 62.33 112.52 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -105.94 176.13 5.27 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.125 0.488 . . . . 74.03 111.733 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 41.9 tp -105.09 120.2 40.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.338 -0.392 . . . . 62.25 111.431 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -129.25 132.78 47.27 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.739 0.304 . . . . 74.42 111.647 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -112.28 139.85 47.49 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.294 0.569 . . . . 61.55 111.548 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 53.7 m-85 -121.97 157.51 31.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.752 -0.658 . . . . 65.22 110.726 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -121.0 129.01 53.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.922 0.489 . . . . 75.24 111.079 -174.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 41.0 t -115.26 119.25 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.758 0.313 . . . . 74.32 111.353 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.601 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 49.3 m-70 -96.26 104.6 16.57 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.6 -0.273 . . . . 65.45 110.98 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.617 HG12 HG12 ' A' ' 442' ' ' VAL . 18.7 m -106.77 124.76 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.856 0.36 . . . . 72.13 110.988 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.46 ' HG3' HG23 ' A' ' 441' ' ' THR . 6.6 pttm -140.92 158.73 43.53 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.31 0.856 . . . . 65.24 113.31 -175.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.638 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.5 t-20 -107.94 128.7 54.86 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.677 -1.147 . . . . 63.34 109.468 175.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 86.4 mt -119.17 16.75 13.21 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.785 0.326 . . . . 75.21 111.86 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -100.81 -12.48 37.25 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.114 -0.565 . . . . 74.31 113.331 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.83 21.15 69.16 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.149 -0.548 . . . . 71.45 113.735 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.492 HG23 ' HB3' ' A' ' 438' ' ' PRO . 3.7 tt -134.67 132.99 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 122.602 -0.352 . . . . 73.42 111.048 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -66.43 134.61 33.37 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.367 -0.444 . . . . 72.33 113.679 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.94 116.06 16.82 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 122.562 0.345 . . . . 45.4 111.74 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.99 -11.21 12.42 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.117 2.544 . . . . 64.01 112.593 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . 0.425 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 50.8 m -80.65 11.78 3.58 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.043 0.757 . . . . 71.31 113.043 -174.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.1 m -88.61 95.12 10.12 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.951 0.882 . . . . 61.11 111.937 -169.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -106.5 126.54 52.39 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.24 -0.891 . . . . 74.23 110.558 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.612 HG21 HG11 ' A' ' 462' ' ' VAL . 44.6 t -106.8 122.98 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 122.3 -0.25 . . . . 73.41 111.614 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . 0.62 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 46.9 mtt180 -115.75 146.9 41.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.746 0.308 . . . . 54.22 111.339 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 77.9 t -121.6 121.86 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.917 0.389 . . . . 72.23 111.308 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -112.1 141.12 46.17 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.305 -0.407 . . . . 71.14 111.826 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.55 HG12 HG12 ' A' ' 513' ' ' ILE . 53.8 mt -124.24 111.77 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.552 -0.295 . . . . 74.52 110.811 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 52.77 34.83 17.15 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.532 0.567 . . . . 71.21 112.532 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 90.41 3.05 72.55 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 120.858 -0.686 . . . . 54.0 113.887 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.7 m -110.73 121.61 45.76 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.423 -0.457 . . . . 71.34 111.432 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.6 tp -64.17 114.8 4.44 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.923 0.392 . . . . 72.42 110.643 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -84.33 -45.09 13.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.492 -0.322 . . . . 64.13 111.673 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -171.27 159.25 5.71 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.786 0.327 . . . . 72.03 111.449 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.87 153.81 42.72 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.324 0.49 . . . . 73.43 112.324 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -129.56 149.53 51.28 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.083 -0.508 . . . . 65.42 110.864 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 91.2 m -114.46 119.46 36.96 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.768 0.318 . . . . 54.42 110.766 174.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.77 173.59 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.366 0.603 . . . . 64.31 111.747 -177.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.0 p -123.43 138.09 54.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.055 -0.52 . . . . 75.5 110.456 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.512 HD12 HD22 ' A' ' 440' ' ' LEU . 90.7 mt -117.54 119.06 33.87 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.736 0.303 . . . . 44.44 111.141 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -77.25 -171.6 35.85 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.208 -0.52 . . . . 73.24 112.994 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.09 100.63 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.378 2.052 . . . . 54.22 112.329 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.6 mttt 66.64 40.39 3.36 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.494 -0.775 . . . . 72.05 112.068 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -99.69 151.4 21.26 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.941 -0.572 . . . . 60.23 111.136 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -132.47 137.39 47.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.899 0.381 . . . . 64.13 111.419 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -120.03 146.54 45.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.506 -0.316 . . . . 73.24 110.262 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 49.1 t -113.79 115.04 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.929 0.395 . . . . 64.25 111.311 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 69.4 mt -107.39 130.81 54.76 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.415 -0.357 . . . . 71.02 111.438 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 51.5 p -113.86 150.75 33.13 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.221 0.534 . . . . 71.24 112.001 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 49.5 p90 -144.36 148.56 34.87 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.127 -0.488 . . . . 72.32 111.395 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 78.5 p -110.48 115.28 29.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.26 0.553 . . . . 60.21 110.957 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -112.36 136.88 51.28 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.288 -0.415 . . . . 74.31 111.363 -176.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.0 m -118.18 103.9 49.01 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.345 -0.389 . . . . 74.22 111.047 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . 0.418 ' HB2' HG11 ' A' ' 539' ' ' VAL . 98.4 Cg_endo -80.13 99.37 1.17 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.708 2.272 . . . . 62.0 112.711 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.6 p -78.23 -12.83 60.03 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.589 0.589 . . . . 62.13 112.589 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -122.17 141.63 51.25 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.762 0.315 . . . . 64.14 110.884 174.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.87 151.86 31.56 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.179 0.514 . . . . 54.32 112.083 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 145.43 -173.51 25.8 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.043 -0.598 . . . . 61.32 113.175 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 511' ' ' TYR . 0.0 OUTLIER -90.63 133.8 34.86 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.014 0.435 . . . . 61.32 110.839 179.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . 0.462 ' N ' ' SD ' ' A' ' 510' ' ' MET . 96.0 m-85 -132.25 120.46 22.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.133 0.492 . . . . 73.24 111.791 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 479' ' ' ILE . 47.9 ttp85 -94.15 118.37 31.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.224 -0.444 . . . . 74.41 111.072 177.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.55 HG12 HG12 ' A' ' 479' ' ' ILE . 55.6 mt -103.9 126.03 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.985 0.421 . . . . 72.24 111.48 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -125.8 142.55 51.46 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.979 0.418 . . . . 61.22 111.681 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -119.09 133.56 55.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.261 -0.427 . . . . 64.5 110.758 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . 0.535 HG22 HG22 ' A' ' 532' ' ' VAL . 33.9 p -130.82 140.71 50.29 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.323 -0.398 . . . . 73.15 111.689 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.02 140.67 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.933 0.397 . . . . 71.33 111.226 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 39.7 t0 42.53 66.61 0.72 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.62 -0.718 . . . . 62.21 111.685 -174.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . 0.62 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.8 mm-40 -57.5 -31.94 66.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.0 -0.546 . . . . 74.03 111.293 173.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.43 ' HB2' HG23 ' A' ' 522' ' ' THR . 6.7 mm-40 -68.5 -25.78 65.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.85 -0.614 . . . . 74.23 110.761 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 56.59 63.85 1.84 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.808 0.813 . . . . 73.1 110.663 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . 0.43 HG23 ' HB2' ' A' ' 520' ' ' GLU . 67.0 p -94.86 -15.66 23.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.503 -0.771 . . . . 64.44 111.892 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.5 p -118.68 142.53 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.665 0.269 . . . . 53.33 111.056 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . 0.403 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 50.4 t -82.68 121.04 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.847 0.356 . . . . 72.42 111.2 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.96 159.31 15.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.068 -0.514 . . . . 62.02 112.285 -171.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 439' ' ' ASP . 94.4 mt -68.57 -33.5 74.18 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.961 0.41 . . . . 71.04 111.521 174.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -145.56 129.31 17.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.377 -0.374 . . . . 55.45 110.795 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -83.15 -24.93 32.33 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.177 0.513 . . . . 74.34 111.542 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -86.91 13.98 8.1 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.901 0.381 . . . . 71.32 111.453 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.514 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 62.7 t30 -106.82 -15.02 14.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.103 0.477 . . . . 74.14 111.001 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -73.19 -16.86 61.41 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.724 0.638 . . . . 70.21 112.724 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.535 HG22 HG22 ' A' ' 516' ' ' THR . 45.2 t -111.69 133.33 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.754 0.65 . . . . 72.34 112.754 -171.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -123.52 139.0 54.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.166 -0.47 . . . . 52.23 110.719 173.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 87.5 m -119.86 134.71 55.14 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.033 0.383 . . . . 54.12 112.033 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -139.8 136.54 34.17 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.868 0.366 . . . . 65.3 110.527 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.63 133.32 50.57 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.09 0.472 . . . . 75.31 112.17 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 64.0 t -124.74 141.21 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.286 -0.415 . . . . 71.42 111.65 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.9 t -118.19 117.54 29.43 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.472 -0.331 . . . . 25.42 110.679 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 505' ' ' PRO . 66.5 t -101.31 123.02 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.026 0.441 . . . . 61.43 111.801 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.42 167.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 116.023 -0.535 . . . . 75.25 112.248 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.03 10.33 16.83 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.914 0.387 . . . . 61.33 111.684 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.254 1.322 0 CA-C-N 116.304 -0.407 . . . . 71.54 112.086 -176.567 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 120.722 0.296 . . . . 75.3 110.756 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.589 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 64.3 Cg_endo -72.41 173.65 12.82 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.493 2.129 . . . . 72.32 113.208 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -140.61 87.36 2.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.548 -0.538 . . . . 70.44 109.548 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.476 ' HB3' HG21 ' A' ' 517' ' ' VAL . 79.4 mt -90.58 137.9 31.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.092 -0.504 . . . . 75.44 111.364 -175.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.463 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.6 t -148.81 165.32 31.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.079 0.466 . . . . 64.22 112.014 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.604 HG12 HG12 ' A' ' 462' ' ' VAL . 27.5 m -133.72 149.19 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.83 -0.623 . . . . 74.13 111.569 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 6.5 mm-40 -130.99 129.76 42.51 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.229 -0.441 . . . . 72.11 111.519 176.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 50.1 mt -107.99 117.77 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.181 -0.463 . . . . 54.44 110.591 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -136.01 139.29 43.02 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.925 0.393 . . . . 75.22 111.73 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.66 -163.31 36.18 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.091 -0.504 . . . . 53.41 112.885 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.04 118.77 5.7 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.779 2.319 . . . . 64.14 113.027 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -86.74 -14.26 42.92 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.299 0.481 . . . . 64.51 112.299 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.0 t -128.87 117.85 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 122.146 -0.346 . . . . 61.41 110.704 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.94 164.21 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.241 0.543 . . . . 54.34 112.178 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -96.46 163.48 22.85 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 116.195 -0.457 . . . . 44.41 112.998 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.7 p -71.53 140.05 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 120.861 0.362 . . . . 75.44 111.214 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 65.87 17.33 10.8 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.656 0.613 . . . . 71.45 112.656 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -98.33 176.3 5.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.863 0.363 . . . . 72.13 111.457 176.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 502' ' ' SER . 40.4 tp -115.28 130.14 56.82 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.747 0.308 . . . . 54.33 111.33 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.07 134.22 47.23 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.881 0.326 . . . . 73.22 111.881 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.3 128.31 53.89 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.108 0.48 . . . . 72.31 111.934 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -122.01 154.88 36.66 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.961 -0.563 . . . . 75.31 110.274 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.544 ' HG2' HG22 ' A' ' 500' ' ' THR . 54.8 mt-10 -120.34 127.74 52.62 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.899 0.38 . . . . 74.32 111.631 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 24.2 t -96.8 112.56 29.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.008 -0.542 . . . . 64.2 109.651 169.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 35.2 m-70 -94.13 108.95 20.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.832 0.348 . . . . 72.12 110.39 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.812 HG11 HG21 ' A' ' 475' ' ' VAL . 14.4 m -106.1 126.88 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 63.34 110.079 -176.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.544 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.7 ptpt -144.03 148.92 35.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.791 0.663 . . . . 74.51 112.791 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -105.91 127.42 53.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.273 -0.876 . . . . 52.02 109.314 174.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.544 HD21 ' HD3' ' A' ' 463' ' ' LYS . 73.5 mt -118.05 8.7 12.52 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.825 0.306 . . . . 74.11 111.825 -177.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -87.87 -16.16 60.13 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.247 -0.501 . . . . 75.01 113.769 -177.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 83.0 17.17 67.99 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 120.911 -0.661 . . . . 51.15 113.468 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.4 tt -134.66 135.58 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 122.909 0.484 . . . . 71.24 111.035 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.496 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -70.95 132.62 21.91 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.474 -0.393 . . . . 70.5 113.701 -176.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 62.6 t -128.23 114.0 19.97 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 111.984 0.364 . . . . 64.23 111.984 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.87 -9.84 11.85 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.091 2.527 . . . . 73.1 112.739 174.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . 0.466 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 39.0 m -80.87 10.6 4.81 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.688 0.996 . . . . 65.34 113.688 -171.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . 0.421 HG23 HG23 ' A' ' 517' ' ' VAL . 94.3 m -88.14 100.59 13.07 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.86 0.838 . . . . 72.32 112.629 -166.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -114.4 117.54 31.31 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.291 -0.868 . . . . 73.41 110.746 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.812 HG21 HG11 ' A' ' 462' ' ' VAL . 45.3 t -104.17 132.72 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.063 0.394 . . . . 71.15 112.063 -173.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . 0.692 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 93.7 mtt180 -114.47 152.42 31.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.965 0.412 . . . . 64.44 111.832 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 82.5 t -122.43 126.27 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.056 -0.52 . . . . 75.44 111.008 173.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 513' ' ' ILE . 95.3 m-85 -115.47 138.83 50.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.851 0.357 . . . . 74.15 111.775 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 64.2 mt -115.0 107.93 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.954 -0.387 . . . . 54.14 109.954 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 55.94 34.76 24.23 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.088 0.47 . . . . 73.32 111.708 -173.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.13 -6.64 83.26 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 121.344 -0.455 . . . . 55.3 113.693 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.0 m -92.38 124.8 36.7 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 122.388 -0.478 . . . . 74.2 111.31 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.42 122.6 16.64 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.177 0.513 . . . . 54.33 111.579 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -101.97 -45.37 5.21 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.098 -0.501 . . . . 70.25 112.187 -178.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . 0.474 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 33.6 ttpt -171.01 160.09 6.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.242 0.217 . . . . 71.54 110.869 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.31 154.16 38.58 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.832 0.349 . . . . 53.55 111.863 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . 0.474 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 19.3 m-90 -129.83 147.22 51.58 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.313 -0.403 . . . . 74.24 111.362 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 34.6 m -110.28 118.57 36.69 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 110.326 -0.25 . . . . 72.02 110.326 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.56 172.17 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.49 0.662 . . . . 70.3 111.858 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 77.6 p -120.0 133.42 55.55 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.887 -0.597 . . . . 53.52 110.955 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.9 mt -118.48 118.93 33.06 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.861 0.362 . . . . 72.13 111.31 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . 0.496 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -82.21 -166.39 37.95 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.164 -0.541 . . . . 63.53 113.62 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.98 105.87 0.49 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.622 2.215 . . . . 63.41 112.518 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.5 mmtp 67.46 30.97 6.57 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.114 0.483 . . . . 72.1 111.573 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -94.33 149.45 21.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.325 -0.398 . . . . 45.03 111.97 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 32.7 tt0 -134.58 139.1 45.12 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.004 0.431 . . . . 74.42 111.554 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -125.67 140.65 52.53 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.325 -0.398 . . . . 75.54 110.273 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.32 117.37 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.894 0.378 . . . . 74.12 111.428 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.53 138.96 41.75 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.35 -0.386 . . . . 62.34 110.698 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.544 HG22 ' HG2' ' A' ' 459' ' ' GLU . 42.6 p -120.55 155.46 33.62 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.349 0.595 . . . . 65.45 112.125 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -152.29 148.28 27.35 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.688 -0.687 . . . . 75.35 110.831 170.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.533 ' HB2' HD11 ' A' ' 455' ' ' LEU . 20.4 p -117.19 114.96 24.41 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.156 0.503 . . . . 61.34 110.949 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -109.06 136.7 48.14 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.217 -0.447 . . . . 73.02 111.9 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 87.9 m -113.24 101.32 53.34 Favored Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.974 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 61.1 Cg_endo -72.38 88.48 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.472 2.115 . . . . 71.44 112.925 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.2 p -75.67 6.73 4.48 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.786 0.662 . . . . 54.44 112.786 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -143.5 135.75 26.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 110.483 -0.192 . . . . 63.01 110.483 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.76 151.32 37.61 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.092 0.472 . . . . 71.42 112.238 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.95 -169.08 28.09 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.16 -0.543 . . . . 62.31 113.064 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 12.5 tpt -99.46 124.53 44.7 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.733 0.301 . . . . 63.24 110.859 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -128.32 111.95 13.92 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.179 0.514 . . . . 75.42 111.688 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 32.8 ttm180 -94.66 120.82 35.48 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.119 -0.492 . . . . 75.12 111.141 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 478' ' ' TYR . 67.6 mt -95.41 126.05 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.087 0.47 . . . . 73.51 111.523 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -124.95 129.15 49.78 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.289 -0.414 . . . . 74.3 111.324 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.3 146.3 38.48 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.846 0.355 . . . . 55.21 111.326 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . 0.525 HG22 HG22 ' A' ' 532' ' ' VAL . 76.4 p -130.19 140.92 50.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.18 -0.464 . . . . 75.02 111.011 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' ' 442' ' ' VAL . 7.4 p -100.51 138.42 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 110.207 -0.294 . . . . 63.34 110.207 174.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.5 t0 35.46 71.58 0.12 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.604 0.716 . . . . 64.31 110.961 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . 0.692 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.4 tm-20 -51.29 -45.52 62.16 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.098 -0.955 . . . . 55.23 111.71 -176.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -69.72 -17.29 63.45 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.411 -0.359 . . . . 62.31 111.49 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 51.51 79.36 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.798 0.809 . . . . 54.31 111.394 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 81.9 p -97.34 2.59 50.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.156 -0.929 . . . . 62.32 110.861 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.57 142.03 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.832 -0.622 . . . . 63.33 110.51 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.58 116.02 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.782 0.325 . . . . 72.23 111.847 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -92.59 170.33 9.82 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.349 0.595 . . . . 65.44 111.903 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.48 -29.25 67.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.853 -0.612 . . . . 75.13 111.978 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -141.38 128.33 20.64 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.773 0.32 . . . . 74.24 111.42 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.75 -24.17 31.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.131 0.491 . . . . 64.11 111.643 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -79.76 4.32 16.72 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.659 0.742 . . . . 62.21 110.767 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.463 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 56.0 t30 -92.16 -20.16 21.52 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.878 -0.601 . . . . 62.1 111.553 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . 0.459 ' HA ' HG12 ' A' ' 517' ' ' VAL . 12.9 m120 -72.8 -25.48 61.17 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.922 1.082 . . . . 72.44 113.922 -172.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 516' ' ' THR . 42.9 t -109.32 143.37 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.922 0.712 . . . . 75.42 112.922 -172.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -129.95 142.81 50.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.172 -0.467 . . . . 43.44 111.043 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 72.4 m -118.9 129.24 55.08 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.134 0.42 . . . . 74.13 112.134 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -143.17 117.67 9.73 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.648 0.261 . . . . 74.34 110.849 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 10.3 p-10 -93.42 137.78 32.38 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.246 0.461 . . . . 63.42 112.246 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 56.1 t -125.95 134.56 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.392 -0.367 . . . . 74.45 111.672 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 45.5 t -104.08 126.26 51.05 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.56 -0.291 . . . . 72.35 111.297 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.12 121.93 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.975 0.416 . . . . 65.05 111.465 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.9 m -111.83 161.74 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.367 0.506 . . . . 75.24 112.367 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 86.7 mt -82.66 16.92 1.97 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.264 0.468 . . . . 70.31 112.264 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 119.324 -0.37 . . . . 75.35 111.83 -179.705 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 120.405 0.145 . . . . 75.51 110.935 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 64.7 Cg_endo -74.91 173.39 14.55 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.434 2.09 . . . . 65.2 113.474 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -157.2 94.08 1.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.369 -0.832 . . . . 61.23 109.447 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.555 HD22 HD12 ' A' ' 491' ' ' LEU . 53.4 mt -98.26 114.54 26.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.045 0.45 . . . . 53.23 111.382 -175.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.527 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.9 t -122.67 150.6 42.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.179 0.514 . . . . 72.2 112.116 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.552 HG12 HG12 ' A' ' 462' ' ' VAL . 28.8 m -121.31 148.88 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.064 -0.516 . . . . 74.44 111.286 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.9 mt-10 -136.83 143.18 42.97 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.655 -0.248 . . . . 71.42 110.911 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 57.7 mt -120.39 135.5 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 120.974 0.416 . . . . 64.12 111.599 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -137.23 147.05 45.53 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.29 -0.414 . . . . 54.54 110.652 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 160.51 -166.46 35.37 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.676 -0.774 . . . . 72.53 113.489 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.9 132.55 24.99 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.985 2.456 . . . . 74.54 113.491 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -78.66 -43.51 25.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.14 -0.482 . . . . 73.41 112.173 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.433 HG22 ' HB3' ' A' ' 538' ' ' SER . 44.1 t -123.7 129.78 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.767 0.318 . . . . 43.33 111.082 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.47 163.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.147 0.498 . . . . 62.33 111.74 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -95.25 162.89 23.9 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.279 -0.486 . . . . 62.31 113.196 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.546 HG22 ' ND2' ' A' ' 453' ' ' ASN . 12.9 p -67.65 136.18 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 121.228 0.537 . . . . 75.35 111.625 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . 0.546 ' ND2' HG22 ' A' ' 452' ' ' VAL . 51.7 m-80 65.2 14.75 9.61 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.858 -0.61 . . . . 73.33 112.479 -177.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . 0.503 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.2 mmmt -97.07 153.84 17.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.068 0.461 . . . . 74.11 111.645 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.572 HD11 ' HB2' ' A' ' 502' ' ' SER . 46.3 tp -90.19 138.79 31.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.019 0.438 . . . . 71.23 111.569 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -135.86 133.02 37.33 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.824 0.345 . . . . 73.32 111.656 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -109.45 134.58 51.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.849 0.357 . . . . 72.31 111.657 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -125.53 154.62 41.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.28 -0.418 . . . . 60.1 111.176 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -119.59 127.75 53.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.159 0.504 . . . . 75.31 110.719 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 39.8 t -105.54 115.34 47.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.997 -0.547 . . . . 73.13 110.949 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.595 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 27.1 m-70 -92.6 105.34 17.52 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.654 0.264 . . . . 71.04 110.643 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.552 HG12 HG12 ' A' ' 442' ' ' VAL . 33.8 m -106.24 122.74 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.075 0.464 . . . . 71.31 110.178 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -139.09 153.09 47.98 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.84 0.682 . . . . 74.04 112.84 -173.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 53.4 t-20 -106.1 128.64 54.02 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.256 -0.883 . . . . 71.2 110.025 176.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 90.7 mt -113.83 -2.42 13.65 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.023 0.379 . . . . 63.2 112.023 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -81.17 -16.44 74.38 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.247 -0.501 . . . . 54.14 113.884 -177.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.42 21.89 68.74 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.077 -0.582 . . . . 73.02 113.737 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 3.2 tt -137.68 133.3 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.577 0.351 . . . . 73.42 111.405 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 491' ' ' LEU . . . -71.36 134.54 22.9 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 114.214 0.445 . . . . 74.0 114.214 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 50.7 t -131.14 114.54 16.21 Favored Pre-proline 0 CA--C 1.547 0.833 0 O-C-N 122.585 -0.362 . . . . 62.21 111.663 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -83.93 -10.24 9.41 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.151 2.567 . . . . 75.44 113.004 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 20.3 t -81.95 11.83 4.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.548 0.739 . . . . 64.1 112.328 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.2 m -88.82 97.39 11.13 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.719 0.771 . . . . 54.33 112.27 -167.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -101.87 130.63 48.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.357 -0.838 . . . . 70.34 110.66 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.485 HG21 HG11 ' A' ' 462' ' ' VAL . 60.4 t -115.37 133.41 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 122.793 0.437 . . . . 75.54 111.058 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . 0.503 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 90.6 mtt180 -126.66 149.04 49.75 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.828 0.347 . . . . 74.12 111.557 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.28 120.54 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.466 -0.334 . . . . 73.21 111.182 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -112.46 139.02 48.38 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.987 0.422 . . . . 74.21 111.699 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.524 HG12 HG12 ' A' ' 513' ' ' ILE . 54.0 mt -114.13 107.58 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 109.855 -0.424 . . . . 73.23 109.855 172.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . 0.436 HD21 ' HA ' ' A' ' 511' ' ' TYR . 94.6 m-20 54.57 34.47 21.36 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.262 -0.426 . . . . 73.25 112.04 -175.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 103.29 -30.06 11.12 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.125 -0.56 . . . . 72.23 113.75 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.9 m -82.35 125.47 31.05 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.42 -0.459 . . . . 44.22 112.004 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.0 tp -65.57 115.73 6.08 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.01 0.433 . . . . 60.35 111.319 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -82.67 -44.14 16.07 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.355 -0.384 . . . . 72.31 111.38 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . 0.427 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 32.6 ttpt -170.38 157.83 6.28 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.672 -0.24 . . . . 75.31 110.876 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . 0.407 ' HB2' ' HG2' ' A' ' 476' ' ' ARG . 6.6 p30 -137.38 156.69 47.91 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.095 0.474 . . . . 72.42 111.945 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . 0.427 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 18.2 m-90 -137.3 149.12 46.85 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.118 -0.492 . . . . 75.52 110.79 177.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 89.6 m -121.54 119.24 31.4 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 110.057 -0.349 . . . . 61.13 110.057 174.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.0 m -139.83 172.74 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.369 0.604 . . . . 75.25 112.115 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.7 p -115.1 133.88 55.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.925 -0.579 . . . . 54.52 110.474 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.555 HD12 HD22 ' A' ' 440' ' ' LEU . 73.5 mt -116.75 120.43 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.858 0.361 . . . . 63.23 111.098 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.47 -173.88 48.54 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.163 -0.541 . . . . 72.55 113.264 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.9 99.53 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.532 2.155 . . . . 74.12 112.484 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 98.0 mttt 67.57 50.45 0.91 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.918 -0.583 . . . . 51.23 111.796 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -110.39 148.36 32.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.516 -0.765 . . . . 60.52 111.27 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -130.04 136.87 49.87 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.058 0.456 . . . . 75.11 111.444 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -118.87 135.63 54.46 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.544 -0.539 . . . . 64.24 109.544 173.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 89.9 t -100.96 113.12 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.266 0.555 . . . . 73.14 111.116 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 63.6 mt -105.82 126.68 52.45 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.844 -0.616 . . . . 71.51 110.711 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 22.1 p -112.3 154.36 25.78 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.317 0.579 . . . . 62.44 111.909 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -145.64 148.9 33.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.608 -0.724 . . . . 72.43 110.701 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.572 ' HB2' HD11 ' A' ' 455' ' ' LEU . 24.0 p -110.24 113.75 26.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.308 0.575 . . . . 64.13 110.642 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -110.48 137.12 48.6 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.865 -0.607 . . . . 73.23 111.192 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 36.5 m -122.65 100.3 41.17 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 116.475 -0.329 . . . . 73.55 111.073 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.3 Cg_endo -76.52 106.8 2.32 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.318 2.012 . . . . 63.34 112.638 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 64.4 p -89.08 -5.88 57.5 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.817 0.342 . . . . 73.54 111.913 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -125.68 136.04 52.79 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.605 -0.27 . . . . 73.42 110.9 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -73.34 151.08 41.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.936 0.398 . . . . 74.25 111.93 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.8 178.33 24.65 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.223 -0.513 . . . . 54.24 112.913 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 14.4 tpt -92.74 114.58 27.17 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.877 0.37 . . . . 73.13 111.061 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . 0.436 ' HA ' HD21 ' A' ' 480' ' ' ASN . 75.3 m-85 -111.22 144.9 39.64 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.678 0.275 . . . . 74.25 111.447 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . 0.471 ' HG2' ' OD1' ' A' ' 514' ' ' ASN . 16.2 ttm180 -123.19 115.45 21.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.735 0.302 . . . . 75.22 111.075 176.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.524 HG12 HG12 ' A' ' 479' ' ' ILE . 59.9 mt -96.05 113.7 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.135 -0.484 . . . . 75.4 111.21 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.471 ' OD1' ' HG2' ' A' ' 512' ' ' ARG . 4.0 m-20 -118.91 145.79 45.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.405 -0.361 . . . . 73.13 111.469 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 532' ' ' VAL . . . -115.48 145.15 42.87 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.779 0.324 . . . . 71.03 111.274 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . 0.555 HG22 HG22 ' A' ' 532' ' ' VAL . 58.9 p -132.82 148.76 52.31 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.183 -0.462 . . . . 65.34 111.643 -178.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.23 152.69 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 120.756 0.312 . . . . 65.24 111.243 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 35.8 t70 54.72 39.99 31.65 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.702 0.763 . . . . 75.13 111.369 -176.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . 0.503 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 8.5 mm-40 -52.6 -31.6 37.16 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.802 -0.636 . . . . 75.24 111.315 172.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.452 ' HB2' HG23 ' A' ' 522' ' ' THR . 4.2 mm-40 -67.67 -25.39 65.68 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.732 -0.667 . . . . 72.32 111.153 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.6 m120 59.31 71.92 0.56 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.419 0.628 . . . . 74.1 110.614 -176.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . 0.452 HG23 ' HB2' ' A' ' 520' ' ' GLU . 82.6 p -107.41 -32.89 7.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.581 -0.736 . . . . 75.11 112.355 -174.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.441 HG21 ' HG3' ' A' ' 438' ' ' PRO . 14.4 p -124.37 143.31 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.589 0.588 . . . . 64.21 112.589 -172.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.3 111.69 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.45 -0.341 . . . . 73.42 110.716 176.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -99.73 -179.49 4.2 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.427 0.528 . . . . 74.45 112.427 -175.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.58 -41.08 24.66 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.251 -0.431 . . . . 54.21 111.552 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -130.31 98.49 4.73 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.124 0.488 . . . . 53.44 111.006 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -84.3 10.19 11.14 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.274 0.559 . . . . 71.14 111.502 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -108.16 0.62 21.66 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.467 0.651 . . . . 73.42 110.131 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.527 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.4 t30 -95.54 -0.84 51.64 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.85 -0.614 . . . . 74.13 111.551 -174.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -81.95 -19.25 41.06 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.424 0.898 . . . . 74.42 113.424 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 516' ' ' THR . 39.9 t -112.42 141.19 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 112.365 0.506 . . . . 74.54 112.365 -174.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -132.49 135.52 46.07 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.597 -0.274 . . . . 64.21 111.439 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 30.6 m -106.53 134.91 48.95 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.472 0.545 . . . . 72.32 112.472 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -142.99 117.5 9.72 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.174 -0.467 . . . . 73.42 110.28 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.34 137.45 33.47 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.253 0.549 . . . . 70.33 112.155 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.21 130.64 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.95 -0.568 . . . . 63.41 111.518 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . 0.433 ' HB3' HG22 ' A' ' 449' ' ' VAL . 41.3 t -96.97 117.97 32.34 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.527 -0.306 . . . . 70.33 111.351 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 505' ' ' PRO . 61.8 t -105.95 120.47 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.935 0.398 . . . . 73.31 111.077 178.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.58 166.54 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 112.498 0.555 . . . . 72.54 112.498 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.87 -12.3 55.72 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.177 0.436 . . . . 72.34 112.177 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.252 1.206 0 N-CA-C 112.513 0.56 . . . . 55.12 112.513 178.748 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 110.146 -0.316 . . . . 71.34 110.146 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.612 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 56.9 Cg_endo -72.16 174.41 11.44 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.269 1.979 . . . . 73.24 112.92 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -154.06 80.29 1.13 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.365 0.602 . . . . 73.13 110.041 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.468 HD22 HD12 ' A' ' 491' ' ' LEU . 61.1 mt -80.05 116.54 20.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.953 -0.567 . . . . 65.33 111.596 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.419 ' HB ' HD22 ' A' ' 530' ' ' ASN . 8.1 t -126.38 153.53 44.82 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.859 0.361 . . . . 72.44 111.096 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.571 HG12 HG12 ' A' ' 462' ' ' VAL . 21.0 m -131.84 149.58 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.193 0.52 . . . . 71.31 112.358 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 49.4 mt-10 -128.47 144.03 51.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.883 -0.599 . . . . 72.11 110.843 175.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.402 HD13 HG22 ' A' ' 513' ' ' ILE . 65.8 mt -114.75 132.73 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.635 0.255 . . . . 65.31 110.766 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -132.81 145.87 51.35 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.579 0.228 . . . . 63.41 110.929 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.77 -173.66 36.51 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.672 -0.775 . . . . 74.21 113.752 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.62 126.43 12.09 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.991 2.461 . . . . 71.3 112.993 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -76.37 -21.47 56.04 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.153 -0.476 . . . . 63.23 112.218 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.6 t -131.0 128.82 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.754 0.312 . . . . 74.33 111.09 176.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.78 156.41 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 120.997 0.427 . . . . 75.51 111.682 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.34 154.57 24.37 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.319 -0.467 . . . . 64.0 113.25 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 11.7 p -65.62 141.46 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.889 0.376 . . . . 75.32 111.781 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 65.53 8.54 5.15 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.257 0.623 . . . . 55.02 112.272 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . 0.555 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 31.3 mmmt -96.13 167.15 11.38 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.943 0.402 . . . . 51.44 111.473 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' A' ' 502' ' ' SER . 33.4 tp -103.81 134.06 47.75 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.68 0.276 . . . . 62.2 111.35 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -133.57 140.13 46.98 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.799 0.333 . . . . 75.32 111.774 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -100.53 138.15 37.98 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.907 0.384 . . . . 74.22 111.595 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -129.66 155.15 46.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.943 0.401 . . . . 70.3 111.084 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -119.73 127.55 52.94 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.096 -0.502 . . . . 55.31 111.379 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 29.9 t -104.54 113.01 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.271 -0.422 . . . . 71.4 110.046 171.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 41.9 m-70 -94.81 105.13 17.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.519 -0.31 . . . . 73.04 110.31 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.636 HG11 HG21 ' A' ' 475' ' ' VAL . 26.4 m -106.14 126.02 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.087 0.47 . . . . 72.31 110.346 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.454 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.8 ptpt -146.69 157.32 43.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.297 0.57 . . . . 71.04 112.315 -175.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -114.32 127.17 55.73 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.552 -0.749 . . . . 62.41 109.662 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.454 HD21 ' HD3' ' A' ' 463' ' ' LYS . 85.2 mt -113.28 0.91 14.99 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.843 0.354 . . . . 73.41 111.844 -177.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -76.99 -19.44 77.46 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.039 -0.6 . . . . 54.44 113.32 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.16 13.31 64.21 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.319 -0.467 . . . . 73.31 113.87 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.7 tt -137.35 133.26 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 122.575 0.35 . . . . 72.42 110.651 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.38 137.77 20.17 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.775 0.67 . . . . 71.21 114.775 -173.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 46.8 t -123.76 113.19 28.74 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 122.76 0.424 . . . . 53.42 111.184 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.78 -10.79 9.34 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.93 2.42 . . . . 43.52 112.807 175.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 29.0 t -83.28 11.21 6.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.229 0.612 . . . . 73.14 112.467 -176.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 97.6 m -90.17 113.55 25.34 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.093 0.775 . . . . 74.44 113.093 -166.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -103.89 131.24 51.3 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.964 -0.562 . . . . 73.22 111.617 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.636 HG21 HG11 ' A' ' 462' ' ' VAL . 53.7 t -110.36 130.58 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 122.885 0.474 . . . . 61.44 111.264 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . 0.693 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 68.2 mtt180 -125.97 152.54 45.55 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.133 0.492 . . . . 75.12 111.755 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 75.9 t -120.89 128.75 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.117 -0.492 . . . . 51.4 110.818 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -118.68 136.52 53.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.835 0.35 . . . . 55.01 111.569 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 66.2 mt -108.1 108.05 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.965 -0.383 . . . . 73.04 109.965 173.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 56.68 33.64 23.19 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.099 0.476 . . . . 72.14 111.413 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 99.71 -26.56 23.95 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.409 -0.424 . . . . 43.5 113.76 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 86.1 m -81.88 129.72 34.84 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 117.078 0.439 . . . . 71.25 111.727 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 54.8 tp -65.65 121.36 14.8 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.199 0.523 . . . . 75.33 111.831 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -92.75 -43.79 8.86 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.791 -0.641 . . . . 72.15 111.686 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -161.77 154.5 20.27 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.69 -0.232 . . . . 72.53 110.826 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.62 147.87 47.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.362 0.504 . . . . 61.23 112.362 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -133.23 146.79 51.77 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.04 -0.527 . . . . 74.41 110.844 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.2 m -115.0 118.74 34.27 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.9 -0.408 . . . . 74.34 109.9 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.37 172.5 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.576 0.703 . . . . 63.31 112.471 -172.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 87.2 p -116.06 134.01 55.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.649 -0.705 . . . . 71.3 110.594 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.468 HD12 HD22 ' A' ' 440' ' ' LEU . 92.6 mt -124.41 119.18 28.47 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.814 0.34 . . . . 72.01 111.066 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.07 -174.08 48.43 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.126 -0.488 . . . . 53.45 113.622 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.68 106.07 0.58 Allowed 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.619 2.213 . . . . 45.14 112.416 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.9 mttt 66.25 36.23 5.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.364 0.602 . . . . 75.4 111.653 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -95.85 142.77 27.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.757 -0.656 . . . . 64.33 111.165 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -128.15 133.56 48.96 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.915 0.388 . . . . 73.41 111.416 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -126.74 134.2 50.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.281 -0.418 . . . . 55.42 111.208 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 51.3 t -102.61 113.08 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.047 0.451 . . . . 52.34 111.414 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 57.5 mt -104.05 126.57 51.27 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.231 -0.441 . . . . 63.15 110.323 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 32.9 p -113.46 151.09 31.88 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.356 0.598 . . . . 75.41 112.361 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -146.58 148.99 32.69 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.635 -0.711 . . . . 71.44 110.875 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.487 ' HB2' HD11 ' A' ' 455' ' ' LEU . 86.1 p -110.19 115.55 29.92 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.324 0.583 . . . . 74.12 110.669 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -107.82 137.23 46.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.983 -0.553 . . . . 71.53 111.757 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 86.0 m -109.05 101.37 44.5 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.298 -0.41 . . . . 74.13 111.307 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . 0.555 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.9 Cg_endo -75.56 92.19 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.324 2.016 . . . . 62.01 112.722 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 40.0 p -82.38 12.32 4.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.275 0.472 . . . . 52.14 112.275 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -143.56 130.99 21.0 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.406 -0.361 . . . . 72.13 110.644 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.1 150.87 33.63 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.498 0.555 . . . . 71.34 112.498 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 143.13 -170.2 25.46 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.817 -0.706 . . . . 72.02 113.94 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.85 117.13 28.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.776 0.43 . . . . 72.51 111.033 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -119.02 143.28 47.16 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.059 0.457 . . . . 73.42 111.347 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 57.5 ttp180 -123.52 120.16 32.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.562 -0.29 . . . . 71.52 110.748 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.402 HG22 HD13 ' A' ' 444' ' ' ILE . 62.6 mt -95.07 120.45 44.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 73.2 110.755 178.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 18.2 m120 -118.92 132.98 56.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.311 -0.404 . . . . 63.41 111.093 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.8 137.39 49.8 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.8 0.333 . . . . 73.03 110.774 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . 0.569 HG22 HG22 ' A' ' 532' ' ' VAL . 39.7 p -122.81 140.37 52.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.017 -0.538 . . . . 73.51 110.936 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 440' ' ' LEU . 14.9 p -115.53 141.69 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.538 -0.301 . . . . 72.35 111.353 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.1 t70 48.1 58.58 4.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.946 0.879 . . . . 72.14 110.199 -170.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . 0.693 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 2.6 mm-40 -55.33 -32.89 62.86 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.925 -1.034 . . . . 73.23 113.172 -176.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -77.22 -12.55 59.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.541 0.21 . . . . 60.14 111.493 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 54.63 69.75 0.69 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.687 0.756 . . . . 64.11 110.847 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 80.4 p -100.3 -7.0 25.05 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.234 -0.894 . . . . 72.13 112.01 -174.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.3 p -140.12 142.01 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.954 0.407 . . . . 72.45 111.926 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 80.3 t -83.89 118.87 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.477 -0.329 . . . . 64.14 110.523 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.612 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 19.7 mt-10 -110.71 174.62 5.78 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.044 0.757 . . . . 73.33 113.044 -173.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.32 -39.36 93.74 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.771 -0.65 . . . . 64.33 112.304 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -145.15 108.62 4.64 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.895 0.379 . . . . 62.25 111.325 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . 0.468 ' HA ' ' OD1' ' A' ' 531' ' ' ASN . 12.6 pt-20 -83.68 21.84 1.19 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.979 0.419 . . . . 73.24 111.796 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -107.49 -19.19 13.64 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.453 0.538 . . . . 71.34 112.453 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.419 HD22 ' HB ' ' A' ' 441' ' ' THR . 1.9 p-10 -99.71 12.73 35.86 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.571 0.582 . . . . 54.44 112.571 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 528' ' ' GLU . 15.0 m120 -77.79 -5.02 49.38 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.325 0.491 . . . . 62.44 112.325 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . 0.569 HG22 HG22 ' A' ' 516' ' ' THR . 41.2 t -127.94 133.25 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 120.901 0.382 . . . . 72.12 111.639 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -114.33 141.81 47.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.546 -0.297 . . . . 65.31 111.057 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 52.4 m -122.67 122.33 38.54 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.205 0.446 . . . . 54.55 112.205 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -137.74 117.16 12.82 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.286 -0.415 . . . . 74.23 110.041 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 1.1 p30 -97.88 136.32 38.35 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.511 0.672 . . . . 75.32 112.302 -177.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.59 142.1 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.317 -0.856 . . . . 64.24 111.515 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.5 t -104.05 123.31 46.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.161 -0.472 . . . . 72.34 110.977 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 50.6 t -103.15 120.72 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.767 0.317 . . . . 72.51 111.373 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.7 m -114.36 159.55 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.269 0.557 . . . . 72.52 112.194 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 90.2 mt -82.36 0.21 42.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.123 -0.489 . . . . 71.34 112.192 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 C--O 1.251 1.147 0 N-CA-C 112.471 0.545 . . . . 73.44 112.471 -174.472 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 438' ' ' PRO . 97.6 m-85 . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 120.678 0.275 . . . . 71.31 110.891 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.567 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 2.8 Cg_exo -74.99 174.41 12.83 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.014 2.476 . . . . 60.23 113.69 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -154.85 81.64 1.09 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.296 -0.866 . . . . 75.15 109.003 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.513 HD11 HG11 ' A' ' 470' ' ' VAL . 69.5 mt -86.72 127.94 34.99 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.857 -0.611 . . . . 73.22 111.811 -173.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . 0.603 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.5 t -130.48 156.28 45.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.046 0.45 . . . . 73.43 111.762 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.636 HG12 HG12 ' A' ' 462' ' ' VAL . 31.6 m -132.8 147.78 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.972 -0.558 . . . . 74.43 111.586 -177.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 54.9 mt-10 -133.04 139.64 47.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.453 -0.34 . . . . 74.52 111.151 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 58.4 mt -109.21 129.22 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.972 0.415 . . . . 74.0 111.472 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -131.28 131.0 43.54 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.508 -0.315 . . . . 64.45 111.335 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 167.11 -168.49 40.42 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.486 -0.864 . . . . 74.34 113.871 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.52 122.8 7.67 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.802 2.335 . . . . 54.32 113.179 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -70.72 -33.19 70.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.234 -0.439 . . . . 75.22 111.501 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.3 t -120.83 132.01 71.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.775 0.321 . . . . 52.4 111.267 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.2 m -132.56 163.29 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.112 0.482 . . . . 55.34 111.712 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -94.71 149.49 19.38 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.234 -0.508 . . . . 71.54 112.849 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.504 HG22 ' ND2' ' A' ' 453' ' ' ASN . 11.2 p -63.28 137.46 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-O 120.906 0.384 . . . . 42.34 111.829 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . 0.504 ' ND2' HG22 ' A' ' 452' ' ' VAL . 55.4 m-80 62.07 25.23 15.11 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.996 0.519 . . . . 64.41 112.392 -178.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -111.73 162.46 15.2 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.964 0.411 . . . . 72.15 111.577 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 502' ' ' SER . 50.6 tp -90.5 128.04 36.42 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.843 0.354 . . . . 73.31 111.583 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.33 143.05 49.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.793 0.33 . . . . 72.33 111.38 177.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -122.74 144.51 49.11 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.945 0.402 . . . . 44.14 111.491 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -132.05 157.55 43.86 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.007 0.432 . . . . 55.31 111.296 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -120.52 127.74 52.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.858 -0.61 . . . . 75.12 110.738 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.95 116.13 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.37 -0.377 . . . . 64.21 111.319 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 30.2 m-70 -93.22 113.98 26.33 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.399 -0.364 . . . . 63.23 110.652 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.638 HG11 HG21 ' A' ' 475' ' ' VAL . 17.8 m -116.08 122.42 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.781 0.324 . . . . 52.12 110.751 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 496' ' ' GLU . 0.7 OUTLIER -139.93 154.47 47.23 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.064 0.765 . . . . 74.01 113.064 -176.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.542 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.4 t-20 -103.03 128.6 49.82 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.119 -0.946 . . . . 70.23 110.386 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.421 HD21 ' HD3' ' A' ' 463' ' ' LYS . 88.6 mt -115.32 4.87 14.52 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.078 0.399 . . . . 73.0 112.078 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -85.75 -23.86 44.52 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.248 -0.501 . . . . 71.21 113.43 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.44 17.8 58.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.959 -0.639 . . . . 75.31 113.68 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 12.2 tt -137.37 141.73 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 122.57 0.348 . . . . 72.5 110.617 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.475 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -65.68 136.31 36.1 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.139 -0.553 . . . . 64.0 113.612 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.513 HG11 HD11 ' A' ' 440' ' ' LEU . 38.5 t -129.88 112.97 17.48 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 112.515 0.561 . . . . 62.43 112.515 -176.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.77 -11.41 12.64 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.236 2.624 . . . . 63.43 112.22 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 70.1 m -80.18 11.61 3.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.5 0.72 . . . . 73.34 112.161 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 33.5 m -88.28 90.83 8.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.849 0.833 . . . . 71.13 111.073 -169.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -106.02 123.16 47.56 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.194 -0.912 . . . . 61.11 110.272 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.638 HG21 HG11 ' A' ' 462' ' ' VAL . 39.2 t -103.71 121.02 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.826 0.346 . . . . 70.34 110.904 -177.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 476' ' ' ARG . 33.3 ttm180 -129.13 144.96 51.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.694 0.283 . . . . 75.31 111.656 -174.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 66.3 t -120.5 130.27 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.071 0.463 . . . . 71.2 111.722 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -119.52 137.04 54.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.96 -0.564 . . . . 74.4 111.177 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 513' ' ' ILE . 59.2 mt -111.94 107.76 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.712 0.292 . . . . 61.22 110.32 174.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 57.29 34.87 25.38 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.929 0.395 . . . . 52.14 111.31 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.95 -2.18 85.47 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.336 -0.459 . . . . 25.22 113.398 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 63.1 m -90.25 123.42 34.03 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.606 -0.349 . . . . 54.33 111.389 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . 0.403 HD13 ' HD3' ' A' ' 476' ' ' ARG . 44.4 tp -63.88 115.06 4.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.98 0.419 . . . . 74.14 111.0 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -105.05 -44.05 4.89 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.102 0.779 . . . . 72.0 113.102 -175.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -165.88 161.02 17.45 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 122.168 -0.332 . . . . 70.12 111.17 -172.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . 0.561 HD22 ' N ' ' A' ' 486' ' ' ASN . 0.0 OUTLIER -161.1 154.32 21.46 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.826 0.676 . . . . 74.02 112.826 177.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -136.0 149.79 48.97 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.687 0.795 . . . . 72.4 110.44 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.2 m -115.08 119.41 36.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.9 0.381 . . . . 74.45 111.21 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.9 m -137.57 173.56 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.158 0.504 . . . . 73.22 111.695 -176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 95.3 p -125.57 135.11 51.88 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.871 0.367 . . . . 75.25 110.882 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.473 HD12 HD22 ' A' ' 440' ' ' LEU . 94.9 mt -117.63 120.1 37.01 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.455 -0.339 . . . . 75.31 111.24 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . 0.475 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -77.78 -170.09 34.62 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.223 -0.513 . . . . 24.44 113.279 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.56 97.03 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.341 2.027 . . . . 74.45 112.445 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.6 mttt 66.29 59.61 0.65 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.853 0.835 . . . . 74.55 111.791 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -120.85 152.94 37.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.046 -0.979 . . . . 74.31 110.651 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 39.5 tt0 -134.63 137.25 43.5 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.936 0.398 . . . . 64.22 111.931 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.444 ' HG2' ' CD2' ' A' ' 491' ' ' LEU . 28.5 mmmt -116.94 150.3 38.74 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.203 -0.453 . . . . 75.45 110.241 174.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.4 113.56 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.925 0.393 . . . . 72.14 111.555 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 77.9 mt -110.51 136.07 50.21 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.24 -0.436 . . . . 74.51 111.314 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 41.0 p -117.91 150.62 38.91 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.094 0.473 . . . . 62.42 111.943 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -145.63 151.61 38.35 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.248 -0.433 . . . . 74.42 111.02 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.56 ' HB2' HD11 ' A' ' 455' ' ' LEU . 72.9 p -111.67 141.47 45.22 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.28 -0.418 . . . . 53.43 111.297 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.5 t90 -139.34 137.49 35.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.281 -0.418 . . . . 74.35 111.094 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.1 m -118.2 100.43 51.75 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-O 120.758 0.313 . . . . 74.14 111.277 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.99 102.99 1.63 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.519 2.146 . . . . 71.0 112.841 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 81.1 p -81.58 -1.21 45.57 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.167 0.432 . . . . 74.55 112.167 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -137.24 145.74 43.94 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.711 0.291 . . . . 74.3 111.316 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.484 ' HA ' ' HB ' ' A' ' 539' ' ' VAL . 0.3 OUTLIER -83.19 152.03 25.41 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.516 0.561 . . . . 52.32 112.516 -177.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.63 -176.32 30.07 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.038 -0.601 . . . . 53.22 113.694 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 1.2 tpt -92.56 106.28 18.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.536 0.335 . . . . 72.43 110.669 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -107.66 121.9 45.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.179 0.514 . . . . 72.32 111.795 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . 0.505 ' HD2' HG23 ' A' ' 534' ' ' THR . 19.6 tpp85 -94.21 112.74 24.56 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.188 -0.46 . . . . 74.14 111.52 177.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 479' ' ' ILE . 40.6 mt -98.75 127.24 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.068 0.461 . . . . 74.3 110.858 175.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -124.09 138.15 54.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.335 -0.393 . . . . 72.3 111.553 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.94 132.48 54.73 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.832 -0.433 . . . . 75.15 109.832 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 38.9 p -132.93 141.1 48.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.352 -0.385 . . . . 75.51 111.497 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.419 HG13 HD22 ' A' ' 531' ' ' ASN . 7.7 p -110.55 140.05 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.762 0.315 . . . . 72.24 110.949 175.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.2 t0 43.98 67.9 0.6 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.517 0.675 . . . . 62.11 111.594 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -55.8 -31.67 62.85 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.821 -0.627 . . . . 72.05 112.246 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' GLU . . . . . 0.452 ' HB2' HG23 ' A' ' 522' ' ' THR . 8.4 mm-40 -78.17 -19.29 54.25 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.276 -0.42 . . . . 72.24 111.518 -178.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 62.16 46.62 6.14 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.742 0.782 . . . . 73.15 110.011 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' THR . . . . . 0.452 HG23 ' HB2' ' A' ' 520' ' ' GLU . 52.1 p -67.59 -37.76 83.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.486 -0.779 . . . . 73.35 111.588 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.468 HG21 ' HG2' ' A' ' 438' ' ' PRO . 10.7 p -102.33 143.91 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 116.096 -0.502 . . . . 74.45 110.993 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' VAL . . . . . 0.459 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 59.1 t -81.87 115.62 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.992 0.425 . . . . 74.13 111.119 -177.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -91.75 155.96 17.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.888 -0.596 . . . . 73.22 112.32 -173.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.19 -39.53 78.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.145 0.498 . . . . 73.53 110.472 173.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -133.92 113.35 12.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.832 -0.622 . . . . 73.3 110.495 174.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -83.17 -3.43 57.36 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.318 0.58 . . . . 74.12 111.379 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -92.54 -1.64 56.79 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.982 0.42 . . . . 75.43 111.306 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' ASN . . . . . 0.603 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 65.5 t30 -95.82 -6.65 39.0 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 116.345 -0.388 . . . . 70.34 112.0 -174.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 531' ' ' ASN . . . . . 0.419 HD22 HG13 ' A' ' 517' ' ' VAL . 11.5 m120 -83.66 3.92 30.83 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.54 0.941 . . . . 71.21 113.54 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 52.4 t -126.86 142.21 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 112.798 0.666 . . . . 70.12 112.798 -173.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . 0.472 ' HB2' HG23 ' A' ' 442' ' ' VAL . . . -128.58 143.96 51.06 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.119 -0.491 . . . . 71.41 111.232 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . 0.505 HG23 ' HD2' ' A' ' 512' ' ' ARG . 59.6 m -120.66 134.12 55.31 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 111.94 0.348 . . . . 72.01 111.94 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -142.5 136.88 29.8 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 120.713 0.292 . . . . 74.31 111.067 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -104.87 125.01 50.45 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.662 0.268 . . . . 55.33 111.692 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.6 t -114.3 128.77 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.8 0.333 . . . . 62.35 111.28 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 30.1 t -112.88 121.59 45.12 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.655 0.264 . . . . 65.23 111.02 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.484 ' HB ' ' HA ' ' A' ' 508' ' ' GLU . 41.9 t -98.93 131.43 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.691 0.281 . . . . 54.43 111.353 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.435 ' HB ' ' HG2' ' A' ' 542' ' ' GLU . 28.8 m -113.16 156.32 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.226 0.454 . . . . 74.21 112.226 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 94.9 mt -95.57 -13.36 24.48 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.323 -0.399 . . . . 74.3 111.652 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 542' ' ' GLU . . . . . 0.435 ' HG2' ' HB ' ' A' ' 540' ' ' VAL . 8.3 pt-20 . . . . . 0 C--O 1.249 1.055 0 N-CA-C 112.449 0.537 . . . . 61.21 112.449 -176.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.84 0.352 . . . . 71.22 110.105 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -97.59 117.57 32.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.228 0.537 . . . . 75.11 111.752 -174.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -121.37 128.61 25.6 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.746 -0.661 . . . . 72.31 110.226 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.625 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 59.2 Cg_endo -75.41 175.18 11.6 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.577 2.184 . . . . 65.22 113.399 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -153.58 81.59 1.17 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.847 -0.615 . . . . 75.52 110.194 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.514 HD22 HD12 ' A' ' 491' ' ' LEU . 96.6 mt -81.34 145.09 31.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.22 0.534 . . . . 63.22 111.833 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.556 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 12.0 t -148.55 156.37 42.34 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.103 0.478 . . . . 64.4 111.672 176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.537 HG12 HG12 ' A' ' 462' ' ' VAL . 27.9 m -125.76 147.95 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.941 -0.572 . . . . 71.54 110.871 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 40.2 mt-10 -134.57 117.98 16.75 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.854 0.359 . . . . 63.32 111.623 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 59.5 mt -94.21 131.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.406 -0.361 . . . . 72.52 110.727 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -142.44 138.85 31.34 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.632 0.253 . . . . 75.02 111.486 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.62 -162.39 32.44 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.017 -0.611 . . . . 73.33 113.51 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.46 124.52 10.42 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.886 2.391 . . . . 55.54 113.189 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -85.72 -15.81 41.01 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.123 0.416 . . . . 62.15 112.123 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.483 HG22 ' HB3' ' A' ' 538' ' ' SER . 87.2 t -133.01 126.61 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 120.711 0.291 . . . . 72.52 110.574 175.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.61 163.4 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 121.02 0.438 . . . . 71.22 111.648 -177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.17 157.52 26.03 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.165 -0.541 . . . . 63.53 113.012 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.542 HG22 ' ND2' ' A' ' 453' ' ' ASN . 8.1 p -72.34 140.49 17.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.006 0.432 . . . . 65.24 111.393 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . 0.542 ' ND2' HG22 ' A' ' 452' ' ' VAL . 41.9 m-80 60.23 23.81 13.19 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.658 0.383 . . . . 73.41 111.936 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.569 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -112.3 155.62 23.78 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.545 -0.298 . . . . 74.35 111.075 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 502' ' ' SER . 33.5 tp -90.55 139.81 30.34 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.878 0.37 . . . . 72.45 111.568 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -131.89 143.59 50.26 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.847 0.356 . . . . 60.34 111.608 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -111.32 126.09 54.53 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.103 0.478 . . . . 62.22 111.643 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -121.96 150.27 42.27 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.152 -0.476 . . . . 73.22 110.729 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.553 ' HG2' HG22 ' A' ' 500' ' ' THR . 37.8 mt-10 -121.8 128.08 51.29 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.129 -0.487 . . . . 73.55 111.384 -176.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 42.6 t -107.65 114.74 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.183 -0.462 . . . . 62.22 111.229 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.571 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 42.0 m-70 -90.49 111.55 22.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.722 0.296 . . . . 74.22 110.377 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.681 HG11 HG21 ' A' ' 475' ' ' VAL . 31.6 m -107.82 122.81 62.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 121.005 0.431 . . . . 71.22 110.36 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -141.69 152.86 44.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.586 0.707 . . . . 73.21 112.765 -173.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 49.1 t-20 -100.8 138.68 37.53 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.159 -0.928 . . . . 71.23 109.758 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 94.4 mt -120.94 -5.58 9.58 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.409 0.522 . . . . 73.3 112.409 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -77.83 -25.19 62.96 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.211 -0.518 . . . . 34.22 114.047 -176.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.62 15.98 59.15 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 121.243 -0.503 . . . . 74.12 113.776 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.2 tt -134.66 142.69 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.113 0.565 . . . . 71.43 110.736 177.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.82 140.78 35.22 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 114.322 0.489 . . . . 64.44 114.322 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.508 HG11 HD11 ' A' ' 440' ' ' LEU . 47.0 t -131.85 114.3 15.28 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 122.454 0.301 . . . . 55.35 111.671 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -88.84 -10.57 4.19 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 123.196 2.597 . . . . 70.01 113.281 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 84.9 p -85.0 13.27 6.23 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.636 0.775 . . . . 72.11 112.876 -174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 63.3 m -87.4 93.35 9.38 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.909 0.861 . . . . 70.32 112.32 -165.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -97.44 127.28 43.27 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.144 -0.934 . . . . 52.0 110.441 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.681 HG21 HG11 ' A' ' 462' ' ' VAL . 47.7 t -114.06 125.1 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.673 0.273 . . . . 71.22 111.079 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . 0.491 ' HD2' ' OE1' ' A' ' 519' ' ' GLU . 62.8 mtt85 -125.52 149.79 47.99 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.99 0.424 . . . . 55.43 111.812 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.87 127.09 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.125 0.488 . . . . 73.3 111.436 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -120.37 136.8 54.59 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.932 -0.577 . . . . 70.54 111.384 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.414 HG12 HG12 ' A' ' 513' ' ' ILE . 60.1 mt -109.0 107.87 23.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.22 -0.446 . . . . 74.22 109.982 175.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 57.43 34.9 25.3 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.123 0.487 . . . . 74.22 111.214 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.57 -5.86 84.22 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 116.122 -0.49 . . . . 74.01 113.848 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 42.3 m -93.34 125.63 38.04 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 117.051 0.426 . . . . 53.24 111.33 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.1 tp -65.72 117.56 8.32 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.115 0.413 . . . . 62.33 112.115 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -88.74 -45.21 9.97 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.535 -0.302 . . . . 74.22 111.449 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -169.99 161.98 8.98 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.671 0.272 . . . . 54.03 111.4 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -131.93 152.04 51.33 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.038 0.447 . . . . 64.24 111.595 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -134.54 147.27 50.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.029 -0.532 . . . . 74.11 110.864 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.0 m -121.36 119.21 31.48 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.116 -0.328 . . . . 44.42 110.116 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.5 172.81 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.154 0.502 . . . . 75.3 111.476 -176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 91.5 p -126.0 132.44 52.02 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.252 -0.431 . . . . 55.45 110.649 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.514 HD12 HD22 ' A' ' 440' ' ' LEU . 95.9 mt -118.23 119.74 35.59 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.842 0.353 . . . . 73.34 111.373 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -78.45 -165.49 27.77 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.056 -0.593 . . . . 70.43 112.975 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.24 95.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.084 1.856 . . . . 63.45 112.413 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.0 mttt 65.78 44.05 2.97 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.646 -0.706 . . . . 60.41 112.61 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -98.43 152.57 19.36 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.089 -0.505 . . . . 73.53 111.347 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -130.72 138.8 50.16 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.934 0.397 . . . . 72.33 111.694 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -119.55 138.76 52.98 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.948 -0.39 . . . . 61.2 109.948 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.01 113.24 36.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.021 0.439 . . . . 51.24 111.801 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 82.3 mt -103.88 146.46 28.62 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.288 -0.414 . . . . 71.33 111.267 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.553 HG22 ' HG2' ' A' ' 459' ' ' GLU . 43.4 p -127.06 156.76 41.16 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.189 0.518 . . . . 64.01 111.803 176.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -155.56 148.23 24.12 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.97 -0.559 . . . . 75.03 111.031 171.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.558 ' HB3' HD11 ' A' ' 455' ' ' LEU . 43.3 m -110.98 115.23 29.13 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.297 -0.411 . . . . 72.54 110.849 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -108.54 135.03 50.48 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.818 0.342 . . . . 73.5 111.763 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 27.3 m -116.14 100.68 53.7 Favored Pre-proline 0 N--CA 1.472 0.665 0 CA-C-N 116.39 -0.368 . . . . 71.13 111.262 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . 0.569 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 74.5 Cg_endo -76.17 97.36 1.11 Allowed 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.388 2.059 . . . . 72.53 112.881 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 67.0 p -76.71 -22.61 53.66 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.104 0.409 . . . . 70.12 112.104 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -107.33 138.58 43.26 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.843 0.354 . . . . 73.31 110.803 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' A' ' 508' ' ' GLU . 0.2 OUTLIER -85.74 140.41 30.52 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.285 0.565 . . . . 65.04 112.189 -174.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 148.49 -179.13 25.58 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.89 -0.595 . . . . 70.51 112.153 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 67.6 mtp -94.02 126.35 39.19 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.8 -0.824 . . . . 51.3 111.664 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.93 131.61 53.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.122 -0.49 . . . . 71.22 111.126 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -97.24 122.01 39.78 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.914 0.388 . . . . 73.41 111.263 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.414 HG12 HG12 ' A' ' 479' ' ' ILE . 63.1 mt -100.58 119.59 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.03 0.443 . . . . 63.43 110.951 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -115.82 151.87 34.41 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.04 0.448 . . . . 74.32 111.712 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -128.12 132.8 48.94 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.063 -0.517 . . . . 43.45 110.547 174.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 44.0 p -128.89 143.14 50.81 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.317 -0.401 . . . . 75.04 111.292 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.415 HG13 HD22 ' A' ' 531' ' ' ASN . 7.4 p -119.9 141.13 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.019 0.437 . . . . 61.1 111.697 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 21.8 t70 50.23 49.75 19.94 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.632 0.773 . . . . 72.2 112.632 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . 0.491 ' OE1' ' HD2' ' A' ' 476' ' ' ARG . 54.6 mt-10 -53.0 -29.45 29.29 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.247 0.546 . . . . 73.11 111.171 172.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.47 ' HB2' HG23 ' A' ' 522' ' ' THR . 0.0 OUTLIER -65.24 -17.3 64.38 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.655 -0.702 . . . . 64.13 110.933 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.91 56.57 5.27 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.243 0.544 . . . . 64.15 110.394 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . 0.47 HG23 ' HB2' ' A' ' 520' ' ' GLU . 64.5 p -83.9 -36.66 23.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.207 -0.451 . . . . 71.53 111.413 -178.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.22 141.68 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.459 0.54 . . . . 74.4 112.459 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 57.8 t -85.09 119.43 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.197 -0.456 . . . . 70.32 110.461 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.625 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 25.5 mt-10 -115.14 174.8 5.8 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.992 0.738 . . . . 74.32 112.992 -174.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.06 -39.65 55.0 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.511 -0.768 . . . . 73.54 112.286 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -120.07 118.66 31.19 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.207 0.527 . . . . 45.35 111.346 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -83.78 -20.84 32.6 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.345 0.593 . . . . 64.44 111.495 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -93.39 -4.38 51.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.227 0.537 . . . . 74.25 111.339 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.556 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 62.5 t30 -86.73 -10.79 52.88 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 120.982 0.42 . . . . 63.22 111.72 -174.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . 0.415 HD22 HG13 ' A' ' 517' ' ' VAL . 12.4 m120 -85.02 1.45 47.57 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.117 0.784 . . . . 74.3 113.117 -173.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.2 t -127.46 136.93 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 112.38 0.511 . . . . 62.21 112.38 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -125.44 141.19 52.19 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.269 -0.423 . . . . 55.01 110.883 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 84.4 m -127.59 119.7 26.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.168 0.433 . . . . 61.2 112.168 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -126.22 123.38 38.05 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.822 0.344 . . . . 71.5 110.847 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -94.38 120.56 34.8 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.877 0.37 . . . . 75.55 111.848 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.9 t -112.68 141.26 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.191 0.519 . . . . 72.52 111.94 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . 0.483 ' HB3' HG22 ' A' ' 449' ' ' VAL . 40.2 t -113.79 115.88 28.48 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.296 -0.411 . . . . 74.53 111.031 177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 43.6 t -99.8 120.83 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.859 0.362 . . . . 73.23 111.05 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 16.0 m -120.6 164.5 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.498 0.555 . . . . 72.33 112.498 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.4 mt -77.73 -30.86 51.85 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.356 0.502 . . . . 71.12 112.356 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--O 1.251 1.167 0 N-CA-C 112.383 0.512 . . . . 75.25 112.383 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 71.2 mtm . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.911 0.386 . . . . 74.12 111.304 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -88.09 120.39 29.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.381 -0.372 . . . . 60.54 110.391 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -112.93 134.48 21.76 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.645 -0.252 . . . . 74.34 110.461 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.576 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 61.3 Cg_endo -71.73 175.73 9.2 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.711 2.274 . . . . 75.53 112.789 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -151.6 83.66 1.29 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.123 -0.49 . . . . 70.03 109.872 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.532 HD22 HD12 ' A' ' 491' ' ' LEU . 80.0 mt -83.23 99.15 9.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.014 -0.539 . . . . 73.34 111.132 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.479 HG23 ' HG3' ' A' ' 463' ' ' LYS . 6.5 t -116.64 149.62 39.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.451 . . . . 51.13 111.149 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.602 HG12 HG12 ' A' ' 462' ' ' VAL . 31.4 m -121.37 148.56 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-N 116.263 -0.426 . . . . 63.43 111.227 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.3 mt-10 -130.01 117.74 20.51 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.628 0.251 . . . . 71.25 111.388 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 55.4 mt -92.47 131.05 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 110.456 -0.202 . . . . 63.11 110.456 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -142.45 144.51 33.08 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.541 0.21 . . . . 74.32 111.23 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.32 -159.3 29.04 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.989 -0.624 . . . . 74.43 113.38 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.69 134.22 21.71 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.906 2.404 . . . . 71.24 113.22 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -92.3 -20.25 21.3 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.433 0.531 . . . . 73.52 112.433 -177.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.1 t -127.97 125.75 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.959 -0.463 . . . . 75.31 111.241 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 33.6 m -135.65 161.27 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.982 0.42 . . . . 75.11 111.32 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -95.51 166.49 25.39 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.061 -0.59 . . . . 65.14 113.012 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.521 HG22 ' ND2' ' A' ' 453' ' ' ASN . 12.4 p -69.93 139.27 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 O-C-N 122.277 -0.543 . . . . 73.43 111.409 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . 0.521 ' ND2' HG22 ' A' ' 452' ' ' VAL . 48.4 m-80 63.6 17.95 10.75 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.913 0.485 . . . . 43.4 112.166 -177.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.534 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.8 mmmt -95.15 150.85 19.75 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.857 0.361 . . . . 70.55 110.812 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' A' ' 502' ' ' SER . 37.6 tp -96.69 118.97 34.28 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.7 0.286 . . . . 64.12 111.004 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.06 134.74 54.67 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.886 0.374 . . . . 73.22 111.715 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -108.55 130.05 55.3 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.0 0.428 . . . . 73.34 111.45 178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -122.33 166.44 14.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.088 0.47 . . . . 74.45 111.488 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -121.19 127.5 51.56 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.975 -0.557 . . . . 53.43 111.24 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 29.8 t -104.83 113.04 40.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.26 -0.427 . . . . 41.43 110.024 173.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 29.9 m-70 -98.34 106.22 18.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.648 0.261 . . . . 75.52 110.512 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.602 HG12 HG12 ' A' ' 442' ' ' VAL . 19.4 m -105.8 123.48 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.2 0.524 . . . . 64.12 110.104 -178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.548 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.2 ptpt -139.89 144.18 37.05 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.517 0.562 . . . . 62.14 112.517 -170.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.4 t-20 -102.76 126.7 49.98 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.191 -0.67 . . . . 71.11 109.191 172.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.548 HD21 ' HD3' ' A' ' 463' ' ' LYS . 67.9 mt -112.69 0.15 15.25 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.011 -0.43 . . . . 75.22 112.034 -176.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -83.87 -21.47 57.5 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.073 -0.584 . . . . 63.12 113.797 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.61 21.4 47.8 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.07 -0.586 . . . . 34.31 113.861 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.402 HG23 ' HB3' ' A' ' 438' ' ' PRO . 3.7 tt -138.1 133.77 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 122.662 -0.316 . . . . 70.53 111.076 175.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.1 141.41 34.28 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 114.684 0.634 . . . . 72.23 114.684 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.67 116.27 16.02 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.834 0.454 . . . . 61.13 111.344 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.71 -12.17 11.19 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.056 2.504 . . . . 74.4 113.086 175.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 50.7 m -81.59 13.51 3.06 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.587 0.755 . . . . 71.05 112.79 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . 0.424 HG23 HG21 ' A' ' 517' ' ' VAL . 62.9 m -86.56 91.15 8.47 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 122.119 0.962 . . . . 62.44 111.465 -165.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -95.08 121.7 36.99 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.698 -1.137 . . . . 74.34 110.364 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.544 HG21 HG11 ' A' ' 462' ' ' VAL . 41.4 t -104.31 118.24 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.001 0.429 . . . . 54.32 111.291 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -116.58 144.37 44.46 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.642 0.258 . . . . 72.42 111.555 -177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 95.6 t -120.17 120.25 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.801 0.334 . . . . 64.44 110.881 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -116.08 137.39 52.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.25 -0.432 . . . . 74.05 111.387 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.485 HG12 HG12 ' A' ' 513' ' ' ILE . 63.3 mt -111.85 107.94 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.799 -0.445 . . . . 42.03 109.799 174.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . 0.401 HD21 ' HA ' ' A' ' 511' ' ' TYR . 95.9 m-20 56.27 34.44 24.04 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.093 0.473 . . . . 75.24 111.183 -173.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.9 -20.65 47.88 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 116.252 -0.431 . . . . 54.42 113.732 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 45.5 m -81.93 121.71 26.84 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.357 -0.496 . . . . 75.41 111.81 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -63.91 120.32 11.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.077 0.465 . . . . 65.34 111.555 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -102.91 -43.89 5.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.201 -0.454 . . . . 74.12 111.982 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -146.91 152.53 38.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.583 0.23 . . . . 65.22 111.107 -174.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -145.3 139.15 26.87 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.103 0.478 . . . . 73.41 111.496 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -129.7 148.86 51.63 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.121 -0.49 . . . . 75.31 110.709 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 78.5 m -117.62 118.48 32.24 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.69 0.281 . . . . 72.21 110.244 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.1 m -141.8 173.43 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.283 0.563 . . . . 61.43 111.765 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 64.9 m -121.35 135.48 55.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.121 -0.49 . . . . 72.31 110.914 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.532 HD12 HD22 ' A' ' 440' ' ' LEU . 85.1 mt -118.11 119.85 35.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.806 0.336 . . . . 65.33 111.072 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -82.72 -169.03 43.6 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.326 -0.464 . . . . 61.02 113.449 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.51 107.88 0.64 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.417 2.078 . . . . 54.12 112.7 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.0 mmtp 68.45 29.21 5.79 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.126 -0.488 . . . . 75.24 111.596 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -92.2 147.4 22.96 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.369 -0.378 . . . . 71.31 111.728 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -135.12 129.35 33.75 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.605 0.362 . . . . 71.43 111.479 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.404 ' HG2' ' CD2' ' A' ' 491' ' ' LEU . 30.2 mmmt -116.79 136.63 52.8 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.677 0.275 . . . . 74.12 110.704 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 63.1 t -101.77 113.54 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 121.199 0.523 . . . . 61.34 111.488 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 68.7 mt -110.7 131.15 55.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.97 -0.559 . . . . 45.14 110.489 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 26.6 p -113.9 154.7 27.08 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.267 0.556 . . . . 71.22 112.32 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -144.4 148.8 35.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.645 -0.707 . . . . 64.14 110.816 174.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.509 ' HB2' HD11 ' A' ' 455' ' ' LEU . 76.0 p -115.04 114.36 25.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.065 0.46 . . . . 72.23 110.805 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.8 t90 -113.56 137.18 51.94 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.24 -0.436 . . . . 61.24 112.002 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.4 m -116.24 102.03 53.72 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.093 -0.503 . . . . 51.41 111.222 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 60.7 Cg_endo -71.92 99.38 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.534 2.156 . . . . 74.21 112.955 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 33.1 p -74.04 -21.88 59.77 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.944 0.402 . . . . 75.34 111.907 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -112.36 141.19 46.39 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.413 -0.358 . . . . 71.44 111.107 176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.68 151.18 23.64 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.257 0.551 . . . . 75.23 111.926 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 148.02 -170.97 28.6 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.06 -0.591 . . . . 70.15 112.77 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 13.7 tpt -98.76 120.83 39.87 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.503 -0.41 . . . . 74.32 110.729 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . 0.401 ' HA ' HD21 ' A' ' 480' ' ' ASN . 96.1 m-85 -120.23 116.22 25.17 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.899 0.38 . . . . 71.21 111.701 -177.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -92.47 112.94 25.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.901 0.381 . . . . 72.14 110.482 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.485 HG12 HG12 ' A' ' 479' ' ' ILE . 58.1 mt -93.8 117.34 37.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.254 0.55 . . . . 75.31 110.907 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -117.05 134.66 54.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 73.42 111.1 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.35 133.16 53.87 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.733 0.301 . . . . 53.53 110.646 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . 0.575 HG22 HG22 ' A' ' 532' ' ' VAL . 66.5 p -125.41 140.32 52.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.99 0.424 . . . . 73.33 111.61 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.424 HG21 HG23 ' A' ' 473' ' ' THR . 7.4 p -120.29 140.83 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.814 0.34 . . . . 72.14 111.022 174.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.6 t0 43.43 58.74 3.3 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.393 0.677 . . . . 71.31 112.778 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -57.75 -29.99 65.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.608 0.718 . . . . 74.33 110.475 171.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -67.62 -17.3 64.56 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.259 -0.882 . . . . 73.44 111.791 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 19.7 m120 51.4 55.4 9.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.671 0.748 . . . . 70.43 111.306 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 51.1 p -67.21 -19.72 65.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.377 -0.829 . . . . 74.22 111.363 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.22 141.13 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.188 -0.46 . . . . 61.31 111.749 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 74.0 t -83.58 119.78 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 110.069 -0.345 . . . . 74.31 110.069 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.576 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 18.9 mt-10 -110.24 -175.03 2.63 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.699 0.629 . . . . 73.04 112.699 -171.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 99.2 mt -69.48 -39.26 77.79 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.275 -0.42 . . . . 64.15 111.209 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -126.73 124.85 40.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.343 -0.39 . . . . 63.01 110.864 175.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -83.2 -23.98 32.61 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.848 0.314 . . . . 74.5 111.848 -176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -103.49 4.2 35.71 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.631 0.604 . . . . 71.33 112.631 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.474 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.7 t30 -86.62 -1.75 57.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.087 0.47 . . . . 74.22 111.373 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -80.85 -1.06 41.69 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.677 0.621 . . . . 74.14 112.677 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 516' ' ' THR . 56.6 t -124.53 129.61 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.112 0.412 . . . . 61.12 112.112 -176.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -114.3 142.86 45.76 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.342 -0.39 . . . . 42.32 111.162 177.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 63.2 m -116.22 130.14 56.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.36 -0.382 . . . . 51.21 111.963 -178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -142.88 117.64 9.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.443 -0.344 . . . . 71.24 110.28 174.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -96.34 134.31 39.64 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.185 0.516 . . . . 60.43 112.277 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.03 138.12 54.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.086 -0.506 . . . . 74.21 111.52 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.3 t -104.26 127.28 51.87 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.597 -0.274 . . . . 75.04 111.422 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 47.1 t -111.35 126.61 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.803 0.335 . . . . 73.01 111.258 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 28.8 m -121.04 164.3 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.596 0.591 . . . . 72.52 112.596 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 79.6 mt -88.26 11.06 17.55 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.508 0.558 . . . . 72.54 112.508 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--O 1.251 1.179 0 N-CA-C 112.369 0.507 . . . . 52.3 112.369 -176.688 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 59.8 mtt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.873 0.368 . . . . 74.34 111.122 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.76 127.11 35.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.994 0.426 . . . . 73.13 111.295 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -112.18 134.14 21.55 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.451 -0.34 . . . . 71.11 110.759 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.587 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 74.4 Cg_endo -81.77 175.96 8.86 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.944 2.429 . . . . 75.23 113.433 -177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -155.73 86.79 1.06 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.051 -0.522 . . . . 73.31 109.997 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.531 HD22 HD12 ' A' ' 491' ' ' LEU . 75.7 mt -89.0 105.37 17.74 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.975 0.417 . . . . 62.32 111.981 -176.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.707 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 8.0 t -113.14 152.12 30.03 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.2 0.524 . . . . 74.14 111.804 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.633 HG12 HG12 ' A' ' 462' ' ' VAL . 33.5 m -124.35 147.88 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.788 -0.642 . . . . 63.55 111.123 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 41.7 mt-10 -133.47 142.31 48.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.691 -0.231 . . . . 73.05 111.263 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 58.2 mt -111.59 129.77 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.723 0.297 . . . . 75.43 111.077 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -133.02 133.9 43.7 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.25 -0.281 . . . . 75.04 111.202 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.38 -170.94 39.75 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.89 -0.672 . . . . 65.33 113.5 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.14 126.87 13.54 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.702 2.268 . . . . 64.03 113.079 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -77.9 -19.99 53.72 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.058 0.392 . . . . 73.04 112.058 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.67 127.94 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 122.438 0.295 . . . . 54.51 110.38 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.1 m -127.84 163.93 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.28 0.562 . . . . 72.02 111.885 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.14 153.74 20.34 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.229 -0.51 . . . . 72.32 113.253 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.461 HG11 HD23 ' A' ' 541' ' ' LEU . 14.4 p -68.47 141.76 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.626 0.25 . . . . 72.21 111.236 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 59.97 21.44 10.51 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.058 0.456 . . . . 73.15 111.808 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -107.26 165.08 11.64 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.011 0.434 . . . . 75.42 111.483 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 502' ' ' SER . 29.4 tp -103.77 117.37 34.2 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.415 -0.357 . . . . 74.33 111.341 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.94 133.27 56.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.687 0.28 . . . . 71.2 111.509 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -110.7 133.76 53.05 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.081 0.467 . . . . 72.22 111.836 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -123.49 163.25 21.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.94 -0.573 . . . . 72.34 111.144 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -119.86 127.31 52.62 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.854 0.359 . . . . 75.34 110.569 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.47 112.96 36.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.69 -0.485 . . . . 71.4 109.69 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 30.7 m-70 -96.21 107.83 20.21 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.425 -0.352 . . . . 73.22 110.661 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.633 HG12 HG12 ' A' ' 442' ' ' VAL . 14.4 m -108.97 122.0 62.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.139 0.495 . . . . 51.24 110.451 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.481 ' HG3' HG23 ' A' ' 441' ' ' THR . 4.6 ptpp? -138.63 144.2 39.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.382 0.611 . . . . 71.41 112.253 -173.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 51.6 t-20 -99.96 127.3 46.17 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.599 -0.728 . . . . 71.4 109.808 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.427 HD21 ' HD3' ' A' ' 463' ' ' LYS . 82.7 mt -111.92 -1.9 15.33 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.958 0.355 . . . . 63.12 111.958 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -81.71 -15.72 74.88 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.388 -0.434 . . . . 63.35 113.831 -178.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.88 20.4 65.57 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 120.938 -0.649 . . . . 73.03 113.854 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.418 HG23 ' HB3' ' A' ' 438' ' ' PRO . 5.8 tt -138.47 135.03 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 122.731 -0.276 . . . . 74.55 111.412 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -66.88 134.88 32.27 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 114.123 0.409 . . . . 52.41 114.123 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 440' ' ' LEU . 86.9 t -129.6 116.75 18.41 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 122.651 0.38 . . . . 71.31 111.842 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -82.2 -10.44 11.28 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.085 2.523 . . . . 65.32 113.143 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 13.8 t -80.62 12.52 3.06 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.149 0.58 . . . . 71.24 112.469 -174.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . 0.432 HG23 HG21 ' A' ' 517' ' ' VAL . 67.7 m -87.61 91.09 8.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.958 0.885 . . . . 74.3 111.803 -166.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 517' ' ' VAL . 91.4 mttt -94.5 124.15 38.35 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.956 -1.02 . . . . 64.41 110.29 173.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.589 HG21 HG11 ' A' ' 462' ' ' VAL . 41.3 t -110.19 119.61 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.721 0.296 . . . . 70.42 111.005 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . 0.419 ' NH1' ' HB2' ' A' ' 519' ' ' GLU . 71.8 mtt180 -122.5 146.81 47.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 111.79 0.293 . . . . 73.04 111.79 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.8 t -120.65 124.18 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.044 0.45 . . . . 75.13 111.186 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -111.78 137.15 50.1 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.976 -0.557 . . . . 65.03 110.704 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.542 HG12 HG12 ' A' ' 513' ' ' ILE . 59.8 mt -117.37 108.67 25.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.854 0.359 . . . . 65.34 111.34 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 66.2 t30 60.06 34.1 21.31 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.266 0.555 . . . . 72.45 111.462 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 97.65 -12.79 64.47 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.274 -0.489 . . . . 44.33 114.031 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 89.8 m -105.21 127.07 52.75 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 117.332 0.566 . . . . 62.45 111.75 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.7 tp -61.98 128.0 34.06 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.943 0.401 . . . . 73.53 110.855 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -105.38 -43.6 4.94 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.644 0.609 . . . . 61.01 112.644 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -162.75 159.33 24.05 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.272 -0.267 . . . . 74.32 111.02 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -145.53 157.2 44.03 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.894 0.378 . . . . 61.23 111.753 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 -137.2 148.75 46.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.191 -0.459 . . . . 75.3 110.754 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 51.8 m -117.96 118.04 30.89 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.881 0.372 . . . . 64.31 110.168 172.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.12 174.55 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.21 0.528 . . . . 72.22 111.752 -175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 89.9 p -129.39 140.08 51.47 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.148 -0.478 . . . . 71.51 110.608 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.531 HD12 HD22 ' A' ' 440' ' ' LEU . 79.4 mt -117.44 121.49 41.19 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.852 0.358 . . . . 70.11 111.752 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -78.41 -172.18 40.1 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.357 -0.449 . . . . 71.12 113.08 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.16 110.54 0.89 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.45 2.1 . . . . 53.44 112.906 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 39.5 mmtm 67.0 26.63 9.01 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.986 -0.552 . . . . 74.21 111.929 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -99.2 146.89 25.69 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.109 -0.496 . . . . 73.31 112.064 -174.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 41.6 tt0 -129.07 145.77 51.19 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.103 0.478 . . . . 63.23 111.937 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.417 ' HG2' ' CD2' ' A' ' 491' ' ' LEU . 31.8 mmmt -121.6 137.18 54.85 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.784 -0.45 . . . . 74.41 109.784 172.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 52.9 t -101.04 112.12 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.139 0.495 . . . . 72.12 110.814 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 57.8 mt -103.15 146.57 28.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.989 -0.551 . . . . 62.22 110.714 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 20.0 p -130.21 155.31 46.47 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.549 0.69 . . . . 63.43 112.591 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.26 148.65 26.1 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.32 -0.855 . . . . 60.12 110.21 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.521 ' HB2' HD11 ' A' ' 455' ' ' LEU . 51.8 p -116.88 114.79 24.38 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.911 0.386 . . . . 44.31 110.984 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -104.15 136.72 43.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.262 -0.426 . . . . 73.51 111.896 -174.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.6 m -117.43 100.7 52.86 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 116.39 -0.368 . . . . 52.42 111.096 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . 0.424 ' HB2' HG11 ' A' ' 539' ' ' VAL . 90.7 Cg_endo -81.16 100.14 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.751 2.3 . . . . 64.11 113.072 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.9 p -78.57 -29.64 46.35 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.268 0.47 . . . . 74.32 112.268 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -100.43 131.67 46.22 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.832 0.349 . . . . 64.03 110.73 172.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.412 ' HG2' HD21 ' A' ' 541' ' ' LEU . 0.3 OUTLIER -87.36 150.37 23.88 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.11 0.481 . . . . 73.22 112.068 -176.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.79 -170.38 29.91 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.365 -0.445 . . . . 51.35 112.924 -178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 14.9 tpt -91.6 124.54 35.84 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 122.437 -0.449 . . . . 74.31 111.565 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -128.4 151.96 48.76 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.985 0.421 . . . . 74.33 111.258 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -124.18 119.72 30.22 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.104 -0.372 . . . . 52.22 111.615 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.542 HG12 HG12 ' A' ' 479' ' ' ILE . 52.6 mt -95.95 126.77 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.019 0.438 . . . . 61.22 111.306 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -123.01 145.21 48.7 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.989 0.423 . . . . 75.32 111.575 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.68 134.26 53.76 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.185 -0.461 . . . . 74.43 110.309 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 50.5 p -136.93 151.37 48.96 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.955 0.407 . . . . 71.4 111.945 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 474' ' ' LYS . 7.8 p -128.92 149.8 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 116.26 -0.427 . . . . 72.43 111.722 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 17.2 t70 47.9 43.53 17.57 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.71 0.767 . . . . 65.42 111.741 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . 0.419 ' HB2' ' NH1' ' A' ' 476' ' ' ARG . 6.9 mm-40 -51.4 -30.94 20.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.68 -0.691 . . . . 65.25 111.627 174.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -23.65 66.33 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.807 -0.633 . . . . 75.1 110.678 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 62.59 82.11 0.19 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.249 0.619 . . . . 75.33 110.303 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 53.8 p -109.45 -26.95 9.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.056 -0.52 . . . . 72.41 111.637 -177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 9.5 p -135.04 141.59 42.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 112.978 0.733 . . . . 62.11 112.978 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 99.0 t -84.6 114.5 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.141 -0.481 . . . . 74.44 110.296 172.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 27.3 mt-10 -101.78 176.8 5.1 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.636 0.606 . . . . 74.35 112.636 -174.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.15 -39.61 86.99 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.904 -0.589 . . . . 71.15 110.944 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.561 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 32.2 t30 -141.55 93.19 2.54 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.371 0.605 . . . . 64.15 110.302 173.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.55 14.95 3.37 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.064 -0.516 . . . . 64.4 112.212 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -104.62 -3.44 23.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.718 0.771 . . . . 72.11 109.67 167.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.707 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.1 t30 -86.55 -0.65 56.56 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.418 -0.81 . . . . 74.4 111.355 -174.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -83.76 -6.86 59.53 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.882 0.697 . . . . 73.44 112.882 -174.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.49 138.45 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 112.215 0.45 . . . . 75.41 112.215 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.08 142.84 50.57 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.215 -0.448 . . . . 63.2 111.183 176.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.4 m -126.77 133.91 50.73 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.665 0.269 . . . . 73.34 111.626 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -143.15 129.73 20.19 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.818 0.342 . . . . 74.34 111.08 177.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -93.6 134.7 35.61 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.877 0.37 . . . . 74.11 111.883 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 63.0 t -128.83 128.36 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.044 0.449 . . . . 44.04 111.43 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 46.6 t -103.82 120.88 41.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.77 0.319 . . . . 72.53 111.078 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.424 HG11 ' HB2' ' A' ' 505' ' ' PRO . 48.7 t -99.23 120.08 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.896 0.379 . . . . 72.24 111.321 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.442 HG23 ' H ' ' A' ' 542' ' ' GLU . 35.0 m -119.49 167.74 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.183 0.516 . . . . 74.44 112.116 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . 0.461 HD23 HG11 ' A' ' 452' ' ' VAL . 98.0 mt -80.4 25.94 0.39 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.215 0.45 . . . . 74.3 112.215 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . 0.442 ' H ' HG23 ' A' ' 540' ' ' VAL . 41.7 mt-10 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.545 -0.741 . . . . 64.43 111.914 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 120.806 0.336 . . . . 72.33 110.106 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -98.64 146.38 25.9 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.229 -0.442 . . . . 71.42 111.569 -173.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -117.07 134.93 22.96 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 116.335 -0.393 . . . . 74.02 110.425 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.424 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 86.7 Cg_endo -79.86 174.19 11.93 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.707 2.271 . . . . 65.43 114.046 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.0 93.97 2.99 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.424 -0.807 . . . . 74.13 109.471 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.4 HD11 HG11 ' A' ' 470' ' ' VAL . 98.4 mt -98.07 108.21 20.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.872 0.368 . . . . 71.15 111.348 -175.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 8.7 t -123.34 152.68 41.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.136 0.493 . . . . 61.13 111.669 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.516 HG12 HG12 ' A' ' 462' ' ' VAL . 34.8 m -120.87 147.85 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.972 -0.558 . . . . 51.03 110.846 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.629 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 43.1 mt-10 -130.28 137.18 49.86 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.666 -0.243 . . . . 55.04 110.747 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 57.4 mt -114.05 138.02 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 121.146 0.498 . . . . 61.34 111.689 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -137.1 146.1 44.7 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.049 -0.523 . . . . 74.45 110.97 178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.64 -171.2 33.63 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.674 -0.774 . . . . 61.25 114.025 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.04 123.45 8.38 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.819 2.346 . . . . 73.01 112.712 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -84.48 -13.32 52.34 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.397 0.517 . . . . 72.21 112.397 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 80.2 t -131.38 122.96 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.653 0.263 . . . . 73.44 110.75 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 31.2 m -135.81 163.19 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.172 0.511 . . . . 54.34 111.802 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -100.78 163.91 18.59 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 116.188 -0.46 . . . . 41.5 112.979 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.464 HG22 ' ND2' ' A' ' 453' ' ' ASN . 8.6 p -68.91 144.01 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 122.496 -0.414 . . . . 74.22 111.339 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . 0.464 ' ND2' HG22 ' A' ' 452' ' ' VAL . 40.2 m-80 60.17 17.61 7.06 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.221 0.452 . . . . 73.25 112.221 -177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.442 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.1 mmmt -103.82 138.84 39.86 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.923 0.392 . . . . 62.2 111.299 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 502' ' ' SER . 36.2 tp -85.39 125.35 32.91 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.194 -0.457 . . . . 52.32 111.251 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -124.79 136.66 54.04 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.917 0.389 . . . . 70.54 111.81 178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.33 133.94 46.43 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.049 0.452 . . . . 65.44 111.746 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 86.1 m-85 -122.31 150.93 41.68 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.205 -0.452 . . . . 70.34 111.03 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -120.88 127.23 51.68 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.951 -0.568 . . . . 41.23 110.875 -175.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.6 t -113.68 127.47 71.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 122.785 0.434 . . . . 64.25 111.212 -178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.629 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 77.7 m-70 -107.75 110.67 22.55 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.812 0.339 . . . . 72.55 110.594 176.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.617 HG11 HG21 ' A' ' 475' ' ' VAL . 33.6 m -107.47 124.27 63.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 120.896 0.379 . . . . 64.33 110.304 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.543 ' HD3' HD21 ' A' ' 465' ' ' LEU . 13.4 ptpt -143.73 153.75 42.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.159 0.8 . . . . 64.54 113.159 -170.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 48.9 t-20 -112.0 126.45 55.16 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.355 -0.839 . . . . 70.23 109.47 173.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.543 HD21 ' HD3' ' A' ' 463' ' ' LYS . 47.1 mt -114.28 5.16 15.69 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.867 0.365 . . . . 52.55 111.658 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -82.36 -20.14 62.96 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.308 -0.472 . . . . 54.41 113.682 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.84 14.91 62.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.021 -0.609 . . . . 42.14 113.603 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.9 tt -135.94 133.46 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 122.52 0.328 . . . . 43.55 111.119 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -72.36 139.86 28.6 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 114.172 0.429 . . . . 72.24 114.172 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 440' ' ' LEU . 52.8 t -130.36 114.35 17.12 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 111.95 0.352 . . . . 65.12 111.95 -177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.28 -11.33 13.32 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.982 2.455 . . . . 73.33 112.755 174.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . 0.494 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 20.1 m -80.55 11.38 3.77 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.658 0.783 . . . . 65.22 112.773 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 39.9 m -89.53 91.92 8.89 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.652 0.739 . . . . 65.23 112.316 -165.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -101.9 126.75 48.87 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.403 -0.817 . . . . 71.15 110.357 171.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.617 HG21 HG11 ' A' ' 462' ' ' VAL . 55.6 t -112.62 128.97 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.813 0.339 . . . . 54.14 111.286 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . 0.543 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 82.6 mtt180 -115.63 151.22 35.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.78 0.324 . . . . 75.24 111.312 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.3 t -121.31 120.21 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.835 0.35 . . . . 53.5 111.08 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -114.29 144.67 42.87 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.277 -0.419 . . . . 74.11 111.553 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.538 HG12 HG12 ' A' ' 513' ' ' ILE . 55.2 mt -123.6 107.93 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.115 -0.493 . . . . 60.34 109.73 173.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 53.42 39.14 29.48 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 120.88 0.371 . . . . 72.14 111.84 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 85.63 -0.96 88.31 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 121.097 -0.573 . . . . 52.51 114.066 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 94.4 m -98.51 120.45 38.95 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.25 0.525 . . . . 73.0 111.401 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 59.7 tp -69.7 115.04 8.48 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.189 0.518 . . . . 73.3 111.376 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -90.03 -43.28 10.63 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.121 -0.491 . . . . 75.31 111.754 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -167.32 162.25 14.72 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.664 0.268 . . . . 64.44 111.516 -174.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -147.49 152.6 38.33 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.688 0.28 . . . . 73.2 111.139 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 24.7 m-90 -130.0 134.77 47.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.818 0.342 . . . . 74.43 110.764 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 57.1 m -104.38 118.12 35.84 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.731 0.3 . . . . 72.33 110.257 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 22.3 m -140.83 172.85 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.343 0.592 . . . . 71.44 111.489 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 79.6 p -118.51 135.05 54.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.94 -0.573 . . . . 72.12 110.281 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.1 mt -116.96 119.68 36.08 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.886 0.374 . . . . 64.44 110.882 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -80.3 -177.35 50.9 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.079 -0.582 . . . . 51.42 113.116 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.56 108.75 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.476 2.117 . . . . 73.32 112.457 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.2 mmtp 67.91 32.98 4.9 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.14 -0.482 . . . . 72.14 111.816 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -101.33 148.61 24.95 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 111.92 0.341 . . . . 61.12 111.92 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 14.4 tt0 -131.8 143.68 50.38 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.428 -0.351 . . . . 70.42 111.206 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.406 ' HB3' ' NZ ' ' A' ' 497' ' ' LYS . 2.3 mmmp? -124.67 134.85 52.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.72 0.295 . . . . 74.13 110.575 175.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.06 117.57 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 121.244 0.545 . . . . 71.14 111.295 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 52.4 mt -114.07 146.7 39.87 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.038 -0.528 . . . . 73.23 110.861 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 33.3 p -129.41 154.47 46.91 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.27 0.557 . . . . 64.02 112.026 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.1 p90 -148.01 149.49 32.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.779 -0.646 . . . . 73.02 110.651 173.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.552 ' HB3' HD11 ' A' ' 455' ' ' LEU . 43.0 m -110.11 115.29 29.49 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.013 0.435 . . . . 62.34 110.333 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -118.05 136.58 53.47 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.969 0.414 . . . . 75.22 112.043 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.7 m -119.11 112.27 36.34 Favored Pre-proline 0 N--CA 1.472 0.653 0 CA-C-N 116.17 -0.468 . . . . 74.32 111.121 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 67.4 Cg_endo -75.06 118.85 5.4 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.418 2.079 . . . . 70.41 112.684 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 42.1 p -92.22 0.75 57.47 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.788 0.662 . . . . 64.11 112.788 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -143.75 145.93 32.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.701 0.286 . . . . 65.21 110.835 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -79.32 150.28 31.51 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.125 0.488 . . . . 71.1 111.148 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.76 -170.31 30.58 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.256 -0.497 . . . . 75.3 112.542 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 510' ' ' MET . 0.0 OUTLIER -96.43 111.14 23.35 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.93 0.395 . . . . 51.1 110.481 178.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -115.21 111.5 21.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.068 0.461 . . . . 61.31 111.644 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -96.31 124.85 40.46 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.901 0.381 . . . . 70.12 111.135 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.538 HG12 HG12 ' A' ' 479' ' ' ILE . 57.9 mt -98.55 124.1 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.214 -0.448 . . . . 70.22 111.127 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 21.3 m120 -122.61 138.47 54.58 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.026 0.441 . . . . 71.53 111.415 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.08 132.89 54.57 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.596 -0.275 . . . . 62.43 110.443 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . 0.541 HG22 HG22 ' A' ' 532' ' ' VAL . 54.1 p -123.47 140.34 53.1 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.875 0.369 . . . . 73.44 111.768 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.42 147.73 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.77 0.319 . . . . 74.03 111.319 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 37.9 t70 57.38 42.23 25.14 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.611 0.72 . . . . 74.03 111.81 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . 0.543 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.2 mm-40 -56.22 -32.55 64.54 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.966 -0.459 . . . . 71.24 111.481 174.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -67.71 -19.39 65.15 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.259 -0.428 . . . . 71.31 111.64 -178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 65.52 78.94 0.26 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.093 0.473 . . . . 71.14 111.306 -175.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 44.7 p -132.81 -13.54 2.86 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.061 0.763 . . . . 71.51 113.061 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.9 p -134.64 143.63 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.167 0.508 . . . . 62.22 112.272 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 68.0 t -100.73 117.96 46.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 116.343 -0.389 . . . . 74.12 111.096 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -92.64 175.31 6.86 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.242 0.544 . . . . 73.33 111.4 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.3 mt -75.57 -29.97 59.5 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.114 -0.494 . . . . 73.54 110.828 172.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -135.35 145.42 47.37 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.697 -0.683 . . . . 60.33 110.239 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.23 2.33 10.85 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.303 0.483 . . . . 54.21 112.303 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -87.25 -4.12 59.07 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.791 0.329 . . . . 61.1 111.708 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -111.83 -2.85 15.1 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.442 0.534 . . . . 63.35 112.442 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -69.67 -17.6 63.5 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.213 0.449 . . . . 74.33 112.213 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 516' ' ' THR . 41.1 t -124.13 131.99 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 120.672 0.272 . . . . 54.11 111.121 -178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -113.63 138.49 50.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.659 0.266 . . . . 54.1 111.083 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 50.0 m -112.18 127.65 56.01 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.123 0.416 . . . . 72.45 112.123 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -134.86 126.85 29.6 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.37 -0.377 . . . . 62.02 110.303 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -94.98 124.92 39.31 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.081 0.4 . . . . 53.1 112.081 -176.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.18 128.45 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.139 0.495 . . . . 71.4 111.301 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.6 t -105.37 120.12 40.78 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.256 -0.277 . . . . 75.31 110.726 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 53.7 t -104.7 128.58 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 120.911 0.386 . . . . 75.34 111.871 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.83 160.08 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 116.337 -0.392 . . . . 73.02 111.546 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.57 -17.03 61.74 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.141 0.423 . . . . 74.13 112.141 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--O 1.252 1.233 0 N-CA-C 112.104 0.409 . . . . 72.44 112.104 -178.845 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 10.6 tpt . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 121.078 0.466 . . . . 74.44 110.821 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -100.18 136.45 40.05 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.015 0.436 . . . . 74.43 111.816 -177.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -122.39 131.62 24.37 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.882 -0.599 . . . . 73.53 109.855 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 60.4 Cg_endo -73.45 173.91 13.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.25 1.966 . . . . 71.44 113.96 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -152.95 109.13 3.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.156 -0.929 . . . . 73.31 109.462 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.536 HD22 HD12 ' A' ' 491' ' ' LEU . 83.1 mt -105.36 156.85 17.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.98 0.419 . . . . 72.45 111.171 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.642 HG23 ' HG3' ' A' ' 463' ' ' LYS . 2.0 t -161.28 149.89 15.97 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.037 0.446 . . . . 71.11 112.026 177.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.577 HG12 HG12 ' A' ' 462' ' ' VAL . 35.8 m -121.11 147.67 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.03 -0.532 . . . . 73.13 111.621 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -139.56 135.39 33.35 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.112 -0.494 . . . . 64.3 111.153 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 59.2 mt -109.18 131.36 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.534 0.206 . . . . 61.55 110.958 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -133.78 145.17 49.53 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.479 0.181 . . . . 63.13 110.952 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.39 -171.2 34.06 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 120.797 -0.716 . . . . 52.43 113.999 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.54 123.1 9.84 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.956 2.437 . . . . 71.31 112.991 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -83.58 -8.76 59.25 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.286 0.476 . . . . 75.02 112.286 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 73.3 t -131.67 120.87 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 122.342 -0.224 . . . . 71.53 110.783 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 32.9 m -135.4 164.15 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.054 0.454 . . . . 75.31 111.853 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -94.89 162.33 24.03 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.3 -0.476 . . . . 34.14 113.439 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.557 HG22 ' ND2' ' A' ' 453' ' ' ASN . 8.4 p -74.26 140.71 17.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 O-C-N 122.436 -0.45 . . . . 71.01 111.484 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . 0.557 ' ND2' HG22 ' A' ' 452' ' ' VAL . 46.5 m-80 59.4 16.57 5.22 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.227 0.611 . . . . 70.14 112.056 -177.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -98.75 157.9 15.97 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.995 0.426 . . . . 75.42 111.394 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' A' ' 502' ' ' SER . 26.8 tp -96.07 130.94 42.96 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.343 -0.389 . . . . 72.14 111.2 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -134.91 134.39 40.61 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.519 0.2 . . . . 63.24 111.339 177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -100.31 133.05 45.3 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.351 0.596 . . . . 62.33 111.921 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -122.66 164.0 19.04 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.735 -0.666 . . . . 64.44 110.633 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.414 ' HG2' HG22 ' A' ' 500' ' ' THR . 57.2 mt-10 -121.32 127.7 51.56 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.108 0.48 . . . . 75.51 111.965 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 52.7 t -100.03 113.78 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.068 -0.514 . . . . 74.12 110.062 172.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -99.35 110.45 22.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.346 -0.388 . . . . 74.13 110.699 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.75 HG11 HG21 ' A' ' 475' ' ' VAL . 30.5 m -110.72 122.95 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.079 0.466 . . . . 63.51 110.517 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.642 ' HG3' HG23 ' A' ' 441' ' ' THR . 3.0 ptpp? -135.44 151.39 50.37 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.785 0.661 . . . . 53.14 112.785 -173.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 51.2 t-20 -106.19 128.37 53.88 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.296 -0.865 . . . . 72.11 109.761 175.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.443 HD21 ' HD3' ' A' ' 463' ' ' LYS . 73.6 mt -107.61 -23.32 12.18 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.91 0.337 . . . . 63.41 111.91 -178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -60.22 -25.97 63.16 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 114.604 0.602 . . . . 44.44 114.604 -173.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.53 17.49 58.47 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.831 -0.7 . . . . 74.41 113.271 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.6 tt -137.73 140.92 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 122.785 0.434 . . . . 72.35 110.85 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.441 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -67.43 136.29 31.89 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.204 0.442 . . . . 44.31 114.204 -176.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.405 HG11 HD11 ' A' ' 440' ' ' LEU . 46.7 t -127.4 113.7 21.27 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-O 120.799 0.333 . . . . 72.14 111.339 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -88.36 -9.73 4.95 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.267 2.645 . . . . 74.2 113.095 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . 0.461 ' HB2' ' OG1' ' A' ' 522' ' ' THR . 93.2 p -87.79 11.95 14.16 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.5 0.926 . . . . 43.53 113.5 -173.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 60.3 m -87.85 108.58 19.23 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.605 0.717 . . . . 63.21 112.825 -164.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -112.12 131.03 55.69 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.437 -0.801 . . . . 62.12 111.181 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.75 HG21 HG11 ' A' ' 462' ' ' VAL . 41.5 t -111.23 137.24 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 122.458 0.303 . . . . 74.5 111.564 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 75.0 mtt180 -131.52 143.08 50.12 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 122.468 0.307 . . . . 62.52 111.495 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 96.5 t -120.96 122.89 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.863 0.363 . . . . 73.22 111.278 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -113.37 139.29 49.0 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.867 0.467 . . . . 53.31 110.831 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.423 HG12 HG12 ' A' ' 513' ' ' ILE . 56.7 mt -119.65 111.15 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.68 0.276 . . . . 74.12 110.28 176.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 55.05 34.02 21.61 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.297 -0.41 . . . . 63.23 111.807 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 101.06 -29.14 13.16 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 116.327 -0.397 . . . . 44.25 113.581 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 91.0 m -81.92 125.82 31.19 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 122.411 -0.464 . . . . 74.4 111.899 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 56.7 tp -65.79 114.54 5.12 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.267 0.556 . . . . 73.23 110.815 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -88.43 -43.97 11.08 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.319 0.489 . . . . 73.23 112.319 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -167.02 160.51 14.17 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 111.589 0.218 . . . . 64.44 111.589 -175.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -141.65 152.94 44.39 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 120.914 0.388 . . . . 72.41 111.741 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -131.84 148.94 52.58 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.76 0.424 . . . . 61.31 111.346 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 81.4 m -115.46 119.19 35.38 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.487 -0.324 . . . . 74.4 110.147 173.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 29.3 m -142.34 173.86 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.442 0.639 . . . . 51.44 112.261 -175.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 88.1 p -129.28 133.6 47.55 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.866 -0.606 . . . . 63.31 110.378 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.536 HD12 HD22 ' A' ' 440' ' ' LEU . 96.1 mt -117.26 120.45 38.28 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.985 0.422 . . . . 74.24 111.45 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.441 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -84.09 -177.62 51.47 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.066 -0.588 . . . . 71.22 112.882 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.53 107.68 0.22 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.876 2.384 . . . . 71.54 113.04 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 74.3 mmtt 67.01 34.43 5.16 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.045 -0.525 . . . . 73.3 112.04 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -102.41 151.85 21.79 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.372 0.508 . . . . 72.21 112.372 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 34.9 tt0 -133.87 141.44 47.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.089 0.471 . . . . 73.43 111.345 173.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -116.85 131.65 56.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.149 -0.478 . . . . 52.13 109.835 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 57.2 t -100.03 113.26 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.234 0.54 . . . . 64.45 111.312 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 47.6 mt -105.87 146.15 30.31 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.834 -0.621 . . . . 73.43 111.106 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.414 HG22 ' HG2' ' A' ' 459' ' ' GLU . 32.0 p -125.23 154.84 41.01 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.274 0.559 . . . . 70.52 111.947 177.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -154.76 150.54 27.67 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.829 -0.623 . . . . 72.14 110.588 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.556 ' HB2' HD11 ' A' ' 455' ' ' LEU . 79.6 p -109.93 114.3 27.72 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.018 0.437 . . . . 71.33 110.641 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . 0.403 ' HZ3' HG11 ' A' ' 537' ' ' VAL . 33.0 t90 -108.59 138.19 45.3 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.884 -0.598 . . . . 74.42 111.947 -174.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 94.7 m -124.31 109.0 29.25 Favored Pre-proline 0 N--CA 1.473 0.69 0 CA-C-N 116.109 -0.496 . . . . 73.23 111.56 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.37 119.32 3.77 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.787 2.324 . . . . 75.54 112.918 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 66.5 p -89.31 13.77 12.69 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.255 0.465 . . . . 73.11 112.255 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . 0.621 ' HB3' ' OH ' ' A' ' 511' ' ' TYR . 25.9 tt0 -143.14 142.02 31.36 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.746 0.418 . . . . 62.13 110.474 176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -88.47 135.87 33.27 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.105 0.479 . . . . 74.41 110.883 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.85 -166.99 29.9 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.087 -0.577 . . . . 70.32 112.872 -175.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 96.2 mmm -83.97 120.62 26.33 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.167 0.508 . . . . 73.53 112.319 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . 0.621 ' OH ' ' HB3' ' A' ' 507' ' ' GLN . 48.9 m-85 -118.62 113.62 21.51 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.155 -0.475 . . . . 64.34 111.446 175.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 512' ' ' ARG . 15.7 ttm180 -96.48 111.38 23.51 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.914 0.388 . . . . 64.32 110.687 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.423 HG12 HG12 ' A' ' 479' ' ' ILE . 57.6 mt -96.52 113.81 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.023 0.44 . . . . 75.02 111.409 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 21.5 m120 -107.59 151.84 25.08 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.929 0.395 . . . . 53.42 111.725 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -134.79 136.87 42.89 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.767 0.317 . . . . 63.22 111.074 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 58.1 p -129.17 152.37 48.83 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.215 -0.448 . . . . 50.22 111.034 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.14 141.82 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.212 0.529 . . . . 72.24 111.898 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 2.8 t0 48.78 44.33 21.66 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.832 0.853 . . . . 64.54 112.471 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -51.75 -30.06 21.12 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.232 0.539 . . . . 64.02 111.181 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 522' ' ' THR . 0.9 OUTLIER -66.92 -16.99 64.69 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.66 -0.7 . . . . 71.12 111.431 -176.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 27.4 m120 59.75 44.82 13.58 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.379 0.609 . . . . 64.13 111.213 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . 0.461 ' OG1' ' HB2' ' A' ' 472' ' ' SER . 57.0 p -67.03 -39.47 87.0 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.83 -0.623 . . . . 42.54 111.581 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.417 HG21 ' HG3' ' A' ' 438' ' ' PRO . 12.5 p -115.28 143.57 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 116.146 -0.479 . . . . 73.43 111.844 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . 0.518 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 52.2 t -83.27 117.05 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 O-C-N 122.164 -0.335 . . . . 65.53 111.007 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -103.35 177.63 4.79 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.789 0.662 . . . . 74.45 112.789 -175.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.16 -39.06 18.29 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.662 -0.699 . . . . 74.45 112.339 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -114.97 164.2 14.49 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.216 0.531 . . . . 72.54 112.284 -172.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -125.01 -7.43 7.19 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.088 0.47 . . . . 72.31 111.695 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -107.46 16.88 23.4 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.63 0.604 . . . . 74.43 112.63 -173.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.565 ' HB2' ' HB ' ' A' ' 441' ' ' THR . 6.8 p-10 -114.78 -17.77 11.51 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.258 1.207 . . . . 62.43 114.258 -173.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -89.37 17.81 5.82 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.62 0.97 . . . . 74.34 113.62 -172.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.41 134.27 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.062 0.458 . . . . 72.54 111.511 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -128.37 141.89 51.28 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.501 -0.318 . . . . 54.23 111.176 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.0 m -129.32 121.6 27.83 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.889 0.329 . . . . 71.13 111.889 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -121.78 126.11 48.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.804 0.335 . . . . 75.44 110.873 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.75 119.21 32.43 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.888 0.375 . . . . 74.43 111.742 -177.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.403 HG11 ' HZ3' ' A' ' 503' ' ' TRP . 48.2 t -112.66 134.99 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.269 0.557 . . . . 75.1 111.924 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 31.0 t -108.83 114.32 28.0 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.965 -0.561 . . . . 55.13 110.543 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 450' ' ' VAL . 40.4 t -102.19 125.79 56.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.994 0.426 . . . . 72.23 111.775 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 542' ' ' GLU . 28.2 m -115.17 168.34 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 115.89 -0.595 . . . . 63.14 111.434 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 70.9 mt -71.38 1.34 6.41 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.132 0.79 . . . . 74.53 113.132 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . 0.408 ' H ' HG23 ' A' ' 540' ' ' VAL . 6.0 pt-20 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 112.318 0.488 . . . . 74.05 112.318 -176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.633 0.254 . . . . 75.54 111.102 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -90.5 145.5 24.84 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.933 0.397 . . . . 71.54 111.92 -175.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.25 134.49 25.81 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.209 -0.45 . . . . 75.41 110.793 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.706 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 58.9 Cg_endo -73.05 175.63 10.22 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.158 2.572 . . . . 55.41 114.236 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -153.7 86.84 1.21 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.578 -0.737 . . . . 72.02 109.706 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.538 HD22 HD12 ' A' ' 491' ' ' LEU . 88.7 mt -90.09 109.68 20.72 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.119 0.485 . . . . 64.22 112.193 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.424 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.6 t -113.2 152.84 29.23 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.127 -0.358 . . . . 72.54 111.722 177.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.579 HG12 HG12 ' A' ' 462' ' ' VAL . 28.3 m -128.42 148.86 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.18 0.514 . . . . 64.45 112.154 -176.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.594 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 44.2 mt-10 -129.35 146.66 51.18 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.177 -0.465 . . . . 62.14 111.47 175.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 62.1 mt -110.01 135.16 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.026 0.441 . . . . 72.51 110.722 173.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.565 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 63.6 tttp -135.12 145.03 47.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.357 -0.383 . . . . 65.43 110.521 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 154.64 -167.08 32.51 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.282 -0.961 . . . . 63.14 114.341 176.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.474 ' HD2' ' CZ ' ' A' ' 458' ' ' TYR . 16.5 Cg_exo -65.66 141.02 64.6 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 123.312 2.675 . . . . 53.43 113.776 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.28 -52.2 5.34 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.84 0.456 . . . . 74.24 111.236 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 538' ' ' SER . 59.4 t -116.31 127.15 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.691 -0.231 . . . . 60.1 110.717 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.15 163.21 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 121.007 0.432 . . . . 61.3 111.972 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.69 155.81 25.1 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 116.2 -0.455 . . . . 74.22 112.921 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.517 HG22 ' ND2' ' A' ' 453' ' ' ASN . 13.2 p -67.96 143.61 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.119 0.485 . . . . 72.24 111.839 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . 0.517 ' ND2' HG22 ' A' ' 452' ' ' VAL . 55.7 m-80 61.81 21.26 12.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.018 -0.537 . . . . 54.25 112.268 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.541 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.7 mmmt -103.18 150.75 23.37 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.017 0.437 . . . . 73.21 111.732 177.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.513 HD11 ' HB2' ' A' ' 502' ' ' SER . 48.7 tp -93.86 119.38 32.72 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.338 -0.392 . . . . 73.12 111.344 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.59 133.03 54.99 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.706 0.288 . . . . 50.44 111.584 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.95 137.73 38.93 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.115 0.483 . . . . 65.32 111.688 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . 0.474 ' CZ ' ' HD2' ' A' ' 447' ' ' PRO . 10.3 m-85 -122.27 162.23 21.85 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.67 -0.696 . . . . 74.05 110.76 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 445' ' ' LYS . 51.9 mt-10 -120.38 127.3 52.17 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.998 0.427 . . . . 72.21 111.661 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 28.9 t -101.95 114.02 40.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.212 -0.449 . . . . 60.22 109.9 171.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.594 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 12.2 m-70 -101.3 110.6 22.63 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.702 0.287 . . . . 74.51 110.736 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.579 HG12 HG12 ' A' ' 442' ' ' VAL . 14.5 m -119.59 137.54 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.069 0.461 . . . . 74.11 110.917 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.22 152.87 37.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.1 0.476 . . . . 75.32 111.764 -176.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.5 t-20 -99.87 127.44 46.04 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.052 -0.522 . . . . 75.3 110.12 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 82.0 mt -110.29 -7.93 14.78 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.971 0.36 . . . . 52.22 111.971 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -76.59 -23.12 70.98 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.182 -0.533 . . . . 41.4 113.447 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 84.48 22.7 53.27 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.021 -0.609 . . . . 72.12 113.546 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.2 tt -139.71 136.96 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.594 0.358 . . . . 51.34 111.362 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.555 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -69.57 135.54 27.06 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 114.94 0.736 . . . . 74.12 114.94 -175.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.41 115.37 16.08 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 122.816 0.446 . . . . 63.22 111.632 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -82.38 -11.46 10.7 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.052 2.502 . . . . 64.32 113.251 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 45.6 m -81.14 11.35 4.26 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.256 0.622 . . . . 42.12 112.592 -175.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . 0.45 HG23 HD13 ' A' ' 440' ' ' LEU . 56.5 m -86.88 98.98 11.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.828 0.823 . . . . 33.12 111.973 -162.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -108.24 123.04 48.16 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.119 -0.946 . . . . 74.41 111.195 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.528 HG21 HG11 ' A' ' 462' ' ' VAL . 46.2 t -104.24 123.7 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.379 -0.373 . . . . 55.21 110.72 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 515' ' ' ALA . 83.2 mtt180 -114.9 145.99 41.61 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.713 0.292 . . . . 74.23 111.75 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.63 119.73 59.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.995 0.426 . . . . 63.54 111.085 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -112.2 145.11 40.47 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.37 -0.377 . . . . 73.55 111.149 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 66.3 mt -121.77 107.54 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.952 -0.388 . . . . 74.12 109.952 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 56.63 33.87 23.51 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.054 0.454 . . . . 75.45 111.365 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 100.08 -30.97 9.02 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.432 -0.414 . . . . 41.32 113.679 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 85.4 m -82.02 119.2 23.69 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 122.393 -0.475 . . . . 74.02 111.787 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.4 tp -62.57 115.03 3.91 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.063 0.458 . . . . 74.33 111.342 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -87.29 -43.4 12.19 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.373 -0.376 . . . . 72.5 111.854 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -166.11 161.1 16.93 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.357 -0.214 . . . . 72.4 111.324 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . 0.42 HD22 ' N ' ' A' ' 486' ' ' ASN . 0.1 OUTLIER -155.24 159.63 40.21 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.798 0.332 . . . . 75.32 111.613 177.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -133.41 149.36 51.82 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.33 -0.395 . . . . 64.41 111.12 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 38.5 m -115.32 118.63 33.8 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.89 0.376 . . . . 72.44 110.589 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.6 173.42 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-O 121.197 0.522 . . . . 72.34 111.424 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 92.6 p -120.59 132.59 55.22 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.356 -0.384 . . . . 55.31 110.139 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.538 HD12 HD22 ' A' ' 440' ' ' LEU . 96.5 mt -118.22 119.05 33.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.818 0.342 . . . . 72.34 110.948 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.555 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -80.52 -167.07 35.95 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 115.992 -0.549 . . . . 50.34 113.082 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -59.95 105.72 0.29 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.596 2.197 . . . . 73.2 112.426 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 33.9 mmtp 67.67 29.93 6.73 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.342 0.591 . . . . 75.32 111.461 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -83.47 152.71 24.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.502 -0.772 . . . . 62.03 111.13 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -135.0 150.7 50.37 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.839 0.352 . . . . 73.1 111.68 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.419 ' O ' HG22 ' A' ' 462' ' ' VAL . 23.8 mmtm -145.25 127.16 15.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.078 0.466 . . . . 73.51 111.32 176.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.48 112.93 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.127 0.489 . . . . 60.25 110.805 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 27.5 mt -107.93 137.14 46.45 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.051 -0.522 . . . . 73.04 111.209 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 22.4 p -112.89 149.49 33.09 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.653 0.612 . . . . 72.5 112.653 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 55.1 p90 -144.33 148.56 34.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.764 -0.653 . . . . 41.34 110.909 173.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 455' ' ' LEU . 83.0 p -115.82 115.27 25.99 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.891 0.377 . . . . 71.13 111.214 -178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 30.6 t90 -116.51 137.98 51.75 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.456 -0.338 . . . . 73.31 111.808 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 85.9 m -111.98 101.04 50.83 Favored Pre-proline 0 N--CA 1.474 0.733 0 CA-C-N 116.538 -0.301 . . . . 74.1 111.681 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 59.5 Cg_endo -71.61 88.67 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.155 1.904 . . . . 74.53 112.417 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 19.2 p -76.2 -0.99 24.2 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.102 0.408 . . . . 61.33 112.102 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -129.54 135.88 49.14 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.519 -0.309 . . . . 63.54 110.44 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -83.27 151.18 25.73 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.766 0.654 . . . . 64.03 112.766 -174.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 141.9 -179.82 19.56 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.999 -0.546 . . . . 64.05 112.518 -178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 56.1 mtp -93.11 115.88 28.51 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.486 0.643 . . . . 74.43 111.655 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -110.49 129.84 55.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.19 -0.459 . . . . 71.52 111.321 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -99.45 116.41 31.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.056 0.455 . . . . 74.5 111.598 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 66.4 mt -95.73 127.65 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.847 -0.615 . . . . 64.34 110.948 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -122.42 131.42 53.87 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.494 -0.321 . . . . 74.15 111.472 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 476' ' ' ARG . . . -111.82 133.08 54.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.711 0.291 . . . . 75.23 110.37 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . 0.499 HG22 HG22 ' A' ' 532' ' ' VAL . 71.5 p -133.74 155.9 48.93 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.778 0.323 . . . . 65.21 111.517 -176.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.1 p -130.38 140.53 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.831 0.348 . . . . 71.5 111.62 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 1.6 t70 41.13 50.39 3.29 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.884 0.874 . . . . 62.21 112.754 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -53.97 -32.93 55.54 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.048 0.451 . . . . 74.02 112.178 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.58 ' HG3' HG23 ' A' ' 522' ' ' THR . 7.4 pt-20 -81.49 2.65 27.92 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.809 -0.632 . . . . 74.3 112.603 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 55.74 36.22 26.83 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.404 0.89 . . . . 61.53 113.404 171.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . 0.58 HG23 ' HG3' ' A' ' 520' ' ' GLU . 75.0 p -63.06 -25.92 68.6 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.059 0.457 . . . . 73.54 111.141 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 10.8 p -107.49 140.76 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 116.201 -0.454 . . . . 70.43 111.271 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . 0.405 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 74.6 t -90.77 115.32 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 122.148 -0.345 . . . . 60.31 110.444 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.706 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 15.2 mt-10 -113.02 -174.02 2.37 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.92 0.711 . . . . 65.25 112.92 -174.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 88.0 mt -82.6 -38.81 23.09 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.587 -0.733 . . . . 63.13 111.271 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -138.77 158.6 43.93 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.982 0.42 . . . . 64.2 110.942 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -129.51 -8.07 4.65 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.981 0.419 . . . . 73.43 111.553 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -77.21 -20.72 54.92 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.339 0.496 . . . . 73.32 112.339 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.424 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 17.4 p-10 -101.75 5.55 41.33 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.179 0.437 . . . . 64.02 112.179 -177.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -82.2 1.2 37.56 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.181 0.437 . . . . 70.3 112.181 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.499 HG22 HG22 ' A' ' 516' ' ' THR . 58.3 t -131.14 129.37 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.013 0.435 . . . . 53.12 111.644 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -115.26 136.09 53.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.382 -0.372 . . . . 54.43 110.744 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 61.8 m -117.82 129.7 55.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.659 0.266 . . . . 74.33 111.552 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -139.87 129.28 24.1 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.792 0.33 . . . . 74.23 111.244 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -95.42 137.62 34.23 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.692 0.282 . . . . 72.21 111.707 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 53.6 t -123.74 141.13 45.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.876 0.37 . . . . 60.11 110.991 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . 0.529 ' HB3' HG22 ' A' ' 449' ' ' VAL . 48.3 t -112.54 114.83 27.69 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.917 0.389 . . . . 74.31 111.296 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.76 124.1 52.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.947 0.403 . . . . 73.43 111.357 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.29 163.17 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.299 0.571 . . . . 75.22 112.182 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 97.5 mt -90.4 14.81 11.94 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.133 -0.485 . . . . 75.02 111.83 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 C--O 1.249 1.055 0 N-CA-C 112.609 0.596 . . . . 75.43 112.609 -172.121 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.761 -0.459 . . . . 74.31 109.761 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -98.14 142.94 29.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.118 0.485 . . . . 73.4 112.093 -173.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -113.24 130.72 23.36 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.03 -0.532 . . . . 54.44 110.642 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.438 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 55.5 Cg_endo -72.91 175.37 10.49 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.516 2.144 . . . . 61.13 113.23 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -153.94 81.42 1.14 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.086 0.469 . . . . 73.32 110.113 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.498 HD22 HD12 ' A' ' 491' ' ' LEU . 93.9 mt -87.44 143.76 27.07 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.329 0.585 . . . . 64.1 111.769 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.462 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.9 t -153.4 164.93 37.3 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.076 -0.511 . . . . 73.02 111.403 176.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 462' ' ' VAL . 30.9 m -133.71 148.19 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 116.142 -0.481 . . . . 62.53 111.108 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 53.1 mt-10 -127.05 132.31 50.72 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.509 -0.314 . . . . 61.51 111.113 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 63.2 mt -100.33 125.28 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.02 0.438 . . . . 53.13 110.648 176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 26.9 tptp -128.05 131.6 49.12 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.43 -0.35 . . . . 73.44 110.893 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.75 -172.51 35.01 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 120.667 -0.777 . . . . 35.54 113.956 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.5 135.51 22.25 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.971 2.447 . . . . 71.44 113.244 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -85.24 -15.71 42.6 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.213 0.449 . . . . 71.41 112.213 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 86.6 t -131.28 131.56 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.59 0.233 . . . . 70.32 110.672 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.34 157.55 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.058 0.456 . . . . 73.44 111.779 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.56 158.87 26.65 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.116 -0.564 . . . . 71.11 113.124 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.558 HG22 ' ND2' ' A' ' 453' ' ' ASN . 9.1 p -66.84 134.49 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.095 0.474 . . . . 73.55 111.575 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . 0.558 ' ND2' HG22 ' A' ' 452' ' ' VAL . 44.1 m-80 64.9 9.16 5.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.542 0.737 . . . . 75.24 112.347 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -87.93 162.24 17.0 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.042 0.449 . . . . 71.54 111.496 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 502' ' ' SER . 27.1 tp -100.45 121.08 40.96 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.869 0.366 . . . . 72.23 111.188 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -120.34 132.72 55.41 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.569 0.223 . . . . 74.43 111.499 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -102.89 128.75 49.54 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.218 0.532 . . . . 72.43 111.919 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -122.45 154.09 38.24 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.79 -0.641 . . . . 62.45 110.803 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.546 ' HG2' HG22 ' A' ' 500' ' ' THR . 41.3 mt-10 -121.29 127.56 51.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.271 -0.422 . . . . 72.13 111.071 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.2 t -102.44 113.45 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.827 0.346 . . . . 62.32 110.507 173.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.626 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 35.5 m-70 -92.17 110.5 21.88 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 110.313 -0.254 . . . . 74.42 110.313 176.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 442' ' ' VAL . 24.7 m -105.45 123.07 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.098 0.475 . . . . 75.4 109.871 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.554 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.5 ptpt -141.0 145.69 36.27 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.842 0.682 . . . . 44.35 112.842 -170.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -102.66 128.4 49.38 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.345 -0.843 . . . . 70.24 109.449 173.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.554 HD21 ' HD3' ' A' ' 463' ' ' LYS . 61.1 mt -117.64 -2.03 11.52 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.097 -0.377 . . . . 71.24 111.845 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -79.69 -21.57 66.06 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.07 -0.586 . . . . 72.13 113.691 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.5 19.19 55.39 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.199 -0.524 . . . . 64.51 113.57 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 3.1 tt -136.86 133.63 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 122.417 -0.461 . . . . 70.24 111.185 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.492 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -62.94 130.3 42.14 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 114.202 0.441 . . . . 63.41 114.202 -176.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.477 HG11 HD11 ' A' ' 440' ' ' LEU . 61.5 t -126.81 113.6 22.36 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 112.125 0.417 . . . . 74.53 112.125 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.13 -10.28 10.26 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.208 2.605 . . . . 74.33 112.701 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 49.9 m -80.4 12.01 3.27 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.424 0.69 . . . . 72.5 112.678 -175.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 32.6 m -88.51 93.53 9.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.848 0.832 . . . . 75.33 112.257 -167.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -110.39 123.88 50.69 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.224 -0.898 . . . . 72.21 110.504 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.486 HG21 HG11 ' A' ' 462' ' ' VAL . 63.2 t -115.0 129.49 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.832 0.348 . . . . 75.05 111.742 -174.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -120.08 151.8 38.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.862 0.363 . . . . 75.41 111.326 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 96.6 t -121.15 122.16 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.41 -0.359 . . . . 75.53 111.189 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -116.16 136.84 52.65 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.925 0.393 . . . . 74.14 111.533 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.548 HG12 HG12 ' A' ' 513' ' ' ILE . 51.1 mt -111.86 108.47 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 122.676 0.39 . . . . 71.31 110.043 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 55.03 34.71 23.07 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.996 0.427 . . . . 63.44 111.382 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.27 0.62 84.79 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.3 -0.476 . . . . 22.51 113.652 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 36.9 m -103.31 119.61 39.2 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.373 -0.486 . . . . 60.15 111.113 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.0 tp -63.07 120.43 11.42 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.389 0.515 . . . . 74.51 112.389 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -88.64 -45.38 9.89 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.332 -0.395 . . . . 75.42 111.305 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.549 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 31.0 ttpt -171.89 162.26 6.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.546 0.213 . . . . 72.45 111.098 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -139.95 150.98 45.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.962 0.411 . . . . 62.44 111.725 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . 0.549 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 18.7 m-90 -130.82 149.23 52.56 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.86 0.464 . . . . 74.24 111.438 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 60.8 m -120.24 118.91 31.69 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.613 0.244 . . . . 71.14 110.436 173.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.2 m -139.87 172.98 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.073 0.463 . . . . 55.25 111.713 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 96.0 p -122.88 133.23 54.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.251 -0.431 . . . . 73.34 110.329 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.498 HD12 HD22 ' A' ' 440' ' ' LEU . 96.0 mt -118.64 119.67 35.16 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.721 0.296 . . . . 73.13 111.246 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.492 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -79.39 -171.52 41.46 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.186 -0.53 . . . . 73.05 113.133 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.44 106.43 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.6 2.2 . . . . 63.21 112.581 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.9 mmtp 69.89 23.38 5.56 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.118 -0.492 . . . . 62.53 111.881 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -89.04 149.97 22.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.039 0.385 . . . . 65.34 112.039 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . 0.42 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 24.1 tt0 -135.09 143.87 46.87 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.785 0.326 . . . . 72.12 111.478 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -126.89 133.59 50.65 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.819 -0.437 . . . . 70.4 109.819 173.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 37.9 t -101.17 112.76 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.074 0.464 . . . . 73.54 111.591 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 61.9 mt -100.38 147.65 25.59 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.326 -0.397 . . . . 70.55 110.933 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.546 HG22 ' HG2' ' A' ' 459' ' ' GLU . 12.0 p -125.66 149.78 48.16 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.952 0.406 . . . . 72.12 111.956 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.72 147.82 27.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.071 0.462 . . . . 70.42 111.149 172.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.519 ' HB2' HD11 ' A' ' 455' ' ' LEU . 83.2 p -111.36 119.12 37.79 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.098 -0.501 . . . . 42.1 111.067 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -107.7 136.64 47.11 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.01 0.433 . . . . 70.51 111.645 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.9 m -122.06 100.88 42.34 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.125 -0.489 . . . . 72.53 110.695 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -81.6 101.46 1.2 Allowed 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.813 2.342 . . . . 72.42 113.228 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.2 p -82.67 6.64 17.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.213 0.449 . . . . 71.12 112.213 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -140.47 127.21 20.42 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.565 -0.289 . . . . 73.43 110.599 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -73.19 151.62 41.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.21 0.528 . . . . 73.25 112.381 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.94 -168.89 31.88 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.151 -0.547 . . . . 75.25 113.125 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 15.8 tpt -99.2 118.1 35.15 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 122.45 -0.441 . . . . 53.15 110.993 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -123.94 113.09 18.0 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.862 0.363 . . . . 73.32 111.902 -177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -94.67 115.17 27.21 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.922 0.392 . . . . 72.02 110.785 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.548 HG12 HG12 ' A' ' 479' ' ' ILE . 55.9 mt -95.47 124.03 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.016 0.436 . . . . 71.31 111.045 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -123.15 145.99 48.14 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.966 0.412 . . . . 64.5 111.53 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -122.45 136.87 54.99 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.332 -0.395 . . . . 62.32 110.556 175.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 21.4 p -132.24 141.02 48.88 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.92 0.391 . . . . 73.34 112.032 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.31 142.0 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.78 0.324 . . . . 64.23 111.375 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.53 49.77 15.97 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.788 0.804 . . . . 74.41 111.42 -176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -51.7 -28.51 15.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.663 -0.699 . . . . 73.41 111.603 171.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -65.68 -22.21 66.61 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.052 -0.522 . . . . 74.23 111.308 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 55.97 72.14 0.51 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.358 0.599 . . . . 75.33 111.432 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 66.0 p -117.88 -14.19 10.07 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.516 0.561 . . . . 62.42 112.516 -175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 10.0 p -126.89 141.27 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 112.797 0.666 . . . . 71.01 112.797 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 87.2 t -94.29 110.76 24.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.959 -0.564 . . . . 61.32 110.136 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 24.9 mt-10 -102.94 179.97 4.12 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.744 0.646 . . . . 73.43 112.744 -174.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 95.4 mt -68.95 -39.89 79.26 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.032 -0.531 . . . . 73.01 112.05 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 530' ' ' ASN . 52.3 t-20 -120.26 112.86 19.58 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.924 0.392 . . . . 62.33 110.317 178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -83.74 -7.94 59.36 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 120.955 0.407 . . . . 64.41 111.941 -174.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -101.03 8.64 42.86 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.344 0.592 . . . . 73.24 110.821 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.539 ' HB2' ' HB3' ' A' ' 527' ' ' ASN . 57.6 t30 -88.85 -22.59 23.12 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.815 -0.629 . . . . 75.42 112.297 -171.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -78.51 -4.31 47.92 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.014 1.116 . . . . 72.23 114.014 -168.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 61.5 t -123.16 130.88 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 112.489 0.551 . . . . 74.25 112.489 -175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -123.82 142.03 51.49 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.298 -0.41 . . . . 54.11 111.104 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 53.1 m -128.86 135.72 49.48 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.355 0.502 . . . . 74.54 112.355 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -140.69 133.09 28.4 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 120.894 0.378 . . . . 73.21 111.353 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.38 130.5 43.49 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.928 0.344 . . . . 71.42 111.928 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 60.7 t -124.14 131.88 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.142 0.496 . . . . 74.02 111.582 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.9 t -105.9 121.99 45.21 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.423 -0.353 . . . . 74.35 111.0 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.0 t -103.65 120.72 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.775 0.322 . . . . 74.22 111.402 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.48 165.36 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 121.132 0.492 . . . . 44.14 111.974 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 86.0 mt -85.72 10.28 13.97 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.303 0.483 . . . . 71.24 112.303 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 112.299 0.481 . . . . 73.15 112.299 -175.613 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 11.9 tpt . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.681 0.277 . . . . 71.53 111.255 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -88.17 130.31 35.09 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.788 0.327 . . . . 63.42 111.165 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -113.05 137.49 21.93 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.359 -0.382 . . . . 73.44 110.297 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.616 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 55.6 Cg_endo -70.99 173.78 11.57 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.597 2.198 . . . . 72.12 113.495 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -153.84 87.59 1.22 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.731 -0.668 . . . . 55.0 109.267 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 491' ' ' LEU . 51.5 mt -91.91 111.85 23.54 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.043 -0.526 . . . . 72.14 111.549 -175.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.638 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 13.5 t -120.81 155.99 32.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.159 0.504 . . . . 70.14 111.865 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.627 HG12 HG12 ' A' ' 462' ' ' VAL . 32.2 m -126.63 148.52 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.88 -0.6 . . . . 71.32 111.116 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 41.1 mt-10 -122.97 146.88 47.23 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.715 0.265 . . . . 54.23 111.715 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.495 HD11 ' N ' ' A' ' 515' ' ' ALA . 49.1 mt -124.48 114.62 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.872 0.368 . . . . 61.5 110.547 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -129.62 139.29 51.48 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.863 0.363 . . . . 64.25 111.483 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.32 -171.37 39.83 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 121.36 -0.448 . . . . 70.33 112.914 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.17 135.16 28.79 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.579 2.186 . . . . 74.3 113.573 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -79.11 -50.6 10.77 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.105 0.409 . . . . 70.41 112.105 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 538' ' ' SER . 87.8 t -110.03 128.53 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.98 0.419 . . . . 70.23 111.198 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.76 160.95 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.057 0.456 . . . . 63.41 111.692 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -87.71 154.99 26.36 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.267 -0.492 . . . . 52.41 113.095 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.419 HG22 ' ND2' ' A' ' 453' ' ' ASN . 12.4 p -69.15 139.27 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 O-C-N 122.383 -0.481 . . . . 72.32 111.103 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . 0.419 ' ND2' HG22 ' A' ' 452' ' ' VAL . 30.9 m-80 66.5 20.18 10.87 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.202 0.601 . . . . 73.1 111.908 -176.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.532 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -103.33 159.78 15.26 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.978 0.418 . . . . 72.13 111.516 176.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 502' ' ' SER . 39.2 tp -95.59 122.95 38.89 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.327 -0.397 . . . . 75.34 111.249 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.04 132.73 54.66 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.803 0.335 . . . . 74.33 111.555 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -107.6 136.18 47.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.298 0.57 . . . . 73.25 112.1 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -126.9 159.02 35.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.865 -0.607 . . . . 73.12 110.559 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.481 ' HG2' HG22 ' A' ' 500' ' ' THR . 52.2 mt-10 -119.26 127.5 53.3 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.791 0.329 . . . . 53.13 111.175 177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 43.9 t -100.8 112.52 33.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.734 -0.469 . . . . 54.35 109.734 170.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 46.1 m-70 -100.6 109.35 21.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.692 0.282 . . . . 61.14 110.255 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.648 HG11 HG21 ' A' ' 475' ' ' VAL . 10.8 m -110.82 126.37 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.18 0.514 . . . . 62.34 110.556 -177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.46 ' HD3' HD21 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -144.53 150.2 37.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.223 0.535 . . . . 63.43 112.375 -174.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.9 t-20 -102.61 127.14 49.83 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.582 -0.735 . . . . 75.12 109.592 174.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.46 HD21 ' HD3' ' A' ' 463' ' ' LYS . 97.8 mt -108.72 -10.29 15.18 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.009 0.374 . . . . 73.31 112.009 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.616 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -73.1 -19.16 79.52 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.076 -0.583 . . . . 60.03 114.052 -177.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 86.71 15.53 63.31 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.032 -0.604 . . . . 60.22 113.954 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.9 tt -137.52 140.08 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 122.69 0.396 . . . . 74.44 110.863 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -75.38 142.55 29.34 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 114.827 0.691 . . . . 74.32 114.827 -172.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 471' ' ' PRO . 59.2 t -131.74 120.12 17.44 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 122.977 0.511 . . . . 73.31 111.282 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 470' ' ' VAL . 4.7 Cg_endo -86.42 -12.05 5.77 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.119 2.546 . . . . 73.1 113.098 177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 23.0 t -84.33 13.39 5.4 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.959 0.726 . . . . 61.51 112.959 -175.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . 0.447 HG23 ' CG2' ' A' ' 517' ' ' VAL . 90.5 m -86.47 91.81 8.66 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.016 0.912 . . . . 72.4 112.126 -165.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -97.69 131.01 44.62 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.123 -0.944 . . . . 55.41 110.681 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.648 HG21 HG11 ' A' ' 462' ' ' VAL . 45.2 t -113.07 127.26 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.596 0.358 . . . . 71.12 110.898 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -130.17 148.02 51.96 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.898 0.38 . . . . 72.21 111.917 -175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 72.0 t -120.25 122.21 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.862 0.363 . . . . 64.53 111.134 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -113.25 136.82 52.33 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.357 -0.383 . . . . 70.43 111.308 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 513' ' ' ILE . 62.0 mt -110.68 112.02 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 110.068 -0.345 . . . . 71.22 110.068 175.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 54.77 34.93 22.91 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.901 0.381 . . . . 72.22 111.461 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 100.37 -36.33 4.21 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 121.189 -0.529 . . . . 43.24 113.96 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 52.2 m -82.45 131.59 35.22 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 117.163 0.481 . . . . 74.13 111.795 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.5 tp -62.22 132.94 54.38 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.216 0.532 . . . . 64.24 111.852 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -105.19 -43.89 4.9 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.161 -0.472 . . . . 73.24 111.852 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -161.3 151.06 16.93 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.647 -0.251 . . . . 73.53 110.497 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -140.12 152.01 45.78 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.32 0.581 . . . . 71.11 112.522 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -136.62 149.42 47.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.528 -0.76 . . . . 73.14 111.063 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 63.1 m -122.97 119.13 29.48 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.14 -0.318 . . . . 74.5 110.14 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 30.1 m -136.93 173.42 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.304 0.573 . . . . 72.2 111.569 -177.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 36.4 p -120.45 135.02 55.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.976 -0.556 . . . . 75.14 110.479 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.512 HD12 HD22 ' A' ' 440' ' ' LEU . 74.7 mt -117.33 120.15 37.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.84 0.353 . . . . 64.42 111.315 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -83.06 -170.31 45.91 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.948 -0.644 . . . . 61.2 113.091 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.02 109.34 0.68 Allowed 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.423 2.082 . . . . 62.21 112.491 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.3 mmtm 70.19 19.23 6.72 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.954 0.501 . . . . 64.13 112.176 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -80.08 150.96 30.12 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.175 0.435 . . . . 75.43 112.175 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -135.5 134.12 39.18 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.341 -0.391 . . . . 64.22 111.358 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -116.9 129.83 56.31 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.801 -0.444 . . . . 75.41 109.801 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.16 115.81 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.176 0.512 . . . . 73.03 111.303 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.444 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 76.7 mt -105.38 143.53 33.42 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.979 -0.555 . . . . 72.13 110.986 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.481 HG22 ' HG2' ' A' ' 459' ' ' GLU . 6.9 p -129.29 147.12 51.1 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.069 0.461 . . . . 72.53 111.409 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -149.48 148.44 29.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.078 -0.51 . . . . 75.43 110.463 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.48 ' HB2' HD11 ' A' ' 455' ' ' LEU . 79.4 p -115.6 114.18 24.58 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.222 0.534 . . . . 64.44 110.995 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.9 t90 -102.14 134.07 45.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.055 -0.52 . . . . 73.4 111.323 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 37.0 m -113.29 100.76 52.39 Favored Pre-proline 0 N--CA 1.469 0.494 0 CA-C-N 116.366 -0.379 . . . . 74.31 110.701 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.4 Cg_endo -76.06 95.4 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.485 2.123 . . . . 61.35 113.088 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 65.6 p -80.43 5.98 13.55 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.994 0.426 . . . . 75.31 111.66 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -133.56 142.53 48.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.841 0.457 . . . . 75.51 109.94 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.9 150.92 20.26 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.099 0.476 . . . . 61.25 112.168 -175.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.96 -169.73 30.04 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.222 -0.514 . . . . 43.31 112.952 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 14.0 tpt -98.65 112.87 24.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.987 0.422 . . . . 55.12 110.447 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.26 112.37 21.49 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.907 0.384 . . . . 71.23 111.682 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -92.37 115.05 27.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.18 0.514 . . . . 61.11 110.943 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 479' ' ' ILE . 60.6 mt -98.1 125.55 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.99 -0.55 . . . . 73.01 111.453 -178.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -120.84 143.79 48.7 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.988 0.423 . . . . 73.12 111.683 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . 0.495 ' N ' HD11 ' A' ' 444' ' ' ILE . . . -120.47 138.75 53.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.322 -0.399 . . . . 51.51 110.365 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . 0.433 HG22 HG22 ' A' ' 532' ' ' VAL . 48.8 p -133.1 158.0 43.88 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.019 0.438 . . . . 50.23 111.593 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.447 ' CG2' HG23 ' A' ' 473' ' ' THR . 7.6 p -132.53 140.49 47.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.163 -0.471 . . . . 73.11 111.423 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 28.1 t70 42.73 54.76 4.51 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.474 0.654 . . . . 74.35 111.952 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -55.17 -32.85 62.49 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.199 0.524 . . . . 71.4 111.522 178.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -67.89 -5.76 18.45 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.282 -0.872 . . . . 74.1 112.457 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.2 t30 53.07 55.09 9.37 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.501 0.667 . . . . 73.34 111.221 173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 34.9 p -88.44 -35.44 17.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.937 -0.574 . . . . 65.2 111.449 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 12.5 p -103.72 144.14 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 116.091 -0.504 . . . . 72.14 111.829 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . 0.512 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 75.4 t -83.41 114.87 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.758 0.314 . . . . 72.22 110.953 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -92.28 176.08 6.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.498 0.666 . . . . 75.13 112.617 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 87.4 mt -82.26 -25.65 33.88 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.793 -0.64 . . . . 72.02 109.947 167.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 26.2 t30 -155.39 110.64 3.02 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.565 -0.743 . . . . 73.15 110.447 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 38.0 mp0 -82.81 -1.61 52.28 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.985 0.421 . . . . 54.2 111.719 -173.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -93.08 -8.84 41.61 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.273 0.559 . . . . 75.33 110.973 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.638 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 65.3 t30 -86.53 -6.78 58.8 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.051 0.453 . . . . 65.13 111.743 -175.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -79.06 8.22 6.09 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.844 0.683 . . . . 73.42 112.844 -175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 516' ' ' THR . 48.5 t -132.46 145.84 33.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 112.321 0.489 . . . . 73.55 112.321 -176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -133.9 142.31 47.71 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.288 -0.415 . . . . 72.03 110.757 172.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 90.6 m -121.89 125.38 46.29 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.354 0.501 . . . . 71.34 112.354 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -133.12 141.06 47.96 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.886 0.374 . . . . 73.11 110.495 175.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -116.72 126.62 53.42 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.045 0.45 . . . . 75.13 112.161 -176.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.5 t -117.21 143.72 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 116.033 -0.53 . . . . 74.31 111.783 -177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . 0.425 ' HB3' HG22 ' A' ' 449' ' ' VAL . 46.6 t -118.02 120.73 38.69 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.332 -0.394 . . . . 71.04 110.996 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 44.5 t -103.42 123.38 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.692 0.282 . . . . 53.12 111.23 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.7 m -109.28 160.25 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 112.612 0.597 . . . . 71.42 112.612 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 92.5 mt -88.71 -5.98 57.74 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.296 -0.411 . . . . 64.54 112.101 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.253 1.238 0 N-CA-C 112.594 0.59 . . . . 53.24 112.594 -177.059 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 34.9 tpp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.811 0.339 . . . . 74.14 111.424 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -88.12 125.35 34.54 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.802 0.334 . . . . 72.32 111.251 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 438' ' ' PRO . 98.5 m-85 -115.34 136.56 22.73 Favored Pre-proline 0 N--CA 1.469 0.523 0 CA-C-O 120.573 0.225 . . . . 75.15 111.153 177.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 24.5 Cg_exo -64.86 173.03 6.23 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.026 2.484 . . . . 74.24 114.417 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -161.25 86.81 0.69 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.897 -1.047 . . . . 74.45 108.462 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 74.8 mt -97.41 132.39 43.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.233 0.54 . . . . 65.33 112.006 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.519 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.0 t -132.85 151.74 51.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.03 0.443 . . . . 60.13 111.906 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 462' ' ' VAL . 32.2 m -123.23 148.66 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.95 -0.568 . . . . 62.12 111.439 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 44.4 mt-10 -130.99 129.68 42.41 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.551 -0.295 . . . . 65.53 111.68 178.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.6 mt -101.99 126.94 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 120.659 0.266 . . . . 74.14 110.798 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -131.68 134.58 46.09 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.411 -0.181 . . . . 73.21 111.135 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.37 -169.88 35.57 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.603 -0.808 . . . . 54.2 113.762 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.3 127.41 14.12 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.809 2.339 . . . . 63.31 113.058 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -85.86 -20.78 28.58 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.135 0.42 . . . . 52.21 112.135 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.23 121.32 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-O 120.625 0.25 . . . . 74.35 110.801 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 30.1 m -130.72 162.74 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.207 0.527 . . . . 73.31 111.852 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.62 163.27 28.42 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.1 -0.571 . . . . 51.31 113.246 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.545 HG22 ' ND2' ' A' ' 453' ' ' ASN . 10.8 p -70.31 140.22 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.037 0.446 . . . . 62.11 111.578 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . 0.545 ' ND2' HG22 ' A' ' 452' ' ' VAL . 42.3 m-80 63.63 18.22 10.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.084 0.554 . . . . 74.22 112.136 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -102.35 164.72 11.52 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.193 0.521 . . . . 74.12 111.937 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 502' ' ' SER . 53.2 tp -95.29 136.8 35.2 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.13 -0.486 . . . . 75.04 111.493 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -135.49 132.22 37.08 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.906 0.384 . . . . 63.22 110.96 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -113.49 131.96 55.85 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.045 0.45 . . . . 73.25 111.364 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 74.8 m-85 -122.28 159.49 27.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.038 -0.528 . . . . 74.34 110.957 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -120.11 127.18 52.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.994 -0.548 . . . . 74.34 110.942 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 42.1 t -102.69 112.65 36.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.829 -0.434 . . . . 24.33 109.829 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 40.2 m-70 -100.04 112.72 25.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.748 0.309 . . . . 71.51 110.315 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 442' ' ' VAL . 24.5 m -113.12 124.45 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.212 0.529 . . . . 62.13 110.828 -177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.46 ' HD3' HD21 ' A' ' 465' ' ' LEU . 0.0 OUTLIER -136.4 151.67 49.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.258 0.552 . . . . 74.42 112.284 -176.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.2 t-20 -99.9 128.5 45.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.639 -0.71 . . . . 63.24 110.225 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.46 HD21 ' HD3' ' A' ' 463' ' ' LYS . 89.5 mt -113.71 -6.4 13.32 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.023 -0.423 . . . . 72.21 112.034 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -75.37 -18.89 79.82 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.971 -0.633 . . . . 74.2 113.556 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 80.39 19.35 69.17 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.126 -0.559 . . . . 61.42 113.383 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 10.1 tt -135.35 138.67 48.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 122.554 0.341 . . . . 74.2 110.803 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.529 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -66.73 122.86 21.04 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.402 -0.428 . . . . 30.41 113.784 -177.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 438' ' ' PRO . 48.0 t -119.68 113.72 34.59 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 122.615 -0.344 . . . . 50.53 111.841 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.08 -11.12 10.01 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.94 2.426 . . . . 74.51 112.394 172.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . 0.607 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 47.8 m -81.23 12.04 3.82 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.857 0.863 . . . . 73.4 113.033 -173.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . 0.406 HG23 ' CG2' ' A' ' 517' ' ' VAL . 88.1 m -88.91 99.71 12.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.773 0.797 . . . . 61.1 112.332 -167.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -105.13 130.65 53.26 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.675 -0.693 . . . . 64.12 110.895 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.423 HG21 HG11 ' A' ' 462' ' ' VAL . 25.9 t -105.31 118.72 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 122.439 0.296 . . . . 71.02 111.03 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . 0.529 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 86.3 mtt180 -116.54 138.15 51.62 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.107 -0.371 . . . . 74.32 111.121 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 89.6 t -120.88 130.47 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.975 0.417 . . . . 71.05 111.466 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -121.68 139.29 53.75 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.19 -0.459 . . . . 75.43 111.257 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.506 HG12 HG12 ' A' ' 513' ' ' ILE . 55.6 mt -118.83 115.95 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 110.139 -0.319 . . . . 75.2 110.139 172.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 52.67 38.87 27.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.122 0.487 . . . . 74.22 111.573 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.91 -17.51 50.26 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.227 -0.511 . . . . 55.32 113.829 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 73.2 m -88.94 130.82 35.37 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 117.168 0.484 . . . . 74.11 111.623 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.4 tp -64.33 115.06 4.7 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.946 0.403 . . . . 72.55 111.233 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -89.99 -43.86 10.26 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.171 -0.468 . . . . 74.21 112.141 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -168.5 160.03 10.72 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.518 -0.31 . . . . 74.33 110.456 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -150.83 149.87 30.24 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.057 0.456 . . . . 64.0 112.072 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . 0.413 ' CD2' HD13 ' A' ' 499' ' ' LEU . 24.5 m-90 -129.79 144.01 51.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.848 0.459 . . . . 72.03 110.716 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 38.5 m -111.02 117.79 34.29 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.859 -0.423 . . . . 73.01 109.859 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.49 174.34 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.277 0.56 . . . . 72.43 112.02 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 83.0 p -122.55 134.99 54.53 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.986 -0.552 . . . . 71.11 111.046 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 94.5 mt -120.18 119.45 33.3 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.648 0.261 . . . . 74.21 111.084 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.529 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -79.63 -171.52 41.96 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.086 -0.578 . . . . 70.5 113.205 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.63 103.5 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.668 2.245 . . . . 65.23 112.524 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.1 mttt 63.63 36.97 10.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.266 0.555 . . . . 72.44 112.117 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -95.96 155.48 16.73 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.966 -0.561 . . . . 73.4 110.845 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -134.82 143.29 46.96 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.842 0.353 . . . . 71.23 111.76 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -126.35 132.33 51.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.867 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 50.3 t -101.39 117.62 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.007 0.432 . . . . 73.2 111.435 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.413 HD13 ' CD2' ' A' ' 487' ' ' TRP . 49.7 mt -111.85 146.12 38.25 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.201 -0.454 . . . . 74.42 110.815 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 16.7 p -135.46 152.3 51.23 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.366 0.603 . . . . 74.33 112.354 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 47.9 p90 -145.36 154.39 42.26 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.768 -0.651 . . . . 72.14 111.073 175.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.524 ' HB2' HD11 ' A' ' 455' ' ' LEU . 32.3 p -112.58 114.7 27.47 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.049 0.452 . . . . 75.51 111.229 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . 0.424 ' CZ2' ' HB3' ' A' ' 505' ' ' PRO . 31.1 t90 -114.38 137.47 51.78 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.08 0.552 . . . . 72.42 111.341 -175.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 96.7 m -126.14 103.47 26.53 Favored Pre-proline 0 N--CA 1.473 0.694 0 CA-C-O 120.751 0.31 . . . . 71.41 111.749 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . 0.424 ' HB3' ' CZ2' ' A' ' 503' ' ' TRP . 98.7 Cg_endo -80.9 97.92 1.03 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.495 2.13 . . . . 70.4 112.905 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 68.4 p -77.33 -6.78 54.52 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.071 0.462 . . . . 75.12 111.121 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . 0.445 ' HB3' ' OH ' ' A' ' 511' ' ' TYR . 51.1 tt0 -114.48 141.29 47.88 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.122 -0.49 . . . . 74.4 110.238 176.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.13 149.88 21.62 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.861 0.362 . . . . 65.4 111.194 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 140.39 -171.62 23.89 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.328 -0.463 . . . . 62.31 112.883 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 94.6 mmm -83.9 127.58 33.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.076 0.465 . . . . 72.22 111.975 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . 0.445 ' OH ' ' HB3' ' A' ' 507' ' ' GLN . 76.9 m-85 -126.32 111.94 15.11 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.992 -0.549 . . . . 63.42 110.923 176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -93.79 115.44 27.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.01 0.434 . . . . 51.05 111.307 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.506 HG12 HG12 ' A' ' 479' ' ' ILE . 60.3 mt -96.2 128.43 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.864 -0.607 . . . . 72.53 110.962 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -124.81 132.31 53.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.5 -0.318 . . . . 74.31 111.294 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . 0.402 ' O ' HG21 ' A' ' 442' ' ' VAL . . . -112.33 134.4 53.89 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.469 -0.332 . . . . 64.2 110.283 173.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . 0.453 HG22 HG22 ' A' ' 532' ' ' VAL . 80.2 p -133.62 141.01 47.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.918 0.39 . . . . 74.02 111.257 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.452 HG13 HD22 ' A' ' 531' ' ' ASN . 7.5 p -109.22 139.26 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.928 0.394 . . . . 65.42 110.96 174.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 34.5 t0 38.74 64.89 0.71 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.798 0.839 . . . . 73.24 112.685 -175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . 0.529 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.1 mm-40 -52.54 -33.7 46.76 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.498 0.666 . . . . 71.52 111.048 172.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -72.61 -24.28 61.05 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.18 -0.918 . . . . 72.21 111.633 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 14.7 m120 54.15 55.52 8.14 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.886 0.85 . . . . 74.11 110.521 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . 0.607 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 60.5 p -73.34 -6.06 43.67 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.888 -1.051 . . . . 63.03 111.628 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 14.5 p -134.34 143.25 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.255 -0.43 . . . . 72.41 110.9 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . 0.51 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 48.1 t -81.52 109.57 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 121.027 0.441 . . . . 74.45 110.998 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.482 ' HG2' ' HB2' ' A' ' 438' ' ' PRO . 37.1 mt-10 -98.58 177.02 5.45 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.274 0.559 . . . . 75.13 112.141 -175.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -86.03 -38.75 17.55 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.208 -0.451 . . . . 60.53 112.204 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.524 HD21 ' HB2' ' A' ' 529' ' ' ASN . 7.2 t30 -142.07 120.0 12.0 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.868 0.322 . . . . 75.34 111.868 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . 0.557 ' HA ' ' OD1' ' A' ' 531' ' ' ASN . 11.4 pt-20 -93.5 14.2 19.46 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.337 0.495 . . . . 63.14 112.337 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . 0.524 ' HB2' HD21 ' A' ' 527' ' ' ASN . 73.1 m-20 -90.66 -26.38 19.62 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.335 0.494 . . . . 62.0 112.335 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.519 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 17.1 p-10 -97.89 -5.05 35.29 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 111.974 0.361 . . . . 70.33 111.974 -175.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' A' ' 528' ' ' GLU . 12.3 m120 -62.96 -24.73 68.02 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.125 0.417 . . . . 72.11 112.125 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 516' ' ' THR . 47.3 t -115.51 137.36 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.876 0.369 . . . . 64.14 111.706 -176.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.51 127.31 43.77 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.455 -0.339 . . . . 65.13 110.872 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 57.2 m -105.39 132.89 51.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.856 0.36 . . . . 60.43 111.628 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -139.7 117.28 11.47 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.765 0.317 . . . . 70.32 110.803 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.94 127.33 39.65 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.99 0.424 . . . . 64.22 111.924 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.96 137.63 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.109 -0.496 . . . . 44.52 111.235 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.8 t -107.44 122.42 46.59 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.826 0.346 . . . . 72.32 111.009 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.1 t -108.19 129.99 61.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.102 0.477 . . . . 54.1 111.305 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 21.5 m -125.33 162.74 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.157 0.503 . . . . 65.0 112.257 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.93 -12.23 60.11 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.945 0.402 . . . . 74.41 111.995 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 119.24 -0.409 . . . . 74.22 111.724 179.959 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 22.6 ttt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 121.267 0.556 . . . . 64.41 109.868 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -104.74 131.3 52.36 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.897 -0.592 . . . . 74.35 111.798 -171.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -114.06 140.0 24.36 Favored Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 116.284 -0.416 . . . . 74.22 110.469 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.553 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 58.5 Cg_endo -72.67 173.34 13.51 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.216 1.944 . . . . 74.31 113.152 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -153.29 87.99 1.28 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.892 -0.595 . . . . 63.04 109.59 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.1 mt -89.15 112.0 22.89 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.278 -0.419 . . . . 75.24 111.548 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.56 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.0 t -120.84 158.97 26.45 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.067 0.46 . . . . 62.34 111.688 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.622 HG12 HG12 ' A' ' 462' ' ' VAL . 35.2 m -134.31 148.59 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.062 -0.517 . . . . 34.51 111.537 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.624 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.3 mt-10 -125.45 136.3 53.24 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.479 -0.328 . . . . 72.52 111.258 177.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 515' ' ' ALA . 56.2 mt -105.41 124.61 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.733 0.301 . . . . 70.23 110.536 174.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 459' ' ' GLU . 29.1 tptp -132.88 131.99 41.57 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.616 -0.266 . . . . 75.25 110.931 -177.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 166.32 -175.06 41.85 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.743 -0.742 . . . . 50.14 113.801 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.03 134.16 31.05 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.983 2.455 . . . . 74.03 113.537 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.6 -38.53 65.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.192 -0.458 . . . . 71.12 111.911 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.8 t -121.18 131.87 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.642 0.258 . . . . 53.33 111.31 -178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.61 163.53 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 121.176 0.512 . . . . 64.32 111.672 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.43 158.44 21.01 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.183 -0.532 . . . . 71.11 113.341 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.409 HG11 HD23 ' A' ' 541' ' ' LEU . 14.0 p -64.9 137.94 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 O-C-N 122.54 -0.388 . . . . 73.33 111.598 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . 0.401 ' OD1' ' HA ' ' A' ' 506' ' ' THR . 92.9 m-20 62.6 14.62 7.27 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.511 0.56 . . . . 71.23 112.511 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.5 mmmt -94.33 150.02 20.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.818 0.342 . . . . 64.34 111.155 175.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 502' ' ' SER . 32.2 tp -92.77 117.07 29.61 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.872 0.368 . . . . 72.14 110.936 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -120.67 132.69 55.23 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.901 0.382 . . . . 72.03 111.679 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -102.16 139.15 38.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.154 0.502 . . . . 71.11 111.84 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -123.66 165.14 17.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.862 -0.608 . . . . 62.31 111.26 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 445' ' ' LYS . 51.5 mt-10 -119.95 127.49 52.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.911 -0.586 . . . . 54.34 110.907 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.5 t -108.27 112.78 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.668 -0.493 . . . . 64.31 109.668 170.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.624 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 48.3 m-70 -97.92 107.65 20.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.737 0.303 . . . . 75.41 110.641 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.756 HG11 HG21 ' A' ' 475' ' ' VAL . 14.0 m -108.34 125.98 65.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.01 0.433 . . . . 74.02 110.55 -176.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.602 ' HD3' HD21 ' A' ' 465' ' ' LEU . 16.0 ptpt -145.76 147.02 31.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.549 0.574 . . . . 75.54 112.549 -174.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.9 t-20 -100.31 126.99 46.71 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.756 -0.657 . . . . 75.02 109.557 174.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.602 HD21 ' HD3' ' A' ' 463' ' ' LYS . 85.6 mt -116.26 8.65 14.35 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.037 0.384 . . . . 70.33 112.037 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -86.59 -20.89 53.15 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.099 -0.572 . . . . 52.13 113.02 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.74 14.34 63.33 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.116 -0.564 . . . . 44.45 113.591 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 7.4 tt -136.42 133.78 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 O-C-N 122.608 -0.348 . . . . 75.04 110.934 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -70.43 143.84 37.92 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 114.824 0.69 . . . . 44.43 114.824 -172.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 49.3 t -131.27 113.53 15.82 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 122.702 0.401 . . . . 64.44 111.41 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -82.79 -10.57 10.55 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 123.093 2.529 . . . . 74.34 113.324 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 65.6 m -87.87 13.22 11.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.602 0.761 . . . . 51.54 112.839 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 96.9 m -87.86 106.87 18.38 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.678 0.752 . . . . 71.52 112.649 -165.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -107.42 131.26 54.47 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.551 -0.749 . . . . 65.25 111.243 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.756 HG21 HG11 ' A' ' 462' ' ' VAL . 45.6 t -114.79 127.86 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 122.609 0.364 . . . . 63.34 110.823 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . 0.453 ' NH2' ' HB2' ' A' ' 519' ' ' GLU . 20.9 mtm180 -130.53 152.94 49.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.068 0.461 . . . . 62.14 112.16 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 91.0 t -121.21 122.73 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.111 -0.495 . . . . 65.24 111.319 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -113.93 137.53 51.56 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.2 -0.454 . . . . 63.14 111.388 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.539 HG12 HG12 ' A' ' 513' ' ' ILE . 58.9 mt -114.38 111.07 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 109.909 -0.404 . . . . 63.42 109.909 174.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 58.01 33.53 23.29 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.265 0.555 . . . . 74.33 110.8 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 91.79 -19.51 47.98 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 116.073 -0.512 . . . . 74.52 113.783 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 34.3 m -82.23 124.46 29.94 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.331 -0.511 . . . . 74.21 111.41 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.9 tp -64.91 115.16 5.08 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.083 0.468 . . . . 74.11 111.186 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -91.23 -44.03 9.47 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.15 -0.477 . . . . 74.12 111.979 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -162.98 155.49 18.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.648 0.261 . . . . 73.2 111.159 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . 0.411 ' HB3' ' HG2' ' A' ' 476' ' ' ARG . 0.8 OUTLIER -143.23 143.35 31.71 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.744 0.646 . . . . 73.22 112.744 -177.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -129.52 146.61 51.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.751 -0.659 . . . . 73.43 110.786 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 66.4 m -115.87 118.09 32.0 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 110.012 -0.366 . . . . 65.32 110.012 170.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.35 173.22 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.343 0.592 . . . . 54.14 112.022 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 72.0 p -124.76 132.93 53.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.06 -0.518 . . . . 73.33 110.569 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.26 121.52 38.88 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.894 0.378 . . . . 41.22 111.203 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -79.7 -170.51 40.41 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.318 -0.467 . . . . 22.22 113.429 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.03 110.6 1.19 Allowed 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.573 2.182 . . . . 62.2 112.626 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.9 mmtp 62.82 37.76 12.08 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.086 0.469 . . . . 74.04 111.428 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -105.03 147.34 27.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.187 -0.46 . . . . 74.22 111.554 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -132.51 143.44 49.75 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.161 0.505 . . . . 61.54 112.332 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -126.37 144.05 50.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.938 -0.573 . . . . 74.13 110.775 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 47.0 t -106.64 112.01 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 121.033 0.444 . . . . 75.0 110.696 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.4 mt -106.41 125.61 51.21 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.351 -0.386 . . . . 75.33 110.315 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 35.2 p -113.39 153.33 28.75 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.238 0.542 . . . . 74.2 112.165 -178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -144.51 150.9 38.33 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.824 -0.625 . . . . 65.21 110.382 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.525 ' HB2' HD11 ' A' ' 455' ' ' LEU . 87.3 p -110.19 114.32 27.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.797 0.332 . . . . 74.45 110.585 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -106.26 130.24 54.15 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.017 0.437 . . . . 75.2 111.936 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 85.5 m -113.97 100.96 53.47 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 115.97 -0.559 . . . . 55.42 110.86 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 72.0 Cg_endo -74.26 91.05 0.96 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.426 2.084 . . . . 72.21 113.018 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . 0.401 ' HA ' ' OD1' ' A' ' 453' ' ' ASN . 58.0 p -67.97 -16.92 64.27 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.193 0.442 . . . . 72.2 112.193 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -119.34 132.86 55.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.441 -0.345 . . . . 64.25 110.499 174.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.32 150.87 22.39 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.533 0.682 . . . . 65.13 112.469 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.45 -168.43 30.94 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.691 -0.686 . . . . 44.03 112.249 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 13.8 tpt -94.68 124.46 38.73 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 122.332 -0.51 . . . . 73.4 111.076 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -127.92 152.95 47.23 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.042 0.448 . . . . 74.34 112.007 -177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -123.78 122.31 37.7 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.206 -0.452 . . . . 74.45 110.87 175.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.539 HG12 HG12 ' A' ' 479' ' ' ILE . 59.8 mt -103.1 123.93 56.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.968 0.414 . . . . 72.14 111.125 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -119.73 138.9 53.03 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.398 -0.364 . . . . 75.03 111.419 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . 0.428 ' N ' HD11 ' A' ' 444' ' ' ILE . . . -112.44 134.02 54.2 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.925 0.393 . . . . 70.31 110.481 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 82.4 p -123.34 144.43 49.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.169 -0.469 . . . . 74.53 111.254 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.405 HG13 HD22 ' A' ' 531' ' ' ASN . 7.1 p -120.83 139.61 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.594 0.235 . . . . 63.15 111.133 174.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 35.8 t0 36.28 60.97 0.83 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.876 0.87 . . . . 74.31 112.855 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . 0.453 ' HB2' ' NH2' ' A' ' 476' ' ' ARG . 39.9 mt-10 -58.63 -32.66 69.24 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.044 0.45 . . . . 75.21 110.985 173.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -66.23 -24.21 66.56 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.357 -0.608 . . . . 65.31 109.357 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . 0.436 HD22 ' HA ' ' A' ' 521' ' ' ASN . 1.2 t-20 51.04 74.15 0.25 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.965 -1.016 . . . . 72.43 110.809 177.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 30.3 p -84.83 -10.64 56.97 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.879 -1.055 . . . . 64.13 111.408 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.443 HG21 ' HG3' ' A' ' 438' ' ' PRO . 11.3 p -135.24 143.61 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.914 -0.585 . . . . 43.04 112.255 -172.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.2 t -82.47 115.48 25.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.074 0.464 . . . . 63.43 110.709 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -107.2 -179.84 4.05 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.821 0.674 . . . . 63.32 112.821 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -76.98 -39.06 51.86 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.983 -0.553 . . . . 74.21 112.237 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -142.54 124.19 14.99 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.225 0.536 . . . . 72.1 111.432 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -84.08 -20.2 33.03 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.965 -0.562 . . . . 54.4 111.956 -175.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -85.48 3.42 40.37 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.11 0.481 . . . . 62.23 111.092 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.56 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 66.7 t30 -92.16 -13.24 30.95 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.21 0.528 . . . . 72.15 111.376 -176.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . 0.405 HD22 HG13 ' A' ' 517' ' ' VAL . 11.6 m120 -78.81 0.22 27.89 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 113.368 0.877 . . . . 64.1 113.368 -174.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.6 t -130.68 135.38 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.588 0.588 . . . . 75.2 112.588 -175.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -122.11 142.85 49.96 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.148 -0.478 . . . . 73.44 110.859 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 92.7 m -124.01 126.13 45.76 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.617 0.599 . . . . 73.41 112.617 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -139.67 123.44 17.48 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.517 -0.31 . . . . 74.11 110.964 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -93.64 137.3 33.04 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.984 0.421 . . . . 71.11 111.96 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.38 132.29 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.227 -0.442 . . . . 71.5 111.444 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.0 t -100.44 117.76 35.27 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.319 -0.4 . . . . 30.31 110.993 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.481 HG11 ' HB2' ' A' ' 505' ' ' PRO . 38.2 t -106.21 130.65 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.96 0.41 . . . . 64.43 111.466 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 16.2 m -133.27 168.23 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 120.978 0.418 . . . . 72.31 111.993 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . 0.409 HD23 HG11 ' A' ' 452' ' ' VAL . 83.7 mt -74.58 -36.98 63.03 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.495 0.554 . . . . 64.11 112.495 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 C--O 1.253 1.259 0 N-CA-C 112.83 0.678 . . . . 65.12 112.83 -176.666 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 23.1 ptt? . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 121.173 0.511 . . . . 65.3 111.135 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -111.85 123.69 50.77 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.249 -0.432 . . . . 72.12 111.168 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -112.81 124.17 32.28 Favored Pre-proline 0 N--CA 1.468 0.471 0 N-CA-C 110.014 -0.365 . . . . 63.32 110.014 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.572 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 55.3 Cg_endo -80.13 174.86 10.96 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.552 2.168 . . . . 74.11 113.746 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -147.81 93.39 2.19 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.29 -0.868 . . . . 62.14 109.651 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.417 HD11 HG11 ' A' ' 470' ' ' VAL . 79.3 mt -91.81 111.87 23.57 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.098 0.475 . . . . 74.35 111.357 -177.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.41 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 9.0 t -114.47 148.36 37.93 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.165 0.507 . . . . 72.45 111.35 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.554 HG12 HG12 ' A' ' 462' ' ' VAL . 33.8 m -121.99 148.13 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.079 -0.51 . . . . 65.54 111.069 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 36.6 mt-10 -131.81 139.76 48.97 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.415 -0.357 . . . . 63.25 110.563 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 56.1 mt -114.16 132.69 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.899 0.381 . . . . 71.52 111.381 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -135.27 147.07 49.12 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.403 -0.362 . . . . 61.11 111.308 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.0 -173.35 35.86 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.001 -0.619 . . . . 62.31 113.103 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.18 129.61 18.52 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.63 2.22 . . . . 74.13 113.306 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.33 -41.9 65.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.044 0.449 . . . . 70.44 111.475 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.31 129.48 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.339 -0.391 . . . . 72.4 111.111 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.22 163.15 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.91 0.385 . . . . 73.02 111.509 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -92.92 153.36 21.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.306 -0.473 . . . . 74.55 112.99 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.561 HG22 ' ND2' ' A' ' 453' ' ' ASN . 12.1 p -67.43 136.66 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 121.001 0.429 . . . . 53.05 111.745 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . 0.561 ' ND2' HG22 ' A' ' 452' ' ' VAL . 46.6 m-80 65.07 17.57 11.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.239 0.616 . . . . 75.5 112.298 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -104.38 167.17 9.92 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.13 0.49 . . . . 70.55 111.75 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 502' ' ' SER . 31.6 tp -100.34 131.3 46.34 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.268 -0.424 . . . . 72.43 111.423 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.45 132.39 45.68 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.844 0.354 . . . . 74.12 111.796 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -103.68 135.55 45.03 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.866 0.365 . . . . 74.44 111.278 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -125.54 161.6 26.79 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.449 -0.342 . . . . 73.25 110.909 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -119.67 127.93 53.34 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.782 0.325 . . . . 74.41 111.234 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 50.4 t -102.44 113.11 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.95 0.405 . . . . 75.33 110.012 170.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.587 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 41.1 m-70 -96.57 105.71 17.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.454 -0.339 . . . . 62.25 110.857 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.681 HG11 HG21 ' A' ' 475' ' ' VAL . 17.5 m -106.52 123.69 61.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.15 0.5 . . . . 64.55 110.476 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.484 ' HD3' HD21 ' A' ' 465' ' ' LEU . 3.7 ptpp? -142.52 148.21 37.26 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.878 0.695 . . . . 72.25 112.878 -173.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.1 t-20 -99.42 128.55 45.55 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.347 -0.842 . . . . 71.13 109.814 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.484 HD21 ' HD3' ' A' ' 463' ' ' LYS . 81.8 mt -111.71 -14.73 13.56 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.092 0.405 . . . . 75.42 112.092 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -66.27 -22.7 71.2 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 121.479 -0.391 . . . . 64.23 113.947 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.45 18.79 56.41 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 121.178 -0.534 . . . . 23.31 113.912 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.427 HG23 ' HB3' ' A' ' 438' ' ' PRO . 5.5 tt -137.44 138.1 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 122.795 0.438 . . . . 62.24 111.001 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -65.19 135.08 36.82 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 121.485 -0.388 . . . . 73.11 113.87 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.417 HG11 HD11 ' A' ' 440' ' ' LEU . 60.3 t -129.0 114.71 18.81 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 112.16 0.43 . . . . 63.21 112.16 -176.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.58 -10.94 14.4 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.037 2.491 . . . . 65.15 112.504 173.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . 0.45 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 50.3 m -81.15 11.84 3.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.617 0.767 . . . . 72.44 112.976 -175.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 48.6 m -88.95 94.05 9.81 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.798 0.809 . . . . 75.21 112.183 -169.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -111.67 123.38 50.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.293 -0.867 . . . . 64.32 110.507 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.681 HG21 HG11 ' A' ' 462' ' ' VAL . 29.6 t -105.49 132.49 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 111.873 0.323 . . . . 73.22 111.873 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -128.25 144.53 51.13 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.901 0.381 . . . . 74.23 111.366 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -121.19 126.7 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 120.895 0.379 . . . . 74.23 111.266 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 482' ' ' THR . 82.6 m-85 -121.93 137.03 54.95 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.309 -0.405 . . . . 72.21 111.426 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 513' ' ' ILE . 59.0 mt -108.73 107.5 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 110.091 -0.337 . . . . 73.02 110.091 173.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 57.66 34.1 24.07 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.896 0.379 . . . . 70.54 111.289 -174.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.23 -10.36 74.47 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.207 -0.52 . . . . 64.51 113.537 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 478' ' ' TYR . 40.9 m -85.14 127.32 34.21 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.603 -0.351 . . . . 73.02 111.17 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.8 tp -69.15 118.41 12.01 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.853 0.359 . . . . 53.22 111.331 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -94.79 -45.1 7.47 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.818 0.342 . . . . 72.21 111.743 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -170.52 160.08 7.16 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.564 0.221 . . . . 74.32 111.073 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -132.1 157.2 44.81 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.088 0.47 . . . . 75.44 111.52 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 30.9 m-90 -135.99 143.78 44.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.095 0.558 . . . . 74.05 110.785 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 98.8 m -122.09 116.97 25.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.711 0.291 . . . . 70.34 110.422 173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.7 173.93 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.363 0.601 . . . . 62.23 111.872 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 55.1 p -125.68 133.68 52.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.958 -0.565 . . . . 75.13 110.693 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.437 HD21 ' HG2' ' A' ' 497' ' ' LYS . 75.3 mt -116.94 120.46 38.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.796 0.331 . . . . 74.44 111.502 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -75.35 -170.51 27.77 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.052 -0.594 . . . . 63.2 112.746 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.89 118.08 4.95 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.175 1.917 . . . . 73.13 112.364 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 74.4 mmtt 65.32 21.8 12.01 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 116.111 -0.495 . . . . 72.21 112.109 175.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -89.98 154.74 19.6 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.454 0.539 . . . . 65.44 112.454 -175.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -135.0 145.09 47.75 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.855 0.359 . . . . 70.21 111.927 177.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.437 ' HG2' HD21 ' A' ' 491' ' ' LEU . 31.6 mmmt -122.31 129.83 52.55 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.2 -0.454 . . . . 74.01 109.887 170.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.2 t -100.28 117.31 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.183 0.516 . . . . 73.32 111.213 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 50.9 mt -106.61 146.46 30.67 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.027 -0.533 . . . . 54.31 111.05 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 21.3 p -127.06 147.02 50.16 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.005 0.431 . . . . 71.1 111.657 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -147.87 148.67 31.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.113 -0.494 . . . . 62.34 110.648 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.533 ' HB2' HD11 ' A' ' 455' ' ' LEU . 68.3 p -113.0 114.07 26.38 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.269 0.557 . . . . 75.43 111.419 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -106.2 137.2 44.56 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.643 -0.708 . . . . 75.25 111.341 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.7 m -119.35 100.8 49.7 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.606 -0.27 . . . . 63.34 111.125 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -82.47 108.43 1.72 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.624 2.216 . . . . 72.42 113.353 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 58.7 p -85.16 -13.43 50.11 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.108 0.41 . . . . 73.14 112.108 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -113.55 134.87 54.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.66 0.266 . . . . 75.41 111.183 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.74 151.55 37.59 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.6 0.714 . . . . 72.5 112.387 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 135.97 175.76 14.0 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.815 -0.629 . . . . 23.52 112.538 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 65.0 mtp -88.35 128.13 35.5 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.176 0.512 . . . . 65.02 111.542 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -120.05 119.48 33.49 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.15 -0.477 . . . . 60.42 110.762 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -92.75 114.37 26.91 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.059 0.457 . . . . 63.41 110.857 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 479' ' ' ILE . 59.0 mt -98.77 123.64 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.039 -0.528 . . . . 70.21 111.277 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -120.72 136.82 54.76 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.87 0.367 . . . . 72.32 111.806 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.27 143.99 42.43 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.327 -0.397 . . . . 72.23 110.917 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . 0.418 HG22 HG22 ' A' ' 532' ' ' VAL . 60.8 p -131.14 157.0 44.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.253 -0.43 . . . . 73.41 111.427 -178.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.74 140.18 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-O 121.005 0.431 . . . . 72.34 111.403 171.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 25.2 t0 41.51 62.48 1.52 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.138 0.975 . . . . 70.33 113.159 -176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.7 -30.86 71.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.015 0.436 . . . . 61.14 111.317 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.12 -9.38 39.1 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.254 -0.43 . . . . 54.51 112.121 -177.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 57.61 49.69 12.15 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.141 0.496 . . . . 62.22 111.383 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . 0.45 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 60.1 p -88.03 -12.31 44.71 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.294 -0.412 . . . . 61.23 111.773 -178.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.3 p -131.28 142.34 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.877 0.37 . . . . 61.52 111.242 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . 0.448 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 74.8 t -82.75 110.25 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.023 0.44 . . . . 72.02 111.218 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.69 162.12 13.91 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.845 -0.616 . . . . 74.43 112.117 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.72 -38.79 73.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.83 -0.623 . . . . 74.4 111.564 174.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -137.82 126.4 23.59 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.802 -0.181 . . . . 42.1 111.16 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -83.47 -24.88 31.6 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.251 0.548 . . . . 62.41 111.109 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -81.34 -0.66 42.12 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.181 -0.463 . . . . 61.13 112.088 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.41 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 57.8 t30 -96.47 -23.0 16.78 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.897 0.379 . . . . 72.1 111.765 -177.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.78 16.37 1.16 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.058 0.762 . . . . 62.12 113.058 -174.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.418 HG22 HG22 ' A' ' 516' ' ' THR . 77.0 t -135.08 142.5 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 120.896 0.379 . . . . 73.23 111.62 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -127.25 144.03 51.12 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.545 0.338 . . . . 71.41 111.103 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.9 m -123.42 124.99 44.14 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.559 0.578 . . . . 75.24 112.559 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -134.13 124.22 25.73 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.682 0.277 . . . . 74.43 110.545 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -99.17 130.19 45.46 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.361 0.6 . . . . 72.14 112.132 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 46.5 t -116.38 145.02 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.729 -0.669 . . . . 75.33 111.413 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 48.3 t -117.68 113.99 22.71 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.853 0.358 . . . . 61.42 111.236 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.91 120.16 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.503 -0.317 . . . . 73.21 111.223 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.8 m -114.84 165.38 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.099 0.476 . . . . 61.35 112.231 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.8 mt -82.24 -1.26 48.72 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.204 0.446 . . . . 71.13 112.204 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 C--O 1.253 1.27 0 N-CA-C 112.126 0.417 . . . . 72.32 112.126 -179.138 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.135 0.493 . . . . 74.44 110.74 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -96.35 156.25 16.42 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.052 -0.522 . . . . 73.31 111.344 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -124.66 128.15 25.0 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.467 -0.333 . . . . 71.43 110.933 178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.526 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 60.5 Cg_endo -72.13 174.92 10.62 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.794 2.329 . . . . 53.52 113.02 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 25.4 t70 -150.0 81.22 1.38 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.866 -0.606 . . . . 62.3 109.901 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.521 HD22 HD12 ' A' ' 491' ' ' LEU . 43.7 mt -84.45 105.72 15.48 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.858 -0.61 . . . . 64.22 111.487 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.472 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 8.1 t -113.08 148.08 35.97 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.079 0.466 . . . . 74.33 111.334 178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.629 HG12 HG12 ' A' ' 462' ' ' VAL . 27.3 m -121.08 146.91 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.226 -0.443 . . . . 75.14 111.108 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 46.3 mt-10 -137.0 136.35 38.4 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.252 -0.431 . . . . 65.41 111.305 -175.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.2 mt -110.14 132.51 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.914 0.388 . . . . 74.44 111.62 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -136.61 136.39 39.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.45 -0.341 . . . . 74.04 111.093 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.51 -170.76 39.79 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.209 -0.52 . . . . 73.22 112.97 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.77 121.21 7.7 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.574 2.183 . . . . 72.42 112.921 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -83.4 -16.75 44.68 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.041 0.385 . . . . 73.52 112.041 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 63.6 t -129.33 123.97 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.682 0.277 . . . . 72.24 110.676 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.41 160.99 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.281 0.562 . . . . 74.53 112.27 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -90.43 158.19 26.28 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.049 -0.523 . . . . 62.12 112.8 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.411 HG11 HD23 ' A' ' 541' ' ' LEU . 13.8 p -69.21 140.54 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 120.95 0.405 . . . . 63.0 111.948 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 68.1 12.35 8.74 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.178 0.591 . . . . 73.52 112.405 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -93.58 174.63 7.09 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.0 0.429 . . . . 72.1 111.476 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 502' ' ' SER . 40.3 tp -108.15 119.39 39.34 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.894 0.378 . . . . 74.24 111.338 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -114.05 131.55 56.33 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.026 0.441 . . . . 64.31 111.54 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -116.65 130.44 56.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.281 0.562 . . . . 53.41 111.658 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -122.56 162.37 21.94 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.786 -0.643 . . . . 75.23 111.089 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -120.34 127.55 52.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.828 0.347 . . . . 72.54 111.151 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 38.3 t -100.49 113.25 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.077 0.465 . . . . 71.23 110.151 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 52.2 m-70 -94.27 105.85 17.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.29 -0.413 . . . . 74.22 110.341 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.629 HG12 HG12 ' A' ' 442' ' ' VAL . 8.7 m -106.19 123.12 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-O 121.119 0.485 . . . . 54.31 110.246 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.457 ' HG3' HG23 ' A' ' 441' ' ' THR . 3.5 ptpp? -139.39 147.05 40.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.158 0.504 . . . . 64.0 112.276 -173.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 53.5 t-20 -104.69 126.91 52.23 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.801 -0.636 . . . . 71.43 109.877 175.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 89.3 mt -103.97 -20.61 13.82 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.051 -0.406 . . . . 72.33 111.972 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -60.94 -26.01 64.89 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.309 -0.472 . . . . 74.14 114.016 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.81 18.35 56.49 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.986 -0.626 . . . . 65.43 113.471 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 6.6 tt -137.07 133.8 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 122.613 0.365 . . . . 73.4 110.705 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -69.9 145.31 41.39 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 114.718 0.647 . . . . 62.41 114.718 -174.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.8 117.9 16.42 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 122.817 0.447 . . . . 63.11 111.44 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -81.67 -12.19 11.23 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.752 2.302 . . . . 72.33 112.594 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 17.3 m -81.02 11.63 3.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.812 0.845 . . . . 74.02 112.804 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 74.1 m -88.57 93.83 9.68 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.952 0.882 . . . . 54.32 112.591 -166.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -99.02 126.37 44.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.203 -0.908 . . . . 73.35 110.176 172.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.582 HG21 HG11 ' A' ' 462' ' ' VAL . 47.3 t -112.17 118.81 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.754 0.312 . . . . 54.44 110.97 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -125.25 152.64 44.33 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.123 0.487 . . . . 72.21 111.785 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 99.3 t -121.21 130.07 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.108 -0.496 . . . . 43.33 111.33 -176.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -123.39 136.46 54.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.077 -0.51 . . . . 74.04 111.592 -177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 65.6 mt -109.33 112.33 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 110.076 -0.342 . . . . 64.14 110.076 174.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 53.87 33.75 17.85 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.974 0.416 . . . . 64.22 111.45 -175.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 99.54 -23.67 35.26 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.252 -0.499 . . . . 32.23 113.91 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 85.3 m -82.86 133.52 35.12 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.338 0.569 . . . . 75.22 111.763 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.5 tp -68.01 116.84 9.1 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.008 0.432 . . . . 74.44 111.495 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -96.5 -43.57 7.56 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 111.957 0.354 . . . . 71.35 111.957 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.5 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 8.9 tppt? -150.23 155.26 39.39 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.593 -0.276 . . . . 61.41 110.822 -174.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . 0.431 ' N ' ' HG3' ' A' ' 485' ' ' LYS . 8.1 p30 -143.97 141.99 30.49 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.995 0.426 . . . . 74.35 111.525 177.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . 0.5 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 8.6 m-90 -133.19 148.7 52.06 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.145 -0.479 . . . . 73.33 111.126 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 65.1 m -120.34 119.04 31.96 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 110.234 -0.284 . . . . 74.53 110.234 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.5 174.79 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.132 0.492 . . . . 62.51 111.491 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 92.5 p -121.64 139.4 53.59 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.527 -0.306 . . . . 61.24 110.332 174.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.521 HD12 HD22 ' A' ' 440' ' ' LEU . 68.1 mt -117.78 120.6 38.44 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.884 0.374 . . . . 64.24 111.105 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -84.37 -169.37 45.47 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.239 -0.505 . . . . 42.24 112.939 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.27 111.95 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.399 2.066 . . . . 74.24 112.519 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 45.5 mmtm 66.46 18.41 10.82 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.267 -0.424 . . . . 74.41 112.01 178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -86.39 149.14 25.22 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.064 0.394 . . . . 63.2 112.064 -176.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -133.84 135.7 43.92 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.235 -0.439 . . . . 75.33 111.618 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.409 ' O ' HG22 ' A' ' 462' ' ' VAL . 2.3 mmmp? -122.39 134.09 54.63 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.44 -0.345 . . . . 50.34 110.582 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.73 115.67 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 120.979 0.418 . . . . 62.45 111.247 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 72.0 mt -107.92 128.93 55.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.247 -0.433 . . . . 61.44 110.801 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 36.5 p -113.08 150.01 32.68 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.546 0.688 . . . . 74.14 112.617 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -145.65 148.34 32.98 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.586 -0.734 . . . . 74.11 110.982 175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.525 ' HB2' HD11 ' A' ' 455' ' ' LEU . 78.5 p -111.69 113.57 26.02 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.182 0.515 . . . . 43.24 111.216 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -108.63 134.27 51.6 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.391 -0.368 . . . . 71.23 110.993 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.3 m -111.08 100.72 47.94 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-N 116.37 -0.377 . . . . 63.25 110.946 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . 0.479 ' HB2' HG11 ' A' ' 539' ' ' VAL . 71.6 Cg_endo -74.06 88.77 1.07 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.258 1.972 . . . . 73.31 112.693 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 22.4 p -73.97 -14.24 61.0 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.211 0.448 . . . . 74.34 112.211 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -115.75 146.21 42.11 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.706 0.288 . . . . 74.15 110.711 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.12 149.55 21.49 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.83 0.348 . . . . 51.15 111.87 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.3 -167.62 27.92 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.998 -0.62 . . . . 63.35 113.416 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 2.4 tpt -90.91 107.63 19.32 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.795 0.331 . . . . 53.22 111.503 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -114.17 146.84 39.8 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.051 -0.406 . . . . 51.43 111.526 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 35.5 ttp180 -124.42 116.78 23.09 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.554 -0.293 . . . . 72.24 111.268 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 63.2 mt -96.4 130.16 45.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.843 0.354 . . . . 60.25 111.249 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -125.41 147.79 49.05 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.869 0.366 . . . . 71.34 111.567 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -121.63 133.68 54.98 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.317 -0.401 . . . . 60.32 110.604 174.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.0 p -127.57 142.65 51.31 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.813 0.339 . . . . 52.34 111.726 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.43 139.66 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 120.733 0.302 . . . . 74.34 111.3 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 46.6 t0 38.96 66.59 0.52 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.682 0.793 . . . . 63.25 112.595 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -61.95 -31.81 72.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.097 -0.501 . . . . 63.45 111.655 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.88 -19.63 62.6 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.352 -0.386 . . . . 74.14 111.044 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.1 m120 59.74 51.88 5.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.46 0.648 . . . . 71.33 110.917 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 68.5 p -67.02 -29.09 68.81 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.76 -0.654 . . . . 73.15 111.205 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.41 HG21 ' HG3' ' A' ' 438' ' ' PRO . 9.8 p -114.88 143.41 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.03 -0.532 . . . . 43.25 111.032 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . 0.492 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 51.4 t -82.62 118.18 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.071 0.462 . . . . 70.33 111.227 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -92.38 162.01 14.43 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.775 -0.648 . . . . 70.12 112.593 -174.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 87.5 mt -70.05 -38.12 75.71 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.134 -0.485 . . . . 71.1 110.814 172.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -130.53 118.17 20.67 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.089 -0.505 . . . . 74.34 111.079 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.39 3.16 32.99 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.007 0.432 . . . . 73.2 112.106 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -107.19 16.78 23.71 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.542 0.687 . . . . 71.22 110.03 173.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.472 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.4 t30 -100.18 -22.44 15.16 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.514 -0.766 . . . . 54.53 112.41 -170.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -81.58 11.54 4.57 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.913 1.079 . . . . 72.35 113.913 -167.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.73 144.22 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.501 0.556 . . . . 45.24 112.501 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . 0.541 ' HB2' HG23 ' A' ' 442' ' ' VAL . . . -129.28 142.75 50.75 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.997 -0.547 . . . . 53.23 110.957 173.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.0 m -128.49 123.3 33.25 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.975 0.417 . . . . 43.31 111.872 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -142.74 117.72 10.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.881 0.372 . . . . 74.21 110.652 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 0.5 OUTLIER -97.24 137.21 36.6 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.485 0.66 . . . . 72.1 112.561 -177.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 59.4 t -121.58 132.38 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.653 -0.703 . . . . 74.53 111.558 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 44.3 t -99.27 122.04 41.88 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.893 0.377 . . . . 63.1 111.07 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 505' ' ' PRO . 26.1 t -103.85 132.42 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.441 -0.345 . . . . 71.43 110.688 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.83 164.37 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.092 0.472 . . . . 71.3 112.241 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . 0.411 HD23 HG11 ' A' ' 452' ' ' VAL . 95.4 mt -78.42 -1.9 35.77 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.265 0.468 . . . . 65.52 112.265 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.254 1.332 0 N-CA-C 112.434 0.531 . . . . 75.33 112.434 -175.707 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 53.6 ttm . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 120.928 0.394 . . . . 63.21 111.134 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -95.6 143.04 27.23 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.066 0.46 . . . . 72.44 111.584 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -116.17 134.97 22.72 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 116.028 -0.533 . . . . 53.14 110.495 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 524' ' ' VAL . 72.0 Cg_endo -77.0 173.85 13.8 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.506 2.137 . . . . 54.5 114.241 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -145.17 94.93 2.59 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.161 -0.927 . . . . 75.21 108.679 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.529 HD22 HD12 ' A' ' 491' ' ' LEU . 66.5 mt -100.25 120.66 40.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.076 0.465 . . . . 73.41 111.579 -172.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.623 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.5 t -129.36 159.55 35.85 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.319 0.58 . . . . 54.12 112.375 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.631 HG12 HG12 ' A' ' 462' ' ' VAL . 28.7 m -122.42 148.37 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.772 -0.649 . . . . 74.54 111.473 -178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 37.6 mt-10 -132.27 136.87 47.24 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.406 -0.361 . . . . 74.3 110.241 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 56.6 mt -112.88 126.95 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 120.934 0.397 . . . . 62.34 111.8 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -131.0 144.05 51.18 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.198 -0.455 . . . . 60.45 110.334 178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.9 -176.35 36.63 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.653 -0.784 . . . . 63.4 113.317 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.52 114.86 3.43 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.842 2.362 . . . . 71.12 113.122 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -74.93 -14.49 60.65 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.611 0.597 . . . . 72.31 112.611 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 90.3 t -132.65 126.48 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 122.171 -0.331 . . . . 45.02 110.76 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.93 162.09 37.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.261 0.553 . . . . 73.1 111.796 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -97.96 153.91 20.14 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.213 -0.518 . . . . 52.31 112.957 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.566 HG11 HD23 ' A' ' 541' ' ' LEU . 14.5 p -64.0 142.22 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 O-C-N 122.619 -0.342 . . . . 72.44 111.414 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 65.82 13.45 9.0 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.628 0.603 . . . . 75.21 112.628 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -105.29 162.75 13.15 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.059 0.457 . . . . 61.15 111.943 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 502' ' ' SER . 49.2 tp -92.94 133.54 36.01 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.468 -0.333 . . . . 73.21 111.634 -179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -131.4 132.58 44.49 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.797 0.332 . . . . 73.42 111.46 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -112.92 131.88 55.56 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.804 0.335 . . . . 53.31 111.183 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 61.6 m-85 -121.59 157.61 30.39 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.235 -0.438 . . . . 75.11 111.013 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.511 ' HG2' HG22 ' A' ' 500' ' ' THR . 41.9 mt-10 -120.26 127.02 52.01 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.997 -0.547 . . . . 63.14 111.344 -179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.62 113.68 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.165 173.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.546 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 44.8 m-70 -95.09 111.63 23.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.869 0.366 . . . . 75.32 110.267 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.631 HG12 HG12 ' A' ' 442' ' ' VAL . 33.1 m -106.57 122.71 60.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.99 0.424 . . . . 71.44 110.652 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.527 ' HD3' HD21 ' A' ' 465' ' ' LEU . 1.4 ptpp? -130.42 148.55 52.25 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.295 0.569 . . . . 64.55 112.282 -174.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.569 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 50.7 t-20 -99.64 128.07 45.75 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.668 -0.696 . . . . 73.32 110.014 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.527 HD21 ' HD3' ' A' ' 463' ' ' LYS . 79.9 mt -109.45 -10.7 14.88 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.752 0.311 . . . . 73.2 111.747 -178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -76.26 -28.48 60.0 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.294 -0.479 . . . . 40.55 113.566 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.13 22.39 45.27 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.955 -0.64 . . . . 72.04 113.389 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.6 tt -137.73 135.82 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 122.738 0.415 . . . . 53.25 111.102 178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.413 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -70.02 133.08 24.32 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 114.608 0.603 . . . . 62.4 114.608 -174.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 60.2 t -131.39 118.48 17.09 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.21 0.604 . . . . 63.22 111.306 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -88.85 -9.86 4.47 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.074 2.516 . . . . 73.12 113.851 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.3 p -81.65 11.95 4.29 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.83 0.678 . . . . 72.15 112.83 -177.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . 0.486 ' HA ' ' OD1' ' A' ' 518' ' ' ASP . 98.7 m -87.24 109.96 19.85 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.072 0.939 . . . . 44.35 112.094 -164.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -119.99 128.14 53.28 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.009 -0.996 . . . . 75.03 110.892 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.629 HG21 HG11 ' A' ' 462' ' ' VAL . 25.1 t -104.59 135.83 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.404 -0.362 . . . . 62.04 111.902 -175.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . 0.562 ' NH1' ' HB2' ' A' ' 519' ' ' GLU . 59.2 mtt85 -123.64 143.39 50.27 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.369 -0.378 . . . . 75.31 111.273 177.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.52 123.18 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 120.996 0.427 . . . . 61.33 111.123 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -111.55 137.82 48.9 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.042 -0.526 . . . . 63.45 110.7 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 62.5 mt -115.99 109.66 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 110.025 -0.361 . . . . 75.43 110.025 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 55.16 34.62 23.04 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.089 0.471 . . . . 73.41 111.292 -174.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 97.39 -24.09 33.0 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 116.049 -0.523 . . . . 72.0 113.699 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 66.0 m -82.67 120.4 25.52 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 122.394 -0.474 . . . . 55.53 111.76 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -62.8 115.05 4.0 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.054 0.454 . . . . 75.15 110.971 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -89.74 -43.54 10.62 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.382 0.512 . . . . 64.14 112.382 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -164.45 161.23 21.31 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 122.19 -0.319 . . . . 44.34 111.454 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.58 154.98 42.75 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.936 0.398 . . . . 74.51 111.941 177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -135.02 148.87 50.05 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.848 0.459 . . . . 73.42 111.431 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 79.6 m -105.64 119.24 38.64 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 110.156 -0.313 . . . . 75.44 110.156 171.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.07 173.34 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.394 0.616 . . . . 62.44 111.876 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 75.1 p -126.58 134.71 50.75 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.081 -0.508 . . . . 63.4 110.686 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.529 HD12 HD22 ' A' ' 440' ' ' LEU . 92.1 mt -117.38 118.89 33.48 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.875 0.369 . . . . 65.13 111.275 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.413 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -81.47 -166.56 36.95 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.193 -0.527 . . . . 60.32 112.652 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.03 107.12 0.73 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.15 1.9 . . . . 74.43 112.172 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 41.6 mmtm 68.66 22.9 7.32 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.204 -0.453 . . . . 52.34 111.772 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -81.81 149.88 28.14 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.892 0.33 . . . . 74.21 111.892 -177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 462' ' ' VAL . 41.5 tt0 -135.38 134.59 39.91 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.744 0.307 . . . . 63.12 111.286 176.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -118.91 149.79 40.98 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.639 -0.255 . . . . 73.5 110.621 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 43.9 t -114.92 113.22 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.001 0.429 . . . . 71.42 111.48 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 50.6 mt -105.71 146.23 30.05 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.242 -0.436 . . . . 65.24 111.047 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.511 HG22 ' HG2' ' A' ' 459' ' ' GLU . 20.9 p -129.47 149.8 51.09 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.367 0.603 . . . . 72.44 112.611 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 49.0 p90 -144.33 148.46 34.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.793 -0.639 . . . . 70.53 111.156 174.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.568 ' HB2' HD11 ' A' ' 455' ' ' LEU . 24.8 p -110.96 115.06 28.85 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.207 0.527 . . . . 72.43 111.577 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 33.3 t90 -120.88 137.44 54.58 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.008 -0.542 . . . . 51.3 111.601 -174.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 92.9 m -120.61 102.05 45.32 Favored Pre-proline 0 N--CA 1.473 0.688 0 CA-C-N 116.458 -0.337 . . . . 65.11 111.282 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.97 104.43 1.91 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.578 2.185 . . . . 74.52 113.068 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 77.0 p -86.82 -15.76 38.23 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.021 0.438 . . . . 73.22 111.995 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -104.22 137.13 42.59 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.731 0.301 . . . . 71.1 110.837 171.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.17 150.21 25.65 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.009 0.433 . . . . 74.25 112.151 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 143.98 -167.73 26.7 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.177 -0.535 . . . . 75.02 113.181 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 89.6 mmm -89.57 121.1 31.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.064 0.459 . . . . 74.5 111.395 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -121.58 111.7 17.55 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.427 0.632 . . . . 74.4 111.207 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -104.02 120.34 40.85 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.805 -0.634 . . . . 72.32 111.308 -177.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 62.2 mt -95.73 128.44 46.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.841 -0.618 . . . . 73.34 111.473 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -122.95 135.3 54.43 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.196 -0.457 . . . . 74.24 111.041 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.56 139.53 48.07 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.784 0.325 . . . . 62.41 111.416 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . 0.527 HG22 HG22 ' A' ' 532' ' ' VAL . 71.2 p -129.26 151.85 49.47 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.921 0.391 . . . . 73.02 111.035 177.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.5 p -130.0 141.8 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 116.525 -0.307 . . . . 52.23 111.524 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' A' ' 473' ' ' THR . 1.3 m-20 50.17 47.91 22.9 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.456 0.539 . . . . 72.53 112.456 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . 0.562 ' HB2' ' NH1' ' A' ' 476' ' ' ARG . 6.0 mm-40 -53.62 -32.78 52.67 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.283 0.475 . . . . 74.13 112.283 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -68.42 -17.05 64.12 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.171 0.434 . . . . 72.21 112.171 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 49.84 37.17 12.81 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.742 0.645 . . . . 64.3 112.742 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 38.5 p -72.38 -16.66 61.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.858 0.361 . . . . 60.44 111.78 178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 8.3 p -108.01 136.53 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.417 -0.356 . . . . 74.04 111.07 176.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . 0.434 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 90.7 t -84.23 113.3 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.873 0.368 . . . . 75.33 110.879 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -100.61 174.23 6.17 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.259 0.552 . . . . 65.41 112.269 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.7 mt -82.85 -24.39 33.29 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.68 -0.691 . . . . 72.21 111.675 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.57 ' ND2' ' HB2' ' A' ' 530' ' ' ASN . 25.0 t-20 -118.6 158.24 25.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.145 0.498 . . . . 54.34 111.579 -174.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -118.35 -23.8 7.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.165 -0.471 . . . . 74.43 111.981 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -105.89 -7.39 18.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.3 0.481 . . . . 72.42 112.3 -174.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.623 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 58.2 t30 -86.77 -7.7 58.02 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.713 0.634 . . . . 72.43 112.713 -170.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -75.42 -0.27 19.44 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.159 0.799 . . . . 73.33 113.159 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 516' ' ' THR . 48.4 t -126.86 146.05 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 112.439 0.533 . . . . 53.31 112.439 -175.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . 0.407 ' CB ' HG23 ' A' ' 442' ' ' VAL . . . -136.14 142.69 44.25 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.245 -0.434 . . . . 53.31 111.276 174.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.8 m -117.3 134.83 54.34 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.404 0.52 . . . . 72.53 112.404 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -138.54 126.64 22.71 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.369 -0.378 . . . . 63.03 110.363 174.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -102.6 123.44 46.34 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.825 0.345 . . . . 74.32 111.85 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.47 144.45 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.996 0.427 . . . . 71.4 111.667 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.0 t -112.95 127.03 56.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.776 0.322 . . . . 75.14 111.413 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.1 120.51 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.85 0.357 . . . . 74.41 111.066 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.74 158.91 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.442 0.534 . . . . 55.22 112.442 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . 0.566 HD23 HG11 ' A' ' 452' ' ' VAL . 89.9 mt -81.3 -28.43 34.62 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.251 -0.431 . . . . 74.02 111.632 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.254 1.339 0 N-CA-C 112.725 0.639 . . . . 75.31 112.725 -176.893 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . 0.58 ' N ' ' SD ' ' A' ' 435' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.46 0.171 . . . . 71.32 111.168 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -96.77 131.99 42.92 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.977 0.418 . . . . 63.05 111.571 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 438' ' ' PRO . 96.5 m-85 -128.28 146.1 58.26 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 116.139 -0.482 . . . . 75.34 110.474 177.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.479 ' HG2' HG21 ' A' ' 523' ' ' VAL . 2.6 Cg_exo -75.03 173.91 13.7 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.922 2.415 . . . . 71.33 114.223 -176.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -152.87 78.2 1.18 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.784 -1.098 . . . . 73.41 108.972 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.418 HD22 HD12 ' A' ' 491' ' ' LEU . 70.4 mt -84.12 110.48 18.53 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.669 -0.696 . . . . 73.13 111.416 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.472 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 13.7 t -115.57 149.32 38.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.146 0.498 . . . . 70.31 111.459 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.599 HG12 HG12 ' A' ' 462' ' ' VAL . 27.1 m -121.02 148.41 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.966 -0.561 . . . . 73.13 111.144 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 43.7 mt-10 -139.69 131.58 27.65 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.496 -0.32 . . . . 73.21 110.872 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 53.8 mt -105.55 138.69 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 122.129 -0.357 . . . . 72.12 111.463 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -141.59 134.97 29.56 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 120.563 0.221 . . . . 65.02 111.287 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.68 -164.87 37.63 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.947 -0.644 . . . . 63.31 113.678 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.2 136.84 32.81 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.743 2.296 . . . . 65.03 113.44 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -82.95 -44.94 14.73 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.898 0.38 . . . . 70.44 111.751 -178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.16 133.72 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 120.989 0.423 . . . . 71.4 111.278 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.5 m -135.7 162.99 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.068 0.461 . . . . 75.1 111.539 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -98.34 165.65 21.66 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.178 -0.534 . . . . 71.44 113.056 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.523 HG22 ' ND2' ' A' ' 453' ' ' ASN . 11.9 p -69.44 136.76 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 120.853 0.359 . . . . 63.13 111.591 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . 0.523 ' ND2' HG22 ' A' ' 452' ' ' VAL . 53.3 m-80 64.67 15.65 9.87 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.151 0.58 . . . . 71.32 112.547 -176.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.419 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.0 mmmt -95.82 143.93 26.62 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.13 0.49 . . . . 70.44 111.656 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 502' ' ' SER . 43.1 tp -81.75 123.14 28.51 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.277 -0.42 . . . . 71.31 111.159 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -118.36 132.31 56.27 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.84 0.352 . . . . 75.12 111.288 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -120.7 132.03 54.86 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.201 0.524 . . . . 50.42 111.747 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -123.76 159.42 29.51 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.739 -0.664 . . . . 75.45 110.96 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.471 ' HG3' HG22 ' A' ' 500' ' ' THR . 1.9 mp0 -120.22 127.46 52.45 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.069 0.462 . . . . 74.44 110.745 175.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.7 t -100.52 121.46 51.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.274 -0.421 . . . . 50.52 111.48 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.57 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 11.6 m-70 -96.22 110.58 22.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.081 -0.509 . . . . 74.11 110.522 176.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.599 HG12 HG12 ' A' ' 442' ' ' VAL . 19.8 m -114.4 123.42 70.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.962 0.411 . . . . 75.33 110.342 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.587 ' HD3' HD21 ' A' ' 465' ' ' LEU . 4.5 ptpp? -139.17 148.37 43.1 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.467 0.651 . . . . 75.32 112.705 -172.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 49.4 t-20 -100.23 127.58 46.48 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.495 -0.775 . . . . 61.12 109.873 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.587 HD21 ' HD3' ' A' ' 463' ' ' LYS . 77.9 mt -115.02 -2.66 12.76 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.364 0.505 . . . . 64.02 112.364 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -72.88 -22.85 78.8 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.979 -0.629 . . . . 53.14 113.174 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.75 16.42 59.92 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.255 -0.498 . . . . 73.24 113.307 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 10.2 tt -135.69 139.73 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 O-C-N 122.729 -0.277 . . . . 73.3 110.942 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -71.4 137.08 25.65 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.171 -0.538 . . . . 55.15 114.079 -176.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 57.7 t -131.68 112.9 15.16 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 120.802 0.334 . . . . 75.33 111.796 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -88.01 -10.9 4.78 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.3 2.667 . . . . 50.44 113.057 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 79.9 p -81.95 13.3 3.4 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.534 0.734 . . . . 72.21 112.674 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 91.0 m -87.42 108.82 19.18 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.755 0.788 . . . . 62.15 112.436 -164.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -110.57 130.59 55.53 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.352 -0.84 . . . . 70.33 111.42 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.533 HG21 HG11 ' A' ' 462' ' ' VAL . 47.3 t -111.53 130.74 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 122.314 0.246 . . . . 63.1 110.981 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . 0.603 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 96.0 mtt180 -124.2 150.11 45.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.945 0.402 . . . . 65.44 111.418 178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.98 120.71 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.218 -0.446 . . . . 55.34 111.085 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -113.75 137.1 52.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.473 -0.33 . . . . 74.35 110.99 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 513' ' ' ILE . 63.2 mt -113.34 111.89 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 110.166 -0.309 . . . . 61.02 110.166 174.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 54.46 34.38 20.84 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.108 0.48 . . . . 64.34 111.77 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.18 -19.06 55.35 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.382 -0.437 . . . . 71.31 113.482 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 89.7 m -87.11 124.38 33.18 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.543 -0.386 . . . . 55.52 111.693 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.6 tp -62.7 120.4 11.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.1 0.476 . . . . 63.11 111.774 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . 0.453 ' CE2' ' HE2' ' A' ' 485' ' ' LYS . 19.3 t80 -94.81 -43.07 8.39 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.19 -0.459 . . . . 74.33 112.124 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.453 ' HE2' ' CE2' ' A' ' 484' ' ' TYR . 4.5 ttpt -167.67 159.78 12.21 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 122.235 -0.291 . . . . 74.54 111.464 -177.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -143.17 144.12 32.06 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 120.939 0.4 . . . . 64.23 112.037 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -132.78 149.6 52.25 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.991 0.516 . . . . 75.3 111.208 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.0 m -118.06 119.95 36.31 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 110.202 -0.295 . . . . 74.24 110.202 170.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.48 172.98 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.32 0.581 . . . . 71.11 111.966 -175.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 79.1 p -111.9 137.4 49.92 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.04 -0.527 . . . . 74.43 110.752 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.418 HD12 HD22 ' A' ' 440' ' ' LEU . 69.0 mt -127.55 118.99 25.01 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.828 0.347 . . . . 73.34 110.721 174.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -84.43 -174.79 50.53 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.951 -0.642 . . . . 74.32 112.702 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.97 105.84 0.23 Allowed 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.365 2.043 . . . . 70.23 112.052 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 34.7 mmtp 71.59 29.19 2.67 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.154 0.427 . . . . 75.23 112.154 177.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -97.95 155.31 17.14 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.814 0.34 . . . . 61.33 111.869 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -130.34 143.21 50.63 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.215 -0.448 . . . . 64.44 111.393 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.445 ' HB2' ' CG2' ' A' ' 462' ' ' VAL . 43.6 mmtm -117.21 146.85 42.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.052 0.541 . . . . 65.32 110.039 172.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.57 113.14 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.047 0.451 . . . . 73.04 110.938 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 56.7 mt -110.84 141.24 44.47 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.405 -0.362 . . . . 73.52 111.166 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.471 HG22 ' HG3' ' A' ' 459' ' ' GLU . 21.5 p -113.81 151.7 31.69 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.493 0.553 . . . . 74.14 112.493 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -150.84 148.51 28.56 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.019 -0.537 . . . . 63.15 111.311 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.569 ' HB2' HD11 ' A' ' 455' ' ' LEU . 89.9 p -118.42 125.89 50.91 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.271 -0.422 . . . . 75.53 111.111 -178.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 28.2 t90 -125.97 136.8 53.42 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.914 0.388 . . . . 74.04 111.136 -177.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 90.4 m -121.31 100.77 44.71 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.694 0.283 . . . . 64.33 111.016 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 80.3 Cg_endo -77.64 106.3 2.17 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.623 2.215 . . . . 62.03 113.108 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.8 p -87.54 12.17 13.09 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.042 0.386 . . . . 72.25 112.042 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -142.74 132.72 24.31 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.711 0.404 . . . . 61.31 110.967 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -73.68 150.73 41.07 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.475 0.546 . . . . 73.22 112.475 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 145.76 -173.35 26.15 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.879 -0.676 . . . . 35.4 113.397 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 95.9 mmm -99.31 112.61 24.74 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.049 0.452 . . . . 72.12 111.032 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -115.05 119.21 35.68 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.2 0.524 . . . . 75.33 111.431 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -97.72 117.91 33.07 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.104 -0.498 . . . . 73.23 111.153 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 479' ' ' ILE . 65.0 mt -95.29 120.01 44.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.0 -0.545 . . . . 73.32 111.119 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.48 137.35 52.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.934 0.397 . . . . 72.52 111.341 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.1 132.96 54.54 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.299 -0.409 . . . . 70.53 110.738 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . 0.488 HG22 HG22 ' A' ' 532' ' ' VAL . 43.9 p -126.03 141.14 52.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.887 0.375 . . . . 73.34 111.244 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.36 141.89 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.95 0.405 . . . . 74.52 111.43 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.3 t0 49.89 58.66 5.21 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.643 0.735 . . . . 62.44 111.919 -177.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . 0.603 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.9 mm-40 -59.12 -32.69 70.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.284 0.564 . . . . 75.51 111.322 174.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -68.55 -18.05 64.27 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.763 -0.653 . . . . 71.41 111.68 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 52.02 70.22 0.58 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.719 0.771 . . . . 54.51 110.8 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 67.4 p -96.76 -10.87 25.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.472 -0.785 . . . . 73.33 111.689 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.479 HG21 ' HG2' ' A' ' 438' ' ' PRO . 11.7 p -141.66 144.15 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.057 0.456 . . . . 74.42 111.736 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.5 t -82.79 116.27 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.968 0.413 . . . . 74.31 111.528 -178.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.88 156.25 17.62 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.888 -0.597 . . . . 73.22 112.423 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.84 -38.85 70.05 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.765 -0.652 . . . . 65.22 111.329 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -119.81 122.07 40.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.842 0.353 . . . . 72.34 110.703 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -83.05 -17.55 42.84 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.006 0.431 . . . . 70.12 111.934 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -102.08 14.98 30.46 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.102 -0.374 . . . . 74.34 111.669 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.472 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 66.3 t30 -104.93 -11.39 16.72 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.289 0.477 . . . . 73.35 112.289 -172.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -86.56 6.11 32.33 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.923 0.712 . . . . 72.23 112.923 -172.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.488 HG22 HG22 ' A' ' 516' ' ' THR . 51.4 t -130.42 143.15 41.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.018 0.437 . . . . 54.05 112.107 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -129.73 143.2 50.7 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.386 -0.37 . . . . 72.41 111.023 175.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 56.9 m -117.78 135.48 54.03 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.856 0.36 . . . . 61.34 111.909 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -141.98 116.91 9.9 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.51 -0.552 . . . . 74.23 109.51 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -101.62 124.34 47.11 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.201 0.524 . . . . 60.34 111.813 -175.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 47.7 t -112.32 144.44 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.961 -0.563 . . . . 72.42 111.64 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 30.1 t -112.38 128.53 56.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.525 -0.307 . . . . 44.33 111.131 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.6 t -111.12 125.59 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 120.827 0.346 . . . . 73.24 111.691 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.7 m -116.75 161.12 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.165 0.507 . . . . 71.23 111.893 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 94.9 mt -81.0 -14.37 58.0 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.754 0.65 . . . . 65.04 112.754 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 C--O 1.253 1.28 0 N-CA-C 112.856 0.687 . . . . 62.21 112.856 -176.298 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.708 0.289 . . . . 74.4 111.016 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -101.29 130.94 47.54 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.841 0.353 . . . . 75.31 111.142 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -118.24 143.56 33.24 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 116.557 -0.292 . . . . 73.21 110.788 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.626 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 20.6 Cg_endo -79.99 174.37 11.63 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.334 2.022 . . . . 52.31 113.53 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 11.7 t70 -149.38 82.96 1.42 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.686 -0.688 . . . . 73.2 109.794 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.522 HD11 HG11 ' A' ' 470' ' ' VAL . 92.1 mt -84.73 114.76 22.28 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.105 -0.498 . . . . 72.2 111.771 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.476 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.2 t -126.37 158.6 35.47 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.009 0.433 . . . . 63.13 111.382 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 462' ' ' VAL . 33.8 m -132.1 148.13 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 116.112 -0.495 . . . . 65.32 111.319 -177.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.5 mt-10 -125.08 137.15 54.2 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.421 0.288 . . . . 71.01 110.994 177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 60.8 mt -108.76 127.68 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.919 0.39 . . . . 41.03 111.471 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -128.37 132.04 48.55 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.673 -0.239 . . . . 75.33 111.15 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 172.15 -173.77 45.27 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.654 -0.784 . . . . 75.13 113.678 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -73.75 136.48 23.26 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.774 2.316 . . . . 73.3 113.395 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.57 -47.89 58.04 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.966 -0.561 . . . . 65.45 111.898 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 58.1 t -117.83 125.83 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.765 0.317 . . . . 72.11 111.078 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.3 160.77 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.179 0.514 . . . . 73.41 111.867 -178.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.53 148.56 19.34 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.074 -0.584 . . . . 63.14 113.323 -178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.526 HG22 ' ND2' ' A' ' 453' ' ' ASN . 11.0 p -64.39 138.42 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-O 120.857 0.361 . . . . 72.1 111.284 177.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . 0.526 ' ND2' HG22 ' A' ' 452' ' ' VAL . 45.0 m-80 63.56 18.68 11.25 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.959 0.504 . . . . 72.14 111.951 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -108.9 161.38 15.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.194 0.521 . . . . 71.21 111.623 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 502' ' ' SER . 37.8 tp -99.0 126.24 44.65 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.004 -0.544 . . . . 55.04 111.745 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.51 132.69 45.75 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.814 0.34 . . . . 54.21 111.582 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -104.98 138.58 40.97 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.42 0.629 . . . . 72.15 112.098 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 59.1 m-85 -122.84 151.34 41.79 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.554 -0.748 . . . . 71.55 110.302 177.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -120.02 127.2 52.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.094 0.474 . . . . 75.22 111.029 -175.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 21.6 t -105.07 114.78 45.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.101 -0.5 . . . . 75.21 111.124 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.591 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 46.8 m-70 -92.16 107.56 19.3 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.851 0.358 . . . . 74.43 110.299 174.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.621 HG11 HG21 ' A' ' 475' ' ' VAL . 20.2 m -105.55 133.21 50.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.927 0.394 . . . . 71.43 110.193 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.564 ' HD3' HD21 ' A' ' 465' ' ' LEU . 0.1 OUTLIER -148.2 152.3 36.98 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.585 0.587 . . . . 61.25 112.585 -172.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.553 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.8 t-20 -107.72 127.46 53.7 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.634 -0.712 . . . . 73.52 109.524 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.564 HD21 ' HD3' ' A' ' 463' ' ' LYS . 79.9 mt -111.86 0.05 16.02 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.172 0.434 . . . . 62.05 112.172 -176.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -82.91 -25.38 49.61 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.92 -0.657 . . . . 55.0 113.632 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.88 22.73 41.22 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 121.101 -0.571 . . . . 73.2 113.577 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 9.5 tt -138.18 144.18 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 O-C-N 122.51 -0.406 . . . . 63.14 110.763 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.48 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -71.82 138.72 27.51 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.154 -0.546 . . . . 62.14 114.059 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.522 HG11 HD11 ' A' ' 440' ' ' LEU . 40.7 t -129.71 117.36 18.44 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 112.34 0.496 . . . . 72.51 112.34 -177.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.2 -11.0 8.77 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.105 2.537 . . . . 73.24 112.759 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 57.7 m -80.98 11.44 4.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.457 0.703 . . . . 45.32 112.685 -176.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 39.3 m -88.97 91.1 8.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.661 0.743 . . . . 63.23 112.422 -166.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . 0.571 ' O ' ' HA ' ' A' ' 517' ' ' VAL . 95.9 mttt -96.81 131.33 43.65 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.514 -0.766 . . . . 71.32 110.152 171.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.621 HG21 HG11 ' A' ' 462' ' ' VAL . 49.4 t -117.89 118.36 58.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 122.12 -0.363 . . . . 61.0 110.709 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 35.4 mtm180 -126.43 153.47 44.98 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.276 0.56 . . . . 63.23 112.076 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 84.8 t -120.41 135.79 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.006 -0.543 . . . . 75.14 111.141 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . 0.403 ' HE1' ' OG1' ' A' ' 516' ' ' THR . 25.1 m-85 -124.51 142.09 51.59 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.188 -0.46 . . . . 74.41 111.196 -178.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 513' ' ' ILE . 64.5 mt -114.82 111.55 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.295 -0.412 . . . . 74.13 109.998 175.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 54.34 34.03 19.74 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.195 0.521 . . . . 72.21 111.278 -173.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 98.07 -25.69 26.58 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.177 -0.465 . . . . 72.34 113.765 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 28.0 m -82.04 129.75 34.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.327 0.563 . . . . 74.15 111.851 -174.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.3 tp -62.48 124.23 20.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.096 0.474 . . . . 71.42 111.689 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -105.58 -43.72 4.87 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 112.518 0.562 . . . . 74.02 112.518 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.419 ' HD3' ' HB3' ' A' ' 501' ' ' PHE . 83.6 tttt -155.45 152.55 29.12 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 110.324 -0.25 . . . . 74.31 110.324 -176.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -141.09 147.89 39.27 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.434 0.531 . . . . 75.04 112.434 -176.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.5 m-90 -132.69 148.81 52.34 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.949 -0.569 . . . . 74.54 110.94 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 90.9 m -124.88 117.12 23.39 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.557 -0.534 . . . . 70.24 109.557 167.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.42 172.87 11.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.139 0.495 . . . . 75.41 111.587 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 30.3 m -116.93 133.89 55.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.186 -0.461 . . . . 70.35 110.335 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 72.8 mt -120.53 120.48 35.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.941 0.401 . . . . 74.41 110.978 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.48 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -80.85 -168.83 40.14 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.176 -0.535 . . . . 51.5 113.141 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -63.08 109.95 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.463 2.109 . . . . 71.2 112.307 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 99.5 mttt 63.45 37.48 10.62 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.618 0.723 . . . . 75.45 111.239 -178.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -85.98 149.35 25.24 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.208 -0.905 . . . . 71.1 111.419 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -136.09 145.42 45.91 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.839 0.352 . . . . 71.12 111.473 172.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -141.6 147.33 37.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.002 0.521 . . . . 73.22 111.018 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 42.3 t -111.15 112.99 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.209 0.528 . . . . 33.13 111.54 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 14.3 mt -111.7 127.85 55.9 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.178 -0.465 . . . . 74.23 110.268 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 76.0 p -112.96 163.05 15.14 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.136 0.791 . . . . 73.22 113.136 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . 0.419 ' HB3' ' HD3' ' A' ' 485' ' ' LYS . 47.8 p90 -152.23 148.29 27.4 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.305 -0.861 . . . . 74.34 110.906 172.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.569 ' HB2' HD11 ' A' ' 455' ' ' LEU . 78.6 p -114.9 114.72 25.86 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.072 0.463 . . . . 64.04 111.08 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . 0.47 ' CZ2' ' HB3' ' A' ' 505' ' ' PRO . 25.1 t90 -107.73 137.33 45.94 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.069 0.547 . . . . 75.14 111.776 -174.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 93.4 m -125.9 101.47 29.39 Favored Pre-proline 0 N--CA 1.473 0.696 0 CA-C-N 116.407 -0.36 . . . . 73.3 111.02 176.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . 0.47 ' HB3' ' CZ2' ' A' ' 503' ' ' TRP . 85.5 Cg_endo -82.22 102.18 1.18 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.528 2.152 . . . . 74.21 113.321 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 63.4 p -76.38 -21.77 55.63 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.856 0.36 . . . . 74.44 111.185 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -107.91 125.76 51.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.932 0.396 . . . . 65.43 111.373 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.06 150.86 46.15 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.4 0.519 . . . . 74.31 112.4 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.83 -173.12 33.23 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.083 -0.579 . . . . 74.1 113.061 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 8.8 tpt -99.71 126.94 45.83 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.577 -0.366 . . . . 74.55 110.727 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -132.86 112.0 11.54 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.337 0.495 . . . . 75.33 112.337 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -93.03 118.23 30.95 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.869 0.366 . . . . 74.23 110.776 176.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 479' ' ' ILE . 64.2 mt -95.47 127.93 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.093 0.473 . . . . 74.21 111.507 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -121.43 152.57 38.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.926 0.393 . . . . 73.4 111.194 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -128.9 135.35 48.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.769 0.318 . . . . 41.12 111.135 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 532' ' ' VAL . 38.5 p -123.73 149.44 45.55 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.326 -0.397 . . . . 71.24 111.431 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 474' ' ' LYS . 7.3 p -119.4 139.56 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-N 116.422 -0.354 . . . . 73.24 111.459 170.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.9 t70 43.8 70.41 0.32 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.609 0.764 . . . . 63.01 111.687 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -61.97 -33.06 73.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.792 -0.64 . . . . 71.24 111.437 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -69.34 -13.66 62.5 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.651 0.612 . . . . 72.33 112.651 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 6.1 t30 56.34 55.9 6.22 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.535 0.683 . . . . 71.21 110.428 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 68.5 p -85.25 -31.73 22.96 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.923 -0.58 . . . . 70.34 111.133 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.56 141.75 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.01 -0.541 . . . . 65.54 111.034 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.8 112.13 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 120.844 0.354 . . . . 74.34 111.557 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.483 ' OE2' ' HG2' ' A' ' 438' ' ' PRO . 13.5 mm-40 -91.22 163.7 14.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.258 0.551 . . . . 73.13 112.124 -176.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 71.6 mt -71.98 -39.14 69.49 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.279 0.561 . . . . 72.34 110.854 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -129.46 110.48 11.91 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.945 -0.57 . . . . 54.54 110.271 177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . 0.403 ' HA ' ' OD1' ' A' ' 531' ' ' ASN . 10.0 pt-20 -83.09 -21.8 33.6 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.989 0.423 . . . . 62.43 111.4 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -75.39 -12.31 60.23 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.147 0.499 . . . . 72.33 110.821 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.476 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 41.7 t30 -86.72 -14.62 41.91 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.999 -0.546 . . . . 74.14 111.145 -177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . 0.463 HD22 HG13 ' A' ' 517' ' ' VAL . 11.8 m120 -69.0 -13.97 62.77 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.08 0.77 . . . . 62.14 113.08 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.531 HG22 HG22 ' A' ' 516' ' ' THR . 57.7 t -116.57 134.0 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 112.528 0.566 . . . . 73.13 112.528 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 442' ' ' VAL . . . -114.42 143.07 45.52 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.218 -0.446 . . . . 63.15 110.54 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 70.0 m -125.76 125.86 43.64 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.022 0.439 . . . . 60.02 111.888 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -137.65 122.98 19.44 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.042 0.449 . . . . 74.11 110.781 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -93.36 129.12 39.6 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.411 -0.359 . . . . 64.22 111.386 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.4 t -123.87 142.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-O 121.332 0.587 . . . . 63.43 111.93 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 22.8 t -118.38 127.2 53.45 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.343 -0.389 . . . . 75.41 111.189 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.0 t -104.85 123.62 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.825 0.345 . . . . 62.34 111.31 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 31.0 m -116.1 161.75 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.795 0.665 . . . . 62.43 112.795 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.02 -17.38 43.54 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.037 -0.529 . . . . 74.31 111.737 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.253 1.267 0 CA-C-N 116.031 -0.531 . . . . 73.2 112.176 178.499 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.735 0.302 . . . . 74.21 110.78 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . 0.496 ' HB2' HD12 ' A' ' 468' ' ' ILE . 5.9 mp0 -95.2 146.53 24.26 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.192 0.52 . . . . 75.13 112.023 -174.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -118.87 113.68 35.85 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.237 -0.438 . . . . 71.12 110.392 175.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.595 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 72.9 Cg_endo -74.27 169.53 22.27 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.344 2.029 . . . . 61.43 113.567 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . 0.458 ' HB2' HD12 ' A' ' 526' ' ' LEU . 37.3 t70 -128.74 96.05 4.27 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.727 -0.669 . . . . 74.03 109.833 176.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 491' ' ' LEU . 88.7 mt -94.36 112.81 24.61 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.873 0.368 . . . . 61.31 111.077 -177.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.514 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 6.8 t -122.46 153.42 39.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.994 0.426 . . . . 73.41 111.92 -177.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.617 HG12 HG12 ' A' ' 462' ' ' VAL . 32.2 m -129.79 150.16 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.131 -0.486 . . . . 62.53 111.814 -177.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 49.6 mt-10 -130.23 144.81 51.58 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.21 -0.45 . . . . 54.03 110.918 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 53.4 mt -116.27 129.66 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 120.931 0.395 . . . . 74.14 111.199 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -134.19 137.43 44.43 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.414 -0.357 . . . . 74.11 110.981 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.29 -176.87 40.86 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.265 -0.969 . . . . 61.34 114.074 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.62 117.18 5.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.831 2.354 . . . . 73.52 113.071 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -71.85 -30.37 65.37 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.783 0.66 . . . . 64.12 112.783 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 94.6 t -120.73 122.98 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 121.885 -0.51 . . . . 62.15 111.503 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.97 163.28 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.084 0.469 . . . . 71.45 112.059 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -91.75 156.91 24.13 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.346 -0.454 . . . . 50.05 113.296 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.569 HG22 ' ND2' ' A' ' 453' ' ' ASN . 10.7 p -69.95 140.41 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.015 0.436 . . . . 63.12 111.807 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . 0.569 ' ND2' HG22 ' A' ' 452' ' ' VAL . 56.4 m-80 60.7 24.4 14.22 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.52 0.563 . . . . 62.33 112.52 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -105.94 176.13 5.27 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.125 0.488 . . . . 74.03 111.733 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 41.9 tp -105.09 120.2 40.9 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.338 -0.392 . . . . 62.25 111.431 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -129.25 132.78 47.27 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.739 0.304 . . . . 74.42 111.647 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -112.28 139.85 47.49 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.294 0.569 . . . . 61.55 111.548 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 53.7 m-85 -121.97 157.51 31.12 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.752 -0.658 . . . . 65.22 110.726 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -121.0 129.01 53.22 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.922 0.489 . . . . 75.24 111.079 -174.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 41.0 t -115.26 119.25 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.758 0.313 . . . . 74.32 111.353 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.601 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 49.3 m-70 -96.26 104.6 16.57 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.6 -0.273 . . . . 65.45 110.98 176.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.617 HG12 HG12 ' A' ' 442' ' ' VAL . 18.7 m -106.77 124.76 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.856 0.36 . . . . 72.13 110.988 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.46 ' HG3' HG23 ' A' ' 441' ' ' THR . 6.6 pttm -140.92 158.73 43.53 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.31 0.856 . . . . 65.24 113.31 -175.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.638 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.5 t-20 -107.94 128.7 54.86 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.677 -1.147 . . . . 63.34 109.468 175.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 86.4 mt -119.17 16.75 13.21 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.785 0.326 . . . . 75.21 111.86 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -100.81 -12.48 37.25 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.114 -0.565 . . . . 74.31 113.331 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.83 21.15 69.16 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 121.149 -0.548 . . . . 71.45 113.735 179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.496 HD12 ' HB2' ' A' ' 436' ' ' GLU . 3.7 tt -134.67 132.99 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 122.602 -0.352 . . . . 73.42 111.048 178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -66.43 134.61 33.37 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.367 -0.444 . . . . 72.33 113.679 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.94 116.06 16.82 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 122.562 0.345 . . . . 45.4 111.74 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.99 -11.21 12.42 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.117 2.544 . . . . 64.01 112.593 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . 0.425 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 50.8 m -80.65 11.78 3.58 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.043 0.757 . . . . 71.31 113.043 -174.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.1 m -88.61 95.12 10.12 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.951 0.882 . . . . 61.11 111.937 -169.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -106.5 126.54 52.39 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.24 -0.891 . . . . 74.23 110.558 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.612 HG21 HG11 ' A' ' 462' ' ' VAL . 44.6 t -106.8 122.98 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 O-C-N 122.3 -0.25 . . . . 73.41 111.614 -178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . 0.62 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 46.9 mtt180 -115.75 146.9 41.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.746 0.308 . . . . 54.22 111.339 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 77.9 t -121.6 121.86 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.917 0.389 . . . . 72.23 111.308 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -112.1 141.12 46.17 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.305 -0.407 . . . . 71.14 111.826 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.55 HG12 HG12 ' A' ' 513' ' ' ILE . 53.8 mt -124.24 111.77 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.552 -0.295 . . . . 74.52 110.811 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 52.77 34.83 17.15 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.532 0.567 . . . . 71.21 112.532 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 90.41 3.05 72.55 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 120.858 -0.686 . . . . 54.0 113.887 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.7 m -110.73 121.61 45.76 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.423 -0.457 . . . . 71.34 111.432 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.6 tp -64.17 114.8 4.44 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.923 0.392 . . . . 72.42 110.643 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -84.33 -45.09 13.15 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.492 -0.322 . . . . 64.13 111.673 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -171.27 159.25 5.71 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.786 0.327 . . . . 72.03 111.449 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -143.87 153.81 42.72 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.324 0.49 . . . . 73.43 112.324 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -129.56 149.53 51.28 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.083 -0.508 . . . . 65.42 110.864 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 91.2 m -114.46 119.46 36.96 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.768 0.318 . . . . 54.42 110.766 174.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.77 173.59 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.366 0.603 . . . . 64.31 111.747 -177.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.0 p -123.43 138.09 54.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.055 -0.52 . . . . 75.5 110.456 175.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.512 HD12 HD22 ' A' ' 440' ' ' LEU . 90.7 mt -117.54 119.06 33.87 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.736 0.303 . . . . 44.44 111.141 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -77.25 -171.6 35.85 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.208 -0.52 . . . . 73.24 112.994 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.09 100.63 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.378 2.052 . . . . 54.22 112.329 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.6 mttt 66.64 40.39 3.36 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.494 -0.775 . . . . 72.05 112.068 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -99.69 151.4 21.26 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.941 -0.572 . . . . 60.23 111.136 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -132.47 137.39 47.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.899 0.381 . . . . 64.13 111.419 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -120.03 146.54 45.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.506 -0.316 . . . . 73.24 110.262 176.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 49.1 t -113.79 115.04 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 120.929 0.395 . . . . 64.25 111.311 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 69.4 mt -107.39 130.81 54.76 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.415 -0.357 . . . . 71.02 111.438 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 51.5 p -113.86 150.75 33.13 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.221 0.534 . . . . 71.24 112.001 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 49.5 p90 -144.36 148.56 34.87 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.127 -0.488 . . . . 72.32 111.395 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 78.5 p -110.48 115.28 29.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.26 0.553 . . . . 60.21 110.957 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.2 t90 -112.36 136.88 51.28 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.288 -0.415 . . . . 74.31 111.363 -176.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.0 m -118.18 103.9 49.01 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.345 -0.389 . . . . 74.22 111.047 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . 0.418 ' HB2' HG11 ' A' ' 539' ' ' VAL . 98.4 Cg_endo -80.13 99.37 1.17 Allowed 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.708 2.272 . . . . 62.0 112.711 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.6 p -78.23 -12.83 60.03 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.589 0.589 . . . . 62.13 112.589 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -122.17 141.63 51.25 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.762 0.315 . . . . 64.14 110.884 174.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.87 151.86 31.56 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.179 0.514 . . . . 54.32 112.083 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 145.43 -173.51 25.8 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.043 -0.598 . . . . 61.32 113.175 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 511' ' ' TYR . 0.0 OUTLIER -90.63 133.8 34.86 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.014 0.435 . . . . 61.32 110.839 179.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . 0.462 ' N ' ' SD ' ' A' ' 510' ' ' MET . 96.0 m-85 -132.25 120.46 22.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.133 0.492 . . . . 73.24 111.791 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 479' ' ' ILE . 47.9 ttp85 -94.15 118.37 31.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.224 -0.444 . . . . 74.41 111.072 177.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.55 HG12 HG12 ' A' ' 479' ' ' ILE . 55.6 mt -103.9 126.03 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 120.985 0.421 . . . . 72.24 111.48 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -125.8 142.55 51.46 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.979 0.418 . . . . 61.22 111.681 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -119.09 133.56 55.72 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.261 -0.427 . . . . 64.5 110.758 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . 0.535 HG22 HG22 ' A' ' 532' ' ' VAL . 33.9 p -130.82 140.71 50.29 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.323 -0.398 . . . . 73.15 111.689 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.02 140.67 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 120.933 0.397 . . . . 71.33 111.226 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 39.7 t0 42.53 66.61 0.72 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.62 -0.718 . . . . 62.21 111.685 -174.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . 0.62 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.8 mm-40 -57.5 -31.94 66.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.0 -0.546 . . . . 74.03 111.293 173.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.43 ' HB2' HG23 ' A' ' 522' ' ' THR . 6.7 mm-40 -68.5 -25.78 65.13 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.85 -0.614 . . . . 74.23 110.761 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 56.59 63.85 1.84 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.808 0.813 . . . . 73.1 110.663 -175.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . 0.43 HG23 ' HB2' ' A' ' 520' ' ' GLU . 67.0 p -94.86 -15.66 23.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.503 -0.771 . . . . 64.44 111.892 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 11.5 p -118.68 142.53 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 120.665 0.269 . . . . 53.33 111.056 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . 0.403 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 50.4 t -82.68 121.04 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 120.847 0.356 . . . . 72.42 111.2 -178.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -100.96 159.31 15.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.068 -0.514 . . . . 62.02 112.285 -171.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 439' ' ' ASP . 94.4 mt -68.57 -33.5 74.18 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.961 0.41 . . . . 71.04 111.521 174.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -145.56 129.31 17.21 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.377 -0.374 . . . . 55.45 110.795 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -83.15 -24.93 32.33 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.177 0.513 . . . . 74.34 111.542 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -86.91 13.98 8.1 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.901 0.381 . . . . 71.32 111.453 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.514 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 62.7 t30 -106.82 -15.02 14.84 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.103 0.477 . . . . 74.14 111.001 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -73.19 -16.86 61.41 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.724 0.638 . . . . 70.21 112.724 -177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.535 HG22 HG22 ' A' ' 516' ' ' THR . 45.2 t -111.69 133.33 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.754 0.65 . . . . 72.34 112.754 -171.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -123.52 139.0 54.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.166 -0.47 . . . . 52.23 110.719 173.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 87.5 m -119.86 134.71 55.14 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.033 0.383 . . . . 54.12 112.033 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -139.8 136.54 34.17 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.868 0.366 . . . . 65.3 110.527 176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.63 133.32 50.57 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.09 0.472 . . . . 75.31 112.17 -176.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 64.0 t -124.74 141.21 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.286 -0.415 . . . . 71.42 111.65 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 47.9 t -118.19 117.54 29.43 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.472 -0.331 . . . . 25.42 110.679 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 505' ' ' PRO . 66.5 t -101.31 123.02 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.026 0.441 . . . . 61.43 111.801 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.42 167.79 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 116.023 -0.535 . . . . 75.25 112.248 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.03 10.33 16.83 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.914 0.387 . . . . 61.33 111.684 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 C--O 1.254 1.322 0 CA-C-N 116.304 -0.407 . . . . 71.54 112.086 -176.567 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 50.7 tpp . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 121.155 0.502 . . . . 70.24 109.982 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -89.08 141.65 28.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.175 -0.466 . . . . 71.51 111.857 -171.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -119.72 129.92 25.11 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.547 -0.297 . . . . 75.3 110.756 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.589 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 64.3 Cg_endo -72.41 173.65 12.82 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 122.493 2.129 . . . . 72.32 113.208 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -140.61 87.36 2.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.548 -0.538 . . . . 70.44 109.548 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.476 ' HB3' HG21 ' A' ' 517' ' ' VAL . 79.4 mt -90.58 137.9 31.99 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.092 -0.504 . . . . 75.44 111.364 -175.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.463 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.6 t -148.81 165.32 31.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.079 0.466 . . . . 64.22 112.014 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.604 HG12 HG12 ' A' ' 462' ' ' VAL . 27.5 m -133.72 149.19 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.83 -0.623 . . . . 74.13 111.569 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 6.5 mm-40 -130.99 129.76 42.51 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.229 -0.441 . . . . 72.11 111.519 176.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 50.1 mt -107.99 117.77 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 116.181 -0.463 . . . . 54.44 110.591 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -136.01 139.29 43.02 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.925 0.393 . . . . 75.22 111.73 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 164.66 -163.31 36.18 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 116.091 -0.504 . . . . 53.41 112.885 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.04 118.77 5.7 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.779 2.319 . . . . 64.14 113.027 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -86.74 -14.26 42.92 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.299 0.481 . . . . 64.51 112.299 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.0 t -128.87 117.85 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 O-C-N 122.146 -0.346 . . . . 61.41 110.704 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.94 164.21 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.241 0.543 . . . . 54.34 112.178 -177.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -96.46 163.48 22.85 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 116.195 -0.457 . . . . 44.41 112.998 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 8.7 p -71.53 140.05 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 120.861 0.362 . . . . 75.44 111.214 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 65.87 17.33 10.8 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.656 0.613 . . . . 71.45 112.656 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.6 mmmt -98.33 176.3 5.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.863 0.363 . . . . 72.13 111.457 176.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' A' ' 502' ' ' SER . 40.4 tp -115.28 130.14 56.82 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.747 0.308 . . . . 54.33 111.33 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -130.07 134.22 47.23 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.881 0.326 . . . . 73.22 111.881 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -106.3 128.31 53.89 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.108 0.48 . . . . 72.31 111.934 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -122.01 154.88 36.66 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.961 -0.563 . . . . 75.31 110.274 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.544 ' HG2' HG22 ' A' ' 500' ' ' THR . 54.8 mt-10 -120.34 127.74 52.62 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.899 0.38 . . . . 74.32 111.631 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 24.2 t -96.8 112.56 29.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.008 -0.542 . . . . 64.2 109.651 169.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 35.2 m-70 -94.13 108.95 20.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.832 0.348 . . . . 72.12 110.39 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.812 HG11 HG21 ' A' ' 475' ' ' VAL . 14.4 m -106.1 126.88 61.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.03 -0.532 . . . . 63.34 110.079 -176.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.544 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.7 ptpt -144.03 148.92 35.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.791 0.663 . . . . 74.51 112.791 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -105.91 127.42 53.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.273 -0.876 . . . . 52.02 109.314 174.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.544 HD21 ' HD3' ' A' ' 463' ' ' LYS . 73.5 mt -118.05 8.7 12.52 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.825 0.306 . . . . 74.11 111.825 -177.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -87.87 -16.16 60.13 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.247 -0.501 . . . . 75.01 113.769 -177.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 83.0 17.17 67.99 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 120.911 -0.661 . . . . 51.15 113.468 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 2.4 tt -134.66 135.58 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 122.909 0.484 . . . . 71.24 111.035 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.496 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -70.95 132.62 21.91 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 121.474 -0.393 . . . . 70.5 113.701 -176.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 62.6 t -128.23 114.0 19.97 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 111.984 0.364 . . . . 64.23 111.984 -178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.87 -9.84 11.85 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 123.091 2.527 . . . . 73.1 112.739 174.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . 0.466 ' HB3' ' OG1' ' A' ' 522' ' ' THR . 39.0 m -80.87 10.6 4.81 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.688 0.996 . . . . 65.34 113.688 -171.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . 0.421 HG23 HG23 ' A' ' 517' ' ' VAL . 94.3 m -88.14 100.59 13.07 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.86 0.838 . . . . 72.32 112.629 -166.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -114.4 117.54 31.31 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.291 -0.868 . . . . 73.41 110.746 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.812 HG21 HG11 ' A' ' 462' ' ' VAL . 45.3 t -104.17 132.72 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.063 0.394 . . . . 71.15 112.063 -173.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . 0.692 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 93.7 mtt180 -114.47 152.42 31.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.965 0.412 . . . . 64.44 111.832 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 82.5 t -122.43 126.27 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.056 -0.52 . . . . 75.44 111.008 173.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 513' ' ' ILE . 95.3 m-85 -115.47 138.83 50.61 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.851 0.357 . . . . 74.15 111.775 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 64.2 mt -115.0 107.93 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.954 -0.387 . . . . 54.14 109.954 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 55.94 34.76 24.23 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.088 0.47 . . . . 73.32 111.708 -173.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.13 -6.64 83.26 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 121.344 -0.455 . . . . 55.3 113.693 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.0 m -92.38 124.8 36.7 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 122.388 -0.478 . . . . 74.2 111.31 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 52.6 tp -63.42 122.6 16.64 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 121.177 0.513 . . . . 54.33 111.579 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -101.97 -45.37 5.21 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.098 -0.501 . . . . 70.25 112.187 -178.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.474 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 33.6 ttpt -171.01 160.09 6.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.242 0.217 . . . . 71.54 110.869 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.31 154.16 38.58 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.832 0.349 . . . . 53.55 111.863 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . 0.474 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 19.3 m-90 -129.83 147.22 51.58 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.313 -0.403 . . . . 74.24 111.362 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 34.6 m -110.28 118.57 36.69 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 110.326 -0.25 . . . . 72.02 110.326 173.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.56 172.17 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.49 0.662 . . . . 70.3 111.858 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 77.6 p -120.0 133.42 55.55 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.887 -0.597 . . . . 53.52 110.955 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.9 mt -118.48 118.93 33.06 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.861 0.362 . . . . 72.13 111.31 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.496 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -82.21 -166.39 37.95 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.164 -0.541 . . . . 63.53 113.62 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.98 105.87 0.49 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.622 2.215 . . . . 63.41 112.518 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 35.5 mmtp 67.46 30.97 6.57 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.114 0.483 . . . . 72.1 111.573 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -94.33 149.45 21.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.325 -0.398 . . . . 45.03 111.97 -177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 463' ' ' LYS . 32.7 tt0 -134.58 139.1 45.12 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.004 0.431 . . . . 74.42 111.554 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -125.67 140.65 52.53 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.325 -0.398 . . . . 75.54 110.273 174.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.32 117.37 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 120.894 0.378 . . . . 74.12 111.428 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.53 138.96 41.75 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.35 -0.386 . . . . 62.34 110.698 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.544 HG22 ' HG2' ' A' ' 459' ' ' GLU . 42.6 p -120.55 155.46 33.62 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.349 0.595 . . . . 65.45 112.125 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -152.29 148.28 27.35 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.688 -0.687 . . . . 75.35 110.831 170.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.533 ' HB2' HD11 ' A' ' 455' ' ' LEU . 20.4 p -117.19 114.96 24.41 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.156 0.503 . . . . 61.34 110.949 -178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -109.06 136.7 48.14 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.217 -0.447 . . . . 73.02 111.9 -175.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 87.9 m -113.24 101.32 53.34 Favored Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.974 175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 61.1 Cg_endo -72.38 88.48 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.472 2.115 . . . . 71.44 112.925 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 34.2 p -75.67 6.73 4.48 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.786 0.662 . . . . 54.44 112.786 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -143.5 135.75 26.96 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 110.483 -0.192 . . . . 63.01 110.483 176.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.76 151.32 37.61 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.092 0.472 . . . . 71.42 112.238 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.95 -169.08 28.09 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.16 -0.543 . . . . 62.31 113.064 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 12.5 tpt -99.46 124.53 44.7 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.733 0.301 . . . . 63.24 110.859 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -128.32 111.95 13.92 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.179 0.514 . . . . 75.42 111.688 -178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 32.8 ttm180 -94.66 120.82 35.48 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.119 -0.492 . . . . 75.12 111.141 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 478' ' ' TYR . 67.6 mt -95.41 126.05 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.087 0.47 . . . . 73.51 111.523 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -124.95 129.15 49.78 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.289 -0.414 . . . . 74.3 111.324 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -112.3 146.3 38.48 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.846 0.355 . . . . 55.21 111.326 178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . 0.525 HG22 HG22 ' A' ' 532' ' ' VAL . 76.4 p -130.19 140.92 50.7 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.18 -0.464 . . . . 75.02 111.011 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' ' 442' ' ' VAL . 7.4 p -100.51 138.42 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 110.207 -0.294 . . . . 63.34 110.207 174.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.5 t0 35.46 71.58 0.12 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.604 0.716 . . . . 64.31 110.961 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . 0.692 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 5.4 tm-20 -51.29 -45.52 62.16 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.098 -0.955 . . . . 55.23 111.71 -176.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -69.72 -17.29 63.45 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.411 -0.359 . . . . 62.31 111.49 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 51.51 79.36 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.798 0.809 . . . . 54.31 111.394 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 472' ' ' SER . 81.9 p -97.34 2.59 50.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.156 -0.929 . . . . 62.32 110.861 178.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.0 p -139.57 142.03 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.832 -0.622 . . . . 63.33 110.51 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.58 116.02 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.782 0.325 . . . . 72.23 111.847 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -92.59 170.33 9.82 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.349 0.595 . . . . 65.44 111.903 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -68.48 -29.25 67.83 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.853 -0.612 . . . . 75.13 111.978 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -141.38 128.33 20.64 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.773 0.32 . . . . 74.24 111.42 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -83.75 -24.17 31.24 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.131 0.491 . . . . 64.11 111.643 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -79.76 4.32 16.72 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.659 0.742 . . . . 62.21 110.767 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.463 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 56.0 t30 -92.16 -20.16 21.52 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.878 -0.601 . . . . 62.1 111.553 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . 0.459 ' HA ' HG12 ' A' ' 517' ' ' VAL . 12.9 m120 -72.8 -25.48 61.17 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.922 1.082 . . . . 72.44 113.922 -172.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 516' ' ' THR . 42.9 t -109.32 143.37 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.922 0.712 . . . . 75.42 112.922 -172.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -129.95 142.81 50.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.172 -0.467 . . . . 43.44 111.043 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 72.4 m -118.9 129.24 55.08 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.134 0.42 . . . . 74.13 112.134 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -143.17 117.67 9.73 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.648 0.261 . . . . 74.34 110.849 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 10.3 p-10 -93.42 137.78 32.38 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.246 0.461 . . . . 63.42 112.246 -177.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 56.1 t -125.95 134.56 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.392 -0.367 . . . . 74.45 111.672 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 45.5 t -104.08 126.26 51.05 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.56 -0.291 . . . . 72.35 111.297 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.12 121.93 62.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.975 0.416 . . . . 65.05 111.465 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.9 m -111.83 161.74 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.367 0.506 . . . . 75.24 112.367 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 86.7 mt -82.66 16.92 1.97 Allowed 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.264 0.468 . . . . 70.31 112.264 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 119.324 -0.37 . . . . 75.35 111.83 -179.705 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 47.3 ttm . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.033 0.444 . . . . 74.33 111.222 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -97.97 138.64 34.99 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.824 0.345 . . . . 63.41 111.136 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -113.04 131.65 22.72 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.376 -0.375 . . . . 75.51 110.935 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 64.7 Cg_endo -74.91 173.39 14.55 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 122.434 2.09 . . . . 65.2 113.474 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -157.2 94.08 1.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.369 -0.832 . . . . 61.23 109.447 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.555 HD22 HD12 ' A' ' 491' ' ' LEU . 53.4 mt -98.26 114.54 26.84 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.045 0.45 . . . . 53.23 111.382 -175.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.527 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 11.9 t -122.67 150.6 42.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.179 0.514 . . . . 72.2 112.116 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.552 HG12 HG12 ' A' ' 462' ' ' VAL . 28.8 m -121.31 148.88 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.064 -0.516 . . . . 74.44 111.286 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 45.9 mt-10 -136.83 143.18 42.97 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.655 -0.248 . . . . 71.42 110.911 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 57.7 mt -120.39 135.5 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 120.974 0.416 . . . . 64.12 111.599 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -137.23 147.05 45.53 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.29 -0.414 . . . . 54.54 110.652 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 160.51 -166.46 35.37 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.676 -0.774 . . . . 72.53 113.489 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.9 132.55 24.99 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.985 2.456 . . . . 74.54 113.491 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -78.66 -43.51 25.94 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.14 -0.482 . . . . 73.41 112.173 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.433 HG22 ' HB3' ' A' ' 538' ' ' SER . 44.1 t -123.7 129.78 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.767 0.318 . . . . 43.33 111.082 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.47 163.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.147 0.498 . . . . 62.33 111.74 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -95.25 162.89 23.9 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.279 -0.486 . . . . 62.31 113.196 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.546 HG22 ' ND2' ' A' ' 453' ' ' ASN . 12.9 p -67.65 136.18 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 121.228 0.537 . . . . 75.35 111.625 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . 0.546 ' ND2' HG22 ' A' ' 452' ' ' VAL . 51.7 m-80 65.2 14.75 9.61 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.858 -0.61 . . . . 73.33 112.479 -177.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.503 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 30.2 mmmt -97.07 153.84 17.7 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.068 0.461 . . . . 74.11 111.645 178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.572 HD11 ' HB2' ' A' ' 502' ' ' SER . 46.3 tp -90.19 138.79 31.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.019 0.438 . . . . 71.23 111.569 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -135.86 133.02 37.33 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.824 0.345 . . . . 73.32 111.656 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -109.45 134.58 51.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.849 0.357 . . . . 72.31 111.657 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -125.53 154.62 41.85 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.28 -0.418 . . . . 60.1 111.176 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -119.59 127.75 53.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.159 0.504 . . . . 75.31 110.719 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 39.8 t -105.54 115.34 47.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.997 -0.547 . . . . 73.13 110.949 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.595 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 27.1 m-70 -92.6 105.34 17.52 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.654 0.264 . . . . 71.04 110.643 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.552 HG12 HG12 ' A' ' 442' ' ' VAL . 33.8 m -106.24 122.74 60.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-O 121.075 0.464 . . . . 71.31 110.178 177.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -139.09 153.09 47.98 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.84 0.682 . . . . 74.04 112.84 -173.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 53.4 t-20 -106.1 128.64 54.02 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.256 -0.883 . . . . 71.2 110.025 176.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 90.7 mt -113.83 -2.42 13.65 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.023 0.379 . . . . 63.2 112.023 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -81.17 -16.44 74.38 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.247 -0.501 . . . . 54.14 113.884 -177.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 78.42 21.89 68.74 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.077 -0.582 . . . . 73.02 113.737 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 3.2 tt -137.68 133.3 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.577 0.351 . . . . 73.42 111.405 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 491' ' ' LEU . . . -71.36 134.54 22.9 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 114.214 0.445 . . . . 74.0 114.214 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 50.7 t -131.14 114.54 16.21 Favored Pre-proline 0 CA--C 1.547 0.833 0 O-C-N 122.585 -0.362 . . . . 62.21 111.663 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -83.93 -10.24 9.41 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.151 2.567 . . . . 75.44 113.004 173.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 20.3 t -81.95 11.83 4.69 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.548 0.739 . . . . 64.1 112.328 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.2 m -88.82 97.39 11.13 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.719 0.771 . . . . 54.33 112.27 -167.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -101.87 130.63 48.39 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.357 -0.838 . . . . 70.34 110.66 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.485 HG21 HG11 ' A' ' 462' ' ' VAL . 60.4 t -115.37 133.41 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 122.793 0.437 . . . . 75.54 111.058 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . 0.503 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 90.6 mtt180 -126.66 149.04 49.75 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.828 0.347 . . . . 74.12 111.557 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.28 120.54 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.466 -0.334 . . . . 73.21 111.182 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -112.46 139.02 48.38 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.987 0.422 . . . . 74.21 111.699 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.524 HG12 HG12 ' A' ' 513' ' ' ILE . 54.0 mt -114.13 107.58 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 109.855 -0.424 . . . . 73.23 109.855 172.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . 0.436 HD21 ' HA ' ' A' ' 511' ' ' TYR . 94.6 m-20 54.57 34.47 21.36 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.262 -0.426 . . . . 73.25 112.04 -175.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 103.29 -30.06 11.12 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.125 -0.56 . . . . 72.23 113.75 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 88.9 m -82.35 125.47 31.05 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.42 -0.459 . . . . 44.22 112.004 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.0 tp -65.57 115.73 6.08 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.01 0.433 . . . . 60.35 111.319 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -82.67 -44.14 16.07 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.355 -0.384 . . . . 72.31 111.38 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.427 ' HE3' ' CZ2' ' A' ' 487' ' ' TRP . 32.6 ttpt -170.38 157.83 6.28 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.672 -0.24 . . . . 75.31 110.876 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . 0.407 ' HB2' ' HG2' ' A' ' 476' ' ' ARG . 6.6 p30 -137.38 156.69 47.91 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.095 0.474 . . . . 72.42 111.945 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . 0.427 ' CZ2' ' HE3' ' A' ' 485' ' ' LYS . 18.2 m-90 -137.3 149.12 46.85 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.118 -0.492 . . . . 75.52 110.79 177.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 89.6 m -121.54 119.24 31.4 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 110.057 -0.349 . . . . 61.13 110.057 174.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 27.0 m -139.83 172.74 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.369 0.604 . . . . 75.25 112.115 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.7 p -115.1 133.88 55.65 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.925 -0.579 . . . . 54.52 110.474 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.555 HD12 HD22 ' A' ' 440' ' ' LEU . 73.5 mt -116.75 120.43 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.858 0.361 . . . . 63.23 111.098 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.47 -173.88 48.54 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.163 -0.541 . . . . 72.55 113.264 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.9 99.53 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.532 2.155 . . . . 74.12 112.484 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 98.0 mttt 67.57 50.45 0.91 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.918 -0.583 . . . . 51.23 111.796 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -110.39 148.36 32.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.516 -0.765 . . . . 60.52 111.27 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -130.04 136.87 49.87 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.058 0.456 . . . . 75.11 111.444 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -118.87 135.63 54.46 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.544 -0.539 . . . . 64.24 109.544 173.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 89.9 t -100.96 113.12 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.266 0.555 . . . . 73.14 111.116 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 63.6 mt -105.82 126.68 52.45 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.844 -0.616 . . . . 71.51 110.711 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 22.1 p -112.3 154.36 25.78 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.317 0.579 . . . . 62.44 111.909 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -145.64 148.9 33.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.608 -0.724 . . . . 72.43 110.701 175.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.572 ' HB2' HD11 ' A' ' 455' ' ' LEU . 24.0 p -110.24 113.75 26.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.308 0.575 . . . . 64.13 110.642 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -110.48 137.12 48.6 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.865 -0.607 . . . . 73.23 111.192 -175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 36.5 m -122.65 100.3 41.17 Favored Pre-proline 0 N--CA 1.472 0.636 0 CA-C-N 116.475 -0.329 . . . . 73.55 111.073 178.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.3 Cg_endo -76.52 106.8 2.32 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.318 2.012 . . . . 63.34 112.638 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 64.4 p -89.08 -5.88 57.5 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.817 0.342 . . . . 73.54 111.913 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -125.68 136.04 52.79 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.605 -0.27 . . . . 73.42 110.9 177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -73.34 151.08 41.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.936 0.398 . . . . 74.25 111.93 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 149.8 178.33 24.65 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.223 -0.513 . . . . 54.24 112.913 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 14.4 tpt -92.74 114.58 27.17 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.877 0.37 . . . . 73.13 111.061 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . 0.436 ' HA ' HD21 ' A' ' 480' ' ' ASN . 75.3 m-85 -111.22 144.9 39.64 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.678 0.275 . . . . 74.25 111.447 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . 0.471 ' HG2' ' OD1' ' A' ' 514' ' ' ASN . 16.2 ttm180 -123.19 115.45 21.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.735 0.302 . . . . 75.22 111.075 176.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.524 HG12 HG12 ' A' ' 479' ' ' ILE . 59.9 mt -96.05 113.7 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.135 -0.484 . . . . 75.4 111.21 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.471 ' OD1' ' HG2' ' A' ' 512' ' ' ARG . 4.0 m-20 -118.91 145.79 45.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.405 -0.361 . . . . 73.13 111.469 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 532' ' ' VAL . . . -115.48 145.15 42.87 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.779 0.324 . . . . 71.03 111.274 177.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . 0.555 HG22 HG22 ' A' ' 532' ' ' VAL . 58.9 p -132.82 148.76 52.31 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.183 -0.462 . . . . 65.34 111.643 -178.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.23 152.69 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 120.756 0.312 . . . . 65.24 111.243 175.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 35.8 t70 54.72 39.99 31.65 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.702 0.763 . . . . 75.13 111.369 -176.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . 0.503 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 8.5 mm-40 -52.6 -31.6 37.16 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.802 -0.636 . . . . 75.24 111.315 172.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.452 ' HB2' HG23 ' A' ' 522' ' ' THR . 4.2 mm-40 -67.67 -25.39 65.68 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.732 -0.667 . . . . 72.32 111.153 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.6 m120 59.31 71.92 0.56 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.419 0.628 . . . . 74.1 110.614 -176.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . 0.452 HG23 ' HB2' ' A' ' 520' ' ' GLU . 82.6 p -107.41 -32.89 7.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.581 -0.736 . . . . 75.11 112.355 -174.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.441 HG21 ' HG3' ' A' ' 438' ' ' PRO . 14.4 p -124.37 143.31 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.589 0.588 . . . . 64.21 112.589 -172.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 58.5 t -83.3 111.69 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.45 -0.341 . . . . 73.42 110.716 176.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -99.73 -179.49 4.2 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.427 0.528 . . . . 74.45 112.427 -175.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 91.0 mt -80.58 -41.08 24.66 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.251 -0.431 . . . . 54.21 111.552 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -130.31 98.49 4.73 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.124 0.488 . . . . 53.44 111.006 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -84.3 10.19 11.14 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.274 0.559 . . . . 71.14 111.502 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -108.16 0.62 21.66 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.467 0.651 . . . . 73.42 110.131 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.527 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 64.4 t30 -95.54 -0.84 51.64 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.85 -0.614 . . . . 74.13 111.551 -174.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -81.95 -19.25 41.06 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.424 0.898 . . . . 74.42 113.424 -171.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.555 HG22 HG22 ' A' ' 516' ' ' THR . 39.9 t -112.42 141.19 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 112.365 0.506 . . . . 74.54 112.365 -174.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -132.49 135.52 46.07 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.597 -0.274 . . . . 64.21 111.439 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 30.6 m -106.53 134.91 48.95 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.472 0.545 . . . . 72.32 112.472 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -142.99 117.5 9.72 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.174 -0.467 . . . . 73.42 110.28 172.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.34 137.45 33.47 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.253 0.549 . . . . 70.33 112.155 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 49.0 t -126.21 130.64 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-N 115.95 -0.568 . . . . 63.41 111.518 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . 0.433 ' HB3' HG22 ' A' ' 449' ' ' VAL . 41.3 t -96.97 117.97 32.34 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.527 -0.306 . . . . 70.33 111.351 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.406 HG11 ' HB2' ' A' ' 505' ' ' PRO . 61.8 t -105.95 120.47 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.935 0.398 . . . . 73.31 111.077 178.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.58 166.54 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 112.498 0.555 . . . . 72.54 112.498 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.87 -12.3 55.72 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.177 0.436 . . . . 72.34 112.177 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--O 1.252 1.206 0 N-CA-C 112.513 0.56 . . . . 55.12 112.513 178.748 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 50.8 tpp . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.192 0.52 . . . . 52.14 110.23 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -92.25 126.34 37.3 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.965 -0.561 . . . . 74.13 112.063 -171.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -112.62 124.27 32.21 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.034 -0.53 . . . . 71.34 110.146 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.612 ' HG2' ' HG2' ' A' ' 525' ' ' GLU . 56.9 Cg_endo -72.16 174.41 11.44 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.269 1.979 . . . . 73.24 112.92 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -154.06 80.29 1.13 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.365 0.602 . . . . 73.13 110.041 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.468 HD22 HD12 ' A' ' 491' ' ' LEU . 61.1 mt -80.05 116.54 20.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.953 -0.567 . . . . 65.33 111.596 -177.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.419 ' HB ' HD22 ' A' ' 530' ' ' ASN . 8.1 t -126.38 153.53 44.82 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.859 0.361 . . . . 72.44 111.096 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.571 HG12 HG12 ' A' ' 462' ' ' VAL . 21.0 m -131.84 149.58 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.193 0.52 . . . . 71.31 112.358 -176.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 49.4 mt-10 -128.47 144.03 51.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.883 -0.599 . . . . 72.11 110.843 175.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.402 HD13 HG22 ' A' ' 513' ' ' ILE . 65.8 mt -114.75 132.73 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 120.635 0.255 . . . . 65.31 110.766 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -132.81 145.87 51.35 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.579 0.228 . . . . 63.41 110.929 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.77 -173.66 36.51 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.672 -0.775 . . . . 74.21 113.752 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.62 126.43 12.09 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.991 2.461 . . . . 71.3 112.993 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -76.37 -21.47 56.04 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.153 -0.476 . . . . 63.23 112.218 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.6 t -131.0 128.82 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.754 0.312 . . . . 74.33 111.09 176.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.78 156.41 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 120.997 0.427 . . . . 75.51 111.682 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.34 154.57 24.37 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.319 -0.467 . . . . 64.0 113.25 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 11.7 p -65.62 141.46 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-O 120.889 0.376 . . . . 75.32 111.781 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 55.3 m-20 65.53 8.54 5.15 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.257 0.623 . . . . 55.02 112.272 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.555 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 31.3 mmmt -96.13 167.15 11.38 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.943 0.402 . . . . 51.44 111.473 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' A' ' 502' ' ' SER . 33.4 tp -103.81 134.06 47.75 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.68 0.276 . . . . 62.2 111.35 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -133.57 140.13 46.98 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.799 0.333 . . . . 75.32 111.774 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -100.53 138.15 37.98 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.907 0.384 . . . . 74.22 111.595 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -129.66 155.15 46.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.943 0.401 . . . . 70.3 111.084 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -119.73 127.55 52.94 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.096 -0.502 . . . . 55.31 111.379 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 29.9 t -104.54 113.01 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.271 -0.422 . . . . 71.4 110.046 171.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 41.9 m-70 -94.81 105.13 17.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.519 -0.31 . . . . 73.04 110.31 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.636 HG11 HG21 ' A' ' 475' ' ' VAL . 26.4 m -106.14 126.02 61.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.087 0.47 . . . . 72.31 110.346 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.454 ' HD3' HD21 ' A' ' 465' ' ' LEU . 15.8 ptpt -146.69 157.32 43.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.297 0.57 . . . . 71.04 112.315 -175.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.1 t-20 -114.32 127.17 55.73 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.552 -0.749 . . . . 62.41 109.662 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.454 HD21 ' HD3' ' A' ' 463' ' ' LYS . 85.2 mt -113.28 0.91 14.99 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.843 0.354 . . . . 73.41 111.844 -177.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -76.99 -19.44 77.46 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.039 -0.6 . . . . 54.44 113.32 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 88.16 13.31 64.21 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.319 -0.467 . . . . 73.31 113.87 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 4.7 tt -137.35 133.26 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 122.575 0.35 . . . . 72.42 110.651 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.38 137.77 20.17 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.775 0.67 . . . . 71.21 114.775 -173.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 46.8 t -123.76 113.19 28.74 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 122.76 0.424 . . . . 53.42 111.184 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.78 -10.79 9.34 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.93 2.42 . . . . 43.52 112.807 175.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 29.0 t -83.28 11.21 6.95 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.229 0.612 . . . . 73.14 112.467 -176.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 97.6 m -90.17 113.55 25.34 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.093 0.775 . . . . 74.44 113.093 -166.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -103.89 131.24 51.3 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.964 -0.562 . . . . 73.22 111.617 174.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.636 HG21 HG11 ' A' ' 462' ' ' VAL . 53.7 t -110.36 130.58 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 122.885 0.474 . . . . 61.44 111.264 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . 0.693 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 68.2 mtt180 -125.97 152.54 45.55 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.133 0.492 . . . . 75.12 111.755 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 75.9 t -120.89 128.75 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.117 -0.492 . . . . 51.4 110.818 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -118.68 136.52 53.88 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.835 0.35 . . . . 55.01 111.569 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 66.2 mt -108.1 108.05 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.965 -0.383 . . . . 73.04 109.965 173.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 56.68 33.64 23.19 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.099 0.476 . . . . 72.14 111.413 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 99.71 -26.56 23.95 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.409 -0.424 . . . . 43.5 113.76 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 86.1 m -81.88 129.72 34.84 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 117.078 0.439 . . . . 71.25 111.727 -177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 54.8 tp -65.65 121.36 14.8 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.199 0.523 . . . . 75.33 111.831 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -92.75 -43.79 8.86 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.791 -0.641 . . . . 72.15 111.686 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -161.77 154.5 20.27 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.69 -0.232 . . . . 72.53 110.826 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.62 147.87 47.16 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.362 0.504 . . . . 61.23 112.362 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -133.23 146.79 51.77 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.04 -0.527 . . . . 74.41 110.844 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.2 m -115.0 118.74 34.27 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.9 -0.408 . . . . 74.34 109.9 169.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.37 172.5 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.576 0.703 . . . . 63.31 112.471 -172.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 87.2 p -116.06 134.01 55.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.649 -0.705 . . . . 71.3 110.594 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.468 HD12 HD22 ' A' ' 440' ' ' LEU . 92.6 mt -124.41 119.18 28.47 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.814 0.34 . . . . 72.01 111.066 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.07 -174.08 48.43 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.126 -0.488 . . . . 53.45 113.622 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.68 106.07 0.58 Allowed 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.619 2.213 . . . . 45.14 112.416 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.9 mttt 66.25 36.23 5.55 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.364 0.602 . . . . 75.4 111.653 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -95.85 142.77 27.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.757 -0.656 . . . . 64.33 111.165 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -128.15 133.56 48.96 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.915 0.388 . . . . 73.41 111.416 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -126.74 134.2 50.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.281 -0.418 . . . . 55.42 111.208 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 51.3 t -102.61 113.08 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.047 0.451 . . . . 52.34 111.414 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 57.5 mt -104.05 126.57 51.27 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.231 -0.441 . . . . 63.15 110.323 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 32.9 p -113.46 151.09 31.88 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.356 0.598 . . . . 75.41 112.361 -177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -146.58 148.99 32.69 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.635 -0.711 . . . . 71.44 110.875 175.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.487 ' HB2' HD11 ' A' ' 455' ' ' LEU . 86.1 p -110.19 115.55 29.92 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.324 0.583 . . . . 74.12 110.669 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -107.82 137.23 46.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.983 -0.553 . . . . 71.53 111.757 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 86.0 m -109.05 101.37 44.5 Favored Pre-proline 0 N--CA 1.471 0.578 0 CA-C-N 116.298 -0.41 . . . . 74.13 111.307 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . 0.555 ' HD2' ' O ' ' A' ' 454' ' ' LYS . 73.9 Cg_endo -75.56 92.19 1.03 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.324 2.016 . . . . 62.01 112.722 177.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 40.0 p -82.38 12.32 4.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.275 0.472 . . . . 52.14 112.275 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -143.56 130.99 21.0 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.406 -0.361 . . . . 72.13 110.644 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.1 150.87 33.63 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.498 0.555 . . . . 71.34 112.498 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 143.13 -170.2 25.46 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.817 -0.706 . . . . 72.02 113.94 177.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.85 117.13 28.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.776 0.43 . . . . 72.51 111.033 178.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -119.02 143.28 47.16 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.059 0.457 . . . . 73.42 111.347 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 536' ' ' ASP . 57.5 ttp180 -123.52 120.16 32.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.562 -0.29 . . . . 71.52 110.748 177.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.402 HG22 HD13 ' A' ' 444' ' ' ILE . 62.6 mt -95.07 120.45 44.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 73.2 110.755 178.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 533' ' ' ALA . 18.2 m120 -118.92 132.98 56.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.311 -0.404 . . . . 63.41 111.093 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.8 137.39 49.8 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.8 0.333 . . . . 73.03 110.774 175.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . 0.569 HG22 HG22 ' A' ' 532' ' ' VAL . 39.7 p -122.81 140.37 52.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.017 -0.538 . . . . 73.51 110.936 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 440' ' ' LEU . 14.9 p -115.53 141.69 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.538 -0.301 . . . . 72.35 111.353 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.1 t70 48.1 58.58 4.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.946 0.879 . . . . 72.14 110.199 -170.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . 0.693 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 2.6 mm-40 -55.33 -32.89 62.86 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.925 -1.034 . . . . 73.23 113.172 -176.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -77.22 -12.55 59.96 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.541 0.21 . . . . 60.14 111.493 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 54.63 69.75 0.69 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.687 0.756 . . . . 64.11 110.847 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 80.4 p -100.3 -7.0 25.05 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.234 -0.894 . . . . 72.13 112.01 -174.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.3 p -140.12 142.01 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.954 0.407 . . . . 72.45 111.926 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 80.3 t -83.89 118.87 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.477 -0.329 . . . . 64.14 110.523 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.612 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 19.7 mt-10 -110.71 174.62 5.78 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.044 0.757 . . . . 73.33 113.044 -173.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 94.8 mt -64.32 -39.36 93.74 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.771 -0.65 . . . . 64.33 112.304 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -145.15 108.62 4.64 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.895 0.379 . . . . 62.25 111.325 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . 0.468 ' HA ' ' OD1' ' A' ' 531' ' ' ASN . 12.6 pt-20 -83.68 21.84 1.19 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.979 0.419 . . . . 73.24 111.796 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -107.49 -19.19 13.64 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.453 0.538 . . . . 71.34 112.453 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.419 HD22 ' HB ' ' A' ' 441' ' ' THR . 1.9 p-10 -99.71 12.73 35.86 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 112.571 0.582 . . . . 54.44 112.571 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 528' ' ' GLU . 15.0 m120 -77.79 -5.02 49.38 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.325 0.491 . . . . 62.44 112.325 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.569 HG22 HG22 ' A' ' 516' ' ' THR . 41.2 t -127.94 133.25 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 120.901 0.382 . . . . 72.12 111.639 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 514' ' ' ASN . . . -114.33 141.81 47.13 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.546 -0.297 . . . . 65.31 111.057 176.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 52.4 m -122.67 122.33 38.54 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.205 0.446 . . . . 54.55 112.205 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -137.74 117.16 12.82 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.286 -0.415 . . . . 74.23 110.041 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . 0.49 ' HA ' ' HA ' ' A' ' 512' ' ' ARG . 1.1 p30 -97.88 136.32 38.35 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.511 0.672 . . . . 75.32 112.302 -177.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.59 142.1 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 115.317 -0.856 . . . . 64.24 111.515 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.5 t -104.05 123.31 46.99 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.161 -0.472 . . . . 72.34 110.977 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 50.6 t -103.15 120.72 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.767 0.317 . . . . 72.51 111.373 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.7 m -114.36 159.55 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.269 0.557 . . . . 72.52 112.194 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 90.2 mt -82.36 0.21 42.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.123 -0.489 . . . . 71.34 112.192 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 C--O 1.251 1.147 0 N-CA-C 112.471 0.545 . . . . 73.44 112.471 -174.472 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.598 0.237 . . . . 71.52 110.96 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -86.6 124.68 33.16 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.808 0.337 . . . . 55.04 110.928 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 438' ' ' PRO . 97.6 m-85 -114.11 144.34 31.43 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.398 -0.364 . . . . 71.31 110.891 177.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.567 ' HA ' ' HA3' ' A' ' 466' ' ' GLY . 2.8 Cg_exo -74.99 174.41 12.83 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.014 2.476 . . . . 60.23 113.69 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -154.85 81.64 1.09 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.296 -0.866 . . . . 75.15 109.003 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.513 HD11 HG11 ' A' ' 470' ' ' VAL . 69.5 mt -86.72 127.94 34.99 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.857 -0.611 . . . . 73.22 111.811 -173.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.603 ' HB ' ' ND2' ' A' ' 530' ' ' ASN . 10.5 t -130.48 156.28 45.05 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.046 0.45 . . . . 73.43 111.762 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.636 HG12 HG12 ' A' ' 462' ' ' VAL . 31.6 m -132.8 147.78 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.972 -0.558 . . . . 74.43 111.586 -177.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 54.9 mt-10 -133.04 139.64 47.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.453 -0.34 . . . . 74.52 111.151 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 58.4 mt -109.21 129.22 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.972 0.415 . . . . 74.0 111.472 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -131.28 131.0 43.54 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.508 -0.315 . . . . 64.45 111.335 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 167.11 -168.49 40.42 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.486 -0.864 . . . . 74.34 113.871 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.52 122.8 7.67 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.802 2.335 . . . . 54.32 113.179 -179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -70.72 -33.19 70.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.234 -0.439 . . . . 75.22 111.501 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 57.3 t -120.83 132.01 71.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.775 0.321 . . . . 52.4 111.267 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.2 m -132.56 163.29 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.112 0.482 . . . . 55.34 111.712 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -94.71 149.49 19.38 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.234 -0.508 . . . . 71.54 112.849 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.504 HG22 ' ND2' ' A' ' 453' ' ' ASN . 11.2 p -63.28 137.46 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 CA-C-O 120.906 0.384 . . . . 42.34 111.829 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . 0.504 ' ND2' HG22 ' A' ' 452' ' ' VAL . 55.4 m-80 62.07 25.23 15.11 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.996 0.519 . . . . 64.41 112.392 -178.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -111.73 162.46 15.2 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.964 0.411 . . . . 72.15 111.577 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 502' ' ' SER . 50.6 tp -90.5 128.04 36.42 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.843 0.354 . . . . 73.31 111.583 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.33 143.05 49.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.793 0.33 . . . . 72.33 111.38 177.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -122.74 144.51 49.11 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.945 0.402 . . . . 44.14 111.491 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -132.05 157.55 43.86 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.007 0.432 . . . . 55.31 111.296 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -120.52 127.74 52.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.858 -0.61 . . . . 75.12 110.738 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 35.7 t -109.95 116.13 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.37 -0.377 . . . . 64.21 111.319 -179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 30.2 m-70 -93.22 113.98 26.33 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.399 -0.364 . . . . 63.23 110.652 175.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.638 HG11 HG21 ' A' ' 475' ' ' VAL . 17.8 m -116.08 122.42 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.781 0.324 . . . . 52.12 110.751 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 496' ' ' GLU . 0.7 OUTLIER -139.93 154.47 47.23 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.064 0.765 . . . . 74.01 113.064 -176.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.542 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 52.4 t-20 -103.03 128.6 49.82 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.119 -0.946 . . . . 70.23 110.386 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.421 HD21 ' HD3' ' A' ' 463' ' ' LYS . 88.6 mt -115.32 4.87 14.52 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.078 0.399 . . . . 73.0 112.078 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -85.75 -23.86 44.52 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.248 -0.501 . . . . 71.21 113.43 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 87.44 17.8 58.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.959 -0.639 . . . . 75.31 113.68 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 12.2 tt -137.37 141.73 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 122.57 0.348 . . . . 72.5 110.617 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.475 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -65.68 136.31 36.1 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.139 -0.553 . . . . 64.0 113.612 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.513 HG11 HD11 ' A' ' 440' ' ' LEU . 38.5 t -129.88 112.97 17.48 Favored Pre-proline 0 N--CA 1.471 0.58 0 N-CA-C 112.515 0.561 . . . . 62.43 112.515 -176.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.77 -11.41 12.64 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.236 2.624 . . . . 63.43 112.22 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 70.1 m -80.18 11.61 3.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.5 0.72 . . . . 73.34 112.161 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 33.5 m -88.28 90.83 8.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.849 0.833 . . . . 71.13 111.073 -169.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -106.02 123.16 47.56 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.194 -0.912 . . . . 61.11 110.272 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.638 HG21 HG11 ' A' ' 462' ' ' VAL . 39.2 t -103.71 121.02 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.826 0.346 . . . . 70.34 110.904 -177.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 476' ' ' ARG . 33.3 ttm180 -129.13 144.96 51.38 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.694 0.283 . . . . 75.31 111.656 -174.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 66.3 t -120.5 130.27 74.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.071 0.463 . . . . 71.2 111.722 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -119.52 137.04 54.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.96 -0.564 . . . . 74.4 111.177 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 513' ' ' ILE . 59.2 mt -111.94 107.76 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.712 0.292 . . . . 61.22 110.32 174.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 57.29 34.87 25.38 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.929 0.395 . . . . 52.14 111.31 -175.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.95 -2.18 85.47 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.336 -0.459 . . . . 25.22 113.398 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 63.1 m -90.25 123.42 34.03 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 122.606 -0.349 . . . . 54.33 111.389 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . 0.403 HD13 ' HD3' ' A' ' 476' ' ' ARG . 44.4 tp -63.88 115.06 4.49 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.98 0.419 . . . . 74.14 111.0 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -105.05 -44.05 4.89 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.102 0.779 . . . . 72.0 113.102 -175.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -165.88 161.02 17.45 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 122.168 -0.332 . . . . 70.12 111.17 -172.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . 0.561 HD22 ' N ' ' A' ' 486' ' ' ASN . 0.0 OUTLIER -161.1 154.32 21.46 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.826 0.676 . . . . 74.02 112.826 177.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -136.0 149.79 48.97 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.687 0.795 . . . . 72.4 110.44 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.2 m -115.08 119.41 36.35 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.9 0.381 . . . . 74.45 111.21 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 28.9 m -137.57 173.56 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.158 0.504 . . . . 73.22 111.695 -176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 95.3 p -125.57 135.11 51.88 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.871 0.367 . . . . 75.25 110.882 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.473 HD12 HD22 ' A' ' 440' ' ' LEU . 94.9 mt -117.63 120.1 37.01 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.455 -0.339 . . . . 75.31 111.24 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.475 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -77.78 -170.09 34.62 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.223 -0.513 . . . . 24.44 113.279 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.56 97.03 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.341 2.027 . . . . 74.45 112.445 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.6 mttt 66.29 59.61 0.65 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.853 0.835 . . . . 74.55 111.791 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -120.85 152.94 37.8 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.046 -0.979 . . . . 74.31 110.651 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 463' ' ' LYS . 39.5 tt0 -134.63 137.25 43.5 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.936 0.398 . . . . 64.22 111.931 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.444 ' HG2' ' CD2' ' A' ' 491' ' ' LEU . 28.5 mmmt -116.94 150.3 38.74 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.203 -0.453 . . . . 75.45 110.241 174.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 60.5 t -114.4 113.56 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.925 0.393 . . . . 72.14 111.555 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 77.9 mt -110.51 136.07 50.21 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.24 -0.436 . . . . 74.51 111.314 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 41.0 p -117.91 150.62 38.91 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.094 0.473 . . . . 62.42 111.943 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -145.63 151.61 38.35 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.248 -0.433 . . . . 74.42 111.02 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.56 ' HB2' HD11 ' A' ' 455' ' ' LEU . 72.9 p -111.67 141.47 45.22 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.28 -0.418 . . . . 53.43 111.297 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.5 t90 -139.34 137.49 35.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.281 -0.418 . . . . 74.35 111.094 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 89.1 m -118.2 100.43 51.75 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-O 120.758 0.313 . . . . 74.14 111.277 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -77.99 102.99 1.63 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.519 2.146 . . . . 71.0 112.841 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 81.1 p -81.58 -1.21 45.57 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.167 0.432 . . . . 74.55 112.167 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -137.24 145.74 43.94 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.711 0.291 . . . . 74.3 111.316 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.484 ' HA ' ' HB ' ' A' ' 539' ' ' VAL . 0.3 OUTLIER -83.19 152.03 25.41 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.516 0.561 . . . . 52.32 112.516 -177.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.63 -176.32 30.07 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.038 -0.601 . . . . 53.22 113.694 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 1.2 tpt -92.56 106.28 18.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.536 0.335 . . . . 72.43 110.669 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -107.66 121.9 45.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.179 0.514 . . . . 72.32 111.795 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . 0.505 ' HD2' HG23 ' A' ' 534' ' ' THR . 19.6 tpp85 -94.21 112.74 24.56 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.188 -0.46 . . . . 74.14 111.52 177.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 479' ' ' ILE . 40.6 mt -98.75 127.24 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.068 0.461 . . . . 74.3 110.858 175.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -124.09 138.15 54.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.335 -0.393 . . . . 72.3 111.553 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -111.94 132.48 54.73 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.832 -0.433 . . . . 75.15 109.832 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 38.9 p -132.93 141.1 48.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.352 -0.385 . . . . 75.51 111.497 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.419 HG13 HD22 ' A' ' 531' ' ' ASN . 7.7 p -110.55 140.05 31.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.762 0.315 . . . . 72.24 110.949 175.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 41.2 t0 43.98 67.9 0.6 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.517 0.675 . . . . 62.11 111.594 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -55.8 -31.67 62.85 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.821 -0.627 . . . . 72.05 112.246 176.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.452 ' HB2' HG23 ' A' ' 522' ' ' THR . 8.4 mm-40 -78.17 -19.29 54.25 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.276 -0.42 . . . . 72.24 111.518 -178.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 62.16 46.62 6.14 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.742 0.782 . . . . 73.15 110.011 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . 0.452 HG23 ' HB2' ' A' ' 520' ' ' GLU . 52.1 p -67.59 -37.76 83.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.486 -0.779 . . . . 73.35 111.588 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.468 HG21 ' HG2' ' A' ' 438' ' ' PRO . 10.7 p -102.33 143.91 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 116.096 -0.502 . . . . 74.45 110.993 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . 0.459 ' O ' ' HD2' ' A' ' 438' ' ' PRO . 59.1 t -81.87 115.62 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.992 0.425 . . . . 74.13 111.119 -177.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -91.75 155.96 17.89 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.888 -0.596 . . . . 73.22 112.32 -173.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.19 -39.53 78.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.145 0.498 . . . . 73.53 110.472 173.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -133.92 113.35 12.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.832 -0.622 . . . . 73.3 110.495 174.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -83.17 -3.43 57.36 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.318 0.58 . . . . 74.12 111.379 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -92.54 -1.64 56.79 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.982 0.42 . . . . 75.43 111.306 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.603 ' ND2' ' HB ' ' A' ' 441' ' ' THR . 65.5 t30 -95.82 -6.65 39.0 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 116.345 -0.388 . . . . 70.34 112.0 -174.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . 0.419 HD22 HG13 ' A' ' 517' ' ' VAL . 11.5 m120 -83.66 3.92 30.83 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.54 0.941 . . . . 71.21 113.54 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 52.4 t -126.86 142.21 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 112.798 0.666 . . . . 70.12 112.798 -173.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . 0.472 ' HB2' HG23 ' A' ' 442' ' ' VAL . . . -128.58 143.96 51.06 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.119 -0.491 . . . . 71.41 111.232 176.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . 0.505 HG23 ' HD2' ' A' ' 512' ' ' ARG . 59.6 m -120.66 134.12 55.31 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 111.94 0.348 . . . . 72.01 111.94 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -142.5 136.88 29.8 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 120.713 0.292 . . . . 74.31 111.067 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -104.87 125.01 50.45 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.662 0.268 . . . . 55.33 111.692 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 61.6 t -114.3 128.77 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.8 0.333 . . . . 62.35 111.28 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 30.1 t -112.88 121.59 45.12 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.655 0.264 . . . . 65.23 111.02 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.484 ' HB ' ' HA ' ' A' ' 508' ' ' GLU . 41.9 t -98.93 131.43 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.691 0.281 . . . . 54.43 111.353 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.435 ' HB ' ' HG2' ' A' ' 542' ' ' GLU . 28.8 m -113.16 156.32 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 N-CA-C 112.226 0.454 . . . . 74.21 112.226 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 94.9 mt -95.57 -13.36 24.48 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.323 -0.399 . . . . 74.3 111.652 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . 0.435 ' HG2' ' HB ' ' A' ' 540' ' ' VAL . 8.3 pt-20 . . . . . 0 C--O 1.249 1.055 0 N-CA-C 112.449 0.537 . . . . 61.21 112.449 -176.694 . . . . . . . . 1 1 . 1 stop_ save_